Clustering O 0 0.23097479343414307
of O 0 0.05839576572179794
missense O 0 0.26889902353286743
mutations O 0 0.17967677116394043
in O 0 0.03972398489713669
the O 0 0.056196726858615875
ataxia B-Disease 1 0.9999985694885254
- I-Disease 1 0.9937924742698669
telangiectasia I-Disease 1 0.9996374845504761
gene O 0 0.13968148827552795
in O 0 0.03430155664682388
a O 0 0.05561601370573044
sporadic B-Disease 1 0.8672699332237244
T I-Disease 1 0.9998877048492432
- I-Disease 1 0.9694764018058777
cell I-Disease 1 0.9357916116714478
leukaemia I-Disease 1 0.9999415874481201
. O 0 0.07153608649969101

Ataxia B-Disease 1 0.9999970197677612
- I-Disease 1 0.9986742734909058
telangiectasia I-Disease 1 0.9999178647994995
( O 0 0.13080081343650818
A B-Disease 1 0.6022239327430725
- I-Disease 1 0.964191734790802
T I-Disease 1 0.9986271858215332
) O 0 0.04655162990093231
is O 0 0.027668500319123268
a O 0 0.04320121556520462
recessive B-Disease 1 0.9990677237510681
multi I-Disease 1 0.9966076612472534
- I-Disease 1 0.9955775737762451
system I-Disease 1 0.7616451382637024
disorder I-Disease 1 0.9999922513961792
caused O 0 0.17875762283802032
by O 0 0.032101746648550034
mutations O 0 0.12221594899892807
in O 0 0.025475038215517998
the O 0 0.033601731061935425
ATM O 0 0.16877742111682892
gene O 0 0.12175571173429489
at O 0 0.057147685438394547
11q22 O 0 0.47841185331344604
- O 0 0.16392254829406738
q23 O 0 0.22663676738739014
( O 0 0.07829024642705917
ref O 0 0.1780932992696762
. O 0 0.03123912587761879
3 O 0 0.05049864202737808
) O 0 0.044733572751283646
. O 0 0.04085404425859451

The O 0 0.052521709352731705
risk O 0 0.41663315892219543
of O 0 0.03757626190781593
cancer B-Disease 1 0.9999450445175171
, O 0 0.037984687834978104
especially O 0 0.058367494493722916
lymphoid B-Disease 1 0.9928843975067139
neoplasias I-Disease 1 0.5845682621002197
, O 0 0.027080368250608444
is O 0 0.02475387044250965
substantially O 0 0.06294520944356918
elevated O 0 0.09711062908172607
in O 0 0.02889126166701317
A B-Disease 1 0.9010770320892334
- I-Disease 1 0.9991527795791626
T I-Disease 1 0.9999804496765137
patients O 1 0.9989824891090393
and O 0 0.021453432738780975
has O 0 0.022984638810157776
long O 0 0.036166977137327194
been O 0 0.020892856642603874
associated O 0 0.035823043435811996
with O 0 0.03698830306529999
chromosomal O 1 0.9923315048217773
instability O 1 0.9690161347389221
. O 0 0.06583420187234879

By O 0 0.0693635568022728
analysing O 0 0.2091125100851059
tumour B-Disease 1 0.9998989105224609
DNA O 0 0.12585674226284027
from O 0 0.044829316437244415
patients O 1 0.9978004097938538
with O 0 0.04344860464334488
sporadic B-Disease 1 0.9148273468017578
T I-Disease 1 0.9998675584793091
- I-Disease 1 0.9304404258728027
cell I-Disease 1 0.877427875995636
prolymphocytic I-Disease 1 0.9987315535545349
leukaemia I-Disease 1 0.9999991655349731
( O 1 0.8873034715652466
T B-Disease 1 0.999909520149231
- I-Disease 1 0.928820788860321
PLL I-Disease 1 0.9988849759101868
) O 0 0.043991196900606155
, O 0 0.02340371161699295
a O 0 0.03829508274793625
rare O 0 0.09346392005681992
clonal B-Disease 1 0.5685983896255493
malignancy I-Disease 1 0.9941628575325012
with O 0 0.02941093221306801
similarities O 0 0.05207432061433792
to O 0 0.023865122348070145
a O 0 0.04275699332356453
mature B-Disease 1 0.9008024334907532
T I-Disease 1 0.9998705387115479
- I-Disease 1 0.9377396106719971
cell I-Disease 1 0.8309925198554993
leukaemia I-Disease 1 0.9999510049819946
seen O 0 0.05457707867026329
in O 0 0.030885936692357063
A B-Disease 0 0.21145763993263245
- I-Disease 1 0.92962646484375
T I-Disease 1 0.9987471103668213
, O 0 0.02215658687055111
we O 0 0.017422912642359734
demonstrate O 0 0.036772049963474274
a O 0 0.025669032707810402
high O 0 0.04129427671432495
frequency O 0 0.06290549784898758
of O 0 0.026370108127593994
ATM O 0 0.1709119826555252
mutations O 0 0.17427082359790802
in O 0 0.055026825517416
T B-Disease 1 0.999319314956665
- I-Disease 1 0.7702901363372803
PLL I-Disease 1 0.9938888549804688
. O 0 0.08273743093013763

In O 0 0.043496303260326385
marked O 0 0.058974213898181915
contrast O 0 0.053166989237070084
to O 0 0.02226780354976654
the O 0 0.03362781181931496
ATM O 0 0.18044467270374298
mutation O 0 0.17468374967575073
pattern O 0 0.09184655547142029
in O 0 0.032406698912382126
A B-Disease 0 0.25882473587989807
- I-Disease 1 0.9243766665458679
T I-Disease 1 0.9977759718894958
, O 0 0.021628547459840775
the O 0 0.01590849831700325
most O 0 0.019639894366264343
frequent O 0 0.07690449059009552
nucleotide O 0 0.0963606908917427
changes O 0 0.03125784173607826
in O 0 0.02351210080087185
this O 0 0.032593291252851486
leukaemia B-Disease 1 0.9998829364776611
were O 0 0.04907180741429329
missense O 0 0.3212648332118988
mutations O 0 0.24124208092689514
. O 0 0.06778469681739807

These O 0 0.03362298011779785
clustered O 0 0.07790292054414749
in O 0 0.01981399394571781
the O 0 0.01903194561600685
region O 0 0.03890325501561165
corresponding O 0 0.036400340497493744
to O 0 0.01889078877866268
the O 0 0.02804461121559143
kinase O 0 0.1641351878643036
domain O 0 0.04577365145087242
, O 0 0.017584454268217087
which O 0 0.016395363956689835
is O 0 0.019662192091345787
highly O 0 0.037888094782829285
conserved O 0 0.06119448319077492
in O 0 0.034039728343486786
ATM O 0 0.18439412117004395
- O 0 0.10024109482765198
related O 0 0.05696423351764679
proteins O 0 0.07143095880746841
in O 0 0.03131387010216713
mouse O 0 0.13546478748321533
, O 0 0.0344722606241703
yeast O 0 0.1397823840379715
and O 0 0.037411365658044815
Drosophila O 0 0.15242306888103485
. O 0 0.06062493473291397

The O 0 0.05159207805991173
resulting O 0 0.10909925401210785
amino O 0 0.12966789305210114
- O 0 0.15481500327587128
acid O 0 0.17107397317886353
substitutions O 0 0.08706380426883698
are O 0 0.022350570186972618
predicted O 0 0.0449468269944191
to O 0 0.01921240985393524
interfere O 0 0.0607362799346447
with O 0 0.031120283529162407
ATP O 0 0.1713217943906784
binding O 0 0.07718392461538315
or O 0 0.044062286615371704
substrate O 0 0.11592914164066315
recognition O 0 0.07252911478281021
. O 0 0.05101726949214935

Two O 0 0.03893512859940529
of O 0 0.03468885272741318
seventeen O 0 0.1103409081697464
mutated O 1 0.8613959550857544
T B-Disease 1 0.9992684721946716
- I-Disease 0 0.3971227705478668
PLL I-Disease 1 0.9785519242286682
samples O 0 0.07309079170227051
had O 0 0.028046786785125732
a O 0 0.02568468637764454
previously O 0 0.03788761422038078
reported O 0 0.054515477269887924
A B-Disease 0 0.09901981055736542
- I-Disease 1 0.889214813709259
T I-Disease 1 0.9982659220695496
allele O 0 0.2649112045764923
. O 0 0.07041474431753159

In O 0 0.04018721729516983
contrast O 0 0.064319908618927
, O 0 0.02583981491625309
no O 0 0.03050549514591694
mutations O 0 0.0969768613576889
were O 0 0.019221993163228035
detected O 0 0.06918898224830627
in O 0 0.020525328814983368
the O 0 0.032255128026008606
p53 O 0 0.19281025230884552
gene O 0 0.10567042231559753
, O 0 0.02764252759516239
suggesting O 0 0.052390795201063156
that O 0 0.022082757204771042
this O 0 0.03641241788864136
tumour B-Disease 1 0.9999591112136841
suppressor O 1 0.8794767260551453
is O 0 0.02698501944541931
not O 0 0.017479559406638145
frequently O 0 0.039130330085754395
altered O 0 0.05480659380555153
in O 0 0.02610558457672596
this O 0 0.03788944333791733
leukaemia B-Disease 1 0.9999184608459473
. O 0 0.07153857499361038

Occasional O 0 0.1959429681301117
missense O 0 0.3166959881782532
mutations O 0 0.1843823343515396
in O 0 0.04085103049874306
ATM O 0 0.11538160592317581
were O 0 0.01751851849257946
also O 0 0.017527712509036064
found O 0 0.029100744053721428
in O 0 0.033987145870923996
tumour B-Disease 1 0.999915599822998
DNA O 0 0.10446853935718536
from O 0 0.038560088723897934
patients O 1 0.9956614375114441
with O 0 0.0425555557012558
B B-Disease 1 0.9385809898376465
- I-Disease 1 0.6422020792961121
cell I-Disease 0 0.48804858326911926
non I-Disease 1 0.5554233193397522
- I-Disease 1 0.9987043142318726
Hodgkins I-Disease 1 0.9999992847442627
lymphomas I-Disease 1 0.99993896484375
( O 0 0.12877976894378662
B B-Disease 1 0.681083619594574
- I-Disease 0 0.11672258377075195
NHL I-Disease 0 0.09827765077352524
) O 0 0.03565216809511185
and O 0 0.021893955767154694
a O 0 0.04057151824235916
B B-Disease 0 0.17812003195285797
- I-Disease 0 0.11950429528951645
NHL I-Disease 0 0.12722550332546234
cell O 0 0.11067107319831848
line O 0 0.06153389811515808
. O 0 0.04500778019428253

The O 0 0.029858965426683426
evidence O 0 0.026233280077576637
of O 0 0.013853213749825954
a O 0 0.02284534089267254
significant O 0 0.029804116114974022
proportion O 0 0.04476189985871315
of O 0 0.020989857614040375
loss O 0 0.10515082627534866
- O 0 0.08248014003038406
of O 0 0.026562687009572983
- O 0 0.10830798745155334
function O 0 0.06925316900014877
mutations O 0 0.11154200881719589
and O 0 0.01845533959567547
a O 0 0.02317938208580017
complete O 0 0.030032603070139885
absence O 0 0.03651060163974762
of O 0 0.013260004110634327
the O 0 0.01789187267422676
normal O 0 0.045203130692243576
copy O 0 0.0330316387116909
of O 0 0.01815648563206196
ATM O 0 0.08109793812036514
in O 0 0.01569673791527748
the O 0 0.01690683513879776
majority O 0 0.031415436416864395
of O 0 0.032001737505197525
mutated O 1 0.9432578682899475
tumours B-Disease 1 0.9999419450759888
establishes O 1 0.7270774841308594
somatic O 1 0.7467241287231445
inactivation O 0 0.18901227414608002
of O 0 0.022460758686065674
this O 0 0.025027243420481682
gene O 0 0.07613763213157654
in O 0 0.020975179970264435
the O 0 0.029159514233469963
pathogenesis O 1 0.985957145690918
of O 0 0.046857964247465134
sporadic B-Disease 1 0.9052587151527405
T I-Disease 1 0.9997413754463196
- I-Disease 1 0.6291437745094299
PLL I-Disease 1 0.9944818019866943
and O 0 0.034517206251621246
suggests O 0 0.057638660073280334
that O 0 0.02363721840083599
ATM O 0 0.11676257848739624
acts O 0 0.043762799352407455
as O 0 0.02443680539727211
a O 0 0.06528361141681671
tumour B-Disease 1 0.9999489784240723
suppressor O 1 0.9471653699874878
. O 0 0.07312706112861633

As O 0 0.03595803678035736
constitutional O 0 0.0425918884575367
DNA O 0 0.06356453150510788
was O 0 0.020176464691758156
not O 0 0.013766778632998466
available O 0 0.016393940895795822
, O 0 0.017882240936160088
a O 0 0.036791570484638214
putative O 0 0.1920223981142044
hereditary O 1 0.981186032295227
predisposition O 1 0.9957362413406372
to O 0 0.05709664151072502
T B-Disease 1 0.9998517036437988
- I-Disease 1 0.8637836575508118
PLL I-Disease 1 0.9968882203102112
will O 0 0.030371088534593582
require O 0 0.04008254036307335
further O 0 0.02907928265631199
investigation O 0 0.04761071130633354
. O 0 0.02658519335091114
. O 0 0.040427230298519135

Myotonic B-Disease 1 0.9999985694885254
dystrophy I-Disease 1 0.9999997615814209
protein O 0 0.47343629598617554
kinase O 0 0.47975820302963257
is O 0 0.029963016510009766
involved O 0 0.030061893165111542
in O 0 0.015766272321343422
the O 0 0.019909415394067764
modulation O 0 0.11200575530529022
of O 0 0.022723792120814323
the O 0 0.044359657913446426
Ca2 O 1 0.9853453040122986
+ O 1 0.8630244731903076
homeostasis O 1 0.9712604880332947
in O 0 0.06433220952749252
skeletal O 1 0.9989884495735168
muscle O 1 0.9993409514427185
cells O 0 0.47388654947280884
. O 0 0.05913228541612625

Myotonic B-Disease 1 0.9999998807907104
dystrophy I-Disease 1 1.0
( O 1 0.9888941645622253
DM B-Disease 1 0.9999985694885254
) O 0 0.043888065963983536
, O 0 0.01875312440097332
the O 0 0.020192831754684448
most O 0 0.033762551844120026
prevalent O 1 0.9906396865844727
muscular B-Disease 1 0.9999972581863403
disorder I-Disease 1 0.9999945163726807
in O 0 0.03342658281326294
adults O 0 0.0800209492444992
, O 0 0.024976689368486404
is O 0 0.026484031230211258
caused O 0 0.07338499277830124
by O 0 0.02796020358800888
( O 0 0.06842013448476791
CTG O 1 0.9757699966430664
) O 0 0.06567408889532089
n O 0 0.10896694660186768
- O 0 0.10446006059646606
repeat O 0 0.10623233020305634
expansion O 0 0.05543395131826401
in O 0 0.021888500079512596
a O 0 0.03711424395442009
gene O 0 0.10122019797563553
encoding O 0 0.08572587370872498
a O 0 0.05778155475854874
protein O 0 0.16821831464767456
kinase O 1 0.9428723454475403
( O 0 0.14997875690460205
DM B-Disease 1 0.9999905824661255
protein O 0 0.23249442875385284
kinase O 1 0.9051896333694458
; O 0 0.06465547531843185
DMPK O 1 0.5193865299224854
) O 0 0.03548407927155495
and O 0 0.01898859441280365
involves O 0 0.05466091260313988
changes O 0 0.03604155406355858
in O 0 0.028792116791009903
cytoarchitecture O 0 0.17501649260520935
and O 0 0.039644502103328705
ion O 0 0.22821439802646637
homeostasis O 1 0.9094371199607849
. O 0 0.05999951437115669

To O 0 0.034764423966407776
obtain O 0 0.043338388204574585
clues O 0 0.052188385277986526
to O 0 0.015390235930681229
the O 0 0.018024174496531487
normal O 0 0.047224968671798706
biological O 0 0.04480760172009468
role O 0 0.032246217131614685
of O 0 0.02155718207359314
DMPK O 0 0.44803673028945923
in O 0 0.03647719696164131
cellular O 0 0.13100774586200714
ion O 0 0.30264484882354736
homeostasis O 1 0.7471272945404053
, O 0 0.023572247475385666
we O 0 0.016876963898539543
have O 0 0.01589355058968067
compared O 0 0.03649328649044037
the O 0 0.02976207435131073
resting O 0 0.44036605954170227
[ O 0 0.21215267479419708
Ca2 O 1 0.9922335147857666
+ O 1 0.8223891854286194
] O 0 0.09307802468538284
i O 0 0.02975502796471119
, O 0 0.01293785311281681
the O 0 0.017563721165060997
amplitude O 0 0.07415695488452911
and O 0 0.02083544246852398
shape O 0 0.060958124697208405
of O 0 0.03329770639538765
depolarization O 1 0.9986730813980103
- O 1 0.990254819393158
induced O 1 0.9992774128913879
Ca2 O 1 0.9967789053916931
+ O 1 0.8708518147468567
transients O 0 0.4979369044303894
, O 0 0.02398715168237686
and O 0 0.014144171960651875
the O 0 0.01627870462834835
content O 0 0.02624691277742386
of O 0 0.023462558165192604
ATP O 1 0.695700466632843
- O 0 0.13731281459331512
driven O 0 0.11998333781957626
ion O 0 0.17567671835422516
pumps O 0 0.1693839430809021
in O 0 0.05038590729236603
cultured O 0 0.4785405695438385
skeletal O 1 0.9989087581634521
muscle O 1 0.9992183446884155
cells O 0 0.13409167528152466
of O 0 0.028770949691534042
wild O 0 0.07926202565431595
- O 0 0.11838046461343765
type O 0 0.10143785178661346
and O 0 0.04352211952209473
DMPK O 1 0.9951748251914978
[ O 1 0.8467435836791992
- O 1 0.9789624810218811
/ O 1 0.9973637461662292
- O 0 0.3198837637901306
] O 0 0.16469639539718628
knockout O 0 0.23325316607952118
mice O 0 0.23177029192447662
. O 0 0.06430553644895554

In O 0 0.06577182561159134
vitro O 0 0.20587146282196045
- O 0 0.19358453154563904
differentiated O 0 0.3451065421104431
DMPK O 1 0.9972519278526306
[ O 1 0.8934524655342102
- O 1 0.9840720295906067
/ O 1 0.9970744848251343
- O 0 0.23244372010231018
] O 0 0.14778539538383484
myotubes O 0 0.1901465803384781
exhibit O 0 0.0804157555103302
a O 0 0.04312855750322342
higher O 0 0.06594410538673401
resting O 0 0.25224176049232483
[ O 0 0.1641906499862671
Ca2 O 1 0.99068284034729
+ O 1 0.7646137475967407
] O 0 0.11870257556438446
i O 0 0.0393795520067215
than O 0 0.02197134681046009
do O 0 0.029638510197401047
wild O 0 0.07031609863042831
- O 0 0.1203739196062088
type O 0 0.10257666558027267
myotubes O 0 0.14534233510494232
because O 0 0.02559039369225502
of O 0 0.013931138440966606
an O 0 0.020041173323988914
altered O 0 0.058413758873939514
open O 0 0.04830468073487282
probability O 0 0.052595093846321106
of O 0 0.026456454768776894
voltage O 0 0.1090088039636612
- O 0 0.13327345252037048
dependent O 0 0.14038653671741486
l O 1 0.9881397485733032
- O 0 0.43581053614616394
type O 0 0.2222210019826889
Ca2 O 1 0.9799601435661316
+ O 0 0.3104863464832306
and O 0 0.05250697582960129
Na O 1 0.6559979319572449
+ O 0 0.18718819320201874
channels O 0 0.08079583942890167
. O 0 0.05671101436018944

The O 0 0.06274113059043884
mutant O 0 0.1864003837108612
myotubes O 0 0.23002760112285614
exhibit O 0 0.08937618881464005
smaller O 0 0.051101185381412506
and O 0 0.035478025674819946
slower O 0 0.1159607395529747
Ca2 O 1 0.9718915820121765
+ O 0 0.22401446104049683
responses O 0 0.09674430638551712
upon O 0 0.04494841769337654
triggering O 0 0.13292823731899261
by O 0 0.045729879289865494
acetylcholine O 0 0.25497889518737793
or O 0 0.04848726466298103
high O 0 0.055057212710380554
external O 0 0.08183621615171432
K O 1 0.5362897515296936
+ O 0 0.19541248679161072
. O 0 0.06016651540994644

In O 0 0.03570950776338577
addition O 0 0.034951403737068176
, O 0 0.021272214129567146
we O 0 0.02047104574739933
observed O 0 0.037190958857536316
that O 0 0.018330581486225128
these O 0 0.03244408592581749
Ca2 O 1 0.9887386560440063
+ O 1 0.8300193548202515
transients O 1 0.9033342003822327
partially O 0 0.09243413805961609
result O 0 0.044700078666210175
from O 0 0.020868580788373947
an O 0 0.02111898548901081
influx O 0 0.08685126900672913
of O 0 0.03231850638985634
extracellular O 0 0.1893177628517151
Ca2 O 1 0.9465258717536926
+ O 0 0.16377903521060944
through O 0 0.04363926872611046
the O 0 0.039563652127981186
l O 1 0.9777927398681641
- O 0 0.2366684377193451
type O 0 0.18145233392715454
Ca2 O 1 0.9497681856155396
+ O 0 0.20919184386730194
channel O 0 0.10243921726942062
. O 0 0.060113102197647095

Neither O 0 0.067867711186409
the O 0 0.026543734595179558
content O 0 0.03399510309100151
nor O 0 0.03959226980805397
the O 0 0.020273255184292793
activity O 0 0.045274440199136734
of O 0 0.03414543345570564
Na O 1 0.9945871829986572
+ O 1 0.982900083065033
/ O 1 0.9892409443855286
K O 1 0.718779981136322
+ O 1 0.5843074917793274
ATPase O 1 0.930185079574585
and O 0 0.08196242153644562
sarcoplasmic O 1 0.9994341731071472
reticulum O 1 0.9979673027992249
Ca2 O 1 0.9981673955917358
+ O 1 0.9795841574668884
- O 0 0.24532079696655273
ATPase O 1 0.7912309765815735
are O 0 0.03623552992939949
affected O 0 0.07825937122106552
by O 0 0.04144512489438057
DMPK O 1 0.7330983281135559
absence O 0 0.09382056444883347
. O 0 0.05796277895569801

In O 0 0.03774286061525345
conclusion O 0 0.04397697374224663
, O 0 0.01770150102674961
our O 0 0.020182721316814423
data O 0 0.02405242621898651
suggest O 0 0.03653454780578613
that O 0 0.02010895311832428
DMPK O 0 0.2110164761543274
is O 0 0.021333105862140656
involved O 0 0.02843155339360237
in O 0 0.020601488649845123
modulating O 0 0.14920690655708313
the O 0 0.02628704532980919
initial O 0 0.056340985000133514
events O 0 0.035741448402404785
of O 0 0.029203098267316818
excitation O 1 0.7767714262008667
- O 0 0.25729286670684814
contraction O 1 0.6058904528617859
coupling O 0 0.1677459478378296
in O 0 0.05309924855828285
skeletal O 1 0.9994581341743469
muscle O 1 0.9983327984809875
. O 0 0.040897566825151443
. O 0 0.0489078126847744

Constitutional O 0 0.14219345152378082
RB1 O 1 0.999818742275238
- O 1 0.841070294380188
gene O 0 0.22335977852344513
mutations O 0 0.20313136279582977
in O 0 0.041076019406318665
patients O 1 0.9976872205734253
with O 0 0.04484597221016884
isolated O 0 0.14697498083114624
unilateral B-Disease 0 0.3551137149333954
retinoblastoma I-Disease 1 0.999194324016571
. O 0 0.07933906465768814

In O 0 0.04293041303753853
most O 0 0.03531603515148163
patients O 1 0.9955854415893555
with O 0 0.038560934364795685
isolated O 0 0.15745165944099426
unilateral B-Disease 1 0.6057446002960205
retinoblastoma I-Disease 1 0.9998983144760132
, O 0 0.05053921788930893
tumor B-Disease 1 0.998468816280365
development O 0 0.04243385046720505
is O 0 0.025892559438943863
initiated O 0 0.062003977596759796
by O 0 0.03153868019580841
somatic O 0 0.1813402622938156
inactivation O 0 0.15034489333629608
of O 0 0.021691402420401573
both O 0 0.025552328675985336
alleles O 0 0.13868923485279083
of O 0 0.02910756506025791
the O 0 0.052160944789648056
RB1 O 1 0.9981004595756531
gene O 0 0.17574815452098846
. O 0 0.06315148621797562

However O 0 0.032175421714782715
, O 0 0.01725613698363304
some O 0 0.012070996686816216
of O 0 0.015499143861234188
these O 0 0.02398615889251232
patients O 1 0.9988725781440735
can O 0 0.04413910210132599
transmit O 0 0.15636871755123138
retinoblastoma B-Disease 1 0.9996223449707031
predisposition O 1 0.9286996722221375
to O 0 0.022691134363412857
their O 0 0.026807863265275955
offspring O 0 0.1212155818939209
. O 0 0.05304177477955818

To O 0 0.033477798104286194
determine O 0 0.03955446183681488
the O 0 0.023256663233041763
frequency O 0 0.05545230582356453
and O 0 0.017961179837584496
nature O 0 0.035080987960100174
of O 0 0.020926564931869507
constitutional O 0 0.06766436994075775
RB1 O 1 0.9998177886009216
- O 1 0.6949924230575562
gene O 0 0.19469816982746124
mutations O 0 0.1821785867214203
in O 0 0.04048379883170128
patients O 1 0.9988766312599182
with O 0 0.036785565316677094
isolated O 0 0.13470689952373505
unilateral B-Disease 0 0.2267725020647049
retinoblastoma I-Disease 1 0.998988687992096
, O 0 0.030387762933969498
we O 0 0.02287554368376732
analyzed O 0 0.05592143535614014
DNA O 0 0.07534412294626236
from O 0 0.03703781217336655
peripheral O 1 0.9817673563957214
blood O 1 0.8373968601226807
and O 0 0.029096420854330063
from O 0 0.049962978810071945
tumor B-Disease 1 0.9998718500137329
tissue O 1 0.9887131452560425
. O 0 0.0677965059876442

The O 0 0.04557827487587929
analysis O 0 0.058986831456422806
of O 0 0.0335291288793087
tumors B-Disease 1 0.9994304776191711
from O 0 0.0384003110229969
54 O 0 0.07570278644561768
( O 0 0.0525682233273983
71 O 0 0.0717647597193718
% O 0 0.03545418381690979
) O 0 0.0294618122279644
of O 0 0.02097373642027378
76 O 0 0.09660807251930237
informative O 0 0.11246158927679062
patients O 1 0.9971720576286316
showed O 0 0.05616790056228638
loss O 0 0.06478932499885559
of O 0 0.021415825933218002
constitutional O 0 0.05873128026723862
heterozygosity O 1 0.9966753721237183
( O 0 0.1490393728017807
LOH O 1 0.9996817111968994
) O 0 0.05873696506023407
at O 0 0.05540815368294716
intragenic O 0 0.3803544044494629
loci O 0 0.24721919000148773
. O 0 0.06908692419528961

Three O 0 0.04030045121908188
of O 0 0.03163536265492439
13 O 0 0.07245004922151566
uninformative O 1 0.9963112473487854
patients O 1 0.9973430037498474
had O 0 0.0389535017311573
constitutional O 0 0.05036976933479309
deletions O 0 0.1318417638540268
. O 0 0.056455351412296295

For O 0 0.04267245903611183
39 O 0 0.0814327597618103
randomly O 0 0.08507842570543289
selected O 0 0.06982086598873138
tumors B-Disease 1 0.9994598031044006
, O 0 0.0551750473678112
SSCP O 1 0.9754641056060791
, O 0 0.06498204171657562
hetero O 1 0.9987071752548218
- O 0 0.2519516050815582
duplex O 1 0.5300363898277283
analysis O 0 0.05804796144366264
, O 0 0.02773808315396309
sequencing O 0 0.064706951379776
, O 0 0.01786307990550995
and O 0 0.017247965559363365
Southern O 0 0.04211179539561272
blot O 0 0.14042292535305023
analysis O 0 0.03975346311926842
were O 0 0.01610737107694149
used O 0 0.0216385331004858
to O 0 0.022741016000509262
identify O 0 0.0708284080028534
mutations O 0 0.16353705525398254
. O 0 0.05707788094878197

Mutations O 0 0.21439529955387115
were O 0 0.03622055426239967
detected O 0 0.09433257579803467
in O 0 0.02509196847677231
21 O 0 0.04449981078505516
( O 0 0.045394156128168106
91 O 0 0.07927402853965759
% O 0 0.03866562619805336
) O 0 0.027589580044150352
of O 0 0.021100038662552834
23 O 0 0.07396678626537323
tumors B-Disease 1 0.9999433755874634
with O 0 0.06031090393662453
LOH O 1 0.9996991157531738
. O 0 0.06460446864366531

In O 0 0.05247236415743828
6 O 0 0.07181081175804138
( O 0 0.05025237798690796
38 O 0 0.06041697785258293
% O 0 0.03828369826078415
) O 0 0.030457181856036186
of O 0 0.021058838814496994
16 O 0 0.05701373890042305
tumors B-Disease 1 0.9999531507492065
without O 0 0.059744685888290405
LOH O 1 0.9995496869087219
, O 0 0.03423266485333443
one O 0 0.03427322581410408
mutation O 0 0.1333256959915161
was O 0 0.03377499803900719
detected O 0 0.08221472054719925
, O 0 0.01617707870900631
and O 0 0.013969555497169495
in O 0 0.0179973803460598
9 O 0 0.0420210175216198
( O 0 0.036115117371082306
56 O 0 0.051288705319166183
% O 0 0.03209293633699417
) O 0 0.024078931659460068
of O 0 0.016805551946163177
the O 0 0.035648178309202194
tumors B-Disease 1 0.9999899864196777
without O 0 0.056084781885147095
LOH O 1 0.9995081424713135
, O 0 0.02951928973197937
both O 0 0.025755904614925385
mutations O 0 0.11115694046020508
were O 0 0.02255873568356037
found O 0 0.03722217306494713
. O 0 0.04291429743170738

Thus O 0 0.05249842628836632
, O 0 0.020929500460624695
a O 0 0.021176528185606003
total O 0 0.025346703827381134
of O 0 0.019179051741957664
45 O 0 0.0551740936934948
mutations O 0 0.10540510714054108
were O 0 0.0204275194555521
identified O 0 0.0421505942940712
in O 0 0.03466520458459854
tumors B-Disease 1 0.9997089505195618
of O 0 0.029966963455080986
36 O 0 0.07951931655406952
patients O 1 0.997420072555542
. O 0 0.05423597991466522

Thirty O 0 0.0994347482919693
- O 0 0.08333178609609604
nine O 0 0.02857831120491028
of O 0 0.017925895750522614
the O 0 0.030364403501152992
mutations O 0 0.16152791678905487
- O 0 0.08535276353359222
including O 0 0.030183125287294388
34 O 0 0.05532178655266762
small O 0 0.040675852447748184
mutations O 0 0.12449032813310623
, O 0 0.028047336265444756
2 O 0 0.036616209894418716
large O 0 0.029188962653279305
structural O 0 0.07598164677619934
alterations O 0 0.06604990363121033
, O 0 0.021912595257163048
and O 0 0.02501651830971241
hypermethylation O 1 0.9735268354415894
in O 0 0.04021577909588814
3 O 0 0.07881433516740799
tumors O 1 0.9999856948852539
- O 0 0.08247710764408112
were O 0 0.019281232729554176
not O 0 0.019178621470928192
detected O 0 0.06291455030441284
in O 0 0.018513420596718788
the O 0 0.022497594356536865
corresponding O 0 0.07304965704679489
peripheral O 1 0.9874767661094666
blood O 1 0.9223180413246155
DNA O 0 0.1291620433330536
. O 0 0.05910102650523186

In O 0 0.04516676440834999
6 O 0 0.05900750681757927
( O 0 0.043782658874988556
17 O 0 0.041607435792684555
% O 0 0.03445267677307129
) O 0 0.022885670885443687
of O 0 0.013382979668676853
the O 0 0.02252400666475296
36 O 0 0.06623171269893646
patients O 1 0.9960122108459473
, O 0 0.028934437781572342
a O 0 0.03599673882126808
mutation O 0 0.13161443173885345
was O 0 0.032933223992586136
detected O 0 0.07256653904914856
in O 0 0.019841797649860382
constitutional O 0 0.0307161808013916
DNA O 0 0.061413850635290146
, O 0 0.016500018537044525
and O 0 0.012914099730551243
1 O 0 0.020950818434357643
of O 0 0.010995992459356785
these O 0 0.018594427034258842
mutations O 0 0.0994340181350708
is O 0 0.02031354419887066
known O 0 0.023825276643037796
to O 0 0.014505325816571712
be O 0 0.014422277919948101
associated O 0 0.031095407903194427
with O 0 0.029899384826421738
reduced O 0 0.08959463983774185
expressivity O 1 0.9753799438476562
. O 0 0.07170204818248749

The O 0 0.03295367956161499
presence O 0 0.03968152031302452
of O 0 0.01731049083173275
a O 0 0.025982437655329704
constitutional O 0 0.03829627111554146
mutation O 0 0.11400441080331802
was O 0 0.02260003238916397
not O 0 0.014763487502932549
associated O 0 0.024001680314540863
with O 0 0.015280510298907757
an O 0 0.019900035113096237
early O 0 0.03496313467621803
age O 0 0.04604719206690788
at O 0 0.04283847287297249
treatment O 1 0.9740895628929138
. O 0 0.0555359311401844

In O 0 0.05542614683508873
1 O 0 0.07521579414606094
patient O 1 0.8705703020095825
, O 0 0.048416849225759506
somatic O 0 0.4376145005226135
mosaicism O 1 0.9676927328109741
was O 0 0.035233959555625916
demonstrated O 0 0.04952750355005264
by O 0 0.021471336483955383
molecular O 0 0.05798725038766861
analysis O 0 0.032818350940942764
of O 0 0.01872842200100422
DNA O 0 0.06527262926101685
and O 0 0.024402249604463577
RNA O 0 0.10941531509160995
from O 0 0.042847149074077606
peripheral O 1 0.9788153171539307
blood O 1 0.9392820000648499
. O 0 0.06337356567382812

In O 0 0.052390728145837784
2 O 0 0.07306190580129623
patients O 1 0.9865222573280334
without O 0 0.0408107228577137
a O 0 0.047013059258461
detectable O 0 0.19696633517742157
mutation O 0 0.20713917911052704
in O 0 0.0490255132317543
peripheral O 1 0.9966614246368408
blood O 1 0.9847080707550049
, O 0 0.043248120695352554
mosaicism O 1 0.9924267530441284
was O 0 0.031777240335941315
suggested O 0 0.035512469708919525
because O 0 0.02111702226102352
1 O 0 0.022705279290676117
of O 0 0.01444992981851101
the O 0 0.028898727148771286
patients O 1 0.9999203681945801
showed O 1 0.8437289595603943
multifocal O 1 0.9999990463256836
tumors B-Disease 1 0.9999663829803467
and O 0 0.020231982693076134
the O 0 0.015768546611070633
other O 0 0.014412478543817997
later O 0 0.027060311287641525
developed O 0 0.06230693310499191
bilateral B-Disease 0 0.08670000731945038
retinoblastoma I-Disease 1 0.9973030090332031
. O 0 0.0683969184756279

In O 0 0.03774452954530716
conclusion O 0 0.04683279991149902
, O 0 0.020873485133051872
our O 0 0.02412380278110504
results O 0 0.035535961389541626
emphasize O 0 0.04786263778805733
that O 0 0.014119751751422882
the O 0 0.022724278271198273
manifestation O 0 0.11395055055618286
and O 0 0.03010551631450653
transmissibility O 1 0.8880181312561035
of O 0 0.03421425446867943
retinoblastoma B-Disease 1 0.9871900677680969
depend O 0 0.041952624917030334
on O 0 0.014162802137434483
the O 0 0.014022771269083023
nature O 0 0.02272668108344078
of O 0 0.010656234808266163
the O 0 0.01610170491039753
first O 0 0.02502896450459957
mutation O 0 0.10132058709859848
, O 0 0.01706271804869175
its O 0 0.013589734211564064
time O 0 0.014475136995315552
in O 0 0.012268495745956898
development O 0 0.020973265171051025
, O 0 0.012891472317278385
and O 0 0.010628576390445232
the O 0 0.011346808634698391
number O 0 0.01137404516339302
and O 0 0.013960462063550949
types O 0 0.03344491869211197
of O 0 0.0170963816344738
cells O 0 0.0769718661904335
that O 0 0.016055507585406303
are O 0 0.017175644636154175
affected O 0 0.06096843257546425
. O 0 0.027377719059586525
. O 0 0.04163143411278725

Hereditary B-Disease 1 0.9995467066764832
deficiency I-Disease 1 0.9999858140945435
of I-Disease 0 0.02578604966402054
the I-Disease 0 0.024287302047014236
fifth I-Disease 0 0.052406106144189835
component I-Disease 0 0.05484524369239807
of I-Disease 0 0.018738336861133575
complement I-Disease 0 0.06127006188035011
in O 0 0.02569899894297123
man O 0 0.05865565314888954
. O 0 0.043495096266269684

I O 0 0.1147460788488388
. O 0 0.06500443816184998

Clinical O 1 0.9406500458717346
, O 0 0.04997846484184265
immunochemical O 0 0.18566253781318665
, O 0 0.02405771054327488
and O 0 0.019511936232447624
family O 0 0.0407164990901947
studies O 0 0.050931185483932495
. O 0 0.04590737447142601

The O 0 0.03260493651032448
first O 0 0.02881583757698536
recognized O 0 0.04587699845433235
human O 0 0.05082128196954727
kindred O 1 0.9910023808479309
with O 0 0.05256577581167221
hereditary B-Disease 1 0.9993308782577515
deficiency I-Disease 1 0.9999896287918091
of I-Disease 0 0.02241700515151024
the I-Disease 0 0.02279447205364704
fifth I-Disease 0 0.056809693574905396
component I-Disease 0 0.061958469450473785
of I-Disease 0 0.024165520444512367
complement I-Disease 0 0.09171107411384583
( O 0 0.07011303305625916
C5 O 1 0.8773989677429199
) O 0 0.04207269847393036
is O 0 0.028231961652636528
described O 0 0.053629592061042786
. O 0 0.046842530369758606

The O 0 0.048272546380758286
proband O 0 0.16173559427261353
, O 0 0.027053991332650185
a O 0 0.032090988010168076
20 O 0 0.042350925505161285
- O 0 0.0919259637594223
year O 0 0.044974420219659805
- O 0 0.09933233261108398
old O 0 0.056106533855199814
black O 0 0.08443553000688553
female O 0 0.08962171524763107
with O 0 0.4612647593021393
systemic B-Disease 1 1.0
lupus I-Disease 1 1.0
erythematosus I-Disease 1 1.0
since O 0 0.07266131043434143
age O 0 0.05655375495553017
11 O 0 0.04498039931058884
, O 0 0.035855814814567566
lacked O 1 0.6053611636161804
serum O 1 0.9997662901878357
hemolytic O 1 0.999997615814209
complement O 0 0.11584053933620453
activity O 0 0.06255891919136047
, O 0 0.02383844368159771
even O 0 0.030471771955490112
during O 0 0.06044049561023712
remission O 1 0.9977546334266663
. O 0 0.059203386306762695

C5 O 1 0.9219026565551758
was O 0 0.05902237817645073
undetectable O 0 0.42765095829963684
in O 0 0.029186120256781578
her O 0 0.04692034050822258
serum O 0 0.4975530207157135
by O 0 0.027677124366164207
both O 0 0.036802876740694046
immunodiffusion O 1 0.8093730211257935
and O 0 0.06306411325931549
hemolytic O 1 0.9999841451644897
assays O 0 0.20542268455028534
. O 0 0.0652453675866127

Other O 0 0.034814514219760895
complement O 0 0.07286380231380463
components O 0 0.04684796929359436
were O 0 0.021021418273448944
normal O 0 0.06293664127588272
during O 0 0.05129356309771538
remission O 1 0.9993833303451538
of O 0 0.04428350180387497
lupus O 1 0.9999998807907104
, O 0 0.038201551884412766
but O 0 0.034326981753110886
C1 O 1 0.999778687953949
, O 0 0.04607764631509781
C4 O 1 0.9359830021858215
, O 0 0.04413977265357971
C2 O 1 0.9980860948562622
, O 0 0.03336990624666214
and O 0 0.03208377957344055
C3 O 1 0.9955249428749084
levels O 0 0.10289455205202103
fell O 0 0.08803451806306839
during O 0 0.07169177383184433
exacerbations O 1 0.999242901802063
. O 0 0.07020038366317749

A O 0 0.07682636380195618
younger O 0 0.0870443731546402
half O 0 0.05657605826854706
- O 0 0.10235481709241867
sister O 0 0.06400147080421448
, O 0 0.023486671969294548
who O 0 0.024411583319306374
had O 0 0.02592548541724682
no O 0 0.03263397142291069
underlying O 1 0.9183375835418701
disease O 1 0.9999570846557617
, O 0 0.019135283306241035
was O 0 0.018198296427726746
also O 0 0.015058441087603569
found O 0 0.022105582058429718
to O 0 0.02151688002049923
lack O 0 0.07110723853111267
immunochemically O 1 0.8977359533309937
detectable O 0 0.43436238169670105
C5 O 1 0.9511829614639282
. O 0 0.06933039426803589

By O 0 0.10744543373584747
hemolytic O 1 0.999961256980896
assay O 0 0.1977795511484146
, O 0 0.03625139594078064
she O 0 0.03422779589891434
exhibited O 0 0.06877900660037994
1 O 0 0.045165639370679855
- O 0 0.0725763812661171
2 O 0 0.035672057420015335
% O 0 0.02570544183254242
of O 0 0.015425682999193668
the O 0 0.028143202885985374
normal O 0 0.09915368258953094
serum O 1 0.9808510541915894
C5 O 1 0.9206112623214722
level O 0 0.05252876877784729
and O 0 0.024421624839305878
normal O 0 0.0537298321723938
concentrations O 0 0.07566815614700317
of O 0 0.017975913360714912
other O 0 0.01863648183643818
complement O 0 0.07604900002479553
components O 0 0.06627287715673447
. O 0 0.0554150715470314

C5 O 1 0.8990718126296997
levels O 0 0.0739663615822792
of O 0 0.017462842166423798
other O 0 0.01580881141126156
family O 0 0.0278566163033247
members O 0 0.018098754808306694
were O 0 0.015210075303912163
either O 0 0.026344269514083862
normal O 0 0.04354667663574219
or O 0 0.026413511484861374
approximately O 0 0.03374553844332695
half O 0 0.03916086629033089
- O 0 0.08319506049156189
normal O 0 0.05932943522930145
, O 0 0.025614438578486443
consistent O 0 0.052877627313137054
with O 0 0.036583613604307175
autosomal O 1 0.9906855225563049
codominant O 1 0.7001940011978149
inheritance O 0 0.1017669290304184
of O 0 0.02613743022084236
the O 0 0.04145774617791176
gene O 0 0.16831117868423462
determining O 0 0.17723000049591064
C5 B-Disease 1 0.999987006187439
deficiency I-Disease 1 0.9999995231628418
. O 0 0.07880882918834686

Normal O 1 0.8842933177947998
hemolytic O 1 0.9999949932098389
titers O 1 0.9656409621238708
were O 0 0.029920078814029694
restored O 0 0.04582493379712105
to O 0 0.023077629506587982
both O 0 0.035548798739910126
homozygous O 0 0.48157644271850586
C5 B-Disease 1 0.999963641166687
- I-Disease 1 0.9888805150985718
deficient I-Disease 1 0.9998339414596558
( O 0 0.11265847086906433
C5D B-Disease 1 0.9991917014122009
) O 0 0.0505468025803566
sera O 0 0.08818700164556503
by O 0 0.01844385825097561
addition O 0 0.025737175717949867
of O 0 0.019620422273874283
highly O 0 0.05744479224085808
purified O 0 0.1488499790430069
human O 0 0.081962451338768
C5 O 1 0.955578088760376
. O 0 0.05923590436577797

In O 0 0.054366741329431534
specific O 0 0.08151211589574814
C5 O 1 0.9818658232688904
titrations O 1 0.9668111801147461
, O 0 0.02734547294676304
however O 0 0.018078463152050972
, O 0 0.013392963446676731
it O 0 0.011508290655910969
was O 0 0.01510451640933752
noted O 0 0.019119063392281532
that O 0 0.012354775331914425
when O 0 0.020969269797205925
limited O 0 0.03150064870715141
amounts O 0 0.03925245627760887
of O 0 0.024719465523958206
C5 O 0 0.30701062083244324
were O 0 0.02189643122255802
assayed O 0 0.08843587338924408
in O 0 0.017759257927536964
the O 0 0.015780042856931686
presence O 0 0.0386364720761776
of O 0 0.021401328966021538
low O 0 0.07736055552959442
dilutions O 0 0.33408138155937195
of O 0 0.032573483884334564
either O 0 0.06235211342573166
C5D B-Disease 1 0.9996033310890198
serum O 1 0.9782792925834656
, O 0 0.03429010882973671
curving O 0 0.10431458801031113
rather O 0 0.0360565185546875
than O 0 0.03340165317058563
linear O 0 0.1351058930158615
dose O 1 0.9953315854072571
- O 0 0.11418642103672028
response O 0 0.05963040888309479
plots O 0 0.050411079078912735
were O 0 0.018484409898519516
consistently O 0 0.04135650396347046
obtained O 0 0.028674015775322914
, O 0 0.024806007742881775
suggesting O 0 0.05756254121661186
some O 0 0.02916674315929413
inhibitory O 0 0.21436209976673126
effect O 0 0.08094550669193268
. O 0 0.045075323432683945

Further O 0 0.05976947396993637
studies O 0 0.059183187782764435
suggested O 0 0.046411819756031036
that O 0 0.024868911132216454
low O 0 0.0788908451795578
dilutions O 1 0.8557742238044739
of O 0 0.043990619480609894
C5D B-Disease 1 0.9987803101539612
serum O 1 0.967524528503418
contain O 0 0.06087876111268997
a O 0 0.042152080684900284
factor O 0 0.0798841193318367
( O 0 0.038371216505765915
or O 0 0.028098206967115402
factors O 0 0.04424472153186798
) O 0 0.029381612315773964
interfering O 0 0.055740661919116974
at O 0 0.02255571447312832
some O 0 0.013451275415718555
step O 0 0.03087504766881466
in O 0 0.018572403118014336
the O 0 0.03862721845507622
hemolytic O 1 0.9999650716781616
assay O 0 0.17399285733699799
of O 0 0.03747309744358063
C5 O 1 0.7323606610298157
, O 0 0.022063175216317177
rather O 0 0.02375890500843525
than O 0 0.020070144906640053
a O 0 0.03618296980857849
true O 0 0.0699915811419487
C5 O 1 0.9929267764091492
inhibitor O 1 0.9702509045600891
or O 0 0.06624989956617355
inactivator O 0 0.45487937331199646
. O 0 0.05995701625943184

Of O 0 0.04705393314361572
clinical O 0 0.14988449215888977
interest O 0 0.03222816810011864
are O 0 0.016226597130298615
( O 0 0.029016606509685516
a O 0 0.02337215282022953
) O 0 0.025336019694805145
the O 0 0.018861902877688408
documentation O 0 0.05152256041765213
of O 0 0.038346704095602036
membranous O 1 0.9999679327011108
glomerulonephritis B-Disease 1 0.9999990463256836
, O 0 0.07777407020330429
vasculitis B-Disease 1 0.9999988079071045
, O 0 0.04049491509795189
and O 0 0.0376226007938385
arthritis B-Disease 1 1.0
in O 0 0.027052707970142365
an O 0 0.02308672107756138
individual O 0 0.0459742546081543
lacking O 0 0.11809419840574265
C5 O 1 0.9722344279289246
( O 0 0.03784211352467537
and O 0 0.01644240692257881
its O 0 0.02221333421766758
biologic O 0 0.22472338378429413
functions O 0 0.03399207815527916
) O 0 0.02543770708143711
, O 0 0.01501283049583435
and O 0 0.016859767958521843
( O 0 0.042905453592538834
b O 0 0.0856320708990097
) O 0 0.030912932008504868
a O 0 0.031036589294672012
remarkable O 0 0.06678912043571472
propensity O 1 0.7734050750732422
to O 0 0.050865788012742996
bacterial B-Disease 1 0.9999840259552002
infections I-Disease 1 0.9999874830245972
in O 0 0.026856886222958565
the O 0 0.027400774881243706
proband O 0 0.20474141836166382
, O 0 0.022526325657963753
even O 0 0.022587519139051437
during O 0 0.03188225254416466
periods O 0 0.05481285974383354
of O 0 0.02167706936597824
low O 0 0.0838036835193634
- O 0 0.24837066233158112
dose O 1 0.8947925567626953
or O 0 0.045807693153619766
alternate O 0 0.07117839902639389
- O 0 0.17479220032691956
day O 0 0.09529941529035568
corticosteroid O 1 0.9999345541000366
therapy O 1 0.9989680051803589
. O 0 0.06686767935752869

Other O 0 0.03551493585109711
observations O 0 0.05559592321515083
indicate O 0 0.04447711631655693
that O 0 0.016238322481513023
the O 0 0.028011083602905273
C5D B-Disease 1 0.8869340419769287
state O 0 0.027995126321911812
is O 0 0.02328292280435562
compatible O 0 0.04318947717547417
with O 0 0.026541171595454216
normal O 0 0.0852283462882042
coagulation O 1 0.8841054439544678
function O 0 0.04320557042956352
and O 0 0.014971904456615448
the O 0 0.01685255952179432
capacity O 0 0.028282243758440018
to O 0 0.022972477599978447
mount O 0 0.0907311961054802
a O 0 0.07547368109226227
neutrophilic O 1 0.9998308420181274
leukocytosis O 1 0.9998125433921814
during O 0 0.23171095550060272
pyogenic B-Disease 1 0.9999266862869263
infection I-Disease 1 0.9998782873153687
. O 0 0.047761041671037674
. O 0 0.05417279899120331

Susceptibility O 1 0.9972149133682251
to O 0 0.10755619406700134
ankylosing B-Disease 1 0.9999996423721313
spondylitis I-Disease 1 0.9999995231628418
in O 0 0.05367708578705788
twins O 0 0.14452724158763885
: O 0 0.034141622483730316
the O 0 0.016916878521442413
role O 0 0.02986334264278412
of O 0 0.021119531244039536
genes O 0 0.0799821987748146
, O 0 0.0399031937122345
HLA O 1 0.9970295429229736
, O 0 0.022442037239670753
and O 0 0.017143551260232925
the O 0 0.021740883588790894
environment O 0 0.052695438265800476
. O 0 0.04643631726503372

OBJECTIVE O 0 0.08190025389194489
To O 0 0.024717791005969048
determine O 0 0.03670741617679596
the O 0 0.023387029767036438
relative O 0 0.059581007808446884
effects O 0 0.08222153782844543
of O 0 0.02105359360575676
genetic O 0 0.07329743355512619
and O 0 0.022835565730929375
environmental O 0 0.05115150660276413
factors O 0 0.05789563059806824
in O 0 0.03469792753458023
susceptibility O 1 0.9978727102279663
to O 0 0.07056261599063873
ankylosing B-Disease 1 0.9999998807907104
spondylitis I-Disease 1 0.9999998807907104
( O 0 0.08727055042982101
AS B-Disease 0 0.05319136381149292
) O 0 0.04682682827115059
. O 0 0.0412038154900074

METHODS O 0 0.09630494564771652
Twins O 0 0.12385575473308563
with O 0 0.025169065222144127
AS B-Disease 0 0.02731146663427353
were O 0 0.01442316547036171
identified O 0 0.0270785354077816
from O 0 0.016708048060536385
the O 0 0.017994340509176254
Royal O 0 0.05480121076107025
National O 0 0.05333860591053963
Hospital O 1 0.9995771050453186
for O 0 0.059255119413137436
Rheumatic B-Disease 1 0.9999998807907104
Diseases I-Disease 1 0.999988317489624
database O 0 0.10270354151725769
. O 0 0.05500337481498718

Clinical O 1 0.8831315040588379
and O 0 0.042271681129932404
radiographic O 1 0.890301525592804
examinations O 0 0.09257960319519043
were O 0 0.020475318655371666
performed O 0 0.037960153073072433
to O 0 0.022085629403591156
establish O 0 0.05823514237999916
diagnoses O 1 0.9978366494178772
, O 0 0.03218018636107445
and O 0 0.033759117126464844
disease O 1 0.999985933303833
severity O 1 0.9921755194664001
was O 0 0.03140800818800926
assessed O 0 0.054044827818870544
using O 0 0.02708098292350769
a O 0 0.027635792270302773
combination O 0 0.06136549264192581
of O 0 0.01886730268597603
validated O 0 0.07346218824386597
scoring O 0 0.053574685007333755
systems O 0 0.0759945958852768
. O 0 0.05025804415345192

HLA O 1 0.9947643280029297
typing O 0 0.2205081284046173
for O 0 0.07353668659925461
HLA O 1 0.9998570680618286
- O 0 0.4400281012058258
B27 O 1 0.6520687937736511
, O 0 0.07674428820610046
HLA O 1 0.9996094107627869
- O 0 0.18528114259243011
B60 O 0 0.20628009736537933
, O 0 0.04177593067288399
and O 0 0.044362667948007584
HLA O 1 0.9997743964195251
- O 0 0.21165409684181213
DR1 O 1 0.934954822063446
was O 0 0.04241971671581268
performed O 0 0.05398279055953026
by O 0 0.03760330379009247
polymerase O 0 0.19373910129070282
chain O 0 0.10670363903045654
reaction O 0 0.08274757862091064
with O 0 0.031058724969625473
sequence O 0 0.05988987907767296
- O 0 0.08559071272611618
specific O 0 0.04156288504600525
primers O 0 0.14316719770431519
, O 0 0.02823597379028797
and O 0 0.026905400678515434
zygosity O 0 0.14442700147628784
was O 0 0.03506110981106758
assessed O 0 0.07593496143817902
using O 0 0.054914046078920364
microsatellite O 0 0.39028701186180115
markers O 0 0.14934803545475006
. O 0 0.05921795219182968

Genetic O 0 0.15233680605888367
and O 0 0.034330859780311584
environmental O 0 0.058811623603105545
variance O 0 0.0662921592593193
components O 0 0.04216210916638374
were O 0 0.016773389652371407
assessed O 0 0.045910608023405075
with O 0 0.017323751002550125
the O 0 0.02227281779050827
program O 0 0.0642578974366188
Mx O 1 0.532062292098999
, O 0 0.020598143339157104
using O 0 0.01868412271142006
data O 0 0.017319390550255775
from O 0 0.012644198723137379
this O 0 0.010121856816112995
and O 0 0.013413739390671253
previous O 0 0.026765020564198494
studies O 0 0.034561023116111755
of O 0 0.016960740089416504
twins O 0 0.09749041497707367
with O 0 0.026047291234135628
AS B-Disease 0 0.04428359493613243
. O 0 0.0405445359647274

RESULTS O 0 0.07807750999927521
Six O 0 0.04092080518603325
of O 0 0.029557248577475548
8 O 0 0.07782124727964401
monozygotic O 1 0.9876796007156372
( O 0 0.11538724601268768
MZ O 1 0.999370276927948
) O 0 0.07434771209955215
twin O 0 0.14532126486301422
pairs O 0 0.08836635947227478
were O 0 0.04202184081077576
disease O 1 0.9998610019683838
concordant O 0 0.46691519021987915
, O 0 0.025985226035118103
compared O 0 0.03650018572807312
with O 0 0.02111762948334217
4 O 0 0.03240582346916199
of O 0 0.019126174971461296
15 O 0 0.04902491346001625
B27 O 0 0.3801392912864685
- O 0 0.14894583821296692
positive O 0 0.11933694034814835
dizygotic O 1 0.9810284972190857
( O 0 0.0974586233496666
DZ O 1 0.991606593132019
) O 0 0.06122666969895363
twin O 0 0.13512004911899567
pairs O 0 0.09364743530750275
( O 0 0.04911016300320625
27 O 0 0.04553092643618584
% O 0 0.03274385631084442
) O 0 0.025597747415304184
and O 0 0.01592355966567993
4 O 0 0.030837908387184143
of O 0 0.021006237715482712
32 O 0 0.0783463716506958
DZ O 1 0.9919602274894714
twin O 0 0.15930423140525818
pairs O 0 0.09588838368654251
overall O 0 0.06969401240348816
( O 0 0.04018496349453926
12 O 0 0.030110536143183708
. O 0 0.019758807495236397
5 O 0 0.040122196078300476
% O 0 0.043160632252693176
) O 0 0.04164186120033264
. O 0 0.03828383982181549

Nonsignificant O 0 0.3724442422389984
increases O 0 0.08557907491922379
in O 0 0.026502596214413643
similarity O 0 0.05440917983651161
with O 0 0.020957402884960175
regard O 0 0.03381527587771416
to O 0 0.02300630696117878
age O 0 0.053139932453632355
at O 0 0.06615891307592392
disease O 1 0.999995231628418
onset O 1 0.9993773102760315
and O 0 0.017131293192505836
all O 0 0.011328227818012238
of O 0 0.015531007200479507
the O 0 0.033528465777635574
disease O 1 0.9999815225601196
severity O 1 0.9928489923477173
scores O 0 0.0708906352519989
assessed O 0 0.06463057547807693
were O 0 0.019348720088601112
noted O 0 0.03621220588684082
in O 0 0.0397815927863121
disease O 1 0.9999945163726807
- O 1 0.9791229963302612
concordant O 1 0.9923243522644043
MZ O 1 0.9999191761016846
twins O 0 0.4515797197818756
compared O 0 0.08243101835250854
with O 0 0.05163164064288139
concordant O 1 0.9591394662857056
DZ O 1 0.9991039633750916
twins O 0 0.4264243245124817
. O 0 0.07781831920146942

HLA O 1 0.9996976852416992
- O 0 0.2545875012874603
B27 O 0 0.19510893523693085
and O 0 0.033078111708164215
B60 O 0 0.12664733827114105
were O 0 0.01867152377963066
associated O 0 0.028281085193157196
with O 0 0.019926879554986954
the O 0 0.028343552723526955
disease O 1 0.9997724890708923
in O 0 0.02912273444235325
probands O 0 0.46465009450912476
, O 0 0.018989941105246544
and O 0 0.013877424411475658
the O 0 0.019468136131763458
rate O 0 0.044443611055612564
of O 0 0.029554765671491623
disease O 1 0.9998341798782349
concordance O 0 0.15847761929035187
was O 0 0.037031520158052444
significantly O 0 0.06911253184080124
increased O 0 0.05267365276813507
among O 0 0.04715383052825928
DZ O 1 0.9940906167030334
twin O 0 0.13299711048603058
pairs O 0 0.06534307450056076
in O 0 0.020329000428318977
which O 0 0.0176071934401989
the O 0 0.023582495748996735
co O 0 0.22901146113872528
- O 0 0.11080702394247055
twin O 0 0.11496855318546295
was O 0 0.0309967789798975
positive O 0 0.041912637650966644
for O 0 0.017673173919320107
both O 0 0.025317294523119926
B27 O 0 0.15253913402557373
and O 0 0.04792949929833412
DR1 O 1 0.9840337038040161
. O 0 0.0670551210641861

Additive O 0 0.3030090928077698
genetic O 0 0.16166722774505615
effects O 0 0.1026247888803482
were O 0 0.020972561091184616
estimated O 0 0.036996059119701385
to O 0 0.02437572553753853
contribute O 0 0.06808479875326157
97 O 0 0.07828493416309357
% O 0 0.028113888576626778
of O 0 0.013593493029475212
the O 0 0.020857956260442734
population O 0 0.04734911024570465
variance O 0 0.09653103351593018
. O 0 0.05305648222565651

CONCLUSION O 0 0.12663111090660095
Susceptibility O 0 0.3877268433570862
to O 0 0.024154778569936752
AS B-Disease 0 0.02811620570719242
is O 0 0.02081526815891266
largely O 0 0.034545570611953735
genetically O 0 0.054841384291648865
determined O 0 0.03835610672831535
, O 0 0.015452965162694454
and O 0 0.013426726683974266
the O 0 0.019372541457414627
environmental O 0 0.05487748235464096
trigger O 0 0.1041068285703659
for O 0 0.021975331008434296
the O 0 0.031667932868003845
disease O 1 0.9998326301574707
is O 0 0.035912808030843735
probably O 0 0.0546598844230175
ubiquitous O 0 0.11176840960979462
. O 0 0.048994097858667374

HLA O 1 0.9995102882385254
- O 0 0.17892765998840332
B27 O 0 0.1704271286725998
accounts O 0 0.042932767421007156
for O 0 0.01678740419447422
a O 0 0.022472649812698364
minority O 0 0.0328107513487339
of O 0 0.014287511818110943
the O 0 0.02040194720029831
overall O 0 0.06721054017543793
genetic O 0 0.12192564457654953
susceptibility O 0 0.4254869520664215
to O 0 0.028664547950029373
AS B-Disease 0 0.04025951027870178
. O 0 0.043413594365119934

Cell O 0 0.3270915746688843
cycle O 0 0.19482599198818207
- O 0 0.14667218923568726
dependent O 0 0.11979231238365173
colocalization O 0 0.18588697910308838
of O 0 0.03354773670434952
BARD1 O 1 0.6461871266365051
and O 0 0.046589989215135574
BRCA1 O 1 0.9224936366081238
proteins O 0 0.08313709497451782
in O 0 0.03211522847414017
discrete O 0 0.08512380719184875
nuclear O 0 0.07547139376401901
domains O 0 0.10025341808795929
. O 0 0.056074947118759155

Germ O 1 0.9970191717147827
- O 0 0.17034350335597992
line O 0 0.07369968295097351
mutations O 0 0.1292170286178589
of O 0 0.024544991552829742
the O 0 0.04439425468444824
BRCA1 O 1 0.9914320707321167
gene O 0 0.20966364443302155
predispose O 1 0.8339897990226746
women O 0 0.0581466481089592
to O 0 0.030859434977173805
early O 0 0.08271726220846176
- O 1 0.9992807507514954
onset O 1 0.9999963045120239
breast B-Disease 1 0.9999991655349731
and I-Disease 1 0.8322386741638184
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999980926513672
by O 0 0.03443954885005951
compromising O 0 0.0903613492846489
the O 0 0.03370457887649536
genes O 0 0.10598450899124146
presumptive O 0 0.4324726164340973
function O 0 0.05545588955283165
as O 0 0.02892899513244629
a O 0 0.06398634612560272
tumor B-Disease 1 0.9991661310195923
suppressor O 1 0.9365404844284058
. O 0 0.07584444433450699

Although O 0 0.04989076405763626
the O 0 0.03399990499019623
biochemical O 0 0.1207064837217331
properties O 0 0.06002816557884216
of O 0 0.03394978865981102
BRCA1 O 1 0.9699746966362
polypeptides O 0 0.1329488754272461
are O 0 0.019390974193811417
not O 0 0.014930378645658493
understood O 0 0.03706149384379387
, O 0 0.016275422647595406
their O 0 0.017037760466337204
expression O 0 0.05556686595082283
pattern O 0 0.07647527754306793
and O 0 0.027369240298867226
subcellular O 0 0.12929347157478333
localization O 0 0.09831526130437851
suggest O 0 0.045141007751226425
a O 0 0.02665175125002861
role O 0 0.03564352169632912
in O 0 0.02908920682966709
cell O 0 0.14277373254299164
- O 0 0.13402676582336426
cycle O 0 0.13871356844902039
regulation O 0 0.09528455138206482
. O 0 0.053607989102602005

When O 0 0.08188097178936005
resting O 0 0.1892351508140564
cells O 0 0.13360467553138733
are O 0 0.03021697700023651
induced O 1 0.5883074402809143
to O 0 0.028324583545327187
proliferate O 0 0.10332409292459488
, O 0 0.02071119099855423
the O 0 0.023545950651168823
steady O 0 0.07499999552965164
- O 0 0.07245921343564987
state O 0 0.028085418045520782
levels O 0 0.054746437817811966
of O 0 0.02796059288084507
BRCA1 O 1 0.8860073685646057
increase O 0 0.047838568687438965
in O 0 0.026283305138349533
late O 0 0.04701647907495499
G1 O 1 0.6458162665367126
and O 0 0.022437522187829018
reach O 0 0.036358997225761414
a O 0 0.029180588200688362
maximum O 0 0.05755896866321564
during O 0 0.05412859469652176
S O 0 0.4240249693393707
phase O 0 0.11622201651334763
. O 0 0.05295243114233017

Moreover O 0 0.08860349655151367
, O 0 0.02954505942761898
in O 0 0.034674033522605896
S O 1 0.8923196792602539
phase O 0 0.14499099552631378
cells O 0 0.14338521659374237
, O 0 0.047508906573057175
BRCA1 O 1 0.9746633768081665
polypeptides O 0 0.14874783158302307
are O 0 0.02857128530740738
hyperphosphorylated O 0 0.14717715978622437
and O 0 0.031759291887283325
accumulate O 0 0.1190563440322876
into O 0 0.0422687865793705
discrete O 0 0.12823854386806488
subnuclear O 0 0.4182869493961334
foci O 1 0.5352319478988647
termed O 0 0.17114338278770447
" O 0 0.07990453392267227
BRCA1 O 1 0.9682137966156006
nuclear O 0 0.11547189950942993
dots O 0 0.17594629526138306
. O 0 0.059759773313999176

" O 0 0.10553981363773346
BRCA1 O 1 0.9776006937026978
associates O 0 0.22813928127288818
in O 0 0.03689559921622276
vivo O 0 0.13897812366485596
with O 0 0.026431752368807793
a O 0 0.042913444340229034
structurally O 0 0.13027925789356232
related O 0 0.08127840608358383
protein O 0 0.1340576857328415
termed O 0 0.18164657056331635
BARD1 O 1 0.9449434876441956
. O 0 0.06485534459352493

Here O 0 0.03583216667175293
we O 0 0.019146256148815155
show O 0 0.026336515322327614
that O 0 0.013958636671304703
the O 0 0.023127449676394463
steady O 0 0.07431917637586594
- O 0 0.06911089271306992
state O 0 0.027842409908771515
levels O 0 0.05197250843048096
of O 0 0.02458273619413376
BARD1 O 1 0.7744158506393433
, O 0 0.022848473861813545
unlike O 0 0.029744820669293404
those O 0 0.016160383820533752
of O 0 0.022668316960334778
BRCA1 O 1 0.9781606793403625
, O 0 0.030215773731470108
remain O 0 0.03564503416419029
relatively O 0 0.048943892121315
constant O 0 0.07303132861852646
during O 0 0.05751042440533638
cell O 0 0.15944291651248932
cycle O 0 0.21175627410411835
progression O 1 0.8093910217285156
. O 0 0.05792832747101784

However O 0 0.048164211213588715
, O 0 0.03611913323402405
immunostaining O 0 0.15484943985939026
revealed O 0 0.06895694136619568
that O 0 0.03237474337220192
BARD1 O 0 0.41910824179649353
resides O 0 0.10108540952205658
within O 0 0.05745530501008034
BRCA1 O 1 0.9563593864440918
nuclear O 0 0.10757417976856232
dots O 0 0.1483476161956787
during O 0 0.05920867994427681
S O 0 0.15840324759483337
phase O 0 0.07485324889421463
of O 0 0.017485760152339935
the O 0 0.028136800974607468
cell O 0 0.10172657668590546
cycle O 0 0.08986963331699371
, O 0 0.02039792574942112
but O 0 0.015807105228304863
not O 0 0.015128212980926037
during O 0 0.03074726089835167
the O 0 0.036041226238012314
G1 O 1 0.9887757301330566
phase O 0 0.1474764198064804
. O 0 0.05811731517314911

Nevertheless O 0 0.09031625092029572
, O 0 0.04512454569339752
BARD1 O 0 0.4504203498363495
polypeptides O 0 0.10660009831190109
are O 0 0.01629263162612915
found O 0 0.019143080338835716
exclusively O 0 0.021960020065307617
in O 0 0.01447172462940216
the O 0 0.018489044159650803
nuclear O 0 0.04525971785187721
fractions O 0 0.04824545234441757
of O 0 0.01827915944159031
both O 0 0.030516905710101128
G1 O 1 0.9975289702415466
- O 0 0.13320505619049072
and O 0 0.04298824071884155
S O 1 0.9848856329917908
- O 0 0.30207234621047974
phase O 0 0.1669919639825821
cells O 0 0.1582522690296173
. O 0 0.05956226959824562

Therefore O 0 0.06029428541660309
, O 0 0.03787576034665108
progression O 0 0.3571214973926544
to O 0 0.031519565731287
S O 0 0.4790271818637848
phase O 0 0.08340536803007126
is O 0 0.023809077218174934
accompanied O 0 0.041760481894016266
by O 0 0.019132865592837334
the O 0 0.021828580647706985
aggregation O 0 0.08173267543315887
of O 0 0.02803189679980278
nuclear O 0 0.08374011516571045
BARD1 O 0 0.31209656596183777
polypeptides O 0 0.1779080182313919
into O 0 0.06213303655385971
BRCA1 O 1 0.9472296237945557
nuclear O 0 0.12820976972579956
dots O 0 0.17043618857860565
. O 0 0.05731526389718056

This O 0 0.055495262145996094
cell O 0 0.14680860936641693
cycle O 0 0.15286672115325928
- O 0 0.11765974014997482
dependent O 0 0.10793846845626831
colocalization O 0 0.18275484442710876
of O 0 0.03699720650911331
BARD1 O 1 0.6612077355384827
and O 0 0.04075242951512337
BRCA1 O 1 0.9717321395874023
indicates O 0 0.07127664238214493
a O 0 0.029524751007556915
role O 0 0.03395049273967743
for O 0 0.026990598067641258
BARD1 O 1 0.7545075416564941
in O 0 0.05116225779056549
BRCA1 O 1 0.9997673630714417
- O 1 0.9880196452140808
mediated O 1 0.9951196908950806
tumor B-Disease 1 0.9998892545700073
suppression O 1 0.8626998066902161
. O 0 0.06318607926368713

Ethnic O 0 0.05587635189294815
differences O 0 0.04980578273534775
in O 0 0.03163854032754898
the O 0 0.049532752484083176
HFE O 1 0.9845073223114014
codon O 0 0.26061996817588806
282 O 0 0.3066353499889374
( O 0 0.15121670067310333
Cys O 1 0.9995765089988708
/ O 1 0.9905170798301697
Tyr O 1 0.9848301410675049
) O 0 0.08622761070728302
polymorphism O 0 0.1803688257932663
. O 0 0.05807320773601532

Recent O 0 0.06998966634273529
studies O 0 0.05133303627371788
have O 0 0.023896068334579468
shown O 0 0.04511357471346855
that O 0 0.04085782542824745
hereditary B-Disease 1 0.9999880790710449
hemochromatosis I-Disease 1 1.0
( O 1 0.9342973828315735
HH B-Disease 1 0.9999918937683105
) O 0 0.04146566614508629
is O 0 0.021171722561120987
likely O 0 0.029141925275325775
to O 0 0.016679173335433006
be O 0 0.01644991897046566
caused O 0 0.059717144817113876
by O 0 0.023991618305444717
homozygosity O 0 0.12374606728553772
for O 0 0.0279499813914299
a O 0 0.04427686706185341
Cys282Tyr O 0 0.34259551763534546
mutation O 0 0.1474219560623169
in O 0 0.028171347454190254
the O 0 0.03647339716553688
HFE O 1 0.9904077649116516
gene O 0 0.1265435665845871
located O 0 0.06128619611263275
4 O 0 0.05891162529587746
. O 0 0.04554766044020653

5 O 0 0.12997454404830933
Mb O 1 0.940558910369873
telomeric O 1 0.9514877200126648
to O 0 0.06872283667325974
HLA O 1 0.9992753863334656
- O 0 0.13810104131698608
A O 0 0.06864740699529648
. O 0 0.05294482037425041

Population O 0 0.05553591996431351
studies O 0 0.040616173297166824
of O 0 0.01559574343264103
this O 0 0.020565295591950417
polymorphism O 0 0.08784881234169006
are O 0 0.017600489780306816
facilitated O 0 0.057142797857522964
by O 0 0.015511327423155308
the O 0 0.015070575289428234
fact O 0 0.022355973720550537
that O 0 0.017467854544520378
the O 0 0.032627180218696594
Cys282Tyr O 1 0.8966705799102783
mutation O 0 0.2369135320186615
creates O 0 0.09897081553936005
a O 0 0.04679805412888527
Rsal O 0 0.20658567547798157
restriction O 0 0.09169433265924454
site O 0 0.05398355796933174
. O 0 0.04943165183067322

We O 0 0.03354280814528465
have O 0 0.023210756480693817
studied O 0 0.03829546645283699
the O 0 0.04003621265292168
codon O 0 0.1907491534948349
282 O 0 0.2262137532234192
( O 0 0.14026036858558655
Cys O 1 0.9996764659881592
/ O 1 0.9886168837547302
Tyr O 1 0.982225775718689
) O 0 0.05448770150542259
polymorphism O 0 0.10147292166948318
in O 0 0.01947258599102497
different O 0 0.017623845487833023
ethnic O 0 0.03601699694991112
groups O 0 0.047934435307979584
. O 0 0.05172014608979225

In O 0 0.033245570957660675
agreement O 0 0.0321601964533329
with O 0 0.02154875546693802
previous O 0 0.03229393810033798
observations O 0 0.04957331344485283
the O 0 0.033958081156015396
Tyr O 1 0.9503767490386963
allele O 0 0.16042174398899078
appeared O 0 0.03875727951526642
to O 0 0.019010890275239944
be O 0 0.018164776265621185
rare O 0 0.051059164106845856
or O 0 0.030719749629497528
absent O 0 0.07114596664905548
in O 0 0.02838270179927349
Asiatic O 1 0.8544076085090637
( O 0 0.043824512511491776
Indian O 0 0.03815070539712906
, O 0 0.019776642322540283
Chinese O 0 0.03006402589380741
) O 0 0.043348029255867004
populations O 0 0.08305945992469788
. O 0 0.05214015394449234

The O 0 0.04978596419095993
highest O 0 0.0896754339337349
allele O 0 0.2045537531375885
frequency O 0 0.10212555527687073
( O 0 0.04569269344210625
7 O 0 0.03932635858654976
. O 0 0.01963217370212078
5 O 0 0.03324969857931137
% O 0 0.032107800245285034
) O 0 0.02550251968204975
was O 0 0.020126087591052055
found O 0 0.026283495128154755
in O 0 0.026485586538910866
Swedes O 0 0.11054370552301407
. O 0 0.04959425702691078

Saamis O 0 0.46704673767089844
( O 0 0.07109314948320389
2 O 0 0.04587167128920555
% O 0 0.040728677064180374
) O 0 0.03484417498111725
and O 0 0.026607058942317963
Mordvinians O 0 0.20688551664352417
( O 0 0.041146501898765564
1 O 0 0.03318415582180023
. O 0 0.02024536207318306
8 O 0 0.03671446442604065
% O 0 0.035194262862205505
) O 0 0.02702607400715351
had O 0 0.023655768483877182
significantly O 0 0.05570239946246147
lower O 0 0.05107608065009117
frequencies O 0 0.04587406665086746
of O 0 0.019314797595143318
the O 0 0.03337014466524124
Tyr O 1 0.949503481388092
allele O 0 0.24156305193901062
. O 0 0.06808353215456009

Comparisons O 0 0.09832441806793213
with O 0 0.04453829675912857
allele O 0 0.1753806620836258
frequencies O 0 0.08133885264396667
based O 0 0.03695452958345413
on O 0 0.030546138063073158
prevalence O 1 0.6613520383834839
estimates O 0 0.07208296656608582
of O 0 0.035356223583221436
HH B-Disease 1 0.9998778104782104
showed O 0 0.04999968037009239
some O 0 0.016868723556399345
disagreements O 0 0.04246031865477562
with O 0 0.019688820466399193
the O 0 0.02586670033633709
RFLP O 0 0.19607090950012207
data O 0 0.030399320647120476
, O 0 0.02045729011297226
particularly O 0 0.03168323636054993
in O 0 0.027053745463490486
Finns O 0 0.12738503515720367
. O 0 0.05235065147280693

The O 0 0.045655928552150726
newly O 0 0.08161427825689316
described O 0 0.08722427487373352
HFE O 1 0.9794288277626038
marker O 0 0.11624695360660553
provides O 0 0.04799315705895424
a O 0 0.02280081808567047
new O 0 0.019605137407779694
approach O 0 0.033460959792137146
to O 0 0.014403162524104118
the O 0 0.018224487081170082
screening O 0 0.08323630690574646
of O 0 0.03136748820543289
HH B-Disease 1 0.9996187686920166
as O 0 0.02011849172413349
well O 0 0.014970524236559868
as O 0 0.011786893010139465
studies O 0 0.022340303286910057
of O 0 0.010089167393743992
the O 0 0.016609299927949905
relationship O 0 0.04017675668001175
between O 0 0.028608178719878197
the O 0 0.03912751004099846
HFE O 1 0.9989292025566101
Tyr O 1 0.9950299263000488
allele O 0 0.21530884504318237
and O 0 0.037453461438417435
different O 0 0.046765901148319244
disorders O 1 0.9999715089797974
including O 0 0.06978019326925278
cancer B-Disease 1 0.999954342842102

Autosomal B-Disease 1 0.9981923699378967
dominant I-Disease 1 0.96470046043396
neurohypophyseal I-Disease 1 0.9998193383216858
diabetes I-Disease 1 0.9999996423721313
insipidus I-Disease 1 0.9999535083770752
associated O 0 0.07133104652166367
with O 0 0.03371252864599228
a O 0 0.055703055113554
missense O 0 0.26859280467033386
mutation O 0 0.24261818826198578
encoding O 0 0.15025177597999573
Gly23 O 1 0.9926153421401978
- O 1 0.9492762684822083
- O 1 0.6824439764022827
> O 1 0.6878224015235901
Val O 1 0.6999360918998718
in O 0 0.0573902428150177
neurophysin O 1 0.7700244784355164
II O 0 0.14476773142814636
. O 0 0.053698841482400894

Autosomal B-Disease 1 0.9988517761230469
dominant I-Disease 1 0.9631224870681763
neurohypophyseal I-Disease 1 0.9998669624328613
diabetes I-Disease 1 0.9999998807907104
insipidus I-Disease 1 0.999994158744812
( O 0 0.1640668362379074
ADNDI B-Disease 1 0.9956810474395752
) O 0 0.04123103618621826
is O 0 0.025596391409635544
an O 0 0.0436173640191555
inherited B-Disease 1 0.9999960660934448
disease I-Disease 1 1.0
caused O 1 0.9424121975898743
by O 0 0.03727498650550842
progressive O 1 0.9371331930160522
degeneration O 1 0.9999018907546997
of O 0 0.02687029168009758
the O 0 0.04223831743001938
magnocellular O 1 0.9966332316398621
neurons O 0 0.1664082556962967
of O 0 0.022355802357196808
the O 0 0.030636213719844818
hypothalamus O 0 0.22277839481830597
leading O 0 0.04478374868631363
to O 0 0.021954601630568504
decreased O 0 0.06620625406503677
ability O 0 0.03633829206228256
to O 0 0.01998177543282509
produce O 0 0.04065417870879173
the O 0 0.0376356802880764
hormone O 1 0.9112988710403442
arginine O 1 0.7292740345001221
vasopressin O 1 0.9851932525634766
( O 0 0.09371946007013321
AVP O 1 0.9939356446266174
) O 0 0.06382770091295242
. O 0 0.05162090063095093

Affected O 0 0.11214203387498856
individuals O 0 0.04058486595749855
are O 0 0.021382061764597893
not O 0 0.02628600224852562
symptomatic O 1 0.9989854693412781
at O 0 0.03857336938381195
birth O 0 0.05337822809815407
, O 0 0.022253993898630142
but O 0 0.021433040499687195
usually O 0 0.05161811411380768
develop O 1 0.8669218420982361
diabetes B-Disease 1 0.9999994039535522
insipidus I-Disease 1 0.9999605417251587
at O 0 0.06011512130498886
1 O 0 0.05812254548072815
- O 0 0.11475971341133118
6 O 0 0.08115550130605698
yr O 0 0.39046335220336914
of O 0 0.030407577753067017
age O 0 0.06274348497390747
. O 0 0.04718578979372978

The O 0 0.0484699048101902
genetic O 0 0.11326910555362701
locus O 0 0.12887565791606903
of O 0 0.022746993228793144
the O 0 0.031616780906915665
disease O 1 0.999799907207489
is O 0 0.031542614102363586
the O 0 0.03755202144384384
AVP O 1 0.999748170375824
- O 1 0.7684725522994995
neurophysin O 1 0.9648860096931458
II O 1 0.5565920472145081
( O 0 0.08640535175800323
NPII O 1 0.9524518251419067
) O 0 0.055560074746608734
gene O 0 0.08844727277755737
, O 0 0.025276390835642815
and O 0 0.02766307443380356
mutations O 0 0.13853153586387634
that O 0 0.027796652168035507
cause O 0 0.3284355103969574
ADNDI B-Disease 1 0.8748485445976257
have O 0 0.020042546093463898
been O 0 0.014159240759909153
found O 0 0.015166952274739742
in O 0 0.012120352126657963
both O 0 0.013147154822945595
the O 0 0.020285284146666527
signal O 0 0.07134454697370529
peptide O 0 0.10785731673240662
of O 0 0.02173585444688797
the O 0 0.039143554866313934
prepro O 1 0.973463773727417
- O 1 0.8569863438606262
AVP O 1 0.9990087151527405
- O 0 0.36723533272743225
NPII O 1 0.7629667520523071
precursor O 0 0.1182507649064064
and O 0 0.030006997287273407
within O 0 0.0404774472117424
NPII O 1 0.602950930595398
itself O 0 0.06557869166135788
. O 0 0.048509031534194946

An O 0 0.05786227434873581
affected O 0 0.09970670193433762
girl O 0 0.10614428669214249
who O 0 0.032810863107442856
presented O 0 0.03642086684703827
at O 0 0.02869422547519207
9 O 0 0.03458406776189804
months O 0 0.026061078533530235
of O 0 0.015090186148881912
age O 0 0.031060760840773582
and O 0 0.016638774424791336
her O 0 0.03537100926041603
similarly O 0 0.06433732807636261
affected O 0 0.07782740145921707
younger O 0 0.06081561744213104
brother O 0 0.04469447210431099
and O 0 0.01586470566689968
father O 0 0.025795452296733856
were O 0 0.009903036057949066
all O 0 0.009142523631453514
found O 0 0.015981819480657578
to O 0 0.011548020876944065
have O 0 0.013015294447541237
a O 0 0.027627229690551758
novel O 0 0.07184864580631256
missense O 0 0.3336891233921051
mutation O 0 0.39125099778175354
( O 0 0.10403657704591751
G1758 O 1 0.9856451153755188
- O 1 0.9764794707298279
- O 1 0.889809250831604
> O 1 0.893770694732666
T O 1 0.7306921482086182
) O 0 0.048319969326257706
encoding O 0 0.0682310238480568
the O 0 0.03873724117875099
amino O 0 0.13288410007953644
acid O 0 0.2964448630809784
substitution O 0 0.2092544287443161
Gly23 O 1 0.9903116226196289
- O 1 0.9411831498146057
- O 1 0.6115654110908508
> O 1 0.6725770831108093
Val O 1 0.6881721615791321
within O 0 0.07135533541440964
NPII O 1 0.6684794425964355
. O 0 0.06635483354330063

The O 0 0.06512012332677841
mutation O 0 0.1745893508195877
was O 0 0.03612472862005234
confirmed O 0 0.050767529755830765
by O 0 0.034546349197626114
restriction O 0 0.1006028950214386
endonuclease O 0 0.28465786576271057
analysis O 0 0.08035894483327866
. O 0 0.054993148893117905

A O 0 0.11727926880121231
T1 O 1 0.991111695766449
- O 0 0.15364603698253632
weighted O 0 0.11987540125846863
magnetic O 0 0.12976427376270294
resonance O 0 0.15358394384384155
imaging O 0 0.13738523423671722
of O 0 0.025029873475432396
the O 0 0.040395889431238174
fathers O 0 0.13626524806022644
pituitary O 1 0.9992793202400208
gland O 1 0.9975106716156006
demonstrates O 0 0.11716490983963013
an O 0 0.055479418486356735
attenuated O 1 0.9794925451278687
posterior O 1 0.9984279870986938
pituitary O 1 0.9997678399085999
bright O 0 0.35247862339019775
spot O 0 0.10334179550409317
. O 0 0.058888256549835205

This O 0 0.05419467017054558
mutation O 0 0.15749140083789825
may O 0 0.03527868166565895
be O 0 0.013560479506850243
valuable O 0 0.023534182459115982
for O 0 0.017431015148758888
developing O 0 0.04924508184194565
models O 0 0.05203690752387047
of O 0 0.03321025148034096
dominantly B-Disease 1 0.9728772640228271
inherited I-Disease 1 0.9982401132583618
neurodegeneration I-Disease 1 0.9999669790267944
, O 0 0.031886760145425797
as O 0 0.016678400337696075
the O 0 0.01890985108911991
early O 0 0.03424753248691559
age O 0 0.03926892206072807
of O 0 0.031193993985652924
onset O 1 0.9998917579650879
of O 0 0.04484986513853073
symptoms O 1 0.999987006187439
suggests O 0 0.06275933235883713
that O 0 0.01860678568482399
this O 0 0.023635195568203926
mutation O 0 0.1497967541217804
may O 0 0.03221886605024338
be O 0 0.017661090940237045
particularly O 0 0.03884626552462578
deleterious O 0 0.14259929955005646
to O 0 0.025953037664294243
the O 0 0.041486501693725586
magnocellular O 1 0.9941362142562866
neuron O 1 0.9290160536766052
. O 0 0.04542681947350502
. O 0 0.05040169507265091

Frequent O 0 0.18418443202972412
inactivation O 0 0.4738829433917999
of O 0 0.06778852641582489
PTEN O 1 0.9998358488082886
/ O 1 0.9980642199516296
MMAC1 O 1 0.9880406260490417
in O 0 0.057280924171209335
primary O 1 0.9556136727333069
prostate B-Disease 1 1.0
cancer I-Disease 1 0.9999990463256836
. O 0 0.07346834987401962

Sporadic B-Disease 1 0.9989933371543884
prostate I-Disease 1 0.9999998807907104
carcinoma I-Disease 1 0.9999991655349731
is O 0 0.02772427350282669
the O 0 0.01791050098836422
most O 0 0.019549066200852394
common O 0 0.04420799762010574
male B-Disease 0 0.19121946394443512
cancer I-Disease 1 0.9998210072517395
in O 0 0.018159743398427963
the O 0 0.016216877847909927
Western O 0 0.030211232602596283
world O 0 0.02547413296997547
, O 0 0.01505636889487505
yet O 0 0.018868114799261093
many O 0 0.00939152017235756
of O 0 0.010705533437430859
the O 0 0.01873582974076271
major O 0 0.0368170365691185
genetic O 0 0.07357244193553925
events O 0 0.03192469850182533
involved O 0 0.027790913358330727
in O 0 0.014773812144994736
the O 0 0.02128232643008232
progression O 0 0.14440470933914185
of O 0 0.019420038908720016
this O 0 0.02708541601896286
often O 0 0.058484502136707306
fatal O 1 0.9999421834945679
cancer B-Disease 1 0.9999394416809082
remain O 0 0.03478950634598732
to O 0 0.019749542698264122
be O 0 0.021127035841345787
elucidated O 0 0.1337158977985382
. O 0 0.04919607564806938

Numerous O 0 0.08860239386558533
cytogenetic O 1 0.7158752679824829
and O 0 0.04316456988453865
allelotype O 0 0.19655412435531616
studies O 0 0.056663088500499725
have O 0 0.025337137281894684
reported O 0 0.04906585067510605
frequent O 0 0.07244981080293655
loss O 0 0.06984304636716843
of O 0 0.029734069481492043
heterozygosity O 1 0.7968655824661255
on O 0 0.04487539455294609
chromosomal O 1 0.6426319479942322
arm O 1 0.9106295108795166
10q O 1 0.898070216178894
in O 0 0.058391023427248
sporadic B-Disease 1 0.9985474944114685
prostate I-Disease 1 1.0
cancer I-Disease 1 0.9999995231628418
. O 0 0.08045484870672226

Deletion O 0 0.2741306722164154
mapping O 0 0.12183163315057755
studies O 0 0.05525272712111473
have O 0 0.025515418499708176
unambiguously O 0 0.07700210064649582
identified O 0 0.034663502126932144
a O 0 0.026779159903526306
region O 0 0.04321419820189476
of O 0 0.027389202266931534
chromosome O 0 0.16013434529304504
10q23 O 0 0.12627151608467102
to O 0 0.020339002832770348
be O 0 0.014247523620724678
the O 0 0.017815232276916504
minimal O 0 0.05768556520342827
area O 0 0.03569724038243294
of O 0 0.02248460054397583
loss O 0 0.09398896247148514
. O 0 0.04918815940618515

A O 0 0.09484626352787018
new O 0 0.09527257829904556
tumor B-Disease 1 0.9992330074310303
suppressor O 1 0.979636549949646
gene O 0 0.22478310763835907
, O 0 0.0839245393872261
PTEN O 1 0.9997978806495667
/ O 1 0.9934862852096558
MMAC1 O 1 0.8038201928138733
, O 0 0.03086378611624241
was O 0 0.030778422951698303
isolated O 0 0.06603303551673889
recently O 0 0.03632211312651634
at O 0 0.022431794553995132
this O 0 0.015150999650359154
region O 0 0.03846890106797218
of O 0 0.02506815455853939
chromosome O 0 0.16013476252555847
10q23 O 0 0.12611234188079834
and O 0 0.02012486755847931
found O 0 0.02179151587188244
to O 0 0.016090307384729385
be O 0 0.018106747418642044
inactivated O 0 0.10240379720926285
by O 0 0.02910137176513672
mutation O 0 0.14204591512680054
in O 0 0.0346648246049881
three O 0 0.05951874703168869
prostate B-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
cell O 1 0.7579596638679504
lines O 0 0.07574722170829773
. O 0 0.04933523014187813

We O 0 0.06412947922945023
screened O 0 0.1568809598684311
80 O 0 0.1521364450454712
prostate B-Disease 1 0.9999967813491821
tumors I-Disease 1 0.9999133348464966
by O 0 0.04752815142273903
microsatellite O 0 0.2308562844991684
analysis O 0 0.0469161681830883
and O 0 0.026648569852113724
found O 0 0.0440014973282814
chromosome O 0 0.1519370824098587
10q23 O 0 0.13982920348644257
to O 0 0.02229701541364193
be O 0 0.019115252420306206
deleted O 0 0.05491127818822861
in O 0 0.023730594664812088
23 O 0 0.045370522886514664
cases O 0 0.05484405532479286
. O 0 0.04741310328245163

We O 0 0.03776007518172264
then O 0 0.024950796738266945
proceeded O 0 0.040746018290519714
with O 0 0.01967630162835121
sequence O 0 0.036623913794755936
analysis O 0 0.02836606837809086
of O 0 0.01524349581450224
the O 0 0.026808615773916245
entire O 0 0.08693510293960571
PTEN O 1 0.9993458390235901
/ O 1 0.9922463893890381
MMAC1 O 1 0.9052877426147461
coding O 0 0.1390993744134903
region O 0 0.05692308023571968
and O 0 0.024215789511799812
tested O 0 0.07938521355390549
for O 0 0.02908298559486866
homozygous O 0 0.14197230339050293
deletion O 0 0.1464858502149582
with O 0 0.03209420666098595
new O 0 0.04104951396584511
intragenic O 0 0.17792591452598572
markers O 0 0.07310766726732254
in O 0 0.017882071435451508
these O 0 0.01618250645697117
23 O 0 0.03373100236058235
cases O 0 0.036831438541412354
with O 0 0.03156200796365738
10q23 O 0 0.25496116280555725
loss O 0 0.09069377183914185
of O 0 0.03828488290309906
heterozygosity O 1 0.961377739906311
. O 0 0.07373961061239243

The O 0 0.034380123019218445
identification O 0 0.04481195658445358
of O 0 0.015874745324254036
the O 0 0.024001937359571457
second O 0 0.05186903104186058
mutational O 0 0.3622443974018097
event O 0 0.058596156537532806
in O 0 0.02214077301323414
10 O 0 0.03245978802442551
( O 0 0.04401054605841637
43 O 0 0.06335233896970749
% O 0 0.06418278068304062
) O 0 0.08850721269845963
tumors B-Disease 1 0.9999732971191406
establishes O 1 0.9884661436080933
PTEN O 1 0.9999308586120605
/ O 1 0.9905831813812256
MMAC1 O 0 0.45335710048675537
as O 0 0.024329273030161858
a O 0 0.02981938235461712
main O 0 0.045267101377248764
inactivation O 0 0.14724387228488922
target O 0 0.050804052501916885
of O 0 0.0252878088504076
10q O 0 0.3565636873245239
loss O 0 0.1307707130908966
in O 0 0.04778042808175087
sporadic B-Disease 1 0.9989109039306641
prostate I-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
. O 0 0.04840824007987976
. O 0 0.05138270929455757

Risk O 1 0.8678835034370422
reversals O 0 0.16864559054374695
in O 0 0.04233359545469284
predictive O 0 0.17416135966777802
testing O 0 0.12281577289104462
for O 0 0.06219569966197014
Huntington B-Disease 1 0.9999958276748657
disease I-Disease 1 0.9999977350234985
. O 0 0.06934408098459244

The O 0 0.040933385491371155
first O 0 0.037793584167957306
predictive O 0 0.15243755280971527
testing O 0 0.10934270918369293
for O 0 0.05846460536122322
Huntington B-Disease 1 0.9999963045120239
disease I-Disease 1 0.9999970197677612
( O 0 0.08103205263614655
HD B-Disease 0 0.15441739559173584
) O 0 0.028384968638420105
was O 0 0.017123645171523094
based O 0 0.016850870102643967
on O 0 0.013610056601464748
analysis O 0 0.029841214418411255
of O 0 0.020212747156620026
linked O 0 0.11084268987178802
polymorphic O 0 0.3165867030620575
DNA O 0 0.10691525787115097
markers O 0 0.07967463880777359
to O 0 0.022241849452257156
estimate O 0 0.04136591777205467
the O 0 0.022726085036993027
likelihood O 0 0.06726638227701187
of O 0 0.0232541523873806
inheriting O 0 0.12222910672426224
the O 0 0.03878043219447136
mutation O 0 0.16972820460796356
for O 0 0.04448371008038521
HD B-Disease 0 0.19591233134269714
. O 0 0.05358979478478432

Limits O 0 0.06591133773326874
to O 0 0.02603301778435707
accuracy O 0 0.04616229236125946
included O 0 0.030578291043639183
recombination O 0 0.11797882616519928
between O 0 0.025901205837726593
the O 0 0.024189453572034836
DNA O 0 0.07717195898294449
markers O 0 0.07666700333356857
and O 0 0.01914348267018795
the O 0 0.03030899353325367
mutation O 0 0.14921419322490692
, O 0 0.03206172585487366
pedigree O 0 0.10304611176252365
structure O 0 0.03339005261659622
, O 0 0.016606036573648453
and O 0 0.01551524642854929
whether O 0 0.026425981894135475
DNA O 0 0.06245400756597519
samples O 0 0.040177252143621445
were O 0 0.012378653511404991
available O 0 0.01828417368233204
from O 0 0.018564565107226372
family O 0 0.03529324382543564
members O 0 0.03252524510025978
. O 0 0.04159826785326004

With O 0 0.03622986748814583
direct O 0 0.04651112109422684
tests O 0 0.049222514033317566
for O 0 0.02078852616250515
the O 0 0.030333546921610832
HD B-Disease 0 0.19135017693042755
mutation O 0 0.1525002419948578
, O 0 0.02513585239648819
we O 0 0.015993019565939903
have O 0 0.01503665279597044
assessed O 0 0.039209987968206406
the O 0 0.015144113451242447
accuracy O 0 0.03049389272928238
of O 0 0.013833210803568363
results O 0 0.0331326425075531
obtained O 0 0.025844313204288483
by O 0 0.02368279919028282
linkage O 0 0.13043072819709778
approaches O 0 0.0671229138970375
when O 0 0.024875925853848457
requested O 0 0.03148322179913521
to O 0 0.014739979058504105
do O 0 0.019166704267263412
so O 0 0.01478909607976675
by O 0 0.014068090356886387
the O 0 0.01959381066262722
test O 0 0.05544719472527504
individuals O 0 0.046074334532022476
. O 0 0.03882875293493271

For O 0 0.02671360969543457
six O 0 0.0277981236577034
such O 0 0.017089402303099632
individuals O 0 0.02671636827290058
, O 0 0.01624356396496296
there O 0 0.015358129516243935
was O 0 0.01967945322394371
significant O 0 0.03177911415696144
disparity O 0 0.09330414980649948
between O 0 0.023810958489775658
the O 0 0.027527907863259315
tests O 0 0.07193780690431595
. O 0 0.04615139216184616

Three O 0 0.038230642676353455
went O 0 0.04414364695549011
from O 0 0.025757433846592903
a O 0 0.03545265644788742
decreased O 0 0.09914802014827728
risk O 0 0.09505373984575272
to O 0 0.019531210884451866
an O 0 0.02149912714958191
increased O 0 0.044189583510160446
risk O 0 0.09908948093652725
, O 0 0.015244139358401299
while O 0 0.014019237831234932
in O 0 0.01321304589509964
another O 0 0.01986367627978325
three O 0 0.016417531296610832
the O 0 0.026280291378498077
risk O 0 0.11288832128047943
was O 0 0.035931408405303955
decreased O 0 0.10931877046823502
. O 0 0.0493842214345932

Knowledge O 0 0.04890530928969383
of O 0 0.018029997125267982
the O 0 0.019930889829993248
potential O 0 0.04087136313319206
reasons O 0 0.02580159530043602
for O 0 0.012526691891252995
these O 0 0.011884056031703949
changes O 0 0.021388903260231018
in O 0 0.014238928444683552
results O 0 0.030445599928498268
and O 0 0.015736771747469902
impact O 0 0.03647482395172119
of O 0 0.014096207916736603
these O 0 0.020407218486070633
risk O 0 0.16488340497016907
reversals O 0 0.10050540417432785
on O 0 0.02052224799990654
both O 0 0.024193748831748962
patients O 1 0.9875872731208801
and O 0 0.01836315542459488
the O 0 0.02165820635855198
counseling O 0 0.44484180212020874
team O 0 0.03272628411650658
can O 0 0.02108065038919449
assist O 0 0.03251776099205017
in O 0 0.013971177861094475
the O 0 0.015159007161855698
development O 0 0.02520410344004631
of O 0 0.014879919588565826
strategies O 0 0.058205004781484604
for O 0 0.016952618956565857
the O 0 0.023929879069328308
prevention O 1 0.7716540098190308
and O 0 0.016006121411919594
, O 0 0.016204871237277985
where O 0 0.017792101949453354
necessary O 0 0.0251051876693964
, O 0 0.015874342992901802
management O 0 0.03659362345933914
of O 0 0.014097573235630989
a O 0 0.03480865806341171
risk O 0 0.438215970993042
reversal O 0 0.09652886539697647
in O 0 0.0224488265812397
any O 0 0.024545198306441307
predictive O 0 0.11836168169975281
testing O 0 0.07899127900600433
program O 0 0.055951278656721115
. O 0 0.03214503452181816
. O 0 0.04513099789619446

A O 0 0.08560264110565186
novel O 0 0.08388400077819824
common O 0 0.09316713362932205
missense O 0 0.312918484210968
mutation O 0 0.2226538211107254
G301C O 0 0.15147681534290314
in O 0 0.02818109840154648
the O 0 0.032770056277513504
N O 0 0.19517111778259277
- O 0 0.410749226808548
acetylgalactosamine O 1 0.9721234440803528
- O 0 0.4990083873271942
6 O 0 0.12098609656095505
- O 1 0.9676909446716309
sulfate O 1 0.9992955923080444
sulfatase O 1 0.999178946018219
gene O 0 0.18475693464279175
in O 0 0.055486831814050674
mucopolysaccharidosis B-Disease 1 0.9580322504043579
IVA I-Disease 1 0.9972686767578125
. O 0 0.08114387840032578

Mucopolysaccharidosis B-Disease 1 0.9940006136894226
IVA I-Disease 1 0.9994126558303833
( O 0 0.11484677344560623
MPS B-Disease 1 0.875792920589447
IVA I-Disease 1 0.9998496770858765
) O 0 0.05229221284389496
is O 0 0.032250575721263885
an O 0 0.04194508120417595
autosomal B-Disease 1 0.9998407363891602
recessive I-Disease 1 0.9999798536300659
lysosomal I-Disease 1 0.9999939203262329
storage I-Disease 1 0.9983953833580017
disorder I-Disease 1 0.9999974966049194
caused O 0 0.37406277656555176
by O 0 0.029590051621198654
a O 0 0.0468670055270195
genetic B-Disease 1 0.5863240957260132
defect I-Disease 1 0.9956068396568298
in O 0 0.04982016980648041
N O 1 0.5272420644760132
- O 0 0.4451015591621399
acetylgalactosamine O 1 0.97691810131073
- O 1 0.6971974968910217
6 O 0 0.1255827397108078
- O 1 0.9757925868034363
sulfate O 1 0.9996640682220459
sulfatase O 1 0.9997344613075256
( O 0 0.10381901264190674
GALNS O 1 0.9052362442016602
) O 0 0.05741477757692337
. O 0 0.04832179471850395

In O 0 0.034859929233789444
previous O 0 0.037720683962106705
studies O 0 0.03718402609229088
, O 0 0.017477592453360558
we O 0 0.013805605471134186
have O 0 0.011763056740164757
found O 0 0.018313702195882797
two O 0 0.017085326835513115
common O 0 0.05076855421066284
mutations O 0 0.12891559302806854
in O 0 0.03129199892282486
Caucasians O 0 0.15884196758270264
and O 0 0.02396874874830246
Japanese O 0 0.03846054896712303
, O 0 0.024288427084684372
respectively O 0 0.046014536172151566
. O 0 0.044718172401189804

To O 0 0.054612789303064346
characterize O 0 0.12251167744398117
the O 0 0.0432770662009716
mutational O 1 0.6540844440460205
spectrum O 0 0.06964660435914993
in O 0 0.015518234111368656
various O 0 0.013318165205419064
ethnic O 0 0.02589532360434532
groups O 0 0.03429371118545532
, O 0 0.027270600199699402
mutations O 0 0.09976180642843246
in O 0 0.022591885179281235
the O 0 0.028285056352615356
GALNS O 1 0.8259274959564209
gene O 0 0.11653421074151993
in O 0 0.03696151077747345
Colombian O 0 0.13426613807678223
MPS B-Disease 1 0.9966843724250793
IVA I-Disease 1 0.9999963045120239
patients O 1 0.999527096748352
were O 0 0.025350801646709442
investigated O 0 0.05383538082242012
, O 0 0.020028745755553246
and O 0 0.01956331729888916
genetic O 0 0.07230953872203827
backgrounds O 0 0.046973250806331635
were O 0 0.016216445714235306
extensively O 0 0.04067761451005936
analyzed O 0 0.045962680131196976
to O 0 0.02163691259920597
identify O 0 0.04164838790893555
racial O 0 0.049165964126586914
origin O 0 0.029865162447094917
, O 0 0.019550660625100136
based O 0 0.023534178733825684
on O 0 0.022867685183882713
mitochondrial O 0 0.12768636643886566
DNA O 0 0.1189652606844902
( O 0 0.07046346366405487
mtDNA O 0 0.16733218729496002
) O 0 0.06222989782691002
lineages O 0 0.14040407538414001
. O 0 0.05935154855251312

Three O 0 0.06011870130896568
novel O 0 0.10035073012113571
missense O 0 0.32849743962287903
mutations O 0 0.18843965232372284
never O 0 0.05018051341176033
identified O 0 0.036804694682359695
previously O 0 0.02549660950899124
in O 0 0.014677433297038078
other O 0 0.014105819165706635
populations O 0 0.04443429410457611
and O 0 0.014362212270498276
found O 0 0.021301789209246635
in O 0 0.014980808831751347
16 O 0 0.023955613374710083
out O 0 0.01912563294172287
of O 0 0.01972261257469654
19 O 0 0.05525222420692444
Colombian O 0 0.12464910000562668
MPS B-Disease 1 0.6219050288200378
IVA I-Disease 1 0.9995075464248657
unrelated O 0 0.14260731637477875
alleles O 0 0.1909804791212082
account O 0 0.04806436970829964
for O 0 0.0299731083214283
84 O 0 0.1057535856962204
. O 0 0.04839605093002319

2 O 0 0.06017984077334404
% O 0 0.03430310636758804
of O 0 0.01674695685505867
the O 0 0.022542985156178474
alleles O 0 0.1253262609243393
in O 0 0.02294091507792473
this O 0 0.023913051933050156
study O 0 0.05150071531534195
. O 0 0.04347238317131996

The O 0 0.06177651137113571
G301C O 0 0.17653588950634003
and O 0 0.04237726703286171
S162F O 0 0.2052862048149109
mutations O 0 0.1474638283252716
account O 0 0.040776144713163376
for O 0 0.02828792668879032
68 O 0 0.09382639080286026
. O 0 0.04880417883396149

4 O 0 0.06992585957050323
% O 0 0.04572607949376106
and O 0 0.023071803152561188
10 O 0 0.03638399392366409
. O 0 0.044160667806863785

5 O 0 0.06342964619398117
% O 0 0.03962432220578194
of O 0 0.02541329711675644
mutations O 0 0.11296702176332474
, O 0 0.02692132256925106
respectively O 0 0.034587059170007706
, O 0 0.020113851875066757
whereas O 0 0.04147796705365181
the O 0 0.019906239584088326
remaining O 0 0.03735014423727989
F69V O 0 0.16096992790699005
is O 0 0.024855300784111023
limited O 0 0.029267922043800354
to O 0 0.016465820372104645
a O 0 0.02794533036649227
single O 0 0.05224959924817085
allele O 0 0.17181396484375
. O 0 0.0579727478325367

The O 0 0.05327044054865837
skewed O 0 0.15668660402297974
prevalence O 1 0.5401354432106018
of O 0 0.031611137092113495
G301C O 0 0.12746953964233398
in O 0 0.026551296934485435
only O 0 0.02363375946879387
Colombian O 0 0.09515906870365143
patients O 1 0.9970464110374451
and O 0 0.035153672099113464
haplotype O 1 0.9257226586341858
analysis O 0 0.05290205031633377
by O 0 0.027500005438923836
restriction O 0 0.07884577661752701
fragment O 0 0.10846083611249924
length O 0 0.06402970850467682
polymorphisms O 0 0.13378050923347473
in O 0 0.024467231705784798
the O 0 0.03381863608956337
GALNS O 1 0.9307980537414551
gene O 0 0.13510896265506744
suggest O 0 0.060913342982530594
that O 0 0.023541908711194992
G301C O 0 0.13065236806869507
originated O 0 0.05551678687334061
from O 0 0.022809868678450584
a O 0 0.030018754303455353
common O 0 0.04575307294726372
ancestor O 0 0.10640152543783188
. O 0 0.05681175738573074

Investigation O 0 0.06457564234733582
of O 0 0.018563028424978256
the O 0 0.02599748969078064
genetic O 0 0.08298511058092117
background O 0 0.049575310200452805
by O 0 0.021610772237181664
means O 0 0.03740938380360603
of O 0 0.026614736765623093
mtDNA O 0 0.15547746419906616
lineages O 0 0.12393597513437271
indicate O 0 0.04736608266830444
that O 0 0.015055853873491287
all O 0 0.01524162758141756
our O 0 0.029144151136279106
patients O 1 0.9629295468330383
are O 0 0.01654549315571785
probably O 0 0.030126212164759636
of O 0 0.01575452834367752
native O 0 0.03866944462060928
American O 0 0.06189029663801193
descent O 0 0.1605072170495987

Low O 0 0.1429482400417328
frequency O 0 0.11166586726903915
of O 0 0.052271485328674316
BRCA1 O 1 0.9939262270927429
germline O 1 0.9630962610244751
mutations O 0 0.20512740314006805
in O 0 0.040277596563100815
45 O 0 0.0791550725698471
German O 1 0.99699866771698
breast B-Disease 1 1.0
/ I-Disease 1 0.9999997615814209
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
families O 0 0.0978107675909996
. O 0 0.06028250977396965

In O 0 0.028547007590532303
this O 0 0.019542792811989784
study O 0 0.03549756854772568
we O 0 0.021527724340558052
investigated O 0 0.06796789169311523
45 O 0 0.06778111308813095
German O 1 0.9853248000144958
breast B-Disease 1 1.0
/ I-Disease 1 0.9999996423721313
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
families O 0 0.07583808898925781
for O 0 0.04286689683794975
germline O 1 0.9609110355377197
mutations O 0 0.1604386270046234
in O 0 0.030434835702180862
the O 0 0.04285667464137077
BRCA1 O 1 0.9892191290855408
gene O 0 0.1696588397026062
. O 0 0.060419343411922455

We O 0 0.04241297021508217
identified O 0 0.05100554600358009
four O 0 0.04735398292541504
germline O 1 0.6916010975837708
mutations O 0 0.1638721227645874
in O 0 0.031825825572013855
three O 0 0.04324015974998474
breast B-Disease 1 0.9999982118606567
cancer I-Disease 1 0.9999877214431763
families O 0 0.04264885559678078
and O 0 0.019146205857396126
in O 0 0.024777935817837715
one O 0 0.07913888245820999
breast B-Disease 1 1.0
- I-Disease 1 0.9999966621398926
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
family O 0 0.055852264165878296
. O 0 0.01787201687693596
among O 0 0.016755688935518265
these O 0 0.013109815306961536
were O 0 0.01719803735613823
one O 0 0.03417425602674484
frameshift O 1 0.8845078349113464
mutation O 0 0.18319815397262573
, O 0 0.03381931036710739
one O 0 0.03547215089201927
nonsense O 0 0.11436746269464493
mutation O 0 0.14607086777687073
, O 0 0.026156214997172356
one O 0 0.023766344413161278
novel O 0 0.059367138892412186
splice O 0 0.18935737013816833
site O 0 0.0691416785120964
mutation O 0 0.14455546438694
, O 0 0.026962606236338615
and O 0 0.025127343833446503
one O 0 0.044285230338573456
missense O 0 0.24826325476169586
mutation O 0 0.24434663355350494
. O 0 0.06657669693231583

The O 0 0.07231324166059494
missense O 0 0.2652442157268524
mutation O 0 0.17973585426807404
was O 0 0.027998194098472595
also O 0 0.018824519589543343
found O 0 0.023153819143772125
in O 0 0.02100289799273014
2 O 0 0.045691877603530884
. O 0 0.041120246052742004

8 O 0 0.05721689760684967
% O 0 0.03299508988857269
of O 0 0.013448826037347317
the O 0 0.016886113211512566
general O 0 0.02617330104112625
population O 0 0.0289292149245739
, O 0 0.019817356020212173
suggesting O 0 0.042343951761722565
that O 0 0.012747145257890224
it O 0 0.015387829393148422
is O 0 0.021283119916915894
not O 0 0.025121241807937622
disease O 1 0.9998981952667236
associated O 0 0.06301499158143997
. O 0 0.049947649240493774

The O 0 0.0411013588309288
average O 0 0.06406082957983017
age O 0 0.05566658079624176
of O 0 0.035300709307193756
disease O 1 0.9999978542327881
onset O 1 0.9998425245285034
in O 0 0.03281862288713455
those O 0 0.031476497650146484
families O 0 0.07505036890506744
harbouring O 1 0.9938951134681702
causative O 1 0.9730585217475891
mutations O 0 0.16640561819076538
was O 0 0.03236246854066849
between O 0 0.030310504138469696
32 O 0 0.06637032330036163
. O 0 0.05035826191306114

3 O 0 0.06864503026008606
and O 0 0.03209894523024559
37 O 0 0.07746591418981552
. O 0 0.05241099372506142

4 O 0 0.06962969899177551
years O 0 0.03331549093127251
, O 0 0.02263517491519451
whereas O 0 0.0471736341714859
the O 0 0.024438079446554184
family O 0 0.05513865873217583
harbouring O 1 0.6003565788269043
the O 0 0.04666639119386673
missense O 0 0.24889038503170013
mutation O 0 0.1754891574382782
had O 0 0.032238151878118515
an O 0 0.02348516322672367
average O 0 0.04735589027404785
age O 0 0.04177498444914818
of O 0 0.026879368349909782
onset O 1 0.9877891540527344
of O 0 0.03254801034927368
51 O 0 0.0927114337682724
. O 0 0.05278189852833748

2 O 0 0.08404545485973358
years O 0 0.050387367606163025
. O 0 0.04978729411959648

These O 0 0.03186526522040367
findings O 0 0.05515093728899956
show O 0 0.03954702243208885
that O 0 0.02623308263719082
BRCA1 O 1 0.8920600414276123
is O 0 0.030997449532151222
implicated O 0 0.07757409662008286
in O 0 0.01851549930870533
a O 0 0.02333635464310646
small O 0 0.03130088374018669
fraction O 0 0.06915850192308426
of O 0 0.050777725875377655
breast B-Disease 1 1.0
/ I-Disease 1 0.9999997615814209
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999994039535522
families O 0 0.06297606974840164
suggesting O 0 0.05734018236398697
the O 0 0.022367648780345917
involvement O 0 0.06072785705327988
of O 0 0.024683699011802673
another O 0 0.063262440264225
susceptibility O 1 0.9516828060150146
gene O 0 0.1913146674633026
( O 0 0.0962974950671196
s O 0 0.21374298632144928
) O 0 0.09383365511894226

Paternal O 0 0.48621803522109985
transmission O 1 0.7142494320869446
of O 0 0.09550632536411285
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.11049945652484894

We O 0 0.03511664643883705
report O 0 0.029644252732396126
a O 0 0.027667716145515442
rare O 0 0.05438731238245964
case O 0 0.037696704268455505
of O 0 0.03541519120335579
paternally O 1 0.9940640330314636
transmitted O 1 0.9994390606880188
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9982143640518188
DM B-Disease 1 0.9999996423721313
) O 0 0.07217955589294434
. O 0 0.05035372078418732

The O 0 0.05067930743098259
proband O 0 0.15195001661777496
is O 0 0.024525882676243782
a O 0 0.024761730805039406
23 O 0 0.03455541655421257
year O 0 0.029273247346282005
old O 0 0.0456099733710289
, O 0 0.038583558052778244
mentally B-Disease 1 0.9998408555984497
retarded I-Disease 1 0.9993183612823486
male O 0 0.4166683852672577
who O 1 0.6666966676712036
suffers O 1 0.9999986886978149
severe O 1 0.9999964237213135
muscular B-Disease 1 0.9999942779541016
weakness I-Disease 1 0.9995182752609253
. O 0 0.0648416206240654

He O 0 0.04146971181035042
presented O 0 0.04447773098945618
with O 0 0.04215580224990845
respiratory O 1 0.9999939203262329
and O 0 0.02945771999657154
feeding O 0 0.09928468614816666
difficulties O 0 0.08474616706371307
at O 0 0.048750139772892
birth O 0 0.08253898471593857
. O 0 0.049916453659534454

His O 0 0.054892025887966156
two O 0 0.050154875963926315
sibs O 1 0.9993515610694885
suffer O 1 0.9991387128829956
from O 0 0.07342933118343353
childhood O 1 0.999612033367157
onset O 1 0.9999921321868896
DM B-Disease 1 0.9999983310699463
. O 0 0.08637970685958862

Their O 0 0.03320639580488205
late O 0 0.04189951717853546
father O 0 0.038358174264431
had O 0 0.022281629964709282
the O 0 0.02029612474143505
adult O 0 0.06305042654275894
type O 0 0.08677828311920166
of O 0 0.03780669718980789
DM B-Disease 1 0.999998927116394
, O 0 0.03482877090573311
with O 0 0.03561718016862869
onset O 1 0.9947465062141418
around O 0 0.03585130721330643
30 O 0 0.03823661431670189
years O 0 0.033304616808891296
. O 0 0.04361329227685928

Only O 0 0.027757566422224045
six O 0 0.027283258736133575
other O 0 0.01650354638695717
cases O 0 0.033961668610572815
of O 0 0.02279491163790226
paternal O 0 0.1523837298154831
transmission O 0 0.47768059372901917
of O 0 0.057127874344587326
congenital B-Disease 1 1.0
DM I-Disease 1 0.9999994039535522
have O 0 0.037175849080085754
been O 0 0.027901796624064445
reported O 0 0.05052255839109421
recently O 0 0.053418464958667755
. O 0 0.042428918182849884

We O 0 0.03548702970147133
review O 0 0.03551260009407997
the O 0 0.022404000163078308
sex O 0 0.05662938952445984
related O 0 0.05278697982430458
effects O 0 0.08603208512067795
on O 0 0.026385443285107613
transmission O 0 0.14778199791908264
of O 0 0.0551932193338871
congenital B-Disease 1 0.9999997615814209
DM I-Disease 1 0.9999990463256836
. O 0 0.08771269023418427

Decreased O 0 0.31928807497024536
fertility O 0 0.26561322808265686
of O 0 0.03015061654150486
males O 0 0.08674240112304688
with O 0 0.0414457768201828
adult O 1 0.7140542268753052
onset O 1 0.9999964237213135
DM B-Disease 1 0.9999990463256836
and O 0 0.042907413095235825
contraction O 0 0.10648630559444427
of O 0 0.018193822354078293
the O 0 0.021891042590141296
repeat O 0 0.09283942729234695
upon O 0 0.03832005709409714
male O 0 0.07299108058214188
transmission O 0 0.09829262644052505
contribute O 0 0.05194259062409401
to O 0 0.01696842350065708
the O 0 0.01891687698662281
almost O 0 0.03262768313288689
absent O 0 0.08078324794769287
occurrence O 0 0.09853354096412659
of O 0 0.030319442972540855
paternal O 0 0.15949700772762299
transmission O 0 0.3825714886188507
of O 0 0.06723880022764206
congenital B-Disease 1 0.9999998807907104
DM I-Disease 1 0.9999994039535522
. O 0 0.08039020746946335

Also O 0 0.03627092018723488
the O 0 0.025025738403201103
fathers O 0 0.056289806962013245
of O 0 0.01791863702237606
the O 0 0.028886165469884872
reported O 0 0.07038234174251556
congenitally O 1 0.9844383597373962
affected O 0 0.09252990037202835
children O 0 0.04979436844587326
showed O 0 0.04009776562452316
, O 0 0.01701967604458332
on O 0 0.015832025557756424
average O 0 0.04606354981660843
, O 0 0.029847681522369385
shorter O 0 0.10987485200166702
CTG O 1 0.97298264503479
repeat O 0 0.13541238009929657
lengths O 0 0.0843268409371376
and O 0 0.02711859531700611
hence O 0 0.05986285209655762
less O 0 0.05767269432544708
severe O 1 0.9999600648880005
clinical O 1 0.9998724460601807
symptoms O 1 0.9999856948852539
than O 0 0.02299354039132595
the O 0 0.023714100942015648
mothers O 0 0.08755031228065491
of O 0 0.019103240221738815
children O 0 0.053603969514369965
with O 0 0.06707111746072769
congenital B-Disease 1 1.0
DM I-Disease 1 0.9999995231628418
. O 0 0.08460450172424316

We O 0 0.04752044007182121
conclude O 0 0.080245740711689
that O 0 0.02883242256939411
paternal O 0 0.1483885645866394
transmission O 0 0.2513914108276367
of O 0 0.06307899206876755
congenital B-Disease 1 0.9999998807907104
DM I-Disease 1 0.9999997615814209
is O 0 0.04618990421295166
rare O 0 0.06346612423658371
and O 0 0.02972024492919445
preferentially O 0 0.1531561315059662
occurs O 0 0.0920301303267479
with O 0 0.038426902145147324
onset O 1 0.9994407296180725
of O 0 0.0477200485765934
DM B-Disease 1 0.9999947547912598
past O 0 0.047190114855766296
30 O 0 0.027672380208969116
years O 0 0.018554698675870895
in O 0 0.014392958022654057
the O 0 0.017002403736114502
father O 0 0.0415513776242733
. O 0 0.029513636603951454
. O 0 0.040732432156801224

The O 0 0.0971403643488884
RB1 O 1 0.9970980882644653
gene O 0 0.2084754854440689
mutation O 0 0.17650063335895538
in O 0 0.03113878332078457
a O 0 0.03996167704463005
child O 0 0.0822383239865303
with O 0 0.055986955761909485
ectopic B-Disease 1 0.9998077750205994
intracranial I-Disease 1 0.9999741315841675
retinoblastoma I-Disease 1 0.9995830655097961
. O 0 0.08748048543930054

The O 0 0.09817419201135635
RB1 O 1 0.9972161054611206
gene O 0 0.20744547247886658
mutation O 0 0.1789168417453766
was O 0 0.03224324807524681
investigated O 0 0.05309230834245682
in O 0 0.01779114454984665
a O 0 0.0276507455855608
child O 0 0.06537187844514847
with O 0 0.05061136558651924
ectopic B-Disease 1 0.9997588992118835
intracranial I-Disease 1 0.9998948574066162
retinoblastoma I-Disease 1 0.9981691837310791
using O 0 0.0470544770359993
DNA O 0 0.06525792926549911
obtained O 0 0.02720886468887329
from O 0 0.018342914059758186
both O 0 0.017740080133080482
the O 0 0.030681926757097244
pineal B-Disease 1 0.9991588592529297
and I-Disease 0 0.05304610729217529
retinal I-Disease 1 0.9999896287918091
tumours I-Disease 1 0.9998514652252197
of O 0 0.029068414121866226
the O 0 0.03818191587924957
patient O 1 0.9818629622459412
. O 0 0.05957069620490074

A O 0 0.09541189670562744
nonsense O 0 0.15188032388687134
mutation O 0 0.1775686889886856
in O 0 0.0425167940557003
exon O 0 0.18390250205993652
17 O 0 0.07099777460098267
( O 0 0.0702439695596695
codon O 0 0.15849217772483826
556 O 0 0.1475755125284195
) O 0 0.036188870668411255
of O 0 0.018250560387969017
the O 0 0.03779830038547516
RB1 O 1 0.9992757439613342
gene O 0 0.10826127231121063
was O 0 0.024421965703368187
found O 0 0.019059427082538605
to O 0 0.01239707600325346
be O 0 0.01254369132220745
present O 0 0.02518443576991558
homozygously O 0 0.09557190537452698
in O 0 0.016520680859684944
both O 0 0.01619367115199566
the O 0 0.02757103554904461
retinal B-Disease 1 0.9993613362312317
and I-Disease 0 0.033126745373010635
the I-Disease 0 0.05007817968726158
pineal I-Disease 1 0.9998207688331604
tumours I-Disease 1 0.999902606010437
. O 0 0.07330828905105591

The O 0 0.041042350232601166
same O 0 0.0422564372420311
mutation O 0 0.1283065378665924
was O 0 0.02954227477312088
present O 0 0.03125648573040962
heterozygously O 0 0.10993688553571701
in O 0 0.017504127696156502
the O 0 0.018444672226905823
DNA O 0 0.05304157733917236
from O 0 0.017189117148518562
the O 0 0.015391060151159763
constitutional O 0 0.03408167511224747
cells O 0 0.07021310925483704
of O 0 0.01574811153113842
the O 0 0.027463888749480247
patient O 1 0.9188646078109741
, O 0 0.02195916883647442
proving O 0 0.05123385787010193
it O 0 0.012186139822006226
to O 0 0.011924950405955315
be O 0 0.012999340891838074
of O 0 0.021846987307071686
germline O 0 0.253162145614624
origin O 0 0.061723899096250534
. O 0 0.05175110697746277

The O 0 0.047456901520490646
initial O 0 0.09198617935180664
mutation O 0 0.14482459425926208
was O 0 0.027272706851363182
shown O 0 0.029406379908323288
to O 0 0.014485162682831287
have O 0 0.016876641660928726
occurred O 0 0.041262995451688766
in O 0 0.019832471385598183
the O 0 0.03382488712668419
paternally O 0 0.24798929691314697
derived O 0 0.14234696328639984
RB1 O 1 0.9967262744903564
allele O 0 0.2730971872806549
. O 0 0.07527592033147812

The O 0 0.0577518455684185
mutation O 0 0.14540377259254456
is O 0 0.022779695689678192
in O 0 0.015986410900950432
an O 0 0.016284914687275887
area O 0 0.024792324751615524
of O 0 0.013508033007383347
the O 0 0.022308913990855217
gene O 0 0.07954645156860352
that O 0 0.020494746044278145
encodes O 0 0.07463402301073074
the O 0 0.03367353975772858
protein O 0 0.10116113722324371
- O 0 0.09496986120939255
binding O 0 0.061320096254348755
region O 0 0.05239979177713394
known O 0 0.031120629981160164
as O 0 0.015398228541016579
the O 0 0.01965802162885666
pocket O 0 0.08628715574741364
region O 0 0.0401042141020298
and O 0 0.017677446827292442
has O 0 0.018648825585842133
been O 0 0.01976211555302143
detected O 0 0.05525803193449974
in O 0 0.013877424411475658
other O 0 0.013741310685873032
cases O 0 0.035267628729343414
of O 0 0.026669297367334366
retinoblastoma B-Disease 1 0.998329222202301
. O 0 0.03801826760172844
. O 0 0.04363538697361946

Low O 0 0.11466608941555023
levels O 0 0.07695326209068298
of O 0 0.03124086558818817
beta O 0 0.10379895567893982
hexosaminidase O 0 0.14853021502494812
A O 0 0.03673204034566879
in O 0 0.024423997849225998
healthy O 0 0.0954025387763977
individuals O 0 0.036169953644275665
with O 0 0.035309337079524994
apparent O 1 0.9557942152023315
deficiency O 1 0.9999923706054688
of O 0 0.02758549340069294
this O 0 0.034261610358953476
enzyme O 0 0.14937002956867218
. O 0 0.05909876897931099

Appreciable O 0 0.27058112621307373
beta O 0 0.18894606828689575
hexosaminidase O 0 0.20853406190872192
A O 0 0.06477951258420944
( O 0 0.05726492777466774
hex O 0 0.10474628955125809
A O 0 0.04268818721175194
) O 0 0.03619319945573807
activity O 0 0.04042908176779747
has O 0 0.02398594655096531
been O 0 0.024302754551172256
detected O 0 0.08524142950773239
in O 0 0.03734426572918892
cultured O 1 0.9541122913360596
skin O 1 0.9999945163726807
fibroblasts O 1 0.9998164772987366
and O 0 0.10750339180231094
melanoma B-Disease 1 0.9999998807907104
tissue O 1 0.9979041814804077
from O 0 0.04332929849624634
healthy O 0 0.13332244753837585
individuals O 0 0.035557959228754044
previously O 0 0.031338971108198166
reported O 0 0.04192766547203064
as O 0 0.022697383537888527
having O 0 0.05784662812948227
deficiency B-Disease 1 0.999982476234436
of I-Disease 0 0.0300123393535614
hex I-Disease 0 0.11624887585639954
A I-Disease 0 0.0474444217979908
activity O 0 0.05287226289510727
indistinguishable O 0 0.07486939430236816
from O 0 0.019004492089152336
that O 0 0.015886712819337845
of O 0 0.02228730358183384
patients O 1 0.9999487400054932
with O 1 0.8495873212814331
Tay B-Disease 1 1.0
- I-Disease 1 0.9999617338180542
Sachs I-Disease 1 0.9999977350234985
disease I-Disease 1 0.9999985694885254
( O 0 0.33558401465415955
TSD B-Disease 1 0.9997430443763733
) O 0 0.06641114503145218
. O 0 0.04888094216585159

Identification O 0 0.08377471566200256
and O 0 0.03687543794512749
quantitation O 0 0.17723026871681213
of O 0 0.028136905282735825
hex O 0 0.09705157577991486
A O 0 0.03697130084037781
, O 0 0.023230649530887604
amounting O 0 0.06181110814213753
to O 0 0.023655157536268234
3 O 0 0.048997633159160614
. O 0 0.04381740465760231

5 O 0 0.08611437678337097
% O 0 0.0644151121377945
- O 0 0.11453532427549362
6 O 0 0.07828844338655472
. O 0 0.05379832163453102

9 O 0 0.06994999945163727
% O 0 0.03867381438612938
of O 0 0.020616713911294937
total O 0 0.044683635234832764
beta O 0 0.12051329761743546
hexosaminidase O 0 0.1859874278306961
activity O 0 0.0642964243888855
, O 0 0.020851783454418182
has O 0 0.017799653112888336
been O 0 0.017840122804045677
obtained O 0 0.02843654528260231
by O 0 0.03255758062005043
cellulose O 0 0.21836040914058685
acetate O 1 0.9294120073318481
gel O 1 0.9791504144668579
electrophoresis O 1 0.7388803958892822
, O 0 0.06717407703399658
DEAE O 1 0.9904462099075317
- O 0 0.4725175201892853
cellulose O 0 0.4715801179409027
ion O 0 0.430478572845459
- O 0 0.14602726697921753
exchange O 0 0.08699104934930801
chromatography O 0 0.3692933917045593
, O 0 0.05357490852475166
radial O 1 0.8885511755943298
immunodiffusion O 0 0.20596331357955933
, O 0 0.031216518953442574
and O 0 0.033810947090387344
radioimmunoassay O 0 0.1920580118894577
. O 0 0.057360559701919556

Previous O 0 0.06372568756341934
family O 0 0.05200178921222687
studies O 0 0.04056613892316818
suggested O 0 0.03293605148792267
that O 0 0.012788080610334873
these O 0 0.013321047648787498
individuals O 0 0.029331976547837257
may O 0 0.029551923274993896
be O 0 0.019198108464479446
compound O 0 0.08377194404602051
heterozygotes O 0 0.21317584812641144
for O 0 0.0190501157194376
the O 0 0.02511562407016754
common O 0 0.0699961706995964
mutant O 0 0.2314738631248474
TSD B-Disease 1 0.9990052580833435
gene O 0 0.1254667192697525
and O 0 0.026745762676000595
a O 0 0.037151407450437546
rare O 0 0.0838574692606926
( O 0 0.07334156334400177
allelic O 0 0.4185843765735626
) O 0 0.07171225547790527
mutant O 0 0.1807597279548645
gene O 0 0.16550424695014954
. O 0 0.06119627133011818

Thus O 0 0.05491909757256508
, O 0 0.02744986303150654
the O 0 0.029722589999437332
postulated O 0 0.12626756727695465
rate O 0 0.0784125104546547
mutant O 0 0.14988045394420624
gene O 0 0.1207210049033165
appears O 0 0.047387897968292236
to O 0 0.0181148461997509
code O 0 0.02433524839580059
for O 0 0.01334604062139988
the O 0 0.017277119681239128
expression O 0 0.041512198746204376
of O 0 0.01735631376504898
low O 0 0.05088920518755913
amounts O 0 0.039799001067876816
of O 0 0.02212594449520111
hex O 0 0.10267658531665802
A O 0 0.05457308888435364
. O 0 0.04809841886162758

Heterozygotes O 1 0.5934742093086243
for O 0 0.03169238939881325
the O 0 0.031039832159876823
rare O 0 0.07294690608978271
mutant O 0 0.12372416257858276
may O 0 0.041669633239507675
be O 0 0.02131078951060772
indistinguishable O 0 0.08830011636018753
from O 0 0.03149929642677307
heterozygotes O 0 0.22134608030319214
for O 0 0.02362990751862526
the O 0 0.02990005537867546
common O 0 0.08078300952911377
TSD B-Disease 1 0.9988507032394409
mutant O 0 0.2115512490272522
. O 0 0.07251814007759094

However O 0 0.040483854711055756
, O 0 0.027147311717271805
direct O 0 0.0443391390144825
visualization O 0 0.10879664868116379
and O 0 0.02944914996623993
quantitation O 0 0.16342397034168243
of O 0 0.024342892691493034
hex O 0 0.0842352882027626
A O 0 0.030784856528043747
by O 0 0.01724943146109581
the O 0 0.01914273574948311
methods O 0 0.038342222571372986
described O 0 0.04776023328304291
may O 0 0.04099106788635254
prevent O 0 0.06840761750936508
false O 0 0.07423072308301926
- O 0 0.46134132146835327
positive O 0 0.12586912512779236
prenatal O 1 0.9991294741630554
diagnosis O 1 0.9996793270111084
of O 0 0.04490089789032936
TSD B-Disease 1 0.9991087317466736
in O 0 0.03803792595863342
fetuses O 0 0.15330788493156433
having O 0 0.03796860948204994
the O 0 0.022723780944943428
incomplete O 0 0.06007000803947449
hex B-Disease 0 0.1355905532836914
A I-Disease 0 0.07177761197090149
deficiency I-Disease 1 0.9999415874481201
of O 0 0.021944791078567505
the O 0 0.021581754088401794
type O 0 0.05776723474264145
described O 0 0.03411531448364258
in O 0 0.01606869511306286
the O 0 0.020445896312594414
four O 0 0.03602997586131096
healthy O 0 0.12519770860671997
individuals O 0 0.0902104452252388

The O 0 0.10317090898752213
tumor B-Disease 1 0.999681830406189
suppressor O 1 0.992741048336029
gene O 0 0.4973897337913513
Smad4 O 1 0.9904173612594604
/ O 1 0.9716136455535889
Dpc4 O 0 0.22921793162822723
is O 0 0.028291109949350357
required O 0 0.031687311828136444
for O 0 0.024599948897957802
gastrulation O 1 0.6180683374404907
and O 0 0.022510595619678497
later O 0 0.022988414391875267
for O 0 0.02203996665775776
anterior O 1 0.576840341091156
development O 0 0.032625626772642136
of O 0 0.016834601759910583
the O 0 0.03210090100765228
mouse O 0 0.18325932323932648
embryo O 0 0.17117349803447723
. O 0 0.0637396052479744

Mutations O 0 0.19865980744361877
in O 0 0.04338545352220535
the O 0 0.054465118795633316
SMAD4 O 1 0.9991759657859802
/ O 1 0.9993345141410828
DPC4 O 1 0.9992551207542419
tumor B-Disease 1 0.9998151659965515
suppressor O 1 0.9355278611183167
gene O 0 0.12604646384716034
, O 0 0.02738209441304207
a O 0 0.033656034618616104
key O 0 0.049048442393541336
signal O 0 0.08537275344133377
transducer O 0 0.1555696427822113
in O 0 0.02592233195900917
most O 0 0.030974969267845154
TGFbeta O 1 0.9888507723808289
- O 0 0.13251693546772003
related O 0 0.06870696693658829
pathways O 0 0.1133321076631546
, O 0 0.019981132820248604
are O 0 0.013329719193279743
involved O 0 0.024059027433395386
in O 0 0.017576759681105614
50 O 0 0.035381779074668884
% O 0 0.04464234411716461
of O 0 0.041324906051158905
pancreatic B-Disease 1 0.9999492168426514
cancers I-Disease 1 0.9998717308044434
. O 0 0.06874118000268936

Homozygous O 0 0.33360251784324646
Smad4 O 1 0.9128599762916565
mutant O 1 0.53339022397995
mice O 1 0.9717308282852173
die O 0 0.4178313612937927
before O 0 0.03780761733651161
day O 0 0.04212804138660431
7 O 0 0.06036457046866417
. O 0 0.04454661160707474

5 O 0 0.07547694444656372
of O 0 0.03651387244462967
embryogenesis O 0 0.23950351774692535
. O 0 0.07385215908288956

Mutant O 0 0.20960654318332672
embryos O 0 0.10736542195081711
have O 0 0.032042376697063446
reduced O 0 0.05288958176970482
size O 0 0.039505209773778915
, O 0 0.02355053648352623
fail O 0 0.07447678595781326
to O 0 0.027626458555459976
gastrulate O 0 0.14944572746753693
or O 0 0.04040942341089249
express O 0 0.07903765887022018
a O 0 0.0486382320523262
mesodermal O 1 0.8884806036949158
marker O 0 0.12006617337465286
, O 0 0.02675686404109001
and O 0 0.025710996240377426
show O 0 0.06882455199956894
abnormal O 1 0.9724625945091248
visceral O 1 0.9745201468467712
endoderm O 1 0.9871206879615784
development O 0 0.07050564140081406
. O 0 0.05755528062582016

Growth B-Disease 1 0.957138180732727
retardation I-Disease 1 0.9994118213653564
of O 0 0.0334465354681015
the O 0 0.04134945198893547
Smad4 O 1 0.9950726628303528
- O 1 0.576072633266449
deficient O 1 0.9698419570922852
embryos O 0 0.10496071726083755
results O 0 0.05567532032728195
from O 0 0.031885869801044464
reduced O 0 0.07487881183624268
cell O 0 0.12363109737634659
proliferation O 0 0.09465739876031876
rather O 0 0.031862299889326096
than O 0 0.02586088329553604
increased O 0 0.06589765846729279
apoptosis O 0 0.1954386681318283
. O 0 0.05521627515554428

Aggregation O 0 0.16663911938667297
of O 0 0.049439046531915665
mutant O 0 0.21131956577301025
Smad4 O 1 0.9588045477867126
ES O 1 0.9495376944541931
cells O 0 0.135588139295578
with O 0 0.04095258563756943
wild O 0 0.1046484038233757
- O 0 0.17281807959079742
type O 0 0.155223086476326
tetraploid O 1 0.7264218330383301
morulae O 1 0.9005178809165955
rescues O 0 0.40296587347984314
the O 0 0.06242655590176582
gastrulation B-Disease 1 0.9948390126228333
defect I-Disease 1 0.9847144484519958
. O 0 0.07232895493507385

These O 0 0.037280671298503876
results O 0 0.05202404037117958
indicate O 0 0.04684716835618019
that O 0 0.021180136129260063
Smad4 O 0 0.12132429331541061
is O 0 0.020124927163124084
initially O 0 0.024703651666641235
required O 0 0.019437642768025398
for O 0 0.011851026676595211
the O 0 0.01734863966703415
differentiation O 0 0.0689111277461052
of O 0 0.01755952648818493
the O 0 0.0264351274818182
visceral O 1 0.890765368938446
endoderm O 1 0.9132449626922607
and O 0 0.020870577543973923
that O 0 0.018264107406139374
the O 0 0.033495575189590454
gastrulation B-Disease 1 0.9942424893379211
defect I-Disease 1 0.6828595399856567
in O 0 0.02864876762032509
the O 0 0.03191469609737396
epiblast O 1 0.9902916550636292
is O 0 0.032792169600725174
secondary O 0 0.05271900072693825
and O 0 0.02095012180507183
non O 0 0.062140244990587234
- O 0 0.12031763792037964
cell O 0 0.11285406351089478
autonomous O 0 0.08075036853551865
. O 0 0.05597059428691864

Rescued O 0 0.22531801462173462
embryos O 0 0.15518246591091156
show O 0 0.10004813969135284
severe O 1 0.9992006421089172
anterior O 1 0.9988700747489929
truncations O 1 0.7266110777854919
, O 0 0.03368976712226868
indicating O 0 0.052016329020261765
a O 0 0.020250409841537476
second O 0 0.02364315092563629
important O 0 0.01707656867802143
role O 0 0.02826392464339733
for O 0 0.025241214781999588
Smad4 O 0 0.2977179288864136
in O 0 0.03989287465810776
anterior O 1 0.9938400387763977
patterning O 1 0.9736834168434143
during O 0 0.08187989890575409
embryogenesis O 1 0.8456316590309143
. O 0 0.062926284968853

Prevalence O 1 0.9034297466278076
of O 0 0.05660488083958626
p16 O 1 0.902807354927063
and O 0 0.06514594703912735
CDK4 O 1 0.9841406345367432
germline O 1 0.956026017665863
mutations O 0 0.20041489601135254
in O 0 0.04910901561379433
48 O 0 0.3000359833240509
melanoma B-Disease 1 0.9999995231628418
- O 1 0.871003270149231
prone O 1 0.501395583152771
families O 0 0.057465169578790665
in O 0 0.033882055431604385
France O 0 0.07368814945220947
. O 0 0.049365151673555374

The O 0 0.06586161255836487
French O 0 0.15160684287548065
Familial B-Disease 1 0.9999845027923584
Melanoma I-Disease 1 0.9999992847442627
Study O 0 0.09567993134260178
Group O 0 0.08435413241386414
. O 0 0.05346911400556564

Germline O 1 0.928943932056427
mutations O 0 0.19050659239292145
in O 0 0.034428905695676804
the O 0 0.04102340713143349
p16 O 1 0.7868428826332092
and O 0 0.03887385502457619
CDK4 O 1 0.8635528683662415
genes O 0 0.07927004992961884
have O 0 0.020272990688681602
been O 0 0.01811918057501316
reported O 0 0.03181815519928932
in O 0 0.01579994708299637
a O 0 0.028412319719791412
subset O 0 0.08743683248758316
of O 0 0.04009684547781944
melanoma B-Disease 1 0.999995231628418
pedigrees O 0 0.19419550895690918
, O 0 0.02537248283624649
but O 0 0.01805492863059044
their O 0 0.020197540521621704
prevalence O 1 0.781406819820404
is O 0 0.019087426364421844
not O 0 0.013647325336933136
well O 0 0.018698466941714287
known O 0 0.0405382364988327
. O 0 0.0444769449532032

We O 0 0.03979293629527092
searched O 0 0.05966285616159439
for O 0 0.02291007898747921
such O 0 0.033638544380664825
germline O 1 0.7238290309906006
mutations O 0 0.16504159569740295
in O 0 0.03727497532963753
48 O 0 0.08426550775766373
French O 1 0.6116524338722229
melanoma B-Disease 1 0.9999997615814209
- O 1 0.7608538269996643
prone O 0 0.330036461353302
families O 0 0.04439739137887955
selected O 0 0.023310083895921707
according O 0 0.015455778688192368
to O 0 0.01218678429722786
two O 0 0.014839746989309788
major O 0 0.029456306248903275
criteria O 0 0.03807343542575836
families O 0 0.03022923320531845
with O 0 0.01989285834133625
at O 0 0.023303445428609848
least O 0 0.024251697584986687
three O 0 0.019166210666298866
affected O 0 0.05363602936267853
members O 0 0.034549083560705185
( O 0 0.054087281227111816
n O 0 0.10833676904439926
= O 0 0.1214018389582634
20 O 0 0.035681527107954025
) O 0 0.026547452434897423
or O 0 0.02109171263873577
families O 0 0.026060355827212334
with O 0 0.015776434913277626
two O 0 0.017585769295692444
affected O 0 0.04855770245194435
members O 0 0.020611895248293877
, O 0 0.013513091020286083
one O 0 0.01378919743001461
of O 0 0.01184022706001997
them O 0 0.015025384724140167
affected O 0 0.04243599995970726
before O 0 0.01977318897843361
the O 0 0.016007862985134125
age O 0 0.032947640866041183
of O 0 0.02030169777572155
50 O 0 0.04642677679657936
( O 0 0.05582796782255173
n O 0 0.11122512072324753
= O 0 0.12213826179504395
28 O 0 0.039275746792554855
) O 0 0.02449841983616352
, O 0 0.013894117437303066
and O 0 0.012697947211563587
one O 0 0.018823496997356415
additional O 0 0.03573343902826309
minor O 0 0.07583285868167877
criterion O 0 0.10615037381649017
. O 0 0.053053054958581924

Sixteen O 0 0.1036997139453888
different O 0 0.06287211924791336
p16 O 1 0.971540629863739
germline O 1 0.940671443939209
mutations O 0 0.16992144286632538
were O 0 0.02455257996916771
found O 0 0.025246435776352882
in O 0 0.017917217686772346
21 O 0 0.029329286888241768
families O 0 0.03201182186603546
, O 0 0.018060795962810516
while O 0 0.02302664890885353
one O 0 0.03427831828594208
germline O 1 0.9473138451576233
mutation O 0 0.21600951254367828
, O 0 0.043991051614284515
Arg24His O 0 0.17536616325378418
, O 0 0.027403682470321655
was O 0 0.02942347154021263
detected O 0 0.0745675340294838
in O 0 0.022190185263752937
the O 0 0.03662645444273949
CDK4 O 1 0.9544437527656555
gene O 0 0.160862535238266
. O 0 0.06298503279685974

The O 0 0.05272333323955536
frequency O 0 0.0987619087100029
of O 0 0.04147734120488167
p16 O 1 0.9038487076759338
gene O 0 0.17525288462638855
mutation O 0 0.16485151648521423
in O 0 0.026155434548854828
our O 0 0.03339238837361336
sample O 0 0.055961769074201584
( O 0 0.03926759958267212
44 O 0 0.04415024444460869
% O 0 0.03661684691905975
) O 0 0.02657312899827957
is O 0 0.015047929249703884
among O 0 0.017437467351555824
the O 0 0.017306547611951828
highest O 0 0.04525744169950485
rates O 0 0.053577031940221786
yet O 0 0.029091693460941315
reported O 0 0.03193901479244232
and O 0 0.016529833897948265
the O 0 0.027917856350541115
CDK4 O 1 0.8992853760719299
mutation O 0 0.1414804756641388
is O 0 0.024827152490615845
the O 0 0.02189706265926361
second O 0 0.04131419584155083
mutation O 0 0.16549961268901825
detected O 0 0.08254800736904144
in O 0 0.021168483421206474
this O 0 0.024246465414762497
gene O 0 0.11234650760889053
worldwide O 0 0.08288153260946274
. O 0 0.0503275990486145

In O 0 0.04135890305042267
summary O 0 0.06079066917300224
, O 0 0.02048594132065773
our O 0 0.022534498944878578
results O 0 0.04024579003453255
show O 0 0.04234202951192856
frequent O 0 0.07323046773672104
involvement O 0 0.06088406592607498
of O 0 0.022872205823659897
the O 0 0.03971616178750992
p16 O 1 0.9838608503341675
gene O 0 0.1498480886220932
in O 0 0.05099086835980415
familial B-Disease 1 0.9999785423278809
melanoma I-Disease 1 0.9999985694885254
and O 0 0.02515561878681183
confirm O 0 0.03491109609603882
the O 0 0.014164361171424389
role O 0 0.024818386882543564
of O 0 0.014724399894475937
the O 0 0.031016716733574867
CDK4 O 1 0.9132807850837708
gene O 0 0.11436624825000763
as O 0 0.030747568234801292
a O 0 0.06643177568912506
melanoma B-Disease 1 0.9999985694885254
- O 1 0.8268085718154907
predisposing O 1 0.744310200214386
gene O 0 0.15394262969493866
. O 0 0.044328026473522186
. O 0 0.050955552607774734

Progression O 0 0.4645499885082245
of O 0 0.057503215968608856
somatic O 0 0.3282487690448761
CTG O 1 0.9577033519744873
repeat O 0 0.15464437007904053
length O 0 0.0721142441034317
heterogeneity O 0 0.11623673886060715
in O 0 0.026917019858956337
the O 0 0.03543521463871002
blood O 1 0.9882947206497192
cells O 1 0.9685002565383911
of O 0 0.07170753926038742
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9999884366989136
. O 0 0.0774201974272728

The O 0 0.04944944754242897
genetic O 0 0.10637692362070084
basis O 0 0.04483693838119507
of O 0 0.06092547997832298
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9935699701309204
DM B-Disease 1 0.9999990463256836
) O 0 0.042449839413166046
is O 0 0.018308542668819427
the O 0 0.015372630208730698
expansion O 0 0.04046368971467018
of O 0 0.01942606456577778
an O 0 0.0376836434006691
unstable O 1 0.8822954297065735
CTG O 1 0.9765094518661499
repeat O 0 0.10970456898212433
in O 0 0.022826645523309708
the O 0 0.02320963330566883
34 O 0 0.06386124342679977
UTR O 0 0.1799827665090561
of O 0 0.02895946241915226
the O 0 0.0570942759513855
DM B-Disease 1 0.9999786615371704
protein O 0 0.2018951177597046
kinase O 0 0.3978424668312073
gene O 0 0.12719790637493134
on O 0 0.036430783569812775
chromosome O 0 0.1646585911512375
19 O 0 0.07329539954662323
. O 0 0.052235376089811325

One O 0 0.029989682137966156
of O 0 0.015764305368065834
the O 0 0.020104166120290756
principal O 0 0.039209138602018356
features O 0 0.02818826027214527
of O 0 0.02140248753130436
the O 0 0.047678008675575256
DM B-Disease 1 0.9999954700469971
mutation O 0 0.196703240275383
is O 0 0.029400138184428215
an O 0 0.023370105773210526
extraordinarily O 0 0.08299960941076279
high O 0 0.04224983602762222
level O 0 0.03856012970209122
of O 0 0.025432992726564407
somatic O 1 0.6467875242233276
mosaicism O 1 0.9891033172607422
, O 0 0.02537868171930313
due O 0 0.025221925228834152
to O 0 0.01447631511837244
an O 0 0.018176233395934105
extremely O 0 0.0426303893327713
high O 0 0.03519678860902786
degree O 0 0.041902199387550354
of O 0 0.025059562176465988
somatic O 0 0.17021821439266205
instability O 0 0.09960826486349106
both O 0 0.018673086538910866
within O 0 0.017823034897446632
and O 0 0.014132954180240631
between O 0 0.02312043122947216
different O 0 0.027401570230722427
tissues O 0 0.14778965711593628
. O 0 0.05146469548344612

This O 0 0.04487421736121178
instability O 0 0.1248672753572464
appears O 0 0.04891955479979515
to O 0 0.018017809838056564
be O 0 0.016230957582592964
biased O 0 0.05292588844895363
towards O 0 0.0334404893219471
further O 0 0.02696654014289379
expansion O 0 0.045268092304468155
and O 0 0.018942417576909065
continuous O 0 0.047183647751808167
throughout O 0 0.02115589566528797
the O 0 0.01617930270731449
life O 0 0.021066809073090553
of O 0 0.011090323328971863
an O 0 0.016281859949231148
individual O 0 0.02365807257592678
, O 0 0.01702260971069336
features O 0 0.026810580864548683
that O 0 0.012798421084880829
could O 0 0.017719052731990814
be O 0 0.01138389389961958
associated O 0 0.019388362765312195
with O 0 0.015007656998932362
the O 0 0.020728714764118195
progressive O 0 0.07261455059051514
nature O 0 0.03698383644223213
of O 0 0.01880756951868534
the O 0 0.03963829576969147
disease O 1 0.9998992681503296
. O 0 0.06256815046072006

Although O 0 0.05551733821630478
increasing O 0 0.06650009751319885
measured O 0 0.07909159362316132
allele O 0 0.15952101349830627
size O 0 0.06008220836520195
between O 0 0.04505043104290962
patients O 1 0.9969255328178406
clearly O 0 0.05033477023243904
correlates O 0 0.08932449668645859
with O 0 0.02388901822268963
an O 0 0.025966309010982513
increased O 0 0.05461382493376732
severity O 1 0.9928922653198242
of O 0 0.030149398371577263
symptoms O 1 0.9999314546585083
and O 0 0.01784723997116089
an O 0 0.01856992393732071
earlier O 0 0.028292857110500336
age O 0 0.03826575726270676
of O 0 0.023331452161073685
onset O 1 0.9984996318817139
, O 0 0.022414766252040863
this O 0 0.017356835305690765
correlation O 0 0.06301601231098175
is O 0 0.01740974374115467
not O 0 0.015803419053554535
precise O 0 0.03816705197095871
and O 0 0.019319934770464897
measured O 0 0.05832096189260483
allele O 0 0.12409604340791702
length O 0 0.04339532181620598
cannot O 0 0.026623066514730453
be O 0 0.011652021668851376
used O 0 0.01718340814113617
as O 0 0.014351969584822655
an O 0 0.019867490977048874
accurate O 0 0.04697584733366966
predictor O 0 0.1336473971605301
of O 0 0.02324283868074417
age O 0 0.04717089980840683
of O 0 0.036676064133644104
onset O 1 0.9980562925338745
. O 0 0.07045154273509979

In O 0 0.028086422011256218
order O 0 0.021464761346578598
to O 0 0.017497405409812927
further O 0 0.02683272399008274
characterize O 0 0.08923032134771347
the O 0 0.03145994991064072
dynamics O 0 0.11575286835432053
of O 0 0.0625050812959671
DM B-Disease 1 0.9999988079071045
CTG O 1 0.9990334510803223
repeat O 1 0.7327380180358887
somatic O 1 0.586517333984375
instability O 0 0.14676065742969513
, O 0 0.02591763623058796
we O 0 0.018560687080025673
have O 0 0.01698615401983261
studied O 0 0.03688434511423111
repeat O 0 0.08430358022451401
length O 0 0.04006149247288704
changes O 0 0.026333682239055634
over O 0 0.019232654944062233
time O 0 0.026312878355383873
in O 0 0.03372735157608986
111 O 1 0.9981634020805359
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9999599456787109
with O 0 0.040202729403972626
varying O 0 0.08653305470943451
clinical O 1 0.997363269329071
severity O 1 0.9967072606086731
and O 0 0.03687416389584541
CTG O 1 0.9900317192077637
repeat O 0 0.1073445975780487
size O 0 0.03619128838181496
over O 0 0.01847919635474682
time O 0 0.025047682225704193
intervals O 0 0.05171569064259529
of O 0 0.020006980746984482
1 O 0 0.04750277101993561
- O 0 0.09187183529138565
7 O 0 0.05434715375304222
years O 0 0.03928712382912636
. O 0 0.04078930616378784

We O 0 0.031086299568414688
have O 0 0.018828289583325386
found O 0 0.0233484897762537
a O 0 0.027336984872817993
direct O 0 0.043208636343479156
progression O 0 0.11905671656131744
of O 0 0.016965949907898903
the O 0 0.019367968663573265
size O 0 0.04372405633330345
heterogeneity O 0 0.09999707341194153
over O 0 0.024186059832572937
time O 0 0.02594318613409996
related O 0 0.034436654299497604
to O 0 0.02363772690296173
initial O 0 0.08158604800701141
CTG O 1 0.9563459753990173
repeat O 0 0.09947744756937027
size O 0 0.03213951736688614
and O 0 0.014335020445287228
the O 0 0.01706906221807003
time O 0 0.02447647787630558
interval O 0 0.06632190197706223
and O 0 0.01840529404580593
always O 0 0.03147290274500847
biased O 0 0.06267876923084259
towards O 0 0.0361209399998188
further O 0 0.029031354933977127
expansion O 0 0.06556174904108047
. O 0 0.04429885745048523

Attempts O 0 0.07698602974414825
to O 0 0.03396652266383171
mathematically O 0 0.08967071026563644
model O 0 0.050905998796224594
the O 0 0.026630936190485954
dynamics O 0 0.08020728081464767
have O 0 0.024516278877854347
proved O 0 0.04537703096866608
only O 0 0.01997540332376957
partially O 0 0.06538952887058258
successful O 0 0.05021556839346886
suggesting O 0 0.0492645725607872
that O 0 0.015089831314980984
individual O 0 0.02967943623661995
specific O 0 0.03456181287765503
genetic O 0 0.09311533719301224
and O 0 0.029385264962911606
/ O 1 0.8595826029777527
or O 0 0.03153403475880623
environmental O 0 0.0418575145304203
factors O 0 0.03595395386219025
also O 0 0.015862658619880676
play O 0 0.019273879006505013
a O 0 0.023611141368746758
role O 0 0.03641403838992119
in O 0 0.03292391449213028
somatic O 0 0.41817596554756165
mosaicism O 1 0.9807963371276855
. O 0 0.045730844140052795
. O 0 0.051243823021650314

Aspartylglucosaminuria B-Disease 1 0.9635435342788696
among O 0 0.0565638430416584
Palestinian O 0 0.07782118022441864
Arabs O 0 0.10418960452079773
. O 0 0.06715607643127441

Aspartylglucosaminuria B-Disease 1 0.9988466501235962
( O 0 0.16078642010688782
AGU B-Disease 1 0.9999035596847534
) O 0 0.052791960537433624
is O 0 0.02555657923221588
a O 0 0.03743219003081322
rare O 0 0.3147996962070465
disorder B-Disease 1 0.9999392032623291
of I-Disease 0 0.047426946461200714
glycoprotein I-Disease 1 0.9937949180603027
metabolism I-Disease 1 0.974083662033081
caused O 0 0.09063657373189926
by O 0 0.027029119431972504
the O 0 0.03454776480793953
deficiency B-Disease 1 0.9999709129333496
of I-Disease 0 0.031039133667945862
the I-Disease 0 0.04671792685985565
lysosomal I-Disease 1 0.99356609582901
enzyme I-Disease 0 0.3910939693450928
aspartylglucosaminidase I-Disease 1 0.9277485609054565
( O 0 0.09300152212381363
AGA O 1 0.9090496301651001
) O 0 0.055935993790626526
. O 0 0.04848020523786545

AGU B-Disease 1 0.9998428821563721
is O 0 0.06612200289964676
inherited O 0 0.1674187332391739
as O 0 0.03441653028130531
an O 0 0.0480569563806057
autosomal O 1 0.9995232820510864
recessive O 1 0.9993639588356018
trait O 1 0.899247407913208
and O 0 0.031202277168631554
occurs O 0 0.05993940308690071
with O 0 0.019182540476322174
a O 0 0.027438834309577942
high O 0 0.0420072004199028
frequency O 0 0.05508914962410927
in O 0 0.019105833023786545
Finland O 0 0.04471468925476074
because O 0 0.024167949333786964
of O 0 0.015767117962241173
a O 0 0.03787165507674217
founder O 0 0.08152607828378677
effect O 0 0.07597483694553375
. O 0 0.04719557985663414

While O 0 0.04779328405857086
very O 0 0.0351567342877388
few O 0 0.036387160420417786
patients O 1 0.998519241809845
with O 0 0.044961005449295044
AGU B-Disease 1 0.9999634027481079
have O 0 0.026815421879291534
been O 0 0.023853229358792305
reported O 0 0.03846311196684837
from O 0 0.024560607969760895
non O 0 0.057332828640937805
- O 0 0.09065846353769302
Finnish O 0 0.07329446077346802
origin O 0 0.04214686527848244
, O 0 0.02688392624258995
we O 0 0.03306493163108826
diagnosed O 1 0.9999771118164062
the O 0 0.047442901879549026
disorder O 1 0.9999411106109619
in O 0 0.035704221576452255
8 O 0 0.06388930976390839
patients O 1 0.9934861063957214
originating O 0 0.07204829901456833
from O 0 0.0272216796875
3 O 0 0.03886844962835312
unrelated O 0 0.052904367446899414
families O 0 0.03256527706980705
, O 0 0.016833173111081123
all O 0 0.012947245500981808
Palestinian O 0 0.04004046693444252
Arabs O 0 0.04763825237751007
from O 0 0.018852507695555687
the O 0 0.01856938749551773
region O 0 0.042325835675001144
of O 0 0.02357974462211132
Jerusalem O 0 0.071369469165802
. O 0 0.05151022598147392

The O 0 0.07203971594572067
clinical O 1 0.997747004032135
diagnosis O 1 0.9998363256454468
of O 0 0.04816337674856186
AGU B-Disease 1 0.9999639987945557
is O 0 0.03446434810757637
often O 0 0.02883782424032688
difficult O 0 0.029556162655353546
, O 0 0.013743044808506966
in O 0 0.01363095361739397
particular O 0 0.02062166854739189
early O 0 0.019208423793315887
in O 0 0.013442039489746094
the O 0 0.01589118503034115
course O 0 0.0358477383852005
of O 0 0.013421143405139446
the O 0 0.023687127977609634
disease O 1 0.9998255372047424
, O 0 0.01714564673602581
and O 0 0.010779211297631264
most O 0 0.01148910354822874
of O 0 0.01364167220890522
the O 0 0.027312099933624268
patients O 1 0.9998371601104736
are O 0 0.02748562954366207
diagnosed O 1 0.9999667406082153
after O 0 0.03071034513413906
the O 0 0.018199028447270393
age O 0 0.0335531011223793
of O 0 0.017562059685587883
5 O 0 0.03831380233168602
years O 0 0.03245365619659424
. O 0 0.039665330201387405

However O 0 0.04773608595132828
, O 0 0.02502155303955078
since O 0 0.029914921149611473
these O 0 0.025068825110793114
patients O 1 0.9955767393112183
excrete O 0 0.41678735613822937
early O 0 0.038128562271595
large O 0 0.028466111049056053
amounts O 0 0.040203310549259186
of O 0 0.023440707474946976
aspartylglucosamine O 0 0.1557811051607132
in O 0 0.03375409170985222
urine O 0 0.12669405341148376
, O 0 0.03852219879627228
biochemical O 0 0.1362019032239914
screening O 0 0.09750977903604507
is O 0 0.0260320995002985
easy O 0 0.0428171306848526
by O 0 0.027841439470648766
urine O 0 0.14886364340782166
chromatography O 0 0.29243725538253784
. O 0 0.037075359374284744
. O 0 0.04809187352657318

Detection O 0 0.15869159996509552
of O 0 0.03539491444826126
heterozygous O 0 0.15180929005146027
carriers O 0 0.10163901746273041
of O 0 0.029957005754113197
the O 0 0.05948435515165329
ataxia B-Disease 1 0.9999980926513672
- I-Disease 1 0.9959546327590942
telangiectasia I-Disease 1 0.999788224697113
( O 0 0.11228698492050171
ATM O 0 0.1971919685602188
) O 0 0.05760086327791214
gene O 0 0.11471833288669586
by O 0 0.04881032183766365
G2 O 1 0.9974409341812134
phase O 0 0.18957017362117767
chromosomal O 0 0.341533362865448
radiosensitivity O 0 0.43549278378486633
of O 0 0.04989907518029213
peripheral O 1 0.9971408843994141
blood O 1 0.9981321692466736
lymphocytes O 1 0.998641312122345
. O 0 0.07350175082683563

In O 0 0.10982822626829147
ataxia B-Disease 1 0.9999984502792358
- I-Disease 1 0.9989637136459351
telangiectasia I-Disease 1 0.9999655485153198
( O 0 0.19196443259716034
A B-Disease 1 0.909349799156189
- I-Disease 1 0.9982621073722839
T I-Disease 1 0.9999662637710571
) O 0 0.06960863620042801
patients O 1 0.9977893829345703
, O 0 0.031998567283153534
mutations O 0 0.09915444999933243
in O 0 0.01942393183708191
a O 0 0.02846534736454487
single O 0 0.0477280467748642
gene O 0 0.10366595536470413
, O 0 0.03155422583222389
ATM O 0 0.10884297639131546
, O 0 0.021362310275435448
result O 0 0.033577561378479004
in O 0 0.02510255016386509
an O 0 0.0557873509824276
autosomal B-Disease 1 0.9999980926513672
recessive I-Disease 1 0.9999990463256836
syndrome I-Disease 1 1.0
that O 0 0.035666611045598984
embraces O 0 0.08415462076663971
a O 0 0.025879405438899994
variety O 0 0.02740798145532608
of O 0 0.018032338470220566
clinical O 0 0.2144039422273636
features O 0 0.03870972990989685
and O 0 0.02650091052055359
manifests O 0 0.15226683020591736
extreme O 0 0.09740563482046127
radiosensitivity O 0 0.15884287655353546
and O 0 0.02416403405368328
a O 0 0.030059650540351868
strong O 0 0.04651854187250137
pre O 0 0.13737814128398895
- O 0 0.13715553283691406
disposition O 0 0.15182819962501526
to O 0 0.05092976987361908
malignancy B-Disease 1 0.9981605410575867
. O 0 0.06932523101568222

Heterozygotes O 0 0.3606452941894531
for O 0 0.03384559601545334
the O 0 0.036033060401678085
ATM O 0 0.1564285159111023
gene O 0 0.09885308891534805
have O 0 0.022190755233168602
no O 0 0.027239393442869186
clinical O 0 0.11540845781564713
expression O 0 0.051887333393096924
of O 0 0.021690597757697105
A B-Disease 1 0.6590949296951294
- I-Disease 1 0.996198832988739
T I-Disease 1 0.999904990196228
but O 0 0.030808795243501663
may O 0 0.03752310946583748
be O 0 0.030011622235178947
cancer B-Disease 1 0.9999092817306519
prone O 0 0.22419551014900208
with O 0 0.022447949275374413
a O 0 0.028625788167119026
moderate O 0 0.06119472160935402
increase O 0 0.03869502618908882
in O 0 0.020874876528978348
in O 0 0.031882449984550476
vitro O 0 0.1673358529806137
radiosensitivity O 0 0.38936078548431396
. O 0 0.06785115599632263

We O 0 0.03886578604578972
performed O 0 0.053865909576416016
a O 0 0.04115778207778931
blind O 0 0.13744771480560303
chromosomal O 0 0.19956772029399872
analysis O 0 0.05929173156619072
on O 0 0.040699552744627
G2 O 1 0.9998619556427002
- O 0 0.3160359263420105
phase O 0 0.16629919409751892
lymphocytes O 1 0.8359105587005615
from O 0 0.037756457924842834
7 O 0 0.05389263480901718
unrelated O 0 0.09538282454013824
A B-Disease 1 0.8266106843948364
- I-Disease 1 0.9975370168685913
T I-Disease 1 0.9999741315841675
patients O 1 0.9985729455947876
, O 0 0.02994202822446823
13 O 0 0.04916184023022652
obligate O 0 0.46598032116889954
A B-Disease 1 0.7106935977935791
- I-Disease 1 0.9939824938774109
T I-Disease 1 0.9998846054077148
heterozygotes O 1 0.9822252988815308
( O 0 0.05875353515148163
parents O 0 0.03816770017147064
of O 0 0.017465561628341675
the O 0 0.028785543516278267
patients O 1 0.9947697520256042
) O 0 0.029885709285736084
, O 0 0.014641687273979187
and O 0 0.015168235637247562
14 O 0 0.0324893519282341
normal O 0 0.05195232480764389
controls O 0 0.061535563319921494
following O 0 0.04472260922193527
X O 0 0.2658807635307312
- O 0 0.11805029958486557
irradiation O 0 0.1359005868434906
with O 0 0.032584868371486664
1 O 0 0.053134121000766754
Gy O 0 0.31898677349090576
in O 0 0.02258455567061901
order O 0 0.020580129697918892
to O 0 0.022316282615065575
evaluate O 0 0.0689881294965744
this O 0 0.027274945750832558
cytogenetic O 0 0.20640936493873596
method O 0 0.049614664167165756
as O 0 0.01836313121020794
a O 0 0.02667536959052086
tool O 0 0.05453524366021156
for O 0 0.024849824607372284
detection O 0 0.09621763229370117
of O 0 0.03330058604478836
ATM O 0 0.17308324575424194
carriers O 0 0.15121357142925262
. O 0 0.06098206341266632

Both O 0 0.05351229012012482
A B-Disease 0 0.4518723785877228
- I-Disease 1 0.9890813827514648
T I-Disease 1 0.9997076392173767
homozygotes O 1 0.989339292049408
and O 0 0.04599624499678612
heterozygotes O 1 0.9562690258026123
showed O 0 0.0636228397488594
significantly O 0 0.07078342884778976
increased O 0 0.0495951771736145
levels O 0 0.058406583964824677
of O 0 0.03680633381009102
radiation O 1 0.9997132420539856
- O 1 0.9836909770965576
induced O 1 0.997455894947052
chromatid O 1 0.9939756989479065
damage O 0 0.1354122906923294
relative O 0 0.051270492374897
to O 0 0.01683087646961212
that O 0 0.014225305989384651
of O 0 0.019135283306241035
normal O 0 0.06332744657993317
controls O 0 0.08025660365819931
. O 0 0.04980916157364845

These O 0 0.03173990920186043
results O 0 0.04070531204342842
show O 0 0.034964196383953094
that O 0 0.01977786049246788
the O 0 0.038792822510004044
G2 O 1 0.9999213218688965
- O 1 0.5749650597572327
phase O 0 0.2266843020915985
chromosomal O 1 0.5874139070510864
radiosensitivity O 0 0.4892159700393677
assay O 0 0.12946414947509766
can O 0 0.024982627481222153
be O 0 0.011863920837640762
used O 0 0.016148781403899193
for O 0 0.012832274660468102
the O 0 0.02200901508331299
detection O 0 0.08726059645414352
of O 0 0.02535182610154152
A B-Disease 0 0.3278965651988983
- I-Disease 1 0.9850391149520874
T I-Disease 1 0.999777615070343
heterozygotes O 1 0.9812949895858765
. O 0 0.07394150644540787

In O 0 0.046294379979372025
combination O 0 0.09926454722881317
with O 0 0.034637268632650375
molecular O 0 0.09670884162187576
genetic O 0 0.0945647582411766
analyses O 0 0.06307758390903473
, O 0 0.02069110982120037
this O 0 0.015755871310830116
test O 0 0.03703190013766289
may O 0 0.021323611959815025
be O 0 0.00992882251739502
of O 0 0.008965223096311092
value O 0 0.017230145633220673
in O 0 0.01720818132162094
studies O 0 0.03620271384716034
of O 0 0.02444741688668728
familial B-Disease 1 0.9986146688461304
and I-Disease 0 0.04028306156396866
sporadic I-Disease 0 0.44133955240249634
cancers I-Disease 1 0.998991072177887
aimed O 0 0.07064482569694519
at O 0 0.030491430312395096
determination O 0 0.04479051008820534
of O 0 0.014161063358187675
the O 0 0.020628828555345535
potential O 0 0.0509861595928669
involvement O 0 0.06670470535755157
of O 0 0.029757091775536537
ATM O 1 0.5875048637390137
mutations O 0 0.23825427889823914
in O 0 0.04680141061544418
tumor B-Disease 1 0.9999345541000366
risk O 1 0.8206409215927124
or O 0 0.03283834829926491
development O 0 0.035101909190416336
. O 0 0.028500251471996307
. O 0 0.039062853902578354

Ataxia B-Disease 1 0.9999974966049194
- I-Disease 1 0.994597315788269
telangiectasia I-Disease 1 0.9992832541465759
: O 0 0.061113420873880386
identification O 0 0.05314095690846443
and O 0 0.02546003647148609
detection O 0 0.08588837832212448
of O 0 0.025609740987420082
founder O 0 0.08862358331680298
- O 0 0.13659615814685822
effect O 0 0.08395589143037796
mutations O 0 0.12184564024209976
in O 0 0.023813551291823387
the O 0 0.028737636283040047
ATM O 0 0.14149777591228485
gene O 0 0.09313203394412994
in O 0 0.023798353970050812
ethnic O 0 0.04499642178416252
populations O 0 0.08881022036075592
. O 0 0.05028592050075531

To O 0 0.03294094279408455
facilitate O 0 0.05222667381167412
the O 0 0.026325175538659096
evaluation O 0 0.07979810982942581
of O 0 0.03391494229435921
ATM O 0 0.19905756413936615
heterozygotes O 1 0.8372005224227905
for O 0 0.03136010095477104
susceptibility O 1 0.7507890462875366
to O 0 0.020699122920632362
other O 0 0.021814923733472824
diseases O 1 0.999769389629364
, O 0 0.022394580766558647
such O 0 0.02087794803082943
as O 0 0.0359349250793457
breast B-Disease 1 0.9999990463256836
cancer I-Disease 1 0.9999891519546509
, O 0 0.021168949082493782
we O 0 0.01358163170516491
have O 0 0.013921932317316532
attempted O 0 0.029300767928361893
to O 0 0.013931283727288246
define O 0 0.03332753852009773
the O 0 0.01736639253795147
most O 0 0.019833628088235855
common O 0 0.0436672568321228
mutations O 0 0.09710682928562164
and O 0 0.01587584614753723
their O 0 0.019653743132948875
frequencies O 0 0.06520850956439972
in O 0 0.049831077456474304
ataxia B-Disease 1 0.9999953508377075
- I-Disease 1 0.9978501796722412
telangiectasia I-Disease 1 0.9999048709869385
( O 0 0.12238103896379471
A B-Disease 1 0.8045173287391663
- I-Disease 1 0.9900976419448853
T I-Disease 1 0.9996943473815918
) O 0 0.06423261761665344
homozygotes O 1 0.5843954682350159
from O 0 0.031119251623749733
10 O 0 0.03162548318505287
ethnic O 0 0.04437156766653061
populations O 0 0.09345048666000366
. O 0 0.05827072262763977

Both O 0 0.059626031666994095
genomic O 0 0.18035806715488434
mutations O 0 0.13788817822933197
and O 0 0.020794972777366638
their O 0 0.02139529585838318
effects O 0 0.076187364757061
on O 0 0.025195665657520294
cDNA O 0 0.1361856311559677
were O 0 0.029925409704446793
characterized O 0 0.10835344344377518
. O 0 0.052469536662101746

Protein O 0 0.18384601175785065
- O 0 0.1476653665304184
truncation O 0 0.16808494925498962
testing O 0 0.07018664479255676
of O 0 0.01906915009021759
the O 0 0.02694486454129219
entire O 0 0.070650115609169
ATM O 0 0.19913256168365479
cDNA O 0 0.2266305536031723
detected O 0 0.15428513288497925
92 O 0 0.12146537750959396
( O 0 0.06205784156918526
66 O 0 0.08866747468709946
% O 0 0.06044142693281174
) O 0 0.0598570816218853
truncating O 0 0.2629650831222534
mutations O 0 0.17585386335849762
in O 0 0.038014352321624756
140 O 0 0.10845808684825897
mutant O 0 0.19138319790363312
alleles O 0 0.24667814373970032
screened O 0 0.16860555112361908
. O 0 0.06830497831106186

The O 0 0.05926026031374931
haplotyping O 0 0.2579655349254608
of O 0 0.035452235490083694
patients O 1 0.9900075197219849
with O 0 0.03270567208528519
identical O 0 0.07503193616867065
mutations O 0 0.1674744337797165
indicates O 0 0.05209190025925636
that O 0 0.013902711682021618
almost O 0 0.013596395961940289
all O 0 0.008504047058522701
of O 0 0.010561928153038025
these O 0 0.012490304186940193
represent O 0 0.02461450733244419
common O 0 0.035342711955308914
ancestry O 0 0.05593011900782585
and O 0 0.017918158322572708
that O 0 0.01824253238737583
very O 0 0.026802223175764084
few O 0 0.035193171352148056
spontaneously O 0 0.14110463857650757
recurring O 0 0.2658379375934601
ATM O 0 0.43312767148017883
mutations O 0 0.18702411651611328
exist O 0 0.053923629224300385
. O 0 0.050711847841739655

Assays O 0 0.2043515294790268
requiring O 0 0.1024676263332367
minimal O 0 0.0837688222527504
amounts O 0 0.04835640639066696
of O 0 0.023999977856874466
genomic O 0 0.11778809130191803
DNA O 0 0.06756414473056793
were O 0 0.016024356707930565
designed O 0 0.034918591380119324
to O 0 0.0174074899405241
allow O 0 0.03385503217577934
rapid O 0 0.08100458979606628
screening O 0 0.07786530256271362
for O 0 0.020766980946063995
common O 0 0.04527464509010315
ethnic O 0 0.05382021144032478
mutations O 0 0.19275468587875366
. O 0 0.06028192117810249

These O 0 0.05726943165063858
rapid O 0 0.15678459405899048
assays O 0 0.184807687997818
detected O 0 0.15679839253425598
mutations O 0 0.1397954672574997
in O 0 0.03180709481239319
76 O 0 0.07308857887983322
% O 0 0.037119582295417786
of O 0 0.02455003559589386
Costa O 0 0.09131459146738052
Rican O 0 0.12023388594388962
patients O 1 0.997154712677002
( O 0 0.056020792573690414
3 O 0 0.04399663209915161
) O 0 0.029675781726837158
, O 0 0.01801319047808647
50 O 0 0.03131652995944023
% O 0 0.03175835683941841
of O 0 0.02117164060473442
Norwegian O 0 0.08027086406946182
patients O 1 0.9940431714057922
( O 0 0.04922328516840935
1 O 0 0.039519477635622025
) O 0 0.0235583558678627
, O 0 0.01656237058341503
25 O 0 0.025356687605381012
% O 0 0.03164413198828697
of O 0 0.02359084039926529
Polish O 0 0.08756059408187866
patients O 1 0.9984976053237915
( O 0 0.047256991267204285
4 O 0 0.036339908838272095
) O 0 0.026055317372083664
, O 0 0.014656084589660168
and O 0 0.01453017070889473
14 O 0 0.026972783729434013
% O 0 0.02851027064025402
of O 0 0.02320556528866291
Italian O 0 0.10048723965883255
patients O 1 0.9992651343345642
( O 0 0.04569273814558983
1 O 0 0.03318285569548607
) O 0 0.025543922558426857
, O 0 0.012333637103438377
as O 0 0.01163849513977766
well O 0 0.014714139513671398
as O 0 0.015327497385442257
in O 0 0.022638555616140366
patients O 1 0.982115626335144
of O 0 0.03462713956832886
Amish O 1 0.5206292271614075
/ O 1 0.7999105453491211
Mennonite O 0 0.1383979618549347
and O 0 0.027198070660233498
Irish O 0 0.05677512660622597
English O 0 0.03863178938627243
backgrounds O 0 0.09354840964078903
. O 0 0.05155437812209129

Additional O 0 0.08445214480161667
mutations O 0 0.14768722653388977
were O 0 0.023940855637192726
observed O 0 0.04269961267709732
in O 0 0.020510761067271233
Japanese O 0 0.03587273508310318
, O 0 0.02423258125782013
Utah O 0 0.06253712624311447
Mormon O 0 0.06291913986206055
, O 0 0.02128329686820507
and O 0 0.017923923209309578
African O 0 0.061900150030851364
American O 0 0.06691224873065948
patients O 1 0.9970541000366211
. O 0 0.05490672588348389

These O 0 0.03837103396654129
assays O 0 0.10392225533723831
should O 0 0.030517298728227615
facilitate O 0 0.05489237233996391
screening O 0 0.09584756940603256
for O 0 0.03054259531199932
A B-Disease 0 0.398327112197876
- I-Disease 1 0.9870350956916809
T I-Disease 1 0.9996046423912048
heterozygotes O 1 0.5624498128890991
in O 0 0.02663588710129261
the O 0 0.02247198484838009
populations O 0 0.06261278688907623
studied O 0 0.04492911323904991
. O 0 0.03262301906943321
. O 0 0.047999486327171326

The O 0 0.0914105698466301
von B-Disease 1 0.9734504222869873
Hippel I-Disease 1 0.9993714690208435
- I-Disease 1 0.9905964136123657
Lindau I-Disease 1 0.9995317459106445
tumor I-Disease 1 0.999699592590332
suppressor O 1 0.9350569248199463
gene O 0 0.14292164146900177
is O 0 0.03089958429336548
required O 0 0.03492147475481033
for O 0 0.02530243620276451
cell O 0 0.1145743727684021
cycle O 0 0.1396537572145462
exit O 0 0.10304710268974304
upon O 0 0.056027110666036606
serum O 1 0.971496045589447
withdrawal O 0 0.14041393995285034
. O 0 0.059292856603860855

The O 0 0.052930425852537155
inactivation O 0 0.15918834507465363
of O 0 0.02501874417066574
the O 0 0.04476312920451164
von B-Disease 1 0.9809553027153015
Hippel I-Disease 1 0.999057948589325
- I-Disease 1 0.9836347103118896
Lindau I-Disease 1 0.998673677444458
( I-Disease 0 0.16077451407909393
VHL I-Disease 1 0.9997476935386658
) I-Disease 0 0.15060648322105408
tumor I-Disease 1 0.9996993541717529
suppressor O 1 0.9889046549797058
gene O 0 0.2766352891921997
predisposes O 1 0.9932317733764648
affected O 0 0.08432860672473907
individuals O 0 0.0337371751666069
to O 0 0.01863875798881054
the O 0 0.02931784838438034
human O 1 0.8766804337501526
VHL B-Disease 1 0.9999998807907104
cancer I-Disease 1 1.0
syndrome I-Disease 1 0.9999998807907104
and O 0 0.0300801582634449
is O 0 0.025183452293276787
associated O 0 0.03828082233667374
with O 0 0.03795590251684189
sporadic B-Disease 1 0.9956444501876831
renal I-Disease 1 1.0
cell I-Disease 1 0.9993094205856323
carcinomas I-Disease 1 0.9999918937683105
( O 0 0.34829941391944885
RCC B-Disease 1 0.9999094009399414
) O 0 0.05911915749311447
and O 0 0.03871125727891922
brain B-Disease 1 0.9894987344741821
hemangioblastomas I-Disease 1 0.7959325909614563
. O 0 0.05783870071172714

VHL O 1 0.9996296167373657
- O 1 0.6804024577140808
negative O 0 0.16808494925498962
786 O 1 0.9965730905532837
- O 1 0.8418694138526917
0 O 0 0.1756693720817566
RCC B-Disease 1 0.9994220733642578
cells O 0 0.13702940940856934
are O 0 0.026192637160420418
tumorigenic O 0 0.1421024054288864
in O 0 0.029765447601675987
nude O 0 0.11977831274271011
mice O 0 0.13530586659908295
which O 0 0.023614337667822838
is O 0 0.020817024633288383
suppressed O 0 0.054425887763500214
by O 0 0.019107569009065628
the O 0 0.02906365692615509
reintroduction O 0 0.15706314146518707
of O 0 0.051579009741544724
VHL B-Disease 1 0.9968382120132446
. O 0 0.07382626831531525

Remarkably O 0 0.1169155165553093
, O 0 0.03017045371234417
this O 0 0.02365509606897831
occurs O 0 0.057874832302331924
without O 0 0.027345646172761917
affecting O 0 0.05996573716402054
the O 0 0.022987375035881996
growth O 0 0.05334204435348511
rate O 0 0.045922525227069855
and O 0 0.024908801540732384
cell O 0 0.09493022412061691
cycle O 0 0.09251835197210312
profile O 0 0.05332334339618683
of O 0 0.017308268696069717
these O 0 0.019037092104554176
cells O 0 0.07276109606027603
in O 0 0.023977691307663918
culture O 0 0.05574791878461838
. O 0 0.045552946627140045

The O 0 0.07069176435470581
786 O 1 0.9543281197547913
- O 0 0.16476702690124512
0 O 0 0.10874353349208832
cell O 0 0.10007794201374054
line O 0 0.0394454300403595
, O 0 0.023554429411888123
like O 0 0.03048747591674328
many O 0 0.03004557080566883
cancer B-Disease 1 0.9999644756317139
cells O 0 0.17269742488861084
, O 0 0.028094708919525146
fails O 0 0.07628888636827469
to O 0 0.02188332937657833
exit O 0 0.07140937447547913
the O 0 0.028628718107938766
cell O 0 0.11005274951457977
cycle O 0 0.11951455473899841
upon O 0 0.0548940971493721
serum O 1 0.9637291431427002
withdrawal O 0 0.14860446751117706
. O 0 0.0628751590847969

Here O 0 0.03893912211060524
, O 0 0.021527403965592384
it O 0 0.015283072367310524
is O 0 0.01759042777121067
shown O 0 0.028163740411400795
that O 0 0.015339118428528309
reintroduction O 0 0.08384565263986588
of O 0 0.01727900840342045
the O 0 0.027460040524601936
wild O 0 0.08320484310388565
- O 0 0.20697183907032013
type O 0 0.1927308887243271
VHL B-Disease 1 0.9950934648513794
gene O 0 0.16473239660263062
restores O 0 0.13530680537223816
the O 0 0.030790414661169052
ability O 0 0.05534837394952774
of O 0 0.0395275354385376
VHL O 1 0.9999655485153198
- O 1 0.991959273815155
negative O 1 0.9040778875350952
RCC B-Disease 1 0.9999948740005493
cancer I-Disease 1 0.9999858140945435
cells O 0 0.1335449069738388
to O 0 0.026973983272910118
exit O 0 0.07557939738035202
the O 0 0.02799157053232193
cell O 0 0.09661398828029633
cycle O 0 0.10417856276035309
and O 0 0.032901860773563385
enter O 0 0.08881836384534836
G0 O 1 0.9999288320541382
/ O 1 0.9924063086509705
quiescence O 1 0.9273422360420227
in O 0 0.04243302717804909
low O 0 0.10868716239929199
serum O 1 0.9517389535903931
. O 0 0.06721051037311554

Both O 0 0.08355359733104706
VHL O 1 0.9991452693939209
- O 0 0.1870187669992447
positive O 0 0.09318006038665771
and O 0 0.048315614461898804
VHL O 1 0.9999228715896606
- O 1 0.7191482186317444
negative O 0 0.1522294580936432
RCC B-Disease 1 0.9997968077659607
cells O 0 0.1684967577457428
exit O 0 0.09777124971151352
the O 0 0.03034988045692444
cell O 0 0.09951378405094147
cycle O 0 0.09725647419691086
by O 0 0.03193870931863785
contact O 0 0.09695220738649368
inhibition O 0 0.2429480105638504
. O 0 0.06688960641622543

The O 0 0.08874746412038803
cyclin O 1 0.9847122430801392
- O 0 0.318129301071167
dependent O 0 0.20699438452720642
kinase O 1 0.9788190126419067
inhibitor O 1 0.9897897839546204
, O 0 0.06033076345920563
p27 O 1 0.9828048348426819
, O 0 0.04755749553442001
accumulates O 0 0.1454402357339859
upon O 0 0.04864415526390076
serum O 1 0.9581744074821472
withdrawal O 0 0.07891063392162323
, O 0 0.017551293596625328
only O 0 0.011194100603461266
in O 0 0.011786703951656818
the O 0 0.018440095707774162
presence O 0 0.045658860355615616
of O 0 0.025383468717336655
VHL B-Disease 1 0.9973873496055603
, O 0 0.02367357350885868
as O 0 0.015132063999772072
a O 0 0.02071075141429901
result O 0 0.0256345234811306
of O 0 0.015022394247353077
the O 0 0.022759705781936646
stabilization O 0 0.11105084419250488
of O 0 0.021125487983226776
the O 0 0.02956380322575569
protein O 0 0.09953472018241882
. O 0 0.04780033230781555

We O 0 0.033706117421388626
propose O 0 0.05865561589598656
that O 0 0.0158676840364933
the O 0 0.01913193054497242
loss O 0 0.058512162417173386
of O 0 0.02598753571510315
wild O 0 0.09287653863430023
- O 0 0.43219053745269775
type O 0 0.344914048910141
VHL B-Disease 1 0.9985190033912659
gene O 0 0.1253950148820877
results O 0 0.04425496980547905
in O 0 0.02107938937842846
a O 0 0.027532989159226418
specific O 0 0.0407843217253685
cellular O 0 0.11683794856071472
defect O 1 0.9601547718048096
in O 0 0.042204320430755615
serum O 1 0.9939299821853638
- O 0 0.12927672266960144
dependent O 0 0.08937934041023254
growth O 0 0.055546678602695465
control O 0 0.047251392155885696
, O 0 0.021146241575479507
which O 0 0.02495971880853176
may O 0 0.05263439565896988
initiate O 0 0.21780414879322052
tumor B-Disease 1 0.9993162155151367
formation O 0 0.14067518711090088
. O 0 0.05722403526306152

This O 0 0.03322727605700493
is O 0 0.027092287316918373
corrected O 0 0.07664869725704193
by O 0 0.019074715673923492
the O 0 0.021951662376523018
reintroduction O 0 0.12615953385829926
of O 0 0.03395269066095352
wild O 0 0.09762067347764969
- O 1 0.6046724319458008
type O 1 0.6665825247764587
VHL B-Disease 1 0.9998149275779724
, O 0 0.057627785950899124
implicating O 0 0.47612234950065613
VHL B-Disease 1 0.9964370727539062
as O 0 0.023920560255646706
the O 0 0.025195840746164322
first O 0 0.04816479980945587
tumor B-Disease 1 0.9989838004112244
suppressor O 1 0.5226883292198181
involved O 0 0.040405984967947006
in O 0 0.01604625955224037
the O 0 0.020786138251423836
regulation O 0 0.053212594240903854
of O 0 0.024124015122652054
cell O 0 0.11568139493465424
cycle O 0 0.11204952001571655
exit O 0 0.0773720070719719
, O 0 0.020013242959976196
which O 0 0.015592323616147041
is O 0 0.01664719544351101
consistent O 0 0.03520171344280243
with O 0 0.017666669562458992
its O 0 0.024889223277568817
gatekeeper O 0 0.2084863930940628
function O 0 0.05192527174949646
in O 0 0.022433962672948837
the O 0 0.0359022356569767
kidney O 1 0.9998735189437866
. O 0 0.03929134085774422
. O 0 0.049729123711586

Piebaldism B-Disease 1 0.9988877177238464
with O 0 0.08409227430820465
deafness B-Disease 1 0.9999808073043823
: O 0 0.052484266459941864
molecular O 0 0.06579667329788208
evidence O 0 0.02583504281938076
for O 0 0.016950679942965508
an O 0 0.028352798894047737
expanded O 0 0.08187703043222427
syndrome O 1 0.9999986886978149
. O 0 0.06196877360343933

In O 0 0.03406107425689697
a O 0 0.03457583487033844
South O 0 0.04553169757127762
African O 0 0.06264255940914154
girl O 0 0.09731989353895187
of O 0 0.02675553224980831
Xhosa O 1 0.9473385214805603
stock O 0 0.09614443778991699
with O 0 0.04560931771993637
severe O 1 0.9997972846031189
piebaldism B-Disease 1 0.9964876174926758
and O 0 0.05461042374372482
profound O 1 0.9988762736320496
congenital O 1 1.0
sensorineural B-Disease 1 0.9999995231628418
deafness I-Disease 1 0.9999984502792358
we O 0 0.033065129071474075
identified O 0 0.037921059876680374
a O 0 0.033448539674282074
novel O 0 0.06303805112838745
missense O 0 0.18780191242694855
substitution O 0 0.09266797453165054
at O 0 0.034395694732666016
a O 0 0.030308468267321587
highly O 0 0.047165337949991226
conserved O 0 0.07134119421243668
residue O 0 0.09847137331962585
in O 0 0.022926682606339455
the O 0 0.03164952993392944
intracellular O 0 0.1852712482213974
kinase O 0 0.21419838070869446
domain O 0 0.05766042321920395
of O 0 0.021776840090751648
the O 0 0.035320986062288284
KIT O 1 0.9594762921333313
proto O 1 0.9840980172157288
- O 1 0.6373986005783081
oncogene O 1 0.9414561986923218
, O 0 0.06319788098335266
R796G O 0 0.2031906247138977
. O 0 0.0619157999753952

Though O 0 0.08541649580001831
auditory B-Disease 1 0.9692970514297485
anomalies I-Disease 0 0.15596503019332886
have O 0 0.021765774115920067
been O 0 0.02124940976500511
observed O 0 0.042182471603155136
in O 0 0.023998048156499863
mice O 0 0.1362793892621994
with O 0 0.03258586674928665
dominant O 0 0.1003003716468811
white O 0 0.12214507162570953
spotting O 1 0.9751476049423218
( O 0 0.09376613050699234
W O 1 0.988922119140625
) O 0 0.0399969145655632
due O 0 0.033497001975774765
to O 0 0.031596116721630096
KIT O 1 0.9831953644752502
mutations O 1 0.5916231274604797
, O 0 0.05045386403799057
deafness B-Disease 1 0.9999350309371948
is O 0 0.02532041259109974
not O 0 0.01803688146173954
typical O 0 0.04832525551319122
in O 0 0.025291332975029945
human O 0 0.06039441376924515
piebaldism B-Disease 1 0.5071233510971069
. O 0 0.06353017687797546

Thus O 0 0.05006210878491402
, O 0 0.023924000561237335
the O 0 0.030822476372122765
occurrence O 0 0.12268572300672531
of O 0 0.05152834206819534
sensorineural B-Disease 1 0.999996542930603
deafness I-Disease 1 0.9999970197677612
in O 0 0.03698911890387535
this O 0 0.03217293694615364
patient O 1 0.965095043182373
extends O 0 0.08279682695865631
considerably O 0 0.054009728133678436
the O 0 0.024928323924541473
phenotypic O 0 0.09785677492618561
range O 0 0.045831259340047836
of O 0 0.022939974442124367
piebaldism B-Disease 0 0.15076316893100739
due O 0 0.04348502308130264
to O 0 0.03201808035373688
KIT O 1 0.8357160687446594
gene O 0 0.16964277625083923
mutation O 0 0.1827637404203415
in O 0 0.033191945403814316
humans O 0 0.06170269101858139
and O 0 0.03151293098926544
tightens O 1 0.6609402894973755
the O 0 0.03618428483605385
clinical O 0 0.2851751446723938
similarity O 0 0.06587101519107819
between O 0 0.028755858540534973
piebaldism B-Disease 0 0.10693435370922089
and O 0 0.013203734531998634
the O 0 0.013895680196583271
various O 0 0.01691286824643612
forms O 0 0.04752614349126816
of O 0 0.04782300814986229
Waardenburg B-Disease 1 0.9999992847442627
syndrome I-Disease 1 0.9999996423721313
. O 0 0.05032219737768173
. O 0 0.048166777938604355

Cycloheximide O 0 0.30300602316856384
facilitates O 0 0.12705503404140472
the O 0 0.03113888017833233
identification O 0 0.05208183079957962
of O 0 0.027852699160575867
aberrant O 0 0.17343543469905853
transcripts O 0 0.07412220537662506
resulting O 0 0.06084393709897995
from O 0 0.02624860592186451
a O 0 0.03288092836737633
novel O 0 0.06843598186969757
splice O 0 0.22778122127056122
- O 0 0.12697012722492218
site O 0 0.06589420139789581
mutation O 0 0.1422099471092224
in O 0 0.03352661803364754
COL17A1 O 0 0.2883298695087433
in O 0 0.029346652328968048
a O 0 0.044035449624061584
patient O 1 0.9808110594749451
with O 0 0.05521276593208313
generalized O 1 0.998227059841156
atrophic B-Disease 1 0.999996542930603
benign I-Disease 1 0.9999845027923584
epidermolysis I-Disease 1 0.9999932050704956
bullosa I-Disease 1 0.9998815059661865
. O 0 0.10768704861402512

Patients O 1 0.9996166229248047
with O 0 0.08419699966907501
generalized O 1 0.9990334510803223
atrophic B-Disease 1 0.9999967813491821
benign I-Disease 1 0.9999934434890747
epidermolysis I-Disease 1 0.9999978542327881
bullosa I-Disease 1 0.9999693632125854
often O 0 0.0728527158498764
show O 0 0.05524573102593422
decreased O 0 0.08625297248363495
expression O 0 0.06608620285987854
of O 0 0.03156772255897522
type O 1 0.8341837525367737
XVII O 1 0.9999001026153564
collagen O 1 0.9972108006477356
, O 0 0.038240157067775726
a O 0 0.0529981404542923
transmembrane O 0 0.21648836135864258
hemidesmosomal O 0 0.22562392055988312
protein O 0 0.10882999747991562
encoded O 0 0.06382086873054504
by O 0 0.0434168316423893
COL17A1 O 0 0.39451178908348083
. O 0 0.061512116342782974

This O 0 0.02693074196577072
report O 0 0.03144565224647522
documents O 0 0.02325802855193615
a O 0 0.03384009003639221
novel O 0 0.06317569315433502
splice O 0 0.2079884558916092
- O 0 0.11750978976488113
site O 0 0.065873883664608
mutation O 0 0.1474088430404663
in O 0 0.03358380123972893
COL17A1 O 0 0.2763557732105255
in O 0 0.02784653753042221
a O 0 0.04266926646232605
patient O 1 0.9886011481285095
with O 0 0.05856412649154663
generalized O 1 0.9984278678894043
atrophic B-Disease 1 0.9999985694885254
benign I-Disease 1 0.9999964237213135
epidermolysis I-Disease 1 0.9999988079071045
bullosa I-Disease 1 0.99997878074646
, O 0 0.03686719015240669
and O 0 0.020197616890072823
applies O 0 0.04015671834349632
a O 0 0.022632643580436707
new O 0 0.02254030480980873
methodology O 0 0.046006347984075546
to O 0 0.017808450385928154
define O 0 0.046778541058301926
and O 0 0.022063685581088066
characterize O 0 0.09184440225362778
the O 0 0.034398216754198074
resulting O 0 0.09380937367677689
mRNA O 0 0.1374785155057907
splice O 0 0.23835743963718414
variants O 0 0.1310877948999405
. O 0 0.06238950788974762

Mutational O 1 0.6349950432777405
analysis O 0 0.07749788463115692
of O 0 0.03205817565321922
COL17A1 O 0 0.3424500524997711
identified O 0 0.06100410223007202
a O 0 0.05581163242459297
maternally O 0 0.4556557238101959
inherited O 1 0.9737632274627686
G O 1 0.9827585816383362
- O 0 0.14659598469734192
to O 0 0.047148581594228745
- O 1 0.5661661028862
T O 1 0.9887690544128418
transversion O 0 0.18400873243808746
at O 0 0.0317457914352417
the O 0 0.02408767305314541
- O 0 0.07445118576288223
1 O 0 0.034242525696754456
position O 0 0.027500146999955177
of O 0 0.022914830595254898
exon O 0 0.1636825054883957
32 O 0 0.08296220004558563
. O 0 0.05348413810133934

This O 0 0.06964363157749176
acceptor O 1 0.5968182682991028
splice O 0 0.43568891286849976
- O 0 0.14995665848255157
site O 0 0.07114221155643463
mutation O 0 0.14578862488269806
led O 0 0.037943385541439056
to O 0 0.018324019387364388
the O 0 0.02242015302181244
formation O 0 0.06577132642269135
of O 0 0.028949715197086334
aberrant O 0 0.16843199729919434
transcripts O 0 0.07534445822238922
present O 0 0.03677336871623993
at O 0 0.03782578185200691
extremely O 0 0.061569105833768845
low O 0 0.07735861092805862
levels O 0 0.08513051271438599
. O 0 0.049647439271211624

Based O 0 0.044640738517045975
on O 0 0.02064654789865017
our O 0 0.02764730155467987
recent O 0 0.034548234194517136
finding O 0 0.05050882324576378
that O 0 0.03320286050438881
cycloheximide O 1 0.6034842729568481
stabilized O 1 0.8827075958251953
mutant O 0 0.2025536745786667
COL17A1 O 1 0.7558589577674866
transcripts O 0 0.08663999289274216
in O 0 0.038149669766426086
keratinocytes O 1 0.6373873949050903
homozygous O 0 0.14940404891967773
for O 0 0.038438159972429276
a O 0 0.06061944365501404
frameshift O 1 0.9457044005393982
mutation O 0 0.17361754179000854
, O 0 0.027333419770002365
the O 0 0.022716084495186806
effects O 0 0.0748542994260788
of O 0 0.01813938096165657
the O 0 0.032516639679670334
splice O 0 0.21368242800235748
- O 0 0.11804032325744629
site O 0 0.06259262561798096
mutation O 0 0.12793125212192535
on O 0 0.025113778188824654
splicing O 0 0.11260250955820084
of O 0 0.027830911800265312
COL17A1 O 0 0.2006748616695404
transcripts O 0 0.06265836209058762
were O 0 0.01936763897538185
determined O 0 0.04224525764584541
using O 0 0.04425305128097534
reverse O 0 0.14174014329910278
transcriptase O 1 0.648777425289154
polymerase O 0 0.2701609134674072
chain O 0 0.13111543655395508
reaction O 0 0.08792854845523834
of O 0 0.02454882301390171
total O 0 0.04836886748671532
RNA O 0 0.12904410064220428
from O 0 0.04170599207282066
keratinocytes O 0 0.380222886800766
incubated O 0 0.13286465406417847
for O 0 0.03174516186118126
2 O 0 0.05865790322422981
. O 0 0.049592699855566025

5 O 0 0.09097062796354294
h O 0 0.11522471904754639
in O 0 0.021188147366046906
the O 0 0.02066538669168949
presence O 0 0.04252786561846733
or O 0 0.026293130591511726
absence O 0 0.04519885778427124
of O 0 0.020920492708683014
10 O 0 0.046532824635505676
microg O 0 0.49899521470069885
cycloheximide O 0 0.41060057282447815
per O 0 0.07456856966018677
ml O 0 0.49544408917427063
. O 0 0.06413465738296509

Using O 0 0.047868289053440094
this O 0 0.023159602656960487
approach O 0 0.05345913767814636
, O 0 0.025254173204302788
an O 0 0.03909878805279732
abnormally O 1 0.5060192942619324
spliced O 0 0.18855400383472443
transcript O 0 0.10405763238668442
was O 0 0.027565013617277145
identified O 0 0.03663327544927597
that O 0 0.014305130578577518
contains O 0 0.024770615622401237
an O 0 0.020778171718120575
extra O 0 0.057567112147808075
264 O 0 0.11563639342784882
bases O 0 0.06446420401334763
upstream O 0 0.09298568964004517
from O 0 0.03793130815029144
exon O 0 0.15462316572666168
32 O 0 0.059567585587501526
, O 0 0.026361245661973953
resulting O 0 0.05448370426893234
in O 0 0.025790560990571976
a O 0 0.05151725932955742
premature O 1 0.8226771950721741
termination O 1 0.6729512810707092
codon O 0 0.20570331811904907
27 O 0 0.08287936449050903
bp O 0 0.13042744994163513
downstream O 0 0.09854505956172943
from O 0 0.030941670760512352
the O 0 0.0353320837020874
cryptic O 0 0.16784578561782837
splice O 0 0.2184176743030548
site O 0 0.074431411921978
. O 0 0.057486969977617264

Three O 0 0.0412752628326416
other O 0 0.03157547488808632
splice O 0 0.17407971620559692
variants O 0 0.07712975889444351
, O 0 0.01917228475213051
including O 0 0.01605084538459778
one O 0 0.01669187843799591
derived O 0 0.032489314675331116
from O 0 0.01840943843126297
the O 0 0.021857021376490593
skipping O 0 0.08825008571147919
of O 0 0.022390194237232208
exon O 0 0.13348516821861267
32 O 0 0.05007677152752876
, O 0 0.020150676369667053
were O 0 0.014910319820046425
also O 0 0.020557213574647903
identified O 0 0.04874756559729576
. O 0 0.043982669711112976

These O 0 0.03614184260368347
results O 0 0.048169758170843124
indicate O 0 0.04191633313894272
the O 0 0.02298584207892418
usefulness O 0 0.08864718675613403
of O 0 0.0318206250667572
cycloheximide O 1 0.9617418646812439
treatment O 1 0.9231269955635071
in O 0 0.02596970461308956
evaluating O 0 0.06044379249215126
the O 0 0.028404412791132927
abnormal O 0 0.16846296191215515
processing O 0 0.04442762956023216
of O 0 0.01966707967221737
mRNA O 0 0.06835433840751648
due O 0 0.03639375418424606
to O 0 0.03428920730948448
splice O 0 0.21198976039886475
- O 0 0.133378803730011
site O 0 0.0701129138469696
mutations O 0 0.12885938584804535
, O 0 0.027119601145386696
because O 0 0.032934315502643585
( O 0 0.041913192719221115
i O 0 0.04095223918557167
) O 0 0.0430009663105011
aberrant O 0 0.17284731566905975
splicing O 0 0.1484508067369461
often O 0 0.05383700877428055
generates O 0 0.10482588410377502
a O 0 0.060883913189172745
premature O 1 0.8438313007354736
termination O 1 0.7330173850059509
codon O 0 0.17759615182876587
, O 0 0.04260503873229027
( O 0 0.05599236115813255
ii O 0 0.08335602283477783
) O 0 0.04052066430449486
transcripts O 0 0.06406964361667633
with O 0 0.04291299730539322
premature O 1 0.9775166511535645
termination O 1 0.9365648627281189
codons O 0 0.14511443674564362
can O 0 0.039772879332304
occur O 0 0.058287497609853745
at O 0 0.03250665217638016
low O 0 0.06479420512914658
or O 0 0.04352077841758728
undetectable O 1 0.9584380388259888
levels O 0 0.07174630463123322
due O 0 0.041092053055763245
to O 0 0.02945050038397312
nonsense O 0 0.1173456609249115
- O 0 0.1371629387140274
mediated O 0 0.19797873497009277
mRNA O 0 0.13174162805080414
decay O 0 0.09051310271024704
, O 0 0.021551502868533134
and O 0 0.02037750370800495
( O 0 0.04171523079276085
iii O 0 0.07493703067302704
) O 0 0.026235289871692657
the O 0 0.015707025304436684
levels O 0 0.033319536596536636
of O 0 0.011093431152403355
these O 0 0.014279249124228954
transcripts O 0 0.04368463531136513
can O 0 0.021290967240929604
be O 0 0.014407758601009846
increased O 0 0.03615296632051468
by O 0 0.03287438303232193
cycloheximide O 0 0.1991143524646759
. O 0 0.0627003163099289

A O 0 0.10433248430490494
deletion O 0 0.23677025735378265
mutation O 0 0.1943560093641281
in O 0 0.04182589426636696
COL17A1 O 0 0.18093082308769226
in O 0 0.024953195825219154
five O 0 0.030939938500523567
Austrian O 0 0.09007129818201065
families O 0 0.05126368626952171
with O 0 0.05254732072353363
generalized O 1 0.998150110244751
atrophic B-Disease 1 0.9999977350234985
benign I-Disease 1 0.999981164932251
epidermolysis I-Disease 1 0.9999970197677612
bullosa I-Disease 1 0.9999277591705322
represents O 0 0.10365289449691772
propagation O 0 0.09133290499448776
of O 0 0.02243727631866932
an O 0 0.03321050480008125
ancestral O 0 0.12260227650403976
allele O 0 0.22253796458244324
. O 0 0.07465957850217819

Patients O 1 0.9996721744537354
with O 0 0.08633524179458618
generalized O 1 0.9990647435188293
atrophic B-Disease 1 0.9999973773956299
benign I-Disease 1 0.9999914169311523
epidermolysis I-Disease 1 0.9999972581863403
bullosa I-Disease 1 0.9999338388442993
, O 0 0.050466712564229965
a O 0 0.0412881001830101
usually O 0 0.04759086295962334
nonlethal O 0 0.14672590792179108
form O 0 0.054495908319950104
of O 0 0.05153069272637367
junctional B-Disease 1 0.9998903274536133
epidermolysis I-Disease 1 0.999985933303833
bullosa I-Disease 1 0.9999375343322754
, O 0 0.05266440659761429
have O 0 0.03965942934155464
generalized O 1 0.9542600512504578
blistering B-Disease 1 0.9891239404678345
, O 0 0.0833376944065094
nail B-Disease 1 0.9999878406524658
dystrophy I-Disease 1 0.9999998807907104
, O 0 0.0989239439368248
patchy B-Disease 1 0.9999390840530396
alopecia I-Disease 1 0.9999996423721313
, O 0 0.04779067635536194
and O 0 0.04295087605714798
dental B-Disease 1 0.9999523162841797
abnormalities I-Disease 1 0.9987363219261169
. O 0 0.06191600486636162

Skin B-Disease 1 0.9999643564224243
fragility I-Disease 1 0.9871252179145813
in O 0 0.026895787566900253
most O 0 0.01968309096992016
cases O 0 0.03233373537659645
is O 0 0.018950659781694412
due O 0 0.027547642588615417
to O 0 0.021485963836312294
mutations O 0 0.0968141108751297
in O 0 0.020510410889983177
the O 0 0.02778630144894123
gene O 0 0.13389329612255096
encoding O 0 0.12656283378601074
type O 1 0.6835731267929077
XVII O 1 0.9998186230659485
collagen O 1 0.9992424249649048
( O 0 0.11145570129156113
COL17A1 O 1 0.957565188407898
) O 0 0.05805731937289238
. O 0 0.04576973617076874

Recently O 0 0.07248750329017639
, O 0 0.025279827415943146
we O 0 0.020426446571946144
reported O 0 0.03671669214963913
five O 0 0.026436282321810722
Austrian O 0 0.07664619386196136
families O 0 0.05818761885166168
with O 0 0.05493374541401863
generalized O 1 0.9986476302146912
atrophic B-Disease 1 0.9999946355819702
benign I-Disease 1 0.9999897480010986
epidermolysis I-Disease 1 0.9999970197677612
bullosa I-Disease 1 0.9999477863311768
who O 0 0.05727916583418846
share O 0 0.04569984972476959
the O 0 0.026392651721835136
same O 0 0.04543197154998779
COL17A1 O 1 0.9633872509002686
mutation O 0 0.2553698718547821
. O 0 0.06281431019306183

Affected O 0 0.10537625104188919
individuals O 0 0.036398984491825104
in O 0 0.019656118005514145
three O 0 0.019064797088503838
families O 0 0.037936221808195114
are O 0 0.019671807065606117
homozygous O 0 0.10657008737325668
for O 0 0.028803614899516106
4003delTC O 0 0.14500053226947784
, O 0 0.023199863731861115
whereas O 0 0.03774217143654823
those O 0 0.013489071279764175
in O 0 0.012150133959949017
two O 0 0.014637111686170101
others O 0 0.027576586231589317
are O 0 0.02386718988418579
compound O 0 0.128147691488266
heterozygotes O 1 0.8999829888343811
. O 0 0.06721707433462143

To O 0 0.0365033894777298
determine O 0 0.043905094265937805
if O 0 0.02296282723546028
the O 0 0.020258130505681038
occurrence O 0 0.07301399111747742
of O 0 0.022098008543252945
4003delTC O 0 0.11648145318031311
in O 0 0.021126477047801018
these O 0 0.01827549748122692
unrelated O 0 0.06213691085577011
families O 0 0.05050728842616081
signifies O 0 0.10134679824113846
propagation O 0 0.07756712287664413
of O 0 0.018517473712563515
an O 0 0.027237650007009506
ancestral O 0 0.10423587262630463
allele O 0 0.18075896799564362
or O 0 0.05259750783443451
a O 0 0.05587475746870041
mutational O 1 0.9590607285499573
hot O 0 0.11835698038339615
spot O 0 0.0712219700217247
, O 0 0.0315701998770237
haplotypes O 0 0.1767047643661499
were O 0 0.021443236619234085
determined O 0 0.038405027240514755
for O 0 0.021492036059498787
polymorphisms O 0 0.10877817124128342
both O 0 0.02316678874194622
within O 0 0.026625551283359528
and O 0 0.029552260413765907
flanking O 0 0.1904437094926834
COL17A1 O 1 0.9529778957366943
. O 0 0.06568915396928787

Five O 0 0.07847613096237183
intragenic O 0 0.2331768125295639
polymorphisms O 0 0.14461088180541992
were O 0 0.017930883914232254
chosen O 0 0.024779681116342545
based O 0 0.020340057089924812
on O 0 0.015507732518017292
their O 0 0.027015266939997673
informativeness O 0 0.1866539865732193
. O 0 0.056514717638492584

One O 0 0.0303297471255064
of O 0 0.015092347748577595
these O 0 0.014559505507349968
, O 0 0.01612711139023304
not O 0 0.014088640920817852
previously O 0 0.024576572701334953
reported O 0 0.03579393029212952
, O 0 0.01778639480471611
was O 0 0.02531549520790577
2988 O 0 0.11648940294981003
A O 0 0.03822299838066101
or O 0 0.033128414303064346
C O 0 0.08602681010961533
that O 0 0.018625110387802124
introduces O 0 0.05563300475478172
a O 0 0.02729085460305214
new O 0 0.027095921337604523
restriction O 0 0.0529748797416687
site O 0 0.03804299607872963
for O 0 0.029056822881102562
Eco0109 O 0 0.17293524742126465
I O 0 0.06568839401006699
. O 0 0.05061164125800133

All O 0 0.033617954701185226
the O 0 0.038670409470796585
4003delTC O 0 0.20006951689720154
alleles O 0 0.17085367441177368
showed O 0 0.052489157766103745
the O 0 0.022046448662877083
same O 0 0.031989116221666336
haplotype O 0 0.2556946277618408
for O 0 0.02007487788796425
these O 0 0.01889782026410103
five O 0 0.0411376990377903
polymorphic O 0 0.23297446966171265
markers O 0 0.14476598799228668
. O 0 0.056954894214868546

Fourteen O 0 0.13044443726539612
microsatellite O 0 0.31959784030914307
polymorphisms O 0 0.15928038954734802
were O 0 0.02001519873738289
selected O 0 0.023831943050026894
based O 0 0.02154521830379963
on O 0 0.012503474950790405
their O 0 0.01727081649005413
high O 0 0.0470256544649601
heterozygosity O 0 0.19312593340873718
and O 0 0.020308470353484154
their O 0 0.01797543093562126
location O 0 0.03775331750512123
within O 0 0.03872617706656456
10q23 O 0 0.35664454102516174
- O 0 0.1494855135679245
q25 O 0 0.21113790571689606
near O 0 0.10443209111690521
COL17A1 O 1 0.6224865913391113
. O 0 0.07031095027923584

Three O 0 0.0419192798435688
families O 0 0.0643833577632904
shared O 0 0.08491118997335434
microsatellite O 0 0.39543581008911133
polymorphisms O 0 0.19963912665843964
covering O 0 0.07028898596763611
at O 0 0.03529731556773186
most O 0 0.022702381014823914
19 O 0 0.04676502197980881
cM O 0 0.06731008738279343
, O 0 0.020935330539941788
whereas O 0 0.040470872074365616
the O 0 0.019384602084755898
others O 0 0.027563074603676796
shared O 0 0.03162103891372681
smaller O 0 0.03494914993643761
regions O 0 0.04530806094408035
consistent O 0 0.040614400058984756
with O 0 0.021215861663222313
cross O 0 0.04679960757493973
- O 0 0.07034160196781158
over O 0 0.024074437096714973
events O 0 0.03042062744498253
during O 0 0.028592078015208244
passage O 0 0.032368965446949005
of O 0 0.015428912825882435
this O 0 0.02495884895324707
mutation O 0 0.12694227695465088
through O 0 0.03230758756399155
several O 0 0.027706323191523552
generations O 0 0.06781984120607376
. O 0 0.05049138516187668

These O 0 0.03720318526029587
results O 0 0.05639239028096199
indicate O 0 0.05089043825864792
that O 0 0.0252855122089386
4003delTC O 0 0.14789584279060364
occurs O 0 0.06366099417209625
on O 0 0.017559507861733437
a O 0 0.02968016266822815
single O 0 0.04591851681470871
ancestral O 0 0.11407963931560516
allele O 0 0.19096051156520844
. O 0 0.04599987715482712
. O 0 0.05364721268415451

The O 0 0.08251041918992996
haptoglobin O 1 0.9707146286964417
- O 0 0.21224482357501984
gene O 0 0.17960494756698608
deletion O 0 0.1927003562450409
responsible O 0 0.06870010495185852
for O 0 0.03605085238814354
anhaptoglobinemia B-Disease 0 0.32186049222946167
. O 0 0.05871983990073204

We O 0 0.03227636218070984
have O 0 0.01876356080174446
found O 0 0.029205001890659332
an O 0 0.031511835753917694
allelic O 0 0.21526175737380981
deletion O 0 0.143240287899971
of O 0 0.024949172511696815
the O 0 0.03973662480711937
haptoglobin O 1 0.9613136053085327
( O 0 0.076971136033535
Hp O 0 0.16591551899909973
) O 0 0.04773920774459839
gene O 0 0.08013113588094711
from O 0 0.02180633693933487
an O 0 0.020534634590148926
individual O 0 0.03742174059152603
with O 0 0.03677886724472046
anhaptoglobinemia B-Disease 0 0.28507286310195923
. O 0 0.060228701680898666

The O 0 0.06139800697565079
Hp O 0 0.1987050622701645
gene O 0 0.1470600962638855
cluster O 0 0.1066814586520195
consists O 0 0.037089839577674866
of O 0 0.020663080736994743
coding O 0 0.09189428389072418
regions O 0 0.037990521639585495
of O 0 0.01680741272866726
the O 0 0.02633819915354252
alpha O 0 0.09891229122877121
chain O 0 0.08302421122789383
and O 0 0.027497444301843643
beta O 0 0.09278743714094162
chain O 0 0.06646549701690674
of O 0 0.02253531850874424
the O 0 0.04080420359969139
haptoglobin O 1 0.9252467155456543
gene O 0 0.1548338234424591
( O 0 0.061445679515600204
Hp O 0 0.10674293339252472
) O 0 0.024468496441841125
and O 0 0.011295878328382969
of O 0 0.012293413281440735
the O 0 0.02093571051955223
alpha O 0 0.08082661032676697
chain O 0 0.07555726170539856
and O 0 0.02607635408639908
beta O 0 0.08335395157337189
chain O 0 0.06367668509483337
of O 0 0.022520272061228752
the O 0 0.03784600645303726
haptoglobin O 1 0.9878624677658081
- O 0 0.16257411241531372
related O 0 0.08741576224565506
gene O 0 0.15588071942329407
( O 0 0.07343106716871262
Hpr O 1 0.9493416547775269
) O 0 0.03955378010869026
, O 0 0.018125265836715698
in O 0 0.01788048818707466
tandem O 0 0.07624028623104095
from O 0 0.024320386350154877
the O 0 0.024110980331897736
5 O 0 0.042917244136333466
side O 0 0.05856223404407501
. O 0 0.04645330086350441

Southern O 0 0.11619848757982254
blot O 0 0.2411436289548874
and O 0 0.04570746421813965
PCR O 0 0.17818595468997955
analyses O 0 0.06118488684296608
have O 0 0.0187015850096941
indicated O 0 0.03473048284649849
that O 0 0.011417041532695293
the O 0 0.013915183953940868
individual O 0 0.02785484679043293
with O 0 0.027091464027762413
anhaptoglobinemia B-Disease 0 0.14932748675346375
was O 0 0.037154145538806915
homozygous O 0 0.10366647690534592
for O 0 0.02247600629925728
the O 0 0.029500000178813934
gene O 0 0.10529883950948715
deletion O 0 0.12377483397722244
and O 0 0.018617723137140274
that O 0 0.015441355295479298
the O 0 0.024113483726978302
gene O 0 0.10368874669075012
deletion O 0 0.11891834437847137
was O 0 0.0257197804749012
included O 0 0.020266635343432426
at O 0 0.02039211615920067
least O 0 0.020266687497496605
from O 0 0.018368838354945183
the O 0 0.023471616208553314
promoter O 0 0.10601922124624252
region O 0 0.048185668885707855
of O 0 0.022679628804326057
Hp O 0 0.11183739453554153
to O 0 0.038223691284656525
Hpr O 1 0.6134470701217651
alpha O 0 0.09255046397447586
but O 0 0.022550752386450768
not O 0 0.01873077265918255
to O 0 0.032206904143095016
Hpr O 1 0.9305762648582458
beta O 0 0.14121463894844055
( O 0 0.073811836540699
Hpdel O 0 0.35538655519485474
) O 0 0.054693255573511124
. O 0 0.043712068349123

In O 0 0.03277690336108208
addition O 0 0.03341052308678627
, O 0 0.018803587183356285
we O 0 0.013453067280352116
found O 0 0.019314831122756004
seven O 0 0.0214927289634943
individuals O 0 0.027216296643018723
with O 0 0.023644648492336273
hypohaptoglobinemia B-Disease 0 0.12219198793172836
in O 0 0.01743174158036709
three O 0 0.019399546086788177
families O 0 0.029590167105197906
, O 0 0.01470379251986742
and O 0 0.01389907207340002
the O 0 0.019333455711603165
genotypes O 0 0.12689583003520966
of O 0 0.01474072877317667
six O 0 0.017745042219758034
of O 0 0.010938059538602829
the O 0 0.015329686924815178
seven O 0 0.020850175991654396
individuals O 0 0.025737717747688293
were O 0 0.014635530300438404
found O 0 0.021719936281442642
to O 0 0.018713949248194695
be O 0 0.0278877392411232
Hp2 O 1 0.9737550020217896
/ O 1 0.9700657725334167
Hpdel O 0 0.4208184480667114
. O 0 0.06232435256242752

The O 0 0.062109339982271194
phenotypes O 0 0.19368022680282593
and O 0 0.03148633614182472
genotypes O 0 0.14664122462272644
in O 0 0.01828223280608654
one O 0 0.013398577459156513
of O 0 0.011151572689414024
these O 0 0.011043294332921505
three O 0 0.016953319311141968
families O 0 0.03118872083723545
showed O 0 0.03450818359851837
the O 0 0.018629517406225204
father O 0 0.032579898834228516
to O 0 0.020294973626732826
be O 0 0.025304293259978294
hypohaptoglobinemic B-Disease 0 0.38782766461372375
( O 0 0.05872202292084694
Hp2 O 0 0.41113898158073425
) O 0 0.04508299380540848
and O 0 0.034658417105674744
Hp2 O 1 0.9845442175865173
/ O 1 0.9759767651557922
Hpdel O 0 0.25471368432044983
, O 0 0.021882884204387665
the O 0 0.019894864410161972
mother O 0 0.0419691763818264
to O 0 0.02145606279373169
be O 0 0.02449544332921505
Hp2 O 1 0.5467788577079773
- O 0 0.10467320680618286
1 O 0 0.05574542656540871
and O 0 0.03708082064986229
Hp1 O 1 0.9868800640106201
/ O 1 0.9639942049980164
Hp2 O 0 0.15848642587661743
, O 0 0.01910819299519062
one O 0 0.011524227447807789
of O 0 0.008861176669597626
the O 0 0.01177305355668068
two O 0 0.012470289133489132
children O 0 0.030230239033699036
to O 0 0.019850224256515503
be O 0 0.026029767468571663
hypohaptoglobinemic B-Disease 0 0.2202048897743225
( O 0 0.06674477458000183
Hp2 O 0 0.32011792063713074
) O 0 0.04746448993682861
and O 0 0.03686429560184479
Hp2 O 1 0.9906343221664429
/ O 1 0.9793490171432495
Hpdel O 0 0.2394961416721344
, O 0 0.021641163155436516
and O 0 0.013670483604073524
the O 0 0.013834492303431034
other O 0 0.0142550403252244
child O 0 0.04269463196396828
to O 0 0.018659766763448715
be O 0 0.023233598098158836
Hp1 O 0 0.2311347872018814
and O 0 0.04458240047097206
Hp1 O 1 0.988815426826477
/ O 1 0.9808758497238159
Hpdel O 0 0.28613367676734924
, O 0 0.031624969094991684
showing O 0 0.04477333649992943
an O 0 0.032100602984428406
anomalous O 0 0.15990817546844482
inheritance O 0 0.11263798177242279
of O 0 0.034401681274175644
Hp O 0 0.28636670112609863
phenotypes O 0 0.1691046804189682
in O 0 0.026957320049405098
the O 0 0.026506520807743073
child O 0 0.06132877245545387
with O 0 0.04026829078793526
Hp1 O 1 0.5125555396080017
. O 0 0.05945805832743645

The O 0 0.08173663914203644
Hp2 O 1 0.9904707670211792
/ O 1 0.9878508448600769
Hpdel O 0 0.29470863938331604
individuals O 0 0.03903353586792946
had O 0 0.025230661034584045
an O 0 0.021350868046283722
extremely O 0 0.04935289919376373
low O 0 0.05299728363752365
level O 0 0.037204667925834656
of O 0 0.025025274604558945
Hp O 0 0.3007764220237732
( O 0 0.06894856691360474
mean O 0 0.09270305186510086
+ O 1 0.9904298186302185
/ O 1 0.9886958599090576
- O 0 0.18363137543201447
SD O 0 0.49535277485847473
= O 0 0.20228570699691772
0 O 0 0.1141250878572464
. O 0 0.05268837884068489
049 O 1 0.9956167936325073
+ O 1 0.9768654108047485
/ O 1 0.9701201915740967
- O 0 0.15656140446662903
0 O 0 0.11384150385856628
. O 0 0.059004124253988266
043 O 1 0.9910687208175659
mg O 1 0.9982884526252747
/ O 1 0.9943656921386719
ml O 1 0.9570775628089905
; O 0 0.07602718472480774
n O 0 0.12920589745044708
= O 0 0.13297039270401
6 O 0 0.05036617070436478
) O 0 0.029888270422816277
, O 0 0.017755042761564255
compared O 0 0.029410632327198982
with O 0 0.015923768281936646
the O 0 0.01960064470767975
level O 0 0.041443124413490295
( O 0 0.03631214424967766
1 O 0 0.03232068568468094
. O 0 0.024103909730911255
64 O 0 0.07666212320327759
+ O 1 0.9452476501464844
/ O 1 0.907897412776947
- O 0 0.10165472328662872
1 O 0 0.05281814932823181
. O 0 0.04180397465825081
07 O 1 0.9292125105857849
mg O 1 0.9978302121162415
/ O 1 0.9865958094596863
ml O 0 0.3594023287296295
) O 0 0.04170970618724823
obtained O 0 0.03269292786717415
from O 0 0.029101109132170677
52 O 0 0.07587473094463348
healthy O 0 0.11673881113529205
volunteers O 0 0.08424010872840881
having O 0 0.0698673203587532
phenotype O 1 0.9657361507415771
Hp2 O 0 0.45495182275772095
, O 0 0.036353640258312225
whereas O 0 0.06116250157356262
the O 0 0.03535754978656769
serum O 1 0.913981556892395
Hp O 0 0.10716848820447922
level O 0 0.03603534400463104
of O 0 0.014209107495844364
an O 0 0.01959373988211155
individual O 0 0.03221718221902847
with O 0 0.042498841881752014
Hp1 O 1 0.9796935319900513
/ O 1 0.9396184086799622
Hpdel O 0 0.22409863770008087
was O 0 0.045882657170295715
0 O 0 0.09572713077068329
. O 0 0.04909806326031685

50 O 0 0.14267298579216003
mg O 1 0.9961833357810974
/ O 1 0.9798653721809387
ml O 0 0.2882554233074188
, O 0 0.02488754130899906
which O 0 0.018227148801088333
was O 0 0.018321214243769646
approximately O 0 0.024776488542556763
half O 0 0.020771842449903488
the O 0 0.017509376630187035
level O 0 0.031749188899993896
of O 0 0.01896972954273224
Hp O 0 0.08427299559116364
in O 0 0.025269916281104088
control O 0 0.05623513087630272
sera O 0 0.11355628073215485
from O 0 0.026731688529253006
the O 0 0.03808572143316269
Hp1 O 1 0.630631148815155
phenotype O 1 0.7581160664558411
( O 0 0.05645963177084923
1 O 0 0.04356352984905243
. O 0 0.02897748164832592
26 O 0 0.06806542724370956
+ O 1 0.9137172698974609
/ O 1 0.9243830442428589
- O 0 0.11534994095563889
0 O 0 0.0867888480424881
. O 0 0.03382128104567528
33 O 0 0.09383335709571838
mg O 1 0.9930012226104736
/ O 1 0.9891217350959778
ml O 1 0.9005331993103027
; O 0 0.06966999173164368
n O 0 0.12302608788013458
= O 0 0.13547058403491974
9 O 0 0.04763386771082878
) O 0 0.02879169210791588
, O 0 0.021850189194083214
showing O 0 0.045453883707523346
a O 0 0.052528221160173416
gene O 0 0.15433554351329803
- O 0 0.1954011470079422
dosage O 1 0.93410724401474
effect O 0 0.10594131052494049
. O 0 0.052809324115514755

The O 0 0.042974453419446945
other O 0 0.034636981785297394
allele O 0 0.1914498209953308
( O 0 0.07453807443380356
Hp2 O 0 0.18971632421016693
) O 0 0.029657842591404915
of O 0 0.01575332134962082
individuals O 0 0.03682629391551018
with O 0 0.037421051412820816
Hp2 O 1 0.9940709471702576
/ O 1 0.9731936454772949
Hpdel O 0 0.16419179737567902
was O 0 0.022259196266531944
found O 0 0.017222944647073746
to O 0 0.010704063810408115
have O 0 0.013025814667344093
, O 0 0.01126773003488779
in O 0 0.012755416333675385
all O 0 0.016911378130316734
exons O 0 0.09276171028614044
, O 0 0.02533014304935932
no O 0 0.03113037906587124
mutation O 0 0.12316133826971054
, O 0 0.02626998908817768
by O 0 0.026947947219014168
DNA O 0 0.09052268415689468
sequencing O 0 0.11827061325311661
. O 0 0.05402461439371109

On O 0 0.023096589371562004
the O 0 0.01631750352680683
basis O 0 0.016740581020712852
of O 0 0.010701589286327362
the O 0 0.014918824657797813
present O 0 0.024541856721043587
study O 0 0.031178725883364677
, O 0 0.015833139419555664
the O 0 0.01861492544412613
mechanism O 0 0.05588653311133385
of O 0 0.019676055759191513
anhaptoglobinemia B-Disease 0 0.1125883236527443
and O 0 0.018526170402765274
the O 0 0.01916341483592987
mechanism O 0 0.0667952373623848
of O 0 0.023391060531139374
anomalous O 0 0.1526142656803131
inheritance O 0 0.09930402785539627
of O 0 0.03064151480793953
Hp O 0 0.417158842086792
phenotypes O 0 0.16609549522399902
were O 0 0.025140514597296715
well O 0 0.028157072141766548
explained O 0 0.059181809425354004
. O 0 0.04834534972906113

However O 0 0.03810444846749306
, O 0 0.022590111941099167
the O 0 0.023422779515385628
mechanism O 0 0.07547330111265182
of O 0 0.028799787163734436
hypohaptoglobinemia B-Disease 0 0.2643888294696808
remains O 0 0.07609120011329651
unknown O 0 0.09703397750854492

ATM O 0 0.29240673780441284
mutations O 0 0.21042995154857635
and O 0 0.0507509708404541
phenotypes O 1 0.7891734838485718
in O 0 0.0779702365398407
ataxia B-Disease 1 0.9999991655349731
- I-Disease 1 0.9967445135116577
telangiectasia I-Disease 1 0.9995226860046387
families O 0 0.058014582842588425
in O 0 0.02309507504105568
the O 0 0.024216078221797943
British O 0 0.054220013320446014
Isles O 0 0.12162035703659058
: O 0 0.03996337577700615
expression O 0 0.05100337043404579
of O 0 0.0256141759455204
mutant O 0 0.1262839138507843
ATM O 0 0.1196591779589653
and O 0 0.019805990159511566
the O 0 0.024962464347481728
risk O 1 0.9468902945518494
of O 0 0.04720760136842728
leukemia B-Disease 1 1.0
, O 1 0.9281435608863831
lymphoma B-Disease 1 1.0
, O 0 0.04391668736934662
and O 0 0.057399675250053406
breast B-Disease 1 0.9999991655349731
cancer I-Disease 1 0.9999924898147583
. O 0 0.06688305735588074

We O 0 0.029762983322143555
report O 0 0.029026489704847336
the O 0 0.02190837636590004
spectrum O 0 0.06559662520885468
of O 0 0.026550590991973877
59 O 0 0.10575927048921585
ATM O 0 0.19845789670944214
mutations O 0 0.1823510080575943
observed O 0 0.07744772732257843
in O 0 0.052849289029836655
ataxia B-Disease 1 0.9999983310699463
- I-Disease 1 0.9978400468826294
telangiectasia I-Disease 1 0.9999611377716064
( O 0 0.18184307217597961
A B-Disease 1 0.9670763611793518
- I-Disease 1 0.9977231621742249
T I-Disease 1 0.9999490976333618
) O 0 0.05894016474485397
patients O 1 0.9627636671066284
in O 0 0.020310943946242332
the O 0 0.023744024336338043
British O 0 0.05624927952885628
Isles O 0 0.1434023380279541
. O 0 0.055750176310539246

Of O 0 0.04812220484018326
51 O 0 0.12014983594417572
ATM O 0 0.23256579041481018
mutations O 0 0.1611875593662262
identified O 0 0.041442085057497025
in O 0 0.018842516466975212
families O 0 0.03021066077053547
native O 0 0.021757973358035088
to O 0 0.014964899979531765
the O 0 0.01648426242172718
British O 0 0.0400473028421402
Isles O 0 0.09440494328737259
, O 0 0.023354070261120796
11 O 0 0.03220658376812935
were O 0 0.020508697256445885
founder O 0 0.06937341392040253
mutations O 0 0.10355064272880554
, O 0 0.019457874819636345
and O 0 0.014625479467213154
2 O 0 0.021989021450281143
of O 0 0.011145695112645626
these O 0 0.014798304997384548
11 O 0 0.03738086670637131
conferred O 0 0.06865423917770386
a O 0 0.049581486731767654
milder O 1 0.9752289056777954
clinical O 1 0.9580904841423035
phenotype O 1 0.8454862236976624
with O 0 0.024988897144794464
respect O 0 0.027957651764154434
to O 0 0.02274373173713684
both O 0 0.034518882632255554
cerebellar B-Disease 1 0.9999780654907227
degeneration I-Disease 1 0.9999779462814331
and O 0 0.035773128271102905
cellular O 0 0.09808780252933502
features O 0 0.053817156702280045
. O 0 0.052186280488967896

We O 0 0.02955010160803795
report O 0 0.025361796841025352
, O 0 0.014742708764970303
in O 0 0.014538693241775036
two O 0 0.022335143759846687
A B-Disease 0 0.08971456438302994
- I-Disease 1 0.8887299299240112
T I-Disease 1 0.9985257983207703
families O 0 0.04751604050397873
, O 0 0.027876116335392
an O 0 0.035165660083293915
ATM O 0 0.23331773281097412
mutation O 0 0.23549798130989075
( O 0 0.08917759358882904
7271T O 1 0.9884347915649414
- O 1 0.9758708477020264
- O 1 0.9001747369766235
> O 1 0.9365254044532776
G O 0 0.3151950240135193
) O 0 0.03225746750831604
that O 0 0.015016758814454079
may O 0 0.020699625834822655
be O 0 0.01191383134573698
associated O 0 0.023136861622333527
with O 0 0.015562267042696476
an O 0 0.021352941170334816
increased O 0 0.05131553113460541
risk O 1 0.9342818260192871
of O 0 0.04030565544962883
breast B-Disease 1 0.9999988079071045
cancer I-Disease 1 0.9999666213989258
in O 0 0.02660619467496872
both O 0 0.029854316264390945
homozygotes O 1 0.9910497665405273
and O 0 0.043021488934755325
heterozygotes O 1 0.9885677099227905
( O 0 0.05842170864343643
relative O 0 0.06268547475337982
risk O 0 0.09387914091348648
12 O 0 0.0386335588991642
. O 0 0.02309364266693592
7 O 0 0.052080366760492325
; O 0 0.05506744980812073
P O 1 0.956169605255127
= O 0 0.1578783541917801
. O 0 0.04805684834718704
0025 O 1 0.9828458428382874
) O 0 0.039702773094177246
, O 0 0.01970696449279785
although O 0 0.018396789208054543
there O 0 0.014203044585883617
is O 0 0.017458517104387283
a O 0 0.027295824140310287
less O 0 0.04497674107551575
severe O 1 0.9996826648712158
A B-Disease 1 0.8940565586090088
- I-Disease 1 0.9925997257232666
T I-Disease 1 0.9996808767318726
phenotype O 1 0.5423553586006165
in O 0 0.01966742053627968
terms O 0 0.017881374806165695
of O 0 0.012039484456181526
the O 0 0.018757082521915436
degree O 0 0.04777757078409195
of O 0 0.037972304970026016
cerebellar B-Disease 1 0.9999707937240601
degeneration I-Disease 1 0.9999932050704956
. O 0 0.07280583679676056

This O 0 0.06335387378931046
mutation O 0 0.2493366003036499
( O 0 0.09875264018774033
7271T O 1 0.9813317060470581
- O 1 0.9124964475631714
- O 1 0.5708449482917786
> O 1 0.5949977040290833
G O 0 0.16759124398231506
) O 0 0.0353502593934536
also O 0 0.01795847900211811
allows O 0 0.029935568571090698
expression O 0 0.040837325155735016
of O 0 0.017966285347938538
full O 0 0.0412369929254055
- O 0 0.10140825808048248
length O 0 0.07834744453430176
ATM O 0 0.15469777584075928
protein O 0 0.07708463817834854
at O 0 0.02792704850435257
a O 0 0.02572297304868698
level O 0 0.03561979532241821
comparable O 0 0.04585135728120804
with O 0 0.01734398864209652
that O 0 0.01560917403548956
in O 0 0.0249034371227026
unaffected O 0 0.14612095057964325
individuals O 0 0.05221256986260414
. O 0 0.04993759095668793

In O 0 0.031306810677051544
addition O 0 0.03405466303229332
, O 0 0.01921500638127327
we O 0 0.015861861407756805
have O 0 0.014474956318736076
studied O 0 0.030574150383472443
18 O 0 0.0375366136431694
A B-Disease 0 0.3952934741973877
- I-Disease 1 0.9956964254379272
T I-Disease 1 0.9999659061431885
patients O 1 0.994628369808197
, O 0 0.0200488343834877
in O 0 0.016216179355978966
15 O 0 0.02693522721529007
families O 0 0.033724330365657806
, O 0 0.022835755720734596
who O 0 0.04335932806134224
developed O 1 0.9284079670906067
leukemia B-Disease 1 1.0
, O 1 0.7170087695121765
lymphoma B-Disease 1 1.0
, O 0 0.07083094865083694
preleukemic O 1 0.9997922778129578
T O 1 0.9999386072158813
- O 1 0.9097881317138672
cell O 1 0.5204898715019226
proliferation O 1 0.6830616593360901
, O 0 0.04399934783577919
or O 1 0.8755896687507629
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 0 0.03772544488310814
mostly O 0 0.03185758739709854
in O 0 0.03149055689573288
childhood O 0 0.27593597769737244
. O 0 0.05466463416814804

A O 0 0.0638439804315567
wide O 0 0.054375145584344864
variety O 0 0.04180417209863663
of O 0 0.030045215040445328
ATM O 0 0.18458431959152222
mutation O 0 0.16992439329624176
types O 0 0.05886662378907204
, O 0 0.02628544718027115
including O 0 0.0364658422768116
missense O 0 0.23717047274112701
mutations O 0 0.1417742371559143
and O 0 0.025637011975049973
in O 0 0.026896459981799126
- O 0 0.0937424972653389
frame O 0 0.08340830355882645
deletions O 0 0.10288313776254654
, O 0 0.02144140750169754
were O 0 0.014637303538620472
seen O 0 0.028349876403808594
in O 0 0.018875213339924812
these O 0 0.027650916948914528
patients O 1 0.9949995279312134
. O 0 0.04615364223718643

We O 0 0.030938666313886642
also O 0 0.018048681318759918
show O 0 0.025446521118283272
that O 0 0.012260690331459045
25 O 0 0.021441131830215454
% O 0 0.020766165107488632
of O 0 0.012480897828936577
all O 0 0.019765518605709076
A B-Disease 0 0.3499566316604614
- I-Disease 1 0.9950152039527893
T I-Disease 1 0.9999431371688843
patients O 1 0.9981560111045837
carried O 0 0.042066287249326706
in O 0 0.029635341838002205
- O 0 0.11277679353952408
frame O 0 0.108786441385746
deletions O 0 0.1578526496887207
or O 0 0.06538716703653336
missense O 0 0.49781519174575806
mutations O 0 0.14157608151435852
, O 0 0.020109007135033607
many O 0 0.012827662751078606
of O 0 0.010103993117809296
which O 0 0.013080223463475704
were O 0 0.012692340649664402
also O 0 0.015453108586370945
associated O 0 0.026346296072006226
with O 0 0.02088896930217743
expression O 0 0.04986914247274399
of O 0 0.026863032951951027
mutant O 0 0.16758732497692108
ATM O 0 0.20518790185451508
protein O 0 0.13479863107204437
. O 0 0.05539712309837341

The O 0 0.06832915544509888
DMPK O 1 0.881575345993042
gene O 0 0.1505122035741806
of O 0 0.042605526745319366
severely O 1 0.9973167777061462
affected O 1 0.9993385672569275
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9999867677688599
is O 0 0.0486106276512146
hypermethylated O 1 0.9541476964950562
proximal O 1 0.9018263816833496
to O 0 0.019941546022892
the O 0 0.020865434780716896
largely O 0 0.04463984817266464
expanded O 0 0.07104754447937012
CTG O 1 0.9722703099250793
repeat O 0 0.18044468760490417
. O 0 0.0629454031586647

Using O 0 0.08957429975271225
methylation O 0 0.17550089955329895
- O 0 0.12791702151298523
sensitive O 0 0.08523686230182648
restriction O 0 0.09143838286399841
enzymes O 0 0.0832233875989914
, O 0 0.02375159040093422
we O 0 0.022191688418388367
characterized O 0 0.07040446251630783
the O 0 0.028066931292414665
methylation O 0 0.10582373291254044
pattern O 0 0.05957825481891632
on O 0 0.014705092646181583
the O 0 0.01565350778400898
5 O 0 0.028181787580251694
side O 0 0.027738941833376884
of O 0 0.014523208141326904
the O 0 0.02804448828101158
CTG O 1 0.9672024846076965
repeat O 0 0.09402112662792206
in O 0 0.023120775818824768
the O 0 0.0300960261374712
DMPK O 1 0.6205963492393494
gene O 0 0.08663328737020493
of O 0 0.019749093800783157
normal O 0 0.052456676959991455
individuals O 0 0.029261060059070587
and O 0 0.01825934462249279
of O 0 0.02487850934267044
patients O 1 0.9999392032623291
affected O 1 0.8344682455062866
with O 0 0.1470901221036911
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 0.042540423572063446
showing O 0 0.053858984261751175
expansions O 0 0.06995077431201935
of O 0 0.01894080638885498
the O 0 0.03337641432881355
repetitive O 0 0.196516215801239
sequence O 0 0.08937104046344757
. O 0 0.05653849616646767

The O 0 0.05492215231060982
gene O 0 0.12916705012321472
segment O 0 0.0954890102148056
analyzed O 0 0.06580032408237457
corresponds O 0 0.05220015347003937
to O 0 0.021830083802342415
the O 0 0.03349411487579346
genomic O 0 0.19318270683288574
SacI O 1 0.9444802403450012
- O 0 0.19809697568416595
HindIII O 0 0.25183558464050293
fragment O 0 0.1383524388074875
carrying O 0 0.07307368516921997
exons O 0 0.15308843553066254
11 O 0 0.06416155397891998
- O 0 0.10779915750026703
15 O 0 0.05644837021827698
. O 0 0.05135065317153931

There O 0 0.046937257051467896
is O 0 0.040212664753198624
constitutive O 0 0.1624683439731598
methylation O 0 0.14450474083423615
in O 0 0.042892374098300934
intron O 0 0.3792487680912018
12 O 0 0.052066221833229065
at O 0 0.032231949269771576
restriction O 0 0.052017055451869965
sites O 0 0.030955519527196884
of O 0 0.025334564968943596
SacII O 0 0.16212518513202667
and O 0 0.028931008651852608
HhaI O 0 0.20998640358448029
, O 0 0.03209429234266281
localized O 0 0.12590526044368744
1 O 0 0.042895205318927765
, O 0 0.028186628594994545
159 O 0 0.11236097663640976
- O 0 0.10069400817155838
1 O 0 0.045958325266838074
, O 0 0.031245406717061996
232 O 0 0.11800678074359894
bp O 0 0.11527373641729355
upstream O 0 0.07812145352363586
of O 0 0.023084670305252075
the O 0 0.03938346728682518
CTG O 1 0.9836139678955078
repeat O 0 0.11461388319730759
, O 0 0.02410956285893917
whereas O 0 0.0419122613966465
most O 0 0.01709255948662758
, O 0 0.015062395483255386
if O 0 0.014795885421335697
not O 0 0.009838166646659374
all O 0 0.008745227009057999
, O 0 0.010166019201278687
of O 0 0.008758212439715862
the O 0 0.012501142919063568
other O 0 0.010880141519010067
sites O 0 0.02215520292520523
of O 0 0.01932421885430813
SacII O 0 0.3560745120048523
, O 0 0.03690456226468086
HhaI O 0 0.1576191782951355
, O 0 0.02325071580708027
and O 0 0.021184219047427177
HpaII O 0 0.11872917413711548
in O 0 0.01733129844069481
this O 0 0.0161924846470356
region O 0 0.03967060148715973
are O 0 0.019879445433616638
unmethylated O 0 0.20192816853523254
, O 0 0.020962657406926155
in O 0 0.017972124740481377
normal O 0 0.04396440088748932
individuals O 0 0.024241255596280098
and O 0 0.013117974624037743
most O 0 0.013401433825492859
of O 0 0.015191709622740746
the O 0 0.03133635222911835
patients O 1 0.9988538026809692
. O 0 0.05759814381599426

In O 0 0.026399247348308563
a O 0 0.022098371759057045
number O 0 0.014827058650553226
of O 0 0.016482509672641754
young O 0 0.04635325446724892
and O 0 0.029498381540179253
severely O 1 0.9888153672218323
affected O 1 0.5481469631195068
patients O 1 0.9994832277297974
, O 0 0.023622918874025345
however O 0 0.019016383215785027
, O 0 0.016336113214492798
complete O 0 0.032260213047266006
methylation O 0 0.06846792995929718
of O 0 0.013960382901132107
these O 0 0.015512477606534958
restriction O 0 0.0441848486661911
sites O 0 0.023746896535158157
was O 0 0.019920552149415016
found O 0 0.020071357488632202
in O 0 0.017609041184186935
the O 0 0.03067547269165516
mutated O 0 0.19162514805793762
allele O 0 0.22730687260627747
. O 0 0.07404784113168716

In O 0 0.02532380074262619
most O 0 0.016101932153105736
of O 0 0.01420403178781271
these O 0 0.019586829468607903
patients O 1 0.9975395202636719
, O 0 0.022422097623348236
the O 0 0.024526474997401237
onset O 1 0.9987627267837524
of O 0 0.028585035353899002
the O 0 0.045815013349056244
disease O 1 0.9999943971633911
was O 0 0.08542821556329727
congenital O 1 0.9999985694885254
. O 0 0.0657624751329422

Preliminary O 0 0.09230738878250122
in O 0 0.05426099896430969
vivo O 0 0.33848559856414795
footprinting O 1 0.963169276714325
data O 0 0.03585760295391083
gave O 0 0.03162646293640137
evidence O 0 0.0261006411164999
for O 0 0.023438213393092155
protein O 0 0.090973399579525
- O 0 0.1026979610323906
DNA O 0 0.08647271245718002
contact O 0 0.06156221032142639
in O 0 0.027019644156098366
normal O 0 0.07355795055627823
genes O 0 0.07941202819347382
at O 0 0.03477024659514427
an O 0 0.03376105800271034
Sp1 O 1 0.965694010257721
consensus O 0 0.05237027630209923
binding O 0 0.05601311847567558
site O 0 0.03971445560455322
upstream O 0 0.056419700384140015
of O 0 0.017641572281718254
the O 0 0.031110743060708046
CTG O 1 0.9684870839118958
repeat O 0 0.08675231039524078
and O 0 0.01569485291838646
for O 0 0.01499150786548853
a O 0 0.024721728637814522
significant O 0 0.028691591694951057
reduction O 0 0.052360497415065765
of O 0 0.012236835435032845
this O 0 0.014773369766771793
interaction O 0 0.041652433574199677
in O 0 0.020559037104249
cells O 0 0.08299088478088379
with O 0 0.03064795769751072
a O 0 0.05171230062842369
hypermethylated O 1 0.9088352918624878
DMPK O 1 0.9686414003372192
gene O 0 0.14859507977962494
. O 0 0.04005240276455879
. O 0 0.04643581435084343

The O 0 0.10144811123609543
hemochromatosis B-Disease 1 0.9999780654907227
gene O 0 0.17881998419761658
product O 0 0.06972694396972656
complexes O 0 0.09400181472301483
with O 0 0.026807988062500954
the O 0 0.04278364032506943
transferrin O 1 0.9529712200164795
receptor O 0 0.23778414726257324
and O 0 0.03651558607816696
lowers O 0 0.29049158096313477
its O 0 0.03252493962645531
affinity O 0 0.10893365740776062
for O 0 0.033349208533763885
ligand O 0 0.17829284071922302
binding O 0 0.09824126958847046
. O 0 0.0551002211868763

We O 0 0.038631927222013474
recently O 0 0.04497319087386131
reported O 0 0.03932349383831024
the O 0 0.022714268416166306
positional O 0 0.09944584965705872
cloning O 0 0.08464546501636505
of O 0 0.021300027146935463
a O 0 0.03303394094109535
candidate O 0 0.0569646880030632
gene O 0 0.12776833772659302
for O 0 0.05011625587940216
hereditary B-Disease 1 0.9999452829360962
hemochromatosis I-Disease 1 0.9999997615814209
called O 0 0.15389302372932434
HFE O 1 0.9971904158592224
. O 0 0.0819508284330368

The O 0 0.0489814393222332
gene O 0 0.10674788057804108
product O 0 0.042591728270053864
, O 0 0.019013945013284683
a O 0 0.01860281266272068
member O 0 0.017931614071130753
of O 0 0.012168938294053078
the O 0 0.02211412414908409
major O 0 0.05105288326740265
histocompatibility O 1 0.9947038292884827
complex O 0 0.08043268322944641
class O 0 0.08307238668203354
I O 0 0.055999401956796646
- O 0 0.07693444937467575
like O 0 0.03156561031937599
family O 0 0.03200937807559967
, O 0 0.016616085544228554
was O 0 0.01681150496006012
found O 0 0.018066177144646645
to O 0 0.013399258255958557
have O 0 0.016192886978387833
a O 0 0.03524075075984001
mutation O 0 0.17321762442588806
, O 0 0.05588717386126518
Cys O 1 0.9995383024215698
- O 1 0.651507556438446
282 O 1 0.809962809085846
- O 1 0.9379101991653442
- O 1 0.7505406141281128
> O 1 0.890144407749176
Tyr O 1 0.980091392993927
( O 0 0.08876951783895493
C282Y O 0 0.1596897542476654
) O 0 0.03333568945527077
, O 0 0.018314672634005547
in O 0 0.018053028732538223
85 O 0 0.059093963354825974
% O 0 0.038867514580488205
of O 0 0.027982113882899284
patient O 1 0.8903173804283142
chromosomes O 0 0.1440902054309845
. O 0 0.05738082528114319

This O 0 0.055808115750551224
mutation O 0 0.18669283390045166
eliminates O 0 0.12837658822536469
the O 0 0.028074592351913452
ability O 0 0.0481153167784214
of O 0 0.027802426367998123
HFE O 1 0.9465253949165344
to O 0 0.03218362107872963
associate O 0 0.05517232418060303
with O 0 0.03897975757718086
beta2 O 1 0.9518476724624634
- O 0 0.25175735354423523
microglobulin O 1 0.683097243309021
( O 0 0.07708937674760818
beta2m O 0 0.3409478962421417
) O 0 0.045180052518844604
and O 0 0.026334278285503387
prevents O 0 0.17632503807544708
cell O 0 0.3302091360092163
- O 0 0.1122097596526146
surface O 0 0.0875411331653595
expression O 0 0.08338611572980881
. O 0 0.05193362385034561

A O 0 0.07228326797485352
second O 0 0.06364329159259796
mutation O 0 0.1358960121870041
that O 0 0.020516352728009224
has O 0 0.024472089484333992
no O 0 0.025384750217199326
effect O 0 0.04455234110355377
on O 0 0.023516468703746796
beta2m O 0 0.24288655817508698
association O 0 0.06793605536222458
, O 0 0.03149079903960228
H63D O 1 0.5215523838996887
, O 0 0.02108413353562355
was O 0 0.01789259910583496
found O 0 0.01898092031478882
in O 0 0.012888827361166477
eight O 0 0.01856422610580921
out O 0 0.015219257213175297
of O 0 0.01613904908299446
nine O 0 0.04367418959736824
patients O 1 0.9442080855369568
heterozygous O 0 0.12150724232196808
for O 0 0.02444617636501789
the O 0 0.03469250723719597
C282Y O 0 0.20016984641551971
mutant O 0 0.17946498095989227
. O 0 0.0648033618927002

In O 0 0.02832748368382454
this O 0 0.016956528648734093
report O 0 0.024534307420253754
, O 0 0.017826775088906288
we O 0 0.01710822805762291
demonstrate O 0 0.046966418623924255
in O 0 0.028789972886443138
cultured O 0 0.15560533106327057
293 O 1 0.5192505121231079
cells O 1 0.5182809233665466
overexpressing O 1 0.9792125225067139
wild O 0 0.1143646314740181
- O 0 0.13301806151866913
type O 0 0.10261380672454834
or O 0 0.05225444585084915
mutant O 0 0.1706167608499527
HFE O 1 0.971916675567627
proteins O 0 0.06689029186964035
that O 0 0.01763070747256279
both O 0 0.01673576422035694
the O 0 0.022519012913107872
wild O 0 0.0696096196770668
- O 0 0.11146198213100433
type O 0 0.09144178777933121
and O 0 0.03931012377142906
H63D O 1 0.9815130233764648
HFE O 1 0.9889234900474548
proteins O 0 0.09448743611574173
form O 0 0.05556424334645271
stable O 0 0.10024610906839371
complexes O 0 0.10280556231737137
with O 0 0.031762175261974335
the O 0 0.04499922692775726
transferrin O 1 0.9890515208244324
receptor O 1 0.8557689785957336
( O 0 0.10029615461826324
TfR O 1 0.9916119575500488
) O 0 0.060265082865953445
. O 0 0.05021972209215164

The O 0 0.06615763157606125
C282Y O 0 0.2392430305480957
mutation O 0 0.19561928510665894
nearly O 0 0.059756506234407425
completely O 0 0.05833221599459648
prevents O 0 0.07817906141281128
the O 0 0.02361728809773922
association O 0 0.04663515463471413
of O 0 0.018189869821071625
the O 0 0.032475996762514114
mutant O 0 0.17846734821796417
HFE O 1 0.9764252305030823
protein O 0 0.10517476499080658
with O 0 0.03447748348116875
the O 0 0.045663051307201385
TfR O 1 0.9889501929283142
. O 0 0.0666206106543541

Studies O 0 0.08362606912851334
on O 0 0.03307162970304489
cell O 0 0.12526948750019073
- O 0 0.1119145080447197
associated O 0 0.06986411660909653
transferrin O 0 0.25524187088012695
at O 0 0.05276304483413696
37 O 0 0.07385614514350891
degrees O 0 0.07005750387907028
C O 0 0.10835956782102585
suggest O 0 0.0419948473572731
that O 0 0.01774083636701107
the O 0 0.031254906207323074
overexpressed O 0 0.40572333335876465
wild O 0 0.11256437003612518
- O 0 0.17675413191318512
type O 0 0.16776762902736664
HFE O 1 0.9871879816055298
protein O 0 0.13524314761161804
decreases O 0 0.10146360844373703
the O 0 0.02775760367512703
affinity O 0 0.08646441996097565
of O 0 0.01909031718969345
the O 0 0.033767491579055786
TfR O 1 0.9928682446479797
for O 0 0.04293253272771835
transferrin O 1 0.9417054653167725
. O 0 0.06617601960897446

The O 0 0.08233422040939331
overexpressed O 1 0.7511866688728333
H63D O 1 0.8829006552696228
protein O 0 0.11096125096082687
does O 0 0.031511660665273666
not O 0 0.014236492104828358
have O 0 0.014178802259266376
this O 0 0.014539125375449657
effect O 0 0.03549446538090706
, O 0 0.01396183855831623
providing O 0 0.02444671094417572
the O 0 0.01374773122370243
first O 0 0.017474401742219925
direct O 0 0.02751464955508709
evidence O 0 0.019791606813669205
for O 0 0.013489853590726852
a O 0 0.0263605285435915
functional O 0 0.05808385834097862
consequence O 0 0.06822358071804047
of O 0 0.022772418335080147
the O 0 0.03721069172024727
H63D O 1 0.9613445401191711
mutation O 0 0.23508481681346893
. O 0 0.06271804124116898

Addition O 0 0.06580936908721924
of O 0 0.03961234539747238
soluble O 0 0.2915445566177368
wild O 0 0.12259325385093689
- O 1 0.7872633934020996
type O 1 0.8462624549865723
HFE O 1 0.9997718930244446
/ O 1 0.9958152174949646
beta2m O 1 0.9178956747055054
heterodimers O 1 0.8854159712791443
to O 0 0.04095710813999176
cultured O 0 0.1515335738658905
cells O 0 0.11110743135213852
also O 0 0.028532259166240692
decreased O 0 0.06861183792352676
the O 0 0.027372805401682854
apparent O 0 0.0778370350599289
affinity O 0 0.08662531524896622
of O 0 0.021579492837190628
the O 0 0.03078763373196125
TfR O 1 0.8746894001960754
for O 0 0.022978374734520912
its O 0 0.026705458760261536
ligand O 0 0.11847323924303055
under O 0 0.03530452772974968
steady O 0 0.08485241234302521
- O 0 0.0781441181898117
state O 0 0.025424908846616745
conditions O 0 0.04108516499400139
, O 0 0.017474746331572533
both O 0 0.01656394638121128
in O 0 0.022310057654976845
293 O 0 0.18505677580833435
cells O 0 0.09971792250871658
and O 0 0.02432706579566002
in O 0 0.037774085998535156
HeLa O 1 0.9894238114356995
cells O 0 0.18397848308086395
. O 0 0.06141689047217369

Furthermore O 0 0.09027696400880814
, O 0 0.029884161427617073
at O 0 0.03356838598847389
4 O 0 0.04731566458940506
degrees O 0 0.05438282713294029
C O 0 0.08336921036243439
, O 0 0.01772075518965721
the O 0 0.017849449068307877
added O 0 0.03455435857176781
soluble O 0 0.13289932906627655
complex O 0 0.0673285722732544
of O 0 0.04296674579381943
HFE O 1 0.9995691180229187
/ O 1 0.9924193024635315
beta2m O 1 0.6447018980979919
inhibited O 0 0.18371102213859558
binding O 0 0.07288544625043869
of O 0 0.02948594279587269
transferrin O 1 0.5500029921531677
to O 0 0.05277298018336296
HeLa O 1 0.9852575659751892
cell O 0 0.2128458321094513
TfR O 1 0.9645297527313232
in O 0 0.0333993025124073
a O 0 0.04849628731608391
concentration O 0 0.12201855331659317
- O 0 0.12160273641347885
dependent O 0 0.09845250099897385
manner O 0 0.07393316924571991
. O 0 0.05332073196768761

Scatchard O 0 0.23335248231887817
plots O 0 0.06810101866722107
of O 0 0.019827501848340034
these O 0 0.014704261906445026
data O 0 0.020969605073332787
indicate O 0 0.029406635090708733
that O 0 0.012836630456149578
the O 0 0.020560376346111298
added O 0 0.03849884867668152
heterodimer O 0 0.4343712627887726
substantially O 0 0.08215028047561646
reduced O 0 0.056399982422590256
the O 0 0.02788706310093403
affinity O 0 0.10040971636772156
of O 0 0.0348515547811985
TfR O 1 0.9854162335395813
for O 0 0.05368386581540108
transferrin O 1 0.9422591328620911
. O 0 0.058370597660541534

These O 0 0.03220200911164284
results O 0 0.04107598215341568
establish O 0 0.045700568705797195
a O 0 0.031669434159994125
molecular O 0 0.07490106672048569
link O 0 0.0740465596318245
between O 0 0.03753884881734848
HFE O 1 0.9617478251457214
and O 0 0.021297302097082138
a O 0 0.02865615300834179
key O 0 0.043242428451776505
protein O 0 0.06993959099054337
involved O 0 0.03612134978175163
in O 0 0.02421911247074604
iron O 0 0.07951447367668152
transport O 0 0.05128636211156845
, O 0 0.022287875413894653
the O 0 0.028372302651405334
TfR O 1 0.9784882068634033
, O 0 0.022183917462825775
and O 0 0.015865011140704155
raise O 0 0.037513647228479385
the O 0 0.019753266125917435
possibility O 0 0.03785225376486778
that O 0 0.016760293394327164
alterations O 0 0.05049004778265953
in O 0 0.018883682787418365
this O 0 0.020181607455015182
regulatory O 0 0.07256175577640533
mechanism O 0 0.0718466266989708
may O 0 0.02660571224987507
play O 0 0.017636597156524658
a O 0 0.016455890610814095
role O 0 0.02382061444222927
in O 0 0.016801772639155388
the O 0 0.02858174778521061
pathogenesis O 1 0.9991111159324646
of O 0 0.04925810173153877
hereditary B-Disease 1 0.9999785423278809
hemochromatosis I-Disease 1 0.9999998807907104
. O 0 0.05053148418664932
. O 0 0.04879818484187126

Genomic O 0 0.1759370118379593
organization O 0 0.05335299298167229
of O 0 0.02534305490553379
the O 0 0.04776247218251228
UBE3A O 1 0.9995661377906799
/ O 1 0.9986341595649719
E6 O 1 0.9985609650611877
- O 0 0.372501939535141
AP O 0 0.11929675936698914
gene O 0 0.10739628970623016
and O 0 0.028016069903969765
related O 0 0.06360261142253876
pseudogenes O 0 0.19502060115337372
. O 0 0.06268344074487686

The O 0 0.08735817670822144
UBE3A O 1 0.8991382122039795
gene O 0 0.1764863133430481
encodes O 0 0.13721708953380585
the O 0 0.05803510919213295
E6 O 1 0.9960500597953796
- O 0 0.2788342535495758
AP O 0 0.16536487638950348
ubiquitin O 0 0.3585376441478729
- O 0 0.1577502340078354
protein O 0 0.12413454800844193
ligase O 0 0.11923359334468842
and O 0 0.021010423079133034
has O 0 0.02045602910220623
recently O 0 0.03407133370637894
been O 0 0.019055087119340897
shown O 0 0.0296117402613163
to O 0 0.017885111272335052
be O 0 0.025699524208903313
mutated O 1 0.7444822192192078
in O 0 0.360813170671463
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.9999865293502808
who O 0 0.05793174356222153
lack O 0 0.11478953063488007
15q11 O 1 0.9859047532081604
- O 0 0.35130107402801514
q13 O 0 0.35156548023223877
deletions O 0 0.16768598556518555
or O 0 0.06540877372026443
chromosome O 0 0.1926025152206421
15 O 0 0.0729820504784584
paternal O 0 0.2795480191707611
uniparental B-Disease 1 0.9985222220420837
disomy I-Disease 1 0.9246799945831299
. O 0 0.0756605938076973

Previous O 0 0.12613479793071747
UBE3A O 1 0.8275340795516968
cDNA O 0 0.1895323544740677
analysis O 0 0.049721959978342056
has O 0 0.025266969576478004
shown O 0 0.037349097430706024
a O 0 0.031597938388586044
coding O 0 0.10681171715259552
region O 0 0.04475442320108414
of O 0 0.021166637539863586
approximately O 0 0.04482221230864525
2 O 0 0.05233176425099373
. O 0 0.04722214862704277

6 O 0 0.0906025618314743
kb O 0 0.12745922803878784
and O 0 0.026689231395721436
a O 0 0.035944823175668716
3 O 0 0.057190652936697006
- O 0 0.12279613316059113
untranslated O 0 0.21310412883758545
region O 0 0.08744814246892929
( O 0 0.07598656415939331
UTR O 0 0.326968789100647
) O 0 0.044408805668354034
of O 0 0.03006650134921074
< O 0 0.17901703715324402
50 O 0 0.0555366687476635
bp O 0 0.09982142597436905
, O 0 0.026191947981715202
whereas O 0 0.049855560064315796
Northern O 0 0.03693021088838577
analysis O 0 0.037247128784656525
has O 0 0.023081602528691292
indicated O 0 0.05359698086977005
mRNA O 0 0.06967324018478394
sizes O 0 0.04537368565797806
of O 0 0.022353559732437134
5 O 0 0.05511581152677536
- O 0 0.10232476145029068
8 O 0 0.06892530620098114
kb O 0 0.17150083184242249
. O 0 0.06172054260969162

We O 0 0.034186434000730515
have O 0 0.024605393409729004
analyzed O 0 0.05553264543414116
additional O 0 0.04925946146249771
cDNA O 0 0.1525096595287323
clones O 0 0.09994310885667801
and O 0 0.0187459047883749
provide O 0 0.026583677157759666
evidence O 0 0.02042800560593605
for O 0 0.014614379033446312
an O 0 0.020126959308981895
additional O 0 0.04209452122449875
0 O 0 0.08773592859506607
. O 0 0.0489271804690361

5 O 0 0.09146315604448318
kb O 0 0.14739061892032623
of O 0 0.03445300832390785
5 O 0 0.0731724426150322
- O 0 0.13412946462631226
UTR O 0 0.24520915746688843
and O 0 0.04341217502951622
> O 0 0.16128763556480408
2 O 0 0.056826502084732056
kb O 0 0.1271737962961197
of O 0 0.03135180473327637
3 O 0 0.07313316315412521
- O 0 0.15398827195167542
UTR O 0 0.36138322949409485
. O 0 0.07212748378515244

We O 0 0.029148858040571213
have O 0 0.01762061007320881
established O 0 0.02319696731865406
the O 0 0.023465318605303764
genomic O 0 0.10681836307048798
organization O 0 0.043801967054605484
of O 0 0.024224692955613136
UBE3A O 1 0.6187248229980469
and O 0 0.02386283501982689
the O 0 0.0238141231238842
sequence O 0 0.05687881261110306
of O 0 0.036922138184309006
intron O 1 0.9488270878791809
- O 0 0.1798512488603592
exon O 0 0.21419337391853333
borders O 0 0.10086869448423386
. O 0 0.06001877039670944

We O 0 0.031958453357219696
have O 0 0.01840869151055813
also O 0 0.01924838125705719
mapped O 0 0.0508393831551075
two O 0 0.02114599570631981
highly O 0 0.05167742073535919
homologous O 0 0.14896222949028015
processed O 0 0.07269100844860077
pseudogenes O 0 0.18038682639598846
, O 0 0.04609046131372452
UBE3AP1 O 1 0.587589681148529
and O 0 0.027888327836990356
UBE3AP2 O 0 0.2272651642560959
, O 0 0.020730746909976006
to O 0 0.019788725301623344
chromosomes O 0 0.07024025171995163
2 O 0 0.033186040818691254
and O 0 0.016750255599617958
21 O 0 0.030560478568077087
, O 0 0.016672784462571144
respectively O 0 0.0272703655064106
, O 0 0.01596318930387497
and O 0 0.015261600725352764
determined O 0 0.03341483697295189
their O 0 0.022989582270383835
genomic O 0 0.12099257111549377
organization O 0 0.059803884476423264
. O 0 0.046625424176454544

These O 0 0.02909143455326557
results O 0 0.03566482290625572
will O 0 0.015543704852461815
form O 0 0.01935577020049095
the O 0 0.014717146754264832
basis O 0 0.016398288309574127
for O 0 0.014329026453197002
studies O 0 0.03396835923194885
of O 0 0.024272555485367775
mutation O 0 0.13901552557945251
and O 0 0.0367555096745491
imprinting O 0 0.2407412976026535
of O 0 0.0514364130795002
UBE3A O 1 0.9821223020553589
. O 0 0.07886623591184616

Mutation O 0 0.30892857909202576
spectrum O 0 0.1351691633462906
and O 0 0.05260646343231201
genotype O 1 0.9823503494262695
- O 0 0.45010241866111755
phenotype O 1 0.9330652356147766
analyses O 0 0.10975167900323868
in O 0 0.06091190502047539
Cowden B-Disease 1 0.9999955892562866
disease I-Disease 1 0.9999947547912598
and O 0 0.0609159842133522
Bannayan B-Disease 1 0.9999266862869263
- I-Disease 1 0.999736487865448
Zonana I-Disease 1 0.9999830722808838
syndrome I-Disease 1 0.9999997615814209
, O 0 0.05117497593164444
two O 0 0.054025836288928986
hamartoma B-Disease 1 0.9999953508377075
syndromes I-Disease 1 0.9999949932098389
with O 0 0.09216655045747757
germline O 1 0.9983710646629333
PTEN O 1 0.9990708827972412
mutation O 1 0.7160518169403076
. O 0 0.07345237582921982

The O 0 0.10648130625486374
tumour B-Disease 1 0.9999734163284302
suppressor O 1 0.9937376976013184
gene O 0 0.2611101567745209
PTEN O 1 0.9885039925575256
, O 0 0.02720412239432335
which O 0 0.019520228728652
maps O 0 0.04188273474574089
to O 0 0.03152056783437729
10q23 O 0 0.17118002474308014
. O 0 0.05474270135164261

3 O 0 0.06048385053873062
and O 0 0.02720961719751358
encodes O 0 0.09431251883506775
a O 0 0.053919363766908646
403 O 0 0.16407500207424164
amino O 0 0.1339869350194931
acid O 0 0.1993778645992279
dual O 0 0.14623253047466278
specificity O 0 0.20461876690387726
phosphatase O 1 0.9565311670303345
( O 0 0.10174402594566345
protein O 0 0.17583726346492767
tyrosine O 0 0.30423617362976074
phosphatase O 1 0.9806051254272461
; O 0 0.07564785331487656
PTPase O 0 0.26518961787223816
) O 0 0.03859716281294823
, O 0 0.0183551125228405
was O 0 0.016590813174843788
shown O 0 0.02820216305553913
recently O 0 0.025796376168727875
to O 0 0.013356034643948078
play O 0 0.017547447234392166
a O 0 0.02281835488975048
broad O 0 0.04964170232415199
role O 0 0.034401629120111465
in O 0 0.024113835766911507
human O 0 0.06904327869415283
malignancy B-Disease 1 0.9996546506881714
. O 0 0.06126721203327179

Somatic O 1 0.9246942400932312
PTEN O 1 0.9973196387290955
deletions O 0 0.18514829874038696
and O 0 0.038664937019348145
mutations O 0 0.12741126120090485
were O 0 0.02397322468459606
observed O 0 0.04379875212907791
in O 0 0.02704276144504547
sporadic B-Disease 1 0.8817020654678345
breast I-Disease 1 0.9999910593032837
, I-Disease 0 0.0548640675842762
brain I-Disease 1 0.9998904466629028
, I-Disease 0 0.07211247831583023
prostate I-Disease 1 0.9999998807907104
and I-Disease 0 0.3600844740867615
kidney I-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999983310699463
cell O 0 0.26937776803970337
lines O 0 0.03760530427098274
and O 0 0.013346882537007332
in O 0 0.013984426856040955
several O 0 0.016850538551807404
primary O 0 0.07227777689695358
tumours B-Disease 1 0.9998444318771362
such O 0 0.033094048500061035
as O 0 0.0484248511493206
endometrial B-Disease 1 0.9999996423721313
carcinomas I-Disease 1 0.9999998807907104
, O 1 0.997844934463501
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 0.8674889802932739
thyroid B-Disease 1 0.9999998807907104
tumours I-Disease 1 0.9999970197677612
. O 0 0.07655506581068039

In O 0 0.041070327162742615
addition O 0 0.043971940875053406
, O 0 0.04316842928528786
PTEN O 1 0.981801450252533
was O 0 0.03145245835185051
identified O 0 0.033455487340688705
as O 0 0.017926223576068878
the O 0 0.02843836508691311
susceptibility O 1 0.7971320748329163
gene O 0 0.1127181202173233
for O 0 0.03242916241288185
two O 0 0.055705226957798004
hamartoma B-Disease 1 0.9999985694885254
syndromes I-Disease 1 0.9999998807907104
Cowden B-Disease 1 0.999998927116394
disease I-Disease 1 0.9999972581863403
( O 0 0.09101738780736923
CD B-Disease 0 0.11584121733903885
; O 0 0.0638280063867569
MIM O 1 0.997089684009552
158350 O 0 0.3036290109157562
) O 0 0.05621742084622383
and O 0 0.04123880714178085
Bannayan B-Disease 1 0.9817917346954346
- I-Disease 1 0.5939697027206421
Zonana I-Disease 1 0.9893683791160583
( I-Disease 0 0.10874120891094208
BZS I-Disease 1 0.9746295213699341
) I-Disease 0 0.06920067965984344
or I-Disease 0 0.06721474230289459
Ruvalcaba I-Disease 1 0.9999102354049683
- I-Disease 1 0.9878480434417725
Riley I-Disease 1 0.9955910444259644
- I-Disease 1 0.9959994554519653
Smith I-Disease 1 0.988728404045105
syndrome I-Disease 1 0.9999995231628418
( O 0 0.15242630243301392
MIM O 1 0.999243974685669
153480 O 1 0.7246655821800232
) O 0 0.06798256933689117
. O 0 0.05349010229110718

Constitutive O 0 0.2569166421890259
DNA O 0 0.12085866183042526
from O 0 0.036786291748285294
37 O 0 0.05758434161543846
CD B-Disease 0 0.058764807879924774
families O 0 0.03784967586398125
and O 0 0.021057458594441414
seven O 0 0.044742342084646225
BZS B-Disease 1 0.8069900274276733
families O 0 0.058766793459653854
was O 0 0.03883320465683937
screened O 0 0.10869884490966797
for O 0 0.05529940500855446
germline O 1 0.9784290194511414
PTEN O 1 0.9974284768104553
mutations O 0 0.30006417632102966
. O 0 0.06407769024372101

PTEN O 1 0.9935171604156494
mutations O 0 0.18362925946712494
were O 0 0.02379496395587921
identified O 0 0.035829510539770126
in O 0 0.017761729657649994
30 O 0 0.027832945808768272
of O 0 0.018468009307980537
37 O 0 0.05829034745693207
( O 0 0.04864794388413429
81 O 0 0.08332103490829468
% O 0 0.044526904821395874
) O 0 0.037099167704582214
CD B-Disease 0 0.065576933324337
families O 0 0.03801442310214043
, O 0 0.022918445989489555
including O 0 0.029276827350258827
missense O 0 0.16555187106132507
and O 0 0.03155648335814476
nonsense O 0 0.1039513424038887
point O 0 0.052590105682611465
mutations O 0 0.1474337875843048
, O 0 0.03541768342256546
deletions O 0 0.11494717746973038
, O 0 0.03238219395279884
insertions O 0 0.13358834385871887
, O 0 0.029340926557779312
a O 0 0.04636450111865997
deletion O 0 0.2941533923149109
/ O 1 0.8252580165863037
insertion O 0 0.17563998699188232
and O 0 0.041270118206739426
splice O 0 0.21670886874198914
site O 0 0.09057824313640594
mutations O 0 0.18674537539482117
. O 0 0.0620432011783123

These O 0 0.04516381397843361
mutations O 0 0.12227246165275574
were O 0 0.0203386377543211
scattered O 0 0.036507535725831985
over O 0 0.01815224438905716
the O 0 0.016833435744047165
entire O 0 0.03447628766298294
length O 0 0.0442277230322361
of O 0 0.02708633989095688
PTEN O 1 0.9908491373062134
, O 0 0.019206371158361435
with O 0 0.01273935753852129
the O 0 0.012862681411206722
exception O 0 0.029904240742325783
of O 0 0.010492551140487194
the O 0 0.014928042888641357
first O 0 0.018688708543777466
, O 0 0.017294656485319138
fourth O 0 0.033830173313617706
and O 0 0.02101578563451767
last O 0 0.03947923704981804
exons O 0 0.14013893902301788
. O 0 0.05226479470729828

A O 0 0.08703143149614334
hot O 0 0.12523338198661804
spot O 0 0.08676481992006302
for O 0 0.04598787799477577
PTEN O 1 0.9894571900367737
mutation O 0 0.17217318713665009
in O 0 0.03139110282063484
CD B-Disease 0 0.0619494765996933
was O 0 0.023878566920757294
identified O 0 0.03508177027106285
in O 0 0.024171503260731697
exon O 0 0.1165543720126152
5 O 0 0.03668218478560448
that O 0 0.014798672869801521
contains O 0 0.026297587901353836
the O 0 0.02707548439502716
PTPase O 0 0.18021970987319946
core O 0 0.07217760384082794
motif O 0 0.09027542918920517
, O 0 0.021333783864974976
with O 0 0.01854127272963524
13 O 0 0.026122644543647766
of O 0 0.015399270690977573
30 O 0 0.0352320671081543
( O 0 0.03574809804558754
43 O 0 0.054533664137125015
% O 0 0.04613447189331055
) O 0 0.04537692666053772
CD B-Disease 0 0.08943444490432739
mutations O 0 0.11824115365743637
identified O 0 0.03882882371544838
in O 0 0.020593874156475067
this O 0 0.0283143762499094
exon O 0 0.1679156869649887
. O 0 0.059753503650426865

Seven O 0 0.0451570600271225
of O 0 0.025085490196943283
30 O 0 0.04395023733377457
( O 0 0.0428188294172287
23 O 0 0.038794487714767456
% O 0 0.0331202931702137
) O 0 0.021134641021490097
were O 0 0.010228509083390236
within O 0 0.014502379111945629
the O 0 0.01722157932817936
core O 0 0.05088450759649277
motif O 0 0.08045083284378052
, O 0 0.018169205635786057
the O 0 0.016076892614364624
majority O 0 0.029399853199720383
( O 0 0.027228469029068947
five O 0 0.016779368743300438
of O 0 0.011953762732446194
seven O 0 0.021983196958899498
) O 0 0.02321195788681507
of O 0 0.014271371997892857
which O 0 0.018795497715473175
were O 0 0.026863621547818184
missense O 0 0.2148040235042572
mutations O 0 0.15923810005187988
, O 0 0.03141806274652481
possibly O 0 0.049396783113479614
pointing O 0 0.04506079480051994
to O 0 0.014864472672343254
the O 0 0.017955418676137924
functional O 0 0.04441455006599426
significance O 0 0.027670443058013916
of O 0 0.014442366547882557
this O 0 0.018032370135188103
region O 0 0.060275569558143616
. O 0 0.05133132264018059

Germline O 1 0.9953781366348267
PTEN O 1 0.9937463998794556
mutations O 0 0.17826034128665924
were O 0 0.022965017706155777
identified O 0 0.027502907440066338
in O 0 0.013490036129951477
four O 0 0.01379187311977148
of O 0 0.013980325311422348
seven O 0 0.029416030272841454
( O 0 0.043947432190179825
57 O 0 0.07092729210853577
% O 0 0.053026892244815826
) O 0 0.05683737248182297
BZS B-Disease 1 0.940735936164856
families O 0 0.07108402997255325
studied O 0 0.06116316094994545
. O 0 0.04600038751959801

Interestingly O 0 0.13426849246025085
, O 0 0.027730237692594528
none O 0 0.03425661474466324
of O 0 0.01660681515932083
these O 0 0.020873138681054115
mutations O 0 0.10478416830301285
was O 0 0.02962704934179783
observed O 0 0.03799821808934212
in O 0 0.020198671147227287
the O 0 0.031908076256513596
PTPase O 0 0.19845671951770782
core O 0 0.09645181894302368
motif O 0 0.14795085787773132
. O 0 0.05253498628735542

It O 0 0.029678620398044586
is O 0 0.02050045132637024
also O 0 0.018298519775271416
worthy O 0 0.049682922661304474
of O 0 0.015321251936256886
note O 0 0.03802096098661423
that O 0 0.014805925078690052
a O 0 0.025666305795311928
single O 0 0.04593268781900406
nonsense O 0 0.10021810978651047
point O 0 0.052422478795051575
mutation O 0 0.1561204493045807
, O 0 0.03451298549771309
R233X O 0 0.1327950805425644
, O 0 0.022932209074497223
was O 0 0.021286336705088615
observed O 0 0.033562857657670975
in O 0 0.018075406551361084
the O 0 0.02765904739499092
germline O 0 0.26872768998146057
DNA O 0 0.07079710066318512
from O 0 0.02290651947259903
two O 0 0.020779678598046303
unrelated O 0 0.07165150344371796
CD B-Disease 0 0.07087943702936172
families O 0 0.0372624397277832
and O 0 0.02111046575009823
one O 0 0.03162383288145065
BZS B-Disease 1 0.962389349937439
family O 0 0.08473388850688934
. O 0 0.057292476296424866

Genotype O 1 0.9952651262283325
- O 1 0.6287835836410522
phenotype O 1 0.6656234264373779
studies O 0 0.05285186693072319
were O 0 0.015614671632647514
not O 0 0.014321594499051571
performed O 0 0.022482767701148987
on O 0 0.010696138255298138
this O 0 0.012907793745398521
small O 0 0.025320176035165787
group O 0 0.03630787506699562
of O 0 0.030991217121481895
BZS B-Disease 1 0.9700270891189575
families O 0 0.08045466989278793
. O 0 0.056829582899808884

However O 0 0.05628795549273491
, O 0 0.05864724516868591
genotype O 1 0.9640721678733826
- O 0 0.23539136350154877
phenotype O 1 0.6063750982284546
analysis O 0 0.07845135778188705
inthe O 0 0.19040144979953766
group O 0 0.04781131446361542
of O 0 0.021021680906414986
CD B-Disease 0 0.06317941844463348
families O 0 0.03771963343024254
revealed O 0 0.03848358988761902
two O 0 0.017333591356873512
possible O 0 0.03254292532801628
associations O 0 0.04978456720709801
worthy O 0 0.05584657937288284
of O 0 0.017526626586914062
follow O 0 0.0388723760843277
- O 0 0.0645475685596466
up O 0 0.02485485188663006
in O 0 0.020583420991897583
independent O 0 0.03794073686003685
analyses O 0 0.07878321409225464
. O 0 0.04714153707027435

The O 0 0.029151635244488716
first O 0 0.02364104986190796
was O 0 0.021282056346535683
an O 0 0.019993018358945847
association O 0 0.04284588247537613
noted O 0 0.022363832220435143
in O 0 0.012681386433541775
the O 0 0.014961862936615944
group O 0 0.030379444360733032
of O 0 0.017546698451042175
CD B-Disease 0 0.06588459759950638
families O 0 0.05349421873688698
with O 0 0.06360877305269241
breast B-Disease 1 0.999998927116394
disease I-Disease 1 0.99998939037323
. O 0 0.07052864134311676

A O 0 0.06833651661872864
correlation O 0 0.08871623128652573
was O 0 0.026320243254303932
observed O 0 0.03476935252547264
between O 0 0.02029195800423622
the O 0 0.02355520986020565
presence O 0 0.06339278072118759
/ O 1 0.7848714590072632
absence O 0 0.05178195610642433
of O 0 0.021428639069199562
a O 0 0.05131867900490761
PTEN O 1 0.998551070690155
mutation O 0 0.15660840272903442
and O 0 0.021770954132080078
the O 0 0.023710932582616806
type O 0 0.07737386226654053
of O 0 0.034251775592565536
breast O 1 0.9999635219573975
involvement O 0 0.3562571406364441
( O 0 0.0774015411734581
unaffected O 1 0.9718884229660034
versus O 1 0.920804500579834
benign O 1 0.9997852444648743
versus O 1 0.994297206401825
malignant O 1 0.9999878406524658
) O 0 0.06763483583927155
. O 0 0.04906250163912773

Specifically O 0 0.05969071015715599
and O 0 0.019275493919849396
more O 0 0.014512716792523861
directly O 0 0.019649725407361984
, O 0 0.01580113172531128
an O 0 0.016540784388780594
association O 0 0.039911869913339615
was O 0 0.020050086081027985
also O 0 0.015112468972802162
observed O 0 0.029364513233304024
between O 0 0.014868251979351044
the O 0 0.016460027545690536
presence O 0 0.03556351363658905
of O 0 0.0216835867613554
a O 0 0.05722002312541008
PTEN O 1 0.9997304081916809
mutation O 1 0.9933305382728577
and O 0 0.34602469205856323
malignant B-Disease 1 1.0
breast I-Disease 1 1.0
disease I-Disease 1 0.9999986886978149
. O 0 0.07425502687692642

Secondly O 0 0.1100456491112709
, O 0 0.023971425369381905
there O 0 0.01748175360262394
appeared O 0 0.02369186468422413
to O 0 0.0136255519464612
be O 0 0.014140036888420582
an O 0 0.024052493274211884
interdependent O 0 0.12675251066684723
association O 0 0.06676572561264038
between O 0 0.04357115924358368
mutations O 0 0.13862064480781555
upstream O 0 0.06821970641613007
and O 0 0.019582265987992287
within O 0 0.02325342409312725
the O 0 0.025603316724300385
PTPase O 0 0.19904562830924988
core O 0 0.06896211951971054
motif O 0 0.09482358396053314
, O 0 0.019635379314422607
the O 0 0.02096525952219963
core O 0 0.05398813635110855
motif O 0 0.08469144254922867
containing O 0 0.031282924115657806
the O 0 0.019761167466640472
majority O 0 0.03585297241806984
of O 0 0.03052874282002449
missense O 0 0.27324777841567993
mutations O 0 0.13526219129562378
, O 0 0.01950053498148918
and O 0 0.013007847592234612
the O 0 0.015841539949178696
involvement O 0 0.04774738475680351
of O 0 0.014764591120183468
all O 0 0.016787851229310036
major O 0 0.04430638253688812
organ O 0 0.12266560643911362
systems O 0 0.06296975910663605
( O 0 0.050393760204315186
central O 0 0.0543767511844635
nervous O 1 0.9937049746513367
system O 0 0.06516780704259872
, O 0 0.04826069250702858
thyroid O 1 0.9999990463256836
, O 0 0.12344152480363846
breast O 1 0.9999986886978149
, O 0 0.07520196586847305
skin O 1 0.9999969005584717
and O 0 0.0611085519194603
gastrointestinal O 1 0.9999986886978149
tract O 1 0.9997872710227966
) O 0 0.07255484163761139
. O 0 0.05169025436043739

However O 0 0.03177844360470772
, O 0 0.01894620805978775
these O 0 0.013987352140247822
observations O 0 0.03375454246997833
would O 0 0.014914628118276596
need O 0 0.02124669775366783
to O 0 0.012907058000564575
be O 0 0.012063770554959774
confirmed O 0 0.026287807151675224
by O 0 0.013616684824228287
studying O 0 0.022935690358281136
a O 0 0.01880011521279812
larger O 0 0.025350965559482574
number O 0 0.014880562201142311
of O 0 0.017443913966417313
CD B-Disease 0 0.07328399270772934
families O 0 0.05795158073306084
. O 0 0.049336954951286316

Molecular O 0 0.20474785566329956
defects O 1 0.8260399699211121
leading O 0 0.04939044266939163
to O 0 0.02456730417907238
human O 0 0.04665028303861618
complement B-Disease 0 0.12702113389968872
component I-Disease 1 0.9855824708938599
C6 I-Disease 1 0.9999988079071045
deficiency I-Disease 1 0.9999992847442627
in O 0 0.029693372547626495
an O 0 0.02566727064549923
African O 0 0.0758511871099472
- O 0 0.1016126349568367
American O 0 0.05429036542773247
family O 0 0.06539495289325714
. O 0 0.05103997886180878

Complement B-Disease 0 0.4447191059589386
component I-Disease 1 0.9955139756202698
C6 I-Disease 1 0.9999994039535522
deficiency I-Disease 1 0.9999998807907104
( O 0 0.11902237683534622
C6D B-Disease 1 0.9940488338470459
) O 0 0.04859892278909683
was O 0 0.03477644920349121
diagnosed O 1 0.999531626701355
in O 0 0.021847069263458252
a O 0 0.02701655775308609
16 O 0 0.0392724983394146
- O 0 0.08503535389900208
year O 0 0.04020030051469803
- O 0 0.08646687120199203
old O 0 0.053011953830718994
African O 0 0.07889971882104874
- O 0 0.108191579580307
American O 0 0.06259474903345108
male O 0 0.10061962902545929
with O 0 0.08292761445045471
meningococcal B-Disease 1 0.9999995231628418
meningitis I-Disease 1 0.9999983310699463
. O 0 0.08832365274429321

The O 0 0.05384490638971329
patients O 1 0.996590256690979
father O 0 0.04526860639452934
and O 0 0.016645796597003937
two O 0 0.01814582757651806
brothers O 0 0.048334553837776184
also O 0 0.02082410268485546
had O 0 0.034726280719041824
C6D B-Disease 0 0.38019001483917236
, O 0 0.020932244136929512
but O 0 0.015042034909129143
gave O 0 0.02869114652276039
no O 0 0.021623549982905388
history O 0 0.02724291943013668
of O 0 0.027986004948616028
meningitis B-Disease 1 0.9999872446060181
or O 0 0.0470438078045845
other O 0 0.03586601838469505
neisserial B-Disease 1 0.9984752535820007
infection I-Disease 1 0.9998944997787476
. O 0 0.06518889218568802

By O 0 0.04359670355916023
using O 0 0.05422951653599739
exon O 0 0.19594351947307587
- O 0 0.13163235783576965
specific O 0 0.07842880487442017
polymerase O 0 0.23820757865905762
chain O 0 0.1539069563150406
reaction O 0 0.14820325374603271
( O 0 0.08481746166944504
PCR O 0 0.2822994589805603
) O 0 0.06684444099664688
/ O 0 0.4386717975139618
single O 0 0.06247696280479431
- O 0 0.12233587354421616
strand O 0 0.15063774585723877
conformation O 0 0.14351841807365417
polymorphism O 0 0.13004492223262787
as O 0 0.023961354047060013
a O 0 0.03475792706012726
screening O 0 0.08832629770040512
step O 0 0.044607337564229965
and O 0 0.02542954683303833
nucleotide O 0 0.09439752250909805
sequencing O 0 0.08027493953704834
of O 0 0.02168523706495762
target O 0 0.05970468744635582
exons O 0 0.10355498641729355
, O 0 0.024383334442973137
we O 0 0.017761480063199997
determined O 0 0.0324246920645237
that O 0 0.01403480302542448
the O 0 0.02250071056187153
proband O 0 0.127142533659935
was O 0 0.03017130307853222
a O 0 0.03738712519407272
compound O 0 0.1071748360991478
heterozygote O 0 0.2521548867225647
for O 0 0.03287644311785698
two O 0 0.04908159747719765
C6 O 1 0.9941490888595581
gene O 0 0.2129664570093155
mutations O 0 0.20590198040008545
. O 0 0.06283942610025406

The O 0 0.03457282856106758
first O 0 0.028529001399874687
, O 0 0.027094578370451927
1195delC O 0 0.1179337278008461
located O 0 0.04245031997561455
in O 0 0.024290163069963455
exon O 0 0.12589873373508453
7 O 0 0.040875501930713654
, O 0 0.019629038870334625
is O 0 0.018678097054362297
a O 0 0.029515724629163742
novel O 0 0.05171582102775574
mutation O 0 0.1265462189912796
, O 0 0.022043075412511826
while O 0 0.019103117287158966
the O 0 0.01663106679916382
second O 0 0.030218111351132393
, O 0 0.026270845904946327
1936delG O 0 0.12253735959529877
in O 0 0.026955660432577133
exon O 0 0.12258636206388474
12 O 0 0.03665570914745331
, O 0 0.018955642357468605
has O 0 0.01942390203475952
been O 0 0.018546326085925102
described O 0 0.033599141985177994
before O 0 0.02519151382148266
to O 0 0.02552306465804577
cause O 0 0.08985471725463867
C6D B-Disease 0 0.22118015587329865
in O 0 0.022712569683790207
an O 0 0.02371717430651188
unrelated O 0 0.07058627903461456
African O 0 0.07631435990333557
- O 0 0.09625010192394257
American O 0 0.05012673884630203
individual O 0 0.05243057757616043
. O 0 0.04692219942808151

Both O 0 0.06528504192829132
mutations O 0 0.19006945192813873
result O 0 0.06443974375724792
in O 0 0.04468066617846489
premature O 1 0.9610922336578369
termination O 1 0.875826895236969
codons O 0 0.17408576607704163
and O 0 0.05707945674657822
C6 O 1 0.9945434331893921
null O 0 0.16660772264003754
alleles O 0 0.24593700468540192
. O 0 0.0731985867023468

Allele O 0 0.2997056841850281
- O 0 0.14542143046855927
specific O 0 0.06288018077611923
PCR O 0 0.1813657432794571
indicated O 0 0.05280047282576561
that O 0 0.016290225088596344
the O 0 0.021174710243940353
probands O 0 0.11985024064779282
two O 0 0.025553693994879723
brothers O 0 0.06316706538200378
also O 0 0.026763493195176125
inherited O 0 0.10575111210346222
the O 0 0.03779541328549385
1195delC O 0 0.22672873735427856
mutation O 0 0.1567816287279129
from O 0 0.026661835610866547
their O 0 0.025527749210596085
heterozygous O 0 0.13213151693344116
mother O 0 0.061292633414268494
and O 0 0.022676918655633926
the O 0 0.032685160636901855
1936delG O 0 0.1916108876466751
mutation O 0 0.1586049646139145
from O 0 0.028738072142004967
their O 0 0.027237307280302048
homozygous O 0 0.12504160404205322
father O 0 0.05483181029558182
. O 0 0.03052046149969101
. O 0 0.042351678013801575

PAX6 O 1 0.9943408966064453
mutations O 0 0.29063451290130615
reviewed O 0 0.1105647087097168
. O 0 0.06197037547826767

Mutations O 0 0.2576025724411011
in O 0 0.05739619955420494
PAX6 O 1 0.9757678508758545
are O 0 0.02491416037082672
responsible O 0 0.042939625680446625
for O 0 0.02212308906018734
human O 0 0.0438031442463398
aniridia B-Disease 1 0.9029437899589539
and O 0 0.018005548045039177
have O 0 0.013943208381533623
also O 0 0.013396024703979492
been O 0 0.015091270208358765
found O 0 0.025029417127370834
in O 0 0.024147095158696175
patients O 1 0.9986644983291626
with O 0 0.04402806609869003
Peters B-Disease 1 0.9991297125816345
anomaly I-Disease 1 0.9993113279342651
, O 0 0.038763195276260376
with O 0 0.06292302161455154
congenital B-Disease 1 1.0
cataracts I-Disease 1 0.9999995231628418
, O 0 0.03917428106069565
with O 0 0.042944516986608505
autosomal B-Disease 1 0.9995937943458557
dominant I-Disease 1 0.9654346704483032
keratitis I-Disease 1 0.9999932050704956
, O 0 0.0338432602584362
and O 0 0.02096039243042469
with O 0 0.03395087644457817
isolated B-Disease 1 0.5027830004692078
foveal I-Disease 1 0.9996028542518616
hypoplasia I-Disease 1 0.9999308586120605
. O 0 0.07416220754384995

No O 0 0.05671548843383789
locus O 0 0.13029931485652924
other O 0 0.02695770189166069
than O 0 0.03522117808461189
chromosome O 0 0.1719001829624176
11p13 O 0 0.15442806482315063
has O 0 0.028721202164888382
been O 0 0.0270304623991251
implicated O 0 0.09843514859676361
in O 0 0.03125214949250221
aniridia B-Disease 1 0.9706125259399414
, O 0 0.02958148531615734
and O 0 0.02954847551882267
PAX6 O 1 0.9932898879051208
is O 0 0.02446005493402481
clearly O 0 0.027510084211826324
the O 0 0.015444304794073105
major O 0 0.023997601121664047
, O 0 0.015018696896731853
if O 0 0.01675873063504696
not O 0 0.012352635152637959
only O 0 0.015281262807548046
, O 0 0.02414895035326481
gene O 0 0.09767864644527435
responsible O 0 0.06395147740840912
. O 0 0.05022471025586128

Twenty O 0 0.09634533524513245
- O 0 0.09328112006187439
eight O 0 0.036788687109947205
percent O 0 0.0387151725590229
of O 0 0.023499710485339165
identified O 0 0.08146154135465622
PAX6 O 1 0.9957614541053772
mutations O 0 0.19827251136302948
are O 0 0.042853161692619324
C O 1 0.8730534911155701
- O 0 0.4844783842563629
T O 1 0.9434264898300171
changes O 0 0.05898406729102135
at O 0 0.05747111514210701
CpG O 1 0.6207074522972107
dinucleotides O 0 0.1901225596666336
, O 0 0.026826776564121246
20 O 0 0.03210572898387909
% O 0 0.03591786324977875
are O 0 0.023497819900512695
splicing O 0 0.12280869483947754
errors O 0 0.05425392463803291
, O 0 0.017095915973186493
and O 0 0.011750834062695503
more O 0 0.012486142106354237
than O 0 0.015513913705945015
30 O 0 0.025822682306170464
% O 0 0.032214101403951645
are O 0 0.02165994793176651
deletion O 0 0.13395552337169647
or O 0 0.0501708947122097
insertion O 0 0.15392936766147614
events O 0 0.0611225850880146
. O 0 0.05214133486151695

There O 0 0.034375645220279694
is O 0 0.024994580075144768
a O 0 0.03356882184743881
noticeably O 0 0.10536816716194153
elevated O 0 0.1040693148970604
level O 0 0.03948039561510086
of O 0 0.023600200191140175
mutation O 0 0.11577591300010681
in O 0 0.02047346904873848
the O 0 0.02240886352956295
paired O 0 0.08836298435926437
domain O 0 0.050931964069604874
compared O 0 0.034460607916116714
with O 0 0.016035888344049454
the O 0 0.015130571089684963
rest O 0 0.028982842341065407
of O 0 0.015896989032626152
the O 0 0.028044812381267548
gene O 0 0.12431380897760391
. O 0 0.05160384252667427

Increased O 0 0.10074717551469803
mutation O 0 0.16631515324115753
in O 0 0.027887146919965744
the O 0 0.027703527361154556
homeodomain O 0 0.1887948215007782
is O 0 0.029060643166303635
accounted O 0 0.04146798327565193
for O 0 0.016074562445282936
by O 0 0.02086104452610016
the O 0 0.04017578065395355
hypermutable O 1 0.6133067011833191
CpG O 1 0.8500214219093323
dinucleotide O 0 0.3180277943611145
in O 0 0.06165946274995804
codon O 0 0.19128009676933289
240 O 0 0.1281239241361618
. O 0 0.061036158353090286

Very O 0 0.04742351546883583
nearly O 0 0.04128612205386162
all O 0 0.025215595960617065
mutations O 0 0.11634848266839981
appear O 0 0.03613537549972534
to O 0 0.02176949940621853
cause O 0 0.07993202656507492
loss O 0 0.05384913831949234
of O 0 0.015207733027637005
function O 0 0.032580260187387466
of O 0 0.014102372340857983
the O 0 0.025062842294573784
mutant O 0 0.12437773495912552
allele O 0 0.13587595522403717
, O 0 0.021771684288978577
and O 0 0.01274200901389122
more O 0 0.012743688188493252
than O 0 0.016903206706047058
80 O 0 0.03583452105522156
% O 0 0.033105265349149704
of O 0 0.02503899484872818
exonic O 0 0.1853446215391159
substitutions O 0 0.09484031051397324
result O 0 0.05550473928451538
in O 0 0.036397337913513184
nonsense O 0 0.11541660130023956
codons O 0 0.16575418412685394
. O 0 0.058106303215026855

In O 0 0.03834999352693558
a O 0 0.042045049369335175
gene O 0 0.08424215018749237
with O 0 0.02412763424217701
such O 0 0.022158611565828323
extraordinarily O 0 0.09444127231836319
high O 0 0.05457700788974762
sequence O 0 0.06233012303709984
conservation O 0 0.05734279379248619
throughout O 0 0.03205534443259239
evolution O 0 0.03501724824309349
, O 0 0.017723800614476204
there O 0 0.01904301531612873
are O 0 0.020949896425008774
presumed O 0 0.10355763137340546
undiscovered O 0 0.21288444101810455
missense O 0 0.2982218861579895
mutations O 0 0.14804694056510925
, O 0 0.023044386878609657
these O 0 0.015454234555363655
are O 0 0.016286471858620644
hypothesized O 0 0.07213853299617767
to O 0 0.016064925119280815
exist O 0 0.021725274622440338
in O 0 0.015220951288938522
as O 0 0.020426969975233078
- O 0 0.07860095798969269
yet O 0 0.04452977702021599
unidentified O 0 0.10420330613851547
phenotypes O 0 0.19750618934631348
. O 0 0.03637097775936127
. O 0 0.04666808992624283

Genetic O 0 0.19856777787208557
heterogeneity O 0 0.18430118262767792
and O 0 0.042311035096645355
penetrance O 0 0.2137502133846283
analysis O 0 0.046033214777708054
of O 0 0.020191406831145287
the O 0 0.037458788603544235
BRCA1 O 1 0.9739260077476501
and O 0 0.05247628316283226
BRCA2 O 1 0.9975093603134155
genes O 0 0.1754797101020813
in O 0 0.07380163669586182
breast B-Disease 1 0.9999986886978149
cancer I-Disease 1 0.9999946355819702
families O 0 0.09660065919160843
. O 0 0.06529939919710159

The O 0 0.14327161014080048
Breast B-Disease 1 0.9999996423721313
Cancer I-Disease 1 0.9999991655349731
Linkage O 1 0.9796452522277832
Consortium O 0 0.17892250418663025
. O 0 0.06200000271201134

The O 0 0.040426693856716156
contribution O 0 0.06534896045923233
of O 0 0.03354087099432945
BRCA1 O 1 0.9835985898971558
and O 0 0.053902190178632736
BRCA2 O 1 0.9995482563972473
to O 0 0.05975865572690964
inherited B-Disease 1 0.9999964237213135
breast I-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999992847442627
was O 0 0.04540678486227989
assessed O 0 0.0712255910038948
by O 0 0.028464922681450844
linkage O 0 0.13760164380073547
and O 0 0.032515063881874084
mutation O 0 0.14913900196552277
analysis O 0 0.042801499366760254
in O 0 0.024396857246756554
237 O 0 0.08818735927343369
families O 0 0.035280078649520874
, O 0 0.015643281862139702
each O 0 0.013702585361897945
with O 0 0.016237111762166023
at O 0 0.0218000877648592
least O 0 0.0224843081086874
four O 0 0.020577456802129745
cases O 0 0.04216916114091873
of O 0 0.03300480544567108
breast B-Disease 1 0.9999978542327881
cancer I-Disease 1 0.9999862909317017
, O 0 0.02506607212126255
collected O 0 0.023710457608103752
by O 0 0.0235021710395813
the O 0 0.05614975467324257
Breast B-Disease 1 0.9999998807907104
Cancer I-Disease 1 0.9999995231628418
Linkage O 1 0.9711568355560303
Consortium O 0 0.17059776186943054
. O 0 0.06561088562011719

Families O 0 0.06224944815039635
were O 0 0.018219949677586555
included O 0 0.02078491635620594
without O 0 0.020851178094744682
regard O 0 0.026458807289600372
to O 0 0.01455546822398901
the O 0 0.023289743810892105
occurrence O 0 0.101740263402462
of O 0 0.03896496444940567
ovarian B-Disease 1 0.999993085861206
or I-Disease 0 0.042087797075510025
other I-Disease 0 0.034102149307727814
cancers I-Disease 1 0.9997373223304749
. O 0 0.055944498628377914

Overall O 0 0.13689498603343964
, O 0 0.05696118623018265
disease O 1 0.9999085664749146
was O 0 0.03586496785283089
linked O 0 0.069768026471138
to O 0 0.027746563777327538
BRCA1 O 1 0.6019493937492371
in O 0 0.022881941869854927
an O 0 0.020119667053222656
estimated O 0 0.03900968283414841
52 O 0 0.05338185653090477
% O 0 0.03156564384698868
of O 0 0.014299120754003525
families O 0 0.03531264886260033
, O 0 0.02007369138300419
to O 0 0.024627219885587692
BRCA2 O 1 0.7239984273910522
in O 0 0.024737779051065445
32 O 0 0.037135593593120575
% O 0 0.02655363827943802
of O 0 0.013821383006870747
families O 0 0.02963545359671116
, O 0 0.01555576641112566
and O 0 0.013333952985703945
to O 0 0.016423577442765236
neither O 0 0.042899154126644135
gene O 0 0.0787758007645607
in O 0 0.023676466196775436
16 O 0 0.03410648554563522
% O 0 0.03829662501811981
( O 0 0.041360363364219666
95 O 0 0.06160096824169159
% O 0 0.046234842389822006
confidence O 0 0.08145076781511307
interval O 0 0.14315825700759888
[ O 0 0.15635298192501068
CI O 1 0.9991023540496826
] O 0 0.1121375784277916
6 O 0 0.05252309888601303
% O 0 0.04541764408349991
- O 0 0.08044213801622391
28 O 0 0.050034280866384506
% O 0 0.040092188864946365
) O 0 0.03301054984331131
, O 0 0.022099047899246216
suggesting O 0 0.055100031197071075
other O 0 0.02989928051829338
predisposition O 1 0.9029725790023804
genes O 0 0.130685955286026
. O 0 0.060155320912599564

The O 0 0.04520338401198387
majority O 0 0.05577147752046585
( O 0 0.055821459740400314
81 O 0 0.07709121704101562
% O 0 0.0387975312769413
) O 0 0.027550997212529182
of O 0 0.01984275132417679
the O 0 0.057235512882471085
breast B-Disease 1 1.0
- I-Disease 1 0.9999948740005493
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
families O 0 0.04836154356598854
were O 0 0.017487717792391777
due O 0 0.028149021789431572
to O 0 0.02450956217944622
BRCA1 O 1 0.9282903671264648
, O 0 0.02242397703230381
with O 0 0.018528250977396965
most O 0 0.0195784755051136
others O 0 0.0301547609269619
( O 0 0.03827928751707077
14 O 0 0.03750716149806976
% O 0 0.034334417432546616
) O 0 0.03259078040719032
due O 0 0.03751871734857559
to O 0 0.038334187120199203
BRCA2 O 1 0.9884868860244751
. O 0 0.06986761838197708

Conversely O 0 0.13121065497398376
, O 0 0.026422169059515
the O 0 0.017999589443206787
majority O 0 0.027128588408231735
of O 0 0.01494709961116314
families O 0 0.03718091547489166
with O 0 0.023845868185162544
male B-Disease 0 0.06603565812110901
and I-Disease 0 0.02977072261273861
female I-Disease 1 0.6017389297485352
breast I-Disease 1 0.9999988079071045
cancer I-Disease 1 0.9999734163284302
were O 0 0.023332567885518074
due O 0 0.041041068732738495
to O 0 0.034778300672769547
BRCA2 O 1 0.9897514581680298
( O 0 0.07217476516962051
76 O 0 0.09516161680221558
% O 0 0.05297065153717995
) O 0 0.04481907933950424
. O 0 0.04292934015393257

The O 0 0.044016290456056595
largest O 0 0.058673154562711716
proportion O 0 0.07093704491853714
( O 0 0.04993002489209175
67 O 0 0.06780602782964706
% O 0 0.035572316497564316
) O 0 0.02392536588013172
of O 0 0.014065485447645187
families O 0 0.030502840876579285
due O 0 0.027825158089399338
to O 0 0.014845247380435467
other O 0 0.015951072797179222
genes O 0 0.0507359653711319
was O 0 0.01934180222451687
found O 0 0.02098354697227478
in O 0 0.013838806189596653
families O 0 0.024836605414748192
with O 0 0.01619621552526951
four O 0 0.017093878239393234
or O 0 0.019818663597106934
five O 0 0.02104428969323635
cases O 0 0.03519384562969208
of O 0 0.024722089990973473
female O 1 0.5433183312416077
breast B-Disease 1 0.9999983310699463
cancer I-Disease 1 0.9999833106994629
only O 0 0.03602563217282295
. O 0 0.04195104539394379

These O 0 0.03152000159025192
estimates O 0 0.04296444356441498
were O 0 0.01806233637034893
not O 0 0.019456427544355392
substantially O 0 0.061271678656339645
affected O 0 0.052637044340372086
either O 0 0.02516768127679825
by O 0 0.017712313681840897
changing O 0 0.03561573848128319
the O 0 0.026196615770459175
assumed O 0 0.07908974587917328
penetrance O 0 0.3946459889411926
model O 0 0.06162998825311661
for O 0 0.03232970088720322
BRCA1 O 1 0.9413192868232727
or O 0 0.031392354518175125
by O 0 0.019328221678733826
including O 0 0.02140895649790764
or O 0 0.04109353944659233
excluding O 0 0.0897556021809578
BRCA1 O 1 0.9904894828796387
mutation O 0 0.23732665181159973
data O 0 0.05378546938300133
. O 0 0.05111601948738098

Among O 0 0.0452035516500473
those O 0 0.0282035730779171
families O 0 0.051806334406137466
with O 0 0.04197698459029198
disease O 1 0.999940037727356
due O 0 0.04466462880373001
to O 0 0.02956138551235199
BRCA1 O 1 0.9328920245170593
that O 0 0.020239323377609253
were O 0 0.01534397341310978
tested O 0 0.043447986245155334
by O 0 0.013534649275243282
one O 0 0.012038235552608967
of O 0 0.01109361369162798
the O 0 0.01949198544025421
standard O 0 0.05506579577922821
screening O 0 0.10269559174776077
methods O 0 0.04708649590611458
, O 0 0.03142732009291649
mutations O 0 0.10912656784057617
were O 0 0.022444872185587883
detected O 0 0.07296784967184067
in O 0 0.020037585869431496
the O 0 0.02610786445438862
coding O 0 0.11300419270992279
sequence O 0 0.057750292122364044
or O 0 0.03570393845438957
splice O 0 0.13944153487682343
sites O 0 0.03347303345799446
in O 0 0.020473061129450798
an O 0 0.024421289563179016
estimated O 0 0.04977044463157654
63 O 0 0.07835022360086441
% O 0 0.05226564407348633
( O 0 0.046364206820726395
95 O 0 0.07179081439971924
% O 0 0.05878088250756264
CI O 1 0.9971754550933838
51 O 0 0.08392775058746338
% O 0 0.05847591906785965
- O 0 0.11316431313753128
77 O 0 0.0989995077252388
% O 0 0.058472685515880585
) O 0 0.04825058579444885
. O 0 0.04407219961285591

The O 0 0.04200610890984535
estimated O 0 0.05983588472008705
sensitivity O 0 0.09415274858474731
was O 0 0.026382626965641975
identical O 0 0.03586781769990921
for O 0 0.018825694918632507
direct O 0 0.03721369057893753
sequencing O 0 0.06411254405975342
and O 0 0.018339868634939194
other O 0 0.017699245363473892
techniques O 0 0.05826787278056145
. O 0 0.04007139801979065

The O 0 0.062048424035310745
penetrance O 0 0.2778993248939514
of O 0 0.044618263840675354
BRCA2 O 1 0.8807141780853271
was O 0 0.03619515895843506
estimated O 0 0.041849441826343536
by O 0 0.027290914207696915
maximizing O 0 0.11179918795824051
the O 0 0.046849291771650314
LOD O 1 0.9339331388473511
score O 0 0.054898977279663086
in O 0 0.043009012937545776
BRCA2 O 1 0.9988859295845032
- O 0 0.48336368799209595
mutation O 0 0.20121173560619354
families O 0 0.05025570094585419
, O 0 0.019711239263415337
over O 0 0.01899040676653385
all O 0 0.016996458172798157
possible O 0 0.039993610233068466
penetrance O 0 0.20062974095344543
functions O 0 0.05064096674323082
. O 0 0.04551582783460617

The O 0 0.04776822030544281
estimated O 0 0.07663639634847641
cumulative O 0 0.23514926433563232
risk O 1 0.8610447645187378
of O 0 0.04786636680364609
breast B-Disease 1 0.9999963045120239
cancer I-Disease 1 0.9999405145645142
reached O 0 0.0586237832903862
28 O 0 0.04640457406640053
% O 0 0.041127268224954605
( O 0 0.044724240899086
95 O 0 0.07161383330821991
% O 0 0.05926010385155678
CI O 1 0.9971708655357361
9 O 0 0.06274662166833878
% O 0 0.053129177540540695
- O 0 0.09185517579317093
44 O 0 0.05675873905420303
% O 0 0.03993196412920952
) O 0 0.026637505739927292
by O 0 0.018874242901802063
age O 0 0.034472305327653885
50 O 0 0.02785184420645237
years O 0 0.01991668902337551
and O 0 0.01925026811659336
84 O 0 0.06954158842563629
% O 0 0.043268654495477676
( O 0 0.04561817646026611
95 O 0 0.06573189795017242
% O 0 0.06194981560111046
CI O 1 0.9876931309700012
43 O 0 0.07735571265220642
% O 0 0.05208460986614227
- O 0 0.08814879506826401
95 O 0 0.06526681035757065
% O 0 0.040716905146837234
) O 0 0.0320216566324234
by O 0 0.02204909548163414
age O 0 0.04673326015472412
70 O 0 0.053013987839221954
years O 0 0.038218557834625244
. O 0 0.045264631509780884

The O 0 0.07637125253677368
corresponding O 1 0.8486236333847046
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
risks O 1 0.9196329712867737
were O 0 0.03495650738477707
0 O 0 0.08745495975017548
. O 0 0.0466357097029686

4 O 0 0.0745418593287468
% O 0 0.05373285710811615
( O 0 0.052030712366104126
95 O 0 0.07436788827180862
% O 0 0.0724978893995285
CI O 1 0.9970123767852783
0 O 0 0.09011401981115341
% O 0 0.0522691085934639
- O 0 0.0833609476685524
1 O 0 0.04504711180925369
% O 0 0.03860685974359512
) O 0 0.030136849731206894
by O 0 0.019345663487911224
age O 0 0.038269005715847015
50 O 0 0.03092261217534542
years O 0 0.02169341966509819
and O 0 0.0191364549100399
27 O 0 0.03887022286653519
% O 0 0.037576477974653244
( O 0 0.04030647128820419
95 O 0 0.06983122229576111
% O 0 0.06495020538568497
CI O 1 0.9957275390625
0 O 0 0.09026792645454407
% O 0 0.052473925054073334
- O 0 0.08903056383132935
47 O 0 0.06904969364404678
% O 0 0.04276968911290169
) O 0 0.030523190274834633
by O 0 0.021626368165016174
age O 0 0.044609859585762024
70 O 0 0.055670157074928284
years O 0 0.03847779706120491
. O 0 0.046407222747802734

The O 0 0.05126988887786865
lifetime O 0 0.4335232079029083
risk O 1 0.986333429813385
of O 0 0.0521068349480629
breast B-Disease 1 0.9999996423721313
cancer I-Disease 1 0.9999967813491821
appears O 0 0.05608060210943222
similar O 0 0.028708871454000473
to O 0 0.017234772443771362
the O 0 0.024417167529463768
risk O 0 0.12526777386665344
in O 0 0.03504924848675728
BRCA1 O 1 0.9971983432769775
carriers O 0 0.11999589204788208
, O 0 0.022150956094264984
but O 0 0.014798387885093689
there O 0 0.011570948176085949
was O 0 0.013204468414187431
some O 0 0.013234380632638931
suggestion O 0 0.04078322649002075
of O 0 0.015786176547408104
a O 0 0.031774114817380905
lower O 0 0.06380362808704376
risk O 0 0.341291218996048
in O 0 0.04698750376701355
BRCA2 O 1 0.9987320303916931
carriers O 1 0.5542904734611511
< O 0 0.2936205565929413
50 O 0 0.039690639823675156
years O 0 0.02281675487756729
of O 0 0.017001144587993622
age O 0 0.04935915395617485
. O 0 0.04463392496109009

Eye B-Disease 1 0.9866750836372375
movement I-Disease 0 0.1348937302827835
abnormalities I-Disease 1 0.9341446757316589
correlate O 0 0.14576464891433716
with O 0 0.0505022369325161
genotype O 1 0.704879105091095
in O 0 0.06268707662820816
autosomal O 1 0.9983596205711365
dominant O 1 0.9839181900024414
cerebellar B-Disease 1 0.9999954700469971
ataxia I-Disease 1 0.9999946355819702
type I-Disease 1 0.9443490505218506
I I-Disease 0 0.07480107247829437
. O 0 0.048186808824539185

We O 0 0.05145396664738655
compared O 0 0.07686841487884521
horizontal O 0 0.15162649750709534
eye O 1 0.742344319820404
movements O 0 0.08302086591720581
( O 0 0.06392576545476913
visually O 0 0.12706300616264343
guided O 0 0.12169502675533295
saccades O 1 0.994381844997406
, O 0 0.042055290192365646
antisaccades O 0 0.1445864737033844
, O 0 0.024934768676757812
and O 0 0.019703343510627747
smooth O 0 0.07146405428647995
pursuit O 0 0.08791540563106537
) O 0 0.028305521234869957
in O 0 0.019141526892781258
control O 0 0.048248421400785446
subjects O 0 0.0519675612449646
( O 0 0.05586913600564003
n O 0 0.10598478466272354
= O 0 0.12176292389631271
14 O 0 0.04233593866229057
) O 0 0.03156578168272972
and O 0 0.021086467429995537
patients O 1 0.8631691932678223
with O 0 0.019804496318101883
three O 0 0.017940526828169823
forms O 0 0.03511396422982216
of O 0 0.029634179547429085
autosomal O 1 0.9962031245231628
dominant O 1 0.8205545544624329
cerebellar B-Disease 1 0.9999672174453735
ataxias I-Disease 1 0.9983331561088562
type I-Disease 1 0.8978806734085083
I I-Disease 0 0.28285279870033264
spinocerebellar B-Disease 1 0.999596893787384
ataxias I-Disease 1 0.5300511717796326
1 I-Disease 0 0.04515925794839859
and I-Disease 0 0.025115210562944412
2 I-Disease 0 0.04771078750491142
( O 0 0.05505659058690071
SCA1 B-Disease 1 0.7422783374786377
, O 0 0.03817390650510788
n O 0 0.1098388060927391
= O 0 0.14215202629566193
11 O 0 0.05724375694990158
; O 0 0.04612889513373375
SCA2 B-Disease 0 0.253638356924057
, O 0 0.03700483217835426
n O 0 0.10321088135242462
= O 0 0.12103033065795898
10 O 0 0.0369066558778286
) O 0 0.037305478006601334
and O 0 0.03227461501955986
SCA3 B-Disease 1 0.9998352527618408
/ O 1 0.9987075328826904
Machado B-Disease 1 0.9912450909614563
- I-Disease 1 0.9706371426582336
Joseph I-Disease 1 0.5597202777862549
disease I-Disease 1 0.9999792575836182
( O 0 0.10731552541255951
MJD B-Disease 1 0.9996122717857361
) O 0 0.06214970722794533
( O 0 0.062356822192668915
n O 0 0.11485502123832703
= O 0 0.13359041512012482
16 O 0 0.047938209027051926
) O 0 0.04357012361288071
. O 0 0.04069068655371666

In O 0 0.06737244129180908
SCA1 B-Disease 1 0.6929163932800293
, O 0 0.06292875111103058
saccade O 1 0.6001483201980591
amplitude O 0 0.12317626178264618
was O 0 0.03274795413017273
significantly O 0 0.059401437640190125
increased O 0 0.04097604751586914
, O 0 0.02394956909120083
resulting O 0 0.05727937072515488
in O 0 0.035514961928129196
hypermetria B-Disease 0 0.33811989426612854
. O 0 0.060299016535282135

The O 0 0.049682166427373886
smooth O 0 0.10667436569929123
pursuit O 0 0.11898263543844223
gain O 0 0.07616087794303894
was O 0 0.04280088096857071
decreased O 0 0.1152760460972786
. O 0 0.05362870171666145

In O 0 0.06821312010288239
SCA2 B-Disease 0 0.49101200699806213
, O 0 0.05849122628569603
saccade O 1 0.5934383869171143
velocity O 0 0.12699159979820251
was O 0 0.04377227649092674
markedly O 0 0.13228192925453186
decreased O 0 0.1258578896522522
. O 0 0.0491582415997982

The O 0 0.03638137876987457
percentage O 0 0.048549871891736984
of O 0 0.020755181089043617
errors O 0 0.06307916343212128
in O 0 0.02660227380692959
antisaccades O 0 0.16189076006412506
was O 0 0.03173554688692093
greatly O 0 0.04768649861216545
increased O 0 0.0368880033493042
and O 0 0.0198139026761055
was O 0 0.029059726744890213
significantly O 0 0.06355415284633636
correlated O 0 0.0992804691195488
with O 0 0.031169898808002472
age O 0 0.0653800293803215
at O 0 0.07947193831205368
disease O 1 0.9999973773956299
onset O 1 0.9998990297317505
. O 0 0.07168657332658768

In O 0 0.03771614655852318
addition O 0 0.03471577540040016
, O 0 0.02501101978123188
a O 0 0.030006375163793564
correlation O 0 0.08039877563714981
between O 0 0.0315377339720726
smooth O 0 0.0792565569281578
pursuit O 0 0.09175018221139908
gain O 0 0.04471530020236969
and O 0 0.013599389232695103
the O 0 0.015927094966173172
number O 0 0.019388822838664055
of O 0 0.029300903901457787
trinucleotide O 1 0.8828163146972656
repeats O 0 0.12103328108787537
was O 0 0.035303372889757156
found O 0 0.04111577942967415
. O 0 0.047912076115608215

In O 0 0.07141787558794022
SCA3 B-Disease 1 0.9982663989067078
, O 0 0.06276154518127441
gaze B-Disease 1 0.9774996638298035
- I-Disease 1 0.7398777604103088
evoked I-Disease 1 0.7521756291389465
nystagmus I-Disease 1 0.995427131652832
was O 0 0.03433621674776077
often O 0 0.0268488097935915
present O 0 0.026605689898133278
as O 0 0.020877782255411148
was O 0 0.03664417564868927
saccade O 1 0.6900212168693542
hypometria O 0 0.18254795670509338
and O 0 0.03338422626256943
smooth O 0 0.09225819259881973
pursuit O 0 0.11334054172039032
gain O 0 0.06657987833023071
was O 0 0.039965566247701645
markedly O 0 0.12846042215824127
decreased O 0 0.11548976600170135
. O 0 0.05547751113772392

Three O 0 0.04112890362739563
major O 0 0.048776764422655106
criteria O 0 0.0619802288711071
, O 0 0.03939597308635712
saccade O 1 0.6332929134368896
amplitude O 0 0.15474173426628113
, O 0 0.044042475521564484
saccade O 0 0.4769912362098694
velocity O 0 0.08710213750600815
, O 0 0.021885469555854797
and O 0 0.018484298139810562
presence O 0 0.043524883687496185
of O 0 0.02989574335515499
gaze B-Disease 1 0.9067152738571167
- I-Disease 1 0.7415624260902405
evoked I-Disease 1 0.6287273168563843
nystagmus I-Disease 1 0.9923006296157837
, O 0 0.029122531414031982
permitted O 0 0.03549039736390114
the O 0 0.023304874077439308
correct O 0 0.0683024674654007
assignment O 0 0.06158025190234184
of O 0 0.018897447735071182
90 O 0 0.03999368101358414
% O 0 0.02600126527249813
of O 0 0.013721532188355923
the O 0 0.026641326025128365
SCA1 B-Disease 0 0.2421780526638031
, O 0 0.024833081290125847
90 O 0 0.04071880504488945
% O 0 0.02782370150089264
of O 0 0.0150663573294878
the O 0 0.022264523431658745
SCA2 B-Disease 0 0.44210711121559143
, O 0 0.02357618696987629
and O 0 0.020087946206331253
93 O 0 0.06633896380662918
% O 0 0.028905190527439117
of O 0 0.01568354107439518
the O 0 0.025602824985980988
patients O 1 0.9979220032691956
with O 0 0.03345480561256409
SCA3 B-Disease 1 0.9919033646583557
to O 0 0.020102746784687042
their O 0 0.020335368812084198
genetically O 0 0.0781935602426529
confirmed O 0 0.06604550033807755
patient O 1 0.8914605379104614
group O 0 0.042558617889881134
and O 0 0.01723634824156761
, O 0 0.017474893480539322
therefore O 0 0.026585500687360764
, O 0 0.018959535285830498
may O 0 0.03306853026151657
help O 0 0.05480923876166344
orient O 0 0.12672030925750732
diagnoses O 1 0.9634028673171997
of O 0 0.03650843724608421
SCA1 B-Disease 1 0.9654064774513245
, O 0 0.03674687445163727
SCA2 B-Disease 1 0.6010670065879822
, O 0 0.02881458029150963
and O 0 0.027447132393717766
SCA3 B-Disease 1 0.9953495860099792
at O 0 0.03742841258645058
early O 0 0.039380673319101334
clinical O 0 0.16768275201320648
stages O 0 0.06947936862707138
of O 0 0.018454870209097862
the O 0 0.033548880368471146
diseases O 1 0.9995371103286743
. O 0 0.034041356295347214
. O 0 0.048725295811891556

Genetic O 0 0.131969153881073
basis O 0 0.03668488562107086
and O 0 0.02758626639842987
molecular O 0 0.09991665929555893
mechanism O 0 0.1311446577310562
for O 0 0.06937910616397858
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 0.9999995231628418
fibrillation I-Disease 1 0.9999996423721313
. O 0 0.08915915340185165

Ventricular B-Disease 1 0.9999964237213135
fibrillation I-Disease 1 0.9999958276748657
causes O 1 0.7991640567779541
more O 0 0.02536381222307682
than O 0 0.023332364857196808
300 O 0 0.05060351639986038
, O 0 0.030444055795669556
000 O 0 0.09963526576757431
sudden O 0 0.43439456820487976
deaths O 0 0.08507741242647171
each O 0 0.020976588129997253
year O 0 0.02284529246389866
in O 0 0.019245218485593796
the O 0 0.027897341176867485
USA O 0 0.10430782288312912
alone O 0 0.06330844759941101
. O 0 0.04302368313074112

In O 0 0.040714964270591736
approximately O 0 0.04691214859485626
5 O 0 0.048243019729852676
- O 0 0.07596924901008606
12 O 0 0.03365602716803551
% O 0 0.025153150781989098
of O 0 0.012505894526839256
these O 0 0.013535955920815468
cases O 0 0.03141246736049652
, O 0 0.016076747328042984
there O 0 0.014916107058525085
are O 0 0.016638921573758125
no O 0 0.03770477697253227
demonstrable O 1 0.9943344593048096
cardiac O 1 0.9999897480010986
or O 0 0.05367051064968109
non O 1 0.7029761075973511
- O 1 0.9981641173362732
cardiac O 1 0.9999860525131226
causes O 0 0.2784256935119629
to O 0 0.016941018402576447
account O 0 0.01861509494483471
for O 0 0.011158651672303677
the O 0 0.014621625654399395
episode O 0 0.03582986816763878
, O 0 0.014350107870995998
which O 0 0.011939708143472672
is O 0 0.015399024821817875
therefore O 0 0.024485303089022636
classified O 0 0.05268000438809395
as O 0 0.053536735475063324
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 0.9999997615814209
fibrillation I-Disease 1 0.9999998807907104
( O 1 0.7977283596992493
IVF B-Disease 1 0.9999297857284546
) O 0 0.062308769673109055
. O 0 0.04645463824272156

A O 0 0.06424517929553986
distinct O 0 0.06772200018167496
group O 0 0.0531151220202446
of O 0 0.03835393488407135
IVF B-Disease 1 0.9999845027923584
patients O 1 0.9985402822494507
has O 0 0.023100705817341805
been O 0 0.015439100563526154
found O 0 0.017260141670703888
to O 0 0.012405783869326115
present O 0 0.01928737573325634
with O 0 0.020041372627019882
a O 0 0.037896886467933655
characteristic O 0 0.10718615353107452
electrocardiographic O 1 0.723457396030426
pattern O 0 0.12654796242713928
. O 0 0.057530783116817474

Because O 0 0.034882280975580215
of O 0 0.014528423547744751
the O 0 0.015327411703765392
small O 0 0.02192096598446369
size O 0 0.027126595377922058
of O 0 0.013046994805335999
most O 0 0.019441820681095123
pedigrees O 0 0.09100322425365448
and O 0 0.018239295110106468
the O 0 0.02277328073978424
high O 0 0.05412283167243004
incidence O 1 0.9896315932273865
of O 0 0.03283160924911499
sudden B-Disease 1 0.9592829346656799
death I-Disease 0 0.055057309567928314
, O 0 0.020220918580889702
however O 0 0.020325439050793648
, O 0 0.02190709300339222
molecular O 0 0.07929086685180664
genetic O 0 0.08896008878946304
studies O 0 0.0421941876411438
of O 0 0.0269063338637352
IVF B-Disease 1 0.9992971420288086
have O 0 0.020550550892949104
not O 0 0.014372045174241066
yet O 0 0.023411275818943977
been O 0 0.020138176158070564
done O 0 0.039402902126312256
. O 0 0.040017083287239075

Because O 0 0.4486626088619232
IVF B-Disease 1 0.9999896287918091
causes O 1 0.9998857975006104
cardiac O 1 0.9999948740005493
rhythm O 1 0.9757354259490967
disturbance O 1 0.886408805847168
, O 0 0.024973031133413315
we O 0 0.018756235018372536
investigated O 0 0.05851922556757927
whether O 0 0.037713780999183655
malfunction O 0 0.20725461840629578
of O 0 0.027084650471806526
ion O 0 0.1192992702126503
channels O 0 0.06332949548959732
could O 0 0.034963175654411316
cause O 0 0.09227713942527771
the O 0 0.035473406314849854
disorder O 1 0.9995933175086975
by O 0 0.030993221327662468
studying O 0 0.057270437479019165
mutations O 0 0.12935736775398254
in O 0 0.032685536891222
the O 0 0.0465228371322155
cardiac O 1 0.9996991157531738
sodium O 0 0.35452479124069214
channel O 0 0.11930615454912186
gene O 0 0.17213352024555206
SCN5A O 1 0.834443986415863
. O 0 0.06777376681566238

We O 0 0.033423759043216705
have O 0 0.02139623649418354
now O 0 0.026717785745859146
identified O 0 0.040381837636232376
a O 0 0.047445159405469894
missense O 0 0.22286951541900635
mutation O 0 0.19044341146945953
, O 0 0.04238506779074669
a O 0 0.054738350212574005
splice O 0 0.3738671541213989
- O 0 0.36829444766044617
donor O 1 0.5952591896057129
mutation O 0 0.19356869161128998
, O 0 0.0311056450009346
and O 0 0.025158114731311798
a O 0 0.048507124185562134
frameshift O 1 0.824531614780426
mutation O 0 0.15779712796211243
in O 0 0.027263106778264046
the O 0 0.02792731113731861
coding O 0 0.11406578123569489
region O 0 0.05346762761473656
of O 0 0.02770145609974861
SCN5A O 0 0.3065394461154938
in O 0 0.03047393262386322
three O 0 0.045398373156785965
IVF B-Disease 1 0.9984315037727356
families O 0 0.07962000370025635
. O 0 0.06251387298107147

We O 0 0.040138717740774155
show O 0 0.04180232062935829
that O 0 0.02403525821864605
sodium O 0 0.11089833080768585
channels O 0 0.04836780205368996
with O 0 0.024997984990477562
the O 0 0.0385320745408535
missense O 1 0.5429388880729675
mutation O 0 0.39749422669410706
recover O 0 0.2412540763616562
from O 0 0.04004814475774765
inactivation O 0 0.16128262877464294
more O 0 0.023648900911211967
rapidly O 0 0.04873291775584221
than O 0 0.019951820373535156
normal O 0 0.0381646603345871
and O 0 0.014277550391852856
that O 0 0.017667686566710472
the O 0 0.0350186862051487
frameshift O 1 0.9665523171424866
mutation O 0 0.39750078320503235
causes O 0 0.17490780353546143
the O 0 0.0370287150144577
sodium O 0 0.13454262912273407
channel O 0 0.05094699189066887
to O 0 0.01819492131471634
be O 0 0.02030888758599758
non O 0 0.05588977783918381
- O 0 0.10820340365171432
functional O 0 0.0969843938946724
. O 0 0.057618092745542526

Our O 0 0.052238043397665024
results O 0 0.05646948888897896
indicate O 0 0.05666278302669525
that O 0 0.02944345399737358
mutations O 0 0.15774603188037872
in O 0 0.055141568183898926
cardiac O 1 0.9999680519104004
ion O 1 0.6300356388092041
- O 0 0.1176571175456047
channel O 0 0.07404256612062454
genes O 0 0.07421088218688965
contribute O 0 0.05214349180459976
to O 0 0.019710786640644073
the O 0 0.026200370863080025
risk O 0 0.10229574888944626
of O 0 0.029417669400572777
developing O 0 0.11284156143665314
IVF B-Disease 1 0.999402642250061
. O 0 0.03990903124213219
. O 0 0.04742627963423729

Molecular O 0 0.1808967888355255
heterogeneity O 0 0.186379075050354
in O 0 0.05069597810506821
mucopolysaccharidosis B-Disease 1 0.9449185729026794
IVA I-Disease 1 0.9769806861877441
in O 0 0.028983334079384804
Australia O 0 0.03128005191683769
and O 0 0.017640242353081703
Northern O 0 0.03376065194606781
Ireland O 0 0.04302619397640228
: O 0 0.030787425115704536
nine O 0 0.03564522787928581
novel O 0 0.05889405682682991
mutations O 0 0.13282109797000885
including O 0 0.03746839985251427
T312S O 0 0.13428136706352234
, O 0 0.025333479046821594
a O 0 0.03168247267603874
common O 0 0.054956648498773575
allele O 0 0.15131202340126038
that O 0 0.03156790882349014
confers O 0 0.16079463064670563
a O 0 0.06889060884714127
mild O 1 0.9975304007530212
phenotype O 1 0.9915390610694885
. O 0 0.0679410919547081

Mucopolysaccharidosis B-Disease 1 0.9952073693275452
IVA I-Disease 1 0.999518871307373
( O 0 0.11022485047578812
MPS B-Disease 1 0.9465981721878052
IVA I-Disease 1 0.9998196959495544
) O 0 0.05619725212454796
is O 0 0.031907062977552414
an O 0 0.0428018718957901
autosomal B-Disease 1 0.9997997879981995
recessive I-Disease 1 0.9999725818634033
lysosomal I-Disease 1 0.9999905824661255
storage I-Disease 1 0.9977127313613892
disorder I-Disease 1 0.9999969005584717
caused O 0 0.3423239588737488
by O 0 0.027305085211992264
a O 0 0.04525803402066231
genetic B-Disease 1 0.5526189208030701
defect I-Disease 1 0.9964582324028015
in O 0 0.04521786794066429
N O 0 0.3824634850025177
- O 0 0.40944063663482666
acetylgalactosamine O 1 0.9804701209068298
- O 1 0.7889324426651001
6 O 0 0.12176591157913208
- O 1 0.9802069067955017
sulfate O 1 0.9998155236244202
sulfatase O 1 0.9994745850563049
( O 0 0.11447875946760178
GALNS O 1 0.9475459456443787
) O 0 0.06267287582159042
. O 0 0.048711758106946945

Previous O 0 0.05716971680521965
studies O 0 0.049898918718099594
of O 0 0.023783395066857338
patients O 1 0.9872000217437744
from O 0 0.02501150406897068
a O 0 0.030163181945681572
British O 0 0.0531652458012104
- O 0 0.09595534950494766
Irish O 0 0.06355270743370056
population O 0 0.04082952067255974
showed O 0 0.0390748530626297
that O 0 0.017072590067982674
the O 0 0.02723780833184719
I113F O 0 0.16723927855491638
mutation O 0 0.14144867658615112
is O 0 0.01996825449168682
the O 0 0.015605087392032146
most O 0 0.019357243552803993
common O 0 0.043539196252822876
single O 0 0.05687567964196205
mutation O 0 0.25058430433273315
among O 0 0.06469713151454926
MPS B-Disease 1 0.9978345036506653
IVA I-Disease 1 0.9999972581863403
patients O 1 0.999619722366333
and O 0 0.036266423761844635
produces O 0 0.09120773524045944
a O 0 0.05708540976047516
severe O 1 0.9995816349983215
clinical O 1 0.996867835521698
phenotype O 1 0.9895423650741577
. O 0 0.07356290519237518

We O 0 0.04726222902536392
studied O 0 0.05975823476910591
mutations O 0 0.11572590470314026
in O 0 0.02808183990418911
the O 0 0.036791712045669556
GALNS O 1 0.6622530221939087
gene O 0 0.11644857376813889
from O 0 0.0350416861474514
23 O 0 0.05120642110705376
additional O 0 0.058617301285266876
MPS B-Disease 1 0.9904594421386719
IVA I-Disease 1 0.999984622001648
patients O 1 0.9994544386863708
( O 0 0.05394307151436806
15 O 0 0.029929444193840027
from O 0 0.02167688123881817
Australia O 0 0.026603443548083305
, O 0 0.01930992677807808
8 O 0 0.02910684049129486
from O 0 0.019967518746852875
Northern O 0 0.03727962449193001
Ireland O 0 0.03951066732406616
) O 0 0.02785838022828102
, O 0 0.015411716885864735
with O 0 0.018495747819542885
various O 0 0.02682064101099968
clinical O 1 0.9751594066619873
phenotypes O 1 0.9870561361312866
( O 0 0.07588552683591843
severe O 1 0.997734785079956
, O 0 0.02541809342801571
16 O 0 0.031101631000638008
cases O 0 0.03967738151550293
; O 0 0.03140748664736748
intermediate O 0 0.059859078377485275
, O 0 0.022999357432127
4 O 0 0.03958296775817871
cases O 0 0.04758405312895775
; O 0 0.04205610230565071
mild O 1 0.9856719970703125
, O 0 0.03021770901978016
3 O 0 0.04064585641026497
cases O 0 0.04498622938990593
) O 0 0.046043891459703445
. O 0 0.04280233755707741

We O 0 0.030663080513477325
found O 0 0.025857051834464073
two O 0 0.018753722310066223
common O 0 0.05009496957063675
mutations O 0 0.10595303028821945
that O 0 0.016989512369036674
together O 0 0.022487282752990723
accounted O 0 0.04509500786662102
for O 0 0.018096890300512314
32 O 0 0.037754688411951065
% O 0 0.026484884321689606
of O 0 0.014014883898198605
the O 0 0.018719442188739777
44 O 0 0.054868124425411224
unrelated O 0 0.08060826361179352
alleles O 0 0.15298490226268768
in O 0 0.027859708294272423
these O 0 0.02862764149904251
patients O 1 0.9982945322990417
. O 0 0.05227702111005783

One O 0 0.04167032614350319
is O 0 0.02951177768409252
the O 0 0.033956632018089294
T312S O 0 0.19201157987117767
mutation O 0 0.16760320961475372
, O 0 0.031110940501093864
a O 0 0.03442331403493881
novel O 0 0.06157105788588524
mutation O 0 0.13810013234615326
found O 0 0.03589522838592529
exclusively O 0 0.04082684963941574
in O 0 0.036638855934143066
milder O 1 0.9957857728004456
patients O 1 0.9989823698997498
. O 0 0.06741616129875183

The O 0 0.031578656286001205
other O 0 0.0164534542709589
is O 0 0.017618827521800995
the O 0 0.017132706940174103
previously O 0 0.031919464468955994
described O 0 0.047697219997644424
I113F O 0 0.1284470409154892
that O 0 0.028360415250062943
produces O 0 0.08150213211774826
a O 0 0.05815541371703148
severe O 1 0.9976915121078491
phenotype O 1 0.9885185360908508
. O 0 0.0717221274971962

The O 0 0.0640011578798294
I113F O 0 0.19500720500946045
and O 0 0.0440453477203846
T312S O 0 0.2042667269706726
mutations O 0 0.16454890370368958
accounted O 0 0.0722123235464096
for O 0 0.027264535427093506
8 O 0 0.04876049980521202
( O 0 0.03755740821361542
18 O 0 0.03565247356891632
% O 0 0.03551289439201355
) O 0 0.030586281791329384
and O 0 0.02027171105146408
6 O 0 0.04225197434425354
( O 0 0.03519758582115173
14 O 0 0.03344270959496498
% O 0 0.03262251615524292
) O 0 0.025459712371230125
of O 0 0.01869422197341919
44 O 0 0.05856636166572571
unrelated O 0 0.08494599908590317
alleles O 0 0.17202128469944
, O 0 0.03402818739414215
respectively O 0 0.05486951768398285
. O 0 0.045906439423561096

The O 0 0.04640144854784012
relatively O 0 0.07115665078163147
high O 0 0.07139396667480469
residual O 0 0.4323059618473053
GALNS O 1 0.9025408029556274
activity O 0 0.06929018348455429
seen O 0 0.037446528673172
when O 0 0.028260454535484314
the O 0 0.033683352172374725
T312S O 0 0.16975796222686768
mutant O 0 0.15107761323451996
cDNA O 0 0.17692846059799194
is O 0 0.04579510539770126
overexpressed O 0 0.17409755289554596
in O 0 0.03524516150355339
mutant O 0 0.14166930317878723
cells O 0 0.10409711301326752
provides O 0 0.04460358992218971
an O 0 0.020434260368347168
explanation O 0 0.040496811270713806
for O 0 0.018311867490410805
the O 0 0.031221533194184303
mild O 1 0.9983536005020142
phenotype O 1 0.992999792098999
in O 0 0.042001791298389435
patients O 1 0.9958959817886353
with O 0 0.033772073686122894
this O 0 0.035824958235025406
mutation O 0 0.18303132057189941
. O 0 0.05997700244188309

The O 0 0.03488974645733833
distribution O 0 0.03679360821843147
and O 0 0.022400585934519768
relative O 0 0.0419367253780365
frequencies O 0 0.04267549887299538
of O 0 0.018018689006567
the O 0 0.02633734606206417
I113F O 0 0.14142771065235138
and O 0 0.03214100003242493
T312S O 0 0.1899777203798294
mutations O 0 0.12595494091510773
in O 0 0.024065690115094185
Australia O 0 0.03301415964961052
corresponded O 0 0.05760383605957031
to O 0 0.017201052978634834
those O 0 0.01852763630449772
observed O 0 0.03422561660408974
in O 0 0.016541708260774612
Northern O 0 0.02935497649013996
Ireland O 0 0.026950465515255928
and O 0 0.012409639544785023
are O 0 0.01129471231251955
unique O 0 0.020764660090208054
to O 0 0.0125544099137187
these O 0 0.010394532233476639
two O 0 0.013744640164077282
populations O 0 0.05138436704874039
, O 0 0.020580220967531204
suggesting O 0 0.045148592442274094
that O 0 0.015555188059806824
both O 0 0.01954999566078186
mutations O 0 0.0948563888669014
were O 0 0.018457412719726562
probably O 0 0.03209852799773216
introduced O 0 0.022610096260905266
to O 0 0.01342666894197464
Australia O 0 0.02314511127769947
by O 0 0.017442042008042336
Irish O 0 0.04486681893467903
migrants O 0 0.05141393840312958
during O 0 0.034963175654411316
the O 0 0.02486713044345379
19th O 0 0.04737953469157219
century O 0 0.050775472074747086
. O 0 0.04742735996842384

Haplotype O 1 0.717177152633667
analysis O 0 0.07174522429704666
using O 0 0.043945737183094025
6 O 0 0.05980068817734718
RFLPs O 0 0.14216412603855133
provides O 0 0.04268238693475723
additional O 0 0.02582581155002117
data O 0 0.0211542546749115
that O 0 0.015589389950037003
the O 0 0.029623929411172867
I113F O 0 0.18912279605865479
mutation O 0 0.16658525168895721
originated O 0 0.0654284730553627
from O 0 0.026810936629772186
a O 0 0.033570483326911926
common O 0 0.05425749346613884
ancestor O 0 0.1056361049413681
. O 0 0.0625014379620552

The O 0 0.03577487915754318
other O 0 0.0260182972997427
9 O 0 0.05782622843980789
novel O 0 0.06331519782543182
mutations O 0 0.12400159984827042
identified O 0 0.036414969712495804
in O 0 0.01834764890372753
these O 0 0.018549280241131783
23 O 0 0.04940413311123848
patients O 1 0.7158769965171814
were O 0 0.012515980750322342
each O 0 0.015385309234261513
limited O 0 0.024202214553952217
to O 0 0.01579379290342331
a O 0 0.026265334337949753
single O 0 0.04012139514088631
family O 0 0.05672457814216614
. O 0 0.05237293615937233

These O 0 0.024987399578094482
data O 0 0.023811375722289085
provide O 0 0.02268209680914879
further O 0 0.019535677507519722
evidence O 0 0.021252790465950966
for O 0 0.02091323398053646
extensive O 0 0.06951282173395157
allelic O 0 0.3697742521762848
heterogeneity O 0 0.16846051812171936
in O 0 0.04249085858464241
MPS B-Disease 0 0.486244797706604
IVA I-Disease 1 0.9993991851806641
in O 0 0.03876129165291786
British O 0 0.06319427490234375
- O 0 0.13533718883991241
Irish O 0 0.08406806737184525
patients O 1 0.9832857251167297
and O 0 0.019961658865213394
provide O 0 0.02673155628144741
evidence O 0 0.020834356546401978
for O 0 0.013214233331382275
their O 0 0.015760265290737152
transmission O 0 0.06535264849662781
to O 0 0.015347662381827831
Australia O 0 0.02675170823931694
by O 0 0.02143643982708454
British O 0 0.0529404953122139
- O 0 0.097800113260746
Irish O 0 0.07232015579938889
migrants O 0 0.06879080086946487
. O 0 0.03269930183887482
. O 0 0.04473482072353363

Identification O 0 0.08035647869110107
of O 0 0.033171579241752625
constitutional O 0 0.07107405364513397
WT1 O 1 0.9968658089637756
mutations O 0 0.18266592919826508
, O 0 0.031965289264917374
in O 0 0.033031683415174484
patients O 1 0.9991441965103149
with O 0 0.04999186843633652
isolated O 1 0.9915159940719604
diffuse B-Disease 1 0.9999829530715942
mesangial I-Disease 1 0.9999997615814209
sclerosis I-Disease 1 0.9999998807907104
, O 0 0.037485238164663315
and O 0 0.02134726755321026
analysis O 0 0.04040737822651863
of O 0 0.03317803889513016
genotype O 1 0.9938352108001709
/ O 1 0.9882367253303528
phenotype O 1 0.799472451210022
correlations O 0 0.09879687428474426
by O 0 0.0202036090195179
use O 0 0.023235490545630455
of O 0 0.018605215474963188
a O 0 0.043185435235500336
computerized O 0 0.16031308472156525
mutation O 0 0.20672744512557983
database O 0 0.08143958449363708
. O 0 0.054820843040943146

Constitutional O 0 0.09138060361146927
mutations O 0 0.14993518590927124
of O 0 0.03123428300023079
the O 0 0.04697832837700844
WT1 O 1 0.9845965504646301
gene O 0 0.1363496035337448
, O 0 0.03793022036552429
encoding O 0 0.08296758681535721
a O 0 0.06092175841331482
zinc O 1 0.990729033946991
- O 0 0.1842309683561325
finger O 0 0.20352090895175934
transcription O 0 0.15210700035095215
factor O 0 0.08757725358009338
involved O 0 0.05181906744837761
in O 0 0.041789744049310684
renal O 1 0.9999984502792358
and O 0 0.04590902850031853
gonadal O 1 0.9997112154960632
development O 0 0.04229452833533287
, O 0 0.017353922128677368
are O 0 0.011805558577179909
found O 0 0.0192971620708704
in O 0 0.015461323782801628
most O 0 0.02461543306708336
patients O 1 0.9986019730567932
with O 0 0.05213361978530884
Denys B-Disease 1 0.9998952150344849
- I-Disease 1 0.9995676875114441
Drash I-Disease 1 0.9999641180038452
syndrome I-Disease 1 1.0
( O 1 0.7722222208976746
DDS B-Disease 1 0.9999933242797852
) O 0 0.055865705013275146
, O 0 0.032632164657115936
or O 0 0.07864104211330414
diffuse B-Disease 1 0.9999696016311646
mesangial I-Disease 1 0.9999998807907104
sclerosis I-Disease 1 1.0
( O 1 0.8770625591278076
DMS B-Disease 1 0.999915599822998
) O 0 0.04304055497050285
associated O 0 0.0377892330288887
with O 0 0.030882347375154495
pseudohermaphroditism B-Disease 1 0.998462438583374
and O 0 0.04445914551615715
/ O 1 0.9991716146469116
or O 0 0.142497256398201
Wilms B-Disease 1 0.9999939203262329
tumor I-Disease 1 0.9999773502349854
( O 0 0.14984965324401855
WT B-Disease 1 0.9995890259742737
) O 0 0.06501127034425735
. O 0 0.05139252915978432

Most O 0 0.07273049652576447
mutations O 0 0.2061769813299179
in O 0 0.06934695690870285
DDS B-Disease 1 0.999996542930603
patients O 1 0.9993182420730591
lie O 0 0.08287778496742249
in O 0 0.032604627311229706
exon O 0 0.15130755305290222
8 O 0 0.057747982442379
or O 0 0.03959187865257263
exon O 0 0.14265668392181396
9 O 0 0.058072224259376526
, O 0 0.031412649899721146
encoding O 0 0.10504546761512756
zinc O 1 0.804854154586792
finger O 0 0.16750557720661163
2 O 0 0.06559828668832779
or O 0 0.04831412062048912
zinc O 1 0.936653196811676
finger O 0 0.14177359640598297
3 O 0 0.04128552973270416
, O 0 0.01896585524082184
respectively O 0 0.028424348682165146
, O 0 0.017674217000603676
with O 0 0.019081078469753265
a O 0 0.033467888832092285
hot O 0 0.08731918036937714
spot O 0 0.07575444877147675
( O 0 0.06325775384902954
R394W O 0 0.14921750128269196
) O 0 0.04401950165629387
in O 0 0.031056666746735573
exon O 0 0.16336092352867126
9 O 0 0.07922238856554031
. O 0 0.054597675800323486

We O 0 0.03545665368437767
analyzed O 0 0.05083794146776199
a O 0 0.024755097925662994
series O 0 0.028460301458835602
of O 0 0.018428001552820206
24 O 0 0.04730888456106186
patients O 1 0.9833304286003113
, O 0 0.024238569661974907
10 O 0 0.030423946678638458
with O 0 0.034954316914081573
isolated B-Disease 0 0.37743738293647766
DMS I-Disease 1 0.9998883008956909
( O 0 0.09858618676662445
IDMS B-Disease 1 0.9984499216079712
) O 0 0.04589415714144707
, O 0 0.023966185748577118
10 O 0 0.02978268265724182
with O 0 0.03458777815103531
DDS B-Disease 1 0.9999207258224487
, O 0 0.02511453814804554
and O 0 0.018456630408763885
4 O 0 0.041489265859127045
with O 0 0.037962254136800766
urogenital B-Disease 1 0.9997742772102356
abnormalities I-Disease 1 0.9992400407791138
and O 0 0.048963915556669235
/ O 1 0.9965906143188477
or O 0 0.07183761894702911
WT B-Disease 1 0.999207079410553
. O 0 0.06885655224323273

We O 0 0.05681772902607918
report O 0 0.07849250733852386
WT1 O 1 0.9706894755363464
heterozygous O 0 0.2341998815536499
mutations O 0 0.1757311075925827
in O 0 0.03704993799328804
16 O 0 0.05981091782450676
patients O 1 0.9913262724876404
, O 0 0.021686924621462822
4 O 0 0.029591472819447517
of O 0 0.014487816952168941
whom O 0 0.03797095641493797
presented O 0 0.03940153121948242
with O 0 0.04564615711569786
IDMS B-Disease 1 0.9987263083457947
. O 0 0.06209046393632889

One O 0 0.04020346328616142
male O 0 0.06128843128681183
and O 0 0.020673595368862152
two O 0 0.02893945202231407
female O 0 0.11430446803569794
IDMS B-Disease 1 0.9999761581420898
patients O 1 0.9996138215065002
with O 0 0.07740626484155655
WT1 O 1 0.9996238946914673
mutations O 1 0.9051398634910583
underwent O 1 0.9913977384567261
normal O 0 0.15767265856266022
puberty O 1 0.96341472864151
. O 0 0.060875844210386276

Two O 0 0.05616513267159462
mutations O 0 0.17733317613601685
associated O 0 0.052841149270534515
with O 0 0.041679270565509796
IDMS B-Disease 1 0.9920823574066162
are O 0 0.018455157056450844
different O 0 0.014194180257618427
from O 0 0.01580197364091873
those O 0 0.018679769709706306
described O 0 0.042313963174819946
in O 0 0.04432845860719681
DDS B-Disease 1 0.9999982118606567
patients O 1 0.9997960925102234
. O 0 0.061524927616119385

No O 0 0.09506000578403473
WT1 O 1 0.9972713589668274
mutations O 0 0.17464789748191833
were O 0 0.027980893850326538
detected O 0 0.07057303935289383
in O 0 0.01524318102747202
the O 0 0.016544833779335022
six O 0 0.028371170163154602
other O 0 0.03361761197447777
IDMS B-Disease 1 0.9999780654907227
patients O 1 0.9996933937072754
, O 0 0.036887917667627335
suggesting O 0 0.07828707247972488
genetic O 0 0.11482007056474686
heterogeneity O 0 0.12607359886169434
of O 0 0.02936016023159027
this O 0 0.039445772767066956
disease O 1 0.999895453453064
. O 0 0.058708567172288895

We O 0 0.06232185661792755
analyzed O 0 0.13862821459770203
genotype O 1 0.9838048815727234
/ O 1 0.9861737489700317
phenotype O 1 0.7845757007598877
correlations O 0 0.10475778579711914
, O 0 0.016753457486629486
on O 0 0.009870056062936783
the O 0 0.010487418621778488
basis O 0 0.012310772202908993
of O 0 0.009454702027142048
the O 0 0.014194080606102943
constitution O 0 0.022214170545339584
of O 0 0.019192470237612724
a O 0 0.05169385299086571
WT1 O 1 0.9910790324211121
mutation O 0 0.1858552098274231
database O 0 0.061246369034051895
of O 0 0.030085597187280655
84 O 0 0.13862404227256775
germ O 1 0.9991368651390076
- O 0 0.13939878344535828
line O 0 0.06508370488882065
mutations O 0 0.11637789756059647
, O 0 0.01868816837668419
to O 0 0.017327599227428436
compare O 0 0.046309348195791245
the O 0 0.01850956864655018
distribution O 0 0.03229338675737381
and O 0 0.020266354084014893
type O 0 0.061902087181806564
of O 0 0.023904401808977127
mutations O 0 0.10900653898715973
, O 0 0.021190540865063667
according O 0 0.018067926168441772
to O 0 0.01396479457616806
the O 0 0.020502697676420212
different O 0 0.03502628952264786
symptoms O 1 0.9998055100440979
. O 0 0.05742741748690605

This O 0 0.04148426279425621
demonstrated O 0 0.0749814584851265
( O 0 0.043551959097385406
1 O 0 0.03458087518811226
) O 0 0.02729639783501625
the O 0 0.01967071183025837
association O 0 0.048621904104948044
between O 0 0.03556027635931969
mutations O 0 0.11823105067014694
in O 0 0.0292038731276989
exons O 0 0.11806347966194153
8 O 0 0.04327484220266342
and O 0 0.022585073485970497
9 O 0 0.04271151125431061
and O 0 0.02795669063925743
DMS B-Disease 1 0.9996886253356934
; O 0 0.04452276974916458
( O 0 0.043032582849264145
2 O 0 0.040297139436006546
) O 0 0.03437886759638786
among O 0 0.03587246686220169
patients O 1 0.9962511658668518
with O 0 0.044044893234968185
DMS B-Disease 1 0.9990598559379578
, O 0 0.02431214228272438
a O 0 0.02512524649500847
higher O 0 0.03892441466450691
frequency O 0 0.06143272668123245
of O 0 0.02838670089840889
exon O 0 0.17345955967903137
8 O 0 0.07093053311109543
mutations O 0 0.13136792182922363
among O 0 0.040854211896657944
46 O 0 0.08101939409971237
, O 0 0.04737819731235504
XY O 1 0.9997963309288025
patients O 1 0.9972014427185059
with O 0 0.036800846457481384
female O 0 0.08463361859321594
phenotype O 1 0.7222122550010681
than O 0 0.030754471197724342
among O 0 0.03737180680036545
46 O 0 0.07362758368253708
, O 0 0.04943046346306801
XY O 1 0.9997492432594299
patients O 1 0.9984170198440552
with O 0 0.036084529012441635
sexual O 0 0.07100563496351242
ambiguity O 0 0.08883507549762726
or O 0 0.0479469820857048
male O 0 0.11568086594343185
phenotype O 1 0.988541841506958
; O 0 0.039188019931316376
and O 0 0.021726740524172783
( O 0 0.03934365510940552
3 O 0 0.037612639367580414
) O 0 0.032122787088155746
statistically O 0 0.052943672984838486
significant O 0 0.030684953555464745
evidence O 0 0.028090521693229675
that O 0 0.023175140842795372
mutations O 0 0.11612781882286072
in O 0 0.029814939945936203
exons O 0 0.11770406365394592
8 O 0 0.0464264377951622
and O 0 0.025028781965374947
9 O 0 0.05180588364601135
preferentially O 0 0.12507881224155426
affect O 0 0.07371443510055542
amino O 0 0.08124174177646637
acids O 0 0.062390394508838654
with O 0 0.018688568845391273
different O 0 0.01843620464205742
functions O 0 0.02676413208246231
. O 0 0.027709124609827995
. O 0 0.039825379848480225

The O 0 0.08812069892883301
185delAG O 1 0.8617625832557678
BRCA1 O 1 0.993513286113739
mutation O 0 0.3205769658088684
originated O 0 0.07544577121734619
before O 0 0.027003763243556023
the O 0 0.022762225940823555
dispersion O 0 0.08476649224758148
of O 0 0.01442765910178423
Jews O 0 0.023738591000437737
in O 0 0.013729116879403591
the O 0 0.015857946127653122
diaspora O 0 0.0520249679684639
and O 0 0.015718884766101837
is O 0 0.01711980812251568
not O 0 0.015417210757732391
limited O 0 0.034335657954216
to O 0 0.030759450048208237
Ashkenazim O 0 0.21712347865104675
. O 0 0.05496428534388542

The O 0 0.07295281440019608
185delAG O 0 0.4425654411315918
mutation O 0 0.21083730459213257
in O 0 0.04656897485256195
BRCA1 O 1 0.9664901494979858
is O 0 0.0443740114569664
detected O 0 0.09100458025932312
in O 0 0.028091734275221825
Ashkenazi O 0 0.11754287034273148
Jews O 0 0.03681301325559616
both O 0 0.028471453115344048
in O 0 0.040899064391851425
familial B-Disease 1 0.9999984502792358
breast I-Disease 1 0.9999998807907104
and I-Disease 1 0.9831035137176514
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.999998927116394
and O 0 0.020456701517105103
in O 0 0.015171433798968792
the O 0 0.01757468655705452
general O 0 0.03155805543065071
population O 0 0.046721577644348145
. O 0 0.04696844145655632

All O 0 0.04957124963402748
tested O 0 0.15799802541732788
Ashkenazi O 0 0.3056512176990509
mutation O 0 0.2417340874671936
carriers O 0 0.11479076743125916
share O 0 0.046094540506601334
the O 0 0.02606811746954918
same O 0 0.03710092604160309
allelic O 0 0.25524064898490906
pattern O 0 0.10962485522031784
at O 0 0.04929853975772858
the O 0 0.04182758182287216
BRCA1 O 1 0.9621725678443909
locus O 0 0.24170240759849548
. O 0 0.07118191570043564

Our O 0 0.039139971137046814
previous O 0 0.03601961210370064
study O 0 0.03667433187365532
showed O 0 0.03561389818787575
that O 0 0.017090482637286186
this O 0 0.024186765775084496
Ashkenazi O 0 0.17552407085895538
mutation O 0 0.16432660818099976
also O 0 0.027939042076468468
occurs O 0 0.055087242275476456
in O 0 0.016232747584581375
Iraqi O 0 0.03313034772872925
Jews O 0 0.02892432175576687
with O 0 0.020866956561803818
a O 0 0.03616511449217796
similar O 0 0.05748467147350311
allelic O 1 0.7698622345924377
pattern O 0 0.14383670687675476
. O 0 0.06316249072551727

We O 0 0.03663638234138489
extended O 0 0.04445924609899521
our O 0 0.023894278332591057
analysis O 0 0.027441812679171562
to O 0 0.015700260177254677
other O 0 0.01872836984694004
non O 0 0.07003740966320038
- O 0 0.13014347851276398
Ashkenazi O 0 0.1886950433254242
subsets O 0 0.13291838765144348
354 O 0 0.1316673457622528
of O 0 0.02815840020775795
Moroccan O 0 0.09433016180992126
origin O 0 0.04992125928401947
, O 0 0.03273611515760422
200 O 0 0.060237959027290344
Yemenites O 0 0.19753001630306244
and O 0 0.026844056323170662
150 O 0 0.05262494459748268
Iranian O 0 0.04988928884267807
Jews O 0 0.05422161519527435
. O 0 0.05052937567234039

Heteroduplex O 0 0.2648216485977173
analysis O 0 0.06936361640691757
complemented O 0 0.0827556699514389
by O 0 0.02633253112435341
direct O 0 0.05262340232729912
DNA O 0 0.09340023994445801
sequencing O 0 0.08737631142139435
of O 0 0.033783216029405594
abnormally O 0 0.3213520348072052
migrating O 0 0.11918670684099197
bands O 0 0.07568508386611938
were O 0 0.02494305931031704
employed O 0 0.06674157083034515
. O 0 0.055865541100502014

Four O 0 0.03706208989024162
of O 0 0.023600371554493904
Moroccan O 0 0.0941501036286354
origin O 0 0.047849949449300766
( O 0 0.04424460977315903
1 O 0 0.03293880447745323
. O 0 0.01986302062869072
1 O 0 0.031370677053928375
% O 0 0.03365907073020935
) O 0 0.023672878742218018
and O 0 0.01468442752957344
none O 0 0.025446303188800812
of O 0 0.01414019800722599
the O 0 0.026302989572286606
Yemenites O 0 0.46704116463661194
or O 0 0.03635425493121147
Iranians O 0 0.04088038206100464
was O 0 0.01858378015458584
a O 0 0.02370493672788143
carrier O 0 0.06837888062000275
of O 0 0.022664574906229973
the O 0 0.04176260530948639
185delAG O 0 0.489986777305603
mutation O 0 0.2401684671640396
. O 0 0.06687624752521515

BRCA1 O 1 0.995353102684021
allelic O 1 0.7906919121742249
patterns O 0 0.07987639307975769
were O 0 0.017870552837848663
determined O 0 0.03004136122763157
for O 0 0.012436022982001305
four O 0 0.013185543939471245
of O 0 0.010301657021045685
these O 0 0.011597754433751106
individuals O 0 0.02284015528857708
and O 0 0.013891740702092648
for O 0 0.01644471287727356
12 O 0 0.02977874130010605
additional O 0 0.03539705649018288
non O 0 0.07789596170186996
- O 0 0.15504589676856995
Ashkenazi O 0 0.32451531291007996
185delAG O 1 0.88841712474823
mutation O 1 0.7408014535903931
carriers O 0 0.352672278881073
who O 0 0.0676397904753685
had O 1 0.754387378692627
breast B-Disease 1 1.0
/ I-Disease 1 0.9999995231628418
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999995231628418
. O 0 0.07924330234527588

Six O 0 0.06988154351711273
non O 0 0.09610245376825333
- O 0 0.1345026046037674
Ashkenazi O 0 0.16228578984737396
individuals O 0 0.04167163372039795
shared O 0 0.03985586389899254
the O 0 0.027861351147294044
common O 0 0.06639360636472702
Ashkenazi O 1 0.6022605895996094
haplotype O 1 0.9544278979301453
, O 0 0.025057988241314888
four O 0 0.01968119665980339
had O 0 0.022493908181786537
a O 0 0.024164414033293724
closely O 0 0.036777134984731674
related O 0 0.0452713780105114
pattern O 0 0.06424971669912338
, O 0 0.017753945663571358
and O 0 0.013847528025507927
the O 0 0.020842095836997032
rest O 0 0.05194684490561485
( O 0 0.05941760912537575
n O 0 0.1079014241695404
= O 0 0.13555173575878143
6 O 0 0.05582273751497269
) O 0 0.03283872455358505
displayed O 0 0.041362445801496506
a O 0 0.04328512027859688
distinct O 0 0.09973522275686264
BRCA1 O 1 0.9900056719779968
allelic O 1 0.9282134175300598
pattern O 0 0.17178156971931458
. O 0 0.06964173167943954

We O 0 0.04073368012905121
conclude O 0 0.06883715838193893
that O 0 0.02054113894701004
the O 0 0.03994463011622429
185delAG O 1 0.9023782014846802
BRCA1 O 1 0.9972202777862549
mutation O 0 0.3941904306411743
occurs O 0 0.0797237902879715
in O 0 0.02021191269159317
some O 0 0.020694972947239876
non O 0 0.0670667290687561
- O 0 0.14231567084789276
Ashkenazi O 0 0.20387829840183258
populations O 0 0.09508007019758224
at O 0 0.041633736342191696
rates O 0 0.057950954884290695
comparable O 0 0.04729200527071953
with O 0 0.018859736621379852
that O 0 0.01637337915599346
of O 0 0.023837732151150703
Ashkenazim O 1 0.6398893594741821
. O 0 0.05590048432350159

The O 0 0.03613102436065674
majority O 0 0.047138653695583344
of O 0 0.029512031003832817
Jewish O 0 0.08163168281316757
185delAG O 1 0.781206488609314
mutation O 0 0.23884102702140808
carriers O 0 0.10226362198591232
have O 0 0.02472568117082119
a O 0 0.03145033121109009
common O 0 0.05544660985469818
allelic O 1 0.760775089263916
pattern O 0 0.08933800458908081
, O 0 0.021846013143658638
supporting O 0 0.035318780690431595
the O 0 0.02506791427731514
founder O 0 0.07394495606422424
effect O 0 0.05835383012890816
notion O 0 0.047366172075271606
, O 0 0.01978323794901371
but O 0 0.017638590186834335
dating O 0 0.03697981312870979
the O 0 0.020546317100524902
mutations O 0 0.0923532024025917
origin O 0 0.030896028503775597
to O 0 0.014970159158110619
an O 0 0.018529029563069344
earlier O 0 0.024981113150715828
date O 0 0.024005768820643425
than O 0 0.017744550481438637
currently O 0 0.028652960434556007
estimated O 0 0.05032790079712868
. O 0 0.048029519617557526

However O 0 0.03782447800040245
, O 0 0.020319145172834396
the O 0 0.019327159970998764
different O 0 0.02990325354039669
allelic O 0 0.21805033087730408
pattern O 0 0.0931583121418953
at O 0 0.040860287845134735
the O 0 0.03857289254665375
BRCA1 O 1 0.9612823128700256
locus O 0 0.1611078381538391
even O 0 0.03077065572142601
in O 0 0.01929449290037155
some O 0 0.024935046210885048
Jewish O 0 0.06843440234661102
mutation O 0 0.2729063928127289
carriers O 0 0.12294813990592957
, O 0 0.029272958636283875
might O 0 0.03942400589585304
suggest O 0 0.03684625029563904
that O 0 0.01527365855872631
the O 0 0.025965698063373566
mutation O 0 0.15711897611618042
arose O 0 0.07031547278165817
independently O 0 0.04527372121810913
. O 0 0.030327245593070984
. O 0 0.04414369538426399

Crystal O 0 0.1417527198791504
structure O 0 0.05261630192399025
of O 0 0.028701718896627426
the O 0 0.055324602872133255
hemochromatosis B-Disease 1 0.9999949932098389
protein O 0 0.18816789984703064
HFE O 1 0.9855003952980042
and O 0 0.02588030882179737
characterization O 0 0.06400541216135025
of O 0 0.01730511523783207
its O 0 0.024413371458649635
interaction O 0 0.0659259632229805
with O 0 0.046431634575128555
transferrin O 1 0.9592167735099792
receptor O 0 0.33327391743659973
. O 0 0.06690231710672379

HFE O 1 0.9706830382347107
is O 0 0.05155513435602188
an O 0 0.04546763747930527
MHC O 1 0.9960722923278809
- O 0 0.12151259183883667
related O 0 0.05703230947256088
protein O 0 0.06436153501272202
that O 0 0.015914753079414368
is O 0 0.021503377705812454
mutated O 0 0.09623820334672928
in O 0 0.021418841555714607
the O 0 0.03397572040557861
iron B-Disease 1 0.9998272061347961
- I-Disease 1 0.9999035596847534
overload I-Disease 1 0.9999946355819702
disease I-Disease 1 0.9999998807907104
hereditary B-Disease 1 0.9999955892562866
hemochromatosis I-Disease 1 0.9999998807907104
. O 0 0.1000668853521347

HFE O 1 0.9394639730453491
binds O 0 0.22916969656944275
to O 0 0.07215886563062668
transferrin O 1 0.9708225727081299
receptor O 1 0.782446026802063
( O 0 0.09412277489900589
TfR O 1 0.9943246245384216
) O 0 0.03978884592652321
and O 0 0.022575045004487038
reduces O 0 0.09625183045864105
its O 0 0.023473437875509262
affinity O 0 0.08826795220375061
for O 0 0.02968197502195835
iron O 0 0.18707731366157532
- O 0 0.12104377895593643
loaded O 0 0.10262155532836914
transferrin O 1 0.8516579866409302
, O 0 0.05460904538631439
implicating O 0 0.3081360459327698
HFE O 1 0.991071343421936
in O 0 0.05856148153543472
iron O 0 0.43221548199653625
metabolism O 0 0.41901442408561707
. O 0 0.06496089696884155

The O 0 0.047107286751270294
2 O 0 0.060718365013599396
. O 0 0.04847719147801399

6 O 0 0.07950697094202042
A O 0 0.053682148456573486
crystal O 0 0.09045130014419556
structure O 0 0.04750889912247658
of O 0 0.032093774527311325
HFE O 1 0.9893729090690613
reveals O 0 0.07904770970344543
the O 0 0.025293024256825447
locations O 0 0.04515060782432556
of O 0 0.03929523378610611
hemochromatosis B-Disease 1 0.9999964237213135
mutations O 0 0.17171812057495117
and O 0 0.02548889070749283
a O 0 0.034988243132829666
patch O 1 0.6772626042366028
of O 0 0.027604589238762856
histidines O 0 0.16413800418376923
that O 0 0.018322603777050972
could O 0 0.020462168380618095
be O 0 0.014168502762913704
involved O 0 0.03242870047688484
in O 0 0.03305354714393616
pH O 1 0.8068347573280334
- O 0 0.12116619944572449
dependent O 0 0.09964916855096817
interactions O 0 0.09228654205799103
. O 0 0.051964763551950455

We O 0 0.035516757518053055
also O 0 0.02411467395722866
demonstrate O 0 0.05543854460120201
that O 0 0.03247695416212082
soluble O 0 0.4298749566078186
TfR O 1 0.9951304197311401
and O 0 0.04726274684071541
HFE O 1 0.9903636574745178
bind O 0 0.13134627044200897
tightly O 0 0.07041086256504059
at O 0 0.02761049009859562
the O 0 0.017581092193722725
basic O 0 0.039426788687705994
pH O 0 0.13841837644577026
of O 0 0.019126147031784058
the O 0 0.02707592211663723
cell O 0 0.08157336711883545
surface O 0 0.04486469924449921
, O 0 0.015483478084206581
but O 0 0.01261519268155098
not O 0 0.012429519556462765
at O 0 0.0226470697671175
the O 0 0.027359161525964737
acidic O 0 0.3163030445575714
pH O 0 0.3171035945415497
of O 0 0.04103931784629822
intracellular O 0 0.30825328826904297
vesicles O 0 0.40034472942352295
. O 0 0.07198585569858551

TfR O 1 0.9980514049530029
HFE O 1 0.9970420002937317
stoichiometry O 1 0.617107093334198
( O 0 0.07368794828653336
2 O 0 0.055105794221162796
1 O 0 0.04568452760577202
) O 0 0.0387384295463562
differs O 0 0.06999259442090988
from O 0 0.05016379803419113
TfR O 1 0.9985862970352173
transferrin O 1 0.9845392107963562
stoichiometry O 0 0.3980729281902313
( O 0 0.05659226328134537
2 O 0 0.043239887803792953
2 O 0 0.035839978605508804
) O 0 0.025436490774154663
, O 0 0.016829529777169228
implying O 0 0.05748407542705536
a O 0 0.02255627140402794
different O 0 0.018365031108260155
mode O 0 0.051005441695451736
of O 0 0.01712295413017273
binding O 0 0.0547400638461113
for O 0 0.03151700273156166
HFE O 1 0.9861443042755127
and O 0 0.03837776556611061
transferrin O 1 0.7674317359924316
to O 0 0.036490991711616516
TfR O 1 0.980293869972229
, O 0 0.029916971921920776
consistent O 0 0.04518954083323479
with O 0 0.019647322595119476
our O 0 0.026591256260871887
demonstration O 0 0.061219342052936554
that O 0 0.029137706384062767
HFE O 1 0.9919643402099609
, O 0 0.03857066482305527
transferrin O 1 0.6756392121315002
, O 0 0.026641614735126495
and O 0 0.02803090028464794
TfR O 1 0.9804509878158569
form O 0 0.0496821366250515
a O 0 0.043823983520269394
ternary O 0 0.14202037453651428
complex O 0 0.08744771033525467
. O 0 0.05119064822793007

Identification O 0 0.06503492593765259
of O 0 0.019111230969429016
three O 0 0.024301882833242416
novel O 0 0.05381802096962929
mutations O 0 0.11155420541763306
and O 0 0.020094573497772217
a O 0 0.024014359340071678
high O 0 0.03755049780011177
frequency O 0 0.04800810292363167
of O 0 0.017546985298395157
the O 0 0.03176094591617584
Arg778Leu O 1 0.715237021446228
mutation O 0 0.18518373370170593
in O 0 0.036478981375694275
Korean O 0 0.095738485455513
patients O 1 0.9995326995849609
with O 0 0.04686111956834793
Wilson B-Disease 1 0.9898092746734619
disease I-Disease 1 0.9999629259109497
. O 0 0.06609947234392166

Four O 0 0.08311154693365097
mutations O 0 0.4740331768989563
- O 0 0.3483540713787079
- O 0 0.1760222613811493
R778L O 0 0.21773624420166016
, O 0 0.047297969460487366
A874V O 0 0.16888278722763062
, O 0 0.036634866148233414
L1083F O 0 0.12207312136888504
, O 0 0.02571926824748516
and O 0 0.02467222698032856
2304delC O 1 0.5266051888465881
- O 0 0.10802523046731949
- O 0 0.07936685532331467
in O 0 0.02484496310353279
the O 0 0.028228649869561195
copper O 0 0.1065535768866539
- O 0 0.11395376920700073
transporting O 0 0.1005510464310646
enzyme O 0 0.14637883007526398
, O 0 0.05085929483175278
P O 1 0.9869570732116699
- O 0 0.18176238238811493
type O 0 0.16884824633598328
ATPase O 1 0.9840351343154907
( O 0 0.09004560112953186
ATP7B O 1 0.6866594552993774
) O 0 0.03463901951909065
, O 0 0.015867730602622032
were O 0 0.015271450392901897
identified O 0 0.029301704838871956
in O 0 0.02336864173412323
Korean O 0 0.08894022554159164
Patients O 1 0.9996658563613892
with O 0 0.04719484597444534
Wilson B-Disease 1 0.9729113578796387
disease I-Disease 1 0.999950647354126
. O 0 0.06212134286761284

Arg778Leu O 0 0.22640551626682281
, O 0 0.02672911062836647
the O 0 0.02155311033129692
most O 0 0.02171475440263748
frequently O 0 0.04666640982031822
reported O 0 0.05815407633781433
mutation O 0 0.1104969009757042
of O 0 0.018899593502283096
this O 0 0.020855801180005074
enzyme O 0 0.08487498015165329
, O 0 0.018544316291809082
was O 0 0.01715153083205223
found O 0 0.017741691321134567
in O 0 0.012452062219381332
six O 0 0.019003627821803093
of O 0 0.015456077642738819
eight O 0 0.037081532180309296
unrelated O 0 0.09872433543205261
patients O 1 0.9908599853515625
studied O 0 0.046213988214731216
, O 0 0.021671047434210777
an O 0 0.028141770511865616
allele O 0 0.15237018465995789
frequency O 0 0.07682004570960999
of O 0 0.026357274502515793
37 O 0 0.08109553903341293
. O 0 0.05148753151297569

5 O 0 0.0634509027004242
% O 0 0.037156809121370316
, O 0 0.018411511555314064
which O 0 0.016735151410102844
is O 0 0.018931254744529724
considerably O 0 0.04018488526344299
higher O 0 0.025943312793970108
than O 0 0.013379932381212711
those O 0 0.011085817590355873
in O 0 0.012771133333444595
other O 0 0.013942185789346695
Asian O 0 0.06729390472173691
populations O 0 0.08415991067886353
. O 0 0.049057554453611374

The O 0 0.045801982283592224
novel O 0 0.0736401155591011
single O 0 0.07236521691083908
nucleotide O 0 0.1549704521894455
deletion O 0 0.17316441237926483
, O 0 0.03793688118457794
2304delC O 0 0.13424719870090485
, O 0 0.02113366313278675
was O 0 0.019647981971502304
found O 0 0.022613322362303734
in O 0 0.018621286377310753
one O 0 0.030234679579734802
patient O 1 0.9063988327980042
. O 0 0.05161546170711517

Since O 0 0.06970120221376419
a O 0 0.06272102892398834
mutation O 0 0.20190304517745972
at O 0 0.07554366439580917
cDNA O 0 0.24100299179553986
nucleotide O 0 0.2457602322101593
2302 O 1 0.9821391701698303
( O 0 0.09099530428647995
2302insC O 0 0.17449739575386047
) O 0 0.0360419936478138
had O 0 0.019998913630843163
been O 0 0.017308374866843224
previously O 0 0.026258153840899467
described O 0 0.02905436046421528
, O 0 0.013019069097936153
this O 0 0.013059355318546295
region O 0 0.03243265300989151
of O 0 0.01675284467637539
the O 0 0.030527545139193535
ATP7B O 1 0.9909342527389526
gene O 0 0.13084696233272552
may O 0 0.04263967275619507
be O 0 0.02337929978966713
susceptible O 0 0.19737549126148224
to O 0 0.038375239819288254
gene O 0 0.1736779808998108
rearrangements O 1 0.6286420226097107
causing O 1 0.9734950661659241
Wilson B-Disease 1 0.9851002097129822
disease I-Disease 1 0.9999556541442871
. O 0 0.06678862869739532

Disruption O 0 0.18882715702056885
of O 0 0.04289910942316055
splicing O 0 0.14888033270835876
regulated O 0 0.07580924034118652
by O 0 0.028696350753307343
a O 0 0.04805275797843933
CUG O 1 0.9556969404220581
- O 0 0.142289936542511
binding O 0 0.10506685823202133
protein O 0 0.1286330670118332
in O 0 0.07240796089172363
myotonic B-Disease 1 0.9999996423721313
dystrophy I-Disease 1 0.9999997615814209
. O 0 0.09600582718849182

Myotonic B-Disease 1 0.9999998807907104
dystrophy I-Disease 1 1.0
( O 1 0.9939038157463074
DM B-Disease 1 0.9999992847442627
) O 0 0.05594605952501297
is O 0 0.029461538419127464
caused O 0 0.06515920162200928
by O 0 0.023409992456436157
a O 0 0.040712881833314896
CTG O 1 0.553853452205658
expansion O 0 0.05297982320189476
in O 0 0.017769552767276764
the O 0 0.021863272413611412
3 O 0 0.048832524567842484
untranslated O 0 0.1344841718673706
region O 0 0.0479290634393692
of O 0 0.02635098434984684
the O 0 0.05775696039199829
DM B-Disease 1 0.9999868869781494
gene O 0 0.19107165932655334
. O 0 0.06797834485769272

One O 0 0.046974532306194305
model O 0 0.07100531458854675
of O 0 0.04787607118487358
DM B-Disease 1 0.9999996423721313
pathogenesis O 1 0.99959796667099
suggests O 0 0.08334297686815262
that O 0 0.02620658650994301
RNAs O 0 0.11710046231746674
from O 0 0.02127009630203247
the O 0 0.019963955506682396
expanded O 0 0.04117703437805176
allele O 0 0.11731749773025513
create O 0 0.044921696186065674
a O 0 0.03490747511386871
gain O 0 0.05833953619003296
- O 0 0.07973288744688034
of O 0 0.02872738055884838
- O 0 0.10609276592731476
function O 0 0.07060761004686356
mutation O 0 0.13013266026973724
by O 0 0.021670611575245857
the O 0 0.022291256114840508
inappropriate O 0 0.07011046260595322
binding O 0 0.0493168868124485
of O 0 0.018038131296634674
proteins O 0 0.04534553736448288
to O 0 0.020578797906637192
the O 0 0.03225607052445412
CUG O 1 0.8682544231414795
repeats O 0 0.15594570338726044
. O 0 0.056660912930965424

Data O 0 0.04457883909344673
presented O 0 0.035229071974754333
here O 0 0.024438990280032158
indicate O 0 0.037309423089027405
that O 0 0.016256066039204597
the O 0 0.02439013123512268
conserved O 0 0.08515742421150208
heterogeneous O 0 0.15851731598377228
nuclear O 0 0.11475876718759537
ribonucleoprotein O 1 0.9613879919052124
, O 0 0.05893202871084213
CUG O 1 0.8744487762451172
- O 0 0.14615337550640106
binding O 0 0.11400669813156128
protein O 0 0.12926116585731506
( O 0 0.07507798075675964
CUG O 1 0.990347146987915
- O 0 0.14967496693134308
BP O 0 0.15411485731601715
) O 0 0.04118070378899574
, O 0 0.02435358241200447
may O 0 0.03814193606376648
mediate O 0 0.11399222165346146
the O 0 0.03894626349210739
trans O 0 0.17736537754535675
- O 0 0.11383669823408127
dominant O 0 0.08747991174459457
effect O 0 0.0589468851685524
of O 0 0.020876513794064522
the O 0 0.03714762255549431
RNA O 0 0.15123999118804932
. O 0 0.06505778431892395

CUG O 1 0.9801029562950134
- O 0 0.15576981008052826
BP O 0 0.13756810128688812
was O 0 0.02947845309972763
found O 0 0.02484332211315632
to O 0 0.019079310819506645
bind O 0 0.06831125915050507
to O 0 0.01975560188293457
the O 0 0.030166631564497948
human O 0 0.09840523451566696
cardiac O 1 0.999995231628418
troponin O 1 0.9999752044677734
T O 1 0.9986629486083984
( O 0 0.07948928326368332
cTNT O 0 0.37460610270500183
) O 0 0.05691130459308624
pre O 0 0.11746644973754883
- O 0 0.14296773076057434
messenger O 0 0.15054209530353546
RNA O 0 0.11912476271390915
and O 0 0.02556481957435608
regulate O 0 0.07271189987659454
its O 0 0.031351882964372635
alternative O 0 0.08371973037719727
splicing O 0 0.1753637194633484
. O 0 0.06240280717611313

Splicing O 0 0.2073395699262619
of O 0 0.043507665395736694
cTNT O 0 0.2109583169221878
was O 0 0.0478869192302227
disrupted O 0 0.1616544872522354
in O 0 0.06911593675613403
DM B-Disease 1 0.9999997615814209
striated O 1 0.9998763799667358
muscle O 1 0.9989163875579834
and O 0 0.029027065262198448
in O 0 0.026540158316493034
normal O 0 0.07646763324737549
cells O 0 0.1194111779332161
expressing O 0 0.0700804591178894
transcripts O 0 0.06542009115219116
that O 0 0.0252495426684618
contain O 0 0.06551852077245712
CUG O 1 0.7291441559791565
repeats O 0 0.1581185758113861
. O 0 0.06594076007604599

Altered O 0 0.12433591485023499
expression O 0 0.0762476697564125
of O 0 0.029975036159157753
genes O 0 0.10620338469743729
regulated O 0 0.11307452619075775
posttranscriptionally O 0 0.20836012065410614
by O 0 0.046911343932151794
CUG O 1 0.9829382300376892
- O 0 0.16334466636180878
BP O 0 0.16565722227096558
therefore O 0 0.04970956966280937
may O 0 0.043093256652355194
contribute O 0 0.07460018992424011
to O 0 0.052407510578632355
DM B-Disease 1 0.9999996423721313
pathogenesis O 1 0.9991111159324646
. O 0 0.0471678227186203
. O 0 0.050843581557273865

Identification O 0 0.07217461615800858
of O 0 0.027033118531107903
a O 0 0.04160461947321892
novel O 0 0.07196369767189026
nonsense O 0 0.12989863753318787
mutation O 0 0.15454742312431335
and O 0 0.027398156002163887
a O 0 0.0419979989528656
missense O 0 0.18881721794605255
substitution O 0 0.09587906301021576
in O 0 0.028932249173521996
the O 0 0.040444355458021164
vasopressin O 1 0.9933033585548401
- O 0 0.44216516613960266
neurophysin O 1 0.8737622499465942
II O 0 0.1331973820924759
gene O 0 0.08310091495513916
in O 0 0.02028372697532177
two O 0 0.021641971543431282
Spanish O 0 0.06778354197740555
kindreds O 1 0.8344658613204956
with O 0 0.06909247487783432
familial B-Disease 1 0.9998806715011597
neurohypophyseal I-Disease 1 0.9998447895050049
diabetes I-Disease 1 0.9999996423721313
insipidus I-Disease 1 0.9999794960021973
. O 0 0.10303543508052826

Familial B-Disease 1 0.9999451637268066
neurohypophyseal I-Disease 1 0.9999114274978638
diabetes I-Disease 1 0.9999998807907104
insipidus I-Disease 1 0.9999924898147583
( O 0 0.30024048686027527
FNDI B-Disease 1 0.9989987015724182
) O 0 0.044686805456876755
is O 0 0.02845400758087635
an O 0 0.04037883132696152
autosomal B-Disease 1 0.9999130964279175
dominant I-Disease 1 0.9985789060592651
disease I-Disease 1 0.9999996423721313
caused O 1 0.995524525642395
by O 0 0.04729762300848961
deficiency O 1 0.9999959468841553
in O 0 0.03665025159716606
the O 0 0.05045643076300621
antidiuretic O 1 0.9977066516876221
hormone O 1 0.9927453398704529
arginine O 1 0.8537104725837708
vasopressin O 1 0.9673855304718018
( O 0 0.09026619046926498
AVP O 1 0.9526959657669067
) O 0 0.040324609726667404
encoded O 0 0.03882718086242676
by O 0 0.024183887988328934
the O 0 0.034673240035772324
AVP O 1 0.9974924325942993
- O 0 0.3472965657711029
neurophysin O 1 0.8530687689781189
II O 1 0.5505754947662354
( O 0 0.09690315276384354
AVP O 1 0.9991527795791626
- O 0 0.306277334690094
NPII O 1 0.8207879662513733
) O 0 0.0684504434466362
gene O 0 0.10761608183383942
on O 0 0.03802542760968208
chromosome O 0 0.2045511156320572
20p13 O 0 0.2289992868900299
. O 0 0.06632889807224274

In O 0 0.03498906269669533
this O 0 0.02182377502322197
study O 0 0.028646195307374
, O 0 0.01697319746017456
we O 0 0.016933120787143707
analyzed O 0 0.03652855381369591
two O 0 0.018018824979662895
families O 0 0.03672664612531662
with O 0 0.030491648241877556
FNDI B-Disease 1 0.7920656204223633
using O 0 0.03790508210659027
direct O 0 0.05338173359632492
automated O 0 0.09452132135629654
fluorescent O 0 0.12760375440120697
, O 0 0.030913054943084717
solid O 0 0.05854347348213196
phase O 0 0.08115869760513306
, O 0 0.026768820360302925
single O 0 0.04675313085317612
- O 0 0.09972620755434036
stranded O 0 0.14061035215854645
DNA O 0 0.10038939863443375
sequencing O 0 0.10438147932291031
of O 0 0.04132566601037979
PCR O 0 0.3732335865497589
- O 0 0.20159199833869934
amplified O 0 0.2253914326429367
AVP O 1 0.9986608028411865
- O 0 0.4698824882507324
NPII O 1 0.8689940571784973
DNA O 0 0.15481361746788025
. O 0 0.06769728660583496

In O 0 0.027458515018224716
one O 0 0.017948532477021217
of O 0 0.013742100447416306
the O 0 0.01649189554154873
families O 0 0.04035443067550659
, O 0 0.023648971691727638
affected O 0 0.053153205662965775
individuals O 0 0.030996648594737053
presented O 0 0.031659968197345734
a O 0 0.0356295146048069
novel O 0 0.06564538180828094
nonsense O 0 0.11461729556322098
mutation O 0 0.15547598898410797
in O 0 0.03376339003443718
exon O 0 0.1283639371395111
3 O 0 0.03758368268609047
of O 0 0.014677342027425766
the O 0 0.02337026409804821
gene O 0 0.07718118280172348
, O 0 0.020424669608473778
consisting O 0 0.031389717012643814
in O 0 0.021351929754018784
a O 0 0.03557080402970314
G O 0 0.1462617665529251
to O 0 0.03314972668886185
T O 1 0.8028098344802856
transition O 0 0.07125535607337952
at O 0 0.04753756523132324
nucleotide O 0 0.1386180818080902
2101 O 0 0.2557625472545624
, O 0 0.029118353500962257
which O 0 0.02103828825056553
produces O 0 0.05830436944961548
a O 0 0.03193686902523041
stop O 0 0.05967345088720322
signal O 0 0.07087878882884979
in O 0 0.030584080144762993
codon O 0 0.15855635702610016
82 O 0 0.11279501765966415
( O 0 0.08180151879787445
Glu O 1 0.958534300327301
) O 0 0.04511810466647148
of O 0 0.03358161076903343
NPII O 1 0.7783105969429016
. O 0 0.059939999133348465

The O 0 0.07683397084474564
premature O 1 0.9349001049995422
termination O 0 0.4914869964122772
eliminates O 0 0.12354671955108643
part O 0 0.03305673226714134
of O 0 0.01849236711859703
the O 0 0.02812601439654827
C O 0 0.17066186666488647
- O 0 0.10747383534908295
terminal O 0 0.09556446224451065
domain O 0 0.0530739352107048
of O 0 0.023792816326022148
NPII O 0 0.22398819029331207
, O 0 0.023693226277828217
including O 0 0.020199665799736977
a O 0 0.038525406271219254
cysteine O 0 0.12862257659435272
residue O 0 0.09775829315185547
in O 0 0.02080119587481022
position O 0 0.0289528276771307
85 O 0 0.05474120005965233
, O 0 0.015798434615135193
which O 0 0.012696404941380024
could O 0 0.014764945022761822
be O 0 0.009048840031027794
involved O 0 0.021069014444947243
in O 0 0.013040916994214058
the O 0 0.01995820738375187
correct O 0 0.06495920568704605
folding O 0 0.08260387182235718
of O 0 0.02194507047533989
the O 0 0.042772285640239716
prohormone O 1 0.9775854349136353
. O 0 0.0640449970960617

In O 0 0.029847025871276855
the O 0 0.023250482976436615
second O 0 0.03126523643732071
family O 0 0.03734399005770683
, O 0 0.022955521941184998
a O 0 0.0355977900326252
G279A O 0 0.15439553558826447
substitution O 0 0.09059205651283264
at O 0 0.036360468715429306
position O 0 0.03537359461188316
- O 0 0.06822482496500015
1 O 0 0.030803808942437172
of O 0 0.01651235856115818
the O 0 0.024667417630553246
signal O 0 0.08425485342741013
peptide O 0 0.13321512937545776
was O 0 0.029221877455711365
observed O 0 0.04029358923435211
in O 0 0.018796175718307495
all O 0 0.018095925450325012
affected O 0 0.06940589100122452
individuals O 0 0.046520210802555084
. O 0 0.046719521284103394

This O 0 0.07135406136512756
missense O 0 0.271774560213089
mutation O 0 0.18761500716209412
, O 0 0.033440299332141876
which O 0 0.03227098658680916
replaces O 0 0.15606151521205902
Ala O 1 0.9577130675315857
with O 0 0.05174572765827179
Thr O 1 0.9982376098632812
, O 0 0.033875759690999985
is O 0 0.02804700843989849
frequent O 0 0.07315757870674133
among O 0 0.04893701523542404
FNDI B-Disease 1 0.9999287128448486
patients O 1 0.9983567595481873
and O 0 0.01996525004506111
is O 0 0.018097830936312675
thought O 0 0.02924760803580284
to O 0 0.016665682196617126
reduce O 0 0.04908129200339317
the O 0 0.020419659093022346
efficiency O 0 0.05041343346238136
of O 0 0.023475073277950287
cleavage O 0 0.22073502838611603
by O 0 0.035147130489349365
signal O 0 0.09888497740030289
peptidases O 0 0.2199857085943222
. O 0 0.0410802848637104
. O 0 0.046496786177158356

Genetic O 0 0.1932823657989502
heterogeneity O 0 0.1999673694372177
of O 0 0.05639507994055748
Saethre B-Disease 1 0.9996638298034668
- I-Disease 1 0.9991081357002258
Chotzen I-Disease 1 0.9998531341552734
syndrome I-Disease 1 0.9999994039535522
, O 0 0.0328165628015995
due O 0 0.0355527363717556
to O 0 0.029043816030025482
TWIST O 0 0.1490067094564438
and O 0 0.042276907712221146
FGFR O 1 0.9582142233848572
mutations O 0 0.2014467418193817
. O 0 0.059382300823926926

Thirty O 0 0.10747691988945007
- O 0 0.1068044900894165
two O 0 0.03600166738033295
unrelated O 0 0.09828692674636841
patients O 1 0.9736731648445129
with O 0 0.024724064394831657
features O 0 0.04030810669064522
of O 0 0.03083464689552784
Saethre B-Disease 1 0.9995546936988831
- I-Disease 1 0.9971797466278076
Chotzen I-Disease 1 0.9997530579566956
syndrome I-Disease 1 0.9999990463256836
, O 0 0.03748124837875366
a O 0 0.04536067694425583
common O 0 0.07397685945034027
autosomal B-Disease 1 0.997978150844574
dominant I-Disease 0 0.4129180312156677
condition I-Disease 1 0.9629913568496704
of O 0 0.042697474360466
craniosynostosis B-Disease 1 0.9999879598617554
and O 0 0.05450552701950073
limb B-Disease 1 0.99980229139328
anomalies I-Disease 1 0.7025001645088196
, O 0 0.022700274363160133
were O 0 0.017194848507642746
screened O 0 0.07366982847452164
for O 0 0.02910769358277321
mutations O 0 0.10933053493499756
in O 0 0.027257822453975677
TWIST O 0 0.13031020760536194
, O 0 0.03222113847732544
FGFR2 O 1 0.5718443393707275
, O 0 0.02712663821876049
and O 0 0.03070848248898983
FGFR3 O 1 0.8546320796012878
. O 0 0.057142436504364014

Nine O 0 0.059996187686920166
novel O 0 0.05186145007610321
and O 0 0.024163682013750076
three O 0 0.03467711806297302
recurrent O 1 0.9943137168884277
TWIST O 1 0.5855830907821655
mutations O 0 0.14119501411914825
were O 0 0.01988041028380394
found O 0 0.02205934189260006
in O 0 0.017078248783946037
12 O 0 0.035209279507398605
families O 0 0.052707090973854065
. O 0 0.04449502378702164

Seven O 0 0.04917607083916664
families O 0 0.038687434047460556
were O 0 0.01599540002644062
found O 0 0.022045815363526344
to O 0 0.015107381157577038
have O 0 0.017894811928272247
the O 0 0.03208077326416969
FGFR3 O 1 0.9563570022583008
P250R O 0 0.3259519338607788
mutation O 0 0.15785948932170868
, O 0 0.022509222850203514
and O 0 0.014448734000325203
one O 0 0.014355652965605259
individual O 0 0.02220173552632332
was O 0 0.018334995955228806
found O 0 0.016897840425372124
to O 0 0.013374041765928268
have O 0 0.01793859899044037
an O 0 0.0342150516808033
FGFR2 O 1 0.9687644839286804
VV269 O 1 0.6397221088409424
- O 0 0.16865600645542145
270 O 0 0.17698369920253754
deletion O 0 0.23157408833503723
. O 0 0.07143578678369522

To O 0 0.031198477372527122
date O 0 0.03070158138871193
, O 0 0.021864108741283417
our O 0 0.030551515519618988
detection O 0 0.09855535626411438
rate O 0 0.048553869128227234
for O 0 0.0250307135283947
TWIST O 0 0.16136246919631958
or O 0 0.05875880643725395
FGFR O 1 0.9471754431724548
mutations O 0 0.14646263420581818
is O 0 0.029317928478121758
68 O 0 0.06081027537584305
% O 0 0.0328662246465683
in O 0 0.02504872716963291
our O 0 0.04659293219447136
Saethre B-Disease 1 0.999734103679657
- I-Disease 1 0.9995468258857727
Chotzen I-Disease 1 0.9999701976776123
syndrome I-Disease 1 1.0
patients O 1 0.9998468160629272
, O 0 0.023985838517546654
including O 0 0.018627403303980827
our O 0 0.023723186925053596
five O 0 0.029772145673632622
patients O 1 0.9979683756828308
elsewhere O 0 0.05001864582300186
reported O 0 0.053822293877601624
with O 0 0.0360599011182785
TWIST O 0 0.399535596370697
mutations O 0 0.20063547790050507
. O 0 0.060610704123973846

More O 0 0.03037266805768013
than O 0 0.024670539423823357
35 O 0 0.040522146970033646
different O 0 0.03005964495241642
TWIST O 0 0.15683048963546753
mutations O 0 0.11473248898983002
are O 0 0.01642611250281334
now O 0 0.02207953669130802
known O 0 0.025749223306775093
in O 0 0.014849438332021236
the O 0 0.018388383090496063
literature O 0 0.039350107312202454
. O 0 0.04346223920583725

The O 0 0.03666408732533455
most O 0 0.025558138266205788
common O 0 0.04132598638534546
phenotypic O 0 0.09540628641843796
features O 0 0.030201582238078117
, O 0 0.01719612255692482
present O 0 0.017483752220869064
in O 0 0.01231206115335226
more O 0 0.01112453080713749
than O 0 0.012891714461147785
a O 0 0.017192581668496132
third O 0 0.02470088191330433
of O 0 0.016223734244704247
our O 0 0.03262370452284813
patients O 1 0.9954258799552917
with O 0 0.03816641867160797
TWIST O 1 0.6626062393188477
mutations O 0 0.14494509994983673
, O 0 0.02919108420610428
are O 0 0.026149030774831772
coronal B-Disease 1 0.6462836265563965
synostosis I-Disease 0 0.4779790937900543
, O 0 0.043098289519548416
brachycephaly B-Disease 0 0.4660337567329407
, O 0 0.042149752378463745
low B-Disease 0 0.13266301155090332
frontal I-Disease 1 0.999775230884552
hairline I-Disease 1 0.9999853372573853
, O 0 0.07332535833120346
facial B-Disease 1 0.9998177886009216
asymmetry I-Disease 1 0.9899287819862366
, O 0 0.06433162838220596
ptosis B-Disease 1 0.9999455213546753
, O 0 0.061363644897937775
hypertelorism B-Disease 1 0.9974610805511475
, O 0 0.03806590661406517
broad B-Disease 0 0.0768493041396141
great I-Disease 0 0.044995374977588654
toes I-Disease 0 0.15622147917747498
, O 0 0.027834434062242508
and O 0 0.02802102081477642
clinodactyly B-Disease 0 0.28641220927238464
. O 0 0.053401507437229156

Significant O 0 0.09152065217494965
intra O 0 0.18412457406520844
- O 0 0.12918873131275177
and O 0 0.04794715344905853
interfamilial O 0 0.2670165002346039
phenotypic O 0 0.15803125500679016
variability O 0 0.13518962264060974
is O 0 0.023954717442393303
present O 0 0.02500745840370655
for O 0 0.023993568494915962
either O 0 0.04733990505337715
TWIST O 0 0.29330161213874817
mutations O 0 0.21239355206489563
or O 0 0.07057185471057892
FGFR O 1 0.978457510471344
mutations O 0 0.22707752883434296
. O 0 0.06086386740207672

The O 0 0.04363670200109482
overlap O 0 0.07469442486763
in O 0 0.028960956260561943
clinical O 0 0.21377430856227875
features O 0 0.02749006077647209
and O 0 0.012696984224021435
the O 0 0.015653438866138458
presence O 0 0.032992638647556305
, O 0 0.013820636086165905
in O 0 0.013305063359439373
the O 0 0.014356584288179874
same O 0 0.02419949881732464
genes O 0 0.0597500279545784
, O 0 0.020146023482084274
of O 0 0.017229337245225906
mutations O 0 0.09168348461389542
for O 0 0.017056746408343315
more O 0 0.016576876863837242
than O 0 0.0216739010065794
one O 0 0.027897393330931664
craniosynostotic B-Disease 1 0.7336359620094299
condition I-Disease 1 0.5052439570426941
- O 0 0.08280102908611298
such O 0 0.022929739207029343
as O 0 0.03209201246500015
Saethre B-Disease 1 0.9614434838294983
- I-Disease 0 0.17622607946395874
Chotzen I-Disease 1 0.6496706008911133
, I-Disease 0 0.043336689472198486
Crouzon I-Disease 1 0.5763027667999268
, I-Disease 0 0.03564368933439255
and I-Disease 0 0.04275886341929436
Pfeiffer I-Disease 1 0.9999426603317261
syndromes I-Disease 1 0.9999895095825195
- O 0 0.10714980959892273
support O 0 0.03549642860889435
the O 0 0.02397797629237175
hypothesis O 0 0.07734785974025726
that O 0 0.026499103754758835
TWIST O 0 0.11348073184490204
and O 0 0.02435190975666046
FGFRs O 0 0.12028271704912186
are O 0 0.013914844021201134
components O 0 0.02554868906736374
of O 0 0.01284031756222248
the O 0 0.01574959047138691
same O 0 0.026381047442555428
molecular O 0 0.08894230425357819
pathway O 0 0.11537077277898788
involved O 0 0.03373970836400986
in O 0 0.018836557865142822
the O 0 0.025687310844659805
modulation O 0 0.14576716721057892
of O 0 0.03324652835726738
craniofacial O 1 0.9999783039093018
and O 0 0.04165933281183243
limb O 1 0.9978132247924805
development O 0 0.040780652314424515
in O 0 0.02635558694601059
humans O 0 0.06443953514099121
. O 0 0.031176980584859848
. O 0 0.04574141278862953

Mutation O 0 0.24062427878379822
analysis O 0 0.07152216881513596
of O 0 0.04560122638940811
UBE3A O 1 0.999923825263977
in O 1 0.9047912359237671
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.9999822378158569
. O 0 0.07072172313928604

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 0.0871393159031868
AS B-Disease 0 0.04207039251923561
) O 0 0.035292886197566986
is O 0 0.026474835351109505
caused O 0 0.07459665089845657
by O 0 0.041669562458992004
chromosome O 0 0.24241475760936737
15q11 O 1 0.5282440781593323
- O 0 0.17072206735610962
q13 O 0 0.2142544686794281
deletions O 0 0.14574086666107178
of O 0 0.03589067608118057
maternal O 0 0.13762730360031128
origin O 0 0.04864266887307167
, O 0 0.029277706518769264
by O 0 0.03811812400817871
paternal O 1 0.5370844602584839
uniparental B-Disease 1 0.999453604221344
disomy I-Disease 1 0.9890609979629517
( O 0 0.11244224011898041
UPD B-Disease 1 0.9996976852416992
) O 0 0.05237545073032379
15 O 0 0.03727126121520996
, O 0 0.02520129457116127
by O 0 0.036890652030706406
imprinting O 1 0.9144489765167236
defects O 1 0.9542636275291443
, O 0 0.025928126648068428
and O 0 0.018791459500789642
by O 0 0.024556873366236687
mutations O 0 0.11221026629209518
in O 0 0.026898397132754326
the O 0 0.04385295882821083
UBE3A O 1 0.9861246347427368
gene O 0 0.17954866588115692
. O 0 0.06450426578521729

UBE3A O 1 0.8994249105453491
encodes O 0 0.17855168879032135
a O 0 0.07556793093681335
ubiquitin O 0 0.23998752236366272
- O 0 0.16630995273590088
protein O 0 0.13684991002082825
ligase O 0 0.13287284970283508
and O 0 0.028646020218729973
shows O 0 0.06360641866922379
brain O 1 0.9895134568214417
- O 0 0.11491872370243073
specific O 0 0.05500046908855438
imprinting O 0 0.2724568545818329
. O 0 0.06029790639877319

Here O 0 0.05912639573216438
we O 0 0.042604051530361176
describe O 0 0.11058356612920761
UBE3A O 1 0.9791629910469055
coding O 0 0.2538377344608307
- O 0 0.176487535238266
region O 0 0.11273285746574402
mutations O 0 0.21552862226963043
detected O 0 0.11931130290031433
by O 0 0.03343711793422699
SSCP O 0 0.2498352825641632
analysis O 0 0.04236786812543869
in O 0 0.023055175319314003
13 O 0 0.03329182043671608
AS B-Disease 0 0.029585154727101326
individuals O 0 0.030970895662903786
or O 0 0.03308494761586189
families O 0 0.05428861454129219
. O 0 0.04536236822605133

Two O 0 0.04456315189599991
identical O 0 0.08469747006893158
de O 0 0.11877091228961945
novo O 0 0.18635976314544678
5 O 0 0.0758558064699173
- O 0 0.11841583251953125
bp O 0 0.14676399528980255
duplications O 0 0.13617761433124542
in O 0 0.03742363303899765
exon O 0 0.13686390221118927
16 O 0 0.040718551725149155
were O 0 0.021077755838632584
found O 0 0.03908473998308182
. O 0 0.040938571095466614

Among O 0 0.036954402923583984
the O 0 0.021721653640270233
other O 0 0.01747734844684601
11 O 0 0.036810506135225296
unique O 0 0.0472274050116539
mutations O 0 0.11729522794485092
, O 0 0.025126906111836433
8 O 0 0.03417341038584709
were O 0 0.018438590690493584
small O 0 0.036333899945020676
deletions O 0 0.1169360876083374
or O 0 0.05283893272280693
insertions O 0 0.16181446611881256
predicted O 0 0.07228775322437286
to O 0 0.03229261562228203
cause O 0 0.10568804293870926
frameshifts O 0 0.16935615241527557
, O 0 0.026063725352287292
1 O 0 0.02983383648097515
was O 0 0.019808301702141762
a O 0 0.027367176488041878
mutation O 0 0.10719399899244308
to O 0 0.019774440675973892
a O 0 0.031121352687478065
stop O 0 0.06269344687461853
codon O 0 0.11109722405672073
, O 0 0.027331816032528877
1 O 0 0.034165915101766586
was O 0 0.028231671079993248
a O 0 0.047937311232089996
missense O 0 0.21628208458423615
mutation O 0 0.15762223303318024
, O 0 0.025072747841477394
and O 0 0.019812364131212234
1 O 0 0.03266334533691406
was O 0 0.02529107965528965
predicted O 0 0.05015512928366661
to O 0 0.023610316216945648
cause O 0 0.08117914944887161
insertion O 0 0.11312298476696014
of O 0 0.020127905532717705
an O 0 0.028973089531064034
isoleucine O 0 0.13214802742004395
in O 0 0.022201688960194588
the O 0 0.02724994532763958
hect O 0 0.13419564068317413
domain O 0 0.04705287888646126
of O 0 0.018942132592201233
the O 0 0.03188745304942131
UBE3A O 1 0.9221755862236023
protein O 0 0.08215152472257614
, O 0 0.01956517994403839
which O 0 0.01629515364766121
functions O 0 0.0225693266838789
in O 0 0.027865134179592133
E2 O 1 0.5732461810112
binding O 0 0.06391245871782303
and O 0 0.02760487236082554
ubiquitin O 0 0.1308143138885498
transfer O 0 0.05812583491206169
. O 0 0.04734572768211365

Eight O 0 0.036321114748716354
of O 0 0.01721624657511711
the O 0 0.02278313972055912
cases O 0 0.04351670667529106
were O 0 0.026419242843985558
familial O 1 0.9875507950782776
, O 0 0.022700803354382515
and O 0 0.01605592854321003
five O 0 0.020355774089694023
were O 0 0.020646866410970688
sporadic O 0 0.10046502202749252
. O 0 0.050581395626068115

In O 0 0.040613021701574326
two O 0 0.03603602200746536
familial O 1 0.9955625534057617
cases O 0 0.04791855067014694
and O 0 0.019621698185801506
one O 0 0.02539847418665886
sporadic O 0 0.091456837952137
case O 0 0.0469205267727375
, O 0 0.04047491028904915
mosaicism O 1 0.9841981530189514
for O 0 0.057379379868507385
UBE3A O 1 0.9950079917907715
mutations O 0 0.19138896465301514
was O 0 0.03830089792609215
detected O 0 0.0695168524980545
in O 0 0.015393341891467571
the O 0 0.018560579046607018
mother O 0 0.035782136023044586
of O 0 0.013136555440723896
three O 0 0.016546912491321564
AS B-Disease 0 0.028015920892357826
sons O 0 0.05273495614528656
, O 0 0.017584508284926414
in O 0 0.015314923599362373
the O 0 0.02314210869371891
maternal O 0 0.10131444782018661
grandfather O 0 0.05562693253159523
of O 0 0.013318702578544617
two O 0 0.014777061529457569
AS B-Disease 0 0.024331921711564064
first O 0 0.022183740511536598
cousins O 0 0.0614045113325119
, O 0 0.01707826368510723
and O 0 0.012902929447591305
in O 0 0.013060984201729298
the O 0 0.016891688108444214
mother O 0 0.038889553397893906
of O 0 0.014122896827757359
an O 0 0.023727407678961754
AS B-Disease 0 0.04181446135044098
daughter O 0 0.08022549003362656
. O 0 0.05526052787899971

The O 0 0.04038142040371895
frequencies O 0 0.05829516425728798
with O 0 0.02285030111670494
which O 0 0.02100531756877899
we O 0 0.027182606980204582
detected O 0 0.10504056513309479
mutations O 0 0.11597646027803421
were O 0 0.021325843408703804
5 O 0 0.03500175476074219
( O 0 0.033369030803442
14 O 0 0.03256957605481148
% O 0 0.02988649718463421
) O 0 0.024179557338356972
of O 0 0.013465127907693386
35 O 0 0.03326570615172386
in O 0 0.019143087789416313
sporadic O 0 0.07435513287782669
cases O 0 0.03985975682735443
and O 0 0.022941330447793007
8 O 0 0.04050873965024948
( O 0 0.03780394420027733
80 O 0 0.04221290349960327
% O 0 0.03159840404987335
) O 0 0.022793913260102272
of O 0 0.013301407918334007
10 O 0 0.024283891543745995
in O 0 0.025317668914794922
familial O 1 0.9978482723236084
cases O 0 0.05610602721571922
. O 0 0.03014512173831463
. O 0 0.04145539551973343

The O 0 0.10663724690675735
hemochromatosis B-Disease 1 0.9999911785125732
845 O 1 0.9983353018760681
G O 1 0.9966303706169128
- O 1 0.8239557147026062
- O 0 0.17390595376491547
> O 0 0.1627609133720398
A O 0 0.04897372052073479
and O 0 0.03497295081615448
187 O 0 0.13333819806575775
C O 1 0.9448823928833008
- O 1 0.9274305105209351
- O 1 0.8279293179512024
> O 1 0.9386929273605347
G O 1 0.8381285071372986
mutations O 0 0.2221299260854721
: O 0 0.06960359960794449
prevalence O 1 0.5209988951683044
in O 0 0.035312470048666
non O 0 0.08483660221099854
- O 0 0.16142554581165314
Caucasian O 1 0.7076635360717773
populations O 0 0.1422465443611145
. O 0 0.06561954319477081

Hemochromatosis B-Disease 1 0.9999560117721558
, O 0 0.05431370064616203
the O 0 0.04827261343598366
inherited B-Disease 1 0.9998866319656372
disorder I-Disease 1 0.9999977350234985
of I-Disease 0 0.03996877372264862
iron I-Disease 1 0.9482468366622925
metabolism I-Disease 1 0.9203202724456787
, O 0 0.03107977844774723
leads O 0 0.06034065783023834
, O 0 0.022922338917851448
if O 0 0.03098496049642563
untreated O 1 0.993176281452179
, O 0 0.02431877702474594
to O 0 0.024953927844762802
progressive O 1 0.6285224556922913
iron B-Disease 1 0.9741873145103455
overload I-Disease 1 0.9973520040512085
and O 0 0.04946116730570793
premature B-Disease 1 0.9481337666511536
death I-Disease 0 0.09373696148395538
. O 0 0.05562091991305351

The O 0 0.1014087051153183
hemochromatosis B-Disease 1 0.9999885559082031
gene O 0 0.2281428873538971
, O 0 0.05129123106598854
HFE O 1 0.9953710436820984
, O 0 0.03046889789402485
recently O 0 0.03827476501464844
has O 0 0.018161160871386528
been O 0 0.0190877802670002
identified O 0 0.0297450739890337
, O 0 0.016362017020583153
and O 0 0.015142031013965607
characterization O 0 0.05660811439156532
of O 0 0.01509016565978527
this O 0 0.01686115935444832
gene O 0 0.06718865036964417
has O 0 0.018434952944517136
shown O 0 0.025231411680579185
that O 0 0.0121737876906991
it O 0 0.011517547070980072
contains O 0 0.020463284105062485
two O 0 0.019944118335843086
mutations O 0 0.09597831219434738
that O 0 0.020076224580407143
result O 0 0.03660218045115471
in O 0 0.02745286002755165
amino O 0 0.10409484803676605
acid O 0 0.19330048561096191
substitutions O 0 0.14037224650382996
- O 0 0.16469894349575043
cDNA O 0 0.22948147356510162
nucleotides O 0 0.22084200382232666
845 O 1 0.9752156734466553
G O 1 0.9867462515830994
- O 1 0.659434974193573
- O 0 0.18859677016735077
> O 0 0.18667343258857727
A O 0 0.05676833540201187
( O 0 0.052208174020051956
C282Y O 0 0.14108915627002716
) O 0 0.03702932968735695
and O 0 0.026833219453692436
187 O 0 0.12777718901634216
C O 1 0.9529355764389038
- O 1 0.8584456443786621
- O 1 0.6383607387542725
> O 1 0.8516795039176941
G O 1 0.619911789894104
( O 0 0.09580598771572113
H63D O 1 0.7910181283950806
) O 0 0.06339161098003387
. O 0 0.04616428166627884

Although O 0 0.09947199374437332
hemochromatosis B-Disease 1 0.9999850988388062
is O 0 0.03786978870630264
common O 0 0.04699276387691498
in O 0 0.029073117300868034
Caucasians O 1 0.8781554698944092
, O 0 0.045010220259428024
affecting O 0 0.14861555397510529
> O 1 0.9481425881385803
= O 0 0.19694188237190247
1 O 0 0.05921141803264618
/ O 0 0.12947843968868256
300 O 0 0.042466264218091965
individuals O 0 0.025076670572161674
of O 0 0.012251530773937702
northern O 0 0.028956914320588112
European O 0 0.028791168704628944
origin O 0 0.02756348066031933
, O 0 0.015443442389369011
it O 0 0.012171362526714802
has O 0 0.014405904337763786
not O 0 0.012021229602396488
been O 0 0.015335834585130215
recognized O 0 0.026415785774588585
in O 0 0.017545726150274277
other O 0 0.019380591809749603
populations O 0 0.07418499886989594
. O 0 0.05079435557126999

The O 0 0.0366506390273571
present O 0 0.03868019953370094
study O 0 0.043129127472639084
used O 0 0.037456996738910675
PCR O 0 0.1585363894701004
and O 0 0.03067469224333763
restriction O 0 0.0849299356341362
- O 0 0.13383182883262634
enzyme O 0 0.1713385432958603
digestion O 0 0.16463300585746765
to O 0 0.026254190132021904
analyze O 0 0.0484921857714653
the O 0 0.020163847133517265
frequency O 0 0.04919552430510521
of O 0 0.018463188782334328
the O 0 0.03457319363951683
845 O 1 0.9853716492652893
G O 1 0.9893652200698853
- O 0 0.4270355999469757
- O 0 0.16128283739089966
> O 0 0.16408774256706238
A O 0 0.04521346837282181
and O 0 0.03071911446750164
187 O 0 0.13131235539913177
C O 1 0.9390416145324707
- O 1 0.8834058046340942
- O 1 0.6931564807891846
> O 1 0.8673371076583862
G O 1 0.6644707322120667
mutations O 0 0.2003861665725708
in O 0 0.05555618926882744
HLA O 1 0.9993208646774292
- O 0 0.136554554104805
typed O 0 0.09972422569990158
samples O 0 0.07274287939071655
from O 0 0.037102147936820984
non O 0 0.07913395017385483
- O 0 0.1456383913755417
Caucasian O 1 0.5700947642326355
populations O 0 0.08324190974235535
, O 0 0.024529337882995605
comprising O 0 0.03896066173911095
Australian O 0 0.04753169044852257
Aboriginal O 0 0.06774075329303741
, O 0 0.021598301827907562
Chinese O 0 0.0229624193161726
, O 0 0.019821397960186005
and O 0 0.022356076166033745
Pacific O 0 0.08635997027158737
Islanders O 0 0.13784357905387878
. O 0 0.060215771198272705

Results O 0 0.0718969777226448
showed O 0 0.0459543839097023
that O 0 0.019249150529503822
the O 0 0.03729669377207756
845 O 1 0.99553382396698
G O 1 0.9979776740074158
- O 1 0.9012786746025085
- O 0 0.3536764681339264
> O 0 0.2099166065454483
A O 0 0.05742577090859413
mutation O 0 0.1392434984445572
was O 0 0.026032187044620514
present O 0 0.021736254915595055
in O 0 0.015437512658536434
these O 0 0.019712235778570175
populations O 0 0.07199714332818985
( O 0 0.06380476802587509
allele O 0 0.17918051779270172
frequency O 0 0.10176627337932587
0 O 0 0.06522106379270554
. O 0 0.02256029285490513
32 O 0 0.042150743305683136
% O 0 0.032458219677209854
) O 0 0.02510853298008442
, O 0 0.01583852246403694
and O 0 0.014514747075736523
, O 0 0.016015037894248962
furthermore O 0 0.032926592975854874
, O 0 0.015009565278887749
it O 0 0.011751438491046429
was O 0 0.017681753262877464
always O 0 0.024379896000027657
seen O 0 0.025628389790654182
in O 0 0.01873071864247322
conjunction O 0 0.07508529722690582
with O 0 0.04560623690485954
HLA O 1 0.9994072914123535
haplotypes O 1 0.5812392234802246
common O 0 0.05384628102183342
in O 0 0.027468644082546234
Caucasians O 0 0.369838148355484
, O 0 0.032424408942461014
suggesting O 0 0.06384251266717911
that O 0 0.03950728103518486
845 O 1 0.998055100440979
G O 1 0.998755693435669
- O 1 0.9637470841407776
- O 0 0.49881473183631897
> O 0 0.209530770778656
A O 0 0.041203927248716354
may O 0 0.026533544063568115
have O 0 0.01270141452550888
been O 0 0.01334224920719862
introduced O 0 0.02203482761979103
into O 0 0.017865313217043877
these O 0 0.016529176384210587
populations O 0 0.062310557812452316
by O 0 0.03548286482691765
Caucasian O 1 0.7964802384376526
admixture O 1 0.8770788311958313
. O 0 0.07482076436281204

187 O 0 0.24008458852767944
C O 1 0.9330400824546814
- O 1 0.8376806974411011
- O 0 0.38498836755752563
> O 0 0.4583567678928375
G O 0 0.15499372780323029
was O 0 0.02957027219235897
present O 0 0.027145149186253548
at O 0 0.02782444842159748
an O 0 0.02488596923649311
allele O 0 0.1502537876367569
frequency O 0 0.0776146873831749
of O 0 0.024901961907744408
2 O 0 0.053759507834911346
. O 0 0.050174422562122345

68 O 0 0.10101138800382614
% O 0 0.03556136041879654
in O 0 0.01683037355542183
the O 0 0.01592935249209404
two O 0 0.021317869424819946
populations O 0 0.06475260853767395
analyzed O 0 0.06763894855976105
( O 0 0.0406985804438591
Australian O 0 0.04265192896127701
Aboriginal O 0 0.06154170259833336
and O 0 0.02087629958987236
Chinese O 0 0.03490255028009415
) O 0 0.043412722647190094
. O 0 0.04180469736456871

In O 0 0.03356470912694931
the O 0 0.02737392857670784
Australian O 0 0.0472952201962471
Aboriginal O 0 0.07517553865909576
samples O 0 0.06849221140146255
, O 0 0.03928559273481369
187 O 0 0.1289767473936081
C O 1 0.938179612159729
- O 1 0.8061432838439941
- O 1 0.5055148601531982
> O 1 0.5201104283332825
G O 0 0.14989042282104492
was O 0 0.027628496289253235
found O 0 0.022226499393582344
to O 0 0.014060506597161293
be O 0 0.01738864555954933
associated O 0 0.04078783467411995
with O 0 0.04448511824011803
HLA O 1 0.9996328353881836
haplotypes O 1 0.8499386310577393
common O 0 0.06084053963422775
in O 0 0.031212223693728447
Caucasians O 1 0.5514948964118958
, O 0 0.026640336960554123
suggesting O 0 0.04552941024303436
that O 0 0.01449363399296999
it O 0 0.012640888802707195
was O 0 0.017865439876914024
introduced O 0 0.02862963266670704
by O 0 0.02217482402920723
recent O 0 0.05397858843207359
admixture O 1 0.5321335196495056
. O 0 0.06455878168344498

In O 0 0.03272821754217148
the O 0 0.023429686203598976
Chinese O 0 0.03447699546813965
samples O 0 0.057710811495780945
analyzed O 0 0.064350925385952
, O 0 0.0368211455643177
187 O 0 0.12519517540931702
C O 1 0.8556371331214905
- O 1 0.775627076625824
- O 0 0.37081634998321533
> O 0 0.43684452772140503
G O 0 0.13831698894500732
was O 0 0.0258929580450058
present O 0 0.021371610462665558
in O 0 0.017611945047974586
association O 0 0.03654384985566139
with O 0 0.016967613250017166
a O 0 0.023813521489501
wide O 0 0.03321048989892006
variety O 0 0.03764035925269127
of O 0 0.035074058920145035
HLA O 1 0.9996263980865479
haplotypes O 1 0.8455836772918701
, O 0 0.028681470081210136
showing O 0 0.04666193202137947
this O 0 0.020422102883458138
mutation O 0 0.10150423645973206
to O 0 0.017625827342271805
be O 0 0.013506736606359482
widespread O 0 0.036199718713760376
and O 0 0.016414346173405647
likely O 0 0.030158109962940216
to O 0 0.01704304851591587
predate O 0 0.07429755479097366
the O 0 0.020652014762163162
more O 0 0.020612338557839394
genetically O 0 0.07810497283935547
restricted O 0 0.0951395332813263
845 O 1 0.9939035773277283
G O 1 0.9973466396331787
- O 1 0.8987385630607605
- O 0 0.32552555203437805
> O 0 0.29323503375053406
A O 0 0.0854734480381012
mutation O 0 0.2269945740699768
. O 0 0.0692598968744278

Genotype O 1 0.9885191321372986
- O 1 0.7059532999992371
phenotype O 1 0.9433331489562988
correlations O 0 0.2161519080400467
in O 0 0.09656866639852524
attenuated B-Disease 1 0.9996728897094727
adenomatous I-Disease 1 0.9999998807907104
polyposis I-Disease 1 0.9999997615814209
coli I-Disease 1 0.9999775886535645
. O 0 0.10588547587394714

Germ O 1 0.997186005115509
- O 0 0.16381344199180603
line O 0 0.06984066218137741
mutations O 0 0.1305185854434967
of O 0 0.026555856689810753
the O 0 0.051004886627197266
tumor B-Disease 1 0.9996421337127686
suppressor O 1 0.9899544715881348
APC O 1 0.9118116497993469
are O 0 0.03880023583769798
implicated O 0 0.33269888162612915
in O 0 0.06592725217342377
attenuated B-Disease 1 0.9998757839202881
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 0.9999969005584717
( O 1 0.6503360867500305
AAPC B-Disease 1 0.9999493360519409
) O 0 0.05347023904323578
, O 0 0.026765691116452217
a O 0 0.037716690450906754
variant O 0 0.15786594152450562
of O 0 0.06983335316181183
familial B-Disease 1 0.9999992847442627
adenomatous I-Disease 1 0.9999998807907104
polyposis I-Disease 1 1.0
( O 1 0.9667313098907471
FAP B-Disease 1 0.9999613761901855
) O 0 0.07168798893690109
. O 0 0.05181712657213211

AAPC B-Disease 1 0.9989672899246216
is O 0 0.042046885937452316
recognized O 0 0.03498108312487602
by O 0 0.021000830456614494
the O 0 0.026869110763072968
occurrence O 0 0.09954661130905151
of O 0 0.036471493542194366
< O 1 0.5451321005821228
100 O 0 0.08435114473104477
colonic B-Disease 1 0.9978609681129456
adenomas I-Disease 1 0.9990915060043335
and O 0 0.026736604049801826
a O 0 0.0333457849919796
later O 0 0.047283146530389786
onset O 1 0.9999284744262695
of O 0 0.08860453963279724
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
( O 0 0.08701155334711075
age O 0 0.06636352837085724
> O 0 0.2567060887813568
40 O 0 0.04734670743346214
years O 0 0.033636778593063354
) O 0 0.0392967127263546
. O 0 0.039705678820610046

The O 0 0.03325583040714264
aim O 0 0.04899834841489792
of O 0 0.014657564461231232
this O 0 0.015172766521573067
study O 0 0.028193654492497444
was O 0 0.02160305716097355
to O 0 0.026932435110211372
assess O 0 0.13220959901809692
genotype O 1 0.9573701024055481
- O 0 0.29768234491348267
phenotype O 1 0.8448066115379333
correlations O 0 0.18913428485393524
in O 0 0.07449786365032196
AAPC B-Disease 1 0.999790370464325
families O 0 0.09891021996736526
. O 0 0.06694876402616501

By O 0 0.06508250534534454
protein O 0 0.14229829609394073
- O 0 0.1419435739517212
truncation O 0 0.203966423869133
test O 0 0.1063651368021965
( O 0 0.07447207719087601
PTT O 0 0.163276806473732
) O 0 0.05174289643764496
assay O 0 0.09893136471509933
, O 0 0.019319754093885422
the O 0 0.018579035997390747
entire O 0 0.04630385711789131
coding O 0 0.11348309367895126
region O 0 0.04826787859201431
of O 0 0.02057723142206669
the O 0 0.03465159982442856
APC B-Disease 1 0.6167262196540833
gene O 0 0.11286021769046783
was O 0 0.03079100139439106
screened O 0 0.07233767211437225
in O 0 0.024632766842842102
affected O 0 0.056873615831136703
individuals O 0 0.03547500818967819
from O 0 0.034085728228092194
11 O 0 0.07882475852966309
AAPC B-Disease 1 0.9999700784683228
kindreds O 1 0.8270089626312256
, O 0 0.02507139928638935
and O 0 0.014498276636004448
their O 0 0.018631799146533012
phenotypic O 0 0.09483391046524048
differences O 0 0.04116852954030037
were O 0 0.025318723171949387
examined O 0 0.09314432740211487
. O 0 0.05145306512713432

Five O 0 0.07472766190767288
novel O 0 0.10895052552223206
germ O 1 0.9953919649124146
- O 0 0.17289376258850098
line O 0 0.09554155170917511
APC B-Disease 1 0.8798422813415527
mutations O 0 0.14648501574993134
were O 0 0.02375468611717224
identified O 0 0.03842562809586525
in O 0 0.023143181577324867
seven O 0 0.04787275940179825
kindreds O 1 0.5383929014205933
. O 0 0.0631013736128807

Mutations O 0 0.16016845405101776
were O 0 0.02060103602707386
located O 0 0.028535213321447372
in O 0 0.01250908151268959
three O 0 0.013888964429497719
different O 0 0.0138635765761137
regions O 0 0.03126613050699234
of O 0 0.01532916072756052
the O 0 0.034582458436489105
APC B-Disease 1 0.9593664407730103
gene O 0 0.1327824741601944
( O 0 0.04743052273988724
1 O 0 0.03567466139793396
) O 0 0.029756154865026474
at O 0 0.02241259254515171
the O 0 0.017300857231020927
5 O 0 0.035358935594558716
end O 0 0.03793633356690407
spanning O 0 0.06905628740787506
exons O 0 0.11097322404384613
4 O 0 0.03895639628171921
and O 0 0.020383574068546295
5 O 0 0.034971583634614944
, O 0 0.023415250703692436
( O 0 0.03813024237751961
2 O 0 0.03787614405155182
) O 0 0.030929164960980415
within O 0 0.026123877614736557
exon O 0 0.11444032192230225
9 O 0 0.04451853036880493
, O 0 0.020542316138744354
and O 0 0.018073612824082375
( O 0 0.03300070762634277
3 O 0 0.033873673528432846
) O 0 0.026979489251971245
at O 0 0.022080209106206894
the O 0 0.02182675339281559
3 O 0 0.04881766438484192
distal O 0 0.2505464255809784
end O 0 0.034845028072595596
of O 0 0.020123565569519997
the O 0 0.029514912515878677
gene O 0 0.12149374186992645
. O 0 0.05200614780187607

Variability O 0 0.14555831253528595
in O 0 0.020289026200771332
the O 0 0.019735045731067657
number O 0 0.02342444285750389
of O 0 0.03861219808459282
colorectal B-Disease 1 0.9999998807907104
adenomas I-Disease 1 0.999984622001648
was O 0 0.03439705818891525
most O 0 0.02262631431221962
apparent O 0 0.05723689869046211
in O 0 0.01863495074212551
individuals O 0 0.03034624271094799
with O 0 0.025970501825213432
mutations O 0 0.10331948846578598
in O 0 0.021029368042945862
region O 0 0.039603717625141144
1 O 0 0.029930951073765755
, O 0 0.01922159641981125
and O 0 0.02480984851717949
upper O 1 0.9955535531044006
- O 1 0.9980888962745667
gastrointestinal O 1 0.9999923706054688
manifestations O 1 0.8794746994972229
were O 0 0.02226959727704525
more O 0 0.023374730721116066
severe O 1 0.9403398036956787
in O 0 0.02176329307258129
them O 0 0.023556595668196678
. O 0 0.04613284021615982

In O 0 0.03644446283578873
individuals O 0 0.03899095207452774
with O 0 0.028858469799160957
mutations O 0 0.10866209864616394
in O 0 0.02342226728796959
either O 0 0.030379518866539
region O 0 0.04955678433179855
2 O 0 0.03497437760233879
or O 0 0.024443913251161575
region O 0 0.039679065346717834
3 O 0 0.029537484049797058
, O 0 0.013899515382945538
the O 0 0.016214026138186455
average O 0 0.03734523430466652
number O 0 0.01866208016872406
of O 0 0.024678457528352737
adenomas B-Disease 1 0.9989618062973022
tended O 0 0.06468392163515091
to O 0 0.017533959820866585
be O 0 0.012622738257050514
lower O 0 0.031893130391836166
than O 0 0.013077067211270332
those O 0 0.012218044139444828
in O 0 0.014569755643606186
individuals O 0 0.029095079749822617
with O 0 0.027679387480020523
mutations O 0 0.11545412242412567
in O 0 0.023043757304549217
region O 0 0.04540633037686348
1 O 0 0.03411198779940605
, O 0 0.017793387174606323
although O 0 0.025953050702810287
age O 0 0.044560860842466354
at O 0 0.04437635838985443
diagnosis O 1 0.9988605976104736
was O 0 0.029665837064385414
similar O 0 0.04098327457904816
. O 0 0.04153421148657799

In O 0 0.05057091638445854
all O 0 0.04732932522892952
AAPC B-Disease 1 0.9997507929801941
kindreds O 0 0.4790593087673187
, O 0 0.03361358121037483
a O 0 0.03687022253870964
predominance O 0 0.13622111082077026
of O 0 0.03092258609831333
right O 0 0.09288795292377472
- O 1 0.995945394039154
sided O 1 0.9998263716697693
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999994039535522
and O 0 0.37451085448265076
rectal B-Disease 1 0.9999986886978149
polyp I-Disease 1 0.999982476234436
sparing O 1 0.8751214742660522
was O 0 0.051887769252061844
observed O 0 0.07454746961593628
. O 0 0.04886939376592636

No O 0 0.08592942357063293
desmoid B-Disease 1 0.9892823696136475
tumors I-Disease 1 0.9996455907821655
were O 0 0.027476266026496887
found O 0 0.028516605496406555
in O 0 0.02232959493994713
these O 0 0.027454007416963577
kindreds O 0 0.4357849359512329
. O 0 0.05914203077554703

Our O 0 0.04335901513695717
data O 0 0.03339375555515289
suggest O 0 0.03777513653039932
that O 0 0.015988953411579132
, O 0 0.021654924377799034
in O 0 0.03197481110692024
AAPC B-Disease 1 0.9998798370361328
families O 0 0.04480008780956268
, O 0 0.017878595739603043
the O 0 0.01585620455443859
location O 0 0.027647502720355988
of O 0 0.016941068693995476
the O 0 0.033047329634428024
APC B-Disease 1 0.9852838516235352
mutation O 1 0.5718393921852112
may O 0 0.05761832371354103
partially O 0 0.09723155945539474
predict O 0 0.08891302347183228
specific O 0 0.04880146309733391
phenotypic O 0 0.13652393221855164
expression O 0 0.08985252678394318
. O 0 0.04675271362066269

This O 0 0.025069430470466614
should O 0 0.02102113515138626
help O 0 0.02716982364654541
in O 0 0.012861205264925957
the O 0 0.014357616193592548
design O 0 0.03253945708274841
of O 0 0.02275262214243412
tailored O 0 0.14590226113796234
clinical O 1 0.9890195727348328
- O 0 0.13818183541297913
management O 0 0.07533032447099686
protocols O 0 0.06087542325258255
in O 0 0.01838470622897148
this O 0 0.022479865700006485
subset O 0 0.10011350363492966
of O 0 0.0437961183488369
FAP B-Disease 1 0.9999903440475464
patients O 1 0.9995074272155762
. O 0 0.03873472288250923
. O 0 0.04575284570455551

Wilms B-Disease 1 0.9998644590377808
' I-Disease 1 0.6703774929046631
tumor I-Disease 1 0.9951431751251221
1 O 0 0.06309150904417038
and O 0 0.03768431767821312
Dax O 1 0.9297648668289185
- O 0 0.1342136710882187
1 O 0 0.07740578800439835
modulate O 0 0.18626920878887177
the O 0 0.048347167670726776
orphan O 1 0.959843635559082
nuclear O 0 0.13202108442783356
receptor O 1 0.8291829228401184
SF O 1 0.9946345090866089
- O 0 0.11458347737789154
1 O 0 0.044660866260528564
in O 0 0.0288812555372715
sex O 0 0.07157593965530396
- O 0 0.0948074534535408
specific O 0 0.05682994797825813
gene O 0 0.14318940043449402
expression O 0 0.09798605740070343
. O 0 0.05125736817717552

Products O 0 0.08423986285924911
of O 0 0.052160605788230896
steroidogenic O 1 0.9917640089988708
factor O 0 0.1262151151895523
1 O 0 0.07031553238630295
( O 0 0.07836252450942993
SF O 1 0.9989622831344604
- O 0 0.12338326871395111
1 O 0 0.058194976300001144
) O 0 0.04895199462771416
and O 0 0.043754421174526215
Wilms B-Disease 1 0.9999575614929199
tumor I-Disease 1 0.9994660019874573
1 O 0 0.08602416515350342
( O 0 0.08162549883127213
WT1 O 1 0.9936171770095825
) O 0 0.049693044275045395
genes O 0 0.06389472633600235
are O 0 0.016219882294535637
essential O 0 0.034450870007276535
for O 0 0.024217555299401283
mammalian O 0 0.14178259670734406
gonadogenesis O 0 0.1474611908197403
prior O 0 0.03925706073641777
to O 0 0.02570168487727642
sexual O 0 0.07416275143623352
differentiation O 0 0.12414871901273727
. O 0 0.04870234429836273

In O 0 0.05260884016752243
males O 0 0.10947367548942566
, O 0 0.053950559347867966
SF O 1 0.9980632662773132
- O 0 0.11246379464864731
1 O 0 0.051996439695358276
participates O 0 0.08167355507612228
in O 0 0.02387942373752594
sexual O 0 0.045689310878515244
development O 0 0.029569463804364204
by O 0 0.02231987938284874
regulating O 0 0.07505541294813156
expression O 0 0.05249723792076111
of O 0 0.020413968712091446
the O 0 0.04150437191128731
polypeptide O 1 0.7257004976272583
hormone O 1 0.9973676800727844
Mullerian O 1 0.9991424083709717
inhibiting O 1 0.9798493385314941
substance O 1 0.9811236262321472
( O 0 0.11553036421537399
MIS O 1 0.9890146851539612
) O 0 0.06417456269264221
. O 0 0.05512723699212074

Here O 0 0.04526815190911293
, O 0 0.025798501446843147
we O 0 0.023742802441120148
show O 0 0.04133825749158859
that O 0 0.04011254012584686
WT1 O 1 0.9984802603721619
- O 1 0.5479393005371094
KTS O 1 0.9879526495933533
isoforms O 0 0.14136557281017303
associate O 0 0.06914795935153961
and O 0 0.03516510874032974
synergize O 1 0.8846667408943176
with O 0 0.0594860315322876
SF O 1 0.9976111650466919
- O 0 0.09556597471237183
1 O 0 0.04194320738315582
to O 0 0.026387222111225128
promote O 0 0.06870326399803162
MIS O 1 0.8857588768005371
expression O 0 0.1052824854850769
. O 0 0.059425391256809235

In O 0 0.053571417927742004
contrast O 0 0.08654849231243134
, O 0 0.05682910606265068
WT1 O 1 0.9985712766647339
missense O 1 0.7703317999839783
mutations O 0 0.17254896461963654
, O 0 0.03158978745341301
associated O 0 0.03721657767891884
with O 0 0.031776800751686096
male B-Disease 0 0.09825856983661652
pseudohermaphroditism I-Disease 1 0.9955962300300598
in O 0 0.05640355497598648
Denys B-Disease 1 0.9998421669006348
- I-Disease 1 0.9988657236099243
Drash I-Disease 1 0.9998756647109985
syndrome I-Disease 1 0.9999992847442627
, O 0 0.04323619231581688
fail O 0 0.09889041632413864
to O 0 0.03476744517683983
synergize O 1 0.967362642288208
with O 0 0.061178598552942276
SF O 1 0.998611569404602
- O 0 0.1366662234067917
1 O 0 0.07070694863796234
. O 0 0.050593722611665726

Additionally O 0 0.08048751950263977
, O 0 0.029072586447000504
the O 0 0.0304770078510046
X O 0 0.22901591658592224
- O 0 0.11163361370563507
linked O 0 0.09930954873561859
, O 0 0.0354493074119091
candidate O 0 0.06687798351049423
dosage O 1 0.9828476905822754
- O 0 0.14056901633739471
sensitive O 0 0.08399385958909988
sex O 0 0.106190524995327
- O 0 0.2061232030391693
reversal O 0 0.19362019002437592
gene O 0 0.1432594209909439
, O 0 0.04881872609257698
Dax O 1 0.9525548815727234
- O 0 0.12731297314167023
1 O 0 0.055585216730833054
, O 0 0.04328015819191933
antagonizes O 1 0.9181609749794006
synergy O 1 0.5279543995857239
between O 0 0.06984645873308182
SF O 1 0.9991899132728577
- O 0 0.12706312537193298
1 O 0 0.0519634373486042
and O 0 0.03016672655940056
WT1 O 1 0.9808144569396973
, O 0 0.02310631237924099
most O 0 0.017551656812429428
likely O 0 0.02814600057899952
through O 0 0.021237367764115334
a O 0 0.026050664484500885
direct O 0 0.042842186987400055
interaction O 0 0.06186401844024658
with O 0 0.04298045486211777
SF O 1 0.9974199533462524
- O 0 0.13377323746681213
1 O 0 0.06626009941101074
. O 0 0.051695846021175385

We O 0 0.04983706399798393
propose O 0 0.08750756084918976
that O 0 0.03857198357582092
WT1 O 1 0.9868901968002319
and O 0 0.048830773681402206
Dax O 1 0.9317913055419922
- O 0 0.11262611299753189
1 O 0 0.054966848343610764
functionally O 0 0.1089327335357666
oppose O 0 0.05231977626681328
each O 0 0.018478181213140488
other O 0 0.016069840639829636
in O 0 0.02810431458055973
testis O 1 0.5363662838935852
development O 0 0.05623029172420502
by O 0 0.04814670979976654
modulating O 1 0.9505778551101685
SF O 1 0.9974047541618347
- O 0 0.19682879745960236
1 O 0 0.08656379580497742
- O 0 0.16285859048366547
mediated O 0 0.26251304149627686
transactivation O 0 0.49917399883270264
. O 0 0.04470029100775719
. O 0 0.05089671537280083

A O 0 0.09089095890522003
mouse O 0 0.1674061119556427
model O 0 0.08519911020994186
for O 0 0.06223365291953087
Prader B-Disease 1 0.9999994039535522
- I-Disease 1 0.9999332427978516
Willi I-Disease 1 0.9999996423721313
syndrome I-Disease 1 1.0
imprinting O 1 0.9985656142234802
- O 1 0.6254993677139282
centre O 0 0.13897116482257843
mutations O 0 0.22429847717285156
. O 0 0.06746859103441238

Imprinting O 0 0.26425305008888245
in O 0 0.0418156199157238
the O 0 0.04114886373281479
15q11 O 0 0.26510849595069885
- O 0 0.1460578441619873
q13 O 0 0.1912207305431366
region O 0 0.07673340290784836
involves O 0 0.08313113451004028
an O 0 0.04489640146493912
imprinting O 0 0.3726920783519745
centre O 0 0.10863164067268372
( O 0 0.07613163441419601
IC O 1 0.9043530821800232
) O 0 0.037376582622528076
, O 0 0.021403741091489792
mapping O 0 0.04697610065340996
in O 0 0.014637763611972332
part O 0 0.02010279893875122
to O 0 0.015210432931780815
the O 0 0.01948043331503868
promoter O 0 0.09335814416408539
and O 0 0.021147595718503
first O 0 0.029573481529951096
exon O 0 0.13096557557582855
of O 0 0.0365050844848156
SNRPN O 1 0.7922024726867676
. O 0 0.06690745800733566

Deletion O 0 0.20312197506427765
of O 0 0.03629911690950394
this O 0 0.04249546304345131
IC O 1 0.9286451935768127
abolishes O 0 0.2534652054309845
local O 0 0.06345163285732269
paternally O 0 0.21311505138874054
derived O 0 0.0903569832444191
gene O 0 0.1178780123591423
expression O 0 0.0640006884932518
and O 0 0.02283249981701374
results O 0 0.05288921669125557
in O 0 0.061624251306056976
Prader B-Disease 1 1.0
- I-Disease 1 0.9999909400939941
Willi I-Disease 1 0.9999998807907104
syndrome I-Disease 1 1.0
( O 1 0.9178016781806946
PWS B-Disease 1 0.9999953508377075
) O 0 0.07912741601467133
. O 0 0.05500709265470505

We O 0 0.02875884249806404
have O 0 0.020072942599654198
created O 0 0.032799940556287766
two O 0 0.026827692985534668
deletion O 0 0.17960669100284576
mutations O 0 0.15606603026390076
in O 0 0.03766733780503273
mice O 0 0.1688891351222992
to O 0 0.038230136036872864
understand O 0 0.08578390628099442
PWS B-Disease 1 0.9999499320983887
and O 0 0.02253621071577072
the O 0 0.02377540059387684
mechanism O 0 0.06261802464723587
of O 0 0.020379289984703064
this O 0 0.03413737192749977
IC O 1 0.9069926142692566
. O 0 0.054030582308769226

Mice O 1 0.8955506086349487
harbouring O 1 0.8610063791275024
an O 0 0.06280360370874405
intragenic O 0 0.45144230127334595
deletion O 0 0.18197333812713623
in O 0 0.041495196521282196
Snrpn O 0 0.27157121896743774
are O 0 0.031502287834882736
phenotypically O 0 0.18924002349376678
normal O 0 0.06768558919429779
, O 0 0.02590675838291645
suggesting O 0 0.05488298460841179
that O 0 0.023753952234983444
mutations O 0 0.11108025163412094
of O 0 0.024406492710113525
SNRPN O 0 0.3841452896595001
are O 0 0.017037663608789444
not O 0 0.019031336531043053
sufficient O 0 0.044963538646698
to O 0 0.04014948010444641
induce O 1 0.9492475390434265
PWS B-Disease 1 0.999956488609314
. O 0 0.07888691127300262

Mice O 0 0.2152351289987564
with O 0 0.037624258548021317
a O 0 0.03861178830265999
larger O 0 0.05752569064497948
deletion O 0 0.15207363665103912
involving O 0 0.06049290671944618
both O 0 0.02882588654756546
Snrpn O 0 0.17831382155418396
and O 0 0.02534935437142849
the O 0 0.03983881324529648
putative O 1 0.9914445281028748
PWS O 1 0.9999995231628418
- O 1 0.9529955387115479
IC O 1 0.9736565351486206
lack O 0 0.06746234744787216
expression O 0 0.05550811439752579
of O 0 0.021382741630077362
the O 0 0.035137441009283066
imprinted O 0 0.19746482372283936
genes O 0 0.16649575531482697
Zfp127 O 0 0.4453431963920593
( O 0 0.07936178147792816
mouse O 0 0.18166029453277588
homologue O 0 0.21135678887367249
of O 0 0.04753583297133446
ZNF127 O 1 0.7913419008255005
) O 0 0.059258464723825455
, O 0 0.04446468502283096
Ndn O 1 0.9700862169265747
and O 0 0.04330580681562424
Ipw O 0 0.16770847141742706
, O 0 0.02462390810251236
and O 0 0.01961984857916832
manifest O 0 0.06930700689554214
several O 0 0.032092273235321045
phenotypes O 0 0.20434124767780304
common O 0 0.0678686648607254
to O 0 0.059839170426130295
PWS B-Disease 1 0.9999971389770508
infants O 1 0.9946381449699402
. O 0 0.0677671954035759

These O 0 0.026054566726088524
data O 0 0.027459708973765373
demonstrate O 0 0.03507746383547783
that O 0 0.010848546400666237
both O 0 0.010792179964482784
the O 0 0.01190041285008192
position O 0 0.019027533009648323
of O 0 0.011731313541531563
the O 0 0.022178756073117256
IC O 0 0.15836544334888458
and O 0 0.015894275158643723
its O 0 0.01560340914875269
role O 0 0.023831479251384735
in O 0 0.01535102166235447
the O 0 0.018379302695393562
coordinate O 0 0.06497907638549805
expression O 0 0.049415189772844315
of O 0 0.020514175295829773
genes O 0 0.0743827372789383
is O 0 0.028733426705002785
conserved O 0 0.06159846484661102
between O 0 0.0328514501452446
mouse O 0 0.10279925167560577
and O 0 0.01990700140595436
human O 0 0.028594927862286568
, O 0 0.013776563107967377
and O 0 0.013356547802686691
indicate O 0 0.030678002163767815
that O 0 0.012431860901415348
the O 0 0.01880716346204281
mouse O 0 0.09387818723917007
is O 0 0.020876560360193253
a O 0 0.022338788956403732
suitable O 0 0.038136016577482224
model O 0 0.03694470226764679
system O 0 0.02897145226597786
in O 0 0.013385818339884281
which O 0 0.012124298140406609
to O 0 0.01410910114645958
investigate O 0 0.036213237792253494
the O 0 0.019439557567238808
molecular O 0 0.06908679753541946
mechanisms O 0 0.06350328773260117
of O 0 0.021264573559165
imprinting O 0 0.1417691558599472
in O 0 0.019854744896292686
this O 0 0.015230867080390453
region O 0 0.03172130510210991
of O 0 0.014526319690048695
the O 0 0.02584637515246868
genome O 0 0.09793650358915329
. O 0 0.036828283220529556
. O 0 0.04829579219222069

Mutations O 0 0.19082671403884888
of O 0 0.03031623177230358
the O 0 0.042934317141771317
ATM O 0 0.1840094029903412
gene O 0 0.14690491557121277
detected O 0 0.11721742153167725
in O 0 0.03844127431511879
Japanese O 1 0.6768579483032227
ataxia B-Disease 1 0.9999998807907104
- I-Disease 1 0.9998444318771362
telangiectasia I-Disease 1 0.9999933242797852
patients O 1 0.999887228012085
: O 0 0.05677212029695511
possible O 0 0.044930681586265564
preponderance O 0 0.11025955528020859
of O 0 0.015898890793323517
the O 0 0.017862243577837944
two O 0 0.023915985599160194
founder O 0 0.10073201358318329
mutations O 0 0.18766246736049652
4612del165 O 0 0.18366821110248566
and O 0 0.043572016060352325
7883del5 O 0 0.19418993592262268
. O 0 0.06051136925816536

The O 0 0.06708001345396042
ATM O 0 0.23762428760528564
( O 0 0.07859695702791214
A O 0 0.23756615817546844
- O 1 0.950735330581665
T O 1 0.9986311793327332
, O 0 0.04304219409823418
mutated O 0 0.16028441488742828
) O 0 0.04890730232000351
gene O 0 0.08341801911592484
on O 0 0.02506422996520996
human O 0 0.05584247037768364
chromosome O 0 0.2133646309375763
11q22 O 0 0.23082229495048523
. O 0 0.06960662454366684

3 O 0 0.06404396146535873
has O 0 0.027552606537938118
recently O 0 0.0324031226336956
been O 0 0.01670541614294052
identified O 0 0.023668695241212845
as O 0 0.013629704713821411
the O 0 0.01891927607357502
gene O 0 0.07356355339288712
responsible O 0 0.03535464406013489
for O 0 0.01679825782775879
the O 0 0.02860982157289982
human O 0 0.1508185714483261
recessive B-Disease 1 0.9999963045120239
disease I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 0.9998583793640137
telangiectasia I-Disease 1 0.9999908208847046
( O 0 0.23481178283691406
A B-Disease 1 0.8949072957038879
- I-Disease 1 0.988307535648346
T I-Disease 1 0.9995538592338562
) O 0 0.06743661314249039
. O 0 0.05259948596358299

In O 0 0.02756056934595108
order O 0 0.020098555833101273
to O 0 0.016053352504968643
define O 0 0.03971442952752113
the O 0 0.021341130137443542
types O 0 0.04570072144269943
of O 0 0.034128159284591675
disease O 1 0.9999977350234985
- O 1 0.9222380518913269
causing O 1 0.5983518362045288
ATM O 0 0.2449309527873993
mutations O 0 0.14441582560539246
in O 0 0.03005184419453144
Japanese O 0 0.060096558183431625
A B-Disease 1 0.9054083228111267
- I-Disease 1 0.9987936019897461
T I-Disease 1 0.9999747276306152
patients O 1 0.9952731728553772
as O 0 0.01784541830420494
well O 0 0.015333054587244987
as O 0 0.01251878123730421
to O 0 0.01629146933555603
look O 0 0.038305774331092834
for O 0 0.025288226082921028
possible O 0 0.06203253194689751
mutational O 1 0.960911750793457
hotspots O 0 0.20547887682914734
, O 0 0.04017224535346031
reverse O 0 0.11001137644052505
- O 0 0.12588447332382202
transcribed O 0 0.12576375901699066
RNA O 0 0.12153004109859467
derived O 0 0.05684930086135864
from O 0 0.029546966776251793
ten O 0 0.042198311537504196
patients O 1 0.8029429912567139
belonging O 0 0.041352540254592896
to O 0 0.01851537451148033
eight O 0 0.027597220614552498
unrelated O 0 0.06297660619020462
Japanese O 0 0.05661757290363312
A B-Disease 0 0.12005925178527832
- I-Disease 1 0.8519032597541809
T I-Disease 1 0.9981606602668762
families O 0 0.05114385113120079
was O 0 0.028423085808753967
analyzed O 0 0.05762426555156708
for O 0 0.02816706709563732
mutations O 0 0.10974355041980743
by O 0 0.02641012705862522
the O 0 0.03323812782764435
restriction O 0 0.10219888389110565
endonuclease O 0 0.3092685043811798
fingerprinting O 0 0.1707819700241089
method O 0 0.09139962494373322
. O 0 0.05762740224599838

As O 0 0.02911990135908127
has O 0 0.023640191182494164
been O 0 0.01914636604487896
reported O 0 0.0335245244204998
by O 0 0.01778511144220829
others O 0 0.027054863050580025
, O 0 0.02651974931359291
mutations O 0 0.0940171480178833
that O 0 0.018449993804097176
lead O 0 0.046851854771375656
to O 0 0.02957235462963581
exon O 0 0.16978244483470917
skipping O 0 0.1606932431459427
or O 0 0.06974058598279953
premature O 1 0.7050366401672363
protein O 0 0.11247113347053528
truncation O 0 0.12542028725147247
were O 0 0.019414227455854416
also O 0 0.021165072917938232
predominant O 0 0.05799345672130585
in O 0 0.023207413032650948
our O 0 0.03892061114311218
mutants O 0 0.14322441816329956
. O 0 0.05283459648489952

Six O 0 0.0505824089050293
different O 0 0.031406622380018234
mutations O 0 0.10386960208415985
were O 0 0.016543693840503693
identified O 0 0.028643274679780006
on O 0 0.012850463390350342
12 O 0 0.021645091474056244
of O 0 0.01132584735751152
the O 0 0.022442160174250603
16 O 0 0.056162893772125244
alleles O 0 0.1907101422548294
examined O 0 0.12172354757785797
. O 0 0.0584912933409214

Four O 0 0.04022796079516411
were O 0 0.025735249742865562
deletions O 0 0.10081341862678528
involving O 0 0.057386092841625214
a O 0 0.03301668539643288
loss O 0 0.057707350701093674
of O 0 0.01585194282233715
a O 0 0.033140622079372406
single O 0 0.05689234659075737
exon O 0 0.16849134862422943
exon O 0 0.1641535460948944
7 O 0 0.061744384467601776
, O 0 0.030725842341780663
exon O 0 0.12923385202884674
16 O 0 0.05138560011982918
, O 0 0.038272272795438766
exon O 0 0.15245717763900757
33 O 0 0.07913173735141754
or O 0 0.05238133668899536
exon O 0 0.1795647293329239
35 O 0 0.08589199185371399
. O 0 0.055498022586107254

The O 0 0.03716152533888817
others O 0 0.0349842868745327
were O 0 0.02262251265347004
minute O 0 0.058457233011722565
deletions O 0 0.11364150047302246
, O 0 0.03501546382904053
4649delA O 0 0.14093449711799622
in O 0 0.03421349823474884
exon O 0 0.14504759013652802
33 O 0 0.07047665864229202
and O 0 0.02877488173544407
7883del5 O 0 0.1398468315601349
in O 0 0.03718914836645126
exon O 0 0.17641325294971466
55 O 0 0.10156935453414917
. O 0 0.05952366068959236

The O 0 0.07289651036262512
mutations O 0 0.2127099484205246
4612del165 O 0 0.18636508285999298
and O 0 0.034227337688207626
7883del5 O 0 0.1191365048289299
were O 0 0.01900627091526985
found O 0 0.021474458277225494
in O 0 0.013627806678414345
more O 0 0.013233190402388573
than O 0 0.016835391521453857
two O 0 0.01681947335600853
unrelated O 0 0.059926316142082214
families O 0 0.04907961189746857
; O 0 0.03319889307022095
44 O 0 0.0475214459002018
% O 0 0.038811009377241135
( O 0 0.03511614352464676
7 O 0 0.03146049380302429
of O 0 0.01590742915868759
16 O 0 0.028321770951151848
) O 0 0.02233712188899517
of O 0 0.012585297226905823
the O 0 0.02259148098528385
mutant O 0 0.12155292183160782
alleles O 0 0.14471274614334106
had O 0 0.027015378698706627
one O 0 0.014720561914145947
of O 0 0.013421024195849895
the O 0 0.020806673914194107
two O 0 0.03229319304227829
mutations O 0 0.16865600645542145
. O 0 0.05915778875350952

The O 0 0.06337683647871017
4612del165 O 0 0.21348819136619568
mutations O 0 0.12053655833005905
in O 0 0.01791606843471527
three O 0 0.015197481960058212
different O 0 0.013484276831150055
families O 0 0.02425115741789341
were O 0 0.01197586115449667
all O 0 0.012546993792057037
ascribed O 0 0.057978786528110504
to O 0 0.018126748502254486
the O 0 0.022563736885786057
same O 0 0.04272003471851349
T O 1 0.9996337890625
- O 1 0.7673024535179138
- O 0 0.17831175029277802
> O 0 0.17072956264019012
A O 0 0.0569889172911644
substitution O 0 0.08897805958986282
at O 0 0.039370112121105194
the O 0 0.03356931358575821
splice O 0 0.19377343356609344
donor O 0 0.14278294146060944
site O 0 0.055418383330106735
in O 0 0.038479071110486984
intron O 1 0.730476975440979
33 O 0 0.08754454553127289
. O 0 0.05101010948419571

Microsatellite O 1 0.5976013541221619
genotyping O 0 0.24595019221305847
around O 0 0.045240167528390884
the O 0 0.036096516996622086
ATM O 0 0.15104088187217712
locus O 0 0.13378416001796722
also O 0 0.02764553390443325
indicated O 0 0.04640140384435654
that O 0 0.01718505099415779
a O 0 0.028538143262267113
common O 0 0.05395935848355293
haplotype O 1 0.6618665456771851
was O 0 0.022980405017733574
shared O 0 0.03111255168914795
by O 0 0.02072478085756302
the O 0 0.028321972116827965
mutant O 0 0.13551868498325348
alleles O 0 0.16967655718326569
in O 0 0.03311130777001381
both O 0 0.0377802848815918
mutations O 0 0.1666969209909439
. O 0 0.05682005733251572

This O 0 0.03601200133562088
suggests O 0 0.046319905668497086
that O 0 0.014151873998343945
these O 0 0.012914733029901981
two O 0 0.02005257084965706
founder O 0 0.07875702530145645
mutations O 0 0.14089259505271912
may O 0 0.03645721450448036
be O 0 0.01991979591548443
predominant O 0 0.0704054906964302
among O 0 0.036176424473524094
Japanese O 0 0.07255140691995621
ATM O 0 0.2001219540834427
mutant O 0 0.20004069805145264
alleles O 0 0.25319910049438477
. O 0 0.07277362048625946

W474C O 0 0.33850789070129395
amino O 0 0.19464990496635437
acid O 0 0.35374587774276733
substitution O 0 0.15274111926555634
affects O 0 0.13834041357040405
early O 0 0.037948425859212875
processing O 0 0.033321280032396317
of O 0 0.013937637209892273
the O 0 0.02541625127196312
alpha O 0 0.0958719402551651
- O 0 0.10507994890213013
subunit O 0 0.11898045241832733
of O 0 0.034671351313591
beta O 0 0.1236858069896698
- O 0 0.11677893996238708
hexosaminidase O 0 0.14703547954559326
A O 0 0.0360666885972023
and O 0 0.021312454715371132
is O 0 0.02612587809562683
associated O 0 0.04496830701828003
with O 0 0.04868268966674805
subacute O 1 0.9999537467956543
G B-Disease 1 0.979876697063446
( I-Disease 0 0.08777835965156555
M2 I-Disease 1 0.8371807336807251
) I-Disease 0 0.0736648365855217
gangliosidosis I-Disease 0 0.3582058548927307
. O 0 0.055433738976716995

Mutations O 0 0.21036280691623688
in O 0 0.04544910788536072
the O 0 0.05715758726000786
HEXA O 1 0.9889300465583801
gene O 0 0.12814320623874664
, O 0 0.027947260066866875
encoding O 0 0.056858595460653305
the O 0 0.02718920260667801
alpha O 0 0.09935788810253143
- O 0 0.10464618355035782
subunit O 0 0.12277071923017502
of O 0 0.03604470565915108
beta O 0 0.12500937283039093
- O 0 0.13407714664936066
hexosaminidase O 0 0.18929482996463776
A O 0 0.06108783185482025
( O 0 0.05287010595202446
Hex O 0 0.09787320345640182
A O 0 0.041771236807107925
) O 0 0.02792673371732235
, O 0 0.016417240723967552
that O 0 0.019634205847978592
abolish O 0 0.09390323609113693
Hex O 0 0.12179332226514816
A O 0 0.06330849230289459
enzyme O 0 0.19694727659225464
activity O 1 0.5924209952354431
cause O 1 0.9999294281005859
Tay B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999498128890991
Sachs I-Disease 1 0.9999967813491821
disease I-Disease 1 0.9999984502792358
( O 0 0.33306336402893066
TSD B-Disease 1 0.9998753070831299
) O 0 0.04222111403942108
, O 0 0.02362925373017788
the O 0 0.03578558564186096
fatal O 1 0.9993287324905396
infantile B-Disease 1 0.9994232654571533
form I-Disease 0 0.058755114674568176
of I-Disease 0 0.037903666496276855
G I-Disease 1 0.9239878058433533
( I-Disease 0 0.07683634757995605
M2 I-Disease 1 0.8881300687789917
) I-Disease 0 0.06151694059371948
gangliosidosis I-Disease 0 0.24998211860656738
, I-Disease 0 0.035600557923316956
Type I-Disease 0 0.08835860341787338
1 I-Disease 0 0.05530906841158867
. O 0 0.04488693177700043

Less O 0 0.0985226109623909
severe O 1 0.9992897510528564
, O 0 0.06369805335998535
subacute O 1 0.9999977350234985
( O 1 0.6659980416297913
juvenile O 1 0.9996986389160156
- O 1 0.9976286292076111
onset O 1 0.9999208450317383
) O 0 0.060809940099716187
and O 0 0.03818843141198158
chronic O 1 0.9999992847442627
( O 0 0.08411721140146255
adult O 0 0.25693944096565247
- O 1 0.9685993790626526
onset O 1 0.9988435506820679
) O 0 0.0512194000184536
variants O 0 0.06388374418020248
are O 0 0.01920410245656967
characterized O 0 0.06470602005720139
by O 0 0.018886059522628784
a O 0 0.03008602373301983
broad O 0 0.06731210649013519
spectrum O 0 0.07805867493152618
of O 0 0.026004217565059662
clinical O 1 0.9607698321342468
manifestations O 0 0.18500497937202454
and O 0 0.017484458163380623
are O 0 0.013243344612419605
associated O 0 0.02933913841843605
with O 0 0.023432064801454544
residual O 0 0.11960570514202118
levels O 0 0.06288821995258331
of O 0 0.023050457239151
Hex O 0 0.12770843505859375
A O 0 0.06421976536512375
enzyme O 0 0.16117095947265625
activity O 0 0.08856411278247833
. O 0 0.051986731588840485

We O 0 0.04589608684182167
identified O 0 0.0616210401058197
a O 0 0.06510667502880096
1422 O 1 0.9980594515800476
G O 1 0.9965607523918152
- O 1 0.9327676296234131
- O 1 0.7281560301780701
> O 1 0.7119759917259216
C O 0 0.18964900076389313
( O 0 0.08190207183361053
amino O 0 0.12932729721069336
acid O 0 0.23931214213371277
W474C O 0 0.1965290606021881
) O 0 0.04538017138838768
substitution O 0 0.060414768755435944
in O 0 0.01609744317829609
the O 0 0.013317526318132877
first O 0 0.01724696345627308
position O 0 0.022325802594423294
of O 0 0.017760764807462692
exon O 0 0.12227054685354233
13 O 0 0.04368433356285095
of O 0 0.027517138049006462
HEXA O 1 0.9689385890960693
of O 0 0.02550729364156723
a O 0 0.034620631486177444
non O 0 0.06426931172609329
- O 0 0.10732733458280563
Jewish O 0 0.0771627128124237
proband O 0 0.37125200033187866
who O 0 0.04924798384308815
manifested O 0 0.16060660779476166
a O 0 0.07095671445131302
subacute O 1 0.9997245669364929
variant O 0 0.1895168423652649
of O 0 0.0509038120508194
G B-Disease 1 0.8965884447097778
( I-Disease 0 0.0801602378487587
M2 I-Disease 1 0.7038164138793945
) I-Disease 0 0.06892359256744385
gangliosidosis I-Disease 0 0.25620511174201965
. O 0 0.06764614582061768

On O 0 0.03166577219963074
the O 0 0.030539266765117645
second O 0 0.05774081125855446
maternally O 0 0.23835055530071259
inherited O 0 0.1924307644367218
allele O 0 0.1785084307193756
, O 0 0.03260473906993866
we O 0 0.02093644067645073
identified O 0 0.03508041799068451
the O 0 0.030274562537670135
common O 1 0.5828172564506531
infantile O 1 0.9999997615814209
disease O 1 0.9999997615814209
- O 1 0.985926628112793
causing O 1 0.7150129675865173
4 O 0 0.07505469024181366
- O 0 0.1452595740556717
bp O 0 0.1781189888715744
insertion O 0 0.1946285218000412
, O 0 0.05374951288104057
+ O 1 0.7215965986251831
TATC O 1 0.9560081362724304
1278 O 1 0.8477095365524292
, O 0 0.03140983730554581
in O 0 0.03257342427968979
exon O 0 0.16107334196567535
11 O 0 0.06812787801027298
. O 0 0.05640891566872597

Pulse O 1 0.8569430112838745
- O 0 0.16733813285827637
chase O 0 0.15072692930698395
analysis O 0 0.05685804411768913
using O 0 0.04766988009214401
proband O 0 0.42642661929130554
fibroblasts O 1 0.550338864326477
revealed O 0 0.05782872438430786
that O 0 0.020092463120818138
the O 0 0.02967843785881996
W474C O 0 0.1727680265903473
- O 0 0.11297712475061417
containing O 0 0.05941453576087952
alpha O 0 0.12159111350774765
- O 0 0.13860642910003662
subunit O 0 0.1626947671175003
precursor O 0 0.12125348299741745
was O 0 0.034573957324028015
normally O 0 0.05526174232363701
synthesized O 0 0.08877371996641159
, O 0 0.022535452619194984
but O 0 0.018631987273693085
not O 0 0.01960836350917816
phosphorylated O 0 0.11481206864118576
or O 0 0.0362500324845314
secreted O 0 0.0948920026421547
, O 0 0.021977322176098824
and O 0 0.01798783615231514
the O 0 0.03131883218884468
mature O 0 0.12524734437465668
lysosomal O 1 0.9777398705482483
alpha O 0 0.14436209201812744
- O 0 0.12512065470218658
subunit O 0 0.1301296204328537
was O 0 0.03182327002286911
not O 0 0.028355691581964493
detected O 0 0.10438507050275803
. O 0 0.049840446561574936

When O 0 0.052413929253816605
the O 0 0.03750983253121376
W474C O 0 0.1839028000831604
- O 0 0.10346218198537827
containing O 0 0.06221982091665268
alpha O 0 0.11757992208003998
- O 0 0.12607069313526154
subunit O 0 0.15058669447898865
was O 0 0.05456657335162163
transiently O 1 0.5427733063697815
co O 0 0.12453596293926239
- O 0 0.0882757157087326
expressed O 0 0.04114111140370369
with O 0 0.022892145439982414
the O 0 0.03056521527469158
beta O 0 0.1089208796620369
- O 0 0.1029137670993805
subunit O 0 0.11378664523363113
to O 0 0.029686685651540756
produce O 0 0.04884592071175575
Hex O 0 0.11230252683162689
A O 0 0.05611759051680565
( O 0 0.059539489448070526
alphabeta O 0 0.20126768946647644
) O 0 0.04262416064739227
in O 0 0.032928433269262314
COS O 1 0.9987877011299133
- O 0 0.13707424700260162
7 O 0 0.0720210075378418
cells O 0 0.09934462606906891
, O 0 0.02439906634390354
the O 0 0.026231063529849052
mature O 0 0.10043367743492126
alpha O 0 0.10984591394662857
- O 0 0.10542436689138412
subunit O 0 0.1183563843369484
was O 0 0.027777493000030518
present O 0 0.023012276738882065
, O 0 0.015289762057363987
but O 0 0.011915033683180809
its O 0 0.015729837119579315
level O 0 0.02834402024745941
was O 0 0.01840074732899666
much O 0 0.019379261881113052
lower O 0 0.034520313143730164
than O 0 0.015476662665605545
that O 0 0.014304707758128643
from O 0 0.023171450942754745
normal O 0 0.06570033729076385
alpha O 0 0.11160401999950409
- O 0 0.12824758887290955
subunit O 0 0.1583722084760666
transfections O 0 0.16419002413749695
, O 0 0.026635607704520226
although O 0 0.02142980508506298
higher O 0 0.027154363691806793
than O 0 0.014478676952421665
in O 0 0.016381913796067238
those O 0 0.02422366850078106
cells O 0 0.11086452007293701
transfected O 0 0.299841046333313
with O 0 0.03349784016609192
an O 0 0.03675678372383118
alpha O 0 0.11488167941570282
- O 0 0.13418443500995636
subunit O 0 0.16629551351070404
associated O 0 0.07371767610311508
with O 0 0.062158968299627304
infantile O 1 0.9998654127120972
TSD B-Disease 1 0.9994980096817017
. O 0 0.08902886509895325

Furthermore O 0 0.07735621929168701
, O 0 0.02592422254383564
the O 0 0.02116146869957447
precursor O 0 0.08400185406208038
level O 0 0.03632591292262077
of O 0 0.017059238627552986
the O 0 0.031333908438682556
W474C O 0 0.1824704110622406
alpha O 0 0.12171335518360138
- O 0 0.11279184371232986
subunit O 0 0.11565367877483368
was O 0 0.027102965861558914
found O 0 0.024222007021307945
to O 0 0.018675750121474266
accumulate O 0 0.06983428448438644
in O 0 0.016733143478631973
comparison O 0 0.03189726918935776
to O 0 0.017173325642943382
the O 0 0.022326966747641563
normal O 0 0.07730564475059509
alpha O 0 0.12473516166210175
- O 0 0.14670386910438538
subunit O 0 0.18560868501663208
precursor O 0 0.15573973953723907
levels O 0 0.10358650982379913
. O 0 0.058497462421655655

We O 0 0.039269667118787766
conclude O 0 0.06710796058177948
that O 0 0.02366955205798149
the O 0 0.039952490478754044
1422 O 1 0.9991614818572998
G O 1 0.9981974959373474
- O 1 0.9677708745002747
- O 1 0.6291518807411194
> O 1 0.6852564811706543
C O 0 0.19945049285888672
mutation O 0 0.15423773229122162
is O 0 0.02503327652812004
the O 0 0.02226966992020607
cause O 0 0.06969746947288513
of O 0 0.026036685332655907
Hex B-Disease 0 0.1384502798318863
A I-Disease 0 0.08148323744535446
enzyme I-Disease 1 0.9974453449249268
deficiency I-Disease 1 0.999997615814209
in O 0 0.03576486185193062
the O 0 0.0407988503575325
proband O 0 0.3781762421131134
. O 0 0.05655306950211525

The O 0 0.05579011142253876
resulting O 0 0.1149178072810173
W474C O 0 0.2162046581506729
substitution O 0 0.12384507805109024
clearly O 0 0.06417442858219147
interferes O 0 0.14134304225444794
with O 0 0.039406854659318924
alpha O 0 0.10916873067617416
- O 0 0.11444534361362457
subunit O 0 0.12695570290088654
processing O 0 0.04821699485182762
, O 0 0.019896965473890305
but O 0 0.016754966229200363
because O 0 0.02038595825433731
the O 0 0.020368337631225586
base O 0 0.05132535099983215
substitution O 0 0.08012460172176361
falls O 0 0.0680265724658966
at O 0 0.02133925072848797
the O 0 0.013999243266880512
first O 0 0.01700073666870594
position O 0 0.02349330671131611
of O 0 0.020930234342813492
exon O 0 0.1444501131772995
13 O 0 0.05570489913225174
, O 0 0.043886877596378326
aberrant O 0 0.19675926864147186
splicing O 0 0.14358285069465637
may O 0 0.03970612958073616
also O 0 0.02078482136130333
contribute O 0 0.04788399860262871
to O 0 0.026529934257268906
Hex B-Disease 0 0.12321993708610535
A I-Disease 0 0.0666104108095169
deficiency I-Disease 1 0.9999842643737793
in O 0 0.027194032445549965
this O 0 0.023320920765399933
proband O 0 0.17338325083255768
. O 0 0.030082495883107185
. O 0 0.04107564315199852

Two O 0 0.06570528447628021
frequent O 0 0.1652548462152481
missense O 1 0.672020435333252
mutations O 1 0.5937246084213257
in O 0 0.0920756459236145
Pendred B-Disease 1 0.9999669790267944
syndrome I-Disease 1 0.9999998807907104
. O 0 0.08535028994083405

Pendred B-Disease 1 0.9999889135360718
syndrome I-Disease 1 1.0
is O 0 0.06259527802467346
an O 0 0.07877407222986221
autosomal B-Disease 1 0.9999995231628418
recessive I-Disease 1 0.9999998807907104
disorder I-Disease 1 1.0
characterized O 1 0.9922395944595337
by O 0 0.04141947999596596
early O 0 0.07946021109819412
childhood O 1 0.9998353719711304
deafness B-Disease 1 0.9999994039535522
and O 0 0.071995310485363
goiter B-Disease 1 0.9999977350234985
. O 0 0.08179870247840881

A O 0 0.051552511751651764
century O 0 0.03438586741685867
after O 0 0.030797354876995087
its O 0 0.02228204533457756
recognition O 0 0.041799455881118774
as O 0 0.026532521471381187
a O 0 0.06065092980861664
syndrome O 1 0.9999980926513672
by O 0 0.03907560557126999
Vaughan O 0 0.16789956390857697
Pendred O 1 0.600836455821991
, O 0 0.031023385003209114
the O 0 0.043028589338064194
disease O 1 0.9999567270278931
gene O 0 0.23320609331130981
( O 0 0.07358131557703018
PDS O 1 0.9934843182563782
) O 0 0.04036154970526695
was O 0 0.026259081438183784
mapped O 0 0.0715370923280716
to O 0 0.03795606642961502
chromosome O 0 0.2167702615261078
7q22 O 1 0.5486299395561218
- O 0 0.18249791860580444
q31 O 0 0.23321883380413055
. O 0 0.07188870757818222

1 O 0 0.05351073294878006
and O 0 0.02115955948829651
, O 0 0.020439550280570984
recently O 0 0.030087478458881378
, O 0 0.01659143529832363
found O 0 0.019191740080714226
to O 0 0.019187074154615402
encode O 0 0.060109905898571014
a O 0 0.053296152502298355
putative O 0 0.3080555498600006
sulfate O 1 0.9972073435783386
transporter O 1 0.8468222618103027
. O 0 0.07470238953828812

We O 0 0.04692567512392998
performed O 0 0.06545563042163849
mutation O 0 0.1409362256526947
analysis O 0 0.03862590715289116
of O 0 0.018067631870508194
the O 0 0.0285356342792511
PDS B-Disease 1 0.9974315762519836
gene O 0 0.1250620186328888
in O 0 0.03662414848804474
patients O 1 0.9950960278511047
from O 0 0.0293748676776886
14 O 0 0.04410348832607269
Pendred B-Disease 0 0.30694863200187683
families O 0 0.04230932518839836
originating O 0 0.05175206810235977
from O 0 0.018235376104712486
seven O 0 0.01844426803290844
countries O 0 0.016437942162156105
and O 0 0.016442205756902695
identified O 0 0.03589937090873718
all O 0 0.02485806681215763
mutations O 0 0.16050580143928528
. O 0 0.053914278745651245

The O 0 0.05287161096930504
mutations O 0 0.12791045010089874
include O 0 0.03342574089765549
three O 0 0.024265991523861885
single O 0 0.04485881328582764
base O 0 0.06119078770279884
deletions O 0 0.09685976803302765
, O 0 0.027388986200094223
one O 0 0.03402196615934372
splice O 0 0.18366369605064392
site O 0 0.07095871865749359
mutation O 0 0.1582915037870407
and O 0 0.03479120880365372
10 O 0 0.0599493533372879
missense O 0 0.26601988077163696
mutations O 0 0.19210729002952576
. O 0 0.061557527631521225

One O 0 0.09292572736740112
missense O 0 0.3507189452648163
mutation O 0 0.28133177757263184
( O 0 0.08357227593660355
L236P O 0 0.16083192825317383
) O 0 0.03514879196882248
was O 0 0.021466072648763657
found O 0 0.024417728185653687
in O 0 0.01933584362268448
a O 0 0.029316764324903488
homozygous O 0 0.0912201777100563
state O 0 0.02146901562809944
in O 0 0.01867143251001835
two O 0 0.024470282718539238
consanguineous O 0 0.19929036498069763
families O 0 0.03926108777523041
and O 0 0.015447545796632767
in O 0 0.01650025136768818
a O 0 0.024020418524742126
heterozygous O 0 0.08647756278514862
state O 0 0.018906578421592712
in O 0 0.014979655854403973
five O 0 0.021467261016368866
additional O 0 0.03729323670268059
non O 0 0.0715075358748436
- O 0 0.15425798296928406
consanguineous O 1 0.7651238441467285
families O 0 0.09801408648490906
. O 0 0.06077999249100685

Another O 0 0.11938772350549698
missense O 0 0.44607657194137573
mutation O 0 0.3507639169692993
( O 0 0.08779876679182053
T416P O 0 0.16925495862960815
) O 0 0.035272303968667984
was O 0 0.01909755915403366
found O 0 0.01993737742304802
in O 0 0.016511373221874237
a O 0 0.025044463574886322
homozygous O 0 0.08661767095327377
state O 0 0.01645541377365589
in O 0 0.01385908480733633
one O 0 0.014815695583820343
family O 0 0.02337583154439926
and O 0 0.012309578247368336
in O 0 0.015361849218606949
a O 0 0.026263263076543808
heterozygous O 0 0.09506140649318695
state O 0 0.021471748128533363
in O 0 0.01811608485877514
four O 0 0.025429056957364082
families O 0 0.05451162904500961
. O 0 0.05318507179617882

Pendred B-Disease 1 0.9849253296852112
patients O 1 0.9844937324523926
in O 0 0.02772671729326248
three O 0 0.027199063450098038
non O 0 0.06884746998548508
- O 0 0.13583943247795105
consanguineous O 1 0.685936689376831
families O 0 0.048281583935022354
were O 0 0.017344040796160698
shown O 0 0.031751811504364014
to O 0 0.018314139917492867
be O 0 0.022944459691643715
compound O 0 0.10158352553844452
heterozygotes O 0 0.455684632062912
for O 0 0.03538954257965088
L236P O 0 0.1532212346792221
and O 0 0.03965040668845177
T416P O 0 0.18496862053871155
. O 0 0.05528350919485092

In O 0 0.02978859283030033
total O 0 0.02848678268492222
, O 0 0.016327816992998123
one O 0 0.015362152829766273
or O 0 0.018216654658317566
both O 0 0.013086195103824139
of O 0 0.013142027892172337
these O 0 0.017868584021925926
mutations O 0 0.08525622636079788
were O 0 0.01441413164138794
found O 0 0.019703641533851624
in O 0 0.011857387609779835
nine O 0 0.019821738824248314
of O 0 0.013020973652601242
the O 0 0.020141974091529846
14 O 0 0.0394003763794899
families O 0 0.047182850539684296
analyzed O 0 0.08256617188453674
. O 0 0.05480309575796127

The O 0 0.035208988934755325
identification O 0 0.04476713761687279
of O 0 0.018067460507154465
two O 0 0.026333967223763466
frequent O 0 0.11001376807689667
PDS B-Disease 1 0.9962610602378845
mutations O 0 0.13336192071437836
will O 0 0.023454716429114342
facilitate O 0 0.05063679814338684
the O 0 0.032271429896354675
molecular O 0 0.14464208483695984
diagnosis O 1 0.9997709393501282
of O 0 0.06547226756811142
Pendred B-Disease 1 0.999991774559021
syndrome I-Disease 1 1.0
. O 0 0.08468012511730194

Insertional O 1 0.8011671900749207
mutation O 0 0.22701117396354675
by O 0 0.046191729605197906
transposable O 0 0.43511128425598145
element O 0 0.08977021276950836
, O 0 0.0414312407374382
L1 O 1 0.8783283829689026
, O 0 0.026996612548828125
in O 0 0.02300175279378891
the O 0 0.046288616955280304
DMD B-Disease 1 0.999994158744812
gene O 0 0.1404552310705185
results O 0 0.057200584560632706
in O 0 0.03737933933734894
X B-Disease 1 0.9658604264259338
- I-Disease 1 0.8893635869026184
linked I-Disease 1 0.9483960866928101
dilated I-Disease 1 0.9999505281448364
cardiomyopathy I-Disease 1 0.9999995231628418
. O 0 0.08788502961397171

X B-Disease 1 0.9817296862602234
- I-Disease 1 0.9515714645385742
linked I-Disease 1 0.9709053635597229
dilated I-Disease 1 0.9999822378158569
cardiomyopathy I-Disease 1 0.9999998807907104
( O 0 0.10946806520223618
XLDCM B-Disease 1 0.9795359969139099
) O 0 0.04138513654470444
is O 0 0.025232072919607162
a O 0 0.03951484337449074
clinical O 1 0.9011871814727783
phenotype O 1 0.7745627760887146
of O 0 0.029656365513801575
dystrophinopathy B-Disease 0 0.18057842552661896
which O 0 0.022434424608945847
is O 0 0.02435745671391487
characterized O 0 0.07940083742141724
by O 0 0.03488915413618088
preferential O 1 0.9884982705116272
myocardial B-Disease 1 0.9999957084655762
involvement I-Disease 0 0.12041658908128738
without O 0 0.03356138989329338
any O 0 0.028593871742486954
overt O 0 0.1199307069182396
clinical O 1 0.9890353083610535
signs O 0 0.09156224876642227
of O 0 0.04446454718708992
skeletal B-Disease 1 0.9999792575836182
myopathy I-Disease 1 0.9999984502792358
. O 0 0.09705109149217606

To O 0 0.03423381596803665
date O 0 0.028948811814188957
, O 0 0.01910804957151413
several O 0 0.020918216556310654
mutations O 0 0.1095058023929596
in O 0 0.029753616079688072
the O 0 0.05618097260594368
Duchenne B-Disease 1 0.9999991655349731
muscular I-Disease 1 0.9999994039535522
dystrophy I-Disease 1 1.0
gene O 1 0.9828206300735474
, O 0 0.07271043956279755
DMD O 1 0.9999992847442627
, O 0 0.026289140805602074
have O 0 0.0162957813590765
been O 0 0.017545850947499275
identified O 0 0.03569451719522476
in O 0 0.025465307757258415
patients O 1 0.9947291016578674
with O 0 0.034795332700014114
XLDCM B-Disease 1 0.9698770046234131
, O 0 0.022675829008221626
but O 0 0.019307995215058327
a O 0 0.033161770552396774
pathogenic O 0 0.12513257563114166
correlation O 0 0.08991654217243195
of O 0 0.021405143663287163
these O 0 0.030013376846909523
cardiospecific O 1 0.7827381491661072
mutations O 0 0.2063502073287964
in O 0 0.05411609634757042
DMD O 1 0.9999926090240479
with O 0 0.035328805446624756
the O 0 0.038794439285993576
XLDCM B-Disease 1 0.9871993660926819
phenotype O 1 0.7702363133430481
has O 0 0.029034936800599098
remained O 0 0.027939556166529655
to O 0 0.0178141500800848
be O 0 0.024020006880164146
elucidated O 0 0.1369006633758545
. O 0 0.0462149903178215

We O 0 0.03105134889483452
report O 0 0.025671398267149925
here O 0 0.017067741602659225
the O 0 0.014133105985820293
identification O 0 0.03133762627840042
of O 0 0.013773661106824875
a O 0 0.029586661607027054
unique O 0 0.05459430068731308
de O 0 0.12154305726289749
novo O 0 0.27861177921295166
L1 O 1 0.9471325278282166
insertion O 0 0.14652091264724731
in O 0 0.029278671368956566
the O 0 0.03693054988980293
muscle O 1 0.9859150648117065
exon O 0 0.18058176338672638
1 O 0 0.05991874635219574
in O 0 0.04330163449048996
DMD O 1 0.9999920129776001
in O 0 0.029465030878782272
three O 0 0.03612063452601433
XLDCM B-Disease 1 0.994425892829895
patients O 1 0.9929513335227966
from O 0 0.027660127729177475
two O 0 0.023769736289978027
unrelated O 0 0.07296188175678253
Japanese O 0 0.051620177924633026
families O 0 0.06177975609898567
. O 0 0.049016159027814865

The O 0 0.04947254806756973
insertion O 0 0.13426096737384796
was O 0 0.03199348971247673
a O 0 0.033962003886699677
5 O 0 0.0525474026799202
- O 0 0.0914754644036293
truncated O 0 0.1097058653831482
form O 0 0.035167988389730453
of O 0 0.022755306214094162
human O 0 0.059273526072502136
L1 O 1 0.8415724039077759
inversely O 0 0.13194483518600464
integrated O 0 0.06389725208282471
in O 0 0.01934804394841194
the O 0 0.0242131520062685
5 O 0 0.0546916238963604
- O 0 0.09826955199241638
untranslated O 0 0.1498551368713379
region O 0 0.05449828505516052
in O 0 0.023354720324277878
the O 0 0.032876793295145035
muscle O 1 0.990413248538971
exon O 0 0.15616558492183685
1 O 0 0.04196503385901451
, O 0 0.020171651616692543
which O 0 0.018772799521684647
affected O 0 0.045712508261203766
the O 0 0.02427671290934086
transcription O 0 0.07264743745326996
or O 0 0.022326363250613213
the O 0 0.01742400787770748
stability O 0 0.04328638315200806
of O 0 0.01813935674726963
the O 0 0.03066161274909973
muscle O 1 0.9661620259284973
form O 0 0.0429629348218441
of O 0 0.027832867577672005
dystrophin O 1 0.973314106464386
transcripts O 0 0.0625845342874527
but O 0 0.01648186706006527
not O 0 0.010734311304986477
that O 0 0.009123101830482483
of O 0 0.012989714741706848
the O 0 0.029055364429950714
brain O 1 0.9958857893943787
or O 0 0.057820986956357956
Purkinje O 1 0.999509334564209
cell O 0 0.121516652405262
form O 0 0.03702835738658905
, O 0 0.018226634711027145
probably O 0 0.027844712138175964
due O 0 0.01954270526766777
to O 0 0.011851529590785503
its O 0 0.013707142323255539
unique O 0 0.02523130550980568
site O 0 0.02667769230902195
of O 0 0.0191116314381361
integration O 0 0.06662601232528687
. O 0 0.04723752662539482

We O 0 0.04478134214878082
speculate O 0 0.07302667200565338
that O 0 0.018069222569465637
this O 0 0.017419248819351196
insertion O 0 0.1000264436006546
of O 0 0.02336864173412323
an O 0 0.038344983011484146
L1 O 1 0.7912981510162354
sequence O 0 0.07868478447198868
in O 0 0.04933256283402443
DMD O 1 0.9999678134918213
is O 0 0.026220768690109253
responsible O 0 0.02725432999432087
for O 0 0.011334776878356934
some O 0 0.00972901750355959
of O 0 0.010031777434051037
the O 0 0.014835027977824211
population O 0 0.027163006365299225
of O 0 0.01793813146650791
Japanese O 0 0.06030196323990822
patients O 1 0.9968419075012207
with O 0 0.03782477602362633
XLDCM B-Disease 1 0.9577851295471191
. O 0 0.035511620342731476
. O 0 0.04264538735151291

Severe O 1 0.9999256134033203
early O 1 0.7697753310203552
- O 1 0.9998173117637634
onset O 1 0.9999990463256836
obesity B-Disease 1 0.9999997615814209
, O 1 0.7012783288955688
adrenal B-Disease 1 0.9999994039535522
insufficiency I-Disease 1 0.999998927116394
and O 0 0.05327668413519859
red O 1 0.9960786700248718
hair O 1 0.9996080994606018
pigmentation O 1 0.9999691247940063
caused O 1 0.9421738386154175
by O 0 0.06530430167913437
POMC O 1 0.9992350339889526
mutations O 0 0.20464415848255157
in O 0 0.04195600375533104
humans O 0 0.08678863197565079
. O 0 0.05392272025346756

Sequential O 0 0.15269368886947632
cleavage O 0 0.17799784243106842
of O 0 0.026490407064557076
the O 0 0.034665003418922424
precursor O 0 0.13261346518993378
protein O 0 0.12065057456493378
pre O 0 0.1431228667497635
- O 0 0.1427498310804367
pro O 0 0.10983313620090485
- O 0 0.2046232372522354
opiomelanocortin O 1 0.7031368017196655
( O 0 0.10019203275442123
POMC O 1 0.9942975640296936
) O 0 0.05802467092871666
generates O 0 0.0975312665104866
the O 0 0.05064430087804794
melanocortin O 1 0.987579882144928
peptides O 0 0.2525726854801178
adrenocorticotrophin O 1 0.8743835091590881
( O 0 0.09391668438911438
ACTH O 1 0.998319685459137
) O 0 0.06580466032028198
, O 0 0.05060960352420807
melanocyte O 1 0.9992995262145996
- O 1 0.7305344343185425
stimulating O 1 0.9062018394470215
hormones O 1 0.9426255822181702
( O 0 0.11442847549915314
MSH O 1 0.9990102052688599
) O 0 0.059162382036447525
alpha O 0 0.08479677140712738
, O 0 0.031008249148726463
beta O 0 0.07618635892868042
and O 0 0.022778687998652458
gamma O 0 0.08820216357707977
as O 0 0.016465820372104645
well O 0 0.015358158387243748
as O 0 0.0167111586779356
the O 0 0.03491596132516861
opioid O 1 0.9941588640213013
- O 0 0.4612797200679779
receptor O 1 0.5714949369430542
ligand O 1 0.690740168094635
beta O 0 0.4267292320728302
- O 1 0.5315025448799133
endorphin O 1 0.9735956192016602
. O 0 0.09464812278747559

While O 0 0.040490854531526566
a O 0 0.033863600343465805
few O 0 0.029299050569534302
cases O 0 0.04025328904390335
of O 0 0.029392652213573456
isolated O 1 0.9735729098320007
ACTH B-Disease 1 0.9999915361404419
deficiency I-Disease 1 0.9999983310699463
have O 0 0.033558882772922516
been O 0 0.030243681743741035
reported O 0 0.07413187623023987
( O 0 0.07816226035356522
OMIM O 1 0.9995750784873962
201400 O 1 0.5177870392799377
) O 0 0.04180282726883888
, O 0 0.02545117400586605
an O 0 0.03915848210453987
inherited O 1 0.9892145991325378
POMC O 1 0.9999253749847412
defect O 1 0.9822695851325989
has O 0 0.02542584016919136
not O 0 0.014228984713554382
been O 0 0.018253423273563385
described O 0 0.03262913599610329
so O 0 0.02527785673737526
far O 0 0.03308861702680588
. O 0 0.03843275085091591

Recent O 0 0.0679471492767334
studies O 0 0.05052240192890167
in O 0 0.023889118805527687
animal O 0 0.0604093000292778
models O 0 0.05593153089284897
elucidated O 0 0.1122242659330368
a O 0 0.03109319508075714
central O 0 0.03431298956274986
role O 0 0.03620942309498787
of O 0 0.02520121820271015
alpha O 0 0.12171268463134766
- O 0 0.1616310328245163
MSH O 1 0.9904381632804871
in O 0 0.02581266686320305
the O 0 0.021525373682379723
regulation O 0 0.04876123368740082
of O 0 0.020942388102412224
food O 0 0.05609269440174103
intake O 0 0.13244347274303436
by O 0 0.030301295220851898
activation O 0 0.11581360548734665
of O 0 0.02453339658677578
the O 0 0.03815089538693428
brain O 1 0.9966906309127808
melanocortin O 1 0.9994128942489624
- O 0 0.43675777316093445
4 O 0 0.10416850447654724
- O 0 0.29722073674201965
receptor O 1 0.687842845916748
( O 0 0.11936261504888535
MC4 O 1 0.9997910857200623
- O 1 0.6088026165962219
R O 0 0.26276126503944397
; O 0 0.06248515099287033
refs O 0 0.18006330728530884
3 O 0 0.057748399674892426
- O 0 0.08807262778282166
5 O 0 0.04130558669567108
) O 0 0.024722615256905556
and O 0 0.014060309156775475
the O 0 0.021015260368585587
linkage O 0 0.11408389359712601
of O 0 0.024851558730006218
human O 0 0.06195547431707382
obesity B-Disease 1 0.9996947050094604
to O 0 0.03463020548224449
chromosome O 0 0.13460789620876312
2 O 0 0.03371084854006767
in O 0 0.01736188679933548
close O 0 0.03256427124142647
proximity O 0 0.057550687342882156
to O 0 0.023270150646567345
the O 0 0.03525359183549881
POMC O 1 0.9918198585510254
locus O 0 0.1450730264186859
, O 0 0.025454889982938766
led O 0 0.02823980152606964
to O 0 0.013032076880335808
the O 0 0.01414788980036974
proposal O 0 0.0285102017223835
of O 0 0.014223126694560051
an O 0 0.024971406906843185
association O 0 0.05698598176240921
of O 0 0.03321271762251854
POMC O 1 0.9993636012077332
with O 0 0.042628124356269836
human O 0 0.08444817364215851
obesity B-Disease 1 0.9999676942825317
. O 0 0.06510757654905319

The O 0 0.039206717163324356
dual O 0 0.0824805349111557
role O 0 0.05274306610226631
of O 0 0.03133432939648628
alpha O 0 0.1357959806919098
- O 0 0.2023918628692627
MSH O 1 0.9944730401039124
in O 0 0.04222981259226799
regulating O 0 0.10614355653524399
food O 0 0.06997643411159515
intake O 0 0.19862642884254456
and O 0 0.037957947701215744
influencing O 0 0.13541993498802185
hair O 1 0.9959994554519653
pigmentation O 1 0.9997392296791077
predicts O 0 0.11553572863340378
that O 0 0.02264387533068657
the O 0 0.03049618750810623
phenotype O 1 0.7374780774116516
associated O 0 0.04540291056036949
with O 0 0.024112412706017494
a O 0 0.04130479320883751
defect O 1 0.8685989379882812
in O 0 0.04920446500182152
POMC O 1 0.9973330497741699
function O 0 0.062488067895174026
would O 0 0.029252536594867706
include O 0 0.044782377779483795
obesity B-Disease 1 0.9998553991317749
, O 0 0.036124181002378464
alteration O 0 0.11309710144996643
in O 0 0.04365533962845802
pigmentation O 1 0.9998680353164673
and O 0 0.08212295919656754
ACTH B-Disease 1 0.9999946355819702
deficiency I-Disease 1 0.9999986886978149
. O 0 0.0855117216706276

The O 0 0.0407513752579689
observation O 0 0.07733205705881119
of O 0 0.022648850455880165
these O 0 0.02611076831817627
symptoms O 1 0.9995906949043274
in O 0 0.01981024630367756
two O 0 0.024009639397263527
probands O 0 0.37208861112594604
prompted O 0 0.07388907670974731
us O 0 0.037550847977399826
to O 0 0.01978561282157898
search O 0 0.035492729395627975
for O 0 0.023092171177268028
mutations O 0 0.11002711951732635
within O 0 0.03461875393986702
their O 0 0.042250435799360275
POMC O 1 0.9925385117530823
genes O 0 0.14950864017009735
. O 0 0.0614551343023777

Patient O 1 0.8967779278755188
1 O 0 0.04133176431059837
was O 0 0.019052039831876755
found O 0 0.018551336601376534
to O 0 0.012927948497235775
be O 0 0.014488620683550835
a O 0 0.029909497126936913
compound O 0 0.09135035425424576
heterozygote O 0 0.21140901744365692
for O 0 0.023686902597546577
two O 0 0.026457438245415688
mutations O 0 0.11529669165611267
in O 0 0.03384336829185486
exon O 0 0.15902338922023773
3 O 0 0.0642838254570961
( O 0 0.06091124564409256
G7013T O 0 0.16613534092903137
, O 0 0.04096641764044762
C7133delta O 0 0.1739288568496704
) O 0 0.03583742305636406
which O 0 0.01964099518954754
interfere O 0 0.05396121367812157
with O 0 0.024770108982920647
appropriate O 0 0.04892536625266075
synthesis O 0 0.08371356874704361
of O 0 0.029566394165158272
ACTH O 1 0.9837875366210938
and O 0 0.04061436280608177
alpha O 0 0.13828125596046448
- O 1 0.6057905554771423
MSH O 1 0.9979729056358337
. O 0 0.07686179876327515

Patient O 1 0.9219068884849548
2 O 0 0.05429278686642647
was O 0 0.033482734113931656
homozygous O 0 0.1061975359916687
for O 0 0.02441420778632164
a O 0 0.03886064887046814
mutation O 0 0.14659826457500458
in O 0 0.03732308745384216
exon O 0 0.16081750392913818
2 O 0 0.06622879952192307
( O 0 0.06470727920532227
C3804A O 0 0.17661213874816895
) O 0 0.05319678783416748
which O 0 0.043833453208208084
abolishes O 1 0.7772229909896851
POMC O 1 0.987287163734436
translation O 0 0.07906456291675568
. O 0 0.06059691682457924

These O 0 0.027332045137882233
findings O 0 0.04093720391392708
represent O 0 0.021554408594965935
the O 0 0.013718350790441036
first O 0 0.01750151999294758
examples O 0 0.02696922793984413
of O 0 0.01894056797027588
a O 0 0.040569283068180084
genetic B-Disease 0 0.3719429671764374
defect I-Disease 1 0.9909548163414001
within O 0 0.04107232019305229
the O 0 0.041658878326416016
POMC O 1 0.9977908134460449
gene O 0 0.10645250976085663
and O 0 0.022802848368883133
define O 0 0.05109405890107155
a O 0 0.03828035667538643
new O 0 0.05762861296534538
monogenic B-Disease 1 0.9998592138290405
endocrine I-Disease 1 0.9999920129776001
disorder I-Disease 1 0.9999912977218628
resulting O 0 0.0932827740907669
in O 0 0.034298889338970184
early O 0 0.0874173641204834
- O 1 0.9996200799942017
onset O 1 0.9999974966049194
obesity B-Disease 1 0.9999994039535522
, O 1 0.5280776023864746
adrenal B-Disease 1 0.9999995231628418
insufficiency I-Disease 1 0.9999992847442627
and O 0 0.04950902983546257
red O 1 0.9875679016113281
hair O 1 0.9988675117492676
pigmentation O 1 0.9997579455375671
. O 0 0.039463743567466736
. O 0 0.046635642647743225

A O 0 0.07269001007080078
European O 0 0.08010237663984299
multicenter O 1 0.9758718609809875
study O 0 0.07831630110740662
of O 0 0.054485466331243515
phenylalanine B-Disease 1 0.99928879737854
hydroxylase I-Disease 1 0.9999638795852661
deficiency I-Disease 1 0.9999998807907104
: O 0 0.06949781626462936
classification O 0 0.09051308780908585
of O 0 0.026941020041704178
105 O 0 0.09696986526250839
mutations O 0 0.10777253657579422
and O 0 0.017001550644636154
a O 0 0.022018499672412872
general O 0 0.02548915706574917
system O 0 0.04126782715320587
for O 0 0.027808599174022675
genotype O 1 0.730017900466919
- O 0 0.10738115757703781
based O 0 0.04688095301389694
prediction O 0 0.0950520932674408
of O 0 0.038565680384635925
metabolic O 1 0.9871847033500671
phenotype O 1 0.9612699747085571
. O 0 0.07463371753692627

Phenylketonuria B-Disease 1 0.999932050704956
( O 0 0.43653199076652527
PKU B-Disease 1 0.9999828338623047
) O 0 0.06288669258356094
and O 0 0.04345569387078285
mild B-Disease 1 0.9999141693115234
hyperphenylalaninemia I-Disease 1 0.9999092817306519
( O 0 0.4481479525566101
MHP B-Disease 1 0.9999831914901733
) O 0 0.05924331024289131
are O 0 0.03850037604570389
allelic B-Disease 1 0.998736560344696
disorders I-Disease 1 0.9999892711639404
caused O 0 0.26504388451576233
by O 0 0.03160425275564194
mutations O 0 0.11009672284126282
in O 0 0.026747364550828934
the O 0 0.03275112435221672
gene O 0 0.14752893149852753
encoding O 0 0.14934664964675903
phenylalanine O 1 0.7703419923782349
hydroxylase O 1 0.9939520955085754
( O 0 0.19890984892845154
PAH O 1 0.9999154806137085
) O 0 0.07823881506919861
. O 0 0.05976025015115738

Previous O 0 0.06057608872652054
studies O 0 0.04900427907705307
have O 0 0.01991702988743782
suggested O 0 0.027499470859766006
that O 0 0.013443727977573872
the O 0 0.02307487651705742
highly O 0 0.059479970484972
variable O 0 0.16767433285713196
metabolic O 1 0.9940928816795349
phenotypes O 1 0.9867868423461914
of O 0 0.10953743755817413
PAH B-Disease 1 0.9999997615814209
deficiency I-Disease 1 0.999998927116394
correlate O 1 0.9070255160331726
with O 0 0.10603608191013336
PAH O 1 0.9999793767929077
genotypes O 1 0.9628303050994873
. O 0 0.08209897577762604

We O 0 0.0442107729613781
identified O 0 0.051122069358825684
both O 0 0.03675955533981323
causative O 1 0.8443248271942139
mutations O 0 0.20457452535629272
in O 0 0.04568379744887352
686 O 1 0.9959523677825928
patients O 1 0.9958412051200867
from O 0 0.02853073924779892
seven O 0 0.031401291489601135
European O 0 0.04407048597931862
centers O 0 0.06939750909805298
. O 0 0.04677112400531769

On O 0 0.023742174729704857
the O 0 0.016158800572156906
basis O 0 0.01909710466861725
of O 0 0.013449478894472122
the O 0 0.02237369865179062
phenotypic O 0 0.10499811917543411
characteristics O 0 0.055090177804231644
of O 0 0.031186634674668312
297 O 0 0.3463614881038666
functionally O 1 0.5630524754524231
hemizygous O 1 0.993415117263794
patients O 1 0.9964045286178589
, O 0 0.02660936303436756
105 O 0 0.05826153978705406
of O 0 0.017041465267539024
the O 0 0.021103769540786743
mutations O 0 0.08929678797721863
were O 0 0.014852014370262623
assigned O 0 0.028659019619226456
to O 0 0.01221571397036314
one O 0 0.011632533743977547
of O 0 0.012638948857784271
four O 0 0.028316106647253036
arbitrary O 0 0.07062454521656036
phenotype O 0 0.43232467770576477
categories O 0 0.07133111357688904
. O 0 0.051362544298172

We O 0 0.03392677754163742
proposed O 0 0.03448561951518059
and O 0 0.019806496798992157
tested O 0 0.07037319242954254
a O 0 0.030424712225794792
simple O 0 0.0349263958632946
model O 0 0.03669154644012451
for O 0 0.020290391519665718
correlation O 0 0.07998136430978775
between O 0 0.036638293415308
genotype O 0 0.22137291729450226
and O 0 0.03263518959283829
phenotypic O 0 0.1275147944688797
outcome O 0 0.08797949552536011
. O 0 0.0507119856774807

The O 0 0.05946650728583336
observed O 0 0.0991978645324707
phenotype O 1 0.5100299119949341
matched O 0 0.09556372463703156
the O 0 0.03744987025856972
predicted O 0 0.08215217292308807
phenotype O 0 0.39867648482322693
in O 0 0.027941159904003143
79 O 0 0.06968818604946136
% O 0 0.02859523519873619
of O 0 0.012641329318284988
the O 0 0.016279438510537148
cases O 0 0.0280708409845829
, O 0 0.013462604954838753
and O 0 0.012043913826346397
in O 0 0.013130473904311657
only O 0 0.013890289701521397
5 O 0 0.028365714475512505
of O 0 0.0209864042699337
184 O 0 0.11723113805055618
patients O 1 0.9874842762947083
was O 0 0.023913735523819923
the O 0 0.022407270967960358
observed O 0 0.05867353454232216
phenotype O 0 0.18284115195274353
more O 0 0.01746278814971447
than O 0 0.017856596037745476
one O 0 0.01748821698129177
category O 0 0.04139544442296028
away O 0 0.024687698110938072
from O 0 0.01935351826250553
that O 0 0.018571803346276283
expected O 0 0.03578096628189087
. O 0 0.04046938195824623

Among O 0 0.040483832359313965
the O 0 0.02381092868745327
seven O 0 0.03375740349292755
contributing O 0 0.06643015891313553
centers O 0 0.046544380486011505
, O 0 0.017781421542167664
the O 0 0.018319575116038322
proportion O 0 0.04305436089634895
of O 0 0.021379917860031128
patients O 1 0.9947392344474792
for O 0 0.021091487258672714
whom O 0 0.03731979802250862
the O 0 0.024803098291158676
observed O 0 0.06426339596509933
phenotype O 1 0.5860652327537537
did O 0 0.030291136354207993
not O 0 0.015237828716635704
match O 0 0.02986864000558853
the O 0 0.022834589704871178
predicted O 0 0.07722451537847519
phenotype O 0 0.20263758301734924
was O 0 0.03276097774505615
4 O 0 0.046316951513290405
% O 0 0.04283490031957626
- O 0 0.09008392691612244
23 O 0 0.055381279438734055
% O 0 0.06295336037874222
( O 0 0.08429130911827087
P O 1 0.9888629913330078
< O 1 0.8229045867919922
. O 0 0.051776058971881866
0001 O 1 0.8914462327957153
) O 0 0.03684673085808754
, O 0 0.020137380808591843
suggesting O 0 0.040722716599702835
that O 0 0.013180220499634743
differences O 0 0.025777162984013557
in O 0 0.017732061445713043
methods O 0 0.030362455174326897
used O 0 0.023947585374116898
for O 0 0.02721267007291317
mutation O 0 0.2510872483253479
detection O 0 0.25408971309661865
or O 0 0.05869833379983902
phenotype O 1 0.9881993532180786
classification O 0 0.1226360872387886
may O 0 0.03515852987766266
account O 0 0.02168397046625614
for O 0 0.013548344373703003
a O 0 0.02377878688275814
considerable O 0 0.04709142446517944
proportion O 0 0.05863061174750328
of O 0 0.03688949719071388
genotype O 1 0.9930890202522278
- O 1 0.8226897120475769
phenotype O 1 0.9726320505142212
inconsistencies O 0 0.1406538188457489
. O 0 0.06512521952390671

Our O 0 0.05068065971136093
data O 0 0.0345388799905777
indicate O 0 0.04268861934542656
that O 0 0.02295808680355549
the O 0 0.05069703236222267
PAH O 1 0.9999918937683105
- O 0 0.4815983474254608
mutation O 0 0.26786282658576965
genotype O 0 0.23723289370536804
is O 0 0.030620723962783813
the O 0 0.022642217576503754
main O 0 0.03993932530283928
determinant O 0 0.1077951118350029
of O 0 0.037618882954120636
metabolic O 1 0.9755915403366089
phenotype O 1 0.8880153894424438
in O 0 0.03559260070323944
most O 0 0.042552027851343155
patients O 1 0.9999798536300659
with O 1 0.6865569949150085
PAH B-Disease 1 0.9999998807907104
deficiency I-Disease 1 0.9999992847442627
. O 0 0.0807480663061142

In O 0 0.027521615847945213
the O 0 0.021046873182058334
present O 0 0.02606448531150818
study O 0 0.03341510519385338
, O 0 0.01575346291065216
the O 0 0.021700840443372726
classification O 0 0.08520153909921646
of O 0 0.036678288131952286
105 O 1 0.8765954971313477
PAH O 1 0.999984622001648
mutations O 0 0.21800556778907776
may O 0 0.03709597885608673
allow O 0 0.02436152473092079
the O 0 0.020976904779672623
prediction O 0 0.05881040543317795
of O 0 0.01856997422873974
the O 0 0.02885972522199154
biochemical O 0 0.1541399210691452
phenotype O 1 0.7916807532310486
in O 0 0.0414062924683094
> O 0 0.16447100043296814
10 O 0 0.03438965976238251
, O 0 0.026307282969355583
000 O 0 0.07888824492692947
genotypes O 0 0.17815808951854706
, O 0 0.023759668692946434
which O 0 0.017106013372540474
may O 0 0.025545382872223854
be O 0 0.010957643389701843
useful O 0 0.01987125538289547
for O 0 0.011702424846589565
the O 0 0.018090875819325447
management O 0 0.05032110586762428
of O 0 0.024824567139148712
hyperphenylalaninemia B-Disease 1 0.9877216219902039
in O 0 0.043522369116544724
newborns O 1 0.9639826416969299
. O 0 0.06360311061143875

Somatic O 0 0.3092516362667084
instability O 0 0.1436012238264084
of O 0 0.028677262365818024
the O 0 0.04028996452689171
CTG O 1 0.984259307384491
repeat O 0 0.13291622698307037
in O 0 0.0367211289703846
mice O 0 0.1650061458349228
transgenic O 0 0.11726194620132446
for O 0 0.031923338770866394
the O 0 0.059254858642816544
myotonic B-Disease 1 0.9999995231628418
dystrophy I-Disease 1 0.9999998807907104
region O 0 0.10514657944440842
is O 0 0.034901268780231476
age O 0 0.0449126660823822
dependent O 0 0.05624372139573097
but O 0 0.02041521854698658
not O 0 0.01846594549715519
correlated O 0 0.0755615234375
to O 0 0.017998281866312027
the O 0 0.026947960257530212
relative O 0 0.07372614741325378
intertissue O 0 0.26614969968795776
transcription O 0 0.14551766216754913
levels O 0 0.08703756332397461
and O 0 0.04275842383503914
proliferative O 1 0.9995341300964355
capacities O 0 0.12374378740787506
. O 0 0.05637819319963455

A O 0 0.08612075448036194
( O 0 0.08835955709218979
CTG O 1 0.9575331211090088
) O 0 0.049838531762361526
nexpansion O 0 0.11770296096801758
in O 0 0.02090802788734436
the O 0 0.024080317467451096
3 O 0 0.057057011872529984
- O 0 0.11421137303113937
untranslated O 0 0.19674734771251678
region O 0 0.08971341699361801
( O 0 0.07197004556655884
UTR O 0 0.26161447167396545
) O 0 0.040556784719228745
of O 0 0.023805394768714905
the O 0 0.053850676864385605
DM O 1 0.9999843835830688
protein O 0 0.2196284383535385
kinase O 1 0.7765262722969055
gene O 0 0.16525709629058838
( O 0 0.06888215988874435
DMPK O 1 0.6897647380828857
) O 0 0.03925224393606186
is O 0 0.02394554577767849
responsible O 0 0.04884087294340134
for O 0 0.042173366993665695
causing O 1 0.9985583424568176
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9940441250801086
DM B-Disease 1 0.9999992847442627
) O 0 0.07977627217769623
. O 0 0.049864523112773895

Major O 0 0.08041796833276749
instability O 0 0.1266336590051651
, O 0 0.024232130497694016
with O 0 0.018821369856595993
very O 0 0.02417239174246788
large O 0 0.026897398754954338
expansions O 0 0.06424064189195633
between O 0 0.02653643675148487
generations O 0 0.04473307728767395
and O 0 0.019782138988375664
high O 0 0.04304182901978493
levels O 0 0.057829104363918304
of O 0 0.03262301906943321
somatic O 1 0.562178909778595
mosaicism O 1 0.9859271049499512
, O 0 0.03514445573091507
is O 0 0.02813514694571495
observed O 0 0.048934925347566605
in O 0 0.03593138977885246
patients O 1 0.9981839060783386
. O 0 0.05073695629835129

There O 0 0.03396173194050789
is O 0 0.02550322934985161
a O 0 0.03101525828242302
good O 0 0.04161916300654411
correlation O 0 0.0782352164387703
between O 0 0.03138839825987816
repeat O 0 0.0932750254869461
size O 0 0.04657072573900223
( O 0 0.037646908313035965
at O 0 0.026468511670827866
least O 0 0.02672143280506134
in O 0 0.028589725494384766
leucocytes O 0 0.3476739823818207
) O 0 0.04991140216588974
, O 0 0.0323348306119442
clinical O 1 0.9400413036346436
severity O 1 0.9763848185539246
and O 0 0.026406804099678993
age O 0 0.04025110974907875
of O 0 0.03375712409615517
onset O 1 0.9992448091506958
. O 0 0.06447325646877289

The O 0 0.08378113806247711
trinucleotide O 1 0.9912011623382568
repeat O 0 0.32036805152893066
instability O 0 0.2036438137292862
mechanisms O 0 0.10010778158903122
involved O 0 0.054436665028333664
in O 0 0.04246736690402031
DM B-Disease 1 0.9999973773956299
and O 0 0.024369532242417336
other O 0 0.02102475054562092
human O 0 0.07367098331451416
genetic B-Disease 1 0.9983990788459778
diseases I-Disease 1 0.9999895095825195
are O 0 0.025373252108693123
unknown O 0 0.05697241425514221
. O 0 0.0434856042265892

We O 0 0.0527389794588089
studied O 0 0.0704091265797615
somatic O 0 0.1935635507106781
instability O 0 0.12817123532295227
by O 0 0.031428541988134384
measuring O 0 0.07826147228479385
the O 0 0.043655648827552795
CTG O 1 0.9657869338989258
repeat O 0 0.11653653532266617
length O 0 0.04948354512453079
at O 0 0.02615378424525261
several O 0 0.01618308201432228
ages O 0 0.03956509754061699
in O 0 0.01627214625477791
various O 0 0.018542954698204994
tissues O 0 0.09739848971366882
of O 0 0.029822301119565964
transgenic O 0 0.14734499156475067
mice O 0 0.17305608093738556
carrying O 0 0.05826545134186745
a O 0 0.04607747867703438
( O 0 0.07177036255598068
CTG O 1 0.9684644937515259
) O 0 0.05602890998125076
55expansion O 0 0.15282762050628662
surrounded O 0 0.05684904009103775
by O 0 0.02199767902493477
45 O 0 0.04518276825547218
kb O 0 0.1054767370223999
of O 0 0.019125493243336678
the O 0 0.02969907969236374
human O 0 0.07052908092737198
DM B-Disease 1 0.9999904632568359
region O 0 0.06442874670028687
, O 0 0.025067217648029327
using O 0 0.030146503821015358
small O 0 0.04811886325478554
- O 0 0.13261501491069794
pool O 0 0.16663362085819244
PCR O 0 0.25551706552505493
. O 0 0.0654730424284935

These O 0 0.04418931156396866
mice O 0 0.13233740627765656
have O 0 0.02232624776661396
been O 0 0.019335582852363586
shown O 0 0.03175146132707596
to O 0 0.019208865240216255
reproduce O 0 0.05586405470967293
the O 0 0.027641450986266136
intergenerational O 0 0.1837269812822342
and O 0 0.03579046204686165
somatic O 0 0.18162129819393158
instability O 0 0.11393865942955017
of O 0 0.021427014842629433
the O 0 0.03362913802266121
55 O 0 0.1010919064283371
CTG O 1 0.9925090670585632
repeat O 0 0.1336701363325119
suggesting O 0 0.06638776510953903
that O 0 0.019885141402482986
surrounding O 0 0.04227270931005478
sequences O 0 0.046480443328619
and O 0 0.018402358517050743
the O 0 0.022776871919631958
chromatin O 0 0.1024501845240593
environment O 0 0.04206161946058273
are O 0 0.016924716532230377
involved O 0 0.036016397178173065
in O 0 0.029845230281352997
instability O 0 0.14453160762786865
mechanisms O 0 0.11980496346950531
. O 0 0.058743420988321304

As O 0 0.03292522951960564
observed O 0 0.03870787471532822
in O 0 0.014433763921260834
some O 0 0.012355194427073002
of O 0 0.01345262210816145
the O 0 0.024704519659280777
tissues O 1 0.6323345303535461
of O 0 0.04678777977824211
DM B-Disease 1 1.0
patients O 1 0.999840497970581
, O 0 0.022178707644343376
there O 0 0.015493972226977348
is O 0 0.016135580837726593
a O 0 0.024128025397658348
tendency O 0 0.06807389855384827
for O 0 0.023329073563218117
repeat O 0 0.09387855231761932
length O 0 0.05648399516940117
and O 0 0.031249618157744408
somatic O 0 0.22333361208438873
mosaicism O 1 0.9480641484260559
to O 0 0.0251284409314394
increase O 0 0.028325777500867844
with O 0 0.01457177009433508
the O 0 0.015482395887374878
age O 0 0.029240133240818977
of O 0 0.01511719636619091
the O 0 0.029117165133357048
mouse O 0 0.15376003086566925
. O 0 0.055108390748500824

Furthermore O 0 0.08491159975528717
, O 0 0.02948128432035446
we O 0 0.02207333780825138
observed O 0 0.04079311713576317
no O 0 0.024737214669585228
correlation O 0 0.06681802123785019
between O 0 0.028504522517323494
the O 0 0.03507152944803238
somatic O 0 0.3112504184246063
mutation O 0 0.3004777729511261
rate O 0 0.07710712403059006
and O 0 0.035354454070329666
tissue O 1 0.9520871043205261
proliferation O 0 0.1281270980834961
capacity O 0 0.059691596776247025
. O 0 0.04751061275601387

The O 0 0.07330923527479172
somatic O 0 0.3033057153224945
mutation O 0 0.25123271346092224
rates O 0 0.0748167335987091
in O 0 0.022447120398283005
different O 0 0.021921826526522636
tissues O 0 0.07809475064277649
were O 0 0.014417038299143314
also O 0 0.01605452597141266
not O 0 0.01576247066259384
correlated O 0 0.06690392643213272
to O 0 0.017600102350115776
the O 0 0.02391872927546501
relative O 0 0.06903444230556488
inter O 0 0.12669426202774048
- O 0 0.1589188277721405
tissue O 0 0.3215373158454895
difference O 0 0.06946010142564774
in O 0 0.0294401366263628
transcriptional O 0 0.12323527038097382
levels O 0 0.045121803879737854
of O 0 0.014589265920221806
the O 0 0.01985163427889347
three O 0 0.028335506096482277
genes O 0 0.0994727686047554
( O 0 0.07082244753837585
DMAHP O 1 0.8045519590377808
, O 0 0.034224607050418854
DMPK O 0 0.42120927572250366
and O 0 0.025224750861525536
59 O 0 0.06327256560325623
) O 0 0.03224920481443405
surrounding O 0 0.037858981639146805
the O 0 0.02588692121207714
repeat O 0 0.10127457231283188
. O 0 0.030382461845874786
. O 0 0.04540102928876877

A O 0 0.09112575650215149
novel O 0 0.10639446973800659
missense O 0 0.31494763493537903
mutation O 0 0.23141124844551086
in O 0 0.04823630303144455
patients O 1 0.9968339800834656
from O 0 0.036204516887664795
a O 0 0.04824099689722061
retinoblastoma B-Disease 1 0.9990919828414917
pedigree O 0 0.20381508767604828
showing O 0 0.06274940073490143
only O 0 0.02785206399857998
mild O 1 0.8713642358779907
expression O 0 0.052722375839948654
of O 0 0.020966090261936188
the O 0 0.04129382222890854
tumor B-Disease 1 0.9996618032455444
phenotype O 1 0.9896838665008545
. O 0 0.07072438299655914

We O 0 0.03314029425382614
have O 0 0.02050928771495819
used O 0 0.028231225907802582
single O 0 0.05318374186754227
strand O 0 0.13422024250030518
conformation O 0 0.14622949063777924
polymorphism O 0 0.13586758077144623
analysis O 0 0.04298001900315285
to O 0 0.018151700496673584
study O 0 0.030415846034884453
the O 0 0.021894609555602074
27 O 0 0.042406659573316574
exons O 0 0.08801669627428055
of O 0 0.023265372961759567
the O 0 0.03853987529873848
RB1 O 1 0.9972299933433533
gene O 0 0.11553231626749039
in O 0 0.02683521807193756
individuals O 0 0.0305493101477623
from O 0 0.021126769483089447
a O 0 0.028378237038850784
family O 0 0.0465608686208725
showing O 0 0.06694792956113815
mild O 1 0.9574313163757324
expression O 0 0.05486215278506279
of O 0 0.020490044727921486
the O 0 0.04159952327609062
retinoblastoma B-Disease 1 0.9995096921920776
phenotype O 1 0.9851277470588684
. O 0 0.07143901288509369

In O 0 0.034960899502038956
this O 0 0.024023747071623802
family O 0 0.048690881580114365
affected O 0 0.07058947533369064
individuals O 0 0.04645238816738129
developed O 0 0.08083975315093994
unilateral B-Disease 1 0.7346848249435425
tumors I-Disease 1 0.9999148845672607
and O 0 0.01975168101489544
, O 0 0.017126917839050293
as O 0 0.013187261298298836
a O 0 0.020281676203012466
result O 0 0.030672069638967514
of O 0 0.021247252821922302
linkage O 0 0.14134903252124786
analysis O 0 0.06224311515688896
, O 0 0.039954427629709244
unaffected O 0 0.4853357970714569
mutation O 0 0.18818917870521545
carriers O 0 0.09196020662784576
were O 0 0.018352871760725975
also O 0 0.018528731539845467
identified O 0 0.03232016786932945
within O 0 0.02190699614584446
the O 0 0.02802782878279686
pedigree O 0 0.146565780043602
. O 0 0.055638428777456284

A O 0 0.06639011949300766
single O 0 0.058114875108003616
band O 0 0.072990782558918
shift O 0 0.06994466483592987
using O 0 0.04475397989153862
SSCP O 0 0.1735914647579193
was O 0 0.028385238721966743
identified O 0 0.0370325893163681
in O 0 0.024671239778399467
exon O 0 0.12499955296516418
21 O 0 0.04326943680644035
which O 0 0.02050129510462284
resulted O 0 0.04621715098619461
in O 0 0.021618830040097237
a O 0 0.04348751902580261
missense O 0 0.20822113752365112
mutation O 0 0.19164234399795532
converting O 0 0.09201177954673767
a O 0 0.08005549758672714
cys O 1 0.9997499585151672
- O 1 0.9863598942756653
- O 1 0.8791447281837463
> O 1 0.8483741283416748
arg O 1 0.8917872905731201
at O 0 0.059197861701250076
nucleotide O 0 0.10236528515815735
position O 0 0.03468683734536171
28 O 0 0.03381064534187317
in O 0 0.017334267497062683
the O 0 0.02681850455701351
exon O 0 0.17991404235363007
. O 0 0.06669183820486069

The O 0 0.06674846261739731
mutation O 0 0.19000497460365295
destroyed O 0 0.07685098797082901
an O 0 0.04525874927639961
NdeI O 0 0.25911930203437805
restriction O 0 0.11617440730333328
enzyme O 0 0.15649503469467163
site O 0 0.07113660871982574
. O 0 0.05655982717871666

Analysis O 0 0.05430317297577858
of O 0 0.017143895849585533
all O 0 0.013526033610105515
family O 0 0.028749745339155197
members O 0 0.025041650980710983
demonstrated O 0 0.045324571430683136
that O 0 0.01909540966153145
the O 0 0.032152555882930756
missense O 0 0.4705340564250946
mutation O 1 0.8717128038406372
co O 1 0.7266375422477722
- O 0 0.15959157049655914
segregated O 0 0.13737919926643372
with O 0 0.044185616075992584
patients O 1 0.9998487234115601
with O 0 0.04815181717276573
tumors B-Disease 1 0.999983549118042
or O 0 0.03238232061266899
who O 0 0.022113792598247528
, O 0 0.013705440796911716
as O 0 0.011864246800541878
a O 0 0.01978379115462303
result O 0 0.027653129771351814
of O 0 0.016457727178931236
linkage O 0 0.11083655804395676
analysis O 0 0.03772282972931862
had O 0 0.021380417048931122
been O 0 0.018527070060372353
predicted O 0 0.03490067273378372
to O 0 0.017272312194108963
carry O 0 0.03417308256030083
the O 0 0.03895624727010727
predisposing O 0 0.3290117681026459
mutation O 0 0.24766290187835693
. O 0 0.0676829144358635

These O 0 0.035098038613796234
observations O 0 0.04799259826540947
point O 0 0.026602039113640785
to O 0 0.01547522284090519
another O 0 0.022563811391592026
region O 0 0.036016833037137985
of O 0 0.019833508878946304
the O 0 0.04564066231250763
RB1 O 1 0.9992161989212036
gene O 0 0.1355016678571701
where O 0 0.037043049931526184
mutations O 0 0.10764535516500473
only O 0 0.019641151651740074
modify O 0 0.05602232739329338
the O 0 0.021588891744613647
function O 0 0.03423124924302101
of O 0 0.014234069734811783
the O 0 0.021392598748207092
gene O 0 0.07116550952196121
and O 0 0.018849749118089676
raise O 0 0.03791482001543045
important O 0 0.01923087239265442
questions O 0 0.027954991906881332
for O 0 0.022140420973300934
genetic O 0 0.09945393353700638
counseling O 1 0.5623589754104614
in O 0 0.019566640257835388
families O 0 0.02993053011596203
with O 0 0.022036217153072357
these O 0 0.02309601381421089
distinctive O 0 0.10240377485752106
phenotypes O 0 0.21788619458675385
. O 0 0.04402489215135574
. O 0 0.04901786893606186

Maternal B-Disease 1 0.957388699054718
disomy I-Disease 1 0.9956140518188477
and O 0 0.3226735591888428
Prader B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999685287475586
Willi I-Disease 1 0.9999995231628418
syndrome I-Disease 1 0.9999997615814209
consistent O 0 0.10017766803503036
with O 0 0.0553307868540287
gamete O 1 0.9564380049705505
complementation O 1 0.9833984375
in O 0 0.031025003641843796
a O 0 0.030467089265584946
case O 0 0.03464467450976372
of O 0 0.03142396733164787
familial O 1 0.9985748529434204
translocation O 1 0.8627790808677673
( O 0 0.05602389946579933
3 O 0 0.0448693111538887
; O 0 0.033919814974069595
15 O 0 0.03835853189229965
) O 0 0.04762563481926918
( O 0 0.06693204492330551
p25 O 1 0.8650731444358826
; O 0 0.057978950440883636
q11 O 0 0.1368810385465622
. O 0 0.029274901375174522
2 O 0 0.04673323035240173
) O 0 0.04391392320394516
. O 0 0.04780339449644089

Maternal B-Disease 1 0.9827278256416321
uniparental I-Disease 1 0.9995471835136414
disomy I-Disease 1 0.9918782711029053
( I-Disease 0 0.12384187430143356
UPD I-Disease 1 0.9995782971382141
) I-Disease 0 0.04971973970532417
for I-Disease 0 0.025860482826828957
chromosome I-Disease 0 0.1255185753107071
15 I-Disease 0 0.03108372911810875
is O 0 0.01802925579249859
responsible O 0 0.026390409097075462
for O 0 0.012432335875928402
an O 0 0.016678664833307266
estimated O 0 0.031174059957265854
30 O 0 0.0262431837618351
% O 0 0.02578209526836872
of O 0 0.015941202640533447
cases O 0 0.04470058158040047
of O 0 0.05426398292183876
Prader B-Disease 1 1.0
- I-Disease 1 0.9999934434890747
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9219776391983032
PWS B-Disease 1 0.9999948740005493
) O 0 0.08122846484184265
. O 0 0.05443887040019035

We O 0 0.032126203179359436
report O 0 0.022447215393185616
on O 0 0.014342434704303741
an O 0 0.018713172525167465
unusual O 0 0.042651478201150894
case O 0 0.030696095898747444
of O 0 0.02413288503885269
maternal B-Disease 0 0.19712015986442566
disomy I-Disease 0 0.3565525710582733
15 I-Disease 0 0.04945148527622223
in O 0 0.03626947104930878
PWS B-Disease 1 0.9999443292617798
that O 0 0.020446453243494034
is O 0 0.0178968645632267
most O 0 0.01575838215649128
consistent O 0 0.04057192802429199
with O 0 0.023595010861754417
adjacent O 0 0.054156433790922165
- O 0 0.08828914165496826
1 O 0 0.04603755846619606
segregation O 0 0.07439696043729782
of O 0 0.02369779720902443
a O 0 0.04443015158176422
paternal O 0 0.20017868280410767
t O 1 0.934482753276825
( O 0 0.05787588283419609
3 O 0 0.04561733826994896
; O 0 0.03361256793141365
15 O 0 0.04087028652429581
) O 0 0.040691398084163666
( O 0 0.05986570939421654
p25 O 1 0.9120554327964783
; O 0 0.04978207126259804
q11 O 0 0.13620920479297638
. O 0 0.02418104000389576
2 O 0 0.035111796110868454
) O 0 0.02702224627137184
with O 0 0.025780748575925827
simultaneous O 0 0.08310592174530029
maternal O 0 0.2122257798910141
meiotic O 1 0.9645111560821533
nondisjunction O 0 0.2745281457901001
for O 0 0.04224320128560066
chromosome O 0 0.17759627103805542
15 O 0 0.058797068893909454
. O 0 0.05049622058868408

The O 0 0.06908294558525085
patient O 1 0.9911097288131714
( O 0 0.0844198614358902
J O 1 0.980510413646698
. O 0 0.032617658376693726
B O 0 0.08855339139699936
. O 0 0.019465619698166847
) O 0 0.023766571655869484
, O 0 0.016152501106262207
a O 0 0.02329470030963421
17 O 0 0.043088048696517944
- O 0 0.08964879810810089
year O 0 0.04035257548093796
- O 0 0.0954645648598671
old O 0 0.060068096965551376
white O 0 0.07996981590986252
male O 0 0.09603385627269745
with O 0 0.04978425055742264
PWS B-Disease 1 0.9999793767929077
, O 0 0.02573379874229431
was O 0 0.020033733919262886
found O 0 0.01877935416996479
to O 0 0.01487976498901844
have O 0 0.018093569204211235
47 O 0 0.05165722593665123
chromosomes O 0 0.07644528150558472
with O 0 0.02716926299035549
a O 0 0.04211955517530441
supernumerary O 0 0.1677592247724533
, O 0 0.047201309353113174
paternal O 0 0.17479999363422394
der O 0 0.4055871367454529
( O 0 0.045086219906806946
15 O 0 0.029909372329711914
) O 0 0.023623500019311905
consisting O 0 0.023498456925153732
of O 0 0.011789591982960701
the O 0 0.01806638017296791
short O 0 0.04413384199142456
arm O 0 0.08506439626216888
and O 0 0.019551292061805725
the O 0 0.027515606954693794
proximal O 1 0.9647333025932312
long O 0 0.06021415814757347
arm O 0 0.11088459193706512
of O 0 0.02766958437860012
chromosome O 0 0.14244790375232697
15 O 0 0.03880472108721733
, O 0 0.02501494809985161
and O 0 0.035372789949178696
distal O 1 0.9921031594276428
chromosome O 1 0.8123270273208618
arm O 1 0.9641538262367249
3p O 1 0.9871915578842163
. O 0 0.07388132065534592

The O 0 0.06239603832364082
t O 1 0.6990168690681458
( O 0 0.050223708152770996
3 O 0 0.04080301150679588
; O 0 0.029553823173046112
15 O 0 0.02684536762535572
) O 0 0.020629778504371643
was O 0 0.014542930759489536
present O 0 0.016786104068160057
in O 0 0.011979358270764351
the O 0 0.015389692969620228
balanced O 0 0.04435949772596359
state O 0 0.018345287069678307
in O 0 0.01719599962234497
the O 0 0.025313768535852432
patients O 1 0.9950838685035706
father O 0 0.04119537025690079
and O 0 0.020914524793624878
a O 0 0.03687871992588043
sister O 0 0.0813126340508461
. O 0 0.04942379146814346

Fluorescent O 0 0.22331519424915314
in O 0 0.05416225269436836
situ O 0 0.19949211180210114
hybridization O 0 0.1438763588666916
analysis O 0 0.05234790965914726
demonstrated O 0 0.05389280617237091
that O 0 0.02144632488489151
the O 0 0.04013882204890251
PWS B-Disease 1 0.999935507774353
critical O 0 0.07042228430509567
region O 0 0.054742518812417984
resided O 0 0.06814634799957275
on O 0 0.018054135143756866
the O 0 0.0289529450237751
derivative O 0 0.12204144895076752
chromosome O 0 0.14238153398036957
3 O 0 0.03404168039560318
and O 0 0.0134620051831007
that O 0 0.01252731867134571
there O 0 0.014513078145682812
was O 0 0.019387153908610344
no O 0 0.024317707866430283
deletion O 0 0.09375280141830444
of O 0 0.019820978865027428
the O 0 0.03500460088253021
PWS B-Disease 1 0.9999468326568604
region O 0 0.04720989987254143
on O 0 0.014663578011095524
the O 0 0.018364453688263893
normal O 0 0.04720433056354523
pair O 0 0.04440139979124069
of O 0 0.024534039199352264
15s O 0 0.16689229011535645
present O 0 0.04484327882528305
in O 0 0.041066184639930725
J O 1 0.9729030132293701
. O 0 0.06017490476369858

B O 0 0.2541411519050598
. O 0 0.08186046779155731

Methylation O 0 0.18798229098320007
analysis O 0 0.07180386781692505
at O 0 0.04904932156205177
exon O 0 0.1335902065038681
alpha O 0 0.0696198120713234
of O 0 0.017655104398727417
the O 0 0.024419309571385384
small O 0 0.04186536744236946
nuclear O 0 0.10084177553653717
ribonucleoprotein O 1 0.9928765892982483
- O 0 0.15185454487800598
associated O 0 0.08850928395986557
polypeptide O 0 0.2118033468723297
N O 0 0.16445809602737427
( O 0 0.08796919137239456
SNRPN O 1 0.8800603151321411
) O 0 0.058013271540403366
gene O 0 0.10091006755828857
showed O 0 0.0470530241727829
a O 0 0.03316601738333702
pattern O 0 0.07416936010122299
characteristic O 0 0.05854497477412224
of O 0 0.015361026860773563
only O 0 0.017410477623343468
the O 0 0.028078380972146988
maternal O 0 0.1677149534225464
chromosome O 0 0.17232345044612885
15 O 0 0.04725486412644386
in O 0 0.03923534229397774
J O 1 0.9787253737449646
. O 0 0.05868326872587204

B O 0 0.24261198937892914
. O 0 0.07617992162704468

Maternal B-Disease 1 0.5083896517753601
disomy I-Disease 0 0.29607197642326355
was O 0 0.045091662555933
confirmed O 0 0.05232718214392662
by O 0 0.0344664491713047
polymerase O 0 0.19237837195396423
chain O 0 0.11530475318431854
reaction O 0 0.08928725123405457
analysis O 0 0.04464002698659897
of O 0 0.02615704946219921
microsatellite O 0 0.21410022675991058
repeats O 0 0.11105173081159592
at O 0 0.038708560168743134
the O 0 0.03752583637833595
gamma O 0 0.3736892640590668
- O 0 0.19606369733810425
aminobutyric O 1 0.7153958082199097
acid O 1 0.7003629207611084
receptor O 0 0.48922452330589294
beta3 O 0 0.3148674964904785
subunit O 0 0.22155390679836273
( O 0 0.09819018840789795
GABRB3 O 1 0.7233657240867615
) O 0 0.07096318155527115
locus O 0 0.18673738837242126
. O 0 0.06780000776052475

A O 0 0.08936856687068939
niece O 0 0.17735664546489716
( O 0 0.06732142716646194
B O 0 0.11509314924478531
. O 0 0.02807668223977089
B O 0 0.09348843991756439
. O 0 0.01958306133747101
) O 0 0.022372595965862274
with O 0 0.016510210931301117
45 O 0 0.03447582572698593
chromosomes O 0 0.06375346332788467
and O 0 0.016833892092108727
the O 0 0.021746674552559853
derivative O 0 0.08784152567386627
3 O 0 0.03402719274163246
but O 0 0.018935266882181168
without O 0 0.021729638800024986
the O 0 0.02508670836687088
der O 0 0.1486337035894394
( O 0 0.04447564110159874
15 O 0 0.03799906373023987
) O 0 0.034103427082300186
demonstrated O 0 0.053925104439258575
a O 0 0.0374508798122406
phenotype O 0 0.21929091215133667
consistent O 0 0.05090482160449028
with O 0 0.018173348158597946
that O 0 0.01527140662074089
reported O 0 0.034283243119716644
for O 0 0.023701844736933708
haploinsufficiency O 0 0.1475701481103897
of O 0 0.036919645965099335
distal O 1 0.9711840152740479
3 O 0 0.09000744670629501
p O 0 0.1883293241262436
. O 0 0.05273035541176796

Uniparental B-Disease 1 0.9998906850814819
disomy I-Disease 1 0.984152615070343
associated O 0 0.07507950067520142
with O 0 0.03957633301615715
unbalanced O 0 0.16173304617404938
segregation O 0 0.11751701682806015
of O 0 0.0371585488319397
non O 0 0.0913941040635109
- O 0 0.22321969270706177
Robertsonian O 1 0.8199098706245422
translocations O 0 0.2858128547668457
has O 0 0.031926561146974564
been O 0 0.023921338841319084
reported O 0 0.038604266941547394
previously O 0 0.022038079798221588
but O 0 0.013834863901138306
has O 0 0.01322231162339449
not O 0 0.010249331593513489
, O 0 0.010426639579236507
to O 0 0.011036837473511696
our O 0 0.014379138126969337
knowledge O 0 0.02315167337656021
, O 0 0.014529337175190449
been O 0 0.016623925417661667
observed O 0 0.030056502670049667
in O 0 0.01568399742245674
a O 0 0.02516973577439785
case O 0 0.041013799607753754
of O 0 0.040400177240371704
PWS B-Disease 1 0.9999688863754272
. O 0 0.07009357213973999

Furthermore O 0 0.0813249871134758
, O 0 0.026271257549524307
our O 0 0.02315850369632244
findings O 0 0.039580125361680984
are O 0 0.014563499949872494
best O 0 0.026196250692009926
interpreted O 0 0.03442263603210449
as O 0 0.024398570880293846
true O 0 0.06025189161300659
gamete O 1 0.9295392036437988
complementation O 1 0.9961156845092773
resulting O 0 0.09881186485290527
in O 0 0.046201128512620926
maternal B-Disease 1 0.9449504017829895
UPD I-Disease 1 0.9998077750205994
15 I-Disease 0 0.08827190101146698
and O 0 0.06535912305116653
PWS B-Disease 1 0.9999666213989258

Schwartz B-Disease 1 0.998030960559845
- I-Disease 1 0.9953669309616089
Jampel I-Disease 1 0.9994884729385376
syndrome I-Disease 1 0.9999991655349731
type I-Disease 0 0.1753460317850113
2 I-Disease 0 0.05915776640176773
and O 0 0.04055275768041611
Stuve B-Disease 1 0.9998134970664978
- I-Disease 1 0.9996107220649719
Wiedemann I-Disease 1 0.999983549118042
syndrome I-Disease 1 0.9999994039535522
: O 0 0.04881470277905464
a O 0 0.027130575850605965
case O 0 0.03132064640522003
for O 0 0.021309051662683487
" O 0 0.03688441216945648
lumping O 0 0.14865872263908386
" O 0 0.04752330109477043
. O 0 0.04875103756785393

Recent O 0 0.07168423384428024
studies O 0 0.055197007954120636
demonstrated O 0 0.04701588675379753
the O 0 0.01873091422021389
existence O 0 0.029862219467759132
of O 0 0.015455997548997402
a O 0 0.02960439771413803
genetically O 0 0.06653179973363876
distinct O 0 0.05158781260251999
, O 0 0.02394329383969307
usually O 0 0.03410880267620087
lethal O 0 0.10030782222747803
form O 0 0.034730229526758194
of O 0 0.020904721692204475
the O 0 0.040055595338344574
Schwartz B-Disease 1 0.9982117414474487
- I-Disease 1 0.9984839558601379
Jampel I-Disease 1 0.9999375343322754
syndrome I-Disease 1 0.9999998807907104
( O 1 0.7795557379722595
SJS B-Disease 1 0.9999761581420898
) O 0 0.060670629143714905
of O 0 0.03621610254049301
myotonia B-Disease 1 0.9999772310256958
and O 0 0.04926919937133789
skeletal B-Disease 1 0.9998767375946045
dysplasia I-Disease 1 0.999997615814209
, O 0 0.030607689172029495
which O 0 0.022565847262740135
we O 0 0.0275435708463192
called O 0 0.07018479704856873
SJS B-Disease 1 0.9999099969863892
type I-Disease 0 0.11095282435417175
2 I-Disease 0 0.06088263541460037
. O 0 0.048255372792482376

This O 0 0.0637272298336029
disorder O 1 0.9998723268508911
is O 0 0.03316858038306236
reminiscent O 0 0.06398473680019379
of O 0 0.020054198801517487
another O 0 0.03805280476808548
rare O 0 0.0692354291677475
condition O 0 0.24656105041503906
, O 0 0.026623323559761047
the O 0 0.03836619481444359
Stuve B-Disease 1 0.9996678829193115
- I-Disease 1 0.9992074370384216
Wiedemann I-Disease 1 0.9999542236328125
syndrome I-Disease 1 0.9999996423721313
( O 0 0.12067930400371552
SWS B-Disease 1 0.9987805485725403
) O 0 0.04189124330878258
, O 0 0.019861837849020958
which O 0 0.01921854354441166
comprises O 0 0.04981492459774017
campomelia B-Disease 0 0.155532568693161
at O 0 0.04118112474679947
birth O 0 0.07700797915458679
with O 0 0.047893550246953964
skeletal B-Disease 1 0.9999148845672607
dysplasia I-Disease 1 0.9999994039535522
, O 0 0.05969845876097679
contractures B-Disease 1 0.9992104768753052
, O 0 0.028691492974758148
and O 0 0.021793212741613388
early B-Disease 0 0.04384005814790726
death I-Disease 0 0.06007321551442146
. O 0 0.046285953372716904

To O 0 0.037668049335479736
test O 0 0.049069274216890335
for O 0 0.023283593356609344
possible O 0 0.04303044080734253
nosologic O 0 0.15637534856796265
identity O 0 0.04525917023420334
between O 0 0.029682086780667305
these O 0 0.027242805808782578
disorders O 1 0.9998743534088135
, O 0 0.02121707797050476
we O 0 0.01575457490980625
reviewed O 0 0.025625932961702347
the O 0 0.013786090537905693
literature O 0 0.01895192079246044
and O 0 0.012081469409167767
obtained O 0 0.02166152559220791
a O 0 0.02260126918554306
follow O 0 0.036030113697052
- O 0 0.05421464517712593
up O 0 0.017757529392838478
of O 0 0.010506074875593185
the O 0 0.012768915854394436
only O 0 0.014220073819160461
two O 0 0.018797803670167923
surviving O 0 0.0707307755947113
patients O 1 0.9917158484458923
, O 0 0.02503536269068718
one O 0 0.024601219221949577
with O 0 0.042248986661434174
SJS B-Disease 1 0.9999077320098877
type I-Disease 0 0.09391997009515762
2 I-Disease 0 0.04468593746423721
at O 0 0.029688429087400436
age O 0 0.034874122589826584
10 O 0 0.021252596750855446
years O 0 0.017243454232811928
and O 0 0.015242407098412514
another O 0 0.028530258685350418
with O 0 0.03208867833018303
SWS B-Disease 1 0.996401309967041
at O 0 0.04748426377773285
age O 0 0.05231398344039917
7 O 0 0.04395749419927597
years O 0 0.036816615611314774
. O 0 0.04509429261088371

Patients O 1 0.9987484216690063
reported O 0 0.06434508413076401
as O 0 0.02534816414117813
having O 0 0.047063566744327545
either O 0 0.07117356359958649
neonatal O 1 0.9999994039535522
SJS B-Disease 1 0.9999912977218628
or O 0 0.07587705552577972
SWS B-Disease 1 0.9955248832702637
presented O 0 0.043478645384311676
a O 0 0.029300754889845848
combination O 0 0.05810615420341492
of O 0 0.017834383994340897
a O 0 0.03905173018574715
severe O 1 0.9996848106384277
, O 0 0.06910385191440582
prenatal O 1 0.9999954700469971
- O 1 0.9999663829803467
onset O 1 0.9999995231628418
neuromuscular B-Disease 1 1.0
disorder I-Disease 1 0.9999998807907104
( O 0 0.47048887610435486
with O 0 0.0918855220079422
congenital B-Disease 1 1.0
joint I-Disease 1 0.9990842342376709
contractures I-Disease 1 0.9999973773956299
, O 0 0.20695549249649048
respiratory O 1 0.9999991655349731
and O 0 0.03294484317302704
feeding O 0 0.10831911861896515
difficulties O 0 0.0927070677280426
, O 0 0.032039057463407516
tendency O 0 0.09797754883766174
to O 0 0.0415002703666687
hyperthermia B-Disease 1 0.9998513460159302
, O 0 0.025664279237389565
and O 0 0.02215617150068283
frequent O 0 0.07523801922798157
death O 0 0.054308027029037476
in O 0 0.030071906745433807
infancy O 0 0.12888671457767487
) O 0 0.031032945960760117
with O 0 0.02190660499036312
a O 0 0.03515775129199028
distinct O 0 0.08001632243394852
campomelic B-Disease 1 0.9960508942604065
- I-Disease 1 0.9801968336105347
metaphyseal I-Disease 1 0.997499406337738
skeletal I-Disease 1 0.9997609257698059
dysplasia I-Disease 1 0.9999932050704956
. O 0 0.0785013884305954

The O 0 0.03651009872555733
similarity O 0 0.06018756702542305
of O 0 0.017957067117094994
the O 0 0.029686061665415764
clinical O 1 0.5056560635566711
and O 0 0.030872242525219917
radiographic O 1 0.9659697413444519
findings O 0 0.05553417280316353
is O 0 0.02079673670232296
so O 0 0.016534175723791122
extensive O 0 0.028111519291996956
that O 0 0.014674819074571133
these O 0 0.020648285746574402
disorders O 1 0.999721348285675
appear O 0 0.02994576282799244
to O 0 0.012756400741636753
be O 0 0.011299659498035908
a O 0 0.022637350484728813
single O 0 0.039872922003269196
entity O 0 0.07256271690130234
. O 0 0.04967750981450081

The O 0 0.039856523275375366
follow O 0 0.05138251930475235
- O 0 0.07841911166906357
up O 0 0.02680245228111744
observation O 0 0.0561617836356163
of O 0 0.013983887620270252
an O 0 0.016157373785972595
identical O 0 0.03495880961418152
and O 0 0.01821971870958805
unique O 0 0.03851620480418205
pattern O 0 0.07775288820266724
of O 0 0.03261680528521538
progressive O 1 0.996479332447052
bone B-Disease 1 0.9999853372573853
dysplasia I-Disease 1 0.9999898672103882
in O 0 0.02582189068198204
the O 0 0.02266869880259037
two O 0 0.02883901819586754
patients O 1 0.9978927969932556
( O 0 0.04291757568717003
one O 0 0.025090742856264114
with O 0 0.042414117604494095
SJS B-Disease 1 0.9999545812606812
type I-Disease 0 0.09204521775245667
2 I-Disease 0 0.03775084391236305
, O 0 0.01712208054959774
one O 0 0.01941067725419998
with O 0 0.036175355315208435
SWS B-Disease 1 0.9980548620223999
) O 0 0.05157707631587982
surviving O 0 0.07591404765844345
beyond O 0 0.05903981998562813
infancy O 0 0.16232506930828094
adds O 0 0.05767102539539337
to O 0 0.014000283554196358
the O 0 0.014328407123684883
evidence O 0 0.02093743532896042
in O 0 0.01599862053990364
favor O 0 0.029970241710543633
of O 0 0.019105322659015656
identity O 0 0.06152656301856041
. O 0 0.04880101606249809

The O 0 0.05078621208667755
hypothesis O 0 0.1296492964029312
that O 0 0.04904666915535927
SWS B-Disease 1 0.9988683462142944
and O 0 0.07033585757017136
SJS B-Disease 1 0.9999561309814453
type I-Disease 0 0.09137217700481415
2 I-Disease 0 0.03592872992157936
are O 0 0.013932246714830399
the O 0 0.019024668261408806
same O 0 0.035829562693834305
disorder O 1 0.9998089671134949
should O 0 0.025860276073217392
be O 0 0.016271796077489853
testable O 0 0.07259833067655563
by O 0 0.02551279589533806
molecular O 0 0.07122988253831863
methods O 0 0.04603905603289604
. O 0 0.030245648697018623
. O 0 0.039331723004579544

A O 0 0.0853067934513092
mouse O 0 0.16042548418045044
model O 0 0.07559569925069809
of O 0 0.049964211881160736
severe O 1 0.9999938011169434
von B-Disease 1 0.9999980926513672
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 0 0.22427745163440704
defects O 1 0.9976233839988708
in O 0 0.04329661652445793
hemostasis O 1 0.9999349117279053
and O 0 0.07056280970573425
thrombosis B-Disease 1 0.9999986886978149
. O 0 0.07079888135194778

von B-Disease 1 0.9949053525924683
Willebrand I-Disease 1 0.9998284578323364
factor I-Disease 1 0.7905092239379883
( I-Disease 1 0.5570052862167358
vWf I-Disease 1 0.9999480247497559
) I-Disease 1 0.9969340562820435
deficiency I-Disease 1 1.0
causes O 1 0.9999963045120239
severe O 1 0.9999996423721313
von B-Disease 1 0.9999991655349731
Willebrand I-Disease 1 0.9999998807907104
disease I-Disease 1 0.9999996423721313
in O 0 0.04728587716817856
humans O 0 0.10473188757896423
. O 0 0.05738992989063263

We O 0 0.0433255210518837
generated O 0 0.05841502919793129
a O 0 0.03806912899017334
mouse O 0 0.11885800212621689
model O 0 0.04646874964237213
for O 0 0.019736316055059433
this O 0 0.025386007502675056
disease O 1 0.9965793490409851
by O 0 0.025290904566645622
using O 0 0.04274393618106842
gene O 0 0.11603909730911255
targeting O 0 0.10731056332588196
. O 0 0.05352610722184181

vWf B-Disease 1 0.9980484247207642
- I-Disease 1 0.9550254344940186
deficient I-Disease 1 0.9915345311164856
mice O 1 0.5853273272514343
appeared O 0 0.06393643468618393
normal O 0 0.072163425385952
at O 0 0.034996405243873596
birth O 0 0.05250580236315727
; O 0 0.023430658504366875
they O 0 0.013301032595336437
were O 0 0.015406862832605839
viable O 0 0.0608123317360878
and O 0 0.026316316798329353
fertile O 0 0.1232372373342514
. O 0 0.05304015800356865

Neither O 0 0.16043992340564728
vWf O 1 0.9681614637374878
nor O 0 0.1576891392469406
vWf O 1 0.9903302192687988
propolypeptide O 1 0.9874852299690247
( O 0 0.13754375278949738
von B-Disease 1 0.9965215921401978
Willebrand I-Disease 1 0.999967098236084
antigen O 1 0.9988700747489929
II O 0 0.301731139421463
) O 0 0.03821812942624092
were O 0 0.02114996127784252
detectable O 0 0.1147257387638092
in O 0 0.032084282487630844
plasma O 0 0.14336080849170685
, O 0 0.037926338613033295
platelets O 1 0.9423948526382446
, O 0 0.033476293087005615
or O 0 0.04891292005777359
endothelial O 1 0.9957630634307861
cells O 0 0.09652073681354523
of O 0 0.021884532645344734
the O 0 0.03437889739871025
homozygous O 0 0.17662426829338074
mutant O 0 0.21700052917003632
mice O 0 0.37590470910072327
. O 0 0.0732538104057312

The O 0 0.07568623870611191
mutant O 0 0.22988981008529663
mice O 1 0.7866801619529724
exhibited O 0 0.154294952750206
defects O 1 0.9707794189453125
in O 0 0.04638219252228737
hemostasis O 1 0.9974034428596497
with O 0 0.03580910712480545
a O 0 0.04359935224056244
highly O 0 0.0784708559513092
prolonged O 1 0.9988038539886475
bleeding O 1 0.9999017715454102
time O 0 0.0420997254550457
and O 0 0.03480248525738716
spontaneous O 0 0.17244091629981995
bleeding O 1 0.9986135959625244
events O 0 0.04365313798189163
in O 0 0.02168108895421028
approximately O 0 0.03737108036875725
10 O 0 0.028030920773744583
% O 0 0.03896915167570114
of O 0 0.0324539951980114
neonates O 1 0.9570961594581604
. O 0 0.06540777534246445

As O 0 0.027376236394047737
in O 0 0.022561056539416313
the O 0 0.02602262981235981
human O 0 0.05402233451604843
disease O 1 0.9997791647911072
, O 0 0.024501821026206017
the O 0 0.030101332813501358
factor O 0 0.08897554129362106
VIII O 0 0.21458633244037628
level O 0 0.0401419997215271
in O 0 0.02007712423801422
these O 0 0.02057480439543724
mice O 0 0.11444141715765
was O 0 0.027660232037305832
reduced O 0 0.048545610159635544
strongly O 0 0.031153369694948196
as O 0 0.014103498309850693
a O 0 0.018657494336366653
result O 0 0.02477874793112278
of O 0 0.011690601706504822
the O 0 0.017379408702254295
lack O 0 0.03639617934823036
of O 0 0.01771923527121544
protection O 0 0.04843813180923462
provided O 0 0.041633833199739456
by O 0 0.03791089355945587
vWf O 1 0.7074744701385498
. O 0 0.06523310393095016

Defective O 1 0.9992952346801758
thrombosis B-Disease 1 0.9999954700469971
in O 0 0.06108877807855606
mutant O 0 0.1802087128162384
mice O 0 0.17591437697410583
was O 0 0.026915695518255234
also O 0 0.019238078966736794
evident O 0 0.04021424055099487
in O 0 0.014301689341664314
an O 0 0.018169188871979713
in O 0 0.026324212551116943
vivo O 0 0.141283318400383
model O 0 0.05533794313669205
of O 0 0.042280279099941254
vascular B-Disease 1 0.9999939203262329
injury I-Disease 1 0.9968246221542358
. O 0 0.06826252490282059

In O 0 0.030967995524406433
this O 0 0.02088615484535694
model O 0 0.041770823299884796
, O 0 0.023405760526657104
the O 0 0.03153388947248459
exteriorized O 0 0.4864557683467865
mesentery O 1 0.9016116857528687
was O 0 0.05135873705148697
superfused O 1 0.593363344669342
with O 0 0.05342702567577362
ferric O 1 0.9995884299278259
chloride O 1 0.9070319533348083
and O 0 0.02785530313849449
the O 0 0.02976120263338089
accumulation O 0 0.1350548267364502
of O 0 0.040662992745637894
fluorescently O 1 0.8457472324371338
labeled O 0 0.16429127752780914
platelets O 1 0.7179147005081177
was O 0 0.04534555971622467
observed O 0 0.05970018357038498
by O 0 0.03337346017360687
intravital O 0 0.2163015902042389
microscopy O 0 0.18879759311676025
. O 0 0.06161520257592201

We O 0 0.041476260870695114
conclude O 0 0.06902557611465454
that O 0 0.01839878410100937
these O 0 0.021516993641853333
mice O 0 0.12401146441698074
very O 0 0.03672679886221886
closely O 0 0.05712948366999626
mimic O 1 0.99779212474823
severe O 1 0.9999514818191528
human O 1 0.960127592086792
von B-Disease 1 0.9999979734420776
Willebrand I-Disease 1 0.9999998807907104
disease I-Disease 1 0.9999996423721313
and O 0 0.020930172875523567
will O 0 0.014590919017791748
be O 0 0.011277296580374241
very O 0 0.01609305664896965
useful O 0 0.02122640796005726
for O 0 0.01222924329340458
investigating O 0 0.034617532044649124
the O 0 0.01650574430823326
role O 0 0.030379891395568848
of O 0 0.02403409220278263
vWf O 0 0.4913894832134247
in O 0 0.03302786871790886
normal O 0 0.07309217751026154
physiology O 0 0.15075379610061646
and O 0 0.026804771274328232
in O 0 0.03404129669070244
disease O 1 0.9998362064361572
models O 0 0.06551346182823181
. O 0 0.03221429884433746
. O 0 0.043622832745313644

Oral O 0 0.31055817008018494
contraceptives O 0 0.38107830286026
and O 0 0.026084866374731064
the O 0 0.028479881584644318
risk O 1 0.861116886138916
of O 0 0.042623121291399
hereditary B-Disease 1 0.9999943971633911
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
. O 0 0.07091432064771652

Hereditary B-Disease 1 0.9999879598617554
Ovarian I-Disease 1 1.0
Cancer I-Disease 1 0.9999992847442627
Clinical O 1 0.9984832406044006
Study O 0 0.07589077949523926
Group O 0 0.0697198212146759
. O 0 0.04900018125772476

BACKGROUND O 0 0.11232658475637436
Women O 0 0.06437075138092041
with O 0 0.03449918329715729
mutations O 0 0.10927121341228485
in O 0 0.020434780046343803
either O 0 0.02749212644994259
the O 0 0.02995656244456768
BRCA1 O 1 0.9480648636817932
or O 0 0.04093783348798752
the O 0 0.034159496426582336
BRCA2 O 1 0.9927279949188232
gene O 0 0.11546651273965836
have O 0 0.024306371808052063
a O 0 0.0324738435447216
high O 0 0.05890714004635811
lifetime O 1 0.5186575055122375
risk O 1 0.9938818216323853
of O 0 0.07257331162691116
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999991655349731
. O 0 0.07222555577754974

Oral O 1 0.8971951603889465
contraceptives O 1 0.9892215728759766
protect O 0 0.4412279725074768
against O 1 0.8279431462287903
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999992847442627
in O 0 0.02645634114742279
general O 0 0.0221988745033741
, O 0 0.014333189465105534
but O 0 0.011954348534345627
it O 0 0.010909337550401688
is O 0 0.012959969229996204
not O 0 0.01270828116685152
known O 0 0.020857715979218483
whether O 0 0.017363961786031723
they O 0 0.011610313318669796
also O 0 0.016032742336392403
protect O 0 0.041148822754621506
against O 0 0.03556609898805618
hereditary B-Disease 1 0.9223222136497498
forms I-Disease 0 0.07688190042972565
of I-Disease 0 0.07206947356462479
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999994039535522
. O 0 0.07608579099178314

METHODS O 0 0.08785152435302734
We O 0 0.03978413715958595
enrolled O 0 0.09466280043125153
207 O 0 0.16198858618736267
women O 0 0.07474037259817123
with O 0 0.06308530271053314
hereditary B-Disease 1 0.9999899864196777
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999992847442627
and O 0 0.027934815734624863
161 O 0 0.06102290749549866
of O 0 0.012328783050179482
their O 0 0.01629868522286415
sisters O 0 0.041821785271167755
as O 0 0.014477158896625042
controls O 0 0.03410374000668526
in O 0 0.01611984148621559
a O 0 0.02576935477554798
case O 0 0.03901170194149017
- O 0 0.09114376455545425
control O 0 0.06734444200992584
study O 0 0.05854931101202965
. O 0 0.05069536715745926

All O 0 0.03017452545464039
the O 0 0.035374343395233154
patients O 1 0.9704409241676331
carried O 0 0.047429513186216354
a O 0 0.04560314491391182
pathogenic O 0 0.1753792017698288
mutation O 0 0.16476136445999146
in O 0 0.03663990646600723
either O 0 0.06688399612903595
BRCA1 O 1 0.9818175435066223
( O 0 0.07640144228935242
179 O 0 0.12125825881958008
women O 0 0.06487813591957092
) O 0 0.043246906250715256
or O 0 0.04677225649356842
BRCA2 O 1 0.9946997165679932
( O 0 0.055996913462877274
28 O 0 0.04787616804242134
women O 0 0.058300141245126724
) O 0 0.04760337620973587
. O 0 0.04476244002580643

The O 0 0.03938092291355133
control O 0 0.05509120598435402
women O 0 0.04229942336678505
were O 0 0.01747255027294159
enrolled O 0 0.05656610056757927
regardless O 0 0.03244119510054588
of O 0 0.012785281054675579
whether O 0 0.019568143412470818
or O 0 0.018526602536439896
not O 0 0.012195018120110035
they O 0 0.014313195832073689
had O 0 0.022980554029345512
either O 0 0.044181812554597855
mutation O 0 0.18156899511814117
. O 0 0.05278521776199341

Lifetime O 0 0.14970430731773376
histories O 0 0.10387137532234192
of O 0 0.03327139467000961
oral O 1 0.7208231687545776
- O 0 0.2410801500082016
contraceptive O 1 0.9429608583450317
use O 0 0.030636630952358246
were O 0 0.015432084910571575
obtained O 0 0.02317897416651249
by O 0 0.016899550333619118
interview O 0 0.036326147615909576
or O 0 0.02024899795651436
by O 0 0.016039695590734482
written O 0 0.020431626588106155
questionnaire O 0 0.0600133053958416
and O 0 0.014747281558811665
were O 0 0.014521352015435696
compared O 0 0.03932525962591171
between O 0 0.030320588499307632
patients O 1 0.997676432132721
and O 0 0.01990068145096302
control O 0 0.04209860414266586
women O 0 0.03899962827563286
, O 0 0.019864924252033234
after O 0 0.028744639828801155
adjustment O 0 0.060457997024059296
for O 0 0.016672996804118156
year O 0 0.023568324744701385
of O 0 0.019349075853824615
birth O 0 0.062120210379362106
and O 0 0.030010681599378586
parity O 0 0.12985800206661224
. O 0 0.05270015075802803

RESULTS O 0 0.08824661374092102
The O 0 0.033666860312223434
adjusted O 0 0.08598066866397858
odds O 0 0.12758013606071472
ratio O 0 0.1372540146112442
for O 0 0.06751897931098938
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999992847442627
associated O 0 0.046253688633441925
with O 0 0.01949058659374714
any O 0 0.016946658492088318
past O 0 0.02373548597097397
use O 0 0.01936829276382923
of O 0 0.019457239657640457
oral O 0 0.11214924603700638
contraceptives O 0 0.28002381324768066
was O 0 0.04056643694639206
0 O 0 0.09088382869958878
. O 0 0.047031331807374954

5 O 0 0.07973679900169373
( O 0 0.05829041451215744
95 O 0 0.06456789374351501
percent O 0 0.05282451957464218
confidence O 0 0.06509602069854736
interval O 0 0.08645413815975189
, O 0 0.02509313076734543
0 O 0 0.04787798225879669
. O 0 0.017252856865525246
3 O 0 0.02945949137210846
to O 0 0.020139992237091064
0 O 0 0.05483788996934891
. O 0 0.023525157943367958
8 O 0 0.04741619899868965
) O 0 0.04233008995652199
. O 0 0.04152239114046097

The O 0 0.06352320313453674
risk O 0 0.4366591274738312
decreased O 0 0.08769465237855911
with O 0 0.027675844728946686
increasing O 0 0.04833664372563362
duration O 0 0.07172985374927521
of O 0 0.019463416188955307
use O 0 0.033217739313840866
( O 0 0.05566495656967163
P O 0 0.17312520742416382
for O 0 0.026963982731103897
trend O 0 0.08558838069438934
, O 0 0.04548504203557968
< O 0 0.22994934022426605
0 O 0 0.08440559357404709
. O 0 0.032395485788583755
001 O 0 0.18805114924907684
) O 0 0.03426467254757881
; O 0 0.021854834631085396
use O 0 0.017532426863908768
for O 0 0.012104171328246593
six O 0 0.020730290561914444
or O 0 0.01918942481279373
more O 0 0.012840625829994678
years O 0 0.017860261723399162
was O 0 0.018239252269268036
associated O 0 0.023513687774538994
with O 0 0.017283419147133827
a O 0 0.026426225900650024
60 O 0 0.044592779129743576
percent O 0 0.04694687947630882
reduction O 0 0.08760146796703339
in O 0 0.03435693308711052
risk O 0 0.4676620066165924
. O 0 0.05164988711476326

Oral O 1 0.8981059789657593
- O 1 0.6142538189888
contraceptive O 1 0.9880039691925049
use O 0 0.06159505620598793
protected O 0 0.10194896906614304
against O 0 0.31209617853164673
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999960660934448
both O 0 0.027176188305020332
for O 0 0.02158866450190544
carriers O 0 0.06675870716571808
of O 0 0.01940445601940155
the O 0 0.04072478786110878
BRCA1 O 1 0.9975812435150146
mutation O 1 0.6694778800010681
( O 0 0.07432259619235992
odds O 0 0.10936447232961655
ratio O 0 0.08087769150733948
, O 0 0.028580687940120697
0 O 0 0.05342750996351242
. O 0 0.019758081063628197
5 O 0 0.033622857183218
; O 0 0.02627813257277012
95 O 0 0.049144189804792404
percent O 0 0.043233808130025864
confidence O 0 0.05877432972192764
interval O 0 0.0847431868314743
, O 0 0.024905608966946602
0 O 0 0.04909401759505272
. O 0 0.0177162978798151
3 O 0 0.028777174651622772
to O 0 0.01869630627334118
0 O 0 0.051668908447027206
. O 0 0.01956428401172161
9 O 0 0.03167647495865822
) O 0 0.019475920125842094
and O 0 0.01087230909615755
for O 0 0.01578490063548088
carriers O 0 0.06585193425416946
of O 0 0.02134895883500576
the O 0 0.04164734110236168
BRCA2 O 1 0.9957367181777954
mutation O 1 0.5072235465049744
( O 0 0.07564985007047653
odds O 0 0.11410477012395859
ratio O 0 0.08531469106674194
, O 0 0.030271323397755623
0 O 0 0.060553986579179764
. O 0 0.02254095859825611
4 O 0 0.038004592061042786
; O 0 0.03268404304981232
95 O 0 0.052604928612709045
percent O 0 0.04257507249712944
confidence O 0 0.05422426760196686
interval O 0 0.08341724425554276
, O 0 0.023967042565345764
0 O 0 0.04797530546784401
. O 0 0.016807112842798233
2 O 0 0.027008794248104095
to O 0 0.01594453863799572
1 O 0 0.030117308720946312
. O 0 0.02075783535838127
1 O 0 0.04422327131032944
) O 0 0.04285427927970886
. O 0 0.04089190065860748

CONCLUSIONS O 0 0.13805033266544342
Oral O 1 0.748043417930603
- O 0 0.497333824634552
contraceptive O 1 0.9847262501716614
use O 0 0.03844348341226578
may O 0 0.03596271574497223
reduce O 0 0.057551730424165726
the O 0 0.027841635048389435
risk O 1 0.9826124906539917
of O 0 0.05115756392478943
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999994039535522
in O 0 0.03412056714296341
women O 0 0.05094607174396515
with O 0 0.0336131751537323
pathogenic O 0 0.24811802804470062
mutations O 0 0.14880971610546112
in O 0 0.02964850887656212
the O 0 0.03977096080780029
BRCA1 O 1 0.9945458173751831
or O 0 0.10367659479379654
BRCA2 O 1 0.995419979095459
gene O 0 0.3684104084968567

A O 0 0.07203270494937897
Japanese O 0 0.06289873272180557
family O 0 0.05848462134599686
with O 0 0.05251353234052658
adrenoleukodystrophy B-Disease 1 0.9999580383300781
with O 0 0.04756387695670128
a O 0 0.05935368686914444
codon O 0 0.19737082719802856
291 O 0 0.2045634388923645
deletion O 0 0.19981089234352112
: O 0 0.05784272029995918
a O 0 0.04475339129567146
clinical O 0 0.4424368739128113
, O 0 0.034931451082229614
biochemical O 0 0.11486708372831345
, O 0 0.029736241325736046
pathological O 0 0.16670307517051697
, O 0 0.026179883629083633
and O 0 0.024251192808151245
genetic O 0 0.09198376536369324
report O 0 0.04567795991897583
. O 0 0.046904053539037704

We O 0 0.032752182334661484
report O 0 0.029081910848617554
a O 0 0.026915231719613075
Japanese O 0 0.04513617604970932
family O 0 0.05364605039358139
with O 0 0.06112215295433998
adrenoleukodystrophy B-Disease 1 0.9999992847442627
( O 1 0.758262574672699
ALD B-Disease 1 0.9999977350234985
) O 0 0.04099203273653984
with O 0 0.019166996702551842
a O 0 0.022922540083527565
three O 0 0.02316657267510891
base O 0 0.05172288417816162
pair O 0 0.07818520069122314
deletion O 0 0.1931309849023819
( O 0 0.08125098794698715
delGAG O 0 0.27547720074653625
291 O 0 0.15639126300811768
) O 0 0.04158410802483559
in O 0 0.025867462158203125
the O 0 0.048771847039461136
ALD B-Disease 1 0.9999963045120239
gene O 0 0.2019176483154297
. O 0 0.06346952170133591

A O 0 0.05949600413441658
variety O 0 0.039189595729112625
of O 0 0.02706175297498703
phenotypes O 0 0.1445266455411911
were O 0 0.02200128883123398
observed O 0 0.043695900589227676
within O 0 0.022505594417452812
this O 0 0.02036721259355545
family O 0 0.05288589000701904
. O 0 0.048920292407274246

While O 0 0.044082533568143845
the O 0 0.04077846184372902
proband O 1 0.8513233065605164
( O 0 0.08024656772613525
patient O 1 0.8235962390899658
1 O 0 0.04356519132852554
) O 0 0.027945082634687424
was O 0 0.019688941538333893
classified O 0 0.02976367436349392
as O 0 0.014259891584515572
having O 0 0.02519913762807846
a O 0 0.0278403852134943
rare O 0 0.05892064794898033
intermediate O 0 0.08002923429012299
type O 0 0.07118377834558487
of O 0 0.02610432170331478
adult O 0 0.09114904701709747
cerebral O 1 0.99983811378479
and O 0 0.0410265177488327
cerebello O 1 0.9992484450340271
- O 1 0.9786592125892639
brain O 1 0.9944644570350647
stem O 0 0.12238873541355133
forms O 0 0.0416329950094223
, O 0 0.019344765692949295
his O 0 0.025593498721718788
younger O 0 0.06960617005825043
brother O 0 0.07196866720914841
( O 0 0.05737943574786186
patient O 1 0.8174936175346375
2 O 0 0.04555070772767067
) O 0 0.03003806062042713
and O 0 0.021181536838412285
nephew O 0 0.12481851875782013
( O 0 0.06318370997905731
patient O 1 0.9147884249687195
3 O 0 0.04642181470990181
) O 0 0.03357262164354324
had O 0 0.030966168269515038
a O 0 0.05220700055360794
childhood O 1 0.998076319694519
ALD B-Disease 1 0.9999979734420776
type O 0 0.21001429855823517
. O 0 0.06615657359361649

Another O 0 0.0909554585814476
nephew O 0 0.17076317965984344
( O 0 0.07940877228975296
patient O 1 0.8530282378196716
4 O 0 0.04916829243302345
) O 0 0.031250398606061935
of O 0 0.021454231813549995
patient O 0 0.4862944185733795
1 O 0 0.030277861282229424
was O 0 0.018240798264741898
classified O 0 0.03121708147227764
as O 0 0.015233663842082024
having O 0 0.028360186144709587
an O 0 0.029818717390298843
adolescent O 1 0.7940540909767151
form O 0 0.06257796287536621
. O 0 0.050458233803510666

The O 0 0.04582960158586502
tau O 0 0.13707226514816284
level O 0 0.04503282159566879
in O 0 0.02589932456612587
the O 0 0.044444531202316284
cerebrospinal O 1 0.9980807304382324
fluid O 1 0.9470579028129578
( O 0 0.08688440173864365
CSF O 1 0.9951695799827576
) O 0 0.04246880114078522
in O 0 0.02826332114636898
patient O 0 0.46791309118270874
1 O 0 0.028529861941933632
was O 0 0.01657921075820923
as O 0 0.012207177467644215
high O 0 0.024974094703793526
as O 0 0.013151572085916996
that O 0 0.015277072787284851
of O 0 0.026085397228598595
patients O 1 0.9999570846557617
with O 0 0.4930976629257202
Alzheimers B-Disease 1 1.0
disease I-Disease 1 0.9999988079071045
( O 0 0.09192389249801636
AD B-Disease 0 0.16016703844070435
) O 0 0.05892372876405716
. O 0 0.050253719091415405

His O 0 0.08194918185472488
brain O 1 0.9202966690063477
magnetic O 0 0.13530413806438446
resonance O 0 0.15243016183376312
image O 0 0.09781769663095474
( O 0 0.07304947823286057
MRI O 1 0.9830635190010071
) O 0 0.0472414493560791
showed O 0 0.0630011335015297
abnormalities B-Disease 0 0.485537052154541
in I-Disease 0 0.019719412550330162
the I-Disease 0 0.024904396384954453
bilateral I-Disease 0 0.07459806650876999
cerebellar I-Disease 1 0.9996144771575928
hemispheres I-Disease 1 0.7947566509246826
and O 0 0.0440029613673687
brain O 1 0.9984972476959229
stem O 0 0.12683707475662231
, O 0 0.021038467064499855
but O 0 0.013294175267219543
not O 0 0.010592774488031864
in O 0 0.015099862590432167
the O 0 0.0280816201120615
cerebral O 1 0.9996798038482666
white O 0 0.06123461201786995
matter O 0 0.027305154129862785
, O 0 0.01992489956319332
where O 0 0.023955155164003372
marked O 0 0.04712953791022301
reductions O 0 0.05960772931575775
of O 0 0.019832998514175415
the O 0 0.03767188638448715
cerebral O 1 0.9998929500579834
blood O 1 0.9701509475708008
flow O 0 0.08733604848384857
and O 0 0.03001992218196392
oxygen O 1 0.5014448761940002
metabolism O 0 0.15912151336669922
were O 0 0.02334156446158886
clearly O 0 0.0423465371131897
demonstrated O 0 0.06454736739397049
by O 0 0.04035034775733948
positron O 0 0.40220439434051514
emission O 0 0.19065643846988678
tomography O 0 0.2894444167613983
( O 0 0.08506198227405548
PET O 0 0.2631896138191223
) O 0 0.05806167796254158
. O 0 0.048506539314985275

In O 0 0.05879116803407669
patients O 1 0.9871436953544617
2 O 0 0.04090891405940056
and O 0 0.017648562788963318
3 O 0 0.028788365423679352
, O 0 0.01498605776578188
the O 0 0.02044382132589817
autopsy O 0 0.11968318372964859
findings O 0 0.0556534118950367
showed O 0 0.05908842757344246
massive O 0 0.11566805094480515
demyelination B-Disease 1 0.9996115565299988
of I-Disease 0 0.026566853746771812
the I-Disease 0 0.034500040113925934
cerebral I-Disease 1 0.9998667240142822
white I-Disease 0 0.0663192868232727
matter I-Disease 0 0.02751333639025688
with O 0 0.02177693508565426
sparing O 0 0.09788645058870316
of O 0 0.019459132105112076
the O 0 0.032607901841402054
U O 1 0.8679662942886353
- O 0 0.12746860086917877
fibers O 0 0.17356492578983307
, O 0 0.02310802787542343
compatible O 0 0.04103066399693489
with O 0 0.01635798066854477
the O 0 0.017850443720817566
findings O 0 0.04632139950990677
of O 0 0.033369261771440506
childhood O 1 0.9935226440429688
ALD B-Disease 1 0.9999934434890747
. O 0 0.07889609038829803

Oleic O 1 0.6972063183784485
and O 0 0.07500064373016357
erucic O 1 0.9752815365791321
acids O 0 0.15490487217903137
( O 0 0.07161448895931244
Lorenzos O 0 0.19593855738639832
Oil O 0 0.05216012895107269
) O 0 0.028239862993359566
were O 0 0.0180971696972847
administered O 0 0.0713915005326271
to O 0 0.030000656843185425
patients O 1 0.9532427787780762
1 O 0 0.029281029477715492
and O 0 0.015882911160588264
4 O 0 0.028848828747868538
, O 0 0.015908705070614815
but O 0 0.016709184274077415
sufficient O 0 0.04128938913345337
effectiveness O 0 0.06997475028038025
was O 0 0.02358713373541832
not O 0 0.017647622153162956
obtained O 0 0.038162097334861755
. O 0 0.041899438947439194

The O 0 0.03803734481334686
findings O 0 0.047952018678188324
in O 0 0.01903274841606617
this O 0 0.017245331779122353
family O 0 0.03526363894343376
suggest O 0 0.04029018431901932
that O 0 0.01922997646033764
delGAG291 O 0 0.09822684526443481
is O 0 0.0171299297362566
part O 0 0.017828045412898064
of O 0 0.012233269400894642
the O 0 0.020706601440906525
cause O 0 0.07245869189500809
of O 0 0.024627309292554855
Japanese O 0 0.08125115185976028
ALD B-Disease 1 0.9999853372573853
with O 0 0.05117050185799599
phenotypic O 0 0.1544354259967804
variations O 0 0.1028413325548172
. O 0 0.05695224553346634

Moreover O 0 0.08653584867715836
, O 0 0.025055043399333954
although O 0 0.018421856686472893
the O 0 0.015972329303622246
scale O 0 0.03531749173998833
of O 0 0.01137035246938467
the O 0 0.014887371100485325
study O 0 0.028853565454483032
is O 0 0.01669008657336235
limited O 0 0.02511964738368988
, O 0 0.014429171569645405
there O 0 0.013674580492079258
is O 0 0.01607588678598404
a O 0 0.021879767999053
possibility O 0 0.04066719859838486
that O 0 0.0232151597738266
PET O 0 0.1616281121969223
can O 0 0.043206360191106796
detect O 0 0.11698107421398163
an O 0 0.048741333186626434
insidious B-Disease 1 0.9906246066093445
lesion I-Disease 1 0.999474823474884
which O 0 0.03256566449999809
is O 0 0.03549516201019287
undetectable O 1 0.5973999500274658
by O 0 0.04065743088722229
computed O 0 0.14160263538360596
tomogram O 1 0.8908788561820984
( O 0 0.09271962195634842
CT O 1 0.999686598777771
) O 0 0.046941179782152176
or O 0 0.03604612126946449
MRI O 1 0.7209447026252747
analysis O 0 0.033432070165872574
, O 0 0.014032413251698017
and O 0 0.010862195864319801
that O 0 0.008375905454158783
the O 0 0.01363249309360981
higher O 0 0.028592923656105995
level O 0 0.03107326291501522
of O 0 0.018904896453022957
tau O 0 0.11155835539102554
reflects O 0 0.045144468545913696
the O 0 0.02222377434372902
process O 0 0.03391389176249504
of O 0 0.03376355022192001
neuronal B-Disease 1 0.9945540428161621
degeneration I-Disease 1 0.9999836683273315
in O 0 0.07500747591257095
ALD B-Disease 1 0.9999972581863403
. O 0 0.08661238104104996

Lorenzos O 0 0.27895253896713257
Oil O 0 0.06007632613182068
should O 0 0.022814881056547165
be O 0 0.012269385159015656
given O 0 0.016748903319239616
in O 0 0.01275851484388113
the O 0 0.016825024038553238
early O 0 0.036444466561079025
stage O 0 0.07060587406158447
. O 0 0.02791040949523449
. O 0 0.041487712413072586

Nonsense O 0 0.20153187215328217
mutation O 0 0.19192123413085938
in O 0 0.041437700390815735
exon O 0 0.1419459730386734
4 O 0 0.041288282722234726
of O 0 0.021939970552921295
human O 0 0.05035007372498512
complement O 0 0.11273261904716492
C9 O 1 0.9954786896705627
gene O 0 0.1001814603805542
is O 0 0.022302964702248573
the O 0 0.018688982352614403
major O 0 0.03875569626688957
cause O 0 0.07287943363189697
of O 0 0.023362327367067337
Japanese O 0 0.06919149309396744
complement B-Disease 1 0.5760573148727417
C9 I-Disease 1 0.999972939491272
deficiency I-Disease 1 0.9999982118606567
. O 0 0.09222910553216934

Deficiency B-Disease 1 0.9999678134918213
of I-Disease 0 0.02845023386180401
the I-Disease 0 0.02601504698395729
ninth I-Disease 0 0.07551045715808868
component I-Disease 0 0.05581321567296982
of I-Disease 0 0.01879872754216194
human I-Disease 0 0.04263397678732872
complement I-Disease 0 0.09623114764690399
( O 0 0.06915634125471115
C9 O 1 0.9922447800636292
) O 0 0.034498561173677444
is O 0 0.016499830409884453
the O 0 0.0174820888787508
most O 0 0.022464005276560783
common O 0 0.06434714794158936
complement B-Disease 1 0.9966030120849609
deficiency I-Disease 1 0.9999996423721313
in O 0 0.027373503893613815
Japan O 0 0.03628075122833252
but O 0 0.015830883756279945
is O 0 0.015872979536652565
rare O 0 0.031406618654727936
in O 0 0.013605511747300625
other O 0 0.012192031368613243
countries O 0 0.025094693526625633
. O 0 0.03821539133787155

We O 0 0.03508712351322174
studied O 0 0.03369090333580971
the O 0 0.021605603396892548
molecular O 0 0.06331611424684525
basis O 0 0.03050111047923565
of O 0 0.034819312393665314
C9 B-Disease 1 0.9999759197235107
deficiency I-Disease 1 0.999990701675415
in O 0 0.03425158932805061
four O 0 0.03928769752383232
Japanese O 0 0.10017775744199753
C9 B-Disease 1 0.9999568462371826
- I-Disease 1 0.9947201013565063
deficient I-Disease 1 0.999607503414154
patients O 1 0.9998008608818054
who O 0 0.04522918909788132
had O 0 0.04884948581457138
suffered O 1 0.9998475313186646
from O 0 0.12801630795001984
meningococcal B-Disease 1 0.9999997615814209
meningitis I-Disease 1 0.9999992847442627
. O 0 0.09606911987066269

Direct O 0 0.0906214639544487
sequencing O 0 0.11133011430501938
of O 0 0.040695857256650925
amplified O 0 0.1813245415687561
C9 O 1 0.9343171715736389
cDNA O 0 0.17342963814735413
and O 0 0.03383207693696022
DNA O 0 0.08915958553552628
revealed O 0 0.06647049635648727
a O 0 0.046545565128326416
nonsense O 0 0.11230531334877014
substitution O 0 0.12822112441062927
( O 0 0.0809069573879242
CGA O 1 0.9613012671470642
- O 1 0.8488859534263611
- O 1 0.6917777061462402
> O 1 0.8402604460716248
TGA O 1 0.9868302941322327
) O 0 0.06591133773326874
at O 0 0.04480027034878731
codon O 0 0.11783693730831146
95 O 0 0.057068776339292526
in O 0 0.02680186554789543
exon O 0 0.103562131524086
4 O 0 0.03157346323132515
in O 0 0.016269126906991005
the O 0 0.019576234742999077
four O 0 0.04393309727311134
C9 B-Disease 1 0.999675989151001
- I-Disease 1 0.6952059268951416
deficient I-Disease 1 0.9470258355140686
individuals O 0 0.07160809636116028
. O 0 0.05435652285814285

An O 0 0.08045895397663116
allele O 0 0.24976558983325958
- O 0 0.15368369221687317
specific O 0 0.08686166256666183
polymerase O 0 0.233629047870636
chain O 0 0.1370682418346405
reaction O 0 0.08681849390268326
system O 0 0.039380110800266266
designed O 0 0.03554898127913475
to O 0 0.018703633919358253
detect O 0 0.06397071480751038
exclusively O 0 0.02245253138244152
only O 0 0.012119358405470848
one O 0 0.011625127866864204
of O 0 0.00979109387844801
the O 0 0.016574326902627945
normal O 0 0.053469300270080566
and O 0 0.02641822025179863
mutant O 0 0.1358702927827835
alleles O 0 0.16415688395500183
indicated O 0 0.05070647597312927
that O 0 0.01304482202976942
all O 0 0.011492650955915451
the O 0 0.015657812356948853
four O 0 0.02790641412138939
patients O 1 0.9325433373451233
were O 0 0.023371871560811996
homozygous O 0 0.08880539238452911
for O 0 0.018670136108994484
the O 0 0.026288773864507675
mutation O 0 0.12847620248794556
in O 0 0.03064180351793766
exon O 0 0.12636035680770874
4 O 0 0.037427518516778946
and O 0 0.014231473207473755
that O 0 0.012278496287763119
the O 0 0.017406251281499863
parents O 0 0.03793860226869583
of O 0 0.022403044626116753
patient O 0 0.4472162425518036
2 O 0 0.04387914389371872
were O 0 0.0248968917876482
heterozygous O 0 0.14234957098960876
. O 0 0.052466981112957

The O 0 0.051192812621593475
common O 0 0.07560908049345016
mutation O 0 0.19521395862102509
at O 0 0.05826033651828766
codon O 0 0.14040493965148926
95 O 0 0.06409744918346405
in O 0 0.030394837260246277
exon O 0 0.13801448047161102
4 O 0 0.048318568617105484
might O 0 0.03079143352806568
be O 0 0.013710475526750088
responsible O 0 0.02724814973771572
for O 0 0.017167115584015846
most O 0 0.027098527178168297
Japanese O 0 0.10343541204929352
C9 B-Disease 1 0.9999920129776001
deficiency I-Disease 1 0.9999971389770508
. O 0 0.047449592500925064
. O 0 0.05289245769381523

BRCA1 O 1 0.8465384244918823
required O 0 0.060363225638866425
for O 0 0.03792354464530945
transcription O 0 0.1395811140537262
- O 0 0.14187480509281158
coupled O 0 0.14892727136611938
repair O 0 0.43964719772338867
of O 0 0.04538213089108467
oxidative O 1 0.889315664768219
DNA O 0 0.16264289617538452
damage O 0 0.1609458178281784
. O 0 0.057762421667575836

The O 0 0.08775468170642853
breast B-Disease 1 0.9999964237213135
and I-Disease 1 0.8824056386947632
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
susceptibility O 1 0.999669075012207
gene O 1 0.5809293389320374
BRCA1 O 1 0.9916125535964966
encodes O 0 0.14514563977718353
a O 0 0.06333557516336441
zinc O 1 0.795284628868103
finger O 0 0.15556257963180542
protein O 0 0.08759919553995132
of O 0 0.023774366825819016
unknown O 0 0.055054519325494766
function O 0 0.06492101401090622
. O 0 0.05095415934920311

Association O 0 0.08057631552219391
of O 0 0.025228392332792282
the O 0 0.03745643422007561
BRCA1 O 1 0.8683828711509705
protein O 0 0.09422926604747772
with O 0 0.02760912850499153
the O 0 0.03453468531370163
DNA O 0 0.11775331944227219
repair O 1 0.5588908791542053
protein O 0 0.13492082059383392
Rad51 O 1 0.9190269708633423
and O 0 0.025711968541145325
changes O 0 0.024687103927135468
in O 0 0.015418817289173603
the O 0 0.021114850416779518
phosphorylation O 0 0.07614143192768097
and O 0 0.024287980049848557
cellular O 0 0.0814514011144638
localization O 0 0.07746966928243637
of O 0 0.016203060746192932
the O 0 0.02579050324857235
protein O 0 0.08785690367221832
after O 0 0.05571175739169121
exposure O 0 0.4330042898654938
to O 0 0.03545656427741051
DNA O 0 0.11028251051902771
- O 0 0.1143663302063942
damaging O 0 0.1089179664850235
agents O 0 0.05355212837457657
are O 0 0.013958191499114037
consistent O 0 0.03378458693623543
with O 0 0.0166430976241827
a O 0 0.0225408636033535
role O 0 0.032317448407411575
for O 0 0.026271920651197433
BRCA1 O 1 0.9572630524635315
in O 0 0.04263504594564438
DNA O 0 0.1127290353178978
repair O 1 0.6463128328323364
. O 0 0.05375327542424202

Here O 0 0.046343833208084106
, O 0 0.022127315402030945
it O 0 0.01678016223013401
is O 0 0.020329846069216728
shown O 0 0.037291623651981354
that O 0 0.02703368477523327
mouse O 0 0.21137399971485138
embryonic O 0 0.3540411591529846
stem O 0 0.46453186869621277
cells O 1 0.5414857864379883
deficient B-Disease 1 0.9648646116256714
in I-Disease 0 0.04098869487643242
BRCA1 I-Disease 1 0.9734264016151428
are O 0 0.02515553869307041
defective O 0 0.11074734479188919
in O 0 0.018101397901773453
the O 0 0.01650732383131981
ability O 0 0.03428073227405548
to O 0 0.016033930703997612
carry O 0 0.034553200006484985
out O 0 0.035961903631687164
transcription O 0 0.13074298202991486
- O 0 0.14755374193191528
coupled O 0 0.14306093752384186
repair O 1 0.6268928647041321
of O 0 0.03841029107570648
oxidative O 1 0.9670626521110535
DNA O 0 0.10616137832403183
damage O 0 0.08535555005073547
, O 0 0.019649215042591095
and O 0 0.016657430678606033
are O 0 0.01805432140827179
hypersensitive O 0 0.27802836894989014
to O 0 0.043672893196344376
ionizing O 1 0.9409655332565308
radiation O 1 0.8468979597091675
and O 0 0.04228273406624794
hydrogen O 0 0.15018101036548615
peroxide O 1 0.5966590046882629
. O 0 0.06733907014131546

These O 0 0.036326926201581955
results O 0 0.05877436697483063
suggest O 0 0.05495963618159294
that O 0 0.029959620907902718
BRCA1 O 1 0.9633726477622986
participates O 0 0.10873604565858841
, O 0 0.026868069544434547
directly O 0 0.0313110314309597
or O 0 0.028926635161042213
indirectly O 0 0.06574375927448273
, O 0 0.024129081517457962
in O 0 0.02836083620786667
transcription O 0 0.12400860339403152
- O 0 0.13698957860469818
coupled O 0 0.1358608901500702
repair O 1 0.5383588075637817
of O 0 0.04185977950692177
oxidative O 1 0.9130575060844421
DNA O 0 0.13918346166610718
damage O 0 0.1238863468170166
. O 0 0.0353734977543354
. O 0 0.04312891140580177

Truncation O 0 0.3017841875553131
mutations O 0 0.16918104887008667
in O 0 0.02950216643512249
the O 0 0.031962811946868896
transactivation O 0 0.2251584231853485
region O 0 0.06286273896694183
of O 0 0.033513154834508896
PAX6 O 1 0.9962161183357239
result O 0 0.05449762940406799
in O 0 0.0303693488240242
dominant O 0 0.09503248333930969
- O 0 0.12638576328754425
negative O 0 0.10716830939054489
mutants O 0 0.16890911757946014
. O 0 0.0607672818005085

PAX6 O 1 0.9710030555725098
is O 0 0.04868052527308464
a O 0 0.048399731516838074
transcription O 0 0.10391194373369217
factor O 0 0.06129312887787819
with O 0 0.021122895181179047
two O 0 0.024764372035861015
DNA O 0 0.0980558767914772
- O 0 0.1098140999674797
binding O 0 0.0810733437538147
domains O 0 0.09437040984630585
( O 0 0.05954557657241821
paired O 0 0.11475963890552521
box O 0 0.07545969635248184
and O 0 0.03599371016025543
homeobox O 1 0.9067631959915161
) O 0 0.03728893771767616
and O 0 0.02171999029815197
a O 0 0.044108569622039795
proline O 0 0.46852952241897583
- O 0 0.21879702806472778
serine O 0 0.36048462986946106
- O 0 0.20629869401454926
threonine O 0 0.3159351348876953
( O 0 0.09462870657444
PST O 1 0.9905341863632202
) O 0 0.06641819328069687
- O 0 0.11786576360464096
rich O 0 0.10092765092849731
transactivation O 0 0.29865121841430664
domain O 0 0.1119382455945015
. O 0 0.059673283249139786

PAX6 O 1 0.9961691498756409
regulates O 0 0.42638885974884033
eye O 1 0.8640392422676086
development O 0 0.0468163937330246
in O 0 0.023569218814373016
animals O 0 0.04219501093029976
ranging O 0 0.045820120722055435
from O 0 0.03039615787565708
jellyfish O 0 0.12369212508201599
to O 0 0.031157907098531723
Drosophila O 0 0.10427428036928177
to O 0 0.03155403584241867
humans O 0 0.08091486990451813
. O 0 0.05497622489929199

Heterozygous O 0 0.27004578709602356
mutations O 0 0.17867103219032288
in O 0 0.030625514686107635
the O 0 0.031086638569831848
human O 0 0.0691462829709053
PAX6 O 1 0.9982984662055969
gene O 0 0.12902192771434784
result O 0 0.03966105356812477
in O 0 0.01737983338534832
various O 0 0.020944789052009583
phenotypes O 0 0.1516333818435669
, O 0 0.027764391154050827
including O 0 0.03285258635878563
aniridia B-Disease 1 0.9871606826782227
, O 0 0.05217491090297699
Peters B-Disease 1 0.9959003329277039
anomaly I-Disease 1 0.9977411031723022
, O 0 0.05658860504627228
autosomal B-Disease 1 0.9988771080970764
dominant I-Disease 1 0.9526593089103699
keratitis I-Disease 1 0.999993085861206
, O 0 0.0454370342195034
and O 0 0.04574378579854965
familial B-Disease 1 0.9999386072158813
foveal I-Disease 1 0.9997135996818542
dysplasia I-Disease 1 0.9999964237213135
. O 0 0.07683759182691574

It O 0 0.03311973065137863
is O 0 0.021197320893406868
believed O 0 0.030306773260235786
that O 0 0.015165043994784355
the O 0 0.02572546899318695
mutated O 0 0.15645767748355865
allele O 0 0.17939947545528412
of O 0 0.041901201009750366
PAX6 O 1 0.9810712933540344
produces O 0 0.10220632702112198
an O 0 0.039469845592975616
inactive O 0 0.1236337274312973
protein O 0 0.09189964085817337
and O 0 0.030890895053744316
aniridia B-Disease 1 0.9885446429252625
is O 0 0.03413551300764084
caused O 0 0.0796404704451561
due O 0 0.04230378940701485
to O 0 0.032518282532691956
genetic O 0 0.13193054497241974
haploinsufficiency O 0 0.3372659385204315
. O 0 0.06824501603841782

However O 0 0.04590454325079918
, O 0 0.026040786877274513
several O 0 0.029988324269652367
truncation O 0 0.1805662363767624
mutations O 0 0.1360234171152115
have O 0 0.021910423412919044
been O 0 0.016097715124487877
found O 0 0.01953754387795925
to O 0 0.016637668013572693
occur O 0 0.03586691617965698
in O 0 0.016703590750694275
the O 0 0.024726122617721558
C O 0 0.16505461931228638
- O 0 0.09364725649356842
terminal O 0 0.09563463181257248
half O 0 0.042419999837875366
of O 0 0.029537511989474297
PAX6 O 1 0.9988616704940796
in O 0 0.04052460566163063
patients O 1 0.9986536502838135
with O 0 0.04090875759720802
Aniridia B-Disease 1 0.989962100982666
resulting O 0 0.07865217328071594
in O 0 0.03199286758899689
mutant O 0 0.11581093072891235
proteins O 0 0.059276167303323746
that O 0 0.01900300197303295
retain O 0 0.046304091811180115
the O 0 0.026006687432527542
DNA O 0 0.0877900943160057
- O 0 0.09335067123174667
binding O 0 0.06126243621110916
domains O 0 0.05826300382614136
but O 0 0.018502531573176384
have O 0 0.013726146891713142
lost O 0 0.02674202062189579
most O 0 0.011934943497180939
of O 0 0.013471792452037334
the O 0 0.027046754956245422
transactivation O 0 0.24634869396686554
domain O 0 0.08470326662063599
. O 0 0.05312744528055191

It O 0 0.02998344600200653
is O 0 0.018461396917700768
not O 0 0.015163348987698555
clear O 0 0.025990061461925507
whether O 0 0.023781385272741318
such O 0 0.021800575777888298
mutants O 0 0.13173127174377441
really O 0 0.057137664407491684
behave O 0 0.066378653049469
as O 0 0.022702401503920555
loss O 0 0.07483895123004913
- O 0 0.08409962058067322
of O 0 0.028267931193113327
- O 0 0.09865164011716843
function O 0 0.06693706661462784
mutants O 0 0.11689501255750656
as O 0 0.02949114330112934
predicted O 0 0.06671562045812607
by O 0 0.03649209067225456
haploinsufficiency O 0 0.19200795888900757
. O 0 0.05539961904287338

Contrary O 0 0.057624462991952896
to O 0 0.019527852535247803
this O 0 0.014749852009117603
theory O 0 0.027413509786128998
, O 0 0.01421888917684555
our O 0 0.018239807337522507
data O 0 0.02008739858865738
showed O 0 0.028698952868580818
that O 0 0.013781735673546791
these O 0 0.014979767613112926
mutants O 0 0.07996876537799835
are O 0 0.021489286795258522
dominant O 0 0.0789777934551239
- O 0 0.10136526823043823
negative O 0 0.07752450555562973
in O 0 0.038684163242578506
transient O 1 0.9845572710037231
transfection O 1 0.9835532903671265
assays O 0 0.12378720194101334
when O 0 0.027243025600910187
they O 0 0.017550276592373848
are O 0 0.02022380195558071
coexpressed O 0 0.1450786292552948
with O 0 0.03333397954702377
wild O 0 0.09395638108253479
- O 0 0.20307376980781555
type O 0 0.17041239142417908
PAX6 O 1 0.9939072728157043
. O 0 0.07967875897884369

We O 0 0.030901513993740082
found O 0 0.026529956609010696
that O 0 0.01668984442949295
the O 0 0.026326080784201622
dominant O 0 0.09108243137598038
- O 0 0.20531143248081207
negative O 0 0.09396108984947205
effects O 0 0.11228197813034058
result O 0 0.03657999634742737
from O 0 0.020164968445897102
the O 0 0.02105664275586605
enhanced O 0 0.08631247282028198
DNA O 0 0.07622484862804413
binding O 0 0.05649183318018913
ability O 0 0.03920760750770569
of O 0 0.014836017973721027
these O 0 0.02311018295586109
mutants O 0 0.14206944406032562
. O 0 0.051307324320077896

Kinetic O 0 0.14127680659294128
studies O 0 0.05244871973991394
of O 0 0.0207379087805748
binding O 0 0.05660892650485039
and O 0 0.030773300677537918
dissociation O 0 0.18343989551067352
revealed O 0 0.04725236818194389
that O 0 0.01565774530172348
various O 0 0.021427258849143982
truncation O 0 0.14574533700942993
mutants O 0 0.1153286024928093
have O 0 0.02820514887571335
3 O 0 0.052427005022764206
- O 0 0.10272829979658127
5 O 0 0.05572177842259407
- O 0 0.09437967836856842
fold O 0 0.09671477228403091
higher O 0 0.05295371636748314
affinity O 0 0.082431361079216
to O 0 0.019798647612333298
various O 0 0.02213115617632866
DNA O 0 0.09372857958078384
- O 0 0.09285946935415268
binding O 0 0.05339759215712547
sites O 0 0.03279438614845276
when O 0 0.023809047415852547
compared O 0 0.030496779829263687
with O 0 0.017282940447330475
the O 0 0.024456912651658058
wild O 0 0.08974698930978775
- O 0 0.28618815541267395
type O 0 0.23569558560848236
PAX6 O 1 0.9969267249107361
. O 0 0.06897608935832977

These O 0 0.033111292868852615
results O 0 0.04049413651227951
provide O 0 0.031157730147242546
a O 0 0.023623939603567123
new O 0 0.024398289620876312
insight O 0 0.05859354883432388
into O 0 0.017711006104946136
the O 0 0.017937947064638138
role O 0 0.03196481987833977
of O 0 0.02484220080077648
mutant O 0 0.1797344982624054
PAX6 O 1 0.9972478747367859
in O 0 0.05301631987094879
causing O 0 0.39973267912864685
aniridia B-Disease 1 0.9825354814529419
. O 0 0.039817631244659424
. O 0 0.051453039050102234

Reversal O 1 0.8612746000289917
of O 0 0.06770163029432297
severe O 1 0.9999864101409912
hypertrophic B-Disease 1 0.9999998807907104
cardiomyopathy I-Disease 1 0.9999998807907104
and O 0 0.046261027455329895
excellent O 0 0.08767746388912201
neuropsychologic O 0 0.4575370252132416
outcome O 0 0.05507906526327133
in O 0 0.021238859742879868
very B-Disease 0 0.03155563026666641
- I-Disease 0 0.11453692615032196
long I-Disease 0 0.07746747881174088
- I-Disease 0 0.4364047944545746
chain I-Disease 0 0.2604182958602905
acyl I-Disease 1 0.9960864782333374
- I-Disease 1 0.8175873160362244
coenzyme I-Disease 1 0.9437276124954224
A I-Disease 0 0.24590007960796356
dehydrogenase I-Disease 1 0.9998278617858887
deficiency I-Disease 1 0.9999958276748657
. O 0 0.09064516425132751

Very B-Disease 0 0.07678214460611343
- I-Disease 0 0.16672104597091675
long I-Disease 0 0.09244521707296371
- I-Disease 0 0.3178512454032898
chain I-Disease 0 0.31481999158859253
acyl I-Disease 1 0.9929742813110352
- I-Disease 0 0.4667671322822571
coenzyme I-Disease 1 0.6688194274902344
A I-Disease 0 0.12296132743358612
dehydrogenase I-Disease 1 0.9972143769264221
( I-Disease 0 0.14053575694561005
VLCAD I-Disease 1 0.9990277290344238
) I-Disease 0 0.11929822713136673
deficiency I-Disease 1 0.9999940395355225
is O 0 0.03929051756858826
a O 0 0.050312403589487076
disorder O 1 0.9998360872268677
of O 0 0.04470733553171158
fatty O 1 0.9100287556648254
acid O 1 0.9452638626098633
beta O 0 0.17893563210964203
oxidation O 0 0.1493988335132599
that O 0 0.02290615253150463
reportedly O 0 0.053465913981199265
has O 0 0.02506539784371853
high O 0 0.04586103558540344
rates O 0 0.05500677600502968
of O 0 0.027396224439144135
morbidity O 1 0.9699353575706482
and O 0 0.04312201589345932
mortality O 1 0.5925620794296265
. O 0 0.054895833134651184

We O 0 0.03885994106531143
describe O 0 0.048611536622047424
the O 0 0.019473401829600334
outcome O 0 0.03283647447824478
of O 0 0.014705070294439793
a O 0 0.027364663779735565
5 O 0 0.044610101729631424
- O 0 0.08380354195833206
year O 0 0.0383121632039547
- O 0 0.09826482832431793
old O 0 0.06760554015636444
girl O 0 0.20785671472549438
with O 0 0.06089266762137413
VLCAD B-Disease 1 0.9999905824661255
deficiency I-Disease 1 0.9999996423721313
who O 0 0.04003966227173805
was O 0 0.02319437824189663
first O 0 0.01945081166923046
seen O 0 0.031727105379104614
at O 0 0.024619515985250473
5 O 0 0.028743116185069084
months O 0 0.02573988400399685
of O 0 0.017104746773838997
age O 0 0.05075959116220474
with O 0 0.05825447663664818
severe O 1 0.9999982118606567
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
, O 1 0.9401124119758606
hepatomegaly B-Disease 1 0.9999996423721313
, O 0 0.29938873648643494
encephalopathy B-Disease 1 0.9999984502792358
, O 0 0.03866411745548248
and O 0 0.04023757576942444
hypotonia B-Disease 1 0.9988380074501038
. O 0 0.0660853460431099

Biochemical O 0 0.330168753862381
studies O 0 0.11961600184440613
indicated O 1 0.9552407264709473
VLCAD B-Disease 1 0.9999963045120239
deficiency I-Disease 1 0.9999998807907104
caused O 0 0.3246316611766815
by O 0 0.029100406914949417
a O 0 0.036816418170928955
stable O 0 0.0850275307893753
yet O 0 0.05428716167807579
inactive O 0 0.13625751435756683
enzyme O 0 0.18082284927368164
. O 0 0.061235759407281876

Molecular O 0 0.1548035889863968
genetic O 0 0.11409228295087814
analysis O 0 0.0421452634036541
of O 0 0.018790218979120255
her O 0 0.04749002307653427
VLCAD O 1 0.9542283415794373
gene O 0 0.12762150168418884
revealed O 0 0.07207781821489334
a O 0 0.046336572617292404
T1372C O 0 0.20314635336399078
( O 0 0.07370025664567947
F458L O 0 0.3084995746612549
) O 0 0.07524094730615616
missense O 0 0.24178682267665863
mutation O 0 0.17937403917312622
and O 0 0.03820135071873665
a O 0 0.06375320255756378
1668 O 1 0.9310495853424072
ACAG O 1 0.962812066078186
1669 O 1 0.5333681106567383
splice O 0 0.2791139483451843
site O 0 0.10853725671768188
mutation O 0 0.21486744284629822
. O 0 0.06567081063985825

After O 0 0.0791894942522049
initial O 0 0.0991540402173996
treatment O 1 0.992572009563446
with O 0 0.040464404970407486
intravenous O 1 0.9979910850524902
glucose O 1 0.882354736328125
and O 0 0.03833869844675064
carnitine O 1 0.9984684586524963
, O 0 0.03158562630414963
the O 0 0.03118175081908703
patient O 1 0.5895777940750122
has O 0 0.027591433376073837
thrived O 0 0.07395043969154358
on O 0 0.01813642494380474
a O 0 0.03664036840200424
low O 0 0.09064879268407822
- O 0 0.14464542269706726
fat O 0 0.14414122700691223
diet O 0 0.13895416259765625
supplemented O 0 0.09700769931077957
with O 0 0.03955584391951561
medium O 0 0.10353415459394455
- O 0 0.15104898810386658
chain O 0 0.144211083650589
triglyceride O 0 0.4908865690231323
oil O 0 0.06795848906040192
and O 0 0.036353420466184616
carnitine O 1 0.9956265687942505
and O 0 0.041562605649232864
avoidance O 1 0.8819694519042969
of O 0 0.033528465777635574
fasting O 0 0.17177489399909973
. O 0 0.058944329619407654

Her O 0 0.16465944051742554
ventricular O 1 0.9999641180038452
hypertrophy O 1 0.9999043941497803
resolved O 0 0.08826519548892975
significantly O 0 0.06733482331037521
over O 0 0.026111504063010216
1 O 0 0.0315568782389164
year O 0 0.023561876267194748
, O 0 0.01842275634407997
and O 0 0.02130512148141861
cognitively O 0 0.2278057187795639
, O 0 0.019082147628068924
she O 0 0.01988670974969864
is O 0 0.01322721503674984
in O 0 0.013338043354451656
the O 0 0.017434969544410706
superior O 0 0.05820084363222122
range O 0 0.043791890144348145
for O 0 0.023017283529043198
age O 0 0.053106583654880524
. O 0 0.04604204744100571

Clinical O 1 0.9062786102294922
recognition O 0 0.08663274347782135
of O 0 0.04705539718270302
VLCAD B-Disease 1 0.9999966621398926
deficiency I-Disease 1 0.9999997615814209
is O 0 0.028949208557605743
important O 0 0.018707655370235443
because O 0 0.017727496102452278
it O 0 0.010469303466379642
is O 0 0.011730584315955639
one O 0 0.011084489524364471
of O 0 0.010791064240038395
the O 0 0.01978421024978161
few O 0 0.031123751774430275
directly O 0 0.05858193710446358
treatable O 1 0.9999653100967407
causes O 1 0.9940322041511536
of O 0 0.047728586941957474
cardiomyopathy B-Disease 1 0.9999997615814209
in O 0 0.03451146185398102
children O 0 0.0528903603553772
. O 0 0.03073202632367611
. O 0 0.03965724632143974

Cloning O 0 0.11114232987165451
of O 0 0.02184409275650978
a O 0 0.027323784306645393
novel O 0 0.036822449415922165
member O 0 0.025689229369163513
of O 0 0.015419664792716503
the O 0 0.027429575100541115
low O 0 0.08925997465848923
- O 0 0.16987471282482147
density O 0 0.1643909513950348
lipoprotein O 1 0.9957101345062256
receptor O 1 0.5315192341804504
family O 0 0.07704776525497437
. O 0 0.05799608677625656

A O 0 0.09873165190219879
gene O 0 0.14337767660617828
encoding O 0 0.09284962713718414
a O 0 0.04995843395590782
novel O 0 0.07179325073957443
transmembrane O 0 0.17635776102542877
protein O 0 0.0845189094543457
was O 0 0.028814181685447693
identified O 0 0.03999410197138786
by O 0 0.02199317328631878
DNA O 0 0.06733950972557068
sequence O 0 0.04572569578886032
analysis O 0 0.03553738072514534
within O 0 0.025079209357500076
the O 0 0.03764430806040764
insulin B-Disease 1 0.9992375373840332
- I-Disease 1 0.9913694262504578
dependent I-Disease 1 0.9896876215934753
diabetes I-Disease 1 1.0
mellitus I-Disease 1 0.9999988079071045
( O 0 0.14011424779891968
IDDM B-Disease 1 0.9851319193840027
) O 0 0.0844193771481514
locus O 0 0.20786277949810028
IDDM4 O 0 0.4355158805847168
on O 0 0.05054423213005066
chromosome O 0 0.23300743103027344
11q13 O 0 0.23949496448040009
. O 0 0.0694531798362732

Based O 0 0.04182504490017891
on O 0 0.020941056311130524
its O 0 0.027889834716916084
chromosomal O 0 0.14683672785758972
position O 0 0.032763365656137466
, O 0 0.01945335976779461
this O 0 0.018706031143665314
gene O 0 0.06668251752853394
is O 0 0.019448297098279
a O 0 0.02238699421286583
candidate O 0 0.03523741289973259
for O 0 0.023385966196656227
conferring O 0 0.13338062167167664
susceptibility O 1 0.9914085268974304
to O 0 0.05866659805178642
diabetes B-Disease 1 0.9999885559082031
. O 0 0.07449016720056534

The O 0 0.050587888807058334
gene O 0 0.12288913130760193
, O 0 0.04243919998407364
termed O 0 0.12500210106372833
low O 0 0.12333960831165314
- O 0 0.18779364228248596
density O 0 0.17183294892311096
lipoprotein O 1 0.996707022190094
receptor O 1 0.5259435772895813
related O 0 0.07890273630619049
protein O 0 0.10942637175321579
5 O 0 0.06249576807022095
( O 0 0.060003917664289474
LRP5 O 1 0.5075101852416992
) O 0 0.03460916504263878
, O 0 0.022129833698272705
encodes O 0 0.0789036974310875
a O 0 0.04088174179196358
protein O 0 0.08322323858737946
of O 0 0.029678253456950188
1615 O 0 0.16745604574680328
amino O 0 0.09248311072587967
acids O 0 0.06937538087368011
that O 0 0.017599787563085556
contains O 0 0.02877804823219776
conserved O 0 0.051707297563552856
modules O 0 0.04953022301197052
which O 0 0.016006916761398315
are O 0 0.012707624584436417
characteristic O 0 0.04262867197394371
of O 0 0.014569922350347042
the O 0 0.027969300746917725
low O 0 0.09195094555616379
- O 0 0.1936207264661789
density O 0 0.1640232503414154
lipoprotein O 1 0.9987926483154297
( O 0 0.1552416831254959
LDL O 1 0.9997511506080627
) O 0 0.09143461287021637
receptor O 0 0.2310512214899063
family O 0 0.06792552024126053
. O 0 0.05389628931879997

These O 0 0.03499619662761688
modules O 0 0.06872664391994476
include O 0 0.03223176300525665
a O 0 0.04073134437203407
putative O 0 0.14486049115657806
signal O 0 0.09875047951936722
peptide O 0 0.12271090596914291
for O 0 0.026844419538974762
protein O 0 0.07126091420650482
export O 0 0.038075488060712814
, O 0 0.02632298320531845
four O 0 0.041623979806900024
epidermal O 1 0.9989039897918701
growth O 0 0.11043339222669601
factor O 0 0.1320689469575882
( O 0 0.09123386442661285
EGF O 1 0.9933404326438904
) O 0 0.05664689466357231
repeats O 0 0.09495885670185089
with O 0 0.02992757223546505
associated O 0 0.06081170588731766
spacer O 0 0.2347087413072586
domains O 0 0.09434238821268082
, O 0 0.03690996393561363
three O 0 0.050802599638700485
LDL O 1 0.9998894929885864
- O 1 0.6840872764587402
receptor O 1 0.6088438630104065
( O 0 0.08619589358568192
LDLR O 1 0.8833526372909546
) O 0 0.05224558338522911
repeats O 0 0.08492057025432587
, O 0 0.02215578593313694
a O 0 0.029840316623449326
single O 0 0.05083397030830383
transmembrane O 0 0.1392640918493271
spanning O 0 0.07411734759807587
domain O 0 0.05321270227432251
, O 0 0.018922939896583557
and O 0 0.01768573559820652
a O 0 0.03753083199262619
cytoplasmic O 0 0.16537320613861084
domain O 0 0.08964918553829193
. O 0 0.05594364553689957

The O 0 0.04229773208498955
encoded O 0 0.06208234652876854
protein O 0 0.07573161274194717
has O 0 0.021711163222789764
a O 0 0.024671193212270737
unique O 0 0.03709198161959648
organization O 0 0.040456246584653854
of O 0 0.029420966282486916
EGF O 1 0.99592125415802
and O 0 0.04466487467288971
LDLR O 1 0.9788354635238647
repeats O 0 0.11387811601161957
; O 0 0.03837030380964279
therefore O 0 0.031392764300107956
, O 0 0.026810020208358765
LRP5 O 1 0.8315386772155762
likely O 0 0.043427299708127975
represents O 0 0.03859606385231018
a O 0 0.02221112698316574
new O 0 0.02212340757250786
category O 0 0.036017827689647675
of O 0 0.018622616305947304
the O 0 0.032305993139743805
LDLR O 1 0.7979270815849304
family O 0 0.06964758038520813
. O 0 0.049860380589962006

Both O 0 0.038255929946899414
human O 0 0.04894755780696869
and O 0 0.03546423837542534
mouse O 0 0.3911283612251282
LRP5 O 1 0.9864106774330139
cDNAs O 0 0.2516268789768219
have O 0 0.024190625175833702
been O 0 0.022124115377664566
isolated O 0 0.051211584359407425
and O 0 0.01489422656595707
the O 0 0.021560896188020706
encoded O 0 0.05874481052160263
mature O 0 0.08419506251811981
proteins O 0 0.05626540631055832
are O 0 0.020219821482896805
95 O 0 0.053064923733472824
% O 0 0.03834838420152664
identical O 0 0.044304732233285904
, O 0 0.02218705229461193
indicating O 0 0.04882277920842171
a O 0 0.025517432019114494
high O 0 0.03680669143795967
degree O 0 0.03646617382764816
of O 0 0.02012261003255844
evolutionary O 0 0.06764978170394897
conservation O 0 0.06553792953491211
. O 0 0.029140569269657135
. O 0 0.04210181534290314

The O 0 0.07484108954668045
APC B-Disease 1 0.5739456415176392
variants O 0 0.1298370212316513
I1307K O 0 0.16995669901371002
and O 0 0.03278525918722153
E1317Q O 0 0.14500200748443604
are O 0 0.02616899460554123
associated O 0 0.061408285051584244
with O 0 0.07868713140487671
colorectal B-Disease 1 1.0
tumors I-Disease 1 0.9999995231628418
, O 0 0.028585556894540787
but O 0 0.0158516988158226
not O 0 0.01256263442337513
always O 0 0.018684394657611847
with O 0 0.01601695455610752
a O 0 0.026297587901353836
family O 0 0.040649086236953735
history O 0 0.04419921711087227
. O 0 0.04638385772705078

Classical O 0 0.38063302636146545
familial B-Disease 1 0.9999973773956299
adenomatous I-Disease 1 0.9999998807907104
polyposis I-Disease 1 1.0
( O 1 0.8717153072357178
FAP B-Disease 1 0.999868631362915
) O 0 0.04762875661253929
is O 0 0.023791484534740448
a O 0 0.03500979393720627
high O 0 0.06944640725851059
- O 1 0.9531079530715942
penetrance O 1 0.998035728931427
autosomal B-Disease 1 0.9998364448547363
dominant I-Disease 1 0.9889879822731018
disease I-Disease 1 0.999987006187439
that O 0 0.03688362240791321
predisposes O 1 0.9948571920394897
to O 0 0.024659987539052963
hundreds O 0 0.03339817747473717
or O 0 0.030365975573658943
thousands O 0 0.04015390947461128
of O 0 0.046624500304460526
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999996423721313
and I-Disease 0 0.12384999543428421
carcinoma I-Disease 1 0.9999995231628418
and O 0 0.02391374669969082
that O 0 0.01779114454984665
results O 0 0.03932381793856621
from O 0 0.035281676799058914
truncating O 0 0.3448793888092041
mutations O 0 0.12893730401992798
in O 0 0.02544972486793995
the O 0 0.03846510499715805
APC B-Disease 1 0.935890257358551
gene O 0 0.16058313846588135
. O 0 0.05593341961503029

A O 0 0.08599527925252914
variant O 0 0.1649852991104126
of O 0 0.05876871943473816
FAP B-Disease 1 0.9999327659606934
is O 0 0.15845313668251038
attenuated B-Disease 1 0.9999552965164185
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 0.9999998807907104
coli I-Disease 1 0.9999638795852661
, O 0 0.043463222682476044
which O 0 0.023845676332712173
results O 0 0.045827098190784454
from O 0 0.036106351763010025
germ O 1 0.9991390705108643
- O 0 0.12013845890760422
line O 0 0.05632267892360687
mutations O 0 0.10851559787988663
in O 0 0.018166637048125267
the O 0 0.018578410148620605
5 O 0 0.027062684297561646
and O 0 0.015969960018992424
3 O 0 0.02760498970746994
regions O 0 0.029916610568761826
of O 0 0.01671803928911686
the O 0 0.03528638184070587
APC B-Disease 1 0.8891288638114929
gene O 0 0.16002587974071503
. O 0 0.061365142464637756

Attenuated B-Disease 1 0.999969482421875
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 0.9999997615814209
patients O 1 0.9999704360961914
have O 0 0.03791750967502594
" O 0 0.04001721367239952
multiple O 0 0.08074729144573212
" O 0 0.287777841091156
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999957084655762
( O 0 0.05702786520123482
typically O 0 0.04482817277312279
fewer O 0 0.035289961844682693
than O 0 0.017912670969963074
100 O 0 0.031311627477407455
) O 0 0.026436710730195045
without O 0 0.022634346038103104
the O 0 0.030013343319296837
florid O 1 0.5911049842834473
phenotype O 1 0.5311192870140076
of O 0 0.0424400269985199
classical O 0 0.10286851972341537
FAP B-Disease 1 0.9991227984428406
. O 0 0.07236876338720322

Another O 0 0.059886228293180466
group O 0 0.055034421384334564
of O 0 0.030662305653095245
patients O 1 0.9934025406837463
with O 0 0.03297383710741997
multiple O 0 0.08688973635435104
adenomas B-Disease 1 0.9994999170303345
has O 0 0.032179538160562515
no O 0 0.032202351838350296
mutations O 0 0.10342796891927719
in O 0 0.023270465433597565
the O 0 0.030862128362059593
APC B-Disease 1 0.9595433473587036
gene O 0 0.10445854067802429
, O 0 0.022492241114377975
and O 0 0.017062421888113022
their O 0 0.027318714186549187
phenotype O 1 0.8508535623550415
probably O 0 0.055324915796518326
results O 0 0.040013063699007034
from O 0 0.0216496754437685
variation O 0 0.05320524424314499
at O 0 0.03113601915538311
a O 0 0.03448806703090668
locus O 0 0.1297386884689331
, O 0 0.029955578967928886
or O 0 0.04039890319108963
loci O 0 0.14063778519630432
, O 0 0.02420542575418949
elsewhere O 0 0.03162346035242081
in O 0 0.017915818840265274
the O 0 0.0256329458206892
genome O 0 0.10984538495540619
. O 0 0.04699594900012016

Recently O 0 0.0744260922074318
, O 0 0.027193307876586914
however O 0 0.022624392062425613
, O 0 0.021836286410689354
a O 0 0.037469882518053055
missense O 0 0.19453556835651398
variant O 0 0.14555643498897552
of O 0 0.042660925537347794
APC B-Disease 1 0.9341129660606384
( O 0 0.06909557431936264
I1307K O 0 0.15518954396247864
) O 0 0.034836724400520325
was O 0 0.02121366746723652
described O 0 0.03177034109830856
that O 0 0.01912672072649002
confers O 0 0.09230083227157593
an O 0 0.027530653402209282
increased O 0 0.05659892037510872
risk O 1 0.9808813333511353
of O 0 0.05578342080116272
colorectal B-Disease 1 1.0
tumors I-Disease 1 0.9999996423721313
, O 0 0.03744364529848099
including O 0 0.03175117447972298
multiple O 0 0.07756111770868301
adenomas B-Disease 1 0.9993476271629333
, O 0 0.030256055295467377
in O 0 0.03349332883954048
Ashkenazim O 1 0.7952226400375366
. O 0 0.05775882303714752

We O 0 0.03060881979763508
have O 0 0.018161237239837646
studied O 0 0.024207282811403275
a O 0 0.019326403737068176
set O 0 0.020313378423452377
of O 0 0.021075336262583733
164 O 0 0.12199610471725464
patients O 1 0.9987939596176147
with O 0 0.04346143454313278
multiple O 1 0.9193553328514099
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999992847442627
and I-Disease 0 0.07591656595468521
/ I-Disease 1 0.9997366070747375
or I-Disease 0 0.07644126564264297
carcinoma I-Disease 1 0.9999984502792358
and O 0 0.04066573083400726
analyzed O 0 0.11685065925121307
codons O 0 0.22110700607299805
1263 O 1 0.9885580539703369
- O 0 0.3247169852256775
1377 O 1 0.8620221018791199
( O 0 0.09862571209669113
exon O 0 0.21007896959781647
15G O 0 0.23279136419296265
) O 0 0.03342772647738457
of O 0 0.01916692405939102
the O 0 0.03351005166769028
APC B-Disease 1 0.8176610469818115
gene O 0 0.12632614374160767
for O 0 0.04042762517929077
germ O 1 0.9954612851142883
- O 0 0.12564043700695038
line O 0 0.06702061742544174
variants O 0 0.1017392948269844
. O 0 0.053765688091516495

Three O 0 0.06060783565044403
patients O 1 0.9771738052368164
with O 0 0.031224925071001053
the O 0 0.03236805275082588
I1307K O 0 0.17073088884353638
allele O 0 0.16685843467712402
were O 0 0.03037942945957184
detected O 0 0.08283460885286331
, O 0 0.0199721846729517
each O 0 0.019972385838627815
of O 0 0.02387404628098011
Ashkenazi O 0 0.16873207688331604
descent O 0 0.12949661910533905
. O 0 0.057693980634212494

Four O 0 0.0612301342189312
patients O 1 0.9940497875213623
had O 0 0.04069235548377037
a O 0 0.05110636353492737
germ O 1 0.9985752105712891
- O 0 0.1352386772632599
line O 0 0.07790970057249069
E1317Q O 0 0.3276680111885071
missense O 0 0.24374337494373322
variant O 0 0.1400226205587387
of O 0 0.03000030294060707
APC O 0 0.37348729372024536
that O 0 0.01845216564834118
was O 0 0.016890080645680428
not O 0 0.012016117572784424
present O 0 0.017157912254333496
in O 0 0.01524223480373621
controls O 0 0.04119535908102989
; O 0 0.020248237997293472
one O 0 0.012316571548581123
of O 0 0.009677579626441002
these O 0 0.012474281713366508
individuals O 0 0.022412503138184547
had O 0 0.01796508952975273
an O 0 0.019169209524989128
unusually O 0 0.059718191623687744
large O 0 0.026676293462514877
number O 0 0.01888428069651127
of O 0 0.025463052093982697
metaplastic B-Disease 1 0.8341267108917236
polyps I-Disease 1 0.977154552936554
of I-Disease 0 0.02473980188369751
the I-Disease 0 0.035824600607156754
colorectum I-Disease 0 0.24812878668308258
. O 0 0.05737484619021416

There O 0 0.032187946140766144
is O 0 0.02326199784874916
increasing O 0 0.03384414687752724
evidence O 0 0.024902649223804474
that O 0 0.013937310315668583
there O 0 0.01899794116616249
exist O 0 0.03995480388402939
germ O 1 0.9909425377845764
- O 0 0.09876129776239395
line O 0 0.04603229835629463
variants O 0 0.058519329875707626
of O 0 0.020125489681959152
the O 0 0.035584017634391785
APC B-Disease 1 0.8298195600509644
gene O 0 0.12166391313076019
that O 0 0.027944613248109818
predispose O 0 0.1368897259235382
to O 0 0.017776500433683395
the O 0 0.01904282718896866
development O 0 0.03438400849699974
of O 0 0.029590865597128868
multiple O 1 0.8139470815658569
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999994039535522
and I-Disease 0 0.2658807635307312
carcinoma I-Disease 1 0.9999998807907104
, O 0 0.030403809621930122
but O 0 0.019113149493932724
without O 0 0.021321145817637444
the O 0 0.02978864684700966
florid O 1 0.7920611500740051
phenotype O 0 0.4571875333786011
of O 0 0.038718242198228836
classical O 0 0.0756114050745964
FAP B-Disease 1 0.9994893074035645
, O 0 0.024601450189948082
and O 0 0.01685861125588417
possibly O 0 0.036657460033893585
with O 0 0.01969340816140175
importance O 0 0.0422079861164093
for O 0 0.06783363223075867
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
risk O 1 0.9494717717170715
in O 0 0.019275205209851265
the O 0 0.017860954627394676
general O 0 0.025702472776174545
population O 0 0.03518280014395714
. O 0 0.026180880144238472
. O 0 0.039798978716135025

Genomic O 0 0.17656463384628296
structure O 0 0.047452546656131744
of O 0 0.0197251308709383
the O 0 0.03588160499930382
human O 1 0.9156307578086853
congenital B-Disease 1 1.0
chloride I-Disease 1 0.9999995231628418
diarrhea I-Disease 1 1.0
( O 1 0.9588568210601807
CLD B-Disease 1 0.9999817609786987
) O 0 0.08826375007629395
gene O 0 0.14545296132564545
. O 0 0.056534960865974426

Congenital B-Disease 1 1.0
chloride I-Disease 1 0.9999991655349731
diarrhea I-Disease 1 1.0
( O 1 0.9609280824661255
CLD B-Disease 1 0.9999830722808838
) O 0 0.052999284118413925
is O 0 0.027691619470715523
caused O 0 0.0700589269399643
by O 0 0.026399211958050728
mutations O 0 0.10421574860811234
in O 0 0.02384183369576931
a O 0 0.03561003506183624
gene O 0 0.0954781174659729
which O 0 0.026477817445993423
encodes O 0 0.09629198908805847
an O 0 0.05500781908631325
intestinal O 1 0.9998992681503296
anion O 1 0.9870665669441223
transporter O 1 0.9069842100143433
. O 0 0.07842683792114258

We O 0 0.030214058235287666
report O 0 0.026045378297567368
here O 0 0.016358578577637672
the O 0 0.016642222180962563
complete O 0 0.03527428209781647
genomic O 0 0.09628219157457352
organization O 0 0.03521377593278885
of O 0 0.016821272671222687
the O 0 0.028682192787528038
human O 0 0.07749246060848236
CLD B-Disease 1 0.9996129870414734
gene O 0 0.13696761429309845
which O 0 0.03150727599859238
spans O 0 0.08942559361457825
approximately O 0 0.05272352322936058
39kb O 0 0.13424083590507507
, O 0 0.022393224760890007
and O 0 0.019025474786758423
comprises O 0 0.04676204174757004
21 O 0 0.05636540427803993
exons O 0 0.14923347532749176
. O 0 0.06151847913861275

All O 0 0.05428342521190643
exon O 0 0.23409363627433777
/ O 0 0.3941936790943146
intron O 0 0.2530713379383087
boundaries O 0 0.04425164312124252
conform O 0 0.05674997344613075
to O 0 0.026463106274604797
the O 0 0.041066236793994904
GT O 1 0.9991505146026611
/ O 1 0.9975548386573792
AG O 1 0.9933207631111145
rule O 0 0.07569213956594467
. O 0 0.05179747939109802

An O 0 0.037849411368370056
analysis O 0 0.03989887237548828
of O 0 0.020237134769558907
the O 0 0.02998477593064308
putative O 0 0.1493186205625534
promoter O 0 0.15159937739372253
region O 0 0.060464635491371155
sequence O 0 0.05391571670770645
shows O 0 0.04051298275589943
a O 0 0.044217098504304886
putative O 0 0.16238808631896973
TATA O 1 0.8512517213821411
box O 0 0.08508776128292084
and O 0 0.033291708678007126
predicts O 0 0.11774501949548721
multiple O 0 0.08345868438482285
transcription O 0 0.12984563410282135
factor O 0 0.10229101032018661
binding O 0 0.07125592976808548
sites O 0 0.0510893352329731
. O 0 0.04921763390302658

The O 0 0.05011501535773277
genomic O 0 0.13111451268196106
structure O 0 0.046879954636096954
was O 0 0.024886604398489
determined O 0 0.039644621312618256
using O 0 0.02658093348145485
DNA O 0 0.05017014965415001
from O 0 0.016259299591183662
several O 0 0.01405499316751957
sources O 0 0.02019989676773548
including O 0 0.019032081589102745
multiple O 0 0.04666448384523392
large O 0 0.04479359835386276
- O 0 0.12650996446609497
insert O 0 0.16459456086158752
libaries O 0 0.17519044876098633
and O 0 0.03464917838573456
genomic O 0 0.1517411321401596
DNA O 0 0.11093372851610184
from O 0 0.04996488615870476
Finnish O 0 0.35748058557510376
CLD B-Disease 1 0.999987006187439
patients O 1 0.9983421564102173
and O 0 0.03371434658765793
controls O 0 0.07420673221349716
. O 0 0.04714825376868248

Exon O 0 0.28517699241638184
- O 0 0.14441268146038055
specific O 0 0.06040532886981964
primers O 0 0.14795011281967163
developed O 0 0.04827045276761055
in O 0 0.019039135426282883
this O 0 0.016274208202958107
study O 0 0.034690774977207184
will O 0 0.02604091353714466
facilitate O 0 0.0687655434012413
mutation O 0 0.1669197529554367
screening O 0 0.11126864701509476
studies O 0 0.04645586386322975
of O 0 0.023603491485118866
patients O 1 0.9983155727386475
with O 0 0.02999396063387394
the O 0 0.0396154522895813
disease O 1 0.999954342842102
. O 0 0.05875461548566818

Genomic O 0 0.1993924081325531
sequencing O 0 0.1044149249792099
of O 0 0.03277641907334328
a O 0 0.06614832580089569
BAC O 1 0.9981789588928223
clone O 1 0.982517421245575
H O 1 0.9980472326278687
_ O 0 0.0822976604104042
RG364P16 O 0 0.15803517401218414
revealed O 0 0.05311661213636398
the O 0 0.022076141089200974
presence O 0 0.03299371898174286
of O 0 0.015257888473570347
another O 0 0.026456080377101898
, O 0 0.023446744307875633
highly O 0 0.05035628378391266
homologous O 0 0.1436416506767273
gene O 0 0.10531620681285858
3 O 0 0.03921392932534218
of O 0 0.019001491367816925
the O 0 0.040715619921684265
CLD B-Disease 1 0.9998063445091248
gene O 0 0.12315290421247482
, O 0 0.02178248018026352
with O 0 0.019020728766918182
a O 0 0.02644580416381359
similar O 0 0.036016371101140976
genomic O 0 0.11590085923671722
structure O 0 0.04090626537799835
, O 0 0.019106164574623108
recently O 0 0.03441059589385986
identified O 0 0.03519129380583763
as O 0 0.023175805807113647
the O 0 0.04624607414007187
Pendred B-Disease 1 0.9999897480010986
syndrome I-Disease 1 1.0
gene O 1 0.7687373757362366
( O 0 0.08134235441684723
PDS B-Disease 1 0.9972615242004395
) O 0 0.04380519315600395
. O 0 0.02764200046658516
. O 0 0.042861733585596085

The O 0 0.07664788514375687
APCI1307K O 1 0.9739676713943481
allele O 0 0.38484469056129456
and O 0 0.05013977736234665
cancer B-Disease 1 0.9999724626541138
risk O 0 0.2406366616487503
in O 0 0.022219283506274223
a O 0 0.02624667063355446
community O 0 0.0369565524160862
- O 0 0.06358997523784637
based O 0 0.02689884603023529
study O 0 0.03247321769595146
of O 0 0.021304085850715637
Ashkenazi O 0 0.13847194612026215
Jews O 0 0.05945199728012085
. O 0 0.0520097017288208

Mutations O 0 0.24264056980609894
in O 0 0.05623513087630272
APC O 1 0.8631251454353333
are O 0 0.036517657339572906
classically O 1 0.8379662036895752
associated O 0 0.07343719899654388
with O 0 0.07311965525150299
familial B-Disease 1 0.9999992847442627
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9353947639465332
FAP B-Disease 1 0.9999364614486694
) O 0 0.04984505474567413
, O 0 0.025756224989891052
a O 0 0.03983886539936066
highly O 0 0.09950084239244461
penetrant O 1 0.9999724626541138
autosomal B-Disease 1 0.9999964237213135
dominant I-Disease 1 0.9995135068893433
disorder I-Disease 1 0.9999998807907104
characterized O 1 0.9907131791114807
by O 0 0.04123332351446152
multiple O 0 0.42973002791404724
intestinal O 1 0.9999988079071045
polyps B-Disease 1 0.999861478805542
and O 0 0.028818786144256592
, O 0 0.025102246552705765
without O 0 0.033601757138967514
surgical O 1 0.99928879737854
intervention O 0 0.09992153197526932
, O 0 0.020786244422197342
the O 0 0.02018602192401886
development O 0 0.042250849306583405
of O 0 0.05431174859404564
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
( O 0 0.21779359877109528
CRC B-Disease 1 0.9929817914962769
) O 0 0.05352340266108513
. O 0 0.043177612125873566

APC B-Disease 1 0.8548937439918518
is O 0 0.06332393735647202
a O 0 0.08834315836429596
tumour O 1 0.99998939037323
- O 1 0.9595774412155151
suppressor O 1 0.9342286586761475
gene O 0 0.13566797971725464
, O 0 0.03030029684305191
and O 0 0.029158050194382668
somatic O 1 0.5395983457565308
loss O 0 0.2672913074493408
occurs O 0 0.10742814838886261
in O 0 0.046798620373010635
tumours B-Disease 1 0.9998568296432495
. O 0 0.06381066143512726

The O 0 0.08674230426549911
germline O 1 0.9972438812255859
T O 1 0.9977937936782837
- O 0 0.11044786125421524
to O 0 0.0305652916431427
- O 0 0.08390901237726212
A O 0 0.05258314311504364
transversion O 0 0.15025299787521362
responsible O 0 0.04747229814529419
for O 0 0.02238653413951397
the O 0 0.037693966180086136
APC O 1 0.6915512681007385
I1307K O 0 0.22378095984458923
allele O 0 0.18362952768802643
converts O 0 0.08332610875368118
the O 0 0.033970192074775696
wild O 0 0.08007495850324631
- O 0 0.10927433520555496
type O 0 0.0817047506570816
sequence O 0 0.05142509192228317
to O 0 0.025982674211263657
a O 0 0.04491512477397919
homopolymer O 1 0.974545955657959
tract O 1 0.9978137016296387
( O 0 0.08927950263023376
A8 O 1 0.9897720217704773
) O 0 0.03860945999622345
that O 0 0.018582649528980255
is O 0 0.025654364377260208
genetically O 0 0.0790213793516159
unstable O 0 0.25319886207580566
and O 0 0.03390417620539665
prone O 0 0.16907387971878052
to O 0 0.04259730130434036
somatic O 0 0.2625182271003723
mutation O 0 0.24899308383464813
. O 0 0.06577182561159134

The O 0 0.06349693238735199
I1307K O 0 0.20593033730983734
allele O 0 0.16663391888141632
was O 0 0.03419467434287071
found O 0 0.033220067620277405
in O 0 0.02527526207268238
6 O 0 0.05484376102685928
. O 0 0.0412236712872982

1 O 0 0.06342582404613495
% O 0 0.04498884826898575
of O 0 0.03195938467979431
unselected O 0 0.22369490563869476
Ashkenazi O 0 0.15661318600177765
Jews O 0 0.04942786693572998
and O 0 0.025030141696333885
higher O 0 0.0505739189684391
proportions O 0 0.09980708360671997
of O 0 0.028211725875735283
Ashkenazim O 0 0.1770157814025879
with O 0 0.028323721140623093
family O 0 0.04357962682843208
or O 0 0.029345814138650894
personal O 0 0.043509162962436676
histories O 0 0.08407612890005112
of O 0 0.036909472197294235
CRC B-Disease 1 0.9869236350059509
( O 0 0.07163042575120926
ref O 0 0.17898958921432495
. O 0 0.028006279841065407
2 O 0 0.047395676374435425
) O 0 0.04580225050449371
. O 0 0.041162241250276566

To O 0 0.035901255905628204
evaluate O 0 0.07432935386896133
the O 0 0.023730479180812836
role O 0 0.03709004074335098
of O 0 0.026848703622817993
I1307K O 0 0.19384723901748657
in O 0 0.03632538393139839
cancer B-Disease 1 0.9998323917388916
, O 0 0.03169703856110573
we O 0 0.02923683449625969
genotyped O 0 0.16292504966259003
5 O 0 0.058983657509088516
, O 0 0.04474056512117386
081 O 1 0.9264780879020691
Ashkenazi O 0 0.15831421315670013
volunteers O 0 0.07193882763385773
in O 0 0.021616078913211823
a O 0 0.030437957495450974
community O 0 0.04764167219400406
survey O 0 0.05966724082827568
. O 0 0.049191806465387344

Risk O 1 0.8557525873184204
of O 0 0.04006582498550415
developing O 1 0.938113272190094
colorectal B-Disease 1 0.9999998807907104
, I-Disease 0 0.06387456506490707
breast I-Disease 1 0.9999661445617676
and I-Disease 0 0.028747279196977615
other I-Disease 0 0.028925824910402298
cancers I-Disease 1 0.998964786529541
were O 0 0.023642150685191154
compared O 0 0.04796883091330528
between O 0 0.0385487899184227
genotyped O 1 0.6055068373680115
I1307K O 0 0.33775871992111206
carriers O 0 0.10733737796545029
and O 0 0.025417346507310867
non O 0 0.05653572082519531
- O 0 0.09138461202383041
carriers O 0 0.0802495926618576
and O 0 0.018006140366196632
their O 0 0.017044581472873688
first O 0 0.028220832347869873
- O 0 0.09417083859443665
degree O 0 0.07001253217458725
relatives O 0 0.07938891649246216
. O 0 0.04912559315562248

Sperm O 0 0.19534845650196075
DNA O 0 0.1134222149848938
analysis O 0 0.05443289503455162
in O 0 0.03294944390654564
a O 0 0.07082751393318176
Friedreich B-Disease 1 0.9995731711387634
ataxia I-Disease 1 0.9998611211776733
premutation O 1 0.9836938977241516
carrier O 0 0.21139326691627502
suggests O 0 0.07539380341768265
both O 0 0.03588853403925896
meiotic O 1 0.7127360701560974
and O 0 0.0325736328959465
mitotic O 0 0.16204817593097687
expansion O 0 0.05459011346101761
in O 0 0.02479815110564232
the O 0 0.0328722819685936
FRDA B-Disease 1 0.9036548137664795
gene O 0 0.15745268762111664
. O 0 0.05596790462732315

Friedreich B-Disease 1 0.9997093081474304
ataxia I-Disease 1 0.9997654557228088
is O 0 0.05045291408896446
usually O 0 0.04155663773417473
caused O 0 0.05473654717206955
by O 0 0.015724550932645798
an O 0 0.016115564852952957
expansion O 0 0.03665245696902275
of O 0 0.018224196508526802
a O 0 0.04566662386059761
GAA O 0 0.2216479778289795
trinucleotide O 1 0.9753510355949402
repeat O 0 0.12910492718219757
in O 0 0.04226424917578697
intron O 0 0.2706651985645294
1 O 0 0.04888331517577171
of O 0 0.022799693048000336
the O 0 0.039930492639541626
FRDA B-Disease 1 0.8751921057701111
gene O 0 0.16544513404369354
. O 0 0.05725764110684395

Occasionally O 0 0.07351366430521011
, O 0 0.026888161897659302
a O 0 0.026847705245018005
fully O 0 0.04250544309616089
expanded O 0 0.04392071068286896
allele O 0 0.1259736567735672
has O 0 0.025370661169290543
been O 0 0.019001906737685204
found O 0 0.021631542593240738
to O 0 0.016862468793988228
arise O 0 0.05227455124258995
from O 0 0.022103000432252884
a O 0 0.0289875790476799
premutation O 0 0.11731217056512833
of O 0 0.018790962174534798
100 O 0 0.03865039348602295
or O 0 0.03726449981331825
less O 0 0.05253612622618675
triplet O 0 0.328290730714798
repeats O 0 0.16335293650627136
. O 0 0.06124810501933098

We O 0 0.03407147526741028
have O 0 0.021410221233963966
examined O 0 0.05795007199048996
the O 0 0.02635601907968521
sperm O 0 0.10337444394826889
DNA O 0 0.07194318622350693
of O 0 0.021851183846592903
a O 0 0.043814484030008316
premutation O 0 0.33331727981567383
carrier O 0 0.1583816558122635
. O 0 0.05903015285730362

This O 0 0.057646360248327255
mans O 0 0.17725978791713715
leucocyte O 0 0.24538955092430115
DNA O 0 0.11491600424051285
showed O 0 0.05986274406313896
one O 0 0.028752325102686882
normal O 0 0.06829190254211426
allele O 0 0.12421537190675735
and O 0 0.021162787452340126
one O 0 0.025758428499102592
allele O 0 0.11640074849128723
of O 0 0.024146679788827896
approximately O 0 0.047561466693878174
100 O 0 0.05884447321295738
repeats O 0 0.12481971830129623
. O 0 0.052872251719236374

His O 0 0.06183256953954697
sperm O 0 0.13162550330162048
showed O 0 0.05006635561585426
an O 0 0.024521244689822197
expanded O 0 0.04122603312134743
allele O 0 0.11543922871351242
in O 0 0.022244153544306755
a O 0 0.02961718663573265
tight O 0 0.056733645498752594
range O 0 0.040432605892419815
centering O 0 0.06395237892866135
on O 0 0.01562602072954178
a O 0 0.02033907361328602
size O 0 0.02934698387980461
of O 0 0.018073029816150665
approximately O 0 0.05125191807746887
320 O 0 0.1534416675567627
trinucleotide O 1 0.9400930404663086
repeats O 0 0.17665281891822815
. O 0 0.06901513040065765

His O 0 0.05980401113629341
affected O 0 0.09552647173404694
son O 0 0.08333966135978699
has O 0 0.03885931149125099
repeat O 0 0.10266510397195816
sizes O 0 0.060571443289518356
of O 0 0.02742966264486313
1040 O 0 0.3881152272224426
and O 0 0.03556058928370476
540 O 0 0.16023313999176025
. O 0 0.060068510472774506

These O 0 0.029557058587670326
data O 0 0.03128305822610855
suggest O 0 0.03871450573205948
that O 0 0.01800210028886795
expansion O 0 0.04991045221686363
occurs O 0 0.048223596066236496
in O 0 0.01736344024538994
two O 0 0.01664664037525654
stages O 0 0.05110490322113037
, O 0 0.015439724549651146
the O 0 0.014973090961575508
first O 0 0.023710645735263824
during O 0 0.0434102788567543
meiosis O 0 0.12744389474391937
followed O 0 0.038655128329992294
by O 0 0.02027401328086853
a O 0 0.028634287416934967
second O 0 0.04287579655647278
mitotic O 0 0.2022385150194168
expansion O 0 0.08720987290143967
. O 0 0.04968954995274544

We O 0 0.031213700771331787
also O 0 0.017652003094553947
show O 0 0.022651437669992447
that O 0 0.010708052664995193
in O 0 0.014643963426351547
all O 0 0.016414368525147438
informative O 0 0.07108346372842789
carrier O 0 0.10347139090299606
father O 0 0.04574241861701012
to O 0 0.026988932862877846
affected O 0 0.07369953393936157
child O 0 0.06979893147945404
transmissions O 0 0.08156286180019379
, O 0 0.018696533516049385
with O 0 0.01514784712344408
the O 0 0.016873667016625404
notable O 0 0.029150329530239105
exception O 0 0.03702402487397194
of O 0 0.017518600448966026
the O 0 0.02658366784453392
premutation O 0 0.19459787011146545
carrier O 0 0.0998506173491478
, O 0 0.025851737707853317
the O 0 0.02128521353006363
expansion O 0 0.062099650502204895
size O 0 0.055395085364580154
decreases O 0 0.09937188774347305
. O 0 0.03061736933887005
. O 0 0.04091614484786987

The O 0 0.06345611810684204
R496H O 0 0.22604745626449585
mutation O 0 0.18267254531383514
of O 0 0.03351627290248871
arylsulfatase O 0 0.195394828915596
A O 0 0.046681180596351624
does O 0 0.041915908455848694
not O 0 0.03389424458146095
cause O 1 0.8221750855445862
metachromatic B-Disease 1 0.9996113181114197
leukodystrophy I-Disease 1 0.9999872446060181
. O 0 0.08242171257734299

Deficiency B-Disease 1 0.9999761581420898
of I-Disease 0 0.053283244371414185
arylsulfatase I-Disease 1 0.6576112508773804
A I-Disease 0 0.08224236220121384
( O 0 0.09713410586118698
ARSA O 1 0.9971531629562378
) O 0 0.08272106945514679
enzyme O 0 0.2107795923948288
activity O 0 0.14002226293087006
causes O 1 0.9978540539741516
metachromatic B-Disease 1 0.9999254941940308
leukodystrophy I-Disease 1 0.9999983310699463
( O 0 0.49361827969551086
MLD B-Disease 1 0.9999526739120483
) O 0 0.07187895476818085
. O 0 0.0530509352684021

A O 0 0.056030869483947754
number O 0 0.030328232795000076
of O 0 0.038301873952150345
ARSA O 1 0.9953422546386719
gene O 0 0.1998746693134308
mutations O 0 0.17226214706897736
responsible O 0 0.06405428051948547
for O 0 0.03558877110481262
MLD B-Disease 1 0.9997771382331848
have O 0 0.029016798362135887
been O 0 0.024942941963672638
identified O 0 0.05069610849022865
. O 0 0.04670114442706108

Recently O 0 0.0754990428686142
, O 0 0.02780873142182827
the O 0 0.03328113257884979
R496H O 0 0.22437016665935516
mutation O 0 0.17641723155975342
of O 0 0.038822490721940994
ARSA O 1 0.9838205575942993
was O 0 0.025698451325297356
proposed O 0 0.026154477149248123
to O 0 0.015915440395474434
be O 0 0.0140685448423028
a O 0 0.0335233099758625
cause O 0 0.09136977791786194
of O 0 0.04361443966627121
MLD B-Disease 1 0.9999567270278931
( O 0 0.09886450320482254
Draghia O 1 0.8514105677604675
et O 0 0.14109399914741516
al O 0 0.08097969740629196
. O 0 0.025220317766070366
, O 0 0.025163689628243446
1997 O 0 0.05128836631774902
) O 0 0.03914463892579079
. O 0 0.042278360575437546

We O 0 0.03331980109214783
have O 0 0.02613302506506443
investigated O 0 0.06516644358634949
the O 0 0.03348016366362572
R496H O 0 0.2634522318840027
mutation O 0 0.14902694523334503
and O 0 0.022901766002178192
found O 0 0.029935726895928383
this O 0 0.021440353244543076
mutation O 0 0.11437738686800003
at O 0 0.031335022300481796
a O 0 0.027462907135486603
relatively O 0 0.03843320906162262
high O 0 0.03881668299436569
frequency O 0 0.05324162542819977
in O 0 0.01769651100039482
an O 0 0.021004781126976013
African O 0 0.05763547867536545
American O 0 0.047626856714487076
population O 0 0.05026828870177269
( O 0 0.06731940060853958
f O 0 0.13173815608024597
= O 0 0.14857421815395355
0 O 0 0.08108004927635193
. O 0 0.033493801951408386
09 O 0 0.11992645263671875
, O 0 0.03914855048060417
n O 0 0.1202700212597847
= O 0 0.1390829235315323
61 O 0 0.07703942805528641
subjects O 0 0.0538199245929718
) O 0 0.04793727397918701
. O 0 0.04420202225446701

The O 0 0.09802895784378052
ARSA O 1 0.9870160818099976
enzyme O 0 0.18119937181472778
activity O 0 0.06170899048447609
in O 0 0.0206768736243248
subjects O 0 0.031024985015392303
with O 0 0.017774760723114014
and O 0 0.015037739649415016
without O 0 0.023555593565106392
the O 0 0.025929272174835205
R496H O 0 0.2149508148431778
mutation O 0 0.14053133130073547
was O 0 0.027668684720993042
determined O 0 0.03395599126815796
and O 0 0.015346004627645016
found O 0 0.0218974519520998
to O 0 0.016258101910352707
be O 0 0.016421714797616005
normal O 0 0.05552026256918907
. O 0 0.045145489275455475

It O 0 0.032238952815532684
is O 0 0.02375221438705921
therefore O 0 0.026161830872297287
concluded O 0 0.04627925902605057
that O 0 0.017204519361257553
the O 0 0.029633063822984695
R496H O 0 0.20107442140579224
mutation O 0 0.19033163785934448
of O 0 0.049922749400138855
ARSA O 1 0.9951216578483582
does O 0 0.048376575112342834
not O 0 0.022731661796569824
negatively O 0 0.06037108972668648
influence O 0 0.03448500111699104
the O 0 0.02109643816947937
activity O 0 0.04469931125640869
of O 0 0.025820491835474968
ARSA O 1 0.9965265393257141
and O 0 0.022908398881554604
is O 0 0.018820956349372864
not O 0 0.01584649085998535
a O 0 0.03219202160835266
cause O 0 0.09621136635541916
of O 0 0.05462309345602989
MLD B-Disease 1 0.999852180480957

Down O 0 0.0922415480017662
- O 0 0.12247009575366974
regulation O 0 0.0832236185669899
of O 0 0.04091895371675491
transmembrane O 1 0.8375471234321594
carbonic O 1 0.9983997941017151
anhydrases O 1 0.9948136806488037
in O 0 0.09564036130905151
renal B-Disease 1 1.0
cell I-Disease 1 0.9993846416473389
carcinoma I-Disease 1 0.9999995231628418
cell O 0 0.32996419072151184
lines O 0 0.05456138029694557
by O 0 0.03193189203739166
wild O 0 0.09043824672698975
- O 0 0.41205286979675293
type O 0 0.42409607768058777
von B-Disease 1 0.9828159213066101
Hippel I-Disease 1 0.9988328814506531
- I-Disease 1 0.9074280858039856
Lindau I-Disease 1 0.9913758635520935
transgenes O 1 0.8556275963783264
. O 0 0.08578985184431076

To O 0 0.04967394843697548
discover O 0 0.12390729784965515
genes O 0 0.10178722441196442
involved O 0 0.059565454721450806
in O 0 0.05204020068049431
von B-Disease 1 0.9560092091560364
Hippel I-Disease 1 0.9985951781272888
- I-Disease 1 0.9655819535255432
Lindau I-Disease 1 0.9976601600646973
( O 0 0.1428023874759674
VHL B-Disease 1 0.9994811415672302
) O 0 0.09023458510637283
- O 0 0.185625359416008
mediated O 1 0.7728317975997925
carcinogenesis O 1 0.9926702976226807
, O 0 0.041766855865716934
we O 0 0.03341719135642052
used O 0 0.06151619181036949
renal B-Disease 1 0.9999998807907104
cell I-Disease 1 0.9990317821502686
carcinoma I-Disease 1 0.9999992847442627
cell O 1 0.52104651927948
lines O 0 0.09503400325775146
stably O 0 0.20712722837924957
transfected O 1 0.8738848567008972
with O 0 0.05122445151209831
wild O 0 0.11676257848739624
- O 1 0.8291589617729187
type O 1 0.8835374712944031
VHL O 1 0.999832272529602
- O 0 0.3239675760269165
expressing O 0 0.1433543562889099
transgenes O 1 0.6164462566375732
. O 0 0.07217204570770264

Large O 0 0.08042991161346436
- O 0 0.13861964643001556
scale O 0 0.10371539741754532
RNA O 0 0.1344050168991089
differential O 0 0.0935003012418747
display O 0 0.04439844563603401
technology O 0 0.035987790673971176
applied O 0 0.02853226475417614
to O 0 0.01726664789021015
these O 0 0.018403321504592896
cell O 0 0.07459408789873123
lines O 0 0.0434485599398613
identified O 0 0.04020484536886215
several O 0 0.027054423466324806
differentially O 0 0.142110213637352
expressed O 0 0.048508599400520325
genes O 0 0.0668475404381752
, O 0 0.021484384313225746
including O 0 0.021671047434210777
an O 0 0.038632962852716446
alpha O 0 0.15671396255493164
carbonic O 1 0.9888119697570801
anhydrase O 1 0.9840317368507385
gene O 0 0.161936417222023
, O 0 0.048521894961595535
termed O 0 0.1519390195608139
CA12 O 1 0.8936082720756531
. O 0 0.06580318510532379

The O 0 0.05565383657813072
deduced O 0 0.12670932710170746
protein O 0 0.09622208774089813
sequence O 0 0.05242766812443733
was O 0 0.024393092840909958
classified O 0 0.0349140539765358
as O 0 0.014547372236847878
a O 0 0.02395930327475071
one O 0 0.025105303153395653
- O 0 0.09225546568632126
pass O 0 0.07079969346523285
transmembrane O 0 0.18379530310630798
CA O 0 0.09214071929454803
possessing O 0 0.05372601002454758
an O 0 0.028412962332367897
apparently O 0 0.068166583776474
intact O 0 0.08877954632043839
catalytic O 0 0.12053621560335159
domain O 0 0.047341737896203995
in O 0 0.02180989272892475
the O 0 0.03193613514304161
extracellular O 0 0.15787608921527863
CA O 0 0.13116881251335144
module O 0 0.13405215740203857
. O 0 0.051771748811006546

Reintroduced O 0 0.22418545186519623
wild O 0 0.15203940868377686
- O 0 0.39059004187583923
type O 0 0.18231083452701569
VHL B-Disease 1 0.9954071044921875
strongly O 0 0.08561915904283524
inhibited O 0 0.14580224454402924
the O 0 0.03509068861603737
overexpression O 0 0.15569168329238892
of O 0 0.02574731409549713
the O 0 0.03538049757480621
CA12 O 1 0.6931722164154053
gene O 0 0.10154743492603302
in O 0 0.02412327006459236
the O 0 0.0392732098698616
parental O 1 0.999315619468689
renal B-Disease 1 1.0
cell I-Disease 1 0.9998261332511902
carcinoma I-Disease 1 0.9999997615814209
cell O 1 0.8552378416061401
lines O 0 0.08133003860712051
. O 0 0.051173001527786255

Similar O 0 0.06160944327712059
results O 0 0.048799049109220505
were O 0 0.01924225687980652
obtained O 0 0.033805858343839645
with O 0 0.03494198992848396
CA9 O 1 0.9978002905845642
, O 0 0.03820494934916496
encoding O 0 0.07842395454645157
another O 0 0.049796976149082184
transmembrane O 0 0.16886360943317413
CA O 0 0.07946670800447464
with O 0 0.024797460064291954
an O 0 0.028799666091799736
intact O 0 0.09807123988866806
catalytic O 0 0.15647335350513458
domain O 0 0.09592575579881668
. O 0 0.06183350086212158

Although O 0 0.04099290817975998
both O 0 0.023802854120731354
domains O 0 0.05332985520362854
of O 0 0.020455043762922287
the O 0 0.04013698548078537
VHL B-Disease 1 0.9957875609397888
protein O 0 0.1020716205239296
contribute O 0 0.05891542509198189
to O 0 0.02168654091656208
regulation O 0 0.055438410490751266
of O 0 0.027244841679930687
CA12 O 1 0.5724775791168213
expression O 0 0.06021885201334953
, O 0 0.022419974207878113
the O 0 0.022899962961673737
elongin O 0 0.15344734489917755
binding O 0 0.0713890939950943
domain O 0 0.06666197627782822
alone O 0 0.056702569127082825
could O 0 0.03518708795309067
effectively O 0 0.07232242822647095
regulate O 0 0.16188278794288635
CA9 O 1 0.9982505440711975
expression O 0 0.1296519935131073
. O 0 0.06355687230825424

We O 0 0.056754499673843384
mapped O 0 0.12054040282964706
CA12 O 0 0.47999879717826843
and O 0 0.05852048471570015
CA9 O 1 0.9946975708007812
loci O 0 0.21691368520259857
to O 0 0.04885926470160484
chromosome O 0 0.1950758546590805
bands O 0 0.10304634273052216
15q22 O 0 0.15881197154521942
and O 0 0.0417301245033741
17q21 O 0 0.1789860725402832
. O 0 0.057622987776994705

2 O 0 0.0694432258605957
respectively O 0 0.05097968131303787
, O 0 0.03091924637556076
regions O 0 0.05533532425761223
prone O 0 0.1283288300037384
to O 0 0.03002258762717247
amplification O 0 0.12622354924678802
in O 0 0.025070374831557274
some O 0 0.0255750622600317
human O 0 0.06754942238330841
cancers B-Disease 1 0.9992351531982422
. O 0 0.0718148946762085

Additional O 0 0.05998319014906883
experiments O 0 0.06534997373819351
are O 0 0.017667902633547783
needed O 0 0.031189393252134323
to O 0 0.01639825664460659
define O 0 0.03299415856599808
the O 0 0.0167315062135458
role O 0 0.031198089942336082
of O 0 0.025846779346466064
CA O 0 0.22519263625144958
IX O 1 0.6680318117141724
and O 0 0.03631077706813812
CA O 0 0.14741873741149902
XII O 0 0.2302982211112976
enzymes O 0 0.06874963641166687
in O 0 0.018452102318406105
the O 0 0.01937214471399784
regulation O 0 0.04877740517258644
of O 0 0.022215478122234344
pH O 0 0.13602100312709808
in O 0 0.023888546973466873
the O 0 0.029427746310830116
extracellular O 0 0.1369650959968567
microenvironment O 0 0.4377847909927368
and O 0 0.023121951147913933
its O 0 0.02377185970544815
potential O 0 0.05646505579352379
impact O 0 0.06771664321422577
on O 0 0.039886754006147385
cancer B-Disease 1 0.9999665021896362
cell O 0 0.3892819285392761
growth O 0 0.07797227054834366
. O 0 0.04623277485370636

A O 0 0.08688583225011826
gene O 0 0.12988579273223877
encoding O 0 0.09485477954149246
a O 0 0.053222108632326126
transmembrane O 0 0.18853461742401123
protein O 0 0.1057010218501091
is O 0 0.0353582426905632
mutated O 0 0.15438881516456604
in O 0 0.04122735187411308
patients O 1 0.9999575614929199
with O 0 0.18896746635437012
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 0.8253113627433777
optic B-Disease 1 0.9999997615814209
atrophy I-Disease 1 0.9999994039535522
( O 1 0.9988786578178406
Wolfram B-Disease 1 0.9999994039535522
syndrome I-Disease 1 1.0
) O 0 0.06912869960069656
. O 0 0.049362752586603165

Wolfram B-Disease 1 0.9999933242797852
syndrome I-Disease 1 1.0
( O 1 0.8722093105316162
WFS B-Disease 1 0.9999606609344482
; O 0 0.12497091293334961
OMIM O 1 0.9993001222610474
222300 O 1 0.5602387189865112
) O 0 0.05251353234052658
is O 0 0.031120337545871735
an O 0 0.049909453839063644
autosomal B-Disease 1 0.9998817443847656
recessive I-Disease 1 0.9999892711639404
neurodegenerative I-Disease 1 0.9999994039535522
disorder I-Disease 1 0.9999887943267822
defined O 0 0.0673019289970398
by O 0 0.03430980443954468
young O 0 0.18911008536815643
- O 1 0.9894240498542786
onset O 1 0.9999333620071411
non O 1 0.8461852073669434
- O 1 0.9976195693016052
immune O 1 0.999976634979248
insulin B-Disease 1 0.9999655485153198
- I-Disease 1 0.99857497215271
dependent I-Disease 1 0.9972341656684875
diabetes I-Disease 1 1.0
mellitus I-Disease 1 0.9999991655349731
and O 0 0.07979942858219147
progressive O 1 0.9982863068580627
optic B-Disease 1 0.9999936819076538
atrophy I-Disease 1 0.9999421834945679
. O 0 0.06900466978549957

Linkage O 0 0.20390339195728302
to O 0 0.041431792080402374
markers O 0 0.09910484403371811
on O 0 0.03973659500479698
chromosome O 0 0.23465707898139954
4p O 1 0.9619477987289429
was O 0 0.03747589886188507
confirmed O 0 0.0455169714987278
in O 0 0.01781606674194336
five O 0 0.028299998492002487
families O 0 0.04742058366537094
. O 0 0.04919949546456337

On O 0 0.026875315234065056
the O 0 0.017924794927239418
basis O 0 0.02511255256831646
of O 0 0.02699323743581772
meiotic O 1 0.9955974221229553
recombinants O 1 0.9934044480323792
and O 0 0.052407797425985336
disease O 1 0.9999943971633911
- O 0 0.26996567845344543
associated O 0 0.0739719420671463
haplotypes O 1 0.5576562285423279
, O 0 0.03722100704908371
the O 0 0.04166311025619507
WFS B-Disease 1 0.9979277849197388
gene O 0 0.13909997045993805
was O 0 0.04138876870274544
localized O 0 0.11487289518117905
to O 0 0.03141314163804054
a O 0 0.06168624386191368
BAC O 1 0.9973397850990295
/ O 1 0.9801628589630127
P1 O 1 0.8835669159889221
contig O 0 0.15761470794677734
of O 0 0.021499132737517357
less O 0 0.032183658331632614
than O 0 0.028001483529806137
250 O 0 0.07690993696451187
kb O 0 0.17814433574676514
. O 0 0.06346011161804199

Mutations O 0 0.1846664547920227
in O 0 0.032533735036849976
a O 0 0.043173711746931076
novel O 0 0.07425755262374878
gene O 0 0.1411503106355667
( O 0 0.07140269130468369
WFS1 O 1 0.6805974841117859
) O 0 0.04652229696512222
encoding O 0 0.06950189173221588
a O 0 0.04530683904886246
putative O 0 0.15722641348838806
transmembrane O 0 0.19029733538627625
protein O 0 0.08208366483449936
were O 0 0.0172031968832016
found O 0 0.021784303709864616
in O 0 0.014499681070446968
all O 0 0.015076912939548492
affected O 0 0.053194593638181686
individuals O 0 0.030810799449682236
in O 0 0.020102178677916527
six O 0 0.03935501351952553
WFS B-Disease 1 0.999786913394928
families O 0 0.04613320529460907
, O 0 0.019033264368772507
and O 0 0.015283013693988323
these O 0 0.018548261374235153
mutations O 0 0.09651875495910645
were O 0 0.01643613912165165
associated O 0 0.02934386394917965
with O 0 0.02301926165819168
the O 0 0.043679967522621155
disease O 1 0.999984860420227
phenotype O 1 0.9948580265045166
. O 0 0.07397085428237915

WFS1 O 1 0.6235998272895813
appears O 0 0.07032301276922226
to O 0 0.020827727392315865
function O 0 0.036854829639196396
in O 0 0.020415008068084717
survival O 0 0.09089494496583939
of O 0 0.02893860451877117
islet O 0 0.2689107358455658
beta O 0 0.3285068869590759
- O 0 0.22095561027526855
cells O 0 0.13205549120903015
and O 0 0.034950219094753265
neurons O 0 0.1808815449476242
. O 0 0.035836461931467056
. O 0 0.0438295379281044

Stable O 0 0.13355493545532227
interaction O 0 0.06276825070381165
between O 0 0.022351162508130074
the O 0 0.017222346737980843
products O 0 0.0306294783949852
of O 0 0.01800651103258133
the O 0 0.037567440420389175
BRCA1 O 1 0.9914509654045105
and O 0 0.06536336988210678
BRCA2 O 1 0.9998291730880737
tumor B-Disease 1 0.9998975992202759
suppressor O 1 0.9483560919761658
genes O 0 0.11460943520069122
in O 0 0.04050843045115471
mitotic O 0 0.28600379824638367
and O 0 0.049251675605773926
meiotic O 1 0.9930140376091003
cells O 0 0.26923713088035583
. O 0 0.06343831866979599

BRCA1 O 1 0.9738436341285706
and O 0 0.06315121054649353
BRCA2 O 1 0.9403513073921204
account O 0 0.03963964059948921
for O 0 0.018609484657645226
most O 0 0.01615133509039879
cases O 0 0.032230015844106674
of O 0 0.0224030502140522
familial O 1 0.9982385635375977
, O 0 0.04204839468002319
early O 0 0.11313821375370026
onset O 1 0.9999978542327881
breast B-Disease 1 0.9999994039535522
and I-Disease 0 0.2870709002017975
/ I-Disease 1 0.999994158744812
or I-Disease 1 0.986700177192688
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999980926513672
and O 0 0.02781817317008972
encode O 0 0.055330540984869
products O 0 0.030637938529253006
that O 0 0.014314246363937855
each O 0 0.019048769026994705
interact O 0 0.05769932270050049
with O 0 0.03625647723674774
hRAD51 O 0 0.1857389509677887
. O 0 0.05593717470765114

Results O 0 0.06890846788883209
presented O 0 0.03973985090851784
here O 0 0.0238607469946146
show O 0 0.03613582253456116
that O 0 0.02758285030722618
BRCA1 O 1 0.9617070555686951
and O 0 0.03851635009050369
BRCA2 O 1 0.9833452701568604
coexist O 0 0.09664004296064377
in O 0 0.024937493726611137
a O 0 0.03744228184223175
biochemical O 0 0.1088341549038887
complex O 0 0.05220987647771835
and O 0 0.023767391219735146
colocalize O 0 0.17104165256023407
in O 0 0.03704024478793144
subnuclear O 0 0.36223888397216797
foci O 0 0.2533808946609497
in O 0 0.03983604162931442
somatic O 0 0.18144230544567108
cells O 0 0.09361228346824646
and O 0 0.01630594953894615
on O 0 0.014503935351967812
the O 0 0.023089289665222168
axial O 0 0.145859032869339
elements O 0 0.03852856531739235
of O 0 0.024867810308933258
developing O 0 0.09181629121303558
synaptonemal O 1 0.743994414806366
complexes O 0 0.20571118593215942
. O 0 0.059738047420978546

Like O 0 0.10410772264003754
BRCA1 O 1 0.9607182145118713
and O 0 0.06354160606861115
RAD51 O 1 0.995486319065094
, O 0 0.07603145390748978
BRCA2 O 1 0.987413763999939
relocates O 0 0.4797307252883911
to O 0 0.073414646089077
PCNA O 1 0.9953418970108032
+ O 1 0.5765424370765686
replication O 0 0.15447615087032318
sites O 0 0.04362570866942406
following O 0 0.04352699965238571
exposure O 0 0.2544479966163635
of O 0 0.029299994930624962
S O 1 0.896241307258606
phase O 0 0.13048876821994781
cells O 0 0.1285124123096466
to O 0 0.041549600660800934
hydroxyurea O 1 0.9975208640098572
or O 0 0.07988625764846802
UV O 1 0.9990787506103516
irradiation O 0 0.4394407272338867
. O 0 0.06971430778503418

Thus O 0 0.08486611396074295
, O 0 0.05228917673230171
BRCA1 O 1 0.9618818163871765
and O 0 0.04439437761902809
BRCA2 O 1 0.9550096392631531
participate O 0 0.04600197821855545
, O 0 0.017373114824295044
together O 0 0.017379336059093475
, O 0 0.015804680064320564
in O 0 0.01834198832511902
a O 0 0.04157519340515137
pathway O 0 0.17343181371688843
( O 0 0.05668926239013672
s O 0 0.11561907827854156
) O 0 0.034448735415935516
associated O 0 0.029868710786104202
with O 0 0.017839612439274788
the O 0 0.022820955142378807
activation O 0 0.11028189212083817
of O 0 0.026832977309823036
double O 0 0.09845490753650665
- O 0 0.15055759251117706
strand O 0 0.15704721212387085
break O 0 0.09614483267068863
repair O 1 0.703859269618988
and O 0 0.041418030858039856
/ O 1 0.7139390110969543
or O 0 0.047244422137737274
homologous O 0 0.20843252539634705
recombination O 0 0.2635838985443115
. O 0 0.07308072596788406

Dysfunction O 1 0.9995163679122925
of O 0 0.031446173787117004
this O 0 0.029458483681082726
pathway O 0 0.13782253861427307
may O 0 0.03016214445233345
be O 0 0.013082494959235191
a O 0 0.01957990974187851
general O 0 0.02509417198598385
phenomenon O 0 0.056155767291784286
in O 0 0.013344482518732548
the O 0 0.012932823970913887
majority O 0 0.022844750434160233
of O 0 0.016668666154146194
cases O 0 0.03741215541958809
of O 0 0.02715275250375271
hereditary B-Disease 1 0.9997726082801819
breast I-Disease 1 0.9999994039535522
and I-Disease 0 0.269019216299057
/ I-Disease 1 0.9999938011169434
or I-Disease 1 0.9950346946716309
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999995231628418
. O 0 0.04216573014855385
. O 0 0.042727988213300705

A O 0 0.08721694350242615
novel O 0 0.10544612258672714
Arg362Ser O 0 0.2532747685909271
mutation O 0 0.16654817759990692
in O 0 0.033306945115327835
the O 0 0.042559124529361725
sterol O 1 0.9013482332229614
27 O 0 0.10615021735429764
- O 0 0.3502461016178131
hydroxylase O 1 0.9413363933563232
gene O 0 0.17538514733314514
( O 0 0.07958793640136719
CYP27 O 1 0.895332932472229
) O 0 0.039881616830825806
: O 0 0.026850834488868713
its O 0 0.021132690832018852
effects O 0 0.07508885860443115
on O 0 0.025688661262392998
pre O 0 0.11396772414445877
- O 0 0.1294032335281372
mRNA O 0 0.12092635035514832
splicing O 0 0.15406206250190735
and O 0 0.04428837448358536
enzyme O 0 0.15617606043815613
activity O 0 0.08609151840209961
. O 0 0.04776197671890259

A O 0 0.07123368233442307
novel O 0 0.07300185412168503
C O 0 0.11083448678255081
to O 0 0.02384522557258606
A O 0 0.045950692147016525
mutation O 0 0.12126747518777847
in O 0 0.03133887052536011
the O 0 0.03853136673569679
sterol O 1 0.8788920640945435
27 O 0 0.10392247140407562
- O 0 0.28999677300453186
hydroxylase O 1 0.8912163972854614
gene O 0 0.18886181712150574
( O 0 0.08486905694007874
CYP27 O 1 0.6260271072387695
) O 0 0.03900066018104553
was O 0 0.02535116858780384
identified O 0 0.03734308481216431
by O 0 0.027155179530382156
sequencing O 0 0.11823980510234833
amplified O 0 0.1665773093700409
CYP27 O 1 0.5829325318336487
gene O 0 0.11043962091207504
products O 0 0.041677363216876984
from O 0 0.025610970333218575
a O 0 0.04238014295697212
patient O 1 0.9574207067489624
with O 0 0.051065925508737564
cerebrotendinous B-Disease 1 0.9975798726081848
xanthomatosis I-Disease 1 0.9982472658157349
( O 0 0.12206586450338364
CTX B-Disease 1 0.9992873072624207
) O 0 0.07827069610357285
. O 0 0.05335906893014908

The O 0 0.06334947794675827
mutation O 0 0.17841246724128723
changed O 0 0.057888954877853394
the O 0 0.04419451951980591
adrenodoxin O 0 0.4266866445541382
cofactor O 0 0.2616463005542755
binding O 0 0.1138889342546463
residue O 0 0.18047170341014862
362Arg O 0 0.19461707770824432
to O 0 0.04497319087386131
362Ser O 0 0.2788401246070862
( O 0 0.0873599722981453
CGT O 1 0.9453830718994141
362Arg O 1 0.5410383939743042
to O 0 0.06814254075288773
AGT O 1 0.9997968077659607
362Ser O 0 0.33077821135520935
) O 0 0.039203621447086334
, O 0 0.0174726489931345
and O 0 0.015791118144989014
was O 0 0.02202194184064865
responsible O 0 0.043587420135736465
for O 0 0.03333627060055733
deficiency O 1 0.9999709129333496
in O 0 0.03021221049129963
the O 0 0.038153618574142456
sterol O 1 0.9711539149284363
27 O 0 0.09035496413707733
- O 0 0.15419314801692963
hydroxylase O 0 0.49470055103302
activity O 0 0.055676624178886414
, O 0 0.01775004342198372
as O 0 0.01528146956115961
confirmed O 0 0.031134415417909622
by O 0 0.01899154856801033
expression O 0 0.04438537731766701
of O 0 0.02393759973347187
mutant O 0 0.14511685073375702
cDNA O 0 0.17957785725593567
into O 0 0.06674390286207199
COS O 1 0.9960176348686218
- O 0 0.1624857485294342
1 O 0 0.0843602642416954
cells O 0 0.15159888565540314
. O 0 0.06327053159475327

Quantitative O 0 0.13027377426624298
analysis O 0 0.053975701332092285
showed O 0 0.03797702118754387
that O 0 0.015427201986312866
the O 0 0.018316959962248802
expression O 0 0.050804607570171356
of O 0 0.02634376659989357
CYP27 O 0 0.47206738591194153
gene O 0 0.12115975469350815
mRNA O 0 0.07831422239542007
in O 0 0.022156404331326485
the O 0 0.02858378365635872
patient O 0 0.23327994346618652
represented O 0 0.04701435938477516
52 O 0 0.08693436533212662
. O 0 0.04923633113503456

5 O 0 0.055000972002744675
% O 0 0.03426465764641762
of O 0 0.01708824187517166
the O 0 0.025235719978809357
normal O 0 0.06202620267868042
level O 0 0.057127177715301514
. O 0 0.047108881175518036

As O 0 0.03711048513650894
the O 0 0.040753547102212906
mutation O 0 0.16132408380508423
occurred O 0 0.06753924489021301
at O 0 0.029266908764839172
the O 0 0.029105817899107933
penultimate O 0 0.15877825021743774
nucleotide O 0 0.11968604475259781
of O 0 0.032643239945173264
exon O 0 0.16309024393558502
6 O 0 0.0681932270526886
( O 0 0.051198314875364304
- O 0 0.07349652051925659
2 O 0 0.03485444188117981
position O 0 0.026701685041189194
of O 0 0.0252190213650465
exon O 0 0.16428440809249878
6 O 0 0.09093683958053589
- O 0 0.1501692533493042
intron O 1 0.5906962752342224
6 O 0 0.08522249013185501
splice O 0 0.16744452714920044
site O 0 0.042351134121418
) O 0 0.02406620979309082
of O 0 0.013898614794015884
the O 0 0.022294621914625168
gene O 0 0.08921168744564056
, O 0 0.02595687285065651
we O 0 0.025605948641896248
hypothesized O 0 0.08801186084747314
that O 0 0.020445017144083977
the O 0 0.030565530061721802
mutation O 0 0.1589137762784958
may O 0 0.050318870693445206
partially O 0 0.08018472790718079
affect O 0 0.05761798843741417
the O 0 0.02965448796749115
normal O 0 0.07233885675668716
splicing O 0 0.14066295325756073
efficiency O 0 0.0668429359793663
in O 0 0.029785973951220512
exon O 0 0.1348613202571869
6 O 0 0.04974684119224548
and O 0 0.02646954543888569
cause O 0 0.08566340804100037
alternative O 0 0.06889313459396362
splicing O 0 0.11922360211610794
elsewhere O 0 0.04114912822842598
, O 0 0.01772170700132847
which O 0 0.017617590725421906
resulted O 0 0.04246086627244949
in O 0 0.023594295606017113
decreased O 0 0.08481994271278381
transcript O 0 0.07372047752141953
in O 0 0.022839942947030067
the O 0 0.03228697553277016
patient O 1 0.8723009824752808
. O 0 0.053704556077718735

Transfection O 1 0.8709403276443481
of O 0 0.03894612565636635
constructed O 0 0.06331576406955719
minigenes O 0 0.15880531072616577
, O 0 0.02189810387790203
with O 0 0.017676178365945816
or O 0 0.02346065826714039
without O 0 0.020912108942866325
the O 0 0.024792982265353203
mutation O 0 0.13799084722995758
, O 0 0.029053986072540283
into O 0 0.04506199434399605
COS O 1 0.9986768364906311
- O 0 0.15021443367004395
1 O 0 0.06207607686519623
cells O 0 0.09504171460866928
confirmed O 0 0.04151778295636177
that O 0 0.015367564745247364
the O 0 0.022732451558113098
mutant O 0 0.135763019323349
minigene O 0 0.15749317407608032
was O 0 0.03137162700295448
responsible O 0 0.03521816432476044
for O 0 0.018559105694293976
a O 0 0.03195584565401077
mRNA O 0 0.08313753455877304
species O 0 0.04914972186088562
alternatively O 0 0.10805661231279373
spliced O 0 0.13792318105697632
at O 0 0.04133890941739082
an O 0 0.03693563491106033
activated O 0 0.15891581773757935
cryptic O 0 0.1618780493736267
5 O 0 0.07098286598920822
splice O 0 0.1824013739824295
site O 0 0.06603787839412689
88 O 0 0.09722793102264404
bp O 0 0.12325147539377213
upstream O 0 0.06645467877388
from O 0 0.021826326847076416
the O 0 0.02041950821876526
3 O 0 0.03433087468147278
end O 0 0.031214479357004166
of O 0 0.023969223722815514
exon O 0 0.16092097759246826
6 O 0 0.07591074705123901
. O 0 0.05461771413683891

Our O 0 0.042966704815626144
data O 0 0.02857390232384205
suggest O 0 0.03691316023468971
that O 0 0.015427695587277412
the O 0 0.02220103330910206
C O 0 0.08594994246959686
to O 0 0.022679802030324936
A O 0 0.04157048836350441
mutation O 0 0.1264663189649582
at O 0 0.031133221462368965
the O 0 0.025100519880652428
penultimate O 0 0.14636509120464325
nucleotide O 0 0.10965842008590698
of O 0 0.027903486043214798
exon O 0 0.13233521580696106
6 O 0 0.04093235731124878
of O 0 0.020009245723485947
the O 0 0.03248802199959755
CYP27 O 1 0.8895984888076782
gene O 0 0.10218280553817749
not O 0 0.02091379463672638
only O 0 0.02198762632906437
causes O 1 0.5619473457336426
the O 0 0.03692053258419037
deficiency B-Disease 1 0.9999896287918091
in I-Disease 0 0.03031894378364086
the I-Disease 0 0.03943777456879616
sterol I-Disease 1 0.9810509085655212
27 I-Disease 0 0.08699221909046173
- I-Disease 0 0.15523092448711395
hydroxylase I-Disease 1 0.6092790961265564
activity I-Disease 0 0.059264227747917175
, O 0 0.020251398906111717
but O 0 0.01578405871987343
also O 0 0.01795319654047489
partially O 0 0.06467332690954208
leads O 0 0.05962815135717392
to O 0 0.02394707128405571
alternative O 0 0.0652749091386795
pre O 0 0.11034651845693588
- O 0 0.11263390630483627
mRNA O 0 0.10211039334535599
splicing O 0 0.11251840740442276
of O 0 0.02173457480967045
the O 0 0.03456340357661247
gene O 0 0.13026008009910583
. O 0 0.05828704312443733

To O 0 0.026045281440019608
our O 0 0.022556444630026817
knowledge O 0 0.02839304506778717
, O 0 0.014303645119071007
this O 0 0.011364730075001717
is O 0 0.013678818941116333
the O 0 0.013816683553159237
first O 0 0.018982378765940666
report O 0 0.025296006351709366
regarding O 0 0.03443041071295738
effects O 0 0.07495987415313721
on O 0 0.023118235170841217
pre O 0 0.09483619779348373
- O 0 0.10090189427137375
mRNA O 0 0.09660108387470245
splicing O 0 0.10929757356643677
of O 0 0.02425084263086319
a O 0 0.03988106548786163
mutation O 0 0.12799331545829773
at O 0 0.031170176342129707
the O 0 0.0231813695281744
- O 0 0.06876491010189056
2 O 0 0.03340328857302666
position O 0 0.022792423143982887
of O 0 0.015140587463974953
a O 0 0.028998615220189095
5 O 0 0.05275494232773781
splice O 0 0.17297138273715973
site O 0 0.05740421637892723
. O 0 0.04652850702404976

ATM O 1 0.6401311755180359
germline O 1 0.8769086599349976
mutations O 0 0.21163557469844818
in O 0 0.05304703861474991
classical O 0 0.1357751041650772
ataxia B-Disease 1 0.9999995231628418
- I-Disease 1 0.9996405839920044
telangiectasia I-Disease 1 0.9999854564666748
patients O 1 0.9989863038063049
in O 0 0.024320513010025024
the O 0 0.025685928761959076
Dutch O 0 0.06550592184066772
population O 0 0.04763571172952652
. O 0 0.04513515904545784

Germline O 1 0.916499674320221
mutations O 0 0.1948266476392746
in O 0 0.03665072098374367
the O 0 0.0365113727748394
ATM O 0 0.15029503405094147
gene O 0 0.08507391810417175
are O 0 0.01674872823059559
responsible O 0 0.03622797131538391
for O 0 0.0237770713865757
the O 0 0.05473664030432701
autosomal B-Disease 1 0.9999994039535522
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999279975891113
telangiectasia I-Disease 1 0.9999896287918091
( O 0 0.3061996102333069
A B-Disease 1 0.8812611699104309
- I-Disease 1 0.9819840788841248
T I-Disease 1 0.99941086769104
) O 0 0.06269923597574234
. O 0 0.04743903875350952

In O 0 0.03164510428905487
our O 0 0.02467373199760914
study O 0 0.03187384828925133
, O 0 0.016511311754584312
we O 0 0.013152068480849266
have O 0 0.014733278192579746
determined O 0 0.03999056667089462
the O 0 0.032826054841279984
ATM O 0 0.16357044875621796
mutation O 0 0.17028780281543732
spectrum O 0 0.08103373646736145
in O 0 0.024914775043725967
19 O 0 0.04700009152293205
classical O 0 0.05484139919281006
A B-Disease 1 0.803546667098999
- I-Disease 1 0.9988622665405273
T I-Disease 1 0.999981164932251
patients O 1 0.9986671209335327
, O 0 0.02325987070798874
including O 0 0.016970794647932053
some O 0 0.017694074660539627
immigrant O 0 0.0660761222243309
populations O 0 0.05596588924527168
, O 0 0.016077199950814247
as O 0 0.013190804980695248
well O 0 0.013119430281221867
as O 0 0.012961036525666714
12 O 0 0.02375614270567894
of O 0 0.016971955075860023
Dutch O 0 0.051418960094451904
ethnic O 0 0.036995675414800644
origin O 0 0.054721638560295105
. O 0 0.05082669109106064

Both O 0 0.035687584429979324
the O 0 0.03742143139243126
protein O 0 0.10906565934419632
truncation O 0 0.18570370972156525
test O 0 0.08876161277294159
( O 0 0.05726506561040878
PTT O 0 0.12736396491527557
) O 0 0.03139985725283623
and O 0 0.018161015585064888
the O 0 0.026682645082473755
restriction O 0 0.10203797370195389
endonuclease O 1 0.620053768157959
fingerprinting O 0 0.19250519573688507
( O 0 0.08068155497312546
REF O 0 0.32805106043815613
) O 0 0.03498765081167221
method O 0 0.030863985419273376
were O 0 0.011425113305449486
used O 0 0.015986477956175804
and O 0 0.014304694719612598
compared O 0 0.02985573559999466
for O 0 0.015033828094601631
their O 0 0.021881040185689926
detection O 0 0.1027081236243248
efficiency O 0 0.06820113956928253
, O 0 0.024492571130394936
identifying O 0 0.06730066984891891
76 O 0 0.08025867491960526
% O 0 0.033970125019550323
and O 0 0.017516588792204857
60 O 0 0.03496476262807846
% O 0 0.027265483513474464
of O 0 0.014422385022044182
the O 0 0.026157280430197716
mutations O 0 0.12437901645898819
, O 0 0.031052565202116966
respectively O 0 0.050515130162239075
. O 0 0.05040419474244118

Most O 0 0.058428484946489334
patients O 1 0.9531943798065186
were O 0 0.01932617835700512
found O 0 0.02244173176586628
to O 0 0.01862333156168461
be O 0 0.024516891688108444
compound O 0 0.11587075889110565
heterozygote O 1 0.8758627772331238
. O 0 0.06704975664615631

Seventeen O 0 0.1355305016040802
mutations O 0 0.13935822248458862
were O 0 0.023624951019883156
distinct O 0 0.03658226132392883
, O 0 0.015148061327636242
of O 0 0.011921423487365246
which O 0 0.014714346267282963
10 O 0 0.01717163622379303
were O 0 0.013049677945673466
not O 0 0.01474150363355875
reported O 0 0.03873756527900696
previously O 0 0.03935442492365837
. O 0 0.042381759732961655

Mutations O 0 0.20973823964595795
are O 0 0.03283916413784027
small O 0 0.042813170701265335
deletions O 0 0.12276576459407806
or O 0 0.044821131974458694
point O 0 0.05738168954849243
mutations O 0 0.15826061367988586
frequently O 0 0.07821498066186905
affecting O 0 0.12279798090457916
splice O 0 0.22002074122428894
sites O 0 0.07315243035554886
. O 0 0.055599357932806015

Moreover O 0 0.08809702843427658
, O 0 0.029186200350522995
a O 0 0.035670407116413116
16 O 0 0.04725559800863266
. O 0 0.04704330489039421

7 O 0 0.1138961985707283
- O 0 0.15126703679561615
kb O 0 0.19599437713623047
genomic O 0 0.17380991578102112
deletion O 0 0.13752013444900513
of O 0 0.018852828070521355
the O 0 0.01981658861041069
3 O 0 0.033218201249837875
end O 0 0.026337767019867897
of O 0 0.0135435089468956
the O 0 0.020795684307813644
gene O 0 0.08148491382598877
, O 0 0.02117895893752575
most O 0 0.019366426393389702
likely O 0 0.03348192572593689
a O 0 0.02457413822412491
result O 0 0.030785052105784416
of O 0 0.018815629184246063
recombination O 0 0.1149151399731636
between O 0 0.02232765406370163
two O 0 0.017647456377744675
LINE O 0 0.04073358699679375
elements O 0 0.029592029750347137
, O 0 0.01923753321170807
was O 0 0.025287676602602005
identified O 0 0.05086393654346466
. O 0 0.04640111327171326

The O 0 0.0396597720682621
most O 0 0.02810318022966385
frequently O 0 0.04910896345973015
found O 0 0.04041880741715431
mutation O 0 0.1238054633140564
, O 0 0.022971054539084435
identified O 0 0.02932760678231716
in O 0 0.015414532274007797
three O 0 0.018970457836985588
unrelated O 0 0.06094621866941452
Turkish O 0 0.06368934363126755
A B-Disease 0 0.46607357263565063
- I-Disease 1 0.9745516180992126
T I-Disease 1 0.9991550445556641
individuals O 0 0.03600103780627251
, O 0 0.015713883563876152
was O 0 0.016782987862825394
previously O 0 0.01992243155837059
described O 0 0.025431951507925987
to O 0 0.012353930622339249
be O 0 0.011782648973166943
a O 0 0.024264290928840637
Turkish O 0 0.050471656024456024
A B-Disease 0 0.14439406991004944
- I-Disease 1 0.9749974608421326
T I-Disease 1 0.9996023774147034
founder O 0 0.14273665845394135
mutation O 0 0.23211169242858887
. O 0 0.07466207444667816

The O 0 0.03766105696558952
presence O 0 0.049412474036216736
of O 0 0.020065490156412125
a O 0 0.0401557981967926
founder O 0 0.09989678859710693
mutation O 0 0.15355370938777924
among O 0 0.037902358919382095
relatively O 0 0.043366897851228714
small O 0 0.02714383602142334
ethnic O 0 0.0292262751609087
population O 0 0.03620369732379913
groups O 0 0.026502449065446854
in O 0 0.019478656351566315
Western O 0 0.034772880375385284
Europe O 0 0.03457106277346611
could O 0 0.023951832205057144
indicate O 0 0.04114440456032753
a O 0 0.028611531481146812
high O 0 0.043858613818883896
carrier O 0 0.09712233394384384
frequency O 0 0.06328032165765762
in O 0 0.01987745612859726
such O 0 0.022125547751784325
communities O 0 0.052352871745824814
. O 0 0.046879351139068604

In O 0 0.04889615252614021
patients O 1 0.9288986921310425
of O 0 0.018658515065908432
Dutch O 0 0.04917166009545326
ethnic O 0 0.0324285663664341
origin O 0 0.033431146293878555
, O 0 0.01878018118441105
however O 0 0.018917664885520935
, O 0 0.01571805030107498
no O 0 0.020696571096777916
significant O 0 0.0334070585668087
founder O 0 0.06586746126413345
effect O 0 0.04966103285551071
could O 0 0.023596886545419693
be O 0 0.017099183052778244
identified O 0 0.05038115009665489
. O 0 0.04259128496050835

The O 0 0.05075312405824661
observed O 0 0.07622796297073364
genetic O 0 0.09611016511917114
heterogeneity O 0 0.10890617221593857
including O 0 0.022097148001194
the O 0 0.018529681488871574
relative O 0 0.042610492557287216
high O 0 0.038819197565317154
percentage O 0 0.04719448834657669
of O 0 0.03026701882481575
splice O 0 0.20648103952407837
- O 0 0.12787917256355286
site O 0 0.06918042153120041
mutations O 0 0.12178269773721695
had O 0 0.03218720480799675
no O 0 0.026601502671837807
reflection O 0 0.057963818311691284
on O 0 0.021284490823745728
the O 0 0.03635619580745697
phenotype O 1 0.8429058194160461
. O 0 0.06172813102602959

All O 0 0.05198153853416443
patients O 1 0.9943102598190308
manifested O 0 0.1805177479982376
classical O 0 0.07900351285934448
A B-Disease 0 0.20664601027965546
- I-Disease 1 0.8716891407966614
T I-Disease 1 0.9968936443328857
and O 0 0.03247624263167381
increased O 0 0.06674817204475403
cellular O 0 0.13909442722797394
radioresistant O 0 0.35822561383247375
DNA O 0 0.14264333248138428
synthesis O 0 0.13250073790550232
. O 0 0.056115418672561646

Determination O 0 0.07604347914457321
of O 0 0.021723570302128792
the O 0 0.025448041036725044
genomic O 0 0.10395733267068863
structure O 0 0.034202221781015396
of O 0 0.017115822061896324
the O 0 0.030111471191048622
COL4A4 O 1 0.8182252645492554
gene O 0 0.09153017401695251
and O 0 0.01951572112739086
of O 0 0.024335406720638275
novel O 0 0.08351688086986542
mutations O 1 0.9170542359352112
causing O 1 0.9930064678192139
autosomal B-Disease 1 0.9999819993972778
recessive I-Disease 1 0.9999977350234985
Alport I-Disease 1 0.9999996423721313
syndrome I-Disease 1 0.9999998807907104
. O 0 0.09627199918031693

Autosomal B-Disease 1 0.9999696016311646
recessive I-Disease 1 0.9999967813491821
Alport I-Disease 1 0.9999997615814209
syndrome I-Disease 1 0.9999998807907104
is O 0 0.05395513400435448
a O 0 0.053628336638212204
progressive O 1 0.9232566356658936
hematuric B-Disease 1 0.9989155530929565
glomerulonephritis I-Disease 1 0.9999942779541016
characterized O 1 0.8930730223655701
by O 0 0.06590969860553741
glomerular B-Disease 1 0.9998044371604919
basement I-Disease 1 0.9891996383666992
membrane I-Disease 1 0.8060035705566406
abnormalities I-Disease 1 0.9864085912704468
and O 0 0.025655195116996765
associated O 0 0.039679717272520065
with O 0 0.02802027016878128
mutations O 0 0.10136518627405167
in O 0 0.01910393312573433
either O 0 0.023787928745150566
the O 0 0.02515144646167755
COL4A3 O 1 0.6413424015045166
or O 0 0.03147462010383606
the O 0 0.030645161867141724
COL4A4 O 1 0.8349975943565369
gene O 0 0.0960143581032753
, O 0 0.022397277876734734
which O 0 0.01822541654109955
encode O 0 0.053752973675727844
the O 0 0.0354786179959774
alpha3 O 0 0.16868115961551666
and O 0 0.046107977628707886
alpha4 O 1 0.9483575820922852
type O 1 0.7450738549232483
IV O 1 0.9979419112205505
collagen O 1 0.9978805780410767
chains O 0 0.11025405675172806
, O 0 0.03242173045873642
respectively O 0 0.05097416043281555
. O 0 0.04702690616250038

To O 0 0.041407931596040726
date O 0 0.04482656344771385
, O 0 0.037902165204286575
mutation O 0 0.15917053818702698
screening O 0 0.08390571177005768
in O 0 0.018690690398216248
the O 0 0.01734565570950508
two O 0 0.01915077306330204
genes O 0 0.06393621116876602
has O 0 0.02618713118135929
been O 0 0.021041717380285263
hampered O 0 0.08329934626817703
by O 0 0.01755755953490734
the O 0 0.018368924036622047
lack O 0 0.03991018235683441
of O 0 0.02249702252447605
genomic O 0 0.12677806615829468
structure O 0 0.050509870052337646
information O 0 0.03371721878647804
. O 0 0.044650450348854065

We O 0 0.028717724606394768
report O 0 0.027129029855132103
here O 0 0.01762358285486698
the O 0 0.017525291070342064
complete O 0 0.03417158126831055
characterization O 0 0.05568559467792511
of O 0 0.014469711109995842
the O 0 0.02038392424583435
48 O 0 0.05276171490550041
exons O 0 0.0968484953045845
of O 0 0.02058194950222969
the O 0 0.03506378084421158
COL4A4 O 1 0.7595849633216858
gene O 0 0.10742355138063431
, O 0 0.02535073086619377
a O 0 0.03448747098445892
comprehensive O 0 0.07057218998670578
gene O 0 0.09779984503984451
screen O 0 0.04694146662950516
, O 0 0.016103094443678856
and O 0 0.014038557186722755
the O 0 0.018771138042211533
subsequent O 0 0.047395870089530945
detection O 0 0.07673054188489914
of O 0 0.018058640882372856
10 O 0 0.03264550492167473
novel O 0 0.0534636452794075
mutations O 0 0.12274175882339478
in O 0 0.03144004940986633
eight O 0 0.06179129704833031
patients O 1 0.9999904632568359
diagnosed O 1 0.9999990463256836
with O 0 0.1377829760313034
autosomal B-Disease 1 0.9999936819076538
recessive I-Disease 1 0.9999992847442627
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.09814273566007614

Furthermore O 0 0.07839857786893845
, O 0 0.024293649941682816
we O 0 0.01819084957242012
identified O 0 0.03457941859960556
a O 0 0.034303296357393265
glycine O 0 0.13371144235134125
to O 0 0.0345083624124527
alanine O 0 0.16314896941184998
substitution O 0 0.08479754626750946
in O 0 0.022796913981437683
the O 0 0.030187388882040977
collagenous O 1 0.952999472618103
domain O 0 0.05903315544128418
that O 0 0.020907677710056305
is O 0 0.024633709341287613
apparently O 0 0.0534837506711483
silent O 0 0.06702505797147751
in O 0 0.020828235894441605
the O 0 0.026549577713012695
heterozygous O 0 0.1329074501991272
carriers O 0 0.0938306599855423
, O 0 0.024203365668654442
in O 0 0.024893052875995636
11 O 0 0.04776263236999512
. O 0 0.041862983256578445

5 O 0 0.05845531448721886
% O 0 0.02956518903374672
of O 0 0.012900528497993946
all O 0 0.014365837909281254
control O 0 0.03587872162461281
individuals O 0 0.024424295872449875
, O 0 0.01309347152709961
and O 0 0.010917392559349537
in O 0 0.012141861952841282
one O 0 0.016011031344532967
control O 0 0.037534963339567184
individual O 0 0.03396153077483177
homozygous O 0 0.1012006625533104
for O 0 0.022646423429250717
this O 0 0.028701579198241234
glycine O 0 0.18594831228256226
substitution O 0 0.1279647946357727
. O 0 0.050248246639966965

There O 0 0.03106655925512314
has O 0 0.01879880204796791
been O 0 0.01528856996446848
no O 0 0.015194226987659931
previous O 0 0.02076220139861107
finding O 0 0.03141087666153908
of O 0 0.016754966229200363
a O 0 0.03528169170022011
glycine O 0 0.13878893852233887
substitution O 0 0.07396361976861954
that O 0 0.0154526736587286
is O 0 0.015903033316135406
not O 0 0.012499225325882435
associated O 0 0.023265415802598
with O 0 0.01916130818426609
any O 0 0.025799158960580826
obvious O 0 0.07490593194961548
phenotype O 1 0.5306878089904785
in O 0 0.03917701542377472
homozygous O 0 0.14245228469371796
individuals O 0 0.05510430037975311
. O 0 0.054152004420757294

Founder O 0 0.20660287141799927
BRCA1 O 1 0.9791862368583679
and O 0 0.0698268860578537
BRCA2 O 1 0.9940913319587708
mutations O 0 0.19643497467041016
in O 0 0.0397523008286953
French O 0 0.08156117796897888
Canadian O 0 0.40544357895851135
breast B-Disease 1 0.9999983310699463
and I-Disease 1 0.9364331960678101
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
families O 0 0.094512440264225
. O 0 0.05982084199786186

We O 0 0.035577185451984406
have O 0 0.022200746461749077
identified O 0 0.035343728959560394
four O 0 0.023403296247124672
mutations O 0 0.08223836123943329
in O 0 0.015235266648232937
each O 0 0.014138747937977314
of O 0 0.015189312398433685
the O 0 0.04554513096809387
breast B-Disease 1 0.9999995231628418
cancer I-Disease 1 0.9999996423721313
- O 1 0.9868387579917908
susceptibility O 1 0.9915600419044495
genes O 0 0.12778295576572418
, O 0 0.044746555387973785
BRCA1 O 1 0.9810360670089722
and O 0 0.044802822172641754
BRCA2 O 1 0.9803393483161926
, O 0 0.03142613172531128
in O 0 0.026025185361504555
French O 0 0.07182137668132782
Canadian O 1 0.8992690443992615
breast B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999998807907104
and O 1 0.98062664270401
breast B-Disease 1 1.0
/ I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
families O 0 0.06606928259134293
from O 0 0.03995825722813606
Quebec O 0 0.10339245945215225
. O 0 0.05129678547382355

To O 0 0.04954584315419197
identify O 0 0.07628645747900009
founder O 0 0.09925877302885056
effects O 0 0.1064964160323143
, O 0 0.028533626347780228
we O 0 0.024650853127241135
examined O 0 0.0728045105934143
independently O 0 0.05444620922207832
ascertained O 0 0.11469382792711258
French O 0 0.07640599459409714
Canadian O 0 0.09278546273708344
cancer B-Disease 1 0.9994934797286987
families O 0 0.04122016951441765
for O 0 0.016547029837965965
the O 0 0.017142651602625847
distribution O 0 0.027453918009996414
of O 0 0.013555527664721012
these O 0 0.019328013062477112
eight O 0 0.04588021710515022
mutations O 0 0.1522534191608429
. O 0 0.053085438907146454

Mutations O 0 0.16993717849254608
were O 0 0.02271128073334694
found O 0 0.024494189769029617
in O 0 0.018078792840242386
41 O 0 0.045639485120773315
of O 0 0.021740172058343887
97 O 0 0.09396728128194809
families O 0 0.06165905296802521
. O 0 0.047907885164022446

Six O 0 0.044050876051187515
of O 0 0.023167405277490616
eight O 0 0.04454544186592102
mutations O 0 0.11362496763467789
were O 0 0.020935293287038803
observed O 0 0.04501064866781235
at O 0 0.027988653630018234
least O 0 0.030637793242931366
twice O 0 0.04730363190174103
. O 0 0.04454709589481354

The O 0 0.09681347757577896
BRCA1 O 1 0.9878643155097961
C4446T O 1 0.6626876592636108
mutation O 0 0.17027173936367035
was O 0 0.02717742510139942
the O 0 0.0171970222145319
most O 0 0.021040355786681175
common O 0 0.0468897819519043
mutation O 0 0.14162348210811615
found O 0 0.029442844912409782
, O 0 0.01813705451786518
followed O 0 0.0314115434885025
by O 0 0.02083931490778923
the O 0 0.04229964688420296
BRCA2 O 1 0.9953332543373108
8765delAG O 1 0.9198222756385803
mutation O 0 0.3296567499637604
. O 0 0.06537970900535583

Together O 0 0.039581138640642166
, O 0 0.024998599663376808
these O 0 0.0200779028236866
mutations O 0 0.08891558647155762
were O 0 0.015881376340985298
found O 0 0.020849552005529404
in O 0 0.01664871722459793
28 O 0 0.029947554692626
of O 0 0.01660037599503994
41 O 0 0.049567416310310364
families O 0 0.036974597722291946
identified O 0 0.034167543053627014
to O 0 0.016984257847070694
have O 0 0.02018682472407818
a O 0 0.04376447945833206
mutation O 0 0.18035025894641876
. O 0 0.05747423321008682

The O 0 0.03955187276005745
odds O 0 0.07948672771453857
of O 0 0.02283521369099617
detection O 0 0.07445332407951355
of O 0 0.01465960405766964
any O 0 0.014054571278393269
of O 0 0.012174882926046848
the O 0 0.021410049870610237
four O 0 0.04486894607543945
BRCA1 O 1 0.9814780950546265
mutations O 0 0.1639525592327118
was O 0 0.03836445137858391
18 O 0 0.048108525574207306
. O 0 0.04265877977013588

7x O 1 0.9263681173324585
greater O 0 0.06265731900930405
if O 0 0.029399652034044266
one O 0 0.016631511971354485
or O 0 0.020925186574459076
more O 0 0.017797403037548065
cases O 0 0.05293969437479973
of O 0 0.04820450395345688
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999982118606567
were O 0 0.019630467519164085
also O 0 0.014466985128819942
present O 0 0.016040010377764702
in O 0 0.013121158815920353
the O 0 0.018306991085410118
family O 0 0.04499872401356697
. O 0 0.040922798216342926

The O 0 0.04389782249927521
odds O 0 0.08464611321687698
of O 0 0.024334950372576714
detection O 0 0.07339372485876083
of O 0 0.014214158989489079
any O 0 0.014297045767307281
of O 0 0.014067170210182667
the O 0 0.02220752276480198
four O 0 0.0395628921687603
BRCA2 O 1 0.9872530102729797
mutations O 0 0.1969781219959259
was O 0 0.04392766207456589
5 O 0 0.055614929646253586
. O 0 0.049782734364271164

3x O 0 0.28781789541244507
greater O 0 0.05681772902607918
if O 0 0.022316373884677887
there O 0 0.012531588785350323
were O 0 0.012173117138445377
at O 0 0.01788613386452198
least O 0 0.019227199256420135
five O 0 0.02059338428080082
cases O 0 0.03865908831357956
of O 0 0.03444040194153786
breast B-Disease 1 0.9999980926513672
cancer I-Disease 1 0.9999716281890869
in O 0 0.02433548867702484
the O 0 0.022025104612112045
family O 0 0.0512077622115612
. O 0 0.041771359741687775

Interestingly O 0 0.1266525685787201
, O 0 0.02469475381076336
the O 0 0.020521078258752823
presence O 0 0.03856739029288292
of O 0 0.02178572490811348
a O 0 0.06768077611923218
breast B-Disease 1 0.9999980926513672
cancer I-Disease 1 0.9999967813491821
case O 0 0.09131394326686859
< O 0 0.396225243806839
36 O 0 0.04520457610487938
years O 0 0.019739197567105293
of O 0 0.014242246747016907
age O 0 0.038712285459041595
was O 0 0.02338845282793045
strongly O 0 0.03732222691178322
predictive O 0 0.0781712457537651
of O 0 0.014524067752063274
the O 0 0.017365815117955208
presence O 0 0.02669302374124527
of O 0 0.009720035828649998
any O 0 0.012474218383431435
of O 0 0.010855045169591904
the O 0 0.019880615174770355
eight O 0 0.046239469200372696
mutations O 0 0.17325274646282196
screened O 0 0.12984828650951385
. O 0 0.06287234276533127

Carriers O 0 0.12439612299203873
of O 0 0.02280154824256897
the O 0 0.026501256972551346
same O 0 0.03538129851222038
mutation O 0 0.1228320449590683
, O 0 0.0205172561109066
from O 0 0.01735977828502655
different O 0 0.01391472015529871
families O 0 0.030926035717129707
, O 0 0.019312424585223198
shared O 0 0.039081085473299026
similar O 0 0.05068037658929825
haplotypes O 0 0.43131300806999207
, O 0 0.030962185934185982
indicating O 0 0.05223360285162926
that O 0 0.01756664365530014
the O 0 0.027163712307810783
mutant O 0 0.13445919752120972
alleles O 0 0.1502980887889862
were O 0 0.02163703367114067
likely O 0 0.030127162113785744
to O 0 0.013651017099618912
be O 0 0.011573287658393383
identical O 0 0.031066035851836205
by O 0 0.017085691913962364
descent O 0 0.05566994473338127
for O 0 0.019455738365650177
a O 0 0.03321186453104019
mutation O 0 0.11685739457607269
in O 0 0.019156459718942642
the O 0 0.022411435842514038
founder O 0 0.0673997774720192
population O 0 0.050987500697374344
. O 0 0.04756820574402809

The O 0 0.035144731402397156
identification O 0 0.047401729971170425
of O 0 0.026784373447299004
common O 0 0.06976279616355896
BRCA1 O 1 0.9931859970092773
and O 0 0.05536090210080147
BRCA2 O 1 0.9964325428009033
mutations O 0 0.17348143458366394
will O 0 0.03221411630511284
facilitate O 0 0.06683087348937988
carrier O 0 0.12450186908245087
detection O 0 0.11584258824586868
in O 0 0.029816504567861557
French O 0 0.07769159972667694
Canadian O 1 0.8607749342918396
breast B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999998807907104
and O 1 0.9721998572349548
breast B-Disease 1 1.0
/ I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
families O 0 0.10592488944530487
. O 0 0.051389750093221664

Are O 0 0.05217522382736206
Dp71 O 0 0.2602553963661194
and O 0 0.04987882822751999
Dp140 O 1 0.9557191729545593
brain O 1 0.9890311360359192
dystrophin O 1 0.9820918440818787
isoforms O 0 0.13087786734104156
related O 0 0.05927280709147453
to O 0 0.0389532670378685
cognitive B-Disease 1 0.923376739025116
impairment I-Disease 1 0.9998664855957031
in O 0 0.09728513658046722
Duchenne B-Disease 1 0.9999995231628418
muscular I-Disease 1 0.9999994039535522
dystrophy I-Disease 1 0.9999998807907104
? O 1 0.8454283475875854

Molecular O 0 0.13608096539974213
study O 0 0.056012388318777084
and O 0 0.03461074456572533
neuropsychological O 0 0.17749296128749847
analysis O 0 0.04085163772106171
were O 0 0.0170037429779768
performed O 0 0.033812910318374634
concurrently O 0 0.033968087285757065
on O 0 0.025168612599372864
49 O 0 0.08690539747476578
patients O 1 0.9998013377189636
with O 0 0.09424463659524918
Duchenne B-Disease 1 0.9999997615814209
muscular I-Disease 1 0.9999998807907104
dystrophy I-Disease 1 1.0
( O 1 0.9818094968795776
DMD B-Disease 1 0.9999986886978149
) O 0 0.03932642936706543
in O 0 0.015999754890799522
order O 0 0.016625655815005302
to O 0 0.015067986212670803
find O 0 0.030170604586601257
a O 0 0.030033979564905167
molecular O 0 0.06496851146221161
explanation O 0 0.04680226370692253
for O 0 0.01954309456050396
the O 0 0.028792260214686394
cognitive B-Disease 1 0.5829881429672241
impairment I-Disease 1 0.9984448552131653
observed O 0 0.06268509477376938
in O 0 0.030387606471776962
most O 0 0.05500653013586998
DMD B-Disease 1 0.9999998807907104
patients O 1 0.99980229139328
. O 0 0.06474900245666504

Complete O 0 0.06239594146609306
analysis O 0 0.039004065096378326
of O 0 0.01951874978840351
the O 0 0.034593142569065094
dystrophin O 1 0.9425572752952576
gene O 0 0.11713160574436188
was O 0 0.03035341203212738
performed O 0 0.034601785242557526
to O 0 0.01719747483730316
define O 0 0.03858111426234245
the O 0 0.019622256979346275
localization O 0 0.08035510778427124
of O 0 0.022002534940838814
deletions O 0 0.09311166405677795
and O 0 0.02209002897143364
duplications O 0 0.09118061512708664
in O 0 0.02047649957239628
relation O 0 0.035450998693704605
to O 0 0.01880710758268833
the O 0 0.02708876132965088
different O 0 0.04431750625371933
DMD B-Disease 1 0.9999954700469971
promoters O 1 0.7757631540298462
. O 0 0.06083051487803459

Qualitative O 0 0.12064264714717865
analysis O 0 0.04466354474425316
of O 0 0.019358066841959953
the O 0 0.029782412573695183
Dp71 O 0 0.18552462756633759
transcript O 0 0.07985640317201614
and O 0 0.021265199407935143
testing O 0 0.04316142201423645
for O 0 0.013990791514515877
the O 0 0.015411369502544403
specific O 0 0.02344234474003315
first O 0 0.025859665125608444
exon O 0 0.11120118945837021
of O 0 0.023289311677217484
Dp140 O 0 0.10676100850105286
were O 0 0.016633415594697
also O 0 0.01734873652458191
carried O 0 0.03009663335978985
out O 0 0.02904949150979519
. O 0 0.04256686940789223

Neuropsychological O 1 0.6154199242591858
analysis O 0 0.088631771504879
assessed O 0 0.10696428269147873
verbal O 0 0.10810117423534393
and O 0 0.03796403482556343
visuospatial O 1 0.9819639921188354
intelligence O 0 0.060522016137838364
, O 0 0.026779968291521072
verbal O 0 0.07938921451568604
memory O 0 0.060870327055454254
, O 0 0.01961381547152996
and O 0 0.01857794262468815
reading O 0 0.03956959769129753
skills O 0 0.06978721916675568
. O 0 0.04771203547716141

Comparison O 0 0.07124360650777817
of O 0 0.028778061270713806
molecular O 0 0.07828418910503387
and O 0 0.028733136132359505
psychometric O 0 0.19191943109035492
findings O 0 0.06658560037612915
demonstrated O 0 0.059045661240816116
that O 0 0.02126687578856945
deletions O 0 0.09210329502820969
and O 0 0.024763301014900208
duplications O 0 0.09537191689014435
that O 0 0.016293909400701523
were O 0 0.016658049076795578
localized O 0 0.08921412378549576
in O 0 0.019850842654705048
the O 0 0.02530524507164955
distal O 1 0.5575880408287048
part O 0 0.03043338470160961
of O 0 0.01775336265563965
the O 0 0.024581344798207283
gene O 0 0.08837484568357468
seemed O 0 0.045426808297634125
to O 0 0.0175772774964571
be O 0 0.018547900021076202
preferentially O 0 0.10649137943983078
associated O 0 0.047196999192237854
with O 0 0.03937423601746559
cognitive B-Disease 1 0.5740588903427124
impairment I-Disease 1 0.9987397789955139
. O 0 0.07018037885427475

Two O 0 0.05059036239981651
altered O 0 0.10476895421743393
Dp71 O 0 0.1840265989303589
transcripts O 0 0.06589707732200623
and O 0 0.019568171352148056
two O 0 0.025658058002591133
deleted O 0 0.09309560060501099
Dp140 O 0 0.1692420244216919
DNA O 0 0.09703190624713898
sequences O 0 0.05774525925517082
were O 0 0.019102804362773895
found O 0 0.025836728513240814
in O 0 0.01766584999859333
four O 0 0.03385186195373535
patients O 1 0.9996988773345947
with O 0 0.06703618168830872
severe O 1 0.9999874830245972
cerebral B-Disease 1 0.9999995231628418
dysfunction I-Disease 1 0.9999963045120239
. O 0 0.0662836804986

These O 0 0.03904186934232712
findings O 0 0.06044666841626167
suggest O 0 0.04352334514260292
that O 0 0.015351077541708946
some O 0 0.01668345369398594
sequences O 0 0.04109305888414383
located O 0 0.026181690394878387
in O 0 0.01604481413960457
the O 0 0.022387506440281868
distal O 0 0.37300482392311096
part O 0 0.02704007364809513
of O 0 0.014822802506387234
the O 0 0.022517472505569458
gene O 0 0.07278410345315933
and O 0 0.01645958051085472
, O 0 0.015072274953126907
in O 0 0.014547249302268028
particular O 0 0.02900041453540325
, O 0 0.02471078746020794
some O 0 0.031566817313432693
DMD B-Disease 1 0.999983549118042
isoforms O 0 0.11380402743816376
expressed O 0 0.04008844122290611
in O 0 0.021020185202360153
the O 0 0.0282391719520092
brain O 1 0.9819230437278748
may O 0 0.027708249166607857
be O 0 0.012355216778814793
related O 0 0.025292206555604935
to O 0 0.016767743974924088
the O 0 0.027271654456853867
cognitive B-Disease 1 0.5944033861160278
impairment I-Disease 1 0.9994968175888062
associated O 0 0.060902681201696396
with O 0 0.05038667097687721
DMD B-Disease 1 0.9999979734420776
. O 0 0.04609418660402298
. O 0 0.04628049582242966

I1307K O 1 0.5833600759506226
APC O 1 0.6972675919532776
and O 0 0.0502331517636776
hMLH1 O 0 0.20438897609710693
mutations O 0 0.1367943435907364
in O 0 0.023167530074715614
a O 0 0.027780305594205856
non O 0 0.056247469037771225
- O 0 0.08715363591909409
Jewish O 0 0.05223914235830307
family O 0 0.043691977858543396
with O 0 0.03464877977967262
hereditary B-Disease 1 0.999550998210907
non I-Disease 1 0.9980610013008118
- I-Disease 1 0.9999836683273315
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
. O 0 0.08576270937919617

We O 0 0.038411326706409454
describe O 0 0.0603245310485363
a O 0 0.03588110953569412
French O 0 0.06027916818857193
Canadian O 0 0.07854634523391724
hereditary B-Disease 1 0.9981473684310913
non I-Disease 1 0.9974355101585388
- I-Disease 1 0.9999874830245972
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 1 0.9614622592926025
HNPCC B-Disease 1 0.9999921321868896
) O 0 0.0657305121421814
kindred O 1 0.9326770305633545
which O 0 0.025913918390870094
carries O 0 0.04341810196638107
a O 0 0.03440689295530319
novel O 0 0.0667252466082573
truncating O 0 0.3028281331062317
mutation O 0 0.1915167272090912
in O 0 0.04790550097823143
hMLH1 O 0 0.2199038863182068
. O 0 0.06189412623643875

Interestingly O 0 0.13999193906784058
, O 0 0.03642304986715317
the O 0 0.042260777205228806
I1307K O 0 0.2532283067703247
APC O 1 0.7948380708694458
polymorphism O 0 0.15088552236557007
, O 0 0.02928074263036251
associated O 0 0.02908923663198948
with O 0 0.018235282972455025
an O 0 0.02360767312347889
increased O 0 0.05404401570558548
risk O 1 0.991709291934967
of O 0 0.05907433480024338
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999995231628418
, O 0 0.026324156671762466
is O 0 0.017616674304008484
also O 0 0.014600343070924282
present O 0 0.017991017550230026
in O 0 0.01533221174031496
this O 0 0.018280889838933945
family O 0 0.04701445996761322
. O 0 0.047779276967048645

The O 0 0.06403018534183502
I1307K O 0 0.19585736095905304
polymorphism O 0 0.13948532938957214
has O 0 0.02875405363738537
previously O 0 0.023796020075678825
only O 0 0.012918411754071712
been O 0 0.015314426273107529
identified O 0 0.023305730894207954
in O 0 0.013874617405235767
individuals O 0 0.025672638788819313
of O 0 0.019746042788028717
self O 0 0.07480525970458984
- O 0 0.11639881134033203
reported O 0 0.08013788610696793
Ashkenazi O 0 0.17325612902641296
Jewish O 0 0.07613593339920044
origins O 0 0.09431435912847519
. O 0 0.0534513033926487

In O 0 0.02939515933394432
addition O 0 0.0279550738632679
, O 0 0.014829274266958237
in O 0 0.013447693549096584
this O 0 0.013742241077125072
family O 0 0.02772606536746025
, O 0 0.015802737325429916
there O 0 0.01541849970817566
appears O 0 0.02826625294983387
to O 0 0.012133661657571793
be O 0 0.012488876469433308
no O 0 0.017859432846307755
relationship O 0 0.035284411162137985
between O 0 0.021401837468147278
the O 0 0.026263883337378502
I1307K O 0 0.15023452043533325
polymorphism O 0 0.10738018900156021
and O 0 0.016575749963521957
the O 0 0.019468842074275017
presence O 0 0.04268571734428406
or O 0 0.02953432686626911
absence O 0 0.05642911419272423
of O 0 0.030040066689252853
cancer B-Disease 1 0.9999510049819946
. O 0 0.033723264932632446
. O 0 0.04165950044989586

Identification O 0 0.06336365640163422
of O 0 0.01970071904361248
a O 0 0.031948842108249664
novel O 0 0.05278833955526352
mutation O 0 0.1155473068356514
of O 0 0.022462639957666397
the O 0 0.031147761270403862
CPO O 0 0.16092444956302643
gene O 0 0.0969633236527443
in O 0 0.022397108376026154
a O 0 0.03443668782711029
Japanese O 0 0.06400995701551437
hereditary B-Disease 1 0.9008408188819885
coproporphyria I-Disease 1 0.8015032410621643
family O 0 0.07976629585027695
. O 0 0.059518612921237946

Hereditary B-Disease 1 0.9830986857414246
coproporphyria I-Disease 1 0.9869376420974731
( O 0 0.10887766629457474
HCP B-Disease 1 0.9960972666740417
) O 0 0.04303834214806557
is O 0 0.027419231832027435
an O 0 0.03569706156849861
autosomal B-Disease 1 0.9996318817138672
dominant I-Disease 1 0.9947987794876099
disease I-Disease 1 0.9999980926513672
characterized O 1 0.9587441682815552
by O 0 0.036365702748298645
a O 0 0.06387319415807724
deficiency B-Disease 1 0.9999932050704956
of I-Disease 0 0.05319752171635628
coproporphyrinogen I-Disease 1 0.993023157119751
oxidase I-Disease 1 0.9735941886901855
( O 0 0.07998199760913849
CPO O 0 0.2638006806373596
) O 0 0.048568133264780045
caused O 0 0.06699927896261215
by O 0 0.023432327434420586
a O 0 0.03961869701743126
mutation O 0 0.13254426419734955
in O 0 0.02587646059691906
the O 0 0.03560027480125427
CPO O 0 0.22259469330310822
gene O 0 0.14906223118305206
. O 0 0.05896815285086632

Only O 0 0.03784279152750969
11 O 0 0.05260666459798813
mutations O 0 0.10667433589696884
of O 0 0.01752723567187786
the O 0 0.0237638670951128
gene O 0 0.07868172228336334
have O 0 0.020233288407325745
been O 0 0.02251623570919037
reported O 0 0.04720829054713249
in O 0 0.04197569563984871
HCP B-Disease 1 0.9997974038124084
patients O 1 0.9993896484375
. O 0 0.06290637701749802

We O 0 0.039082519710063934
report O 0 0.03483659774065018
another O 0 0.04123661294579506
mutation O 0 0.11419537663459778
in O 0 0.022960325703024864
a O 0 0.030368560925126076
Japanese O 0 0.04529637470841408
family O 0 0.05627410486340523
. O 0 0.044814109802246094

Polymerase O 1 0.5358731746673584
chain O 0 0.18672990798950195
reaction O 0 0.15204836428165436
- O 0 0.12055151909589767
single O 0 0.07645843923091888
strand O 0 0.1630658656358719
conformational O 0 0.16225837171077728
polymorphism O 0 0.12308398634195328
and O 0 0.022829417139291763
direct O 0 0.04438858851790428
sequence O 0 0.05486622080206871
analyses O 0 0.06349337846040726
demonstrated O 0 0.06530998647212982
a O 0 0.04160371422767639
C O 0 0.11132010817527771
to O 0 0.034977514296770096
T O 1 0.8487473726272583
substitution O 0 0.08795800805091858
in O 0 0.02887873537838459
exon O 0 0.12394371628761292
1 O 0 0.03402349725365639
of O 0 0.01840910315513611
the O 0 0.03212738409638405
CPO O 0 0.17691504955291748
gene O 0 0.11742568761110306
at O 0 0.04550790414214134
nucleotide O 0 0.09929939359426498
position O 0 0.037514977157115936
85 O 0 0.06252077221870422
, O 0 0.01939266175031662
which O 0 0.01623034104704857
lies O 0 0.03323819115757942
in O 0 0.0182114876806736
the O 0 0.0253069456666708
putative O 0 0.13822203874588013
presequence O 0 0.15846267342567444
for O 0 0.0276858601719141
targeting O 0 0.06942296773195267
to O 0 0.03357585519552231
mitochondria O 0 0.142766073346138
. O 0 0.04790659248828888

This O 0 0.0575396753847599
mutation O 0 0.16962271928787231
changes O 0 0.04793834313750267
the O 0 0.03172873705625534
codon O 0 0.12462551891803741
for O 0 0.03233499452471733
glutamine O 0 0.13561268150806427
to O 0 0.02993421070277691
a O 0 0.04345335811376572
termination O 0 0.1943756490945816
codon O 0 0.16705365478992462
at O 0 0.05740600824356079
amino O 0 0.10377088934183121
acid O 0 0.15335604548454285
position O 0 0.04685427248477936
29 O 0 0.05753858759999275
. O 0 0.04540291056036949

MaeI O 0 0.34056395292282104
restriction O 0 0.10742146521806717
analysis O 0 0.048242803663015366
showed O 0 0.03433828800916672
two O 0 0.01469032745808363
other O 0 0.01693384349346161
carriers O 0 0.06887062638998032
in O 0 0.020884007215499878
the O 0 0.02380751259624958
family O 0 0.053169943392276764
. O 0 0.047318000346422195

The O 0 0.07415721565485
C O 1 0.9347790479660034
- O 1 0.8262028694152832
T O 1 0.9623410701751709
mutation O 0 0.1806907057762146
is O 0 0.031639423221349716
located O 0 0.03398260846734047
within O 0 0.02331838384270668
a O 0 0.029001986607909203
recently O 0 0.04648542031645775
proposed O 0 0.04898248240351677
putative O 0 0.1355438083410263
alternative O 0 0.08091368526220322
translation O 0 0.06714338809251785
initiation O 0 0.15863288938999176
codon O 0 0.20250390470027924
( O 0 0.09820704162120819
TIC O 1 0.9993159770965576
- O 0 0.12322491407394409
1 O 0 0.049173641949892044
) O 0 0.03314539045095444
, O 0 0.02068305015563965
supporting O 0 0.036961629986763
that O 0 0.02952808327972889
TIC O 1 0.9993118047714233
- O 0 0.09668087214231491
1 O 0 0.036045342683792114
is O 0 0.02029689960181713
the O 0 0.02268788032233715
real O 0 0.06030543893575668
TIC O 1 0.9969803690910339
rather O 0 0.0414188951253891
than O 0 0.038878511637449265
TIC O 1 0.9994189739227295
- O 0 0.10965730249881744
2 O 0 0.04709835350513458
. O 0 0.02771208994090557
. O 0 0.03912683576345444

Human B-Disease 0 0.11114463955163956
complement I-Disease 0 0.187766432762146
factor I-Disease 1 0.9913519620895386
H I-Disease 1 0.9999978542327881
deficiency I-Disease 1 0.9999998807907104
associated O 1 0.6557283997535706
with O 1 0.965998113155365
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.10454510897397995

This O 0 0.03196452185511589
study O 0 0.036952681839466095
reports O 0 0.025897476822137833
on O 0 0.015183871611952782
six O 0 0.0260014571249485
cases O 0 0.03839002922177315
of O 0 0.02944224141538143
deficiency B-Disease 1 0.9999845027923584
in I-Disease 0 0.022586211562156677
the I-Disease 0 0.02243049070239067
human I-Disease 0 0.0447661355137825
complement I-Disease 0 0.09401172399520874
regulatory I-Disease 0 0.1320039927959442
protein I-Disease 0 0.15282048285007477
Factor I-Disease 0 0.2701800763607025
H I-Disease 1 0.9989100694656372
( O 0 0.08875790983438492
FH O 1 0.9984287619590759
) O 0 0.03352348133921623
in O 0 0.015121551230549812
the O 0 0.01582765020430088
context O 0 0.03317837044596672
of O 0 0.02250015176832676
an O 0 0.1525581181049347
acute B-Disease 1 1.0
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.08395861089229584

Five O 0 0.0321880541741848
of O 0 0.015007774345576763
the O 0 0.01715477928519249
cases O 0 0.031070254743099213
were O 0 0.016490455716848373
observed O 0 0.031161589547991753
in O 0 0.018967928364872932
children O 0 0.041596461087465286
presenting O 0 0.09013471752405167
with O 1 0.7113400101661682
idiopathic O 1 1.0
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9904472827911377
HUS B-Disease 1 0.9999839067459106
) O 0 0.07260332256555557
. O 0 0.05240562930703163

Two O 0 0.023959044367074966
of O 0 0.016643567010760307
the O 0 0.022720998153090477
children O 0 0.05576178804039955
exhibited O 0 0.09236159175634384
a O 0 0.059326402842998505
homozygous O 1 0.9850054979324341
deficiency O 1 0.9999982118606567
characterized O 0 0.12364671379327774
by O 0 0.023164348676800728
the O 0 0.01872769370675087
absence O 0 0.03969678655266762
of O 0 0.015049567446112633
the O 0 0.02241695299744606
150 O 0 0.06343311816453934
- O 0 0.13078774511814117
kD O 1 0.6699286699295044
form O 0 0.04595118388533592
of O 0 0.027143508195877075
Factor O 0 0.109756238758564
H O 1 0.866945207118988
and O 0 0.02002372220158577
the O 0 0.02075621858239174
presence O 0 0.03716946765780449
, O 0 0.019055869430303574
upon O 0 0.027025621384382248
immunoblotting O 0 0.10692333430051804
, O 0 0.016721801832318306
of O 0 0.013999965973198414
the O 0 0.026704993098974228
42 O 0 0.08708184957504272
- O 0 0.36431291699409485
kD O 1 0.9908083081245422
Factor O 0 0.3452222943305969
H O 1 0.9959565997123718
- O 0 0.12179971486330032
like O 0 0.04986407980322838
protein O 0 0.0985661968588829
1 O 0 0.06394653767347336
( O 0 0.0716099962592125
FHL O 1 0.9987295269966125
- O 0 0.1094178631901741
1 O 0 0.04252910241484642
) O 0 0.02831282652914524
and O 0 0.017531555145978928
other O 0 0.030692143365740776
FH O 1 0.9998292922973633
- O 0 0.1583012193441391
related O 0 0.08447239547967911
protein O 0 0.13400021195411682
( O 0 0.07467574626207352
FHR O 1 0.7691305875778198
) O 0 0.05456811934709549
bands O 0 0.08035064488649368
. O 0 0.04750024527311325

Southern O 0 0.12120980024337769
blot O 0 0.2281804084777832
and O 0 0.04618469625711441
PCR O 0 0.1635243445634842
analysis O 0 0.04085017740726471
of O 0 0.01846809685230255
DNA O 0 0.058226801455020905
of O 0 0.018811695277690887
one O 0 0.0324859656393528
patient O 1 0.9681136608123779
with O 0 0.047520413994789124
homozygous O 1 0.9499170184135437
deficiency O 1 0.9999945163726807
ruled O 0 0.06333567202091217
out O 0 0.021106932312250137
the O 0 0.01706622913479805
presence O 0 0.03093067556619644
of O 0 0.014603182673454285
a O 0 0.023368654772639275
large O 0 0.03228479251265526
deletion O 0 0.09916901588439941
of O 0 0.02072424814105034
the O 0 0.037273962050676346
FH O 1 0.9992709755897522
gene O 0 0.11049454659223557
as O 0 0.01961514912545681
the O 0 0.024099409580230713
underlying O 0 0.09470120072364807
defect O 1 0.9692530632019043
for O 0 0.028997374698519707
the O 0 0.04617219418287277
deficiency O 1 0.9999959468841553
. O 0 0.0726899653673172

The O 0 0.02994190901517868
other O 0 0.01774044707417488
four O 0 0.02270369604229927
children O 0 0.03998526185750961
presented O 0 0.03708503022789955
with O 0 0.037224408239126205
heterozygous O 1 0.8842711448669434
deficiency O 1 0.9999899864196777
and O 0 0.03232605755329132
exhibited O 0 0.06366831809282303
a O 0 0.03981417790055275
normal O 0 0.07620187103748322
immunoblotting O 0 0.16397534310817719
pattern O 0 0.068545401096344
of O 0 0.018294965848326683
proteins O 0 0.04608028754591942
of O 0 0.020960265770554543
the O 0 0.041845619678497314
FH O 1 0.999553382396698
family O 0 0.08642668277025223
. O 0 0.053449228405952454

Factor B-Disease 1 0.9832568764686584
H I-Disease 1 0.9999681711196899
deficiency I-Disease 1 0.9999916553497314
is O 0 0.032091330736875534
the O 0 0.022355644032359123
only O 0 0.03473068028688431
complement B-Disease 1 0.9893668293952942
deficiency I-Disease 1 0.9999997615814209
associated O 0 0.07803734391927719
with O 0 0.05851323530077934
HUS B-Disease 1 0.9998910427093506
. O 0 0.07177148759365082

These O 0 0.03564976900815964
observations O 0 0.05469781532883644
suggest O 0 0.0437474399805069
a O 0 0.030270569026470184
role O 0 0.03910553455352783
for O 0 0.03621223196387291
FH O 1 0.9998080134391785
and O 0 0.049040380865335464
/ O 1 0.9846997857093811
or O 0 0.065158411860466
FH O 1 0.9995965361595154
receptors O 0 0.17796869575977325
in O 0 0.026158910244703293
the O 0 0.03467881679534912
pathogenesis O 1 0.9991297125816345
of O 0 0.06114508584141731
idiopathic O 1 0.999998927116394
HUS B-Disease 1 0.9999793767929077
. O 0 0.04682188108563423
. O 0 0.05219021812081337

Further O 0 0.03571084886789322
evidence O 0 0.02593393251299858
for O 0 0.014813543297350407
a O 0 0.025060901418328285
major O 0 0.037136510014534
ancient O 0 0.06686826795339584
mutation O 1 0.9786466956138611
underlying O 1 0.998721182346344
myotonic B-Disease 1 0.9999998807907104
dystrophy I-Disease 1 1.0
from O 0 0.0769057422876358
linkage O 1 0.9429044723510742
disequilibrium O 1 0.9442039132118225
studies O 0 0.053532324731349945
in O 0 0.019898779690265656
the O 0 0.019174233078956604
Japanese O 0 0.0489845909178257
population O 0 0.04763597995042801
. O 0 0.04532695561647415

The O 0 0.19973546266555786
myotonic B-Disease 1 0.9999998807907104
dystrophy I-Disease 1 1.0
( O 1 0.9959915280342102
DM B-Disease 1 0.9999996423721313
) O 0 0.08061518520116806
mutation O 0 0.16927480697631836
is O 0 0.0313972607254982
an O 0 0.03748314082622528
unstable O 1 0.9552797079086304
( O 0 0.07964801788330078
CTG O 1 0.9941605925559998
) O 0 0.056885745376348495
n O 0 0.08854158967733383
repeat O 0 0.08482834696769714
, O 0 0.018444258719682693
present O 0 0.021759433671832085
at O 0 0.023401636630296707
a O 0 0.02350381389260292
copy O 0 0.03405225649476051
number O 0 0.017194710671901703
of O 0 0.018016377463936806
5 O 0 0.049415189772844315
- O 0 0.09034233540296555
37 O 0 0.06839142739772797
repeats O 0 0.08826334029436111
on O 0 0.02327405847609043
normal O 0 0.061257168650627136
chromosomes O 0 0.08959104865789413
but O 0 0.026738304644823074
amplified O 0 0.07728612422943115
to O 0 0.023404382169246674
50 O 0 0.04507036879658699
- O 0 0.09405965358018875
3000 O 0 0.1293022334575653
copies O 0 0.0526321604847908
on O 0 0.051471468061208725
DM B-Disease 1 0.9998725652694702
chromosomes O 0 0.1886913776397705
. O 0 0.06567507982254028

Previous O 0 0.06300520151853561
findings O 0 0.06179884076118469
in O 0 0.03470370173454285
Caucasian O 0 0.21618874371051788
populations O 0 0.07944054901599884
of O 0 0.028982212767004967
a O 0 0.07183916121721268
DM B-Disease 1 0.9999942779541016
founder O 0 0.13510960340499878
chromosome O 0 0.16276878118515015
raise O 0 0.056737422943115234
a O 0 0.025786830112338066
question O 0 0.027027197182178497
about O 0 0.016070110723376274
the O 0 0.021515121683478355
molecular O 0 0.06613577157258987
events O 0 0.03809462860226631
involved O 0 0.027850113809108734
in O 0 0.017016738653182983
the O 0 0.02510920912027359
expansion O 0 0.08077527582645416
mutation O 0 0.20165207982063293
. O 0 0.05400880053639412

To O 0 0.037177592515945435
investigate O 0 0.062486693263053894
whether O 0 0.03136691078543663
a O 0 0.03378842771053314
founder O 0 0.08003762364387512
chromosome O 0 0.13143062591552734
for O 0 0.03033089078962803
the O 0 0.05275322496891022
DM B-Disease 1 0.9999961853027344
mutation O 0 0.24362008273601532
exists O 0 0.054195258766412735
in O 0 0.01670430414378643
the O 0 0.01865735836327076
Japanese O 0 0.03901591897010803
population O 0 0.03179411217570305
, O 0 0.02226095087826252
we O 0 0.025218939408659935
genotyped O 0 0.14258737862110138
families O 0 0.053802430629730225
using O 0 0.049816880375146866
polymorphic O 0 0.22755073010921478
markers O 0 0.12013646960258484
near O 0 0.06184972822666168
the O 0 0.03556399792432785
( O 0 0.07389312237501144
CTG O 1 0.964365541934967
) O 0 0.06050199642777443
n O 0 0.10242188721895218
repeat O 0 0.10558465123176575
region O 0 0.056149326264858246
and O 0 0.02947058156132698
constructed O 0 0.0768202468752861
haplotypes O 0 0.38231945037841797
. O 0 0.06436856836080551

Six O 0 0.05401402711868286
different O 0 0.031681958585977554
haplotypes O 0 0.1789238005876541
were O 0 0.022368773818016052
found O 0 0.03548065200448036
and O 0 0.04448438063263893
DM B-Disease 1 0.9999929666519165
alleles O 0 0.19928263127803802
were O 0 0.0343850702047348
always O 0 0.05732414126396179
haplotype O 1 0.6700669527053833
A O 0 0.06161810830235481
. O 0 0.053191833198070526

To O 0 0.027133861556649208
find O 0 0.030480165034532547
an O 0 0.0168902724981308
origin O 0 0.022243572399020195
of O 0 0.01728188991546631
the O 0 0.030570926144719124
( O 0 0.07446998357772827
CTG O 1 0.9843527674674988
) O 0 0.06873707473278046
n O 0 0.1236049234867096
repeat O 0 0.13339750468730927
mutation O 0 0.12966804206371307
and O 0 0.018067335709929466
to O 0 0.015244005247950554
investigate O 0 0.03661477565765381
the O 0 0.019369089975953102
mechanism O 0 0.05028698220849037
of O 0 0.01424127072095871
the O 0 0.020869165658950806
expansion O 0 0.057860903441905975
mutation O 0 0.11062713712453842
in O 0 0.01787075400352478
the O 0 0.016681207343935966
Japanese O 0 0.03705974295735359
population O 0 0.03045714646577835
we O 0 0.016791606321930885
have O 0 0.017355047166347504
studied O 0 0.035806525498628616
90 O 0 0.06332065165042877
Japanese O 0 0.0809616819024086
DM B-Disease 1 0.9999691247940063
families O 0 0.06965770572423935
comprising O 0 0.062286071479320526
190 O 0 0.10292519629001617
affected O 0 0.07672179490327835
and O 0 0.028917424380779266
130 O 0 0.08423811942338943
unaffected O 0 0.14123477041721344
members O 0 0.04255674034357071
. O 0 0.04844317585229874

The O 0 0.04072247073054314
results O 0 0.04976737126708031
suggest O 0 0.041823532432317734
that O 0 0.014467629604041576
a O 0 0.02231479622423649
few O 0 0.020932158455252647
common O 0 0.039188452064991
ancestral O 0 0.09513907879590988
mutations O 0 0.12167257070541382
in O 0 0.01997307687997818
both O 0 0.023762134835124016
Caucasian O 0 0.19499032199382782
and O 0 0.02232174575328827
Japanese O 0 0.03903321176767349
populations O 0 0.05239133909344673
have O 0 0.018474815413355827
originated O 0 0.03856771066784859
by O 0 0.018025491386651993
expansion O 0 0.03810660168528557
of O 0 0.014756596647202969
an O 0 0.026477878913283348
ancestral O 0 0.10861779749393463
n O 0 0.13377362489700317
= O 0 0.1476956009864807
5 O 0 0.0574493445456028
repeat O 0 0.09929129481315613
to O 0 0.036335285753011703
n O 0 0.11514819413423538
= O 0 0.14016012847423553
19 O 0 0.06376893818378448
- O 0 0.09460047632455826
37 O 0 0.06592272967100143
copies O 0 0.04815714806318283
. O 0 0.04927565157413483

These O 0 0.030447939410805702
data O 0 0.032631441950798035
support O 0 0.04547416791319847
multistep O 0 0.16543714702129364
models O 0 0.06363232433795929
of O 0 0.03241593390703201
triplet O 1 0.5490191578865051
repeat O 0 0.10916111618280411
expansion O 0 0.04440609738230705
that O 0 0.01222409401088953
have O 0 0.013786563649773598
been O 0 0.014629637822508812
proposed O 0 0.024095559492707253
for O 0 0.02091224119067192
both O 0 0.03884671628475189
DM B-Disease 1 0.9999979734420776
and O 0 0.05540496110916138
Friedreichs B-Disease 1 0.9971742630004883
ataxia I-Disease 1 0.9995079040527344
. O 0 0.045621518045663834
. O 0 0.05071825161576271

The O 0 0.04841557890176773
molecular O 0 0.08375939726829529
basis O 0 0.039133135229349136
of O 0 0.04654507339000702
C6 B-Disease 1 0.9999986886978149
deficiency I-Disease 1 0.9999990463256836
in O 0 0.02761683240532875
the O 0 0.021267356351017952
western O 0 0.04237626865506172
Cape O 0 0.08033378422260284
, O 0 0.02702946588397026
South O 0 0.05010604113340378
Africa O 0 0.0784328430891037
. O 0 0.048930831253528595

Deficiency B-Disease 1 0.9999645948410034
of I-Disease 0 0.02550698071718216
the I-Disease 0 0.02378849871456623
sixth I-Disease 0 0.058354247361421585
component I-Disease 0 0.05416901409626007
of I-Disease 0 0.01616576686501503
human I-Disease 0 0.040990401059389114
complement I-Disease 0 0.09234792739152908
( O 0 0.07021483778953552
C6 O 1 0.9990432858467102
) O 0 0.032098203897476196
has O 0 0.01722092553973198
been O 0 0.016393601894378662
reported O 0 0.029038231819868088
in O 0 0.012539593502879143
a O 0 0.015298623591661453
number O 0 0.012799854390323162
of O 0 0.01372579112648964
families O 0 0.028134718537330627
from O 0 0.018138743937015533
the O 0 0.01874387450516224
western O 0 0.04041805863380432
Cape O 0 0.0777580514550209
, O 0 0.025596989318728447
South O 0 0.044128112494945526
Africa O 0 0.07062871009111404
. O 0 0.051399603486061096

Meningococcal B-Disease 1 0.999997615814209
disease I-Disease 1 0.9999845027923584
is O 0 0.0473017618060112
endemic O 0 0.10134976357221603
in O 0 0.01937122829258442
the O 0 0.01852043904364109
Cape O 0 0.06189822778105736
and O 0 0.014666893519461155
almost O 0 0.019027195870876312
all O 0 0.016572335734963417
pedigrees O 0 0.10554710775613785
of O 0 0.03467816859483719
total O 0 0.09490122646093369
C6 B-Disease 1 0.9999992847442627
deficiency I-Disease 1 1.0
( O 0 0.0977376252412796
C6Q0 O 1 0.9822027683258057
) O 0 0.03782878443598747
have O 0 0.01776915229856968
been O 0 0.0196757223457098
ascertained O 0 0.08276338875293732
because O 0 0.03164544701576233
of O 0 0.03243333101272583
recurrent O 1 0.9999364614486694
disease O 1 0.9999889135360718
. O 0 0.06887499243021011

We O 0 0.031099218875169754
have O 0 0.023862335830926895
sequenced O 0 0.06671983748674393
the O 0 0.021117471158504486
expressed O 0 0.038945138454437256
exons O 0 0.09427858889102936
of O 0 0.023313749581575394
the O 0 0.040746334940195084
C6 O 1 0.9938058853149414
gene O 0 0.09519993513822556
from O 0 0.022740697488188744
selected O 0 0.02557770162820816
cases O 0 0.02832951955497265
and O 0 0.01441592164337635
have O 0 0.015134983696043491
found O 0 0.022821543738245964
three O 0 0.023946112021803856
molecular O 0 0.09282679855823517
defects O 1 0.7224225997924805
leading O 0 0.044735345989465714
to O 0 0.0273205004632473
total O 0 0.06403832882642746
deficiency O 1 0.9999979734420776
879delG O 1 0.536544144153595
, O 0 0.02240900509059429
which O 0 0.016975240781903267
is O 0 0.016035323962569237
the O 0 0.01844116859138012
common O 0 0.04435986652970314
defect O 1 0.6757546663284302
in O 0 0.01839955896139145
the O 0 0.02162286639213562
Cape O 0 0.07562810927629471
and O 0 0.022984493523836136
hitherto O 0 0.08158186823129654
unreported O 0 0.09466088563203812
, O 0 0.02335100807249546
and O 0 0.023785630241036415
1195delC O 0 0.13601723313331604
and O 0 0.02772146463394165
1936delG O 0 0.12692926824092865
, O 0 0.020685305818915367
which O 0 0.01495698094367981
have O 0 0.012657462619245052
been O 0 0.014165797270834446
previously O 0 0.021692123264074326
reported O 0 0.03621888905763626
in O 0 0.022216089069843292
African O 0 0.07035401463508606
- O 0 0.11607937514781952
Americans O 0 0.07193077355623245
. O 0 0.05456022545695305

We O 0 0.030051304027438164
also O 0 0.01913616992533207
show O 0 0.02722865715622902
that O 0 0.01485796645283699
the O 0 0.02462671883404255
879delG O 0 0.16073915362358093
and O 0 0.035495709627866745
1195delC O 1 0.9041897654533386
defects O 1 0.9021492004394531
are O 0 0.02102612517774105
associated O 0 0.03805713355541229
with O 0 0.038710396736860275
characteristic O 1 0.658677875995636
C6 O 1 0.9999710321426392
/ O 1 0.9984789490699768
C7 O 1 0.9959726929664612
region O 0 0.11011649668216705
DNA O 0 0.13820210099220276
marker O 0 0.14121085405349731
haplotypes O 1 0.5694426894187927
, O 0 0.027610402554273605
although O 0 0.02608484774827957
small O 0 0.02983255684375763
variations O 0 0.043902404606342316
were O 0 0.021140269935131073
observed O 0 0.061705686151981354
. O 0 0.049960602074861526

The O 0 0.066452257335186
1936delG O 1 0.6678965091705322
defect O 1 0.7708461284637451
was O 0 0.0337349995970726
observed O 0 0.035230252891778946
only O 0 0.015404910780489445
once O 0 0.022161278873682022
in O 0 0.014768629334867
the O 0 0.018626905977725983
Cape O 0 0.06708773970603943
, O 0 0.018257979303598404
but O 0 0.015756893903017044
its O 0 0.021190961822867393
associated O 0 0.05420670285820961
haplotype O 1 0.8080060482025146
could O 0 0.03298517316579819
be O 0 0.023618150502443314
deduced O 0 0.09356013685464859
. O 0 0.0465644933283329

The O 0 0.035062700510025024
data O 0 0.029462700709700584
from O 0 0.022063283249735832
the O 0 0.027490518987178802
haplotypes O 0 0.2628026306629181
indicate O 0 0.04061519727110863
that O 0 0.01252136193215847
these O 0 0.012100339867174625
three O 0 0.022133570164442062
molecular O 0 0.0936209112405777
defects O 0 0.45601990818977356
account O 0 0.03162137418985367
for O 0 0.017488889396190643
the O 0 0.020958006381988525
defects O 0 0.2270200252532959
in O 0 0.01585463620722294
all O 0 0.013231025077402592
the O 0 0.023533545434474945
38 O 0 0.06733687967061996
unrelated O 0 0.10150561481714249
C6Q0 O 1 0.8450829982757568
individuals O 0 0.03525475040078163
we O 0 0.01601351425051689
have O 0 0.014521639794111252
studied O 0 0.024230819195508957
from O 0 0.017610518261790276
the O 0 0.026180746033787727
Cape O 0 0.10728959739208221
. O 0 0.057835403829813004

We O 0 0.03330045938491821
have O 0 0.019244205206632614
also O 0 0.01976662129163742
observed O 0 0.04335201159119606
the O 0 0.027674000710248947
879delG O 0 0.22690647840499878
defect O 0 0.20913469791412354
in O 0 0.02981581725180149
two O 0 0.03124205768108368
Dutch O 0 0.2668471038341522
C6 B-Disease 1 0.9999926090240479
- I-Disease 1 0.9762243628501892
deficient I-Disease 1 0.9991415739059448
kindreds O 1 0.8758917450904846
, O 0 0.02873137593269348
but O 0 0.019207332283258438
the O 0 0.028012428432703018
879delG O 1 0.6324114799499512
defect O 1 0.6318813562393188
in O 0 0.020297978073358536
the O 0 0.023331236094236374
Cape O 0 0.08538606017827988
probably O 0 0.03781774640083313
did O 0 0.018898000940680504
not O 0 0.011474978178739548
come O 0 0.018448980525135994
from O 0 0.014562350697815418
The O 0 0.0184271652251482
Netherlands O 0 0.050615351647138596
. O 0 0.03002525493502617
. O 0 0.04101651906967163

Complement B-Disease 1 0.9938219785690308
C7 I-Disease 1 0.9999986886978149
deficiency I-Disease 1 0.9999997615814209
: O 0 0.05707791447639465
seven O 0 0.03407679498195648
further O 0 0.03780465945601463
molecular O 0 0.10111555457115173
defects O 1 0.6686652898788452
and O 0 0.02283303253352642
their O 0 0.024516085162758827
associated O 0 0.06084810197353363
marker O 0 0.15824444591999054
haplotypes O 1 0.7414551377296448
. O 0 0.06911826133728027

Seven O 0 0.05141518637537956
further O 0 0.04181404039263725
molecular O 0 0.08605895936489105
bases O 0 0.06240066513419151
of O 0 0.04707708582282066
C7 B-Disease 1 0.9999964237213135
deficiency I-Disease 1 0.9999992847442627
are O 0 0.034645844250917435
described O 0 0.06627922505140305
. O 0 0.0480259470641613

All O 0 0.028139403089880943
these O 0 0.021204229444265366
new O 0 0.03809674084186554
molecular O 0 0.1166597530245781
defects O 1 0.8279646039009094
involve O 0 0.07548068463802338
single O 0 0.062216535210609436
- O 0 0.11344735324382782
nucleotide O 0 0.1254986673593521
events O 0 0.047085948288440704
, O 0 0.02873970940709114
deletions O 0 0.09833858162164688
and O 0 0.021797597408294678
substitutions O 0 0.05093592777848244
, O 0 0.01531980000436306
some O 0 0.012609528377652168
of O 0 0.013462448492646217
which O 0 0.02424122765660286
alter O 0 0.08951809257268906
splice O 0 0.15394780039787292
sites O 0 0.03774544224143028
, O 0 0.01982617750763893
and O 0 0.019566847011446953
others O 0 0.043823543936014175
codons O 0 0.14566195011138916
. O 0 0.05434843897819519

They O 0 0.025297822430729866
are O 0 0.01517642755061388
distributed O 0 0.02899251878261566
along O 0 0.029837625101208687
the O 0 0.03724333643913269
C7 O 1 0.9858320951461792
gene O 0 0.10542339831590652
, O 0 0.021827396005392075
but O 0 0.017227496951818466
predominantly O 0 0.0309179425239563
towards O 0 0.028784645721316338
the O 0 0.023931104689836502
3 O 0 0.04326369985938072
end O 0 0.05101597681641579
. O 0 0.04482973366975784

All O 0 0.023387160152196884
were O 0 0.017142537981271744
found O 0 0.027550633996725082
in O 0 0.02821527235209942
compound O 0 0.1065206304192543
heterozygous O 0 0.1592375934123993
individuals O 0 0.060895245522260666
. O 0 0.05240897834300995

The O 0 0.11054188013076782
C6 O 1 0.9998327493667603
/ O 1 0.9980241060256958
C7 O 1 0.9973053932189941
marker O 0 0.19484709203243256
haplotypes O 1 0.5108876824378967
associated O 0 0.05675416812300682
with O 0 0.02953648753464222
most O 0 0.04073243960738182
C7 B-Disease 1 0.9994981288909912
defects I-Disease 1 0.9089053869247437
are O 0 0.023035084828734398
tabulated O 0 0.06850554049015045
. O 0 0.03074735589325428
. O 0 0.04070984199643135

A O 0 0.09145814925432205
genome O 0 0.1450098603963852
- O 0 0.10505805909633636
wide O 0 0.05800497159361839
search O 0 0.053530264645814896
for O 0 0.03688231483101845
chromosomal O 0 0.4269002676010132
loci O 0 0.38533833622932434
linked O 0 0.12056047469377518
to O 0 0.04290688410401344
mental O 1 0.9997019171714783
health O 1 0.9799730777740479
wellness O 1 0.993339478969574
in O 0 0.025933315977454185
relatives O 0 0.05663977190852165
at O 0 0.03432850167155266
high O 0 0.05752553418278694
risk O 1 0.9906238913536072
for O 0 0.05717666819691658
bipolar B-Disease 1 1.0
affective I-Disease 1 0.9999954700469971
disorder I-Disease 1 0.9999901056289673
among O 0 0.027802489697933197
the O 0 0.02134835347533226
Old O 0 0.04221399128437042
Order O 0 0.03732889145612717
Amish O 0 0.1478155106306076
. O 0 0.05632336437702179

Bipolar B-Disease 1 0.9999998807907104
affective I-Disease 1 0.9999979734420776
disorder I-Disease 1 0.9999997615814209
( O 1 0.9848639369010925
BPAD B-Disease 1 0.9999988079071045
; O 1 0.9968175888061523
manic B-Disease 1 1.0
- I-Disease 1 0.9999622106552124
depressive I-Disease 1 0.9999997615814209
illness I-Disease 1 0.9999855756759644
) O 0 0.05302521586418152
is O 0 0.027866536751389503
characterized O 0 0.07026072591543198
by O 0 0.02477579563856125
episodes O 0 0.05251653492450714
of O 0 0.03470423072576523
mania B-Disease 1 0.9998327493667603
and O 0 0.05194827541708946
/ O 1 0.99839848279953
or O 0 0.0676475539803505
hypomania B-Disease 1 0.9999061822891235
interspersed O 0 0.1013009175658226
with O 0 0.031677499413490295
periods O 0 0.07441498339176178
of O 0 0.03596200421452522
depression B-Disease 1 0.9982509016990662
. O 0 0.060986924916505814

Compelling O 0 0.0976594015955925
evidence O 0 0.04471023008227348
supports O 0 0.05118081718683243
a O 0 0.032034847885370255
significant O 0 0.041189178824424744
genetic O 0 0.07934200018644333
component O 0 0.06132432073354721
in O 0 0.021137796342372894
the O 0 0.028543874621391296
susceptibility O 1 0.6472154259681702
to O 0 0.03544158861041069
develop O 0 0.1086684986948967
BPAD B-Disease 1 0.9959468245506287
. O 0 0.07273098826408386

To O 0 0.03720647841691971
date O 0 0.036711785942316055
, O 0 0.0195626188069582
however O 0 0.019046543166041374
, O 0 0.022621143609285355
linkage O 0 0.10530713945627213
studies O 0 0.037165526300668716
have O 0 0.016646312549710274
attempted O 0 0.034870002418756485
only O 0 0.014781477861106396
to O 0 0.020787982270121574
identify O 0 0.06604954600334167
chromosomal O 0 0.2719264328479767
loci O 0 0.20180778205394745
that O 0 0.03141875937581062
cause O 0 0.07553217560052872
or O 0 0.026777131482958794
increase O 0 0.03316691517829895
the O 0 0.024316944181919098
risk O 0 0.11061663180589676
of O 0 0.02911694161593914
developing O 0 0.10926375538110733
BPAD B-Disease 1 0.9967061877250671
. O 0 0.06664261221885681

To O 0 0.03168102353811264
determine O 0 0.037678271532058716
whether O 0 0.022917140275239944
there O 0 0.016679055988788605
could O 0 0.019859537482261658
be O 0 0.01908242516219616
protective O 0 0.45015084743499756
alleles O 0 0.15179501473903656
that O 0 0.02621837519109249
prevent O 0 0.05899693816900253
or O 0 0.03272952139377594
reduce O 0 0.0604451447725296
the O 0 0.024315156042575836
risk O 0 0.11551566421985626
of O 0 0.024421118199825287
developing O 0 0.08283957839012146
BPAD B-Disease 1 0.9975699782371521
, O 0 0.022800518199801445
similar O 0 0.02491096779704094
to O 0 0.014779685065150261
what O 0 0.016855379566550255
is O 0 0.01809433288872242
observed O 0 0.033016305416822433
in O 0 0.018472351133823395
other O 0 0.026469336822628975
genetic B-Disease 1 0.9969925880432129
disorders I-Disease 1 0.999998927116394
, O 0 0.02826201356947422
we O 0 0.02081284485757351
used O 0 0.033582016825675964
mental O 1 0.9998522996902466
health O 1 0.9900968074798584
wellness O 1 0.998530387878418
( O 0 0.046239279210567474
absence O 0 0.05255787447094917
of O 0 0.021797923371195793
any O 0 0.037807632237672806
psychiatric B-Disease 1 0.9999969005584717
disorder I-Disease 1 0.9999920129776001
) O 0 0.036456335335969925
as O 0 0.016976043581962585
the O 0 0.02353772148489952
phenotype O 0 0.24198715388774872
in O 0 0.0233138520270586
our O 0 0.03398045152425766
genome O 0 0.12010648846626282
- O 0 0.11051998287439346
wide O 0 0.06673803180456161
linkage O 0 0.1473149061203003
scan O 0 0.10710138827562332
of O 0 0.015883924439549446
several O 0 0.019905392080545425
large O 0 0.03590584918856621
multigeneration O 0 0.15750077366828918
Old O 0 0.056126587092876434
Order O 0 0.04238579422235489
Amish O 0 0.16347816586494446
pedigrees O 0 0.18348832428455353
exhibiting O 0 0.11131693422794342
an O 0 0.034810807555913925
extremely O 0 0.06714662164449692
high O 0 0.06476008892059326
incidence O 1 0.9409908652305603
of O 0 0.04273495450615883
BPAD B-Disease 1 0.9980916380882263
. O 0 0.0652216449379921

We O 0 0.03057190589606762
have O 0 0.02009826898574829
found O 0 0.024565331637859344
strong O 0 0.02709788642823696
evidence O 0 0.023737652227282524
for O 0 0.016934841871261597
a O 0 0.032481200993061066
locus O 0 0.1344042420387268
on O 0 0.04258299991488457
chromosome O 0 0.24896132946014404
4p O 1 0.9443117380142212
at O 0 0.07256876677274704
D4S2949 O 0 0.18707889318466187
( O 0 0.06659621000289917
maximum O 0 0.08189978450536728
GENEHUNTER O 1 0.9434237480163574
- O 0 0.1575515866279602
PLUS O 0 0.1369759440422058
nonparametric O 0 0.22220535576343536
linkage O 0 0.19268685579299927
score O 0 0.07045609503984451
= O 0 0.1343275010585785
4 O 0 0.050864554941654205
. O 0 0.02903897687792778
05 O 0 0.15151093900203705
, O 0 0.043477863073349
P O 0 0.400671124458313
= O 0 0.12398955971002579
5 O 0 0.04352935031056404
. O 0 0.02119562029838562
22 O 0 0.040049463510513306
x O 0 0.08369558304548264
10 O 0 0.041027214378118515
( O 0 0.05198599398136139
- O 0 0.08430274575948715
4 O 0 0.05582387000322342
) O 0 0.04818969592452049
; O 0 0.04942231997847557
SIBPAL O 1 0.7255635857582092
Pempirical O 0 0.2379159927368164
value O 0 0.06076572462916374
< O 0 0.17667919397354126
3 O 0 0.05429619178175926
x O 0 0.08355795592069626
10 O 0 0.0347515232861042
( O 0 0.04893583431839943
- O 0 0.08254428952932358
5 O 0 0.043249014765024185
) O 0 0.03500595688819885
) O 0 0.027090007439255714
and O 0 0.018900448456406593
suggestive O 0 0.08108139038085938
evidence O 0 0.024449696764349937
for O 0 0.01673843152821064
a O 0 0.03264904394745827
locus O 0 0.13775977492332458
on O 0 0.043820008635520935
chromosome O 0 0.29896280169487
4q O 1 0.9947966933250427
at O 0 0.0671469122171402
D4S397 O 0 0.18910209834575653
( O 0 0.06646927446126938
maximum O 0 0.08301648497581482
GENEHUNTER O 1 0.9296917915344238
- O 0 0.14851918816566467
PLUS O 0 0.14157241582870483
nonparametric O 0 0.22265560925006866
linkage O 0 0.19614863395690918
score O 0 0.0703492984175682
= O 0 0.12675920128822327
3 O 0 0.0409342497587204
. O 0 0.0232737697660923
29 O 0 0.04095715284347534
, O 0 0.028996331617236137
P O 0 0.30218976736068726
= O 0 0.11658212542533875
2 O 0 0.042042266577482224
. O 0 0.02304401434957981
57 O 0 0.06597815454006195
x O 0 0.08680219948291779
10 O 0 0.043148841708898544
( O 0 0.04896494001150131
- O 0 0.08624213188886642
3 O 0 0.05331094190478325
) O 0 0.047309037297964096
; O 0 0.049980707466602325
SIBPAL O 1 0.7105154991149902
Pempirical O 0 0.22167453169822693
value O 0 0.06259386986494064
< O 0 0.19004887342453003
1 O 0 0.05520632490515709
x O 0 0.08914259076118469
10 O 0 0.03935493901371956
( O 0 0.04867570102214813
- O 0 0.087748222053051
3 O 0 0.045176055282354355
) O 0 0.03090064600110054
) O 0 0.024007072672247887
that O 0 0.013054044917225838
are O 0 0.01619853265583515
linked O 0 0.06635347753763199
to O 0 0.03435475006699562
mental O 1 0.9995434880256653
health O 1 0.9864746928215027
wellness O 1 0.9949377775192261
. O 0 0.0637708306312561

These O 0 0.03231370449066162
findings O 0 0.04440867528319359
are O 0 0.017275361344218254
consistent O 0 0.03813226521015167
with O 0 0.018071813508868217
the O 0 0.02016879804432392
hypothesis O 0 0.05749238654971123
that O 0 0.016078604385256767
certain O 0 0.030535001307725906
alleles O 0 0.14074069261550903
could O 0 0.034632470458745956
prevent O 0 0.05762993544340134
or O 0 0.02909017540514469
modify O 0 0.06675712764263153
the O 0 0.031045636162161827
clinical O 1 0.9166785478591919
manifestations O 0 0.3979056477546692
of O 0 0.03024507500231266
BPAD B-Disease 1 0.9979293346405029
and O 0 0.024275807663798332
perhaps O 0 0.03753821551799774
other O 0 0.02371426299214363
related O 0 0.13992074131965637
affective B-Disease 1 0.9999521970748901
disorders I-Disease 1 0.9999895095825195
. O 0 0.0711703896522522

Segregation O 0 0.4348549544811249
distortion O 1 0.7314472198486328
in O 0 0.09711313247680664
myotonic B-Disease 1 0.9999986886978149
dystrophy I-Disease 1 0.9999997615814209
. O 0 0.11259610205888748

Myotonic B-Disease 1 0.9999998807907104
dystrophy I-Disease 1 1.0
( O 1 0.9952411651611328
DM B-Disease 1 0.9999985694885254
) O 0 0.053141314536333084
is O 0 0.029749050736427307
an O 0 0.0389305055141449
autosomal B-Disease 1 0.9996645450592041
dominant I-Disease 1 0.9530959129333496
disease I-Disease 1 0.9999444484710693
which O 0 0.021449042484164238
, O 0 0.016644954681396484
in O 0 0.014801224693655968
the O 0 0.019428372383117676
typical O 0 0.060865338891744614
pedigree O 0 0.09751290827989578
, O 0 0.020961709320545197
shows O 0 0.027682458981871605
a O 0 0.025313081219792366
three O 0 0.027463901787996292
generation O 0 0.09337363392114639
anticipation O 0 0.1292128711938858
cascade O 0 0.23190230131149292
. O 0 0.06611847877502441

This O 0 0.040941085666418076
results O 0 0.060966528952121735
in O 0 0.047229066491127014
infertility B-Disease 1 0.999997615814209
and O 1 0.8316515684127808
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.7023516893386841
CDM B-Disease 1 0.9996639490127563
) O 0 0.03285423666238785
with O 0 0.01595310866832733
the O 0 0.02268332429230213
disappearance O 0 0.07225301116704941
of O 0 0.033162131905555725
DM B-Disease 1 0.9999872446060181
in O 0 0.03175974264740944
that O 0 0.03107762709259987
pedigree O 0 0.15595953166484833
. O 0 0.058064475655555725

The O 0 0.032208576798439026
concept O 0 0.04535572603344917
of O 0 0.02533218264579773
segregation O 0 0.12562692165374756
distortion O 0 0.12374842911958694
, O 0 0.0222847368568182
where O 0 0.01774836704134941
there O 0 0.015087898820638657
is O 0 0.018631039187312126
preferential O 0 0.0877913236618042
transmission O 0 0.07435999065637589
of O 0 0.014982737600803375
the O 0 0.019579721614718437
larger O 0 0.04788149520754814
allele O 0 0.15892380475997925
at O 0 0.04735298454761505
the O 0 0.049495451152324677
DM B-Disease 1 0.9999802112579346
locus O 0 0.15125709772109985
, O 0 0.02367761917412281
has O 0 0.017319900915026665
been O 0 0.017241081222891808
put O 0 0.025392703711986542
forward O 0 0.025178829208016396
to O 0 0.017961816862225533
explain O 0 0.04368298873305321
partially O 0 0.06034202128648758
the O 0 0.025968702509999275
maintenance O 0 0.08274958282709122
of O 0 0.03570159524679184
DM B-Disease 1 0.9999624490737915
in O 0 0.02570120058953762
the O 0 0.023777378723025322
population O 0 0.04566340520977974
. O 0 0.05136662721633911

In O 0 0.03339044749736786
a O 0 0.033441364765167236
survey O 0 0.051297251135110855
of O 0 0.03250082582235336
DM B-Disease 1 0.999975323677063
in O 0 0.029933590441942215
Northern O 0 0.039389658719301224
Ireland O 0 0.0464448556303978
, O 0 0.03244529664516449
59 O 0 0.0860067680478096
pedigrees O 0 0.12744347751140594
were O 0 0.034652113914489746
ascertained O 0 0.12217764556407928
. O 0 0.05399882793426514

Sibships O 0 0.2180536836385727
where O 0 0.03089105151593685
the O 0 0.018564913421869278
status O 0 0.024661073461174965
of O 0 0.010489342734217644
all O 0 0.010072204284369946
the O 0 0.01261797733604908
members O 0 0.01756434701383114
had O 0 0.02106153778731823
been O 0 0.018702654168009758
identified O 0 0.027503181248903275
were O 0 0.013924614526331425
examined O 0 0.04319075495004654
to O 0 0.014996889047324657
determine O 0 0.02503439225256443
the O 0 0.019726138561964035
transmission O 0 0.07036574184894562
of O 0 0.017965950071811676
the O 0 0.03438242897391319
DM B-Disease 1 0.9999901056289673
expansion O 0 0.07298848032951355
from O 0 0.03147982060909271
affected O 0 0.05930449813604355
parents O 0 0.04490215331315994
to O 0 0.020418036729097366
their O 0 0.028951745480298996
offspring O 0 0.11778110265731812
. O 0 0.060175079852342606

Where O 0 0.0480034202337265
the O 0 0.034635450690984726
transmitting O 0 0.13148647546768188
parent O 0 0.1175672858953476
was O 0 0.040422242134809494
male O 0 0.07618554681539536
, O 0 0.03538013622164726
58 O 0 0.0941447913646698
. O 0 0.052290380001068115

3 O 0 0.05985803157091141
% O 0 0.03188718110322952
of O 0 0.016850538551807404
the O 0 0.02396143227815628
offspring O 0 0.08061881363391876
were O 0 0.019561786204576492
affected O 0 0.04828424006700516
, O 0 0.01657947525382042
and O 0 0.012753205373883247
in O 0 0.011949652805924416
the O 0 0.01405003946274519
case O 0 0.02395033836364746
of O 0 0.013997714966535568
a O 0 0.026545317843556404
female O 0 0.06111855059862137
transmitting O 0 0.12989157438278198
parent O 0 0.11771966516971588
, O 0 0.038107454776763916
68 O 0 0.09385097771883011
. O 0 0.04923924431204796

7 O 0 0.0706494078040123
% O 0 0.04233552888035774
were O 0 0.02260471135377884
affected O 0 0.07143276929855347
. O 0 0.04794895648956299

Studies O 0 0.08045182377099991
on O 0 0.03775973618030548
meiotic O 1 0.8986021280288696
drive O 0 0.10646901279687881
in O 0 0.054270729422569275
DM B-Disease 1 0.9999899864196777
have O 0 0.02938622236251831
shown O 0 0.04078591987490654
increased O 0 0.039811115711927414
transmission O 0 0.06333184242248535
of O 0 0.012950665317475796
the O 0 0.017482245340943336
larger O 0 0.04493454843759537
allele O 0 0.14694470167160034
at O 0 0.04471056908369064
the O 0 0.046719908714294434
DM B-Disease 1 0.9999767541885376
locus O 0 0.17962250113487244
in O 0 0.04570605605840683
non O 0 0.1419118046760559
- O 1 0.9948169589042664
DM O 1 0.9999949932098389
heterozygotes O 1 0.9756618738174438
for O 0 0.05329403653740883
CTGn O 0 0.3737313449382782
. O 0 0.06129796430468559

This O 0 0.033166609704494476
study O 0 0.04107656702399254
provides O 0 0.038895029574632645
further O 0 0.023482877761125565
evidence O 0 0.026137501001358032
that O 0 0.02011840231716633
the O 0 0.04163513705134392
DM B-Disease 1 0.9999954700469971
expansion O 0 0.08464687317609787
tends O 0 0.07437489181756973
to O 0 0.02206258848309517
be O 0 0.026765896007418633
transmitted O 0 0.1229393258690834
preferentially O 0 0.17094524204730988
. O 0 0.05833883211016655

Diagnosis O 1 0.9996635913848877
of O 0 0.07870576530694962
hemochromatosis B-Disease 1 0.9999932050704956
. O 0 0.08355297893285751

If O 0 0.10419845581054688
untreated O 1 0.9999169111251831
, O 0 0.26241493225097656
hemochromatosis B-Disease 1 0.9999998807907104
can O 0 0.14445210993289948
cause O 1 0.9942681789398193
serious O 1 0.9905982613563538
illness O 1 0.9998828172683716
and O 0 0.023714331910014153
early B-Disease 0 0.03709041699767113
death I-Disease 0 0.0421866849064827
, O 0 0.01817418448626995
but O 0 0.017245138064026833
the O 0 0.025249406695365906
disease O 1 0.9998095631599426
is O 0 0.02679743990302086
still O 0 0.028808027505874634
substantially O 0 0.06641288846731186
under O 0 0.04621969908475876
- O 1 0.9735137224197388
diagnosed O 1 0.9999550580978394
. O 0 0.06829260289669037

The O 0 0.03899700939655304
cornerstone O 0 0.08905085176229477
of O 0 0.02475489117205143
screening O 0 0.0817360207438469
and O 0 0.02415649965405464
case O 0 0.03574756160378456
detection O 0 0.0836043730378151
is O 0 0.017517030239105225
the O 0 0.019237039610743523
measurement O 0 0.06605236232280731
of O 0 0.03367810323834419
serum O 1 0.9810225367546082
transferrin O 1 0.955011248588562
saturation O 0 0.19746463000774384
and O 0 0.028596147894859314
the O 0 0.04466862604022026
serum O 1 0.9685428738594055
ferritin O 1 0.890731930732727
level O 0 0.08073334395885468
. O 0 0.056684885174036026

Once O 0 0.06930949538946152
the O 0 0.04390283301472664
diagnosis O 1 0.9987455606460571
is O 0 0.03291274607181549
suspected O 0 0.0663563534617424
, O 0 0.029636990278959274
physicians O 0 0.12676902115345
must O 0 0.03503512591123581
use O 0 0.04706249758601189
serum O 1 0.9928686022758484
ferritin O 1 0.984255313873291
levels O 0 0.0987011268734932
and O 0 0.04539228975772858
hepatic O 1 0.9999874830245972
iron O 1 0.6290693283081055
stores O 0 0.06942889839410782
on O 0 0.04537087678909302
liver O 1 0.999925971031189
biopsy O 1 0.9987107515335083
specimens O 0 0.07962988317012787
to O 0 0.027881402522325516
assess O 0 0.10204321146011353
patients O 1 0.9742283821105957
for O 0 0.017529452219605446
the O 0 0.02021675743162632
presence O 0 0.04799491912126541
of O 0 0.027818502858281136
iron B-Disease 1 0.8254342675209045
overload I-Disease 1 0.9893267154693604
. O 0 0.06405957043170929

Liver O 1 0.9999710321426392
biopsy O 1 0.9970230460166931
is O 0 0.024789972230792046
also O 0 0.014122014865279198
used O 0 0.0143008166924119
to O 0 0.01224909070879221
establish O 0 0.02926407940685749
the O 0 0.02160496823489666
presence O 0 0.044552918523550034
or O 0 0.03098277933895588
absence O 0 0.05797230452299118
of O 0 0.03064010664820671
cirrhosis B-Disease 1 0.9998372793197632
, O 0 0.027084365487098694
which O 0 0.021243831142783165
can O 0 0.03136727213859558
affect O 0 0.07975567877292633
prognosis O 1 0.9998475313186646
and O 0 0.03331316262483597
management O 0 0.08509241789579391
. O 0 0.05066048353910446

A O 0 0.08127109706401825
DNA O 0 0.11381518095731735
- O 0 0.08951886743307114
based O 0 0.034628115594387054
test O 0 0.048042185604572296
for O 0 0.021338719874620438
the O 0 0.03420623391866684
HFE O 1 0.9909260272979736
gene O 0 0.11382956057786942
is O 0 0.025412991642951965
commercially O 0 0.0387847013771534
available O 0 0.01818419247865677
, O 0 0.013560897670686245
but O 0 0.011873875744640827
its O 0 0.011566437780857086
place O 0 0.018028099089860916
in O 0 0.015046282671391964
the O 0 0.026756810024380684
diagnosis O 1 0.9996432065963745
of O 0 0.042398545891046524
hemochromatosis B-Disease 1 0.9999973773956299
is O 0 0.03001767210662365
still O 0 0.02609628438949585
being O 0 0.02682892419397831
evaluated O 0 0.08465343713760376
. O 0 0.04613374173641205

Currently O 0 0.04278230294585228
, O 0 0.018156951293349266
the O 0 0.01696646772325039
most O 0 0.01732531562447548
useful O 0 0.029047219082713127
role O 0 0.023086855188012123
for O 0 0.01400594413280487
this O 0 0.014492359012365341
test O 0 0.0365820974111557
is O 0 0.015268038958311081
in O 0 0.015076889656484127
the O 0 0.020418712869286537
detection O 0 0.09630700200796127
of O 0 0.029195891693234444
hemochromatosis B-Disease 1 0.9999786615371704
in O 0 0.022527771070599556
the O 0 0.01823936402797699
family O 0 0.03229163959622383
members O 0 0.021896163001656532
of O 0 0.018970536068081856
patients O 1 0.9676116108894348
with O 0 0.02280181646347046
a O 0 0.03093850426375866
proven O 0 0.06336592882871628
case O 0 0.029425812885165215
of O 0 0.019260406494140625
the O 0 0.041154906153678894
disease O 1 0.99983811378479
. O 0 0.06301642954349518

It O 0 0.034769702702760696
is O 0 0.025942014530301094
crucial O 0 0.04699806496500969
to O 0 0.05116311460733414
diagnose O 1 0.9999942779541016
hemochromatosis B-Disease 1 0.9999998807907104
before O 1 0.8462668061256409
hepatic B-Disease 1 0.9999998807907104
cirrhosis I-Disease 1 0.9999991655349731
develops O 1 0.9996088147163391
because O 1 0.5096611380577087
phlebotomy O 1 0.9999957084655762
therapy O 1 0.9999974966049194
can O 0 0.4379487931728363
avert O 1 0.9998996257781982
serious O 1 0.9999505281448364
chronic O 1 1.0
disease O 1 0.9999979734420776
and O 0 0.024141669273376465
can O 0 0.02382666990160942
even O 0 0.021640703082084656
lead O 0 0.03540029376745224
to O 0 0.021777920424938202
normal O 0 0.05456338822841644
life O 0 0.040582433342933655
expectancy O 0 0.09701839834451675
. O 0 0.03330432251095772
. O 0 0.041006918996572495

Prevalence O 1 0.691672682762146
of O 0 0.03759436681866646
the O 0 0.049815595149993896
I1307K O 1 0.7710807919502258
APC B-Disease 1 0.9645171165466309
gene O 0 0.15155623853206635
variant O 0 0.12254761904478073
in O 0 0.02356541156768799
Israeli O 0 0.03464237228035927
Jews O 0 0.023825054988265038
of O 0 0.012618512846529484
differing O 0 0.03605405241250992
ethnic O 0 0.02974751777946949
origin O 0 0.040425531566143036
and O 0 0.030155764892697334
risk O 1 0.991152822971344
for O 0 0.08454235643148422
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999995231628418
. O 0 0.07489430159330368

BACKGROUND O 0 0.13502991199493408
& O 0 0.11380705237388611
AIMS O 0 0.09078153222799301
Israeli O 0 0.04823264479637146
Jews O 0 0.032302409410476685
of O 0 0.01774117723107338
European O 0 0.033333681523799896
birth O 0 0.05748268589377403
, O 0 0.02344564162194729
i O 0 0.029332084581255913
. O 0 0.01940445974469185
e O 0 0.05611039698123932
. O 0 0.018103178590536118
, O 0 0.02247695066034794
Ashkenazim O 0 0.16630427539348602
, O 0 0.021462222561240196
have O 0 0.019268255680799484
the O 0 0.031763989478349686
highest O 1 0.9692398309707642
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
incidence O 1 0.9968215227127075
of O 0 0.023398714140057564
any O 0 0.020597778260707855
Israeli O 0 0.041319236159324646
ethnic O 0 0.04072233662009239
group O 0 0.06828440725803375
. O 0 0.052951447665691376

The O 0 0.08131248503923416
I1307K O 1 0.5671581625938416
APC B-Disease 1 0.9349035620689392
gene O 0 0.1750955730676651
variant O 0 0.13461746275424957
was O 0 0.03178340569138527
found O 0 0.027900446206331253
in O 0 0.022521184757351875
6 O 0 0.05548109859228134
. O 0 0.04737430438399315

1 O 0 0.05287184566259384
% O 0 0.0325610525906086
of O 0 0.0148756830021739
American O 0 0.027803895995020866
Jews O 0 0.031573861837387085
, O 0 0.01954803802073002
28 O 0 0.02888304553925991
% O 0 0.028899168595671654
of O 0 0.01951724849641323
their O 0 0.04505817964673042
familial O 1 0.9999998807907104
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 0 0.11908145248889923
, O 0 0.020227210596203804
but O 0 0.014195307157933712
not O 0 0.012570037506520748
in O 0 0.018163388594985008
non O 0 0.05028001219034195
- O 0 0.08800995349884033
Jews O 0 0.053948964923620224
. O 0 0.051653362810611725

We O 0 0.046603016555309296
assessed O 0 0.07089942693710327
the O 0 0.04238302260637283
I1307K O 0 0.46841752529144287
prevalence O 1 0.6971381306648254
in O 0 0.0260805394500494
Israeli O 0 0.034304969012737274
Jews O 0 0.026090776547789574
of O 0 0.013827051036059856
differing O 0 0.03872636705636978
ethnic O 0 0.03175616264343262
origin O 0 0.03846742585301399
and O 0 0.029640795662999153
risk O 1 0.9963690042495728
for O 0 0.08222460001707077
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
. O 0 0.07664073258638382

METHODS O 0 0.1031450405716896
DNA O 0 0.0988561138510704
samples O 0 0.06268633157014847
from O 0 0.026628339663147926
500 O 0 0.056620653718709946
unrelated O 0 0.060992706567049026
Jews O 0 0.030214201658964157
of O 0 0.015821924433112144
European O 0 0.03199930116534233
or O 0 0.029749933630228043
non O 0 0.05125683546066284
- O 0 0.07057274132966995
European O 0 0.03421316668391228
origin O 0 0.032226596027612686
, O 0 0.016690557822585106
with O 0 0.015287507325410843
or O 0 0.02121761441230774
without O 0 0.018283618614077568
a O 0 0.021047227084636688
personal O 0 0.03161744773387909
and O 0 0.026132352650165558
/ O 1 0.6892003417015076
or O 0 0.03077823854982853
family O 0 0.03920729085803032
history O 0 0.03455144539475441
of O 0 0.02949819155037403
neoplasia B-Disease 1 0.9990960359573364
, O 0 0.02299289032816887
were O 0 0.01493834052234888
examined O 0 0.04853693023324013
for O 0 0.01725810393691063
the O 0 0.027346909046173096
I1307K O 0 0.14338111877441406
variant O 0 0.10177738964557648
by O 0 0.0229614470154047
the O 0 0.030344586819410324
allele O 0 0.19922342896461487
- O 0 0.1300867199897766
specific O 0 0.07242285460233688
oligonucleotide O 1 0.5235053300857544
( O 0 0.07382401078939438
ASO O 1 0.8919932842254639
) O 0 0.051332730799913406
method O 0 0.057227469980716705
. O 0 0.041884563863277435

RESULTS O 0 0.0728202760219574
In O 0 0.026718704029917717
persons O 0 0.03978332504630089
at O 0 0.03572969138622284
average O 0 0.06765303760766983
risk O 1 0.9940823912620544
for O 0 0.08059822767972946
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999995231628418
, O 0 0.03815558925271034
I1307K O 0 0.15517069399356842
was O 0 0.02669391594827175
found O 0 0.026504268869757652
in O 0 0.02140096016228199
5 O 0 0.04748811200261116
. O 0 0.04326752945780754

0 O 0 0.09555011987686157
% O 0 0.039626192301511765
of O 0 0.01854478195309639
120 O 0 0.04544995725154877
European O 0 0.0336652547121048
and O 0 0.022970113903284073
1 O 0 0.047575484961271286
. O 0 0.0442051999270916

6 O 0 0.07621485739946365
% O 0 0.04156810790300369
of O 0 0.023650486022233963
188 O 0 0.10811161249876022
non O 0 0.07431983202695847
- O 0 0.105286605656147
European O 0 0.05230815336108208
Jews O 0 0.06371675431728363
( O 0 0.08417346328496933
P O 1 0.8913095593452454
= O 0 0.15686920285224915
0 O 0 0.07994910329580307
. O 0 0.03332696110010147
08 O 0 0.12111365795135498
) O 0 0.054632656276226044
. O 0 0.04803429916501045

It O 0 0.041356123983860016
occurred O 0 0.055502891540527344
in O 0 0.025010235607624054
15 O 0 0.04496258869767189
. O 0 0.0420050248503685

4 O 0 0.06836146116256714
% O 0 0.04456657916307449
of O 0 0.02436751499772072
52 O 0 0.0812554806470871
Ashkenazi O 0 0.1718399077653885
Israelis O 0 0.10237891227006912
with O 0 0.06047924607992172
familial O 1 0.9999557733535767
cancer B-Disease 1 0.999997615814209
( O 0 0.14319148659706116
P O 1 0.9911619424819946
= O 0 0.18059267103672028
0 O 0 0.08338478952646255
. O 0 0.03196371719241142
02 O 1 0.7394218444824219
) O 0 0.029868047684431076
and O 0 0.01438017189502716
was O 0 0.020072052255272865
not O 0 0.01875961758196354
detected O 0 0.06529116630554199
in O 0 0.019080568104982376
51 O 0 0.05982814356684685
non O 0 0.058465152978897095
- O 0 0.08205349743366241
European O 0 0.04966902360320091
Jews O 0 0.048674583435058594
at O 0 0.05455833673477173
increased O 0 0.11078158766031265
cancer B-Disease 1 0.9999830722808838
risk O 1 0.9589701890945435
. O 0 0.06052003055810928

Colorectal B-Disease 1 0.999993085861206
neoplasia I-Disease 1 0.9999452829360962
occurred O 0 0.10996726900339127
personally O 0 0.06954958289861679
or O 0 0.025181042030453682
in O 0 0.014153111726045609
the O 0 0.01452617533504963
families O 0 0.027668826282024384
of O 0 0.01609889417886734
13 O 0 0.030809111893177032
of O 0 0.019356466829776764
20 O 0 0.051538653671741486
Ashkenazi O 0 0.1693645566701889
I1307K O 0 0.21490979194641113
carriers O 0 0.10533642768859863
, O 0 0.025406459346413612
8 O 0 0.03133499622344971
of O 0 0.013944584876298904
whom O 0 0.03015655279159546
also O 0 0.016519559547305107
had O 0 0.019300313666462898
a O 0 0.020650751888751984
personal O 0 0.027440490201115608
or O 0 0.026314135640859604
family O 0 0.03493224456906319
history O 0 0.03475543111562729
of O 0 0.03611602261662483
noncolonic O 1 0.9857902526855469
neoplasia B-Disease 1 0.9995008707046509
. O 0 0.06960851699113846

CONCLUSIONS O 0 0.10885313153266907
The O 0 0.0574822761118412
I1307K O 1 0.6856864094734192
APC O 1 0.9573097825050354
variant O 0 0.17166045308113098
may O 0 0.045997120440006256
represent O 0 0.03566408529877663
a O 0 0.046970851719379425
susceptibility O 1 0.9828821420669556
gene O 0 0.14156897366046906
for O 0 0.0360865443944931
colorectal B-Disease 1 0.9999961853027344
, I-Disease 0 0.027438204735517502
or I-Disease 0 0.0245364997535944
other I-Disease 0 0.017757005989551544
, I-Disease 0 0.027960902079939842
cancers I-Disease 1 0.9983507394790649
in O 0 0.027811488136649132
Ashkenazi O 0 0.1367313712835312
Jews O 0 0.03854486718773842
, O 0 0.02029423788189888
and O 0 0.01882864348590374
partially O 0 0.06668883562088013
explains O 0 0.0543234720826149
the O 0 0.024770990014076233
higher O 0 0.06092190742492676
incidence O 1 0.9995025396347046
of O 0 0.06724860519170761
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999990463256836
in O 0 0.035695720463991165
European O 0 0.05316805839538574
Israelis O 0 0.09798512607812881
. O 0 0.04866378754377365

Systematic O 0 0.13207702338695526
analysis O 0 0.06756502389907837
of O 0 0.040385566651821136
coproporphyrinogen O 1 0.9610262513160706
oxidase O 1 0.982950747013092
gene O 0 0.45923638343811035
defects O 1 0.9811716079711914
in O 0 0.04422705993056297
hereditary B-Disease 1 0.924656867980957
coproporphyria I-Disease 1 0.818579375743866
and O 0 0.0538637675344944
mutation O 0 0.3741970360279083
update O 0 0.1449957937002182
. O 0 0.060519590973854065

Hereditary B-Disease 1 0.9782665371894836
coproporphyria I-Disease 1 0.9722626209259033
( O 0 0.11581439524888992
HC B-Disease 1 0.9994495511054993
) O 0 0.05381378158926964
is O 0 0.03903665021061897
an O 0 0.05433221906423569
acute O 1 0.9999988079071045
hepatic B-Disease 1 0.9999998807907104
porphyria I-Disease 1 0.9999984502792358
with O 0 0.06982706487178802
autosomal O 1 0.9991790652275085
dominant O 0 0.39696648716926575
inheritance O 1 0.7247272729873657
caused O 0 0.25354528427124023
by O 0 0.041260864585638046
deficient B-Disease 1 0.9145486354827881
activity I-Disease 0 0.06901886314153671
of I-Disease 0 0.035526011139154434
coproporphyrinogen I-Disease 1 0.9703242182731628
III I-Disease 1 0.9109072089195251
oxidase I-Disease 1 0.8897393941879272
( O 0 0.07964954525232315
CPO O 0 0.18181109428405762
) O 0 0.061842501163482666
. O 0 0.0472494512796402

Clinical O 1 0.9812838435173035
manifestations O 0 0.2976205348968506
of O 0 0.024276405572891235
the O 0 0.032826416194438934
disease O 1 0.9999717473983765
are O 0 0.026491085067391396
characterized O 1 0.6783230304718018
by O 0 0.036878280341625214
acute O 1 0.9999916553497314
attacks O 0 0.2679111957550049
of O 0 0.045942455530166626
neurological B-Disease 1 0.9999994039535522
dysfunction I-Disease 1 0.9999958276748657
often O 0 0.06337109208106995
precipitated O 1 0.9538009762763977
by O 0 0.03360901400446892
drugs O 0 0.29460883140563965
, O 0 0.03347211331129074
fasting O 0 0.313133180141449
, O 0 0.04693736508488655
cyclical O 1 0.9963961243629456
hormonal O 1 0.9975211024284363
changes O 0 0.05734674260020256
, O 0 0.034729063510894775
or O 0 0.17610393464565277
infectious B-Disease 1 0.9999953508377075
diseases I-Disease 1 0.9999698400497437
. O 0 0.07011479884386063

Skin O 1 0.9999939203262329
photosensitivity O 1 0.9998449087142944
may O 0 0.051659051328897476
also O 0 0.020706169307231903
be O 0 0.0166005939245224
present O 0 0.03156888857483864
. O 0 0.0416669100522995

The O 0 0.03964352235198021
seven O 0 0.048595402389764786
exons O 0 0.12295259535312653
, O 0 0.03118053451180458
the O 0 0.03893474116921425
exon O 0 0.21662938594818115
/ O 1 0.6113657355308533
intron O 0 0.2215012013912201
boundaries O 0 0.035854361951351166
and O 0 0.01718115247786045
part O 0 0.022390244528651237
of O 0 0.01810474693775177
3 O 0 0.04835508018732071
noncoding O 0 0.16547028720378876
sequence O 0 0.04600260779261589
of O 0 0.01619851589202881
the O 0 0.027460310608148575
CPO O 0 0.15676945447921753
gene O 0 0.09281547367572784
were O 0 0.022700941190123558
systematically O 0 0.06531462073326111
analyzed O 0 0.04970059543848038
by O 0 0.02269374020397663
an O 0 0.0317319817841053
exon O 0 0.16641752421855927
- O 0 0.12288083136081696
by O 0 0.04518001154065132
- O 0 0.1754678189754486
exon O 0 0.2919888496398926
denaturing O 1 0.9238463640213013
gradient O 1 0.7957470417022705
gel O 1 0.9858249425888062
electrophoresis O 1 0.9157178401947021
( O 0 0.10332899540662766
DGGE O 1 0.9043115377426147
) O 0 0.04555673152208328
strategy O 0 0.056298065930604935
followed O 0 0.03180886432528496
by O 0 0.01838529296219349
direct O 0 0.03804045170545578
sequencing O 0 0.06610194593667984
in O 0 0.024540459737181664
seven O 0 0.04089546948671341
unrelated O 0 0.11554662883281708
heterozygous O 1 0.6194053888320923
HC B-Disease 1 0.9999747276306152
patients O 1 0.9995427131652832
from O 0 0.035215720534324646
France O 0 0.05791538208723068
, O 0 0.027002912014722824
Holland O 0 0.08217819035053253
, O 0 0.020432952791452408
and O 0 0.020274242386221886
Czech O 0 0.060777630656957626
Republic O 0 0.04759924113750458
. O 0 0.040039245039224625

Seven O 0 0.07165208458900452
novel O 0 0.07221175730228424
mutations O 0 0.13362044095993042
and O 0 0.02198622189462185
two O 0 0.020327923819422722
new O 0 0.039414651691913605
polymorphisms O 0 0.14951761066913605
were O 0 0.034298162907361984
detected O 0 0.12950940430164337
. O 0 0.052932724356651306

Among O 0 0.04842909052968025
these O 0 0.02741127461194992
mutations O 0 0.1158062070608139
two O 0 0.024617016315460205
are O 0 0.02924494259059429
missense O 0 0.2034425586462021
( O 0 0.06676947325468063
G197W O 0 0.16236385703086853
, O 0 0.03933398053050041
W427R O 0 0.1402040719985962
) O 0 0.03075343929231167
, O 0 0.01764199137687683
two O 0 0.016440188512206078
are O 0 0.022295644506812096
nonsense O 0 0.10312917083501816
( O 0 0.06027795001864433
Q306X O 0 0.15981604158878326
, O 0 0.03861568495631218
Q385X O 0 0.13277238607406616
) O 0 0.029956268146634102
, O 0 0.01531980000436306
two O 0 0.013530492782592773
are O 0 0.017733590677380562
small O 0 0.04217105358839035
deletions O 0 0.13926395773887634
( O 0 0.08489149063825607
662de14bp O 0 0.30715876817703247
; O 0 0.06136740371584892
1168del3bp O 0 0.1902117282152176
removing O 0 0.08084478229284286
a O 0 0.04288269206881523
glycine O 0 0.14058518409729004
at O 0 0.03324001282453537
position O 0 0.03199432045221329
390 O 0 0.09064622223377228
) O 0 0.028924258425831795
, O 0 0.014019527472555637
and O 0 0.01272420585155487
one O 0 0.01779569312930107
is O 0 0.02216256596148014
a O 0 0.0354694128036499
splicing O 0 0.17656683921813965
mutation O 0 0.24215425550937653
( O 0 0.10030530393123627
IVS1 O 1 0.9961004257202148
- O 1 0.9299898743629456
15c O 1 0.9954921007156372
- O 1 0.9692082405090332
- O 1 0.6697036027908325
> O 1 0.5683989524841309
g O 0 0.1476784497499466
) O 0 0.039602622389793396
which O 0 0.021344004198908806
creates O 0 0.06345698982477188
a O 0 0.0329003632068634
new O 0 0.043264567852020264
acceptor O 0 0.2205955982208252
splice O 0 0.22178331017494202
site O 0 0.07113687694072723
. O 0 0.050289105623960495

The O 0 0.04822636395692825
pathological O 0 0.13167309761047363
significance O 0 0.035383887588977814
of O 0 0.01648644171655178
the O 0 0.02382940798997879
point O 0 0.05222224444150925
mutations O 0 0.17412154376506805
G197W O 0 0.18869701027870178
, O 0 0.035956304520368576
W427R O 0 0.12211079150438309
, O 0 0.0179592352360487
and O 0 0.013784806244075298
the O 0 0.016656149178743362
in O 0 0.027906792238354683
- O 0 0.11442533880472183
frame O 0 0.11815231293439865
deletion O 0 0.18352651596069336
390delGly O 0 0.15662585198879242
were O 0 0.0240778885781765
assessed O 0 0.04637499898672104
by O 0 0.014951973222196102
their O 0 0.015652822330594063
respective O 0 0.033999089151620865
expression O 0 0.043609146028757095
in O 0 0.018729059025645256
a O 0 0.027130277827382088
prokaryotic O 0 0.07507604360580444
system O 0 0.04241763427853584
using O 0 0.029137473553419113
site O 0 0.04446924105286598
- O 0 0.09303402155637741
directed O 0 0.0708799809217453
mutagenesis O 0 0.21697035431861877
. O 0 0.0625746101140976

These O 0 0.04637986421585083
mutations O 0 0.14474570751190186
resulted O 0 0.05382978543639183
in O 0 0.018360663205385208
the O 0 0.020737867802381516
absence O 0 0.0516224168241024
or O 0 0.025189809501171112
a O 0 0.02982345223426819
dramatic O 0 0.06704874336719513
decrease O 0 0.07035056501626968
of O 0 0.02844851091504097
CPO O 0 0.17849910259246826
activity O 0 0.08938741683959961
. O 0 0.054301872849464417

The O 0 0.03863293677568436
two O 0 0.03500966727733612
polymorphisms O 0 0.13368766009807587
were O 0 0.027337994426488876
localized O 0 0.11506304889917374
in O 0 0.028884638100862503
noncoding O 0 0.141628697514534
part O 0 0.02883850783109665
of O 0 0.014370139688253403
the O 0 0.02490519918501377
gene O 0 0.09298587590456009
1 O 0 0.04796955734491348
) O 0 0.036887239664793015
a O 0 0.04676252231001854
C O 1 0.5900430679321289
/ O 1 0.8512017130851746
G O 0 0.1698049008846283
polymorphism O 0 0.11172707378864288
in O 0 0.026937950402498245
the O 0 0.031119540333747864
promotor O 1 0.7784841656684875
region O 0 0.06893404573202133
, O 0 0.036164119839668274
142 O 0 0.10899634659290314
bp O 0 0.12716712057590485
upstream O 0 0.07654766738414764
from O 0 0.0258657056838274
the O 0 0.0326501801609993
transcriptional O 0 0.15787848830223083
initiation O 0 0.13914993405342102
site O 0 0.06471039354801178
( O 0 0.0699843242764473
- O 0 0.2890123724937439
142C O 1 0.9325946569442749
/ O 1 0.9737462997436523
G O 0 0.19514495134353638
) O 0 0.03097565472126007
, O 0 0.016601286828517914
and O 0 0.017439983785152435
2 O 0 0.03664272278547287
) O 0 0.031012892723083496
a O 0 0.03609009459614754
6 O 0 0.06818170100450516
bp O 0 0.14336851239204407
deletion O 0 0.16402652859687805
polymorphism O 0 0.11485850065946579
in O 0 0.022863371297717094
the O 0 0.02239040657877922
3 O 0 0.04739345982670784
noncoding O 0 0.13806670904159546
part O 0 0.030004432424902916
of O 0 0.016272200271487236
the O 0 0.028516290709376335
CPO O 0 0.17911459505558014
gene O 0 0.12752695381641388
, O 0 0.040155909955501556
574 O 0 0.17870119214057922
bp O 0 0.12629708647727966
downstream O 0 0.06738360971212387
of O 0 0.015461274422705173
the O 0 0.01733679138123989
last O 0 0.026580149307847023
base O 0 0.03465598449110985
of O 0 0.014470873400568962
the O 0 0.027814801782369614
normal O 0 0.09953755140304565
termination O 1 0.7701453566551208
codon O 0 0.21946588158607483
( O 0 0.09472516924142838
+ O 1 0.6298037171363831
574 O 1 0.647918164730072
delATTCTT O 0 0.3123122751712799
) O 0 0.07330576330423355
. O 0 0.05818035826086998

Five O 0 0.08240694552659988
intragenic O 1 0.5191777348518372
dimorphisms O 0 0.17931582033634186
are O 0 0.02082779072225094
now O 0 0.024809682741761208
well O 0 0.01988532394170761
characterized O 0 0.05789376422762871
and O 0 0.016495143994688988
the O 0 0.017412370070815086
high O 0 0.03527374565601349
degree O 0 0.04535533860325813
of O 0 0.02891579270362854
allelic O 0 0.4023370146751404
heterogeneity O 0 0.16984440386295319
in O 0 0.040096886456012726
HC B-Disease 1 0.998451828956604
is O 0 0.02767673134803772
demonstrated O 0 0.043789587914943695
with O 0 0.017454780638217926
seven O 0 0.02247047610580921
new O 0 0.02178521640598774
different O 0 0.02003970369696617
mutations O 0 0.08847541362047195
making O 0 0.024607976898550987
a O 0 0.023604778572916985
total O 0 0.027523644268512726
of O 0 0.022885113954544067
nineteen O 0 0.09776178747415543
CPO O 1 0.6837915182113647
gene B-Disease 0 0.2856186032295227
defects I-Disease 1 0.9707726836204529
reported O 0 0.05511651188135147
so O 0 0.025898773223161697
far O 0 0.027826320379972458
. O 0 0.027672054246068
. O 0 0.040707919746637344

Coincidence O 0 0.11430800706148148
of O 0 0.024007802829146385
two O 0 0.025639543309807777
novel O 0 0.06589918583631516
arylsulfatase O 0 0.18836311995983124
A O 0 0.06864756345748901
alleles O 0 0.19528347253799438
and O 0 0.057006869465112686
mutation O 0 0.3861350119113922
459 O 1 0.9615222811698914
+ O 1 0.919856071472168
1G O 1 0.9160215854644775
> O 0 0.17643266916275024
A O 0 0.04292568936944008
within O 0 0.028567828238010406
a O 0 0.03228932246565819
family O 0 0.05156557634472847
with O 0 0.050733763724565506
metachromatic B-Disease 1 0.9993547797203064
leukodystrophy I-Disease 1 0.9999642372131348
: O 0 0.051147863268852234
molecular O 0 0.07214906811714172
basis O 0 0.028593219816684723
of O 0 0.025830168277025223
phenotypic O 0 0.1431267410516739
heterogeneity O 0 0.19621090590953827
. O 0 0.06070427969098091

In O 0 0.034952495247125626
a O 0 0.03266077861189842
family O 0 0.033747151494026184
with O 0 0.017704535275697708
three O 0 0.020927805453538895
siblings O 0 0.0675174742937088
, O 0 0.01951507292687893
one O 0 0.020704826340079308
developed O 0 0.05186959356069565
classical O 0 0.06591039896011353
late O 0 0.09854869544506073
infantile O 1 0.9999703168869019
metachromatic B-Disease 1 0.9999527931213379
leukodystrophy I-Disease 1 0.9999991655349731
( O 1 0.7676661610603333
MLD B-Disease 1 0.999984622001648
) O 0 0.06442365795373917
, O 0 0.03791532665491104
fatal O 1 0.9880322217941284
at O 0 0.03482746332883835
age O 0 0.03608105704188347
5 O 0 0.03237496316432953
years O 0 0.021794764325022697
, O 0 0.022413522005081177
with O 0 0.03589719533920288
deficient O 1 0.9629563093185425
arylsulfatase O 1 0.7040389180183411
A O 0 0.0670418068766594
( O 0 0.07834610342979431
ARSA O 1 0.9942954182624817
) O 0 0.04656354710459709
activity O 0 0.0497642457485199
and O 0 0.024956827983260155
increased O 0 0.06944002211093903
galactosylsulfatide O 1 0.9504474997520447
( O 0 0.10676596313714981
GS O 1 0.99989914894104
) O 0 0.08501405268907547
excretion O 0 0.2535167336463928
. O 0 0.06544431298971176

The O 0 0.028851421549916267
two O 0 0.02029578946530819
other O 0 0.019472790881991386
siblings O 0 0.08200906962156296
, O 0 0.031522635370492935
apparently O 0 0.0660368874669075
healthy O 0 0.0873672142624855
at O 0 0.03277004137635231
12 O 0 0.041264645755290985
( O 0 0.04226114600896835
1 O 0 0.05218997597694397
/ O 0 0.15637096762657166
2 O 0 0.03883731737732887
) O 0 0.024233264848589897
and O 0 0.014158009551465511
15 O 0 0.023517170920968056
years O 0 0.019633982330560684
, O 0 0.015569367446005344
respectively O 0 0.024416251108050346
, O 0 0.014341593720018864
and O 0 0.012801162898540497
their O 0 0.01772523857653141
father O 0 0.039387185126543045
, O 0 0.024214353412389755
apparently O 0 0.05759265646338463
healthy O 0 0.0683479979634285
as O 0 0.016523543745279312
well O 0 0.019582092761993408
, O 0 0.020852794870734215
presented O 0 0.0512206144630909
ARSA O 1 0.989844560623169
and O 0 0.04104907438158989
GS O 1 0.9968403577804565
values O 0 0.03783063963055611
within O 0 0.01984606310725212
the O 0 0.02206742949783802
range O 0 0.05151901766657829
of O 0 0.04301702603697777
MLD B-Disease 1 0.9999915361404419
patients O 1 0.9993937015533447
. O 0 0.06214936450123787

Mutation O 0 0.47372904419898987
screening O 0 0.13062132894992828
and O 0 0.0286085344851017
sequence O 0 0.050572384148836136
analysis O 0 0.04142175242304802
disclosed O 0 0.050007544457912445
the O 0 0.020758451893925667
involvement O 0 0.049122635275125504
of O 0 0.015480026602745056
three O 0 0.021355781704187393
different O 0 0.03263033926486969
ARSA O 1 0.9947444200515747
mutations O 0 0.1358357071876526
being O 0 0.02730770967900753
the O 0 0.021664507687091827
molecular O 0 0.05681098997592926
basis O 0 0.02561354450881481
of O 0 0.026678716763854027
intrafamilial O 0 0.2556001543998718
phenotypic O 0 0.19569727778434753
heterogeneity O 0 0.21328450739383698
. O 0 0.06546582281589508

The O 0 0.0643489807844162
late O 0 0.09952019900083542
infantile O 1 0.9999350309371948
patient O 1 0.9979967474937439
inherited O 0 0.23952624201774597
from O 0 0.026557661592960358
his O 0 0.02573264203965664
mother O 0 0.0502101369202137
the O 0 0.029767781496047974
frequent O 0 0.09276601672172546
0 O 0 0.10869135707616806
- O 0 0.14730079472064972
type O 0 0.15315160155296326
mutation O 1 0.5841569304466248
459 O 1 0.9776433110237122
+ O 1 0.9548243880271912
1G O 1 0.9737074971199036
> O 0 0.18178382515907288
A O 0 0.034746937453746796
, O 0 0.015936484560370445
and O 0 0.011890486814081669
from O 0 0.014928526245057583
his O 0 0.01793864369392395
father O 0 0.031455185264348984
a O 0 0.027946120128035545
novel O 0 0.043886858969926834
, O 0 0.02737012878060341
single O 0 0.05469776690006256
basepair O 0 0.19904334843158722
microdeletion O 0 0.16926449537277222
of O 0 0.03473016619682312
guanine O 0 0.13780833780765533
at O 0 0.047983188182115555
nucleotide O 0 0.11242023855447769
7 O 0 0.05008416622877121
in O 0 0.031365618109703064
exon O 0 0.14497557282447815
1 O 0 0.0633535236120224
( O 0 0.06676014512777328
7delG O 0 0.1886303722858429
) O 0 0.051157351583242416
. O 0 0.04495026916265488

The O 0 0.042513709515333176
two O 0 0.0386122390627861
clinically O 0 0.43313395977020264
unaffected O 0 0.1893131583929062
siblings O 0 0.11272823065519333
carried O 0 0.04947475716471672
the O 0 0.040595803409814835
maternal O 0 0.47353318333625793
mutation O 1 0.8433884382247925
459 O 1 0.9877805709838867
+ O 1 0.9833977222442627
1G O 1 0.9831961393356323
> O 0 0.19346128404140472
A O 0 0.03678276017308235
and O 0 0.014883163385093212
, O 0 0.013170822523534298
on O 0 0.01400927733629942
their O 0 0.0204126238822937
paternal O 0 0.1097925677895546
allele O 0 0.14218901097774506
, O 0 0.02771826647222042
a O 0 0.0328315831720829
novel O 0 0.05912671238183975
cytosine O 0 0.14448852837085724
to O 0 0.04086679592728615
thymidine O 0 0.2191902995109558
transition O 0 0.09838809818029404
at O 0 0.06433159112930298
nucleotide O 0 0.1613890826702118
2435 O 1 0.6783974170684814
in O 0 0.04363507032394409
exon O 0 0.1576806902885437
8 O 0 0.05134681984782219
, O 0 0.024853244423866272
resulting O 0 0.04865438491106033
in O 0 0.024165574461221695
substitution O 0 0.07633651047945023
of O 0 0.029053065925836563
alanine O 0 0.2068367451429367
464 O 0 0.21729640662670135
by O 0 0.05434994772076607
valine O 0 0.2831483781337738
( O 0 0.07737867534160614
A464V O 0 0.20147843658924103
) O 0 0.05569658428430557
. O 0 0.05029764026403427

The O 0 0.06100311875343323
fathers O 0 0.12078854441642761
genotype O 0 0.2622542381286621
thus O 0 0.060518089681863785
was O 0 0.05289033427834511
7delG O 1 0.8525561094284058
/ O 1 0.9548091888427734
A464V O 0 0.21347089111804962
. O 0 0.06522216647863388

Mutation O 0 0.4276297986507416
A464V O 0 0.18822833895683289
was O 0 0.0308777317404747
not O 0 0.01867094449698925
found O 0 0.02643207274377346
in O 0 0.023247316479682922
18 O 0 0.05073336511850357
unrelated O 1 0.6031663417816162
MLD B-Disease 1 0.9999964237213135
patients O 1 0.9983421564102173
and O 0 0.03349627926945686
50 O 0 0.054010242223739624
controls O 0 0.07356925308704376
. O 0 0.05164529010653496

A464V O 0 0.22467100620269775
, O 0 0.03926403447985649
although O 0 0.03799714520573616
clearly O 0 0.06293180584907532
modifying O 0 0.14497746527194977
ARSA O 1 0.9991368651390076
and O 0 0.057858843356370926
GS O 1 0.9999269247055054
levels O 0 0.08706267178058624
, O 0 0.030877958983182907
apparently O 0 0.05586101487278938
bears O 0 0.054836705327034
little O 0 0.03649170324206352
significance O 0 0.038681771606206894
for O 0 0.026941996067762375
clinical O 1 0.8605468273162842
manifestation O 1 0.5840346217155457
of O 0 0.03743714466691017
MLD B-Disease 1 0.9999731779098511
, O 0 0.04445215314626694
mimicking O 0 0.14308200776576996
the O 0 0.0464155487716198
frequent O 0 0.1585293710231781
ARSA O 1 0.99601811170578
pseudodeficiency O 1 0.7808837890625
allele O 0 0.27180132269859314
. O 0 0.07878349721431732

Our O 0 0.04562084749341011
results O 0 0.04411139711737633
demonstrate O 0 0.04604104533791542
that O 0 0.014308911748230457
in O 0 0.01808275282382965
certain O 0 0.038132444024086
genetic O 0 0.14076074957847595
conditions O 1 0.8725544214248657
MLD B-Disease 1 0.999997615814209
- O 1 0.556505560874939
like O 0 0.07107724249362946
ARSA O 1 0.9973894953727722
and O 0 0.05056821554899216
GS O 1 0.9991809725761414
values O 0 0.04673982784152031
need O 0 0.02863675355911255
not O 0 0.013423353433609009
be O 0 0.015942048281431198
paralleled O 0 0.0838535949587822
by O 0 0.03748771548271179
clinical O 1 0.9995167255401611
disease O 1 0.9999552965164185
, O 0 0.023384351283311844
a O 0 0.025351768359541893
finding O 0 0.036439139395952225
with O 0 0.02573486603796482
serious O 0 0.08556925505399704
diagnostic O 0 0.3822941482067108
and O 0 0.039269812405109406
prognostic O 1 0.9861082434654236
implications O 0 0.12226874381303787
. O 0 0.058383509516716

Moreover O 0 0.11509058624505997
, O 0 0.04440127685666084
further O 0 0.06287110596895218
ARSA O 1 0.9902437329292297
alleles O 0 0.24576517939567566
functionally O 0 0.15105040371418
similar O 0 0.048286620527505875
to O 0 0.033063363283872604
A464V O 0 0.13896431028842926
might O 0 0.03653973713517189
exist O 0 0.02174307405948639
which O 0 0.013582787476480007
, O 0 0.01296535599976778
together O 0 0.017378145828843117
with O 0 0.02691618725657463
0 O 0 0.0898013785481453
- O 0 0.16379931569099426
type O 0 0.12193889170885086
mutations O 0 0.1538470983505249
, O 0 0.03395884856581688
may O 0 0.05157606676220894
cause O 1 0.8396220803260803
pathological O 1 0.996590256690979
ARSA O 1 0.9998387098312378
and O 0 0.05260900408029556
GS O 1 0.9999533891677856
levels O 0 0.07389485090970993
, O 0 0.0212230421602726
but O 0 0.018222926184535027
not O 0 0.021404115483164787
clinical O 1 0.9897786974906921
outbreak O 1 0.9585120677947998
of O 0 0.021771211177110672
the O 0 0.035378895699977875
disease O 1 0.999958872795105
. O 0 0.03763299435377121
. O 0 0.04545924812555313

Human O 1 0.7410127520561218
MLH1 O 1 0.99998939037323
deficiency O 1 0.9999997615814209
predisposes O 1 0.9997400641441345
to O 0 0.08208683133125305
hematological B-Disease 1 0.9999436140060425
malignancy I-Disease 1 0.9999624490737915
and O 0 0.07120196521282196
neurofibromatosis B-Disease 1 0.9999836683273315
type I-Disease 0 0.1389055848121643
1 I-Disease 0 0.06486953049898148
. O 0 0.048797618597745895

Heterozygous O 1 0.563560426235199
germ O 1 0.9975071549415588
- O 0 0.16261371970176697
line O 0 0.07272961735725403
mutations O 0 0.12078116089105606
in O 0 0.02470318228006363
the O 0 0.02912641316652298
DNA O 0 0.1223864033818245
mismatch O 1 0.8956155776977539
repair O 1 0.5644354224205017
genes O 0 0.11942772567272186
lead O 0 0.07867202907800674
to O 0 0.047693345695734024
hereditary B-Disease 1 0.9994733929634094
nonpolyposis I-Disease 1 0.9999791383743286
colorectal I-Disease 1 1.0
cancer I-Disease 1 0.9999994039535522
. O 0 0.0945044606924057

The O 0 0.07711856067180634
disease O 1 0.9999768733978271
susceptibility O 1 0.9668917655944824
of O 0 0.02515190839767456
individuals O 0 0.0364563874900341
who O 0 0.03031233325600624
constitutionally O 0 0.059840328991413116
lack O 0 0.04578729346394539
both O 0 0.025600479915738106
wild O 0 0.07678889483213425
- O 0 0.1340905874967575
type O 0 0.11688904464244843
alleles O 0 0.1790308654308319
is O 0 0.03647901862859726
unknown O 0 0.062093336135149
. O 0 0.04828956723213196

We O 0 0.02795405685901642
have O 0 0.017909232527017593
identified O 0 0.02838047780096531
three O 0 0.019670626148581505
offspring O 0 0.07451198250055313
in O 0 0.0253460556268692
a O 0 0.05480457469820976
hereditary B-Disease 1 0.9997778534889221
nonpolyposis I-Disease 1 0.9999850988388062
colorectal I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
family O 0 0.11782580614089966
who O 0 0.05153559893369675
developed O 0 0.20813173055648804
hematological B-Disease 1 0.9999288320541382
malignancy I-Disease 1 0.9997387528419495
at O 0 0.03402170538902283
a O 0 0.023298628628253937
very O 0 0.023275885730981827
early O 0 0.02935151942074299
age O 0 0.033890530467033386
, O 0 0.016164109110832214
and O 0 0.012775390408933163
at O 0 0.016940709203481674
least O 0 0.01617591083049774
two O 0 0.010407430119812489
of O 0 0.010048548690974712
them O 0 0.015810374170541763
displayed O 0 0.04299590364098549
signs O 0 0.06543707847595215
of O 0 0.03981268033385277
neurofibromatosis B-Disease 1 0.9999593496322632
type I-Disease 0 0.15756858885288239
1 I-Disease 0 0.07451469451189041
( O 0 0.07612201571464539
NF1 B-Disease 1 0.9953052997589111
) O 0 0.05412900075316429
. O 0 0.04573329910635948

DNA O 0 0.1360873430967331
sequence O 0 0.07549123466014862
analysis O 0 0.047273773699998856
and O 0 0.030901817604899406
allele O 0 0.17186293005943298
- O 0 0.10120674967765808
specific O 0 0.04609720781445503
amplification O 0 0.1260952204465866
in O 0 0.022715779021382332
two O 0 0.022875139489769936
siblings O 0 0.09519040584564209
revealed O 0 0.06611213088035583
a O 0 0.0575949102640152
homozygous O 0 0.2296694964170456
MLH1 O 1 0.9971976280212402
mutation O 1 0.7561683058738708
( O 0 0.11250676214694977
C676T O 1 0.9858479499816895
- O 1 0.9399080872535706
- O 1 0.6904244422912598
> O 1 0.7524581551551819
Arg226Stop O 1 0.595417857170105
) O 0 0.0644012838602066
. O 0 0.048444218933582306

Thus O 0 0.05332145094871521
, O 0 0.030595654621720314
a O 0 0.046345483511686325
homozygous O 0 0.20504379272460938
germ O 1 0.9990624785423279
- O 0 0.31655827164649963
line O 0 0.10131601989269257
MLH1 O 1 0.9982948899269104
mutation O 1 0.7658342719078064
and O 0 0.048689380288124084
consequent O 1 0.9984439015388489
mismatch O 1 0.9999380111694336
repair O 1 0.9999655485153198
deficiency O 1 0.9999995231628418
results O 0 0.05649809166789055
in O 0 0.026881473138928413
a O 0 0.05305973067879677
mutator O 1 0.9989053010940552
phenotype O 1 0.9976784586906433
characterized O 1 0.9568691849708557
by O 0 0.06105547025799751
leukemia B-Disease 1 0.9999998807907104
and O 0 0.06515680253505707
/ O 1 0.9999567270278931
or O 1 0.790539562702179
lymphoma B-Disease 1 1.0
associated O 0 0.07761722803115845
with O 0 0.05303268879652023
neurofibromatosis B-Disease 1 0.9999651908874512
type I-Disease 0 0.11983198672533035
1 I-Disease 0 0.05023465305566788
. O 0 0.02858053520321846
. O 0 0.046321846544742584

Missense O 1 0.530718982219696
mutations O 0 0.1609240174293518
in O 0 0.023548491299152374
the O 0 0.020100338384509087
most O 0 0.019085928797721863
ancient O 0 0.032874830067157745
residues O 0 0.06493672728538513
of O 0 0.022957641631364822
the O 0 0.039592236280441284
PAX6 O 1 0.9929125905036926
paired O 0 0.14045806229114532
domain O 0 0.08403899520635605
underlie O 0 0.1509338766336441
a O 0 0.04270733892917633
spectrum O 0 0.0841340571641922
of O 0 0.032833680510520935
human O 0 0.38878950476646423
congenital B-Disease 1 0.9999997615814209
eye I-Disease 1 0.999943733215332
malformations I-Disease 1 0.9998866319656372
. O 0 0.07101614028215408

Mutations O 0 0.1717686653137207
of O 0 0.02732645720243454
the O 0 0.033710747957229614
human O 0 0.08010432869195938
PAX6 O 1 0.9995735287666321
gene O 1 0.7264427542686462
underlie O 1 0.9956279993057251
aniridia B-Disease 1 0.9997751116752625
( O 0 0.22729377448558807
congenital B-Disease 1 0.9999854564666748
absence I-Disease 0 0.06172969937324524
of I-Disease 0 0.019166992977261543
the I-Disease 0 0.02658170275390148
iris I-Disease 1 0.8150268197059631
) O 0 0.033248838037252426
, O 0 0.01840834505856037
a O 0 0.03059237450361252
rare O 0 0.07324303686618805
dominant O 0 0.111381396651268
malformation B-Disease 1 0.99793541431427
of I-Disease 0 0.023912211880087852
the I-Disease 0 0.03747185319662094
eye I-Disease 1 0.9455202221870422
. O 0 0.054027196019887924

The O 0 0.05294927582144737
spectrum O 0 0.11082683503627777
of O 0 0.04664202407002449
PAX6 O 1 0.9988077878952026
mutations O 0 0.3649240732192993
in O 0 0.05508049950003624
aniridia B-Disease 1 0.9991114735603333
patients O 1 0.9978044629096985
is O 0 0.03003619983792305
highly O 0 0.03721652925014496
biased O 0 0.05777904763817787
, O 0 0.01772192493081093
with O 0 0.01923229731619358
92 O 0 0.06463469564914703
% O 0 0.02752295695245266
of O 0 0.014436199329793453
all O 0 0.017360355705022812
reported O 0 0.05475247651338577
mutations O 0 0.12882345914840698
leading O 0 0.04600656032562256
to O 0 0.03209947794675827
premature O 0 0.16989271342754364
truncation O 0 0.1238042488694191
of O 0 0.02227829024195671
the O 0 0.032769475132226944
protein O 0 0.10455279797315598
( O 0 0.05595776066184044
nonsense O 0 0.09544821828603745
, O 0 0.0344092883169651
splicing O 0 0.12627452611923218
, O 0 0.0340786837041378
insertions O 0 0.1291678100824356
and O 0 0.029400194063782692
deletions O 0 0.10228627175092697
) O 0 0.03250257298350334
and O 0 0.018721403554081917
just O 0 0.024680685251951218
2 O 0 0.031650610268116
% O 0 0.027053507044911385
leading O 0 0.027820486575365067
to O 0 0.01838514767587185
substitution O 0 0.059355128556489944
of O 0 0.01797540672123432
one O 0 0.028715476393699646
amino O 0 0.08850814402103424
acid O 0 0.1307830959558487
by O 0 0.029346002265810966
another O 0 0.05330215021967888
( O 0 0.06541290879249573
missense O 0 0.19699770212173462
) O 0 0.058187566697597504
. O 0 0.052330173552036285

The O 0 0.039528679102659225
extraordinary O 0 0.06605134904384613
conservation O 0 0.054958537220954895
of O 0 0.020431071519851685
the O 0 0.03310474380850792
PAX6 O 1 0.9812941551208496
protein O 0 0.09683806449174881
at O 0 0.035810377448797226
the O 0 0.028833629563450813
amino O 0 0.09948853403329849
acid O 0 0.15635086596012115
level O 0 0.057306237518787384
amongst O 0 0.055101100355386734
vertebrates O 0 0.11026804149150848
predicts O 0 0.13081134855747223
that O 0 0.04393623396754265
pathological O 1 0.902073323726654
missense O 1 0.7066246271133423
mutations O 0 0.16352440416812897
should O 0 0.025801746174693108
in O 0 0.019222671166062355
fact O 0 0.0243166945874691
be O 0 0.013486280106008053
common O 0 0.029671017080545425
even O 0 0.020710423588752747
though O 0 0.018793171271681786
they O 0 0.013407493010163307
are O 0 0.014819285832345486
hardly O 0 0.048888035118579865
ever O 0 0.03414726257324219
seen O 0 0.03901750594377518
in O 0 0.04025961458683014
aniridia B-Disease 1 0.9994674324989319
patients O 1 0.9993725419044495
. O 0 0.05677909776568413

This O 0 0.03646654635667801
indicates O 0 0.05586462467908859
that O 0 0.015931041911244392
there O 0 0.016747018322348595
is O 0 0.01869235187768936
a O 0 0.03235284239053726
heavy O 0 0.08901841938495636
ascertainment O 1 0.9135822057723999
bias O 0 0.0869256779551506
in O 0 0.018357709050178528
the O 0 0.01853584684431553
selection O 0 0.03451165184378624
of O 0 0.02486114203929901
patients O 1 0.9969921112060547
for O 0 0.04196775704622269
PAX6 O 1 0.9987457990646362
mutation O 0 0.19981908798217773
analysis O 0 0.04520723223686218
and O 0 0.01680583693087101
that O 0 0.01553106028586626
the O 0 0.028500879183411598
missing O 0 0.11120564490556717
PAX6 O 1 0.998176097869873
missense O 1 0.9031659364700317
mutations O 0 0.27301308512687683
frequently O 0 0.08940443396568298
may O 0 0.06782885640859604
underlie O 1 0.7968997955322266
phenotypes O 0 0.3174574077129364
distinct O 0 0.07044967263936996
from O 0 0.04674288257956505
textbook O 0 0.14763487875461578
aniridia B-Disease 1 0.9758405089378357
. O 0 0.07517188787460327

Here O 0 0.04066190868616104
we O 0 0.022813161835074425
present O 0 0.027852453291416168
four O 0 0.03473309800028801
novel O 0 0.09042821824550629
PAX6 O 1 0.9974231719970703
missense O 1 0.6097566485404968
mutations O 0 0.15417684614658356
, O 0 0.02246425673365593
two O 0 0.016528021544218063
in O 0 0.020078396424651146
association O 0 0.0586811900138855
with O 0 0.04171754792332649
atypical O 1 0.9986818432807922
phenotypes O 1 0.9770958423614502
ectopia B-Disease 1 0.9792500138282776
pupillae I-Disease 1 0.9131786823272705
( O 0 0.06635073572397232
displaced B-Disease 0 0.10781192034482956
pupils I-Disease 0 0.10758379846811295
) O 0 0.056440938264131546
and O 0 0.04741913080215454
congenital B-Disease 1 0.9999992847442627
nystagmus I-Disease 1 0.9999207258224487
( O 0 0.07289063185453415
searching B-Disease 0 0.08376593887805939
gaze I-Disease 0 0.13355818390846252
) O 0 0.030671831220388412
, O 0 0.01460960041731596
and O 0 0.011276728473603725
two O 0 0.01129285991191864
in O 0 0.015419455245137215
association O 0 0.0388176366686821
with O 0 0.02165197767317295
more O 0 0.028451237827539444
recognizable O 0 0.129457488656044
aniridia B-Disease 1 0.9891285300254822
phenotypes O 0 0.428986519575119
. O 0 0.07757079601287842

Strikingly O 0 0.12405649572610855
, O 0 0.0252819936722517
all O 0 0.01570749655365944
four O 0 0.02860715240240097
mutations O 0 0.09571027755737305
are O 0 0.01562399510294199
located O 0 0.030993109568953514
within O 0 0.026746978983283043
the O 0 0.0372268483042717
PAX6 O 1 0.9784926772117615
paired O 0 0.13120916485786438
domain O 0 0.066398486495018
and O 0 0.029314236715435982
affect O 0 0.07247039675712585
amino O 0 0.08740993589162827
acids O 0 0.06910146027803421
which O 0 0.017977450042963028
are O 0 0.01348623726516962
highly O 0 0.03083333931863308
conserved O 0 0.037316881120204926
in O 0 0.016094693914055824
all O 0 0.016188671812415123
known O 0 0.03923909738659859
paired O 0 0.10134117305278778
domain O 0 0.07893975079059601
proteins O 0 0.08843374997377396
. O 0 0.05309551581740379

Our O 0 0.0464312843978405
results O 0 0.040066253393888474
support O 0 0.027925608679652214
the O 0 0.018649239093065262
hypothesis O 0 0.05634959414601326
that O 0 0.012408887967467308
the O 0 0.014226000756025314
under O 0 0.02305048704147339
- O 0 0.06485837697982788
representation O 0 0.04040088132023811
of O 0 0.03272852674126625
missense O 0 0.41767749190330505
mutations O 0 0.20178963243961334
is O 0 0.038182493299245834
caused O 0 0.09271388500928879
by O 0 0.04075218737125397
ascertainment O 1 0.9423070549964905
bias O 0 0.10674381256103516
and O 0 0.024390602484345436
suggest O 0 0.036664992570877075
that O 0 0.013990899547934532
a O 0 0.026121459901332855
substantial O 0 0.05424850806593895
burden O 0 0.12087560445070267
of O 0 0.04578229412436485
PAX6 B-Disease 1 0.9999943971633911
- I-Disease 1 0.9962772727012634
related I-Disease 1 0.540398120880127
disease I-Disease 1 0.9999681711196899
remains O 0 0.03706265240907669
to O 0 0.01769770309329033
be O 0 0.019409172236919403
uncovered O 0 0.07409598678350449
. O 0 0.02969370409846306
. O 0 0.043220095336437225

The O 0 0.049105849117040634
chromosomal O 0 0.15806983411312103
order O 0 0.029099181294441223
of O 0 0.02302616462111473
genes O 0 0.0835513323545456
controlling O 0 0.08207213878631592
the O 0 0.030578305944800377
major O 0 0.05858195200562477
histocompatibility O 1 0.9961274266242981
complex O 0 0.07660898566246033
, O 0 0.0399957075715065
properdin O 1 0.7905598282814026
factor O 0 0.10969915986061096
B O 0 0.13081324100494385
, O 0 0.02468869835138321
and O 0 0.0258046705275774
deficiency B-Disease 1 0.9999481439590454
of I-Disease 0 0.01579468324780464
the I-Disease 0 0.017417242750525475
second I-Disease 0 0.030644932761788368
component I-Disease 0 0.05787336453795433
of I-Disease 0 0.025794150307774544
complement I-Disease 0 0.09562069922685623
. O 0 0.05290357768535614

The O 0 0.03423546999692917
relationship O 0 0.04535853490233421
of O 0 0.016000984236598015
the O 0 0.0259093064814806
genes O 0 0.0924205332994461
coding O 0 0.13340896368026733
for O 0 0.03575190529227257
HLA O 1 0.9856717586517334
to O 0 0.02619047649204731
those O 0 0.028199193999171257
coding O 0 0.11626558005809784
for O 0 0.03693107143044472
properdin O 0 0.4833381474018097
Factor O 0 0.12438057363033295
B O 0 0.16410242021083832
allotypes O 0 0.1850937157869339
and O 0 0.022577349096536636
for O 0 0.027811488136649132
deficiency B-Disease 1 0.9999111890792847
of I-Disease 0 0.017609931528568268
the I-Disease 0 0.01744147017598152
second I-Disease 0 0.03232137858867645
component I-Disease 0 0.05593287944793701
of I-Disease 0 0.02507856860756874
complement I-Disease 0 0.09350749105215073
( O 0 0.07125986367464066
C2 O 1 0.9976661205291748
) O 0 0.038266461342573166
was O 0 0.02123972773551941
studied O 0 0.029884684830904007
in O 0 0.017047761008143425
families O 0 0.03636996075510979
of O 0 0.02671111933887005
patients O 1 0.9999276399612427
with O 0 0.06224506348371506
connective O 1 0.999992847442627
tissue O 1 0.9999802112579346
disorders O 1 0.9999970197677612
. O 0 0.06280212104320526

Patients O 1 0.9891931414604187
were O 0 0.02222169190645218
selected O 0 0.026997035369277
because O 0 0.020534897223114967
they O 0 0.013929108157753944
were O 0 0.02012282982468605
heterozygous O 0 0.11494211107492447
or O 0 0.04714982211589813
homozygous O 0 0.17013144493103027
for O 0 0.08309005945920944
C2 B-Disease 1 0.9999998807907104
deficiency I-Disease 1 0.9999998807907104
. O 0 0.0839109867811203

12 O 0 0.05763912945985794
families O 0 0.048983894288539886
with O 0 0.031615160405635834
15 O 0 0.05314836651086807
matings O 0 0.2382238805294037
informative O 0 0.11825587600469589
for O 0 0.061502933502197266
C2 B-Disease 1 0.9999997615814209
deficiency I-Disease 1 0.9999995231628418
were O 0 0.04058929532766342
found O 0 0.047650422900915146
. O 0 0.04749291390180588

Of O 0 0.045266591012477875
57 O 0 0.09806126356124878
informative O 0 0.10546240955591202
meioses O 0 0.15599992871284485
, O 0 0.026527009904384613
two O 0 0.02076365239918232
crossovers O 0 0.07584507018327713
were O 0 0.01764557883143425
noted O 0 0.029073147103190422
between O 0 0.033530037850141525
the O 0 0.052372679114341736
C2 B-Disease 1 0.9999997615814209
deficiency I-Disease 1 0.9999998807907104
gene O 0 0.16350236535072327
and O 0 0.030007870867848396
the O 0 0.043083976954221725
HLA O 1 0.9999604225158691
- O 1 0.5067154169082642
B O 0 0.19058102369308472
gene O 0 0.09526289254426956
, O 0 0.020402338355779648
with O 0 0.01928105391561985
a O 0 0.03252989426255226
recombinant O 0 0.1352997124195099
fraction O 0 0.07019271701574326
of O 0 0.028154227882623672
0 O 0 0.08962424099445343
. O 0 0.051215119659900665

035 O 1 0.8932632207870483
. O 0 0.09673743695020676

A O 0 0.10581032931804657
lod O 0 0.2296798974275589
score O 0 0.03894907981157303
of O 0 0.015612419694662094
13 O 0 0.030196407809853554
was O 0 0.023308711126446724
calculated O 0 0.04755830392241478
for O 0 0.0292770154774189
linkage O 0 0.4350191652774811
between O 0 0.10112495720386505
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 0.09538163989782333
HLA O 1 0.9999780654907227
- O 0 0.23428508639335632
B O 0 0.1281948834657669
at O 0 0.0324716679751873
a O 0 0.027037516236305237
maximum O 0 0.0396382212638855
likelihood O 0 0.06354331970214844
value O 0 0.018532492220401764
of O 0 0.013075885362923145
the O 0 0.02187328226864338
recombinant O 0 0.1343245506286621
fraction O 0 0.07438408583402634
of O 0 0.033331237733364105
0 O 0 0.0894918143749237
. O 0 0.046157680451869965

04 O 1 0.7428889870643616
. O 0 0.08254717290401459

18 O 0 0.06333374977111816
families O 0 0.04881436750292778
with O 0 0.027704108506441116
21 O 0 0.046789225190877914
informative O 0 0.08217479288578033
matings O 0 0.15827025473117828
for O 0 0.0317695252597332
both O 0 0.034411318600177765
properdin O 0 0.40330207347869873
Factor O 0 0.13543395698070526
B O 0 0.28973308205604553
allotype O 1 0.8419054746627808
and O 0 0.04813346639275551
HLA O 1 0.9997890591621399
- O 0 0.15579870343208313
B O 0 0.12150754034519196
were O 0 0.023532675579190254
found O 0 0.03777926415205002
. O 0 0.04115888848900795

Of O 0 0.04714950546622276
72 O 0 0.11219768971204758
informative O 0 0.1066618338227272
meioses O 0 0.16848403215408325
, O 0 0.029380980879068375
three O 0 0.025764746591448784
recombinants O 0 0.11666926741600037
were O 0 0.0187652800232172
found O 0 0.025235772132873535
, O 0 0.01743297465145588
giving O 0 0.036032725125551224
a O 0 0.03601861000061035
recombinant O 0 0.13559043407440186
fraction O 0 0.07427684962749481
of O 0 0.030486030504107475
0 O 0 0.09428483992815018
. O 0 0.049576692283153534

042 O 0 0.3678586781024933
. O 0 0.0915365070104599

A O 0 0.09842842072248459
lod O 0 0.22401627898216248
score O 0 0.041163500398397446
of O 0 0.021390192210674286
16 O 0 0.04328903183341026
between O 0 0.05095129832625389
HLA O 1 0.9997157454490662
- O 0 0.16794732213020325
B O 0 0.14582699537277222
and O 0 0.03908420726656914
Factor O 0 0.11576126515865326
B O 0 0.15825243294239044
allotypes O 0 0.1510881632566452
was O 0 0.032773200422525406
calculated O 0 0.04444165527820587
at O 0 0.023832088336348534
a O 0 0.02351151406764984
maximum O 0 0.04248710721731186
likelihood O 0 0.05895913019776344
value O 0 0.018792513757944107
of O 0 0.013355688191950321
the O 0 0.02433151751756668
recombinant O 0 0.12980391085147858
fraction O 0 0.06925110518932343
of O 0 0.029124470427632332
0 O 0 0.08939415216445923
. O 0 0.050030678510665894

04 O 1 0.8954837322235107
. O 0 0.09292531758546829

A O 0 0.06611713767051697
crossover O 0 0.08832844346761703
was O 0 0.02664041332900524
shown O 0 0.02984820120036602
to O 0 0.015372715890407562
have O 0 0.017868852242827415
occurred O 0 0.03903432935476303
between O 0 0.023618316277861595
genes O 0 0.06724246591329575
for O 0 0.030408842489123344
Factor O 0 0.09798002988100052
B O 0 0.2088375836610794
and O 0 0.04446202516555786
HLA O 1 0.9999175071716309
- O 0 0.29617685079574585
D O 0 0.32425493001937866
, O 0 0.02746855653822422
in O 0 0.026541946455836296
which O 0 0.04379222169518471
HLA O 1 0.9999276399612427
- O 1 0.8620666861534119
D O 1 0.9802600741386414
segregared O 1 0.7974148392677307
with O 0 0.06340034306049347
HLA O 1 0.9996009469032288
- O 0 0.12804901599884033
A O 0 0.054008014500141144
and O 0 0.037404146045446396
B O 0 0.15141437947750092
. O 0 0.05329896882176399

These O 0 0.03329157456755638
studies O 0 0.04408399760723114
suggest O 0 0.034569866955280304
that O 0 0.013858550228178501
the O 0 0.019243339076638222
genes O 0 0.06560637056827545
for O 0 0.030093474313616753
Factor O 0 0.12085860222578049
B O 1 0.8601991534233093
and O 0 0.06762760132551193
C2 B-Disease 1 0.9999996423721313
deficiency I-Disease 1 0.9999990463256836
are O 0 0.028225211426615715
located O 0 0.0316932238638401
outside O 0 0.025146137923002243
those O 0 0.01619994454085827
for O 0 0.022306015715003014
HLA O 1 0.9948098659515381
, O 0 0.017179641872644424
that O 0 0.010872897692024708
the O 0 0.013884113170206547
order O 0 0.020913545042276382
of O 0 0.020799214020371437
genese O 0 0.36885377764701843
is O 0 0.05309845507144928
HLA O 1 0.9996104836463928
- O 0 0.11268828064203262
A O 0 0.051015473902225494
, O 0 0.033379554748535156
- O 0 0.12038382887840271
B O 0 0.13296519219875336
, O 0 0.0405917763710022
- O 0 0.19095349311828613
D O 1 0.7724133729934692
, O 0 0.04650885611772537
Factor O 0 0.11917664855718613
B O 1 0.78989177942276
allotype O 1 0.993723452091217
, O 0 0.1616634875535965
C2 B-Disease 1 0.9999997615814209
deficiency I-Disease 1 0.9999997615814209
, O 0 0.028869282454252243
that O 0 0.017624126747250557
the O 0 0.026653088629245758
genes O 0 0.09921687096357346
coding O 0 0.1727447509765625
for O 0 0.064755380153656
C2 B-Disease 1 0.9999998807907104
deficiency I-Disease 1 0.9999997615814209
and O 0 0.0510326512157917
Factor O 0 0.11761045455932617
B O 0 0.1519237905740738
allotypes O 0 0.14319203794002533
are O 0 0.020705733448266983
approximately O 0 0.037263549864292145
3 O 0 0.04675368219614029
- O 0 0.10587689280509949
- O 0 0.1037941575050354
5 O 0 0.058961011469364166
centimorgans O 0 0.13913732767105103
from O 0 0.029664594680070877
the O 0 0.03742809221148491
HLA O 1 0.9997530579566956
- O 0 0.1281050592660904
A O 0 0.054145246744155884
and O 0 0.04807286337018013
HLA O 1 0.9998937845230103
- O 0 0.39158540964126587
B O 0 0.20341530442237854
loci O 0 0.15474620461463928
, O 0 0.020580826327204704
and O 0 0.012986340560019016
that O 0 0.012369201518595219
the O 0 0.0182653795927763
apparent O 0 0.06032475084066391
lack O 0 0.03758735954761505
of O 0 0.019219214096665382
recombinants O 0 0.12008610367774963
between O 0 0.027705704793334007
the O 0 0.03064686246216297
Factor O 0 0.1249905452132225
B O 1 0.8355340361595154
gene O 0 0.23913069069385529
and O 0 0.08580154180526733
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 0.3168677091598511
suggests O 0 0.059331733733415604
that O 0 0.014591830782592297
these O 0 0.011458314955234528
two O 0 0.017714332789182663
genes O 0 0.06350229680538177
lie O 0 0.048972196877002716
in O 0 0.019765757024288177
close O 0 0.03372010961174965
proximity O 0 0.04932105168700218
to O 0 0.017299560829997063
one O 0 0.020479870960116386
another O 0 0.035423919558525085
. O 0 0.045468769967556

Distribution O 0 0.06557456403970718
of O 0 0.03288909047842026
emerin O 0 0.17427287995815277
and O 0 0.0342092365026474
lamins O 1 0.8038482069969177
in O 0 0.028149805963039398
the O 0 0.027329042553901672
heart O 1 0.5661963820457458
and O 0 0.021190209314227104
implications O 0 0.07160545885562897
for O 0 0.03433451056480408
Emery B-Disease 1 0.999432384967804
- I-Disease 1 0.9991804957389832
Dreifuss I-Disease 1 0.9999855756759644
muscular I-Disease 1 0.999997615814209
dystrophy I-Disease 1 0.9999991655349731
. O 0 0.09613572806119919

Emerin O 0 0.2337253838777542
is O 0 0.03945755213499069
a O 0 0.03811532258987427
nuclear O 0 0.06735862046480179
membrane O 0 0.10609883069992065
protein O 0 0.07483543455600739
which O 0 0.021215712651610374
is O 0 0.02352786250412464
missing O 0 0.053799107670784
or O 0 0.0404704287648201
defective O 1 0.5414963960647583
in O 0 0.04892409220337868
Emery B-Disease 1 0.9983371496200562
- I-Disease 1 0.9979350566864014
Dreifuss I-Disease 1 0.9999659061431885
muscular I-Disease 1 0.9999985694885254
dystrophy I-Disease 1 0.9999997615814209
( O 1 0.5296525955200195
EDMD B-Disease 1 0.9996516704559326
) O 0 0.0664776861667633
. O 0 0.05171772465109825

It O 0 0.025914601981639862
is O 0 0.01698540337383747
one O 0 0.014845959842205048
member O 0 0.021012308076024055
of O 0 0.013661235570907593
a O 0 0.02561991475522518
family O 0 0.03745874762535095
of O 0 0.030191805213689804
lamina O 1 0.9991132616996765
- O 0 0.11063581705093384
associated O 0 0.05207270756363869
proteins O 0 0.05498303845524788
which O 0 0.02217555046081543
includes O 0 0.04260782524943352
LAP1 O 1 0.6067249178886414
, O 0 0.03917738050222397
LAP2 O 1 0.7877466082572937
and O 0 0.046221617609262466
lamin O 1 0.9824233055114746
B O 1 0.8917152881622314
receptor O 1 0.9186804294586182
( O 0 0.10598690807819366
LBR O 1 0.9991528987884521
) O 0 0.06613220274448395
. O 0 0.05049930512905121

A O 0 0.05976187437772751
panel O 0 0.05729582533240318
of O 0 0.02831955999135971
16 O 0 0.06950557231903076
monoclonal O 1 0.9019905924797058
antibodies O 1 0.8447743654251099
( O 0 0.08619760721921921
mAbs O 1 0.9146981239318848
) O 0 0.03778338059782982
has O 0 0.01922174170613289
been O 0 0.01627601869404316
mapped O 0 0.041217077523469925
to O 0 0.014007775112986565
six O 0 0.020505327731370926
specific O 0 0.023575428873300552
sites O 0 0.025413192808628082
throughout O 0 0.027307141572237015
the O 0 0.027347112074494362
emerin O 0 0.18816706538200378
molecule O 0 0.12795154750347137
using O 0 0.05866432562470436
phage O 1 0.9965782761573792
- O 0 0.1131075769662857
displayed O 0 0.062163155525922775
peptide O 0 0.13595767319202423
libraries O 0 0.04296921566128731
and O 0 0.014707840979099274
has O 0 0.016248760744929314
been O 0 0.015924232080578804
used O 0 0.021585291251540184
to O 0 0.025416351854801178
localize O 0 0.1755889356136322
emerin O 0 0.15191933512687683
in O 0 0.0276184044778347
human O 0 0.040618348866701126
and O 0 0.0319887138903141
rabbit O 1 0.9855696558952332
heart O 1 0.9891603589057922
. O 0 0.057208266109228134

Several O 0 0.06078337877988815
mAbs O 1 0.5695702433586121
against O 0 0.0449872687458992
different O 0 0.037848226726055145
emerin O 0 0.41261300444602966
epitopes O 0 0.2864401340484619
did O 0 0.036905936896800995
not O 0 0.02273235097527504
recognize O 0 0.06365830451250076
intercalated O 0 0.29345887899398804
discs O 0 0.07728852331638336
in O 0 0.02345174551010132
the O 0 0.027075430378317833
heart O 1 0.6692175269126892
, O 0 0.020466841757297516
though O 0 0.02265116758644581
they O 0 0.016759855672717094
recognized O 0 0.04505239054560661
cardiomyocyte O 0 0.18460728228092194
nuclei O 0 0.10936170071363449
strongly O 0 0.039549022912979126
, O 0 0.014558477327227592
both O 0 0.013127744197845459
at O 0 0.01876254566013813
the O 0 0.018672358244657516
rim O 0 0.08727665990591049
and O 0 0.0201555248349905
in O 0 0.02700778655707836
intranuclear O 0 0.15931332111358643
spots O 0 0.08915679156780243
or O 0 0.03829455003142357
channels O 0 0.07030893117189407
. O 0 0.04393334686756134

A O 0 0.13063949346542358
polyclonal O 1 0.9770212769508362
rabbit O 1 0.9647379517555237
antiserum O 1 0.9401999711990356
against O 0 0.06788595765829086
emerin O 0 0.23141081631183624
did O 0 0.03747951239347458
recognize O 0 0.04644947499036789
both O 0 0.022795530036091805
nuclear O 0 0.05515436455607414
membrane O 0 0.09026314318180084
and O 0 0.027151037007570267
intercalated O 1 0.5701825618743896
discs O 0 0.07559145241975784
but O 0 0.019551200792193413
, O 0 0.020420290529727936
after O 0 0.035728491842746735
affinity O 0 0.106904037296772
purification O 0 0.10170518606901169
against O 0 0.03549942374229431
a O 0 0.0385848805308342
pure O 0 0.07188498228788376
- O 0 0.11899726092815399
emerin O 0 0.157291978597641
band O 0 0.05106351897120476
on O 0 0.017832186073064804
a O 0 0.025890078395605087
western O 0 0.046050261706113815
blot O 0 0.1502981036901474
, O 0 0.022716127336025238
it O 0 0.019693691283464432
stained O 0 0.10287881642580032
only O 0 0.0190429650247097
the O 0 0.02528795786201954
nuclear O 0 0.07408960163593292
membrane O 0 0.1295691430568695
. O 0 0.056965816766023636

These O 0 0.03189535811543465
results O 0 0.038847267627716064
would O 0 0.015668250620365143
not O 0 0.013168813660740852
be O 0 0.013262237422168255
expected O 0 0.022407425567507744
if O 0 0.02826884016394615
immunostaining O 0 0.1531345248222351
at O 0 0.038805264979600906
intercalated O 0 0.2787069082260132
discs O 0 0.05935116857290268
were O 0 0.014947008341550827
due O 0 0.023270823061466217
to O 0 0.012458713725209236
a O 0 0.019231202080845833
product O 0 0.027437282726168633
of O 0 0.01687365025281906
the O 0 0.02776309847831726
emerin O 1 0.5872759222984314
gene O 0 0.08845923840999603
and O 0 0.016098063439130783
, O 0 0.01666727475821972
therefore O 0 0.02007998526096344
, O 0 0.015184200368821621
cast O 0 0.0228149201720953
some O 0 0.01493810210376978
doubt O 0 0.03432713821530342
upon O 0 0.021698815748095512
the O 0 0.02574014477431774
hypothesis O 0 0.09878985583782196
that O 0 0.04249514639377594
cardiac B-Disease 1 0.9999953508377075
defects I-Disease 1 0.9987878203392029
in O 0 0.038896095007658005
EDMD B-Disease 1 0.9985116124153137
are O 0 0.025871209800243378
caused O 0 0.06944034993648529
by O 0 0.024484338238835335
absence O 0 0.05371648073196411
of O 0 0.02713995799422264
emerin O 0 0.17704835534095764
from O 0 0.04523288831114769
intercalated O 1 0.7939179539680481
discs O 0 0.1245732381939888
. O 0 0.06203766539692879

Although O 0 0.06541961431503296
emerin O 0 0.1630481630563736
was O 0 0.03229241818189621
abundant O 0 0.04120597243309021
in O 0 0.01930798776447773
the O 0 0.02116663195192814
membranes O 0 0.1018005758523941
of O 0 0.027749480679631233
cardiomyocyte O 0 0.3642010986804962
nuclei O 0 0.10100863873958588
, O 0 0.020508596673607826
it O 0 0.015539622865617275
was O 0 0.020227182656526566
absent O 0 0.05139492079615593
from O 0 0.019255537539720535
many O 0 0.019395526498556137
non O 0 0.06865250319242477
- O 0 0.45774516463279724
myocyte O 1 0.9942573308944702
cells O 0 0.12293461710214615
in O 0 0.029849717393517494
the O 0 0.038432661443948746
heart O 1 0.9522340893745422
. O 0 0.054694127291440964

This O 0 0.028524206951260567
distribution O 0 0.033623263239860535
of O 0 0.02048931084573269
emerin O 0 0.13176332414150238
was O 0 0.021307457238435745
similar O 0 0.0227036289870739
to O 0 0.01354180183261633
that O 0 0.013381046243011951
of O 0 0.01991761289536953
lamin O 0 0.2543727457523346
A O 0 0.03774005547165871
, O 0 0.020112542435526848
a O 0 0.025580542162060738
candidate O 0 0.04054630920290947
gene O 0 0.07910020649433136
for O 0 0.021985698491334915
an O 0 0.03335151821374893
autosomal O 1 0.9496952891349792
form O 0 0.05638384073972702
of O 0 0.0383613146841526
EDMD B-Disease 1 0.9983843564987183
. O 0 0.06453365832567215

In O 0 0.05679653584957123
contrast O 0 0.09463303536176682
, O 0 0.05697999894618988
lamin O 1 0.9965131878852844
B1 O 1 0.9996850490570068
was O 0 0.05160577595233917
absent O 0 0.08904243260622025
from O 0 0.04107788950204849
cardiomyocyte O 1 0.5125260353088379
nuclei O 0 0.12657082080841064
, O 0 0.03236373886466026
showing O 0 0.06026909127831459
that O 0 0.045381903648376465
lamin O 1 0.9955294728279114
B1 O 1 0.9996156692504883
is O 0 0.026685431599617004
not O 0 0.015202677808701992
essential O 0 0.02851070463657379
for O 0 0.01704562082886696
localization O 0 0.06630491465330124
of O 0 0.017721975222229958
emerin O 0 0.11081743240356445
to O 0 0.021592848002910614
the O 0 0.030022628605365753
nuclear O 0 0.09469091892242432
lamina O 1 0.9830968379974365
. O 0 0.06410815566778183

Lamin O 1 0.9946817755699158
B1 O 1 0.9991580247879028
is O 0 0.04014482721686363
also O 0 0.025057313963770866
almost O 0 0.03151599317789078
completely O 0 0.05096108466386795
absent O 0 0.08575909584760666
from O 0 0.05287116765975952
skeletal O 1 0.9984846711158752
muscle O 1 0.9993170499801636
nuclei O 0 0.2840346097946167
. O 0 0.06082834675908089

In O 0 0.05481633171439171
EDMD B-Disease 1 0.9744887948036194
, O 0 0.022644707933068275
the O 0 0.016256948933005333
additional O 0 0.03160139173269272
absence O 0 0.05911305174231529
of O 0 0.03680851310491562
lamin O 1 0.9978353381156921
B1 O 1 0.9999686479568481
from O 0 0.06120605021715164
heart O 1 0.9979064464569092
and O 0 0.04128750041127205
skeletal O 1 0.9997023940086365
muscle O 1 0.9994719624519348
nuclei O 0 0.15652912855148315
which O 0 0.027541175484657288
already O 0 0.03691181167960167
lack O 0 0.05492803081870079
emerin O 1 0.5737443566322327
may O 0 0.033663634210824966
offer O 0 0.0297760721296072
an O 0 0.018540214747190475
alternative O 0 0.04097189009189606
explanation O 0 0.03863522410392761
of O 0 0.015586156398057938
why O 0 0.030599186196923256
these O 0 0.01824135147035122
tissues O 0 0.08546949923038483
are O 0 0.019226515665650368
particularly O 0 0.04037411883473396
affected O 0 0.06869063526391983
. O 0 0.02938988246023655
. O 0 0.04054507985711098

Genetic O 0 0.16179394721984863
mapping O 0 0.08758266270160675
of O 0 0.02610785886645317
the O 0 0.04278663918375969
copper B-Disease 0 0.40525901317596436
toxicosis I-Disease 1 0.9965903759002686
locus O 0 0.21601031720638275
in O 0 0.05636180564761162
Bedlington O 1 0.977006733417511
terriers O 0 0.29533568024635315
to O 0 0.043498117476701736
dog O 0 0.13637606799602509
chromosome O 0 0.1442231684923172
10 O 0 0.025839464738965034
, O 0 0.013720602728426456
in O 0 0.014370557852089405
a O 0 0.025361137464642525
region O 0 0.05154319480061531
syntenic O 0 0.13295283913612366
to O 0 0.025189079344272614
human O 0 0.051832158118486404
chromosome O 0 0.18184794485569
region O 0 0.09828352928161621
2p13 O 1 0.8687329888343811
- O 0 0.21735869348049164
p16 O 1 0.8854276537895203
. O 0 0.0765012800693512

Abnormal O 1 0.9996984004974365
hepatic B-Disease 1 0.9999974966049194
copper I-Disease 1 0.9572628140449524
accumulation I-Disease 0 0.322214812040329
is O 0 0.03073217160999775
recognized O 0 0.03471366688609123
as O 0 0.023019535467028618
an O 0 0.040246784687042236
inherited B-Disease 1 0.9999066591262817
disorder I-Disease 1 0.999998927116394
in O 0 0.035001855343580246
man O 0 0.0549054853618145
, O 0 0.02869660221040249
mouse O 0 0.133944571018219
, O 0 0.04138488695025444
rat O 1 0.7657918930053711
and O 0 0.037115324288606644
dog O 0 0.13639433681964874
. O 0 0.060879047960042953

The O 0 0.043039001524448395
major O 0 0.05751671642065048
cause O 0 0.15505428612232208
of O 0 0.042408205568790436
hepatic B-Disease 1 0.999996542930603
copper I-Disease 1 0.9608331918716431
accumulation I-Disease 0 0.39649906754493713
in O 0 0.025715438649058342
man O 0 0.04632241278886795
is O 0 0.02729925699532032
a O 0 0.0449487678706646
dysfunctional O 1 0.979487955570221
ATP7B O 1 0.9950370192527771
gene O 0 0.1703854501247406
, O 0 0.04892740771174431
causing O 1 0.9855286478996277
Wilson B-Disease 1 0.9971321821212769
disease I-Disease 1 0.999996542930603
( O 1 0.5017529726028442
WD B-Disease 1 0.9999237060546875
) O 0 0.06600067019462585
. O 0 0.050345130264759064

Mutations O 0 0.18865209817886353
in O 0 0.03173483908176422
the O 0 0.03451930359005928
ATP7B O 1 0.6722468137741089
genes O 0 0.07870066910982132
have O 0 0.01982204057276249
also O 0 0.017815059050917625
been O 0 0.02036861889064312
demonstrated O 0 0.05001870170235634
in O 0 0.029503850266337395
mouse O 0 0.1381075233221054
and O 0 0.04022441804409027
rat O 1 0.8794983625411987
. O 0 0.06341023743152618

The O 0 0.06502294540405273
ATP7B O 1 0.8072054982185364
gene O 0 0.11284226924180984
has O 0 0.02545282617211342
been O 0 0.02018224447965622
excluded O 0 0.04094359278678894
in O 0 0.013850224204361439
the O 0 0.01778736338019371
much O 0 0.03498706594109535
rarer O 1 0.7106564044952393
human O 0 0.07271748781204224
copper B-Disease 1 0.9992179870605469
overload I-Disease 1 0.9999842643737793
disease O 1 0.9999958276748657
non B-Disease 0 0.15076938271522522
- I-Disease 0 0.23789773881435394
Indian I-Disease 0 0.09927352517843246
childhood I-Disease 1 0.9959660768508911
cirrhosis I-Disease 1 0.9999072551727295
, O 0 0.05203041434288025
indicating O 0 0.10908075422048569
genetic O 0 0.14275319874286652
heterogeneity O 0 0.19936423003673553
. O 0 0.06341993808746338

By O 0 0.044881243258714676
investigating O 0 0.07575123757123947
the O 0 0.03731714189052582
common O 0 0.08978704363107681
autosomal O 1 0.9998251795768738
recessive O 1 0.9998780488967896
copper B-Disease 1 0.9991264939308167
toxicosis I-Disease 1 0.9999710321426392
( O 0 0.19942842423915863
CT B-Disease 1 0.9997971653938293
) O 0 0.05454227328300476
in O 0 0.03784225508570671
Bedlington O 1 0.9892365336418152
terriers O 0 0.4105198085308075
, O 0 0.02578643150627613
we O 0 0.015614069998264313
have O 0 0.013842985033988953
identified O 0 0.028855696320533752
a O 0 0.024525420740246773
new O 0 0.03010612726211548
locus O 0 0.13203175365924835
involved O 0 0.05080330744385719
in O 0 0.04294333979487419
progressive O 1 0.9994391798973083
liver B-Disease 1 1.0
disease I-Disease 1 0.9999995231628418
. O 0 0.07660440355539322

We O 0 0.044967588037252426
examined O 0 0.07825076580047607
whether O 0 0.04111596569418907
the O 0 0.04561534896492958
WD B-Disease 1 0.9996066689491272
gene O 0 0.16762347519397736
ATP7B O 0 0.46610206365585327
was O 0 0.031961869448423386
also O 0 0.026166075840592384
causative O 0 0.15782597661018372
for O 0 0.030654426664114
CT B-Disease 1 0.9965440630912781
by O 0 0.026267189532518387
investigating O 0 0.0563884973526001
the O 0 0.0346795879304409
chromosomal O 1 0.5963606238365173
co O 0 0.2770736813545227
- O 0 0.12581442296504974
localization O 0 0.11761463433504105
of O 0 0.02901611477136612
ATP7B O 0 0.487735778093338
and O 0 0.032615989446640015
C04107 O 0 0.1363115906715393
, O 0 0.028201153501868248
using O 0 0.03706895560026169
fluorescence O 0 0.15108373761177063
in O 0 0.04200214892625809
situ O 0 0.19179421663284302
hybridization O 0 0.15446408092975616
( O 0 0.05635540559887886
FISH O 0 0.06995915621519089
) O 0 0.045582689344882965
. O 0 0.043727315962314606

C04107 O 0 0.2139960378408432
is O 0 0.03972027450799942
an O 0 0.03317355364561081
anonymous O 0 0.10408657789230347
microsatellite O 0 0.28065136075019836
marker O 0 0.1396162509918213
closely O 0 0.060972534120082855
linked O 0 0.10263774544000626
to O 0 0.0511145144701004
CT B-Disease 1 0.9982903599739075
. O 0 0.06269409507513046

However O 0 0.05790117010474205
, O 0 0.05252755433320999
BAC O 1 0.9761381149291992
clones O 0 0.15473785996437073
containing O 0 0.07112833112478256
ATP7B O 0 0.2551289498806
and O 0 0.036173708736896515
C04107 O 0 0.14029386639595032
mapped O 0 0.07511570304632187
to O 0 0.024786122143268585
the O 0 0.03258062154054642
canine O 1 0.7965401411056519
chromosome O 0 0.19197852909564972
regions O 0 0.07911869138479233
CFA22q11 O 0 0.2776167690753937
and O 0 0.02881646901369095
CFA10q26 O 0 0.19820240139961243
, O 0 0.023260753601789474
respectively O 0 0.03416666015982628
, O 0 0.021923966705799103
demonstrating O 0 0.05681046098470688
that O 0 0.03147485852241516
WD B-Disease 1 0.9991262555122375
cannot O 0 0.046175915747880936
be O 0 0.025744862854480743
homologous O 0 0.14000150561332703
to O 0 0.05131500959396362
CT B-Disease 1 0.9973727464675903
. O 0 0.06417714804410934

The O 0 0.053746290504932404
copper O 0 0.12070947140455246
transport O 0 0.08753271400928497
genes O 0 0.12932586669921875
CTR1 O 1 0.6032836437225342
and O 0 0.034778937697410583
CTR2 O 0 0.3168516457080841
were O 0 0.016647296026349068
also O 0 0.020114634186029434
excluded O 0 0.0519997701048851
as O 0 0.021284915506839752
candidate O 0 0.046229783445596695
genes O 0 0.07911015301942825
for O 0 0.03261112794280052
CT B-Disease 1 0.9977352619171143
since O 0 0.026183705776929855
they O 0 0.014844006858766079
both O 0 0.01641274429857731
mapped O 0 0.06469929218292236
to O 0 0.0394456684589386
canine O 1 0.620167076587677
chromosome O 0 0.22039403021335602
region O 0 0.10455171763896942
CFA11q22 O 1 0.6271742582321167
. O 0 0.06665528565645218

2 O 0 0.0941571444272995
- O 0 0.1195545569062233
22 O 0 0.06946474313735962
. O 0 0.052363839000463486

5 O 0 0.1001071184873581
. O 0 0.06224305182695389

A O 0 0.07793198525905609
transcribed O 0 0.09580123424530029
sequence O 0 0.06001658737659454
identified O 0 0.03763566166162491
from O 0 0.024089325219392776
the O 0 0.028855737298727036
C04107 O 0 0.21688322722911835
- O 0 0.1080983504652977
containing O 0 0.062068190425634384
BAC O 0 0.37557652592658997
was O 0 0.02529551088809967
found O 0 0.0207161083817482
to O 0 0.0133738461881876
be O 0 0.015014473348855972
homologous O 0 0.08435848355293274
to O 0 0.02061842381954193
a O 0 0.032354190945625305
gene O 0 0.08434900641441345
expressed O 0 0.03765261918306351
from O 0 0.02680215798318386
human O 0 0.057737577706575394
chromosome O 0 0.2735162079334259
2p13 O 1 0.8158230781555176
- O 0 0.17564712464809418
p16 O 0 0.4426332116127014
, O 0 0.030084585770964622
a O 0 0.03030581772327423
region O 0 0.04909723252058029
devoid O 0 0.061087824404239655
of O 0 0.01733713410794735
any O 0 0.026045383885502815
positional O 0 0.09845490753650665
candidate O 0 0.06421311944723129
genes O 0 0.1052989810705185
. O 0 0.05358954891562462

Molecular O 0 0.11990990489721298
analysis O 0 0.0438125804066658
of O 0 0.020136123523116112
the O 0 0.034489020705223083
APC B-Disease 1 0.5448824167251587
gene O 0 0.12371602654457092
in O 0 0.03789316490292549
205 O 0 0.12116099148988724
families O 0 0.061318278312683105
: O 0 0.054991643875837326
extended O 0 0.08575257658958435
genotype O 1 0.9803481698036194
- O 0 0.41587069630622864
phenotype O 1 0.8624694347381592
correlations O 0 0.1544865220785141
in O 0 0.04404420405626297
FAP B-Disease 1 0.9980399012565613
and O 0 0.02186097577214241
evidence O 0 0.02094169892370701
for O 0 0.012892273254692554
the O 0 0.01583324372768402
role O 0 0.03483269363641739
of O 0 0.028026405721902847
APC B-Disease 1 0.8629265427589417
amino O 0 0.14284779131412506
acid O 1 0.7747145891189575
changes O 0 0.07640263438224792
in O 0 0.10652700066566467
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
predisposition O 1 0.9997826218605042
. O 0 0.07256042212247849

BACKGROUND O 0 0.1616981029510498
/ O 0 0.33559027314186096
AIMS O 0 0.08569885045289993
The O 0 0.02715286612510681
development O 0 0.047353848814964294
of O 0 0.04430263862013817
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999978542327881
and O 0 0.027640661224722862
a O 0 0.03700029104948044
variable O 0 0.0899777039885521
range O 0 0.048313744366168976
of O 0 0.029222363606095314
extracolonic O 1 0.9571048617362976
manifestations O 1 0.9538620114326477
in O 0 0.06867305189371109
familial B-Disease 1 0.9999996423721313
adenomatous I-Disease 1 0.9999998807907104
polyposis I-Disease 1 1.0
( O 1 0.9414841532707214
FAP B-Disease 1 0.9999016523361206
) O 0 0.03999415785074234
is O 0 0.01646672934293747
the O 0 0.014635371044278145
result O 0 0.02791823260486126
of O 0 0.013103851117193699
the O 0 0.022727785632014275
dominant O 0 0.07792633771896362
inheritance O 0 0.2968163788318634
of O 0 0.08409995585680008
adenomatous B-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 0.9999947547912598
( O 0 0.21613413095474243
APC B-Disease 1 0.9934832453727722
) O 0 0.09340238571166992
gene O 0 0.18095041811466217
mutations O 0 0.21505118906497955
. O 0 0.06508993357419968

In O 0 0.03359704464673996
this O 0 0.02311161905527115
study O 0 0.03610101342201233
, O 0 0.02364291436970234
direct O 0 0.050137706100940704
mutation O 0 0.13567756116390228
analysis O 0 0.035910241305828094
of O 0 0.018236050382256508
the O 0 0.03261054679751396
APC B-Disease 1 0.672266960144043
gene O 0 0.10876636207103729
was O 0 0.03209396451711655
performed O 0 0.039742082357406616
to O 0 0.023636212572455406
determine O 0 0.06955751031637192
genotype O 1 0.9364309310913086
- O 0 0.1907721608877182
phenotype O 1 0.536796510219574
correlations O 0 0.12518945336341858
for O 0 0.02860332280397415
nine O 0 0.048249635845422745
extracolonic O 0 0.4006381034851074
manifestations O 0 0.10373005270957947
and O 0 0.016997002065181732
to O 0 0.017800146713852882
investigate O 0 0.04840783402323723
the O 0 0.030691951513290405
incidence O 1 0.8542908430099487
of O 0 0.03769369423389435
APC B-Disease 1 0.9858688116073608
mutations O 0 0.1958378106355667
in O 0 0.0404207780957222
non O 1 0.9512585401535034
- O 1 0.9999115467071533
FAP O 1 0.9999998807907104
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
. O 0 0.082701176404953

METHODS O 0 0.09555049240589142
The O 0 0.05257169529795647
APC B-Disease 0 0.4324520230293274
gene O 0 0.12446398288011551
was O 0 0.036002662032842636
analysed O 0 0.07554017752408981
in O 0 0.03075079433619976
190 O 0 0.09931119531393051
unrelated O 0 0.12391793727874756
FAP B-Disease 1 0.9993040561676025
and O 0 0.03904762864112854
15 O 0 0.0608799085021019
non O 1 0.9049729704856873
- O 1 0.999927282333374
FAP O 1 0.9999998807907104
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.9999501705169678
using O 0 0.08458993583917618
denaturing O 1 0.9934940934181213
gradient O 1 0.9106740951538086
gel O 1 0.9891729354858398
electrophoresis O 0 0.3652782142162323
, O 0 0.03502259775996208
the O 0 0.030308576300740242
protein O 0 0.09450314193964005
truncation O 0 0.14503616094589233
test O 0 0.05557289347052574
, O 0 0.02033248543739319
and O 0 0.01983644627034664
direct O 0 0.04285770282149315
sequencing O 0 0.0990968868136406
. O 0 0.04847664386034012

RESULTS O 0 0.12962569296360016
Chain O 0 0.14652138948440552
terminating O 0 0.15128719806671143
signals O 0 0.06531836092472076
were O 0 0.01689210720360279
only O 0 0.015470808371901512
identified O 0 0.030905338004231453
in O 0 0.022044677287340164
patients O 1 0.9514464139938354
belonging O 0 0.04386788606643677
to O 0 0.021582402288913727
the O 0 0.03457636386156082
FAP B-Disease 1 0.9997904896736145
group O 0 0.08458401262760162
( O 0 0.06858134269714355
105 O 0 0.1356176882982254
patients O 1 0.9967554211616516
) O 0 0.06181168928742409
. O 0 0.048809491097927094

Amino O 0 0.1728011965751648
acid O 0 0.16362623870372772
changes O 0 0.039641160517930984
were O 0 0.01833930052816868
identified O 0 0.0301077738404274
in O 0 0.01750553771853447
four O 0 0.02672591246664524
patients O 1 0.9600367546081543
, O 0 0.015399725176393986
three O 0 0.011755840852856636
of O 0 0.012655012309551239
whom O 0 0.029777295887470245
belonged O 0 0.03683411329984665
to O 0 0.016775798052549362
the O 0 0.02075360156595707
non O 0 0.07703184336423874
- O 1 0.9415635466575623
FAP O 1 0.9999467134475708
group O 0 0.1454632580280304
of O 0 0.09304669499397278
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.9999816417694092
. O 0 0.07128225266933441

Genotype O 1 0.9881122708320618
- O 1 0.8028634786605835
phenotype O 1 0.9303179383277893
correlations O 0 0.15009476244449615
identified O 0 0.05111461877822876
significant O 0 0.0282346960157156
differences O 0 0.026276802644133568
in O 0 0.014488961547613144
the O 0 0.01567489467561245
nature O 0 0.029864801093935966
of O 0 0.014657716266810894
certain O 0 0.03511287644505501
extracolonic O 1 0.9768937230110168
manifestations O 1 0.8740491271018982
in O 0 0.04439350962638855
FAP B-Disease 1 0.9999877214431763
patients O 1 0.9986408352851868
belonging O 0 0.05208481848239899
to O 0 0.02385307103395462
three O 0 0.03483914956450462
mutation O 0 0.1973235160112381
subgroups O 0 0.1582709550857544
. O 0 0.06818312406539917

CONCLUSIONS O 0 0.137246236205101
Extended O 0 0.12229900062084198
genotype O 1 0.9772927761077881
- O 0 0.32699620723724365
phenotype O 1 0.6753618717193604
correlations O 0 0.11327926814556122
made O 0 0.021155938506126404
in O 0 0.01570618711411953
this O 0 0.013876077719032764
study O 0 0.02747940830886364
may O 0 0.02161441743373871
have O 0 0.01237143948674202
the O 0 0.01358028408139944
potential O 0 0.02913842350244522
to O 0 0.011724947020411491
determine O 0 0.02559364214539528
the O 0 0.01653696782886982
most O 0 0.01944557949900627
appropriate O 0 0.0448848232626915
surveillance O 0 0.08071931451559067
and O 0 0.03451208025217056
prophylactic O 1 0.9997768998146057
treatment O 1 0.9999189376831055
regimens O 1 0.9995396137237549
for O 0 0.02667294815182686
those O 0 0.026726344600319862
patients O 1 0.9982491731643677
with O 0 0.0349765308201313
mutations O 0 0.15608881413936615
associated O 0 0.0420268289744854
with O 0 0.02453889511525631
life O 0 0.04803375527262688
threatening O 0 0.26679834723472595
conditions O 0 0.09896493703126907
. O 0 0.05615614727139473

This O 0 0.028279997408390045
study O 0 0.033480145037174225
also O 0 0.01795429177582264
provided O 0 0.024905476719141006
evidence O 0 0.020794888958334923
for O 0 0.014165070839226246
the O 0 0.019675301387906075
pathological O 0 0.11779315024614334
nature O 0 0.04304639622569084
of O 0 0.025995077565312386
amino O 0 0.09783944487571716
acid O 0 0.1456696093082428
changes O 0 0.0425565280020237
in O 0 0.02983688935637474
APC O 0 0.44143688678741455
associated O 0 0.03657737746834755
with O 0 0.02102414146065712
both O 0 0.029306627810001373
FAP B-Disease 1 0.9999414682388306
and O 0 0.03913688659667969
non O 1 0.9921994805335999
- O 1 0.9999828338623047
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.9999743700027466
. O 0 0.04162595048546791
. O 0 0.04462406039237976

Inherited B-Disease 1 0.9999693632125854
colorectal I-Disease 1 1.0
polyposis I-Disease 1 0.9999997615814209
and O 0 0.2603861689567566
cancer B-Disease 1 0.9999985694885254
risk O 1 0.6652027368545532
of O 0 0.023841261863708496
the O 0 0.04211742430925369
APC O 1 0.9749787449836731
I1307K O 0 0.3204050362110138
polymorphism O 0 0.19696566462516785
. O 0 0.06817812472581863

Germ O 1 0.9984800219535828
- O 0 0.14035284519195557
line O 0 0.05779826268553734
and O 0 0.03748708963394165
somatic O 0 0.22421014308929443
truncating O 0 0.31480100750923157
mutations O 0 0.1529374122619629
of O 0 0.027624517679214478
the O 0 0.03749939799308777
APC B-Disease 1 0.7782338261604309
gene O 0 0.11069145053625107
are O 0 0.022630896419286728
thought O 0 0.041613709181547165
to O 0 0.03461448848247528
initiate O 1 0.9679633975028992
colorectal B-Disease 1 0.9999998807907104
tumor I-Disease 1 0.9999849796295166
formation O 1 0.971318781375885
in O 0 0.29789379239082336
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 0.22522088885307312
sporadic O 1 0.9990566372871399
colorectal O 1 0.9999998807907104
carcinogenesis O 1 0.999717652797699
, O 0 0.044230952858924866
respectively O 0 0.05797295644879341
. O 0 0.054360806941986084

Recently O 0 0.07885824143886566
, O 0 0.03267376869916916
an O 0 0.04387413710355759
isoleucine O 1 0.9683093428611755
- O 1 0.9194672703742981
- O 1 0.6085365414619446
> O 1 0.5750580430030823
lysine O 0 0.2784091532230377
polymorphism O 0 0.20574110746383667
at O 0 0.08922447264194489
codon O 0 0.22516459226608276
1307 O 1 0.5568258166313171
( O 0 0.07223851978778839
I1307K O 0 0.14259757101535797
) O 0 0.03045670874416828
of O 0 0.016461249440908432
the O 0 0.02970339171588421
APC B-Disease 1 0.5922784209251404
gene O 0 0.10246140509843826
has O 0 0.023591088131070137
been O 0 0.018616482615470886
identified O 0 0.03127983585000038
in O 0 0.0204705148935318
6 O 0 0.0415755957365036
% O 0 0.041689757257699966
- O 0 0.07421214878559113
7 O 0 0.036748386919498444
% O 0 0.027695491909980774
of O 0 0.01439397968351841
the O 0 0.024747829884290695
Ashkenazi O 0 0.14135180413722992
Jewish O 0 0.06745953112840652
population O 0 0.05736736208200455
. O 0 0.04984156787395477

To O 0 0.03611496835947037
assess O 0 0.08735771477222443
the O 0 0.028880827128887177
risk O 0 0.0725136399269104
of O 0 0.01824611984193325
this O 0 0.02427651360630989
common O 0 0.07021597027778625
APC B-Disease 1 0.9942811727523804
allelic O 1 0.980138897895813
variant O 1 0.7493218183517456
in O 0 0.07509773224592209
colorectal O 1 0.9999990463256836
carcinogenesis O 1 0.9993966817855835
, O 0 0.030258137732744217
we O 0 0.01787845604121685
have O 0 0.016316508874297142
analyzed O 0 0.04118978604674339
a O 0 0.027254343032836914
large O 0 0.03879379853606224
cohort O 0 0.1591833233833313
of O 0 0.04011906310915947
unselected O 0 0.22390569746494293
Ashkenazi O 0 0.1845688670873642
Jewish O 0 0.07714907824993134
subjects O 0 0.06691128760576248
with O 0 0.059999845921993256
adenomatous B-Disease 1 0.9999991655349731
polyps I-Disease 1 0.9999021291732788
and O 0 0.03514859452843666
. O 0 0.03206649422645569
or O 1 0.8863892555236816
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.999998927116394
, I-Disease 0 0.03266008198261261
for O 0 0.02301015518605709
the O 0 0.036639560014009476
APC O 1 0.9225241541862488
I1307K O 0 0.3605816960334778
polymorphism O 0 0.20305006206035614
. O 0 0.06086001172661781

The O 0 0.07538265734910965
APC O 1 0.6995019912719727
I1307K O 0 0.2479458451271057
allele O 0 0.1845039427280426
was O 0 0.03650977835059166
identified O 0 0.039754774421453476
in O 0 0.01974254846572876
48 O 0 0.04885576292872429
( O 0 0.03302626311779022
10 O 0 0.024329980835318565
. O 0 0.01773790456354618
1 O 0 0.032417181879282
% O 0 0.03485994040966034
) O 0 0.03144116327166557
of O 0 0.029537439346313477
476 O 1 0.9580047726631165
patients O 1 0.9983817338943481
. O 0 0.059723932296037674

Compared O 0 0.06181689351797104
with O 0 0.021126581355929375
the O 0 0.019296759739518166
frequency O 0 0.04538671672344208
in O 0 0.014389989897608757
two O 0 0.013591178692877293
separate O 0 0.027414528653025627
population O 0 0.03465878218412399
control O 0 0.047856997698545456
groups O 0 0.03356332331895828
, O 0 0.021651796996593475
the O 0 0.030849765986204147
APC O 1 0.9388163089752197
I1307K O 0 0.24226133525371552
allele O 0 0.16796503961086273
is O 0 0.02945881336927414
associated O 0 0.029460955411195755
with O 0 0.017973218113183975
an O 0 0.021422185003757477
estimated O 0 0.047992054373025894
relative O 0 0.06470149010419846
risk O 0 0.09654352813959122
of O 0 0.023760002106428146
1 O 0 0.05018105357885361
. O 0 0.046446774154901505

5 O 0 0.09052547067403793
- O 0 0.12335943430662155
1 O 0 0.06418222934007645
. O 0 0.05166533216834068

7 O 0 0.1073313057422638
for O 0 0.06880222260951996
colorectal B-Disease 1 0.9999983310699463
neoplasia I-Disease 1 0.9998824596405029
( O 0 0.07496245950460434
both O 0 0.045091357082128525
P O 1 0.9413093328475952
= O 0 0.1629382073879242
. O 0 0.0413808599114418
01 O 1 0.6911094784736633
) O 0 0.05573168024420738
. O 0 0.04619885981082916

Furthermore O 0 0.09194333106279373
, O 0 0.033748507499694824
compared O 0 0.04921872168779373
with O 0 0.03468969836831093
noncarriers O 0 0.31750187277793884
, O 0 0.0448642261326313
APC O 1 0.9695608019828796
I1307K O 0 0.39239755272865295
carriers O 0 0.11407464742660522
had O 0 0.03315194323658943
increased O 0 0.041312601417303085
numbers O 0 0.02918790467083454
of O 0 0.030515411868691444
adenomas B-Disease 1 0.9998883008956909
and O 0 0.07328467816114426
colorectal B-Disease 1 0.9999997615814209
cancers I-Disease 1 0.9999731779098511
per O 0 0.0914737805724144
patient O 1 0.9992600083351135
( O 0 0.11171469837427139
P O 1 0.9920604228973389
= O 0 0.16103506088256836
. O 0 0.03284900262951851
03 O 0 0.39752450585365295
) O 0 0.030036134645342827
, O 0 0.014283410273492336
as O 0 0.012394974939525127
well O 0 0.015169389545917511
as O 0 0.015626292675733566
a O 0 0.027845265343785286
younger O 0 0.060547780245542526
age O 0 0.050053223967552185
at O 0 0.05420300364494324
diagnosis O 1 0.9993731379508972
. O 0 0.05257050693035126

We O 0 0.0401773639023304
conclude O 0 0.07471350580453873
that O 0 0.022633761167526245
the O 0 0.035447943955659866
APC O 1 0.9281054735183716
I1307K O 0 0.2928023636341095
variant O 0 0.1723349541425705
leads O 0 0.09186993539333344
to O 0 0.0360151082277298
increased O 0 0.087881900370121
adenoma B-Disease 1 0.9999873638153076
formation O 0 0.10236050933599472
and O 0 0.023161964491009712
directly O 0 0.033057570457458496
contributes O 0 0.0745605081319809
to O 0 0.023351281881332397
3 O 0 0.04310112074017525
% O 0 0.04131188243627548
- O 0 0.06672307103872299
4 O 0 0.03532913699746132
% O 0 0.02699885331094265
of O 0 0.015535164624452591
all O 0 0.02563646249473095
Ashkenazi O 1 0.9639768004417419
Jewish O 1 0.9484712481498718
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999991655349731
. O 0 0.07980640977621078

The O 0 0.041116975247859955
estimated O 0 0.06314640492200851
relative O 0 0.06945771723985672
risk O 0 0.11872637271881104
for O 0 0.025607643648982048
carriers O 0 0.11017844825983047
may O 0 0.045779041945934296
justify O 0 0.07077678292989731
specific O 0 0.04198600351810455
clinical O 0 0.40984511375427246
screening O 0 0.08205591142177582
for O 0 0.017160311341285706
the O 0 0.019164307042956352
360 O 0 0.062237393110990524
, O 0 0.02208421193063259
000 O 0 0.05612896382808685
Americans O 0 0.03833935782313347
expected O 0 0.025359516963362694
to O 0 0.02038121037185192
harbor O 0 0.06745463609695435
this O 0 0.02303481660783291
allele O 0 0.11753822863101959
, O 0 0.023258978500962257
and O 0 0.020033039152622223
genetic O 0 0.06837107986211777
testing O 0 0.049497831612825394
in O 0 0.014784677885472775
the O 0 0.015320532955229282
setting O 0 0.03158368915319443
of O 0 0.01984810270369053
long O 0 0.05419033020734787
- O 0 0.10329391807317734
term O 0 0.06396087259054184
- O 0 0.09964992851018906
outcome O 0 0.06619279086589813
studies O 0 0.055802762508392334
may O 0 0.04663481563329697
impact O 0 0.06502784043550491
significantly O 0 0.08212362229824066
on O 0 0.05578344315290451
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 1 0.999017596244812
in O 0 0.023282069712877274
this O 0 0.021274399012327194
population O 0 0.0431760773062706
. O 0 0.04313644766807556

Localization O 0 0.1526065319776535
of O 0 0.03491661325097084
human O 0 0.05577874556183815
BRCA1 O 1 0.6774270534515381
and O 0 0.022044317796826363
its O 0 0.02153358981013298
loss O 0 0.0520181879401207
in O 0 0.02213522046804428
high O 0 0.04936534911394119
- O 0 0.09379928559064865
grade O 0 0.07253202795982361
, O 0 0.03583063185214996
non B-Disease 0 0.09603574126958847
- I-Disease 1 0.9880319833755493
inherited I-Disease 1 0.999171257019043
breast I-Disease 1 0.9999959468841553
carcinomas I-Disease 1 0.9999552965164185
. O 0 0.08933692425489426

Although O 0 0.033334992825984955
the O 0 0.026348121464252472
link O 0 0.06903024017810822
between O 0 0.03343726694583893
the O 0 0.0549665130674839
BRCA1 O 1 0.9999505281448364
tumour B-Disease 1 0.9999994039535522
- O 1 0.9949555993080139
suppressor O 1 0.9929760694503784
gene O 0 0.17360132932662964
and O 0 0.04819944500923157
hereditary B-Disease 1 0.9998763799667358
breast I-Disease 1 0.9999994039535522
and I-Disease 1 0.8800650835037231
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999988079071045
is O 0 0.030306490138173103
established O 0 0.02599504590034485
, O 0 0.015123353339731693
the O 0 0.01485875528305769
role O 0 0.027371421456336975
, O 0 0.01700798235833645
if O 0 0.017576126381754875
any O 0 0.013772353529930115
, O 0 0.014409893192350864
of O 0 0.018047338351607323
BRCA1 O 1 0.9669509530067444
in O 0 0.03467373177409172
non B-Disease 0 0.12681740522384644
- I-Disease 1 0.9910684823989868
familial I-Disease 1 0.9999450445175171
cancers I-Disease 1 0.9999449253082275
is O 0 0.04446590319275856
unclear O 0 0.06661371141672134
. O 0 0.050605013966560364

BRCA1 O 1 0.9965701103210449
mutations O 0 0.24644865095615387
are O 0 0.029874024912714958
rare O 0 0.06511099636554718
in O 0 0.03193337470293045
sporadic B-Disease 1 0.6548649668693542
cancers I-Disease 1 0.9997628331184387
, O 0 0.02717607468366623
but O 0 0.023594364523887634
loss O 0 0.07156150788068771
of O 0 0.03151248022913933
BRCA1 O 1 0.9909648895263672
resulting O 0 0.08727914094924927
from O 0 0.03350461274385452
reduced O 0 0.06806789338588715
expression O 0 0.06912738084793091
or O 0 0.04256460443139076
incorrect O 0 0.08822440356016159
subcellular O 0 0.14050747454166412
localization O 0 0.09679865837097168
is O 0 0.02554243989288807
postulated O 0 0.06080860272049904
to O 0 0.013758382759988308
be O 0 0.012206228449940681
important O 0 0.01553565263748169
in O 0 0.02205628715455532
non B-Disease 0 0.1077985092997551
- I-Disease 1 0.997094988822937
familial I-Disease 1 0.9999957084655762
breast I-Disease 1 0.9999997615814209
and I-Disease 1 0.9292299747467041
ovarian I-Disease 1 1.0
cancers I-Disease 1 0.9999988079071045
. O 0 0.07572925835847855

Epigenetic O 1 0.5709133148193359
loss O 0 0.10256753861904144
, O 0 0.024057509377598763
however O 0 0.020468197762966156
, O 0 0.01589767448604107
has O 0 0.015944503247737885
not O 0 0.0115603506565094
received O 0 0.025854647159576416
general O 0 0.025749050080776215
acceptance O 0 0.057529665529727936
due O 0 0.029678788036108017
to O 0 0.01715969294309616
controversy O 0 0.04495925456285477
regarding O 0 0.0314786434173584
the O 0 0.026374008506536484
subcellular O 0 0.12798069417476654
localization O 0 0.10634804517030716
of O 0 0.03409045189619064
BRCA1 O 1 0.9358195662498474
proteins O 0 0.0753333568572998
, O 0 0.021172385662794113
reports O 0 0.023273751139640808
of O 0 0.012150267139077187
which O 0 0.01479863841086626
have O 0 0.015550038777291775
ranged O 0 0.049427565187215805
from O 0 0.01630469597876072
exclusively O 0 0.028020581230521202
nuclear O 0 0.039128001779317856
, O 0 0.01678508147597313
to O 0 0.019451260566711426
conditionally O 0 0.08954884856939316
nuclear O 0 0.044655270874500275
, O 0 0.019655317068099976
to O 0 0.020838186144828796
the O 0 0.0356338694691658
ER O 1 0.9990231990814209
/ O 1 0.91350257396698
golgi O 0 0.38738247752189636
, O 0 0.03227962553501129
to O 0 0.03102785535156727
cytoplasmic O 0 0.14513081312179565
invaginations O 0 0.15205363929271698
into O 0 0.03048316389322281
the O 0 0.031810492277145386
nucleus O 0 0.13574787974357605
. O 0 0.05480976402759552

In O 0 0.02800459787249565
an O 0 0.021307198330760002
attempt O 0 0.03891843557357788
to O 0 0.018550565466284752
resolve O 0 0.04778517782688141
this O 0 0.01501249149441719
issue O 0 0.022280042991042137
, O 0 0.017792662605643272
we O 0 0.016552191227674484
have O 0 0.018931785598397255
comprehensively O 0 0.09005799144506454
characterized O 0 0.11566231399774551
19 O 0 0.07446735352277756
anti O 0 0.21867811679840088
- O 1 0.820494532585144
BRCA1 O 1 0.9951083064079285
antibodies O 1 0.8055626749992371
. O 0 0.08027239143848419

These O 0 0.05478836968541145
reagents O 0 0.17764753103256226
detect O 0 0.12975452840328217
a O 0 0.05036491900682449
220 O 0 0.1212121769785881
- O 0 0.17764082551002502
kD O 1 0.8072912096977234
protein O 0 0.13520467281341553
localized O 0 0.13795502483844757
in O 0 0.0334346704185009
discrete O 0 0.08636263012886047
nuclear O 0 0.07636198401451111
foci O 0 0.1619163602590561
in O 0 0.027067383751273155
all O 0 0.025860324501991272
epithelial O 1 0.9806877374649048
cell O 0 0.10392851382493973
lines O 0 0.04044202342629433
, O 0 0.01731816492974758
including O 0 0.01649884320795536
those O 0 0.022087618708610535
derived O 0 0.052592337131500244
from O 0 0.0525197759270668
breast B-Disease 1 0.9999696016311646
malignancies I-Disease 1 0.9987586736679077
. O 0 0.06729398667812347

Immunohistochemical O 1 0.969670295715332
staining O 1 0.5169603824615479
of O 0 0.039693303406238556
human O 0 0.07459240406751633
breast O 1 0.9997095465660095
specimens O 0 0.07770011574029922
also O 0 0.03581921011209488
revealed O 0 0.08373678475618362
BRCA1 O 1 0.9935639500617981
nuclear O 0 0.11272413283586502
foci O 1 0.8324517607688904
in O 0 0.061005979776382446
benign O 1 0.9999692440032959
breast O 1 0.9999964237213135
, O 0 0.08381544053554535
invasive B-Disease 1 0.9999247789382935
lobular I-Disease 1 0.9999994039535522
cancers I-Disease 1 0.9999731779098511
and O 0 0.04633151367306709
low B-Disease 0 0.4075120687484741
- I-Disease 1 0.9253144264221191
grade I-Disease 1 0.7662355899810791
ductal I-Disease 1 0.9999781847000122
carcinomas I-Disease 1 0.9999068975448608
. O 0 0.09276391565799713

Conversely O 0 0.19151292741298676
, O 0 0.059724804013967514
BRCA1 O 1 0.9322851896286011
expression O 0 0.08313465863466263
was O 0 0.030744699761271477
reduced O 0 0.0540628619492054
or O 0 0.03773223236203194
undetectable O 0 0.18014854192733765
in O 0 0.017364708706736565
the O 0 0.016195325180888176
majority O 0 0.02848910540342331
of O 0 0.01928960345685482
high O 0 0.054188523441553116
- O 0 0.12248612940311432
grade O 0 0.1063627079129219
, O 0 0.06122301146388054
ductal B-Disease 1 0.9999922513961792
carcinomas I-Disease 1 0.9999661445617676
, O 0 0.03876635432243347
suggesting O 0 0.05843145772814751
that O 0 0.02037317119538784
absence O 0 0.05255836993455887
of O 0 0.028345197439193726
BRCA1 O 1 0.9920786023139954
may O 0 0.04677892476320267
contribute O 0 0.048359259963035583
to O 0 0.016056854277849197
the O 0 0.022801777347922325
pathogenesis O 1 0.8310723304748535
of O 0 0.018413901329040527
a O 0 0.028717435896396637
significant O 0 0.03534461557865143
percentage O 0 0.04980608820915222
of O 0 0.030251648277044296
sporadic B-Disease 1 0.9709534049034119
breast I-Disease 1 0.9999961853027344
cancers I-Disease 1 0.9999397993087769
. O 0 0.04373510181903839
. O 0 0.04453493654727936

